Citrus Sinensis ID: 020652
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 323 | 2.2.26 [Sep-21-2011] | |||||||
| P51566 | 467 | Serine/threonine-protein | yes | no | 0.990 | 0.685 | 0.8 | 1e-154 | |
| P51567 | 427 | Serine/threonine-protein | no | no | 0.978 | 0.740 | 0.680 | 1e-131 | |
| P51568 | 400 | Serine/threonine-protein | no | no | 0.888 | 0.717 | 0.619 | 1e-107 | |
| Q10156 | 690 | Dual specificity protein | yes | no | 0.699 | 0.327 | 0.510 | 3e-67 | |
| P49762 | 832 | Serine/threonine-protein | no | no | 0.705 | 0.274 | 0.506 | 5e-67 | |
| O35493 | 481 | Dual specificity protein | yes | no | 0.702 | 0.471 | 0.502 | 2e-63 | |
| Q9HAZ1 | 481 | Dual specificity protein | yes | no | 0.702 | 0.471 | 0.497 | 4e-63 | |
| O35491 | 499 | Dual specificity protein | no | no | 0.702 | 0.454 | 0.485 | 6e-63 | |
| P49760 | 499 | Dual specificity protein | no | no | 0.702 | 0.454 | 0.485 | 8e-63 | |
| P22518 | 483 | Dual specificity protein | no | no | 0.702 | 0.469 | 0.489 | 3e-60 |
| >sp|P51566|AFC1_ARATH Serine/threonine-protein kinase AFC1 OS=Arabidopsis thaliana GN=AFC1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 544 bits (1402), Expect = e-154, Method: Compositional matrix adjust.
Identities = 260/325 (80%), Positives = 290/325 (89%), Gaps = 5/325 (1%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVL-----PALYCVQEFGNGGMPNY 55
+ETQR +EFPH+ +DKRPRKRPRLTWD PPL PP P LY EF +G +PN+
Sbjct: 17 LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76
Query: 56 ACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE 115
+MFY +PR GSPPWRPDDKDGHYVF +G+ LTPRY+ILSKMGEGTFGQV+ECFDN+
Sbjct: 77 VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTFGQVLECFDNK 136
Query: 116 KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175
KE+VAIK++RSINKYREAAMIEIDVLQRL RHD+GG+RCVQIRNWFDYRNHICIVFEKL
Sbjct: 137 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 196
Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA+MH+LRLIHTDLKPENILLVS+EY+K+
Sbjct: 197 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 256
Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
PDYKFLSR +KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+Y+VSTRHYRAPEVILG+GW
Sbjct: 257 PDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYRAPEVILGVGW 316
Query: 296 NYPCDLWSVGCILVELCSVSNCYLT 320
NYPCDLWS+GCILVELCS + T
Sbjct: 317 NYPCDLWSIGCILVELCSGEALFQT 341
|
Activator of yeast transcription factor, STE12. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 1 |
| >sp|P51567|AFC2_ARATH Serine/threonine-protein kinase AFC2 OS=Arabidopsis thaliana GN=AFC2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 468 bits (1204), Expect = e-131, Method: Compositional matrix adjust.
Identities = 222/326 (68%), Positives = 266/326 (81%), Gaps = 10/326 (3%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGN------GGMPN 54
ME +R+ EFPH +MD+RPRKR RL WDV P +V ++C QE GN G P+
Sbjct: 1 MEMERVHEFPHTHMDRRPRKRARLGWDVLPQATKAQV--GMFCGQEIGNISSFASSGAPS 58
Query: 55 YACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDN 114
SS+ + R GSPPWR DDKDGHY+F +G++LTPRY+I SKMGEGTFGQV+EC+D
Sbjct: 59 DNSSSLCVKGVARNGSPPWREDDKDGHYIFELGDDLTPRYKIYSKMGEGTFGQVLECWDR 118
Query: 115 EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174
E+KE+VA+KIVR + KYREAAMIEI++LQ+L +HD GG RCVQIRNWFDYRNHICIVFEK
Sbjct: 119 ERKEMVAVKIVRGVKKYREAAMIEIEMLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEK 178
Query: 175 LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234
LG SLYDFLRKN+YRSFPIDLVRE+G QLLE VAFMH+LR+IHTDLKPENILLVS++YVK
Sbjct: 179 LGSSLYDFLRKNNYRSFPIDLVREIGWQLLECVAFMHDLRMIHTDLKPENILLVSSDYVK 238
Query: 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG 294
+P+YK SR +D Y K +PKSSAIK+IDFGSTT+E QD +Y+VSTRHYRAPEVILGLG
Sbjct: 239 IPEYKG-SRLQRDVCY-KRVPKSSAIKVIDFGSTTYERQDQTYIVSTRHYRAPEVILGLG 296
Query: 295 WNYPCDLWSVGCILVELCSVSNCYLT 320
W+YPCD+WSVGCI+VELC+ + T
Sbjct: 297 WSYPCDVWSVGCIIVELCTGEALFQT 322
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P51568|AFC3_ARATH Serine/threonine-protein kinase AFC3 OS=Arabidopsis thaliana GN=AFC3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 388 bits (997), Expect = e-107, Method: Compositional matrix adjust.
Identities = 192/310 (61%), Positives = 238/310 (76%), Gaps = 23/310 (7%)
Query: 12 KNMDK-RPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGS 70
++MDK R RKRPR+TWD P P K ++ G+ G R S
Sbjct: 7 ESMDKERVRKRPRMTWDEAPAEPEAKRA----VIKGHGSDG---------------RILS 47
Query: 71 PPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK 130
PP R DD+DGHYVF++ +NLTPRY+ILSKMGEGTFG+V+EC+D + KE VAIKI+RSI K
Sbjct: 48 PPLRDDDRDGHYVFSLRDNLTPRYKILSKMGEGTFGRVLECWDRDTKEYVAIKIIRSIKK 107
Query: 131 YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRS 190
YR+AAMIEIDVLQ+L + D G TRCVQ++NWFDYRNHICIVFEKLGPSL+DFL++N Y +
Sbjct: 108 YRDAAMIEIDVLQKLVKSDKGRTRCVQMKNWFDYRNHICIVFEKLGPSLFDFLKRNKYSA 167
Query: 191 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250
FP+ LVR+ G QLLESVA+MHEL+L+HTDLKPENILLVS+E VK+PD K RS+ + ++
Sbjct: 168 FPLALVRDFGCQLLESVAYMHELQLVHTDLKPENILLVSSENVKLPDNK---RSAANETH 224
Query: 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
F+ LPKSSAIKLIDFGST +++ H +V TRHYR+PEVILGLGW+Y CDLWS+GCIL E
Sbjct: 225 FRCLPKSSAIKLIDFGSTVCDNRIHHSIVQTRHYRSPEVILGLGWSYQCDLWSIGCILFE 284
Query: 311 LCSVSNCYLT 320
LC+ + T
Sbjct: 285 LCTGEALFQT 294
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q10156|LKH1_SCHPO Dual specificity protein kinase lkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=lkh1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 255 bits (652), Expect = 3e-67, Method: Compositional matrix adjust.
Identities = 122/239 (51%), Positives = 167/239 (69%), Gaps = 13/239 (5%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD DGHY RY ++ +G GTFG+V++C+D AIK+ R+I KYREA+
Sbjct: 344 DDDDGHYKVVPNSKFANRYTVVRLLGHGTFGKVIQCYDQSTGRHCAIKVTRAIPKYREAS 403
Query: 136 MIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
+IE+ VLQ +A D +C+Q+R++FDYR HICIV + G S++DFL+ N+Y FP+
Sbjct: 404 LIELRVLQTIAHSDPTNENKCIQLRDYFDYRKHICIVTDLFGWSVFDFLKNNNYIPFPLK 463
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVS--AEYVKVPDYKFLSRSSKDGSYFK 252
++ L +QL +SVAF+H L L+HTDLKPEN+LLVS + +++P Y+ +Y +
Sbjct: 464 HIQMLSQQLFKSVAFLHSLGLVHTDLKPENVLLVSNASRTIRLP-YR---------NYSQ 513
Query: 253 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ S I+LIDFGS TFE + HS VVSTRHYRAPE+ILGLGW+YPCD+WS+GCILVEL
Sbjct: 514 KVLNSCEIRLIDFGSATFEDEYHSSVVSTRHYRAPEIILGLGWSYPCDVWSIGCILVEL 572
|
Protein kinase that may act as a negative regulator of filamentous growth and flocculation. Appears to have a role in normal cell wall and septum formation and in cell seperation. May have antagonistic function in the regulation of beta-glucan distribution between the sites for cell wall and septum assembly. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49762|DOA_DROME Serine/threonine-protein kinase Doa OS=Drosophila melanogaster GN=Doa PE=1 SV=2 | Back alignment and function description |
|---|
Score = 254 bits (650), Expect = 5e-67, Method: Compositional matrix adjust.
Identities = 120/237 (50%), Positives = 172/237 (72%), Gaps = 9/237 (3%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD DGH ++ G+ L RY+I++ +GEGTFG+VV+ D E+ +A+KI++++ KYREAA
Sbjct: 461 DDADGHLIYHTGDILHHRYKIMATLGEGTFGRVVKVKDMERDYCMALKIIKNVEKYREAA 520
Query: 136 MIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
+EI+ L+++A+ D CV++ +WFDY H+CIVFE LG S++DFLR+N+Y +P+D
Sbjct: 521 KLEINALEKIAQKDPHCDHLCVKMIDWFDYHGHMCIVFEMLGLSVFDFLRENNYEPYPLD 580
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
VR + QL SV F+H+ RL HTDLKPENIL V ++Y ++K ++R +
Sbjct: 581 QVRHMAYQLCYSVKFLHDNRLTHTDLKPENILFVDSDYTSHYNHK-INREVRRV------ 633
Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
K++ ++LIDFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL EL
Sbjct: 634 -KNTDVRLIDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCILFEL 689
|
Negative regulator of the copia retrotransposon element of the white (w) gene. In the eye, it is required for normal pigmentation, photoreceptor cell development and for organization of interommatidial bristles. Also essential for embryonic segmentation and differentiation of the nervous system. Functions in the control of alternative splicing by phosphorylating the argine/serine-rich splicing factors, SR proteins. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|O35493|CLK4_MOUSE Dual specificity protein kinase CLK4 OS=Mus musculus GN=Clk4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 242 bits (618), Expect = 2e-63, Method: Compositional matrix adjust.
Identities = 119/237 (50%), Positives = 164/237 (69%), Gaps = 10/237 (4%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD++GH + G+ L RY I+ +GEG FG+VVEC D+ L VA+KIV+++ +YREA
Sbjct: 141 DDEEGHLICQSGDVLRARYEIVDTLGEGAFGKVVECIDHGMDGLHVAVKIVKNVGRYREA 200
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A EI VL+ L D RCVQ+ WFD+ H+CIVFE LG S YDF+++NS+ F I
Sbjct: 201 ARSEIQVLEHLNSTDPNSVFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQI 260
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
D +R++ Q+ +S+ F+H +L HTDLKPENIL V ++YV K+ S+ +D KN
Sbjct: 261 DHIRQMAYQICQSINFLHHNKLTHTDLKPENILFVKSDYV----VKYNSKMKRDERTLKN 316
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
+ IK++DFGS T++ + HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E
Sbjct: 317 ----TDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 369
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3. Required for the regulation of alternative splicing of MAPT/TAU. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|Q9HAZ1|CLK4_HUMAN Dual specificity protein kinase CLK4 OS=Homo sapiens GN=CLK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 241 bits (616), Expect = 4e-63, Method: Compositional matrix adjust.
Identities = 118/237 (49%), Positives = 164/237 (69%), Gaps = 10/237 (4%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD++GH + G+ L RY I+ +GEG FG+VVEC D+ + VA+KIV+++ +YREA
Sbjct: 141 DDEEGHLICQSGDVLRARYEIVDTLGEGAFGKVVECIDHGMDGMHVAVKIVKNVGRYREA 200
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A EI VL+ L D RCVQ+ WFD+ H+CIVFE LG S YDF+++NS+ F I
Sbjct: 201 ARSEIQVLEHLNSTDPNSVFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQI 260
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
D +R++ Q+ +S+ F+H +L HTDLKPENIL V ++YV K+ S+ +D KN
Sbjct: 261 DHIRQMAYQICQSINFLHHNKLTHTDLKPENILFVKSDYV----VKYNSKMKRDERTLKN 316
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
+ IK++DFGS T++ + HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E
Sbjct: 317 ----TDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 369
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates SRSF1 and SRSF3. Required for the regulation of alternative splicing of MAPT/TAU. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|O35491|CLK2_MOUSE Dual specificity protein kinase CLK2 OS=Mus musculus GN=Clk2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 241 bits (614), Expect = 6e-63, Method: Compositional matrix adjust.
Identities = 115/237 (48%), Positives = 168/237 (70%), Gaps = 10/237 (4%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKYREA 134
DD +GH ++ +G+ L RY I+S +GEGTFG+VV+C D+ + VA+KI++++ KY+EA
Sbjct: 144 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGTQVALKIIKNVEKYKEA 203
Query: 135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A +EI+VL+++ D CVQ+ +WFDY H+CI FE LG S +DFL+ N+Y +PI
Sbjct: 204 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 263
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
VR + QL ++V F+H+ +L HTDLKPENIL V+++Y + L + + S
Sbjct: 264 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYN---LEKKRDERS---- 316
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 317 -VKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFE 372
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P49760|CLK2_HUMAN Dual specificity protein kinase CLK2 OS=Homo sapiens GN=CLK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 241 bits (614), Expect = 8e-63, Method: Compositional matrix adjust.
Identities = 115/237 (48%), Positives = 168/237 (70%), Gaps = 10/237 (4%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKYREA 134
DD +GH ++ +G+ L RY I+S +GEGTFG+VV+C D+ + VA+KI++++ KY+EA
Sbjct: 145 DDAEGHLIYHVGDWLQERYEIVSTLGEGTFGRVVQCVDHRRGGARVALKIIKNVEKYKEA 204
Query: 135 AMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A +EI+VL+++ D CVQ+ +WFDY H+CI FE LG S +DFL+ N+Y +PI
Sbjct: 205 ARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKDNNYLPYPI 264
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
VR + QL ++V F+H+ +L HTDLKPENIL V+++Y + L + + S
Sbjct: 265 HQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYN---LEKKRDERS---- 317
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
KS+A++++DFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCI+ E
Sbjct: 318 -VKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCIIFE 373
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex. May be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing and can cause redistribution of SR proteins from speckles to a diffuse nucleoplasmic distribution. Acts as a suppressor of hepatic gluconeogenesis and glucose output by repressing PPARGC1A transcriptional activity on gluconeogenic genes via its phosphorylation. Phosphorylates PPP2R5B thereby stimulating the assembly of PP2A phosphatase with the PPP2R5B-AKT1 complex leading to dephosphorylation of AKT1. Phosphorylates: PTPN1, SRSF1 and SRSF3. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
| >sp|P22518|CLK1_MOUSE Dual specificity protein kinase CLK1 OS=Mus musculus GN=Clk1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 232 bits (591), Expect = 3e-60, Method: Compositional matrix adjust.
Identities = 116/237 (48%), Positives = 163/237 (68%), Gaps = 10/237 (4%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSINKYREA 134
DD++GH + G+ L+ RY I+ +GEG FG+VVEC D++ VA+KIV+++++Y EA
Sbjct: 142 DDEEGHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKVGGRRVAVKIVKNVDRYCEA 201
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A EI VL+ L D T RCVQ+ WF++R HICIVFE LG S YDF+++NS+ F +
Sbjct: 202 AQSEIQVLEHLNTTDPHSTFRCVQMLEWFEHRGHICIVFELLGLSTYDFIKENSFLPFRM 261
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
D +R++ Q+ +SV F+H +L HTDLKPENIL V ++Y + + K +D N
Sbjct: 262 DHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVKSDYTEAYNPKM----KRDERTIVN 317
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
IK++DFGS T++ + HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E
Sbjct: 318 ----PDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 370
|
Dual specificity kinase acting on both serine/threonine and tyrosine-containing substrates. Phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex and may be a constituent of a network of regulatory mechanisms that enable SR proteins to control RNA splicing. Phosphorylates: SRSF1, SRSF3 and PTPN1. Regulates the alternative splicing of tissue factor (F3) pre-mRNA in endothelial cells and adenovirus E1A pre-mRNA. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 323 | ||||||
| 224138498 | 433 | predicted protein [Populus trichocarpa] | 0.972 | 0.725 | 0.861 | 1e-160 | |
| 147800314 | 448 | hypothetical protein VITISV_001943 [Viti | 0.978 | 0.705 | 0.868 | 1e-158 | |
| 225439856 | 429 | PREDICTED: serine/threonine-protein kina | 0.978 | 0.736 | 0.868 | 1e-158 | |
| 449439982 | 428 | PREDICTED: serine/threonine-protein kina | 0.990 | 0.747 | 0.865 | 1e-156 | |
| 449439980 | 433 | PREDICTED: serine/threonine-protein kina | 0.990 | 0.739 | 0.865 | 1e-156 | |
| 356505140 | 427 | PREDICTED: serine/threonine-protein kina | 0.969 | 0.733 | 0.821 | 1e-156 | |
| 255584557 | 391 | afc, putative [Ricinus communis] gi|2235 | 0.987 | 0.815 | 0.816 | 1e-155 | |
| 356505138 | 444 | PREDICTED: serine/threonine-protein kina | 0.990 | 0.720 | 0.806 | 1e-155 | |
| 255638456 | 444 | unknown [Glycine max] | 0.990 | 0.720 | 0.803 | 1e-154 | |
| 15231839 | 467 | serine/threonine-protein kinase AFC1 [Ar | 0.990 | 0.685 | 0.8 | 1e-152 |
| >gi|224138498|ref|XP_002322829.1| predicted protein [Populus trichocarpa] gi|222867459|gb|EEF04590.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 568 bits (1465), Expect = e-160, Method: Compositional matrix adjust.
Identities = 281/326 (86%), Positives = 296/326 (90%), Gaps = 12/326 (3%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPP----LPPPKVLPALYCVQEFGNGG--MPN 54
METQRI EFPHKNMDKRPRKR RLTWD+PPP L P KV+P ++C QEFGNG +PN
Sbjct: 1 METQRITEFPHKNMDKRPRKRQRLTWDIPPPPPPFLAPAKVVPGMFCGQEFGNGNGVIPN 60
Query: 55 YACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDN 114
Y +FY R GSPPWRPDDKDGHYVFAIG+NLTPRYRILSKMGEGTFGQV+ECFDN
Sbjct: 61 YG---LFYN---RNGSPPWRPDDKDGHYVFAIGDNLTPRYRILSKMGEGTFGQVLECFDN 114
Query: 115 EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174
EKKELVAIKIVRSI+KYREAAM EIDVLQRLARHDIG TRCVQIRNWFDYRNHICIVFEK
Sbjct: 115 EKKELVAIKIVRSIHKYREAAMTEIDVLQRLARHDIGSTRCVQIRNWFDYRNHICIVFEK 174
Query: 175 LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234
LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH+L LIHTDLKPENILLVS+EY+K
Sbjct: 175 LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHDLHLIHTDLKPENILLVSSEYIK 234
Query: 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG 294
VPDYKFLSRS+KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG
Sbjct: 235 VPDYKFLSRSTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG 294
Query: 295 WNYPCDLWSVGCILVELCSVSNCYLT 320
WNYPCD+WSVGCILVELCS + T
Sbjct: 295 WNYPCDIWSVGCILVELCSGEALFQT 320
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147800314|emb|CAN73108.1| hypothetical protein VITISV_001943 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 564 bits (1454), Expect = e-158, Method: Compositional matrix adjust.
Identities = 278/320 (86%), Positives = 300/320 (93%), Gaps = 4/320 (1%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRI EFPHKNMDKRPRKRPRLTWD+PPPLPPPKV+P +YC QEF + NY SS+
Sbjct: 1 METQRITEFPHKNMDKRPRKRPRLTWDMPPPLPPPKVVPGMYCSQEF----VSNYPYSSL 56
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
FY + R GSPPWRPDDKDGHY+FAIGENLTPRYRI+SKMGEGTFGQV+ECFDN+KKE+V
Sbjct: 57 FYKGVTRNGSPPWRPDDKDGHYIFAIGENLTPRYRIISKMGEGTFGQVLECFDNDKKEVV 116
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
AIKIVRSI+KYREAAMIEIDVLQ+LARHD+GGTRCVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 117 AIKIVRSIHKYREAAMIEIDVLQKLARHDVGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 176
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
DFLRKNSYRSFPIDLVRELGRQLLESVAFMH+LRLIHTDLKPENILLVS++Y+KVPDYKF
Sbjct: 177 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHDLRLIHTDLKPENILLVSSDYIKVPDYKF 236
Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
LSR+ KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+YVVSTRHYRAPEVILGLGWNYPCD
Sbjct: 237 LSRTIKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYVVSTRHYRAPEVILGLGWNYPCD 296
Query: 301 LWSVGCILVELCSVSNCYLT 320
LWSVGCIL+ELCS + T
Sbjct: 297 LWSVGCILIELCSGEALFQT 316
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439856|ref|XP_002278124.1| PREDICTED: serine/threonine-protein kinase AFC1 [Vitis vinifera] gi|297741539|emb|CBI32671.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 564 bits (1453), Expect = e-158, Method: Compositional matrix adjust.
Identities = 278/320 (86%), Positives = 300/320 (93%), Gaps = 4/320 (1%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRI EFPHKNMDKRPRKRPRLTWD+PPPLPPPKV+P +YC QEF + NY SS+
Sbjct: 1 METQRITEFPHKNMDKRPRKRPRLTWDMPPPLPPPKVVPGMYCSQEF----VSNYPYSSL 56
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
FY + R GSPPWRPDDKDGHY+FAIGENLTPRYRI+SKMGEGTFGQV+ECFDN+KKE+V
Sbjct: 57 FYKGVTRNGSPPWRPDDKDGHYIFAIGENLTPRYRIISKMGEGTFGQVLECFDNDKKEVV 116
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
AIKIVRSI+KYREAAMIEIDVLQ+LARHD+GGTRCVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 117 AIKIVRSIHKYREAAMIEIDVLQKLARHDVGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 176
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
DFLRKNSYRSFPIDLVRELGRQLLESVAFMH+LRLIHTDLKPENILLVS++Y+KVPDYKF
Sbjct: 177 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHDLRLIHTDLKPENILLVSSDYIKVPDYKF 236
Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
LSR+ KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+YVVSTRHYRAPEVILGLGWNYPCD
Sbjct: 237 LSRTIKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYVVSTRHYRAPEVILGLGWNYPCD 296
Query: 301 LWSVGCILVELCSVSNCYLT 320
LWSVGCIL+ELCS + T
Sbjct: 297 LWSVGCILIELCSGEALFQT 316
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439982|ref|XP_004137764.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 2 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 558 bits (1437), Expect = e-156, Method: Compositional matrix adjust.
Identities = 277/320 (86%), Positives = 295/320 (92%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRIIEFPHKNMDKRPRKR RL WD+PPP+PPPKVLP YC QEFGNG +PNYA SM
Sbjct: 1 METQRIIEFPHKNMDKRPRKRQRLAWDMPPPVPPPKVLPPPYCGQEFGNGQVPNYAYPSM 60
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
+ PR GSPPWRPD+KDGHYVF+IGE LTPRY ILSKMGEGTFGQV+EC D+EKKE+V
Sbjct: 61 YCRGAPRVGSPPWRPDNKDGHYVFSIGECLTPRYTILSKMGEGTFGQVLECLDSEKKEVV 120
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
AIKIVRSI+KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 121 AIKIVRSISKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
DFLRKNSYRSFPIDLVRE RQLLESVAFMHELRLIHTDLKPENILLVS+E+++VPD+KF
Sbjct: 181 DFLRKNSYRSFPIDLVREFARQLLESVAFMHELRLIHTDLKPENILLVSSEFIRVPDHKF 240
Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
LSRS KDGSYFKNLPKS+AIKLIDFGSTT EHQDHSY+VSTRHYRAPEVILGLGWNYPCD
Sbjct: 241 LSRSVKDGSYFKNLPKSAAIKLIDFGSTTTEHQDHSYIVSTRHYRAPEVILGLGWNYPCD 300
Query: 301 LWSVGCILVELCSVSNCYLT 320
LWSVGCILVELCS + T
Sbjct: 301 LWSVGCILVELCSGEALFQT 320
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439980|ref|XP_004137763.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 1 [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 556 bits (1434), Expect = e-156, Method: Compositional matrix adjust.
Identities = 277/320 (86%), Positives = 295/320 (92%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRIIEFPHKNMDKRPRKR RL WD+PPP+PPPKVLP YC QEFGNG +PNYA SM
Sbjct: 1 METQRIIEFPHKNMDKRPRKRQRLAWDMPPPVPPPKVLPPPYCGQEFGNGQVPNYAYPSM 60
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
+ PR GSPPWRPD+KDGHYVF+IGE LTPRY ILSKMGEGTFGQV+EC D+EKKE+V
Sbjct: 61 YCRGAPRVGSPPWRPDNKDGHYVFSIGECLTPRYTILSKMGEGTFGQVLECLDSEKKEVV 120
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
AIKIVRSI+KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 121 AIKIVRSISKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
DFLRKNSYRSFPIDLVRE RQLLESVAFMHELRLIHTDLKPENILLVS+E+++VPD+KF
Sbjct: 181 DFLRKNSYRSFPIDLVREFARQLLESVAFMHELRLIHTDLKPENILLVSSEFIRVPDHKF 240
Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
LSRS KDGSYFKNLPKS+AIKLIDFGSTT EHQDHSY+VSTRHYRAPEVILGLGWNYPCD
Sbjct: 241 LSRSVKDGSYFKNLPKSAAIKLIDFGSTTTEHQDHSYIVSTRHYRAPEVILGLGWNYPCD 300
Query: 301 LWSVGCILVELCSVSNCYLT 320
LWSVGCILVELCS + T
Sbjct: 301 LWSVGCILVELCSGEALFQT 320
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505140|ref|XP_003521350.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 2 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 556 bits (1434), Expect = e-156, Method: Compositional matrix adjust.
Identities = 263/320 (82%), Positives = 288/320 (90%), Gaps = 7/320 (2%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSM 60
METQRIIEFPH+NMDKRPRK+ RLTWD+ VLP +YC QE GNG +PN+A S+
Sbjct: 1 METQRIIEFPHRNMDKRPRKKQRLTWDM-------HVLPTMYCKQEVGNGVVPNHAYPSL 53
Query: 61 FYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELV 120
FY +PR GSPPWRPDDKDGHYVFA+GENLTPRY+ILSKMGEGTFGQV+EC DNEK+E+V
Sbjct: 54 FYRGMPRNGSPPWRPDDKDGHYVFAVGENLTPRYKILSKMGEGTFGQVLECLDNEKEEIV 113
Query: 121 AIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLY 180
AIK+VRSINKYREAA EI+VL RLARHD+ G CVQIRNWFDYRNHICIVFEKLGPSLY
Sbjct: 114 AIKVVRSINKYREAARTEIEVLLRLARHDVDGAHCVQIRNWFDYRNHICIVFEKLGPSLY 173
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
DFLRKNSYRSFPIDLVRE GRQLLESVAFMH+L LIHTDLKPENILL+S+E++KVPDYKF
Sbjct: 174 DFLRKNSYRSFPIDLVREFGRQLLESVAFMHDLCLIHTDLKPENILLISSEFIKVPDYKF 233
Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
LSR++KDGSYFKNLPKSSAIKLIDFGST+FEHQDHSYVVSTRHYRAPEVILGLGWNYPCD
Sbjct: 234 LSRNTKDGSYFKNLPKSSAIKLIDFGSTSFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 293
Query: 301 LWSVGCILVELCSVSNCYLT 320
LWSVGCILVELCS + T
Sbjct: 294 LWSVGCILVELCSGEALFQT 313
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255584557|ref|XP_002533005.1| afc, putative [Ricinus communis] gi|223527216|gb|EEF29380.1| afc, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 552 bits (1423), Expect = e-155, Method: Compositional matrix adjust.
Identities = 280/343 (81%), Positives = 296/343 (86%), Gaps = 24/343 (6%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGN---GGM--PNY 55
METQRI E P +NMDKRPRKRPRLTWD+PPP PP KVL A+YC Q+ GN GG+ N+
Sbjct: 1 METQRITELPLRNMDKRPRKRPRLTWDMPPPPPP-KVLSAMYCGQDLGNNDGGGIINTNF 59
Query: 56 ACSSMFYG------------------AIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRIL 97
+M+Y +PR SPPWRPDDKDGHYVFAIGENLTPRYRIL
Sbjct: 60 GYPNMYYRDVPVSVPVPVPVPIPLPITVPRNVSPPWRPDDKDGHYVFAIGENLTPRYRIL 119
Query: 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQ 157
KMGEGTFGQV+EC DNEKKE+VAIKIVRSI+KYREAAMIEIDVLQRLARHDIGGTRCVQ
Sbjct: 120 GKMGEGTFGQVLECLDNEKKEIVAIKIVRSIHKYREAAMIEIDVLQRLARHDIGGTRCVQ 179
Query: 158 IRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
IRNWFDYRNHICIVFEKLGPSLYDFLRKNSY SFPIDLVRELGRQLLESVAFMH+LRLIH
Sbjct: 180 IRNWFDYRNHICIVFEKLGPSLYDFLRKNSYSSFPIDLVRELGRQLLESVAFMHDLRLIH 239
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
TDLKPENILLVSAEY+KVPDYKFLSRS+KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY
Sbjct: 240 TDLKPENILLVSAEYIKVPDYKFLSRSTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 299
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320
VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS + T
Sbjct: 300 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSGEALFQT 342
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356505138|ref|XP_003521349.1| PREDICTED: serine/threonine-protein kinase AFC1-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 552 bits (1422), Expect = e-155, Method: Compositional matrix adjust.
Identities = 266/330 (80%), Positives = 292/330 (88%), Gaps = 10/330 (3%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDV----------PPPLPPPKVLPALYCVQEFGNG 50
METQRIIEFPH+NMDKRPRK+ RLTWD+ P P P +VLP +YC QE GNG
Sbjct: 1 METQRIIEFPHRNMDKRPRKKQRLTWDMHVPPPPPPPPPLPPPKLQVLPTMYCKQEVGNG 60
Query: 51 GMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVE 110
+PN+A S+FY +PR GSPPWRPDDKDGHYVFA+GENLTPRY+ILSKMGEGTFGQV+E
Sbjct: 61 VVPNHAYPSLFYRGMPRNGSPPWRPDDKDGHYVFAVGENLTPRYKILSKMGEGTFGQVLE 120
Query: 111 CFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170
C DNEK+E+VAIK+VRSINKYREAA EI+VL RLARHD+ G CVQIRNWFDYRNHICI
Sbjct: 121 CLDNEKEEIVAIKVVRSINKYREAARTEIEVLLRLARHDVDGAHCVQIRNWFDYRNHICI 180
Query: 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230
VFEKLGPSLYDFLRKNSYRSFPIDLVRE GRQLLESVAFMH+L LIHTDLKPENILL+S+
Sbjct: 181 VFEKLGPSLYDFLRKNSYRSFPIDLVREFGRQLLESVAFMHDLCLIHTDLKPENILLISS 240
Query: 231 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI 290
E++KVPDYKFLSR++KDGSYFKNLPKSSAIKLIDFGST+FEHQDHSYVVSTRHYRAPEVI
Sbjct: 241 EFIKVPDYKFLSRNTKDGSYFKNLPKSSAIKLIDFGSTSFEHQDHSYVVSTRHYRAPEVI 300
Query: 291 LGLGWNYPCDLWSVGCILVELCSVSNCYLT 320
LGLGWNYPCDLWSVGCILVELCS + T
Sbjct: 301 LGLGWNYPCDLWSVGCILVELCSGEALFQT 330
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255638456|gb|ACU19537.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 549 bits (1415), Expect = e-154, Method: Compositional matrix adjust.
Identities = 265/330 (80%), Positives = 291/330 (88%), Gaps = 10/330 (3%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDV----------PPPLPPPKVLPALYCVQEFGNG 50
METQRIIEFPH+NMDKRPRK+ RLTWD+ P P P +VLP +YC QE GNG
Sbjct: 1 METQRIIEFPHRNMDKRPRKKQRLTWDMHVPPPPPPPPPLPPPKLQVLPTMYCKQEVGNG 60
Query: 51 GMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVE 110
+PN+A S+FY +PR GSPPWRPDDKDGHYVFA+GENLTPRY+ILSKMGEGTFGQV+E
Sbjct: 61 VVPNHAYPSLFYRGMPRNGSPPWRPDDKDGHYVFAVGENLTPRYKILSKMGEGTFGQVLE 120
Query: 111 CFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170
C DNEK+E+VAIK+VRSINKYREAA EI+VL RLARHD+ G CVQIRNWFDYRNHICI
Sbjct: 121 CLDNEKEEIVAIKVVRSINKYREAARTEIEVLLRLARHDVDGAHCVQIRNWFDYRNHICI 180
Query: 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230
VFEKLGPSLYDFLRKN YRSFPIDLVRE GRQLLESVAFMH+L LIHTDLKPENILL+S+
Sbjct: 181 VFEKLGPSLYDFLRKNCYRSFPIDLVREFGRQLLESVAFMHDLCLIHTDLKPENILLISS 240
Query: 231 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI 290
E++KVPDYKFLSR++KDGSYFKNLPKSSAIKLIDFGST+FEHQDHSYVVSTRHYRAPEVI
Sbjct: 241 EFIKVPDYKFLSRNTKDGSYFKNLPKSSAIKLIDFGSTSFEHQDHSYVVSTRHYRAPEVI 300
Query: 291 LGLGWNYPCDLWSVGCILVELCSVSNCYLT 320
LGLGWNYPCDLWSVGCILVELCS + T
Sbjct: 301 LGLGWNYPCDLWSVGCILVELCSGEALFQT 330
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15231839|ref|NP_190925.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|42570490|ref|NP_850695.2| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|79314891|ref|NP_001030853.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|26454604|sp|P51566.2|AFC1_ARATH RecName: Full=Serine/threonine-protein kinase AFC1 gi|642132|dbj|BAA08215.1| protein kinase [Arabidopsis thaliana] gi|6729508|emb|CAB67664.1| protein kinase (AME2/AFC1) [Arabidopsis thaliana] gi|222424132|dbj|BAH20025.1| AT3G53570 [Arabidopsis thaliana] gi|332645589|gb|AEE79110.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|332645590|gb|AEE79111.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] gi|332645591|gb|AEE79112.1| serine/threonine-protein kinase AFC1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 544 bits (1402), Expect = e-152, Method: Compositional matrix adjust.
Identities = 260/325 (80%), Positives = 290/325 (89%), Gaps = 5/325 (1%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDVPPPLPPPKVL-----PALYCVQEFGNGGMPNY 55
+ETQR +EFPH+ +DKRPRKRPRLTWD PPL PP P LY EF +G +PN+
Sbjct: 17 LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76
Query: 56 ACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE 115
+MFY +PR GSPPWRPDDKDGHYVF +G+ LTPRY+ILSKMGEGTFGQV+ECFDN+
Sbjct: 77 VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTFGQVLECFDNK 136
Query: 116 KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175
KE+VAIK++RSINKYREAAMIEIDVLQRL RHD+GG+RCVQIRNWFDYRNHICIVFEKL
Sbjct: 137 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 196
Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA+MH+LRLIHTDLKPENILLVS+EY+K+
Sbjct: 197 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 256
Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
PDYKFLSR +KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+Y+VSTRHYRAPEVILG+GW
Sbjct: 257 PDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYRAPEVILGVGW 316
Query: 296 NYPCDLWSVGCILVELCSVSNCYLT 320
NYPCDLWS+GCILVELCS + T
Sbjct: 317 NYPCDLWSIGCILVELCSGEALFQT 341
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 323 | ||||||
| TAIR|locus:2084006 | 467 | FC1 "FUS3-complementing gene 1 | 0.969 | 0.670 | 0.795 | 2.3e-142 | |
| TAIR|locus:2121984 | 427 | FC2 "FUS3-complementing gene 2 | 0.956 | 0.723 | 0.683 | 1.4e-119 | |
| TAIR|locus:2125622 | 400 | AME3 [Arabidopsis thaliana (ta | 0.770 | 0.622 | 0.694 | 5.3e-100 | |
| FB|FBgn0259220 | 832 | Doa "Darkener of apricot" [Dro | 0.705 | 0.274 | 0.506 | 2.6e-65 | |
| POMBASE|SPAC1D4.11c | 690 | lkh1 "dual specificity protein | 0.724 | 0.339 | 0.502 | 1.1e-62 | |
| ASPGD|ASPL0000062305 | 667 | AN0988 [Emericella nidulans (t | 0.727 | 0.352 | 0.514 | 3e-62 | |
| UNIPROTKB|E1B9M6 | 481 | CLK4 "Uncharacterized protein" | 0.702 | 0.471 | 0.497 | 2.7e-61 | |
| UNIPROTKB|E1C4D7 | 479 | LOC100859563 "Uncharacterized | 0.702 | 0.473 | 0.493 | 3.4e-61 | |
| UNIPROTKB|E1C4D8 | 477 | LOC100859563 "Uncharacterized | 0.702 | 0.475 | 0.493 | 3.4e-61 | |
| MGI|MGI:1098551 | 481 | Clk4 "CDC like kinase 4" [Mus | 0.702 | 0.471 | 0.502 | 4.3e-61 |
| TAIR|locus:2084006 FC1 "FUS3-complementing gene 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1392 (495.1 bits), Expect = 2.3e-142, P = 2.3e-142
Identities = 253/318 (79%), Positives = 282/318 (88%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDXXXXXXX-----XXXXXALYCVQEFGNGGMPNY 55
+ETQR +EFPH+ +DKRPRKRPRLTWD LY EF +G +PN+
Sbjct: 17 LETQRNVEFPHRIVDKRPRKRPRLTWDAAPPLLPPPPPPTVFQPPLYYGPEFASGLVPNF 76
Query: 56 ACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE 115
+MFY +PR GSPPWRPDDKDGHYVF +G+ LTPRY+ILSKMGEGTFGQV+ECFDN+
Sbjct: 77 VYPNMFYNGLPRQGSPPWRPDDKDGHYVFVVGDTLTPRYQILSKMGEGTFGQVLECFDNK 136
Query: 116 KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175
KE+VAIK++RSINKYREAAMIEIDVLQRL RHD+GG+RCVQIRNWFDYRNHICIVFEKL
Sbjct: 137 NKEVVAIKVIRSINKYREAAMIEIDVLQRLTRHDVGGSRCVQIRNWFDYRNHICIVFEKL 196
Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA+MH+LRLIHTDLKPENILLVS+EY+K+
Sbjct: 197 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAYMHDLRLIHTDLKPENILLVSSEYIKI 256
Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
PDYKFLSR +KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH+Y+VSTRHYRAPEVILG+GW
Sbjct: 257 PDYKFLSRPTKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHNYIVSTRHYRAPEVILGVGW 316
Query: 296 NYPCDLWSVGCILVELCS 313
NYPCDLWS+GCILVELCS
Sbjct: 317 NYPCDLWSIGCILVELCS 334
|
|
| TAIR|locus:2121984 FC2 "FUS3-complementing gene 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1177 (419.4 bits), Expect = 1.4e-119, P = 1.4e-119
Identities = 218/319 (68%), Positives = 260/319 (81%)
Query: 1 METQRIIEFPHKNMDKRPRKRPRLTWDXXXXXXXXXXXXALYCVQEFGN------GGMPN 54
ME +R+ EFPH +MD+RPRKR RL WD ++C QE GN G P+
Sbjct: 1 MEMERVHEFPHTHMDRRPRKRARLGWDVLPQATKAQV--GMFCGQEIGNISSFASSGAPS 58
Query: 55 YACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDN 114
SS+ + R GSPPWR DDKDGHY+F +G++LTPRY+I SKMGEGTFGQV+EC+D
Sbjct: 59 DNSSSLCVKGVARNGSPPWREDDKDGHYIFELGDDLTPRYKIYSKMGEGTFGQVLECWDR 118
Query: 115 EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174
E+KE+VA+KIVR + KYREAAMIEI++LQ+L +HD GG RCVQIRNWFDYRNHICIVFEK
Sbjct: 119 ERKEMVAVKIVRGVKKYREAAMIEIEMLQQLGKHDKGGNRCVQIRNWFDYRNHICIVFEK 178
Query: 175 LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234
LG SLYDFLRKN+YRSFPIDLVRE+G QLLE VAFMH+LR+IHTDLKPENILLVS++YVK
Sbjct: 179 LGSSLYDFLRKNNYRSFPIDLVREIGWQLLECVAFMHDLRMIHTDLKPENILLVSSDYVK 238
Query: 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG 294
+P+YK SR +D Y K +PKSSAIK+IDFGSTT+E QD +Y+VSTRHYRAPEVILGLG
Sbjct: 239 IPEYKG-SRLQRDVCY-KRVPKSSAIKVIDFGSTTYERQDQTYIVSTRHYRAPEVILGLG 296
Query: 295 WNYPCDLWSVGCILVELCS 313
W+YPCD+WSVGCI+VELC+
Sbjct: 297 WSYPCDVWSVGCIIVELCT 315
|
|
| TAIR|locus:2125622 AME3 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 949 (339.1 bits), Expect = 5.3e-100, Sum P(2) = 5.3e-100
Identities = 175/252 (69%), Positives = 216/252 (85%)
Query: 62 YGAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVA 121
+G+ R SPP R DD+DGHYVF++ +NLTPRY+ILSKMGEGTFG+V+EC+D + KE VA
Sbjct: 39 HGSDGRILSPPLRDDDRDGHYVFSLRDNLTPRYKILSKMGEGTFGRVLECWDRDTKEYVA 98
Query: 122 IKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYD 181
IKI+RSI KYR+AAMIEIDVLQ+L + D G TRCVQ++NWFDYRNHICIVFEKLGPSL+D
Sbjct: 99 IKIIRSIKKYRDAAMIEIDVLQKLVKSDKGRTRCVQMKNWFDYRNHICIVFEKLGPSLFD 158
Query: 182 FLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241
FL++N Y +FP+ LVR+ G QLLESVA+MHEL+L+HTDLKPENILLVS+E VK+PD K
Sbjct: 159 FLKRNKYSAFPLALVRDFGCQLLESVAYMHELQLVHTDLKPENILLVSSENVKLPDNK-- 216
Query: 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDL 301
RS+ + ++F+ LPKSSAIKLIDFGST +++ H +V TRHYR+PEVILGLGW+Y CDL
Sbjct: 217 -RSAANETHFRCLPKSSAIKLIDFGSTVCDNRIHHSIVQTRHYRSPEVILGLGWSYQCDL 275
Query: 302 WSVGCILVELCS 313
WS+GCIL ELC+
Sbjct: 276 WSIGCILFELCT 287
|
|
| FB|FBgn0259220 Doa "Darkener of apricot" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 641 (230.7 bits), Expect = 2.6e-65, Sum P(2) = 2.6e-65
Identities = 120/237 (50%), Positives = 172/237 (72%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD DGH ++ G+ L RY+I++ +GEGTFG+VV+ D E+ +A+KI++++ KYREAA
Sbjct: 461 DDADGHLIYHTGDILHHRYKIMATLGEGTFGRVVKVKDMERDYCMALKIIKNVEKYREAA 520
Query: 136 MIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
+EI+ L+++A+ D CV++ +WFDY H+CIVFE LG S++DFLR+N+Y +P+D
Sbjct: 521 KLEINALEKIAQKDPHCDHLCVKMIDWFDYHGHMCIVFEMLGLSVFDFLRENNYEPYPLD 580
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
VR + QL SV F+H+ RL HTDLKPENIL V ++Y ++K ++R +
Sbjct: 581 QVRHMAYQLCYSVKFLHDNRLTHTDLKPENILFVDSDYTSHYNHK-INREVRR------- 632
Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
K++ ++LIDFGS TF+H+ HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL EL
Sbjct: 633 VKNTDVRLIDFGSATFDHEHHSTIVSTRHYRAPEVILELGWSQPCDVWSIGCILFEL 689
|
|
| POMBASE|SPAC1D4.11c lkh1 "dual specificity protein kinase Lkh1" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 640 (230.4 bits), Expect = 1.1e-62, P = 1.1e-62
Identities = 124/247 (50%), Positives = 169/247 (68%)
Query: 68 TGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS 127
T P DD DGHY RY ++ +G GTFG+V++C+D AIK+ R+
Sbjct: 336 TAFDPSTFDDDDGHYKVVPNSKFANRYTVVRLLGHGTFGKVIQCYDQSTGRHCAIKVTRA 395
Query: 128 INKYREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKN 186
I KYREA++IE+ VLQ +A D +C+Q+R++FDYR HICIV + G S++DFL+ N
Sbjct: 396 IPKYREASLIELRVLQTIAHSDPTNENKCIQLRDYFDYRKHICIVTDLFGWSVFDFLKNN 455
Query: 187 SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS--AEYVKVPDYKFLSRS 244
+Y FP+ ++ L +QL +SVAF+H L L+HTDLKPEN+LLVS + +++P Y+
Sbjct: 456 NYIPFPLKHIQMLSQQLFKSVAFLHSLGLVHTDLKPENVLLVSNASRTIRLP-YR----- 509
Query: 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSV 304
+Y + + S I+LIDFGS TFE + HS VVSTRHYRAPE+ILGLGW+YPCD+WS+
Sbjct: 510 ----NYSQKVLNSCEIRLIDFGSATFEDEYHSSVVSTRHYRAPEIILGLGWSYPCDVWSI 565
Query: 305 GCILVEL 311
GCILVEL
Sbjct: 566 GCILVEL 572
|
|
| ASPGD|ASPL0000062305 AN0988 [Emericella nidulans (taxid:162425)] | Back alignment and assigned GO terms |
|---|
Score = 636 (228.9 bits), Expect = 3.0e-62, P = 3.0e-62
Identities = 123/239 (51%), Positives = 164/239 (68%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD DGHY+ +T RY I+ +G+GTFG+VVE +D ++K AIKI+RSI KYR+A+
Sbjct: 283 DDDDGHYIVNPNTPITDRYSIIKLLGQGTFGKVVEAYDKQRKARCAIKIIRSIQKYRDAS 342
Query: 136 MIEIDVLQRLARHDIGG-TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
IE+ VL LA +D +C+ +R+ FD+RNHICIV + LG S++DFL+ N + FP
Sbjct: 343 RIELRVLSTLASNDKHNRNKCIHLRDCFDFRNHICIVTDLLGQSVFDFLKGNGFVPFPSS 402
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS---KDGSYF 251
++ RQL SVAF+H+L LIHTDLKPENILLV Y + + SS +
Sbjct: 403 QIQSFARQLFTSVAFLHDLNLIHTDLKPENILLVKNAYQTFTYNRTIPSSSTAISRNARQ 462
Query: 252 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
+ + S I+LIDFGS TF+ + HS VVSTRHYRAPE+IL LGW++PCD+WS+GCILVE
Sbjct: 463 RRVLLDSEIRLIDFGSATFDDEYHSSVVSTRHYRAPEIILNLGWSFPCDIWSIGCILVE 521
|
|
| UNIPROTKB|E1B9M6 CLK4 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 627 (225.8 bits), Expect = 2.7e-61, P = 2.7e-61
Identities = 118/237 (49%), Positives = 165/237 (69%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD++GH + G+ L RY I+ +GEG FG+VVEC D++ + VA+KIV+++ +YREA
Sbjct: 141 DDEEGHLICQSGDVLRARYEIVDTLGEGAFGKVVECIDHDMDGIHVAVKIVKNVGRYREA 200
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A EI VL+ L D RCVQ+ WFD+ H+CIVFE LG S YDF+++NS+ F I
Sbjct: 201 ARSEIQVLEHLNSTDPNSVFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQI 260
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
D +R++ Q+ +S+ F+H +L HTDLKPENIL V ++YV K+ S+ +D KN
Sbjct: 261 DHIRQMAYQICQSINFLHHNKLTHTDLKPENILFVKSDYV----VKYNSKMKRDERTLKN 316
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
+ IK++DFGS T++ + HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E
Sbjct: 317 ----TDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 369
|
|
| UNIPROTKB|E1C4D7 LOC100859563 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 626 (225.4 bits), Expect = 3.4e-61, P = 3.4e-61
Identities = 117/237 (49%), Positives = 167/237 (70%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD++GH + G+ L RY I++ +GEG FG+VVEC D++ + + VA+KIV+++ +YREA
Sbjct: 141 DDEEGHLICESGDVLRARYEIVATLGEGAFGKVVECIDHDMRGMHVAVKIVKNVGRYREA 200
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A EI VL+ L D T RCVQ+ WFD+ H+CIVFE LG S YDF+++NS+ F I
Sbjct: 201 ARSEIQVLEHLNTMDPSSTFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFHI 260
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
+ +R + Q+ +S+ F+H +L HTDLKPENIL V ++Y+ K+ ++ +D KN
Sbjct: 261 NDIRNMAYQICQSINFLHHNKLTHTDLKPENILFVESDYI----VKYNAKMKRDERTLKN 316
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
+ IK++DFGS TF+ + HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E
Sbjct: 317 ----TDIKVVDFGSATFDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 369
|
|
| UNIPROTKB|E1C4D8 LOC100859563 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 626 (225.4 bits), Expect = 3.4e-61, P = 3.4e-61
Identities = 117/237 (49%), Positives = 167/237 (70%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD++GH + G+ L RY I++ +GEG FG+VVEC D++ + + VA+KIV+++ +YREA
Sbjct: 139 DDEEGHLICESGDVLRARYEIVATLGEGAFGKVVECIDHDMRGMHVAVKIVKNVGRYREA 198
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A EI VL+ L D T RCVQ+ WFD+ H+CIVFE LG S YDF+++NS+ F I
Sbjct: 199 ARSEIQVLEHLNTMDPSSTFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFHI 258
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
+ +R + Q+ +S+ F+H +L HTDLKPENIL V ++Y+ K+ ++ +D KN
Sbjct: 259 NDIRNMAYQICQSINFLHHNKLTHTDLKPENILFVESDYI----VKYNAKMKRDERTLKN 314
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
+ IK++DFGS TF+ + HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E
Sbjct: 315 ----TDIKVVDFGSATFDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 367
|
|
| MGI|MGI:1098551 Clk4 "CDC like kinase 4" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 625 (225.1 bits), Expect = 4.3e-61, P = 4.3e-61
Identities = 119/237 (50%), Positives = 164/237 (69%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKEL-VAIKIVRSINKYREA 134
DD++GH + G+ L RY I+ +GEG FG+VVEC D+ L VA+KIV+++ +YREA
Sbjct: 141 DDEEGHLICQSGDVLRARYEIVDTLGEGAFGKVVECIDHGMDGLHVAVKIVKNVGRYREA 200
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A EI VL+ L D RCVQ+ WFD+ H+CIVFE LG S YDF+++NS+ F I
Sbjct: 201 ARSEIQVLEHLNSTDPNSVFRCVQMLEWFDHHGHVCIVFELLGLSTYDFIKENSFLPFQI 260
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
D +R++ Q+ +S+ F+H +L HTDLKPENIL V ++YV K+ S+ +D KN
Sbjct: 261 DHIRQMAYQICQSINFLHHNKLTHTDLKPENILFVKSDYV----VKYNSKMKRDERTLKN 316
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
+ IK++DFGS T++ + HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E
Sbjct: 317 ----TDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 369
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P51566 | AFC1_ARATH | 2, ., 7, ., 1, 2, ., 1 | 0.8 | 0.9907 | 0.6852 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.12 | 0.963 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 323 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-59 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-50 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-45 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-44 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-37 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-37 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-36 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-35 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-31 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-28 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-28 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-27 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-27 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 6e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-26 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-25 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-24 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-23 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-23 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-22 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-22 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-21 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-21 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-21 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-20 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-20 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-20 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-20 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-20 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-20 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-19 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-19 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-17 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-16 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-16 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-15 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-15 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-14 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-14 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-14 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-14 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-13 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-13 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-13 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-11 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-10 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-10 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-10 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 9e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-09 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-09 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-09 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-08 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-08 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-08 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-07 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-05 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-04 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-04 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-04 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-04 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 9e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.001 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 0.002 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.002 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.003 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.003 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 0.003 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 1e-59
Identities = 75/225 (33%), Positives = 111/225 (49%), Gaps = 39/225 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIG 151
Y IL K+GEG+FG+V D + +LVAIK+++ I K RE + EI +L++L +H
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHP-- 57
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V++ + F+ + + +V E G L+D L+K D R RQ+L ++ ++
Sbjct: 58 --NIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYL 113
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H ++H DLKPENILL +DG +KL DFG
Sbjct: 114 HSKGIVHRDLKPENILL-----------------DEDGH----------VKLADFGLARQ 146
Query: 271 EHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
V T Y APEV+LG G+ D+WS+G IL EL +
Sbjct: 147 LDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLT 191
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 2e-50
Identities = 92/246 (37%), Positives = 144/246 (58%), Gaps = 27/246 (10%)
Query: 78 KDGHYVFAIGENL---TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA 134
++GH+ +GE++ T R++ILS +GEGTFG+VVE +D ++KE A+KIVR++ KY
Sbjct: 112 EEGHFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRD 171
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFP 192
A IEI ++++ + D ++I+ +F + H+CIV K GP L D++ K+ S
Sbjct: 172 AKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSH- 230
Query: 193 IDLVRELGRQLLESVA----FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
R L + + ++ F EL L+HTDLKPENIL+ +++ + D
Sbjct: 231 ----RHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSD------------TVVDP 274
Query: 249 SYFKNLPKSSA-IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 307
+ LP +++ D G E + +VSTRHYR+PEV+LGLGW Y D+WS+GCI
Sbjct: 275 VTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCI 334
Query: 308 LVELCS 313
+ EL +
Sbjct: 335 IYELYT 340
|
Length = 467 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-45
Identities = 71/218 (32%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
GEG FG V D + + VAIKI++ + E + EI++L++L H V++
Sbjct: 2 GEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHP----NIVKL 56
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
F+ NH+ +V E G SL D L++N + D + + Q+LE + ++H +IH
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIH 115
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
DLKPENILL S +KL DFG + D S
Sbjct: 116 RDLKPENILLDSDNGK--------------------------VKLADFGLSKLLTSDKSL 149
Query: 278 VVS---TRHYRAPEVILGLG-WNYPCDLWSVGCILVEL 311
+ + T Y APEV+LG G ++ D+WS+G IL EL
Sbjct: 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 2e-44
Identities = 69/229 (30%), Positives = 107/229 (46%), Gaps = 44/229 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSIN-KYREAAMIEIDVLQRLARHD- 149
Y +L K+G G+FG V + ++VA+KI+ RS K + A EI +L+RL H
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I V++ + F+ ++H+ +V E L+D+L + D +++ Q+L +
Sbjct: 60 I-----VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLE 112
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 267
++H +IH DLKPENILL +K+ DFG +
Sbjct: 113 YLHSNGIIHRDLKPENILLDENGV---------------------------VKIADFGLA 145
Query: 268 TTFEHQDHSY--VVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCS 313
S V T Y APEV+L G G+ D+WS+G IL EL +
Sbjct: 146 KKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLT 194
|
Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 65/221 (29%), Positives = 112/221 (50%), Gaps = 32/221 (14%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREA-AMIEIDVLQRLARHDIG 151
Y+++ ++G+GTFG V + E ELVAIK + + + E + E+ L++L H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHP-- 58
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V+++ F + + VFE + +LY ++ + F ++R + Q+L+ +A +H
Sbjct: 59 --NIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
+ H DLKPEN+L+ E VK+ D+ L+R + + T +
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFG-LAREIRSRPPY----------------TDY- 158
Query: 272 HQDHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVEL 311
VSTR YRAPE++L + P D+W++GCI+ EL
Sbjct: 159 -------VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 69/223 (30%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
RY+IL ++GEG G V + D E E VA+K + R A+ EI LQ
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
+ V++ + F + + +V E + L + LR + R P V+ R LL+ VA+
Sbjct: 61 V-----VKLLDVFPHGSGFVLVMEYMPSDLSEVLR-DEERPLPEAQVKSYMRMLLKGVAY 114
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
MH ++H DLKP N+L+ + +K+ D+ L+R +
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFG-LARLFSEE-----------------EPRL 156
Query: 270 FEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVEL 311
+ HQ V+TR YRAPE++ G ++ DLW+VGCI EL
Sbjct: 157 YSHQ-----VATRWYRAPELLYGARKYDPGVDLWAVGCIFAEL 194
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 7e-36
Identities = 71/228 (31%), Positives = 111/228 (48%), Gaps = 44/228 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARHD 149
Y L K+GEGT+G V + D + E+VA+K +R ++ E A+ EI +L+ L +H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR-LDNEEEGIPSTALREISLLKEL-KHP 58
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I V++ + + +VFE L +L K +L++ + QLL +A
Sbjct: 59 NI-----VKLLDVIHTERKLYLVFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLA 112
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 267
+ H R++H DLKP+NIL+ ++DG +KL DFG +
Sbjct: 113 YCHSHRILHRDLKPQNILI-----------------NRDGV----------LKLADFGLA 145
Query: 268 TTFEHQDHSY--VVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELC 312
F +Y V T YRAPE++LG ++ D+WSVGCI E+
Sbjct: 146 RAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 71/227 (31%), Positives = 109/227 (48%), Gaps = 40/227 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDI 150
Y+ L K+GEGT+G V + D E+VAIK ++ + + A+ EI +L+ L +I
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
+++ + F ++ + +VFE + LY ++ R P L++ QLL+ +AF
Sbjct: 61 -----IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFC 114
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H ++H DLKPEN+L + +KL DFG
Sbjct: 115 HSHGILHRDLKPENLL---------------------------INTEGVLKLADFGLARS 147
Query: 271 EHQDHSYV---VSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCS 313
V TR YRAPE++LG G++ P D+WSVGCI EL S
Sbjct: 148 FGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-34
Identities = 70/224 (31%), Positives = 115/224 (51%), Gaps = 35/224 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
+Y +L +GEG +G V++C + E+VAIK ++ A+ E+ VL++L +
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V ++ F + + +VFE + +L + L + P D VR QLL+++A+
Sbjct: 62 I-----VNLKEAFRRKGRLYLVFEYVERTLLELLEASPG-GLPPDAVRSYIWQLLQAIAY 115
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
H +IH D+KPENIL+ + +K+ D+ F + L A L D+
Sbjct: 116 CHSHNIIHRDIKPENILVSESGVLKLCDFGFA----------RALRARPASPLTDY---- 161
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVEL 311
V+TR YRAPE+++G NY P D+W++GCI+ EL
Sbjct: 162 ---------VATRWYRAPELLVG-DTNYGKPVDVWAIGCIMAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 62/222 (27%), Positives = 109/222 (49%), Gaps = 37/222 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHDIGG 152
+ IL K+G+G FG+V + + VAIK+++ + +E + EI +L++ +I
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNI-- 59
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V+ + ++ + IV E G SL D L K++ ++ + + ++LL+ + ++H
Sbjct: 60 ---VKYYGSYLKKDELWIVMEFCSGGSLKDLL-KSTNQTLTESQIAYVCKELLKGLEYLH 115
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTF 270
+IH D+K NILL + DG +KLIDFG S
Sbjct: 116 SNGIIHRDIKAANILL-----------------TSDGE----------VKLIDFGLSAQL 148
Query: 271 EH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ + +V T ++ APEVI G ++Y D+WS+G +EL
Sbjct: 149 SDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIEL 190
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 61/223 (27%), Positives = 96/223 (43%), Gaps = 47/223 (21%)
Query: 101 GEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQ 157
G G+FG V D + EL+A+K + + EA EI +L L +H V+
Sbjct: 9 GRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHP----NIVR 63
Query: 158 IR--NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
+ +N + I E + G SL L+K + P ++R+ RQ+LE +A++H
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQILEGLAYLHSNG 121
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG------ST 268
++H D+K NIL+ S +KL DFG
Sbjct: 122 IVHRDIKGANILVDS---------------------------DGVVKLADFGCAKRLGDI 154
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
S V T ++ APEVI G + D+WS+GC ++E+
Sbjct: 155 ETGEGTGS-VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEM 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 72/238 (30%), Positives = 105/238 (44%), Gaps = 51/238 (21%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
YRIL K+GEG+FG+V D + VA+K++ S +K E + EI +L L
Sbjct: 2 YRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYR-SFPIDLVRELGRQLLESV 207
V++ ++F + +V E + G SL D L+K + + Q+L ++
Sbjct: 59 ----NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSAL 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
++H +IH D+KPENILL +KLIDFG
Sbjct: 115 EYLHSKGIIHRDIKPENILLD--------------------------RDGRVVKLIDFGL 148
Query: 267 --------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPC---DLWSVGCILVELCS 313
ST+ S V T Y APEV+LGL Y D+WS+G L EL +
Sbjct: 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT 206
|
Length = 384 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-28
Identities = 68/230 (29%), Positives = 106/230 (46%), Gaps = 46/230 (20%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARHD 149
Y+IL K+GEGTF +V++ + + AIK ++ + EI L+RL+ H
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIK--CMKKHFKSLEQVNNLREIQALRRLSPHP 58
Query: 150 --IGGTRCVQIRNWFDYR-NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+ + FD + + +VFE + +LY+ + K R P V+ QLL+S
Sbjct: 59 NILRLIEVL-----FDRKTGRLALVFELMDMNLYELI-KGRKRPLPEKRVKSYMYQLLKS 112
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ MH + H D+KPENIL+ K +KL DFG
Sbjct: 113 LDHMHRNGIFHRDIKPENILI----------------------------KDDILKLADFG 144
Query: 267 S--TTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCS 313
S + ++ +STR YRAPE +L G + D+W+VGC+ E+ S
Sbjct: 145 SCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 70/237 (29%), Positives = 107/237 (45%), Gaps = 61/237 (25%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRLARHDI 150
Y ++++GEGT+GQV + + + ELVA+K +R N+ A+ EI +LQ+L RH
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHP- 58
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLY--------DF---LRKNSYRSFPIDLVREL 199
V++ IV K S+Y D L + F ++
Sbjct: 59 ---NIVRL---------KEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-FTESQIKCY 105
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
+QLLE + ++H ++H D+K NIL+ + DG
Sbjct: 106 MKQLLEGLQYLHSNGILHRDIKGSNILI-----------------NNDGV---------- 138
Query: 260 IKLIDFG---STTFEH-QDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVEL 311
+KL DFG T + D++ V T YR PE++LG + D+WSVGCIL EL
Sbjct: 139 LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAEL 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 74/231 (32%), Positives = 107/231 (46%), Gaps = 45/231 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMI-EIDVLQRLARH- 148
Y L+++GEG +G V + D VA+K VR E + + EI +L++L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFE 59
Query: 149 --------DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG 200
D+ C R D + +VFE + L +L K P + +++L
Sbjct: 60 HPNIVRLLDV----CHGPRT--DRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLM 113
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
RQLL V F+H R++H DLKP+NIL+ S VK+ D+ L+R Y + +S
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFG-LARI-----YSFEMALTS-- 165
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
VV T YRAPEV+L + P D+WSVGCI EL
Sbjct: 166 -----------------VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-27
Identities = 63/230 (27%), Positives = 110/230 (47%), Gaps = 41/230 (17%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y I+ ++G+G+FG+V +L +K + N K RE A+ E+ +L++L H
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL--RKNSYRSFPIDLVRELGRQLLES 206
++ F+ + +CIV E G L + +K + FP + + + QL +
Sbjct: 60 ----NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA 115
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++H +++H D+KP+NI L + +G +KL DFG
Sbjct: 116 LKYLHSRKILHRDIKPQNIFL-----------------TSNGL----------VKLGDFG 148
Query: 267 -STTFEH-QDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
S D + VV T +Y +PE+ +NY D+WS+GC+L ELC+
Sbjct: 149 ISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 61/226 (26%), Positives = 103/226 (45%), Gaps = 21/226 (9%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYR--EAAMIEIDVLQRLARHD 149
++ +GEG+F VV + E + AIKI+ R + K + + IE +VL RL H
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH- 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+++ F ++ V E L ++RK Y S R ++L ++
Sbjct: 62 ---PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK--YGSLDEKCTRFYAAEILLALE 116
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDF 265
++H +IH DLKPENILL ++K+ D+ K L +S S N ++ I
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES---NKGDATNIDSQIE 173
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ + V T Y +PE++ DLW++GCI+ ++
Sbjct: 174 KNRRR----FASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQM 215
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 52/232 (22%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---------IVRSINKYREAAMIEIDVLQ 143
+Y LSK+GEG++G V +C + E ++VAIK +++ I A+ EI +L+
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKI------ALREIRMLK 55
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
+L ++ V + F + + +VFE ++ + L KN R P L++++ Q
Sbjct: 56 QLKHPNL-----VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKKIIWQT 109
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
L++V F H+ IH D+KPENIL+ K IKL
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILIT---------------------------KQGQIKLC 142
Query: 264 DFG-STTFEHQDHSYV--VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVEL 311
DFG + Y V+TR YRAPE+++G + P D+W++GC+ EL
Sbjct: 143 DFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 69/227 (30%), Positives = 103/227 (45%), Gaps = 43/227 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA---AMIEIDVLQRLARHD 149
Y++ +G G FG V + + E + VAIK + EA M EID+L+ L +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I V+ + + + I+ E SL ++K + FP LV Q+L+ +A
Sbjct: 61 I-----VKYIGSIETSDSLYIILEYAENGSLRQIIKK--FGPFPESLVAVYVYQVLQGLA 113
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++HE +IH D+K NIL +KDG +KL DFG
Sbjct: 114 YLHEQGVIHRDIKAANILT-----------------TKDGV----------VKLADFGVA 146
Query: 269 T----FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T D S VV T ++ APEVI G + D+WS+GC ++EL
Sbjct: 147 TKLNDVSKDDAS-VVGTPYWMAPEVIEMSGASTASDIWSLGCTVIEL 192
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 4e-25
Identities = 64/222 (28%), Positives = 120/222 (54%), Gaps = 32/222 (14%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
++ +L +GEG +G V++C E KE+VAIK + + +E + E+ +L+ L + +
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V+++ F R + +VFE + ++ + L + P + VR QL++++ +
Sbjct: 62 I-----VELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP-EKVRSYIYQLIKAIHW 115
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
H+ ++H D+KPEN+L+ + +K+ D+ F +R+ +GS
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGF-ARNLSEGS-------------------- 154
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ +++ V+TR YR+PE++LG + D+WSVGCIL EL
Sbjct: 155 --NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 3e-24
Identities = 71/230 (30%), Positives = 106/230 (46%), Gaps = 43/230 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA------AMIEIDVLQRLA 146
RY K+GEGT+ V + D E +VAIK ++ + A+ EI +LQ L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL- 59
Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+H I G V F ++++I +VFE + L ++ S P D ++ L
Sbjct: 60 KHPNIIGLLDV-----FGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD-IKSYMLMTLR 113
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ ++H ++H DLKP N+L+ S +K+ D+ L+RS F
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFG-LARS--------------------F 152
Query: 266 GS--TTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELC 312
GS HQ V TR YRAPE++ G + D+WSVGCI EL
Sbjct: 153 GSPNRKMTHQ-----VVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 9e-24
Identities = 63/237 (26%), Positives = 104/237 (43%), Gaps = 52/237 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARH 148
R++ +K+G GTFG+V + + EL+A+K +R I + E+ VL+ L
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIR-IQDNDPKTIKEIADEMKVLELLKHP 59
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
++ V++ +R + I F + G +L + L R ++R QLLE
Sbjct: 60 NLVKYYGVEV-----HREKVYI-FMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEG 111
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+A++H ++H D+KP NI L + IKL DFG
Sbjct: 112 LAYLHSHGIVHRDIKPANIFLD---------------------------HNGVIKLGDFG 144
Query: 267 S-------TTFEHQDHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCS 313
TT ++ + T Y APEVI G G D+WS+GC+++E+ +
Sbjct: 145 CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 1e-23
Identities = 68/227 (29%), Positives = 108/227 (47%), Gaps = 49/227 (21%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGT 153
+ K+GEGT+G V + + E+VA+K +R A+ EI +L+ L +I
Sbjct: 5 VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI--- 61
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
V++ + N + +VFE L L F+ + P+ L++ QLL+ +AF H
Sbjct: 62 --VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST----- 268
R++H DLKP+N+L+ + +G AIKL DFG
Sbjct: 120 RVLHRDLKPQNLLI-----------------NTEG----------AIKLADFGLARAFGV 152
Query: 269 ---TFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVEL 311
T+ H+ V T YRAPE++LG ++ D+WS+GCI E+
Sbjct: 153 PVRTYTHE-----VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 6e-23
Identities = 63/239 (26%), Positives = 96/239 (40%), Gaps = 59/239 (24%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEIDVLQR 144
RY +L +G G +G V D VAIK + ++ RE I +L+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILRE-----IKLLRH 55
Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGR--- 201
L +I G + + N + IV E + L+ ++ P L + +
Sbjct: 56 LRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS------PQPLTDDHIQYFL 109
Query: 202 -QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
Q+L + ++H +IH DLKP NIL+ N + +
Sbjct: 110 YQILRGLKYLHSANVIHRDLKPSNILV-------------------------N--SNCDL 142
Query: 261 KLIDFG-----STTFEHQDH--SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVEL 311
K+ DFG + + YVV TR YRAPE++L + D+WSVGCI EL
Sbjct: 143 KICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL 200
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 8e-23
Identities = 68/237 (28%), Positives = 112/237 (47%), Gaps = 43/237 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSIN-KYREAAMIEIDVLQRLARHD 149
+++L K+G+G++G V + + A+K V S++ K RE A+ EI +L + +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSY--RSFPIDLVRELGRQLLE 205
I + + F N +CIV E G L + K + P + + QLL
Sbjct: 61 I-----ISYKEAFLDGNKLCIVMEYAPFG-DLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ +HE +++H DLK NILLV+ + VK+ D +S+ K KN+ K+
Sbjct: 115 GLQALHEQKILHRDLKSANILLVANDLVKIGDLG-ISKVLK-----KNMAKT-------- 160
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
+ T HY APEV G ++Y D+WS+GC+L E+ + + PF
Sbjct: 161 ------------QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA----PPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 96.1 bits (240), Expect = 1e-22
Identities = 75/246 (30%), Positives = 116/246 (47%), Gaps = 60/246 (24%)
Query: 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV-----------RSINKYREA 134
I +++ +Y IL K+G+G +G V + D KE+VA+K + R+ +RE
Sbjct: 1 IDKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRT---FRE- 56
Query: 135 AMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNH--ICIVFEKLGPSLYDFLRKNSYRSF 191
I LQ L H I V++ N N I +VFE + L+ +R N
Sbjct: 57 ----IMFLQELGDHPNI-----VKLLNVIKAENDKDIYLVFEYMETDLHAVIRAN----- 102
Query: 192 PIDLVRELGR-----QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
++ ++ + QLL+++ ++H +IH DLKP NILL S VK+ D+ L+RS
Sbjct: 103 ---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFG-LARS-- 156
Query: 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVG 305
+ E+ + V+TR YRAPE++LG D+WSVG
Sbjct: 157 ----------------LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVG 200
Query: 306 CILVEL 311
CIL E+
Sbjct: 201 CILGEM 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (234), Expect = 2e-22
Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 48/231 (20%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMI--EIDVLQRLARHDIGGTRCV 156
G+G+FG+V+ + +L A+K+++ I K +E E ++L R+ H V
Sbjct: 2 GKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPF----IV 56
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
++ F + +V E G L+ L K F + R +++ ++ ++H L +
Sbjct: 57 KLHYAFQTEEKLYLVLEYAPGGELFSHLSK--EGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS----TTFE 271
I+ DLKPENILL DG IKL DFG ++
Sbjct: 115 IYRDLKPENILL-----------------DADGH----------IKLTDFGLAKELSSEG 147
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
+ +++ T Y APEV+LG G+ D WS+G +L E+ PF
Sbjct: 148 SRTNTF-CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEML----TGKPPF 193
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 94.6 bits (235), Expect = 2e-22
Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 35/227 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRLARHD 149
+Y ++++G G +G V + D VA+K VR + + E+ +L+RL D
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 150 IGGTR-----CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
C R D + +VFE + L +L K P + +++L RQ L
Sbjct: 61 HPNIVRLMDVCATSRT--DRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+ F+H ++H DLKPENIL+ S VK+ D+ ++ S
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGL----ARIYSC-------------- 160
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ VV T YRAPEV+L + P D+WSVGCI E+
Sbjct: 161 -------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-22
Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 103 GTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARHDIGGTRCVQI 158
G +G+V ++ AIK+++ + R+ + E D+L + + V++
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYV-----VKL 58
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
F + ++ +V E L G L L + S D+ R +++ ++ ++H +IH
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIAEIVLALEYLHSNGIIH 116
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
DLKP+NIL+ S ++K+ D+ SK G + + + K +
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGL----SKVGLVRRQINLNDDEK------------EDKR 160
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+V T Y APEVILG G + D WS+GCIL E
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEF 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 3e-22
Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 45/227 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
Y+ L K+GEG G+V + D + VAIK +R + +E + EI +++ +I
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI--- 77
Query: 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRE----LGRQLLESVA 208
V + + + + +V E + G SL D + +N + + + R++L+ +
Sbjct: 78 --VDYYDSYLVGDELWVVMEYMDGGSLTDIITQN-----FVRMNEPQIAYVCREVLQGLE 130
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
++H +IH D+K +NILL SKDGS +KL DFG
Sbjct: 131 YLHSQNVIHRDIKSDNILL-----------------SKDGS----------VKLADFGFA 163
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
T E + VV T ++ APEVI + D+WS+G + +E+
Sbjct: 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-22
Identities = 70/226 (30%), Positives = 111/226 (49%), Gaps = 40/226 (17%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK--IVRSINKY-REAAMIEIDVLQRLARHD 149
+Y L +GEG++G V++C E ++VAIK + +K ++ AM EI +L++L RH+
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHE 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
V + F + + +VFE + ++ D L K VR+ Q+L + F
Sbjct: 61 ----NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEF 115
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 268
H +IH D+KPENIL VS +S +KL DFG +
Sbjct: 116 CHSHNIIHRDIKPENIL-VS--------------------------QSGVVKLCDFGFAR 148
Query: 269 TFEHQDHSYV--VSTRHYRAPEVILG-LGWNYPCDLWSVGCILVEL 311
T Y V+TR YRAPE+++G + D+W+VGC++ E+
Sbjct: 149 TLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEM 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 8e-22
Identities = 68/233 (29%), Positives = 107/233 (45%), Gaps = 53/233 (22%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARHD 149
Y+ + K+GEGT+G V + D E+VA+K +R + E A+ EI +L+ L H
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIR-LETEDEGVPSTAIREISLLKEL-NHP 58
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
V++ + N + +VFE L L ++ + L++ QLL+ +A+
Sbjct: 59 ----NIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST- 268
H R++H DLKP+N+L + + A+KL DFG
Sbjct: 115 CHSHRVLHRDLKPQNLL---------------------------IDREGALKLADFGLAR 147
Query: 269 -------TFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELC 312
T+ H+ V T YRAPE++LG Y P D+WS+GCI E+
Sbjct: 148 AFGVPVRTYTHE-----VVTLWYRAPEILLG-SRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-21
Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 35/219 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV------RSINKYREAAMIEIDVLQRLARHDIGGT 153
+G+G FG+V C+D + +A+K V K A EI +L+ L +H+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHE---- 64
Query: 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
R VQ + I E + G S+ D L+ +Y + + R+ RQ+LE V ++H
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK--AYGALTETVTRKYTRQILEGVEYLHS 122
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
++H D+K NIL SA VK+ D+ +SK + I S T
Sbjct: 123 NMIVHRDIKGANILRDSAGNVKLGDFG----ASK---------RLQTICS----SGTGM- 164
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
V T ++ +PEVI G G+ D+WSVGC +VE+
Sbjct: 165 ---KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEM 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 1e-21
Identities = 68/239 (28%), Positives = 112/239 (46%), Gaps = 54/239 (22%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
+Y L+K+G+GTFG+V + + K++VA+K V N+ +E A+ EI +LQ L +H
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLL-KH 70
Query: 149 D-------IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+ I T+ Y+ +VFE L L N F + ++++ +
Sbjct: 71 ENVVNLIEICRTKATPYNR---YKGSFYLVFEFCEHDLAGLL-SNKNVKFTLSEIKKVMK 126
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
LL + ++H +++H D+K NIL+ +KDG +K
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILI-----------------TKDG----------ILK 159
Query: 262 LIDFG-----STTFEHQDHSYV--VSTRHYRAPEVILGLGWNY--PCDLWSVGCILVEL 311
L DFG S + + + Y V T YR PE++LG +Y P D+W GCI+ E+
Sbjct: 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 4e-21
Identities = 66/229 (28%), Positives = 106/229 (46%), Gaps = 27/229 (11%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRL 145
++ PRY+ LS +GEG +G V VAIK + + + + EI +L+R
Sbjct: 1 FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF 60
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+I G + F+ N + IV E + LY ++ + D ++ Q+L
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSN---DHIQYFLYQILR 117
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ ++H ++H DLKP N+LL + +K+ D+ L+R A D
Sbjct: 118 GLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFG-LAR--------------IADPEHDH 162
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCS 313
E+ V+TR YRAPE++L G+ D+WSVGCIL E+ S
Sbjct: 163 TGFLTEY------VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-20
Identities = 68/225 (30%), Positives = 99/225 (44%), Gaps = 44/225 (19%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARHDIGG 152
L+++GEGT+G V D E+VA+K VR ++ R+ I EI +L L RH
Sbjct: 12 LNRIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLREITLLLNL-RH---- 65
Query: 153 TRCVQIRNWF--DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V+++ + + I +V E L L N F V+ L QLL + ++
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL-DNMPTPFSESQVKCLMLQLLRGLQYL 124
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STT 269
HE +IH DLK N+LL +K+ DFG + T
Sbjct: 125 HENFIIHRDLKVSNLLLTD---------------------------KGCLKIADFGLART 157
Query: 270 FEHQDHSY--VVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVEL 311
+ V T YRAPE++LG + D+W+VGCIL EL
Sbjct: 158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAEL 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-20
Identities = 70/228 (30%), Positives = 104/228 (45%), Gaps = 35/228 (15%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---EAAMIEIDVLQRLARHDI 150
Y L K+GEGT+G+V + D +LVA+K R A+ EI +LQ L+ I
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLS-ESI 61
Query: 151 GGTRCVQIRNWFDYRNHICI--VFEKLGPSLYDFL---RKNSYRSFPIDLVRELGRQLLE 205
R + + + + + VFE L L F+ + R P ++ QLL+
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 206 SVAFMHELRLIHTDLKPENILL-VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
VA H+ ++H DLKP+N+L+ +K+ D L R+ I
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLG-LGRAFS----------------IP 164
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVEL 311
S T E + T YRAPEV+LG ++ P D+WSVGCI E+
Sbjct: 165 VKSYTHE-------IVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 44/228 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARHD 149
Y L+++ EGT+G V D + E+VA+K ++ + K +E ++ EI++L +L +H
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLK-MEKEKEGFPITSLREINILLKL-QHP 64
Query: 150 IGGTRCVQIRNWF--DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
V ++ + I +V E + L + + + F V+ L QLL V
Sbjct: 65 ----NIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLM-ETMKQPFLQSEVKCLMLQLLSGV 119
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
A +H+ ++H DLK N+LL + G +K+ DFG
Sbjct: 120 AHLHDNWILHRDLKTSNLLL-----------------NNRG----------ILKICDFGL 152
Query: 267 STTFEHQDHSY--VVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVEL 311
+ + Y +V T YRAPE++LG ++ D+WSVGCI EL
Sbjct: 153 AREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAEL 200
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 62/227 (27%), Positives = 94/227 (41%), Gaps = 41/227 (18%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRCV 156
G G FG+V K A+K V R I + + I E ++L+ H V
Sbjct: 2 GVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILE-ECNHPF----IV 56
Query: 157 QIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
++ F + +I ++ E LG L+ LR F R ++ + ++H +
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGI 114
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
I+ DLKPEN+LL S YVK+ D+ F K + G T+
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGF-------------------AKKLKSGQKTWT---- 151
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
T Y APE+IL G+++ D WS+G +L EL PF
Sbjct: 152 --FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELL----TGRPPF 192
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 4e-20
Identities = 65/232 (28%), Positives = 111/232 (47%), Gaps = 49/232 (21%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIG 151
++ L K+GEGT+ V + + E+VA+K + + A+ EI +++ L +I
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI- 60
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYR-SFPIDLVRELGRQLLESVAFM 210
V++ + N + +VFE + L ++ + R + + V+ QLL+ +AF
Sbjct: 61 ----VRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFC 116
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---- 266
HE R++H DLKP+N+L+ +K G +KL DFG
Sbjct: 117 HENRVLHRDLKPQNLLI-----------------NKRGE----------LKLADFGLARA 149
Query: 267 ----STTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
TF ++ V T YRAP+V+LG ++ D+WSVGCI+ E+ +
Sbjct: 150 FGIPVNTFSNE-----VVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 8e-20
Identities = 60/228 (26%), Positives = 104/228 (45%), Gaps = 17/228 (7%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAA-MIEIDVLQRLARH 148
+ ++ +G G FG+V D + ++ A+K++R I + + A E D+L
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V++ F H+ +V E + G L + L + FP + R +L+ ++
Sbjct: 62 WI-----VKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR--KDVFPEETARFYIAELVLAL 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR--SSKDGSYFKNLPKSSAIKLIDF 265
+H+L IH D+KP+NIL+ + ++K+ D+ + +KD Y+ N + +
Sbjct: 115 DSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 266 GSTTFEHQDHSY---VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
Q V T Y APEV+ G + CD WS+G IL E
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 8e-20
Identities = 60/249 (24%), Positives = 108/249 (43%), Gaps = 40/249 (16%)
Query: 85 AIGENLTPRYRILSK-MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI------ 137
+ +++ RY +GEGT+G+V + +D ++VAIK V+ I +
Sbjct: 1 NMSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVK-IIEISNDVTKDRQLVG 59
Query: 138 ----------EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK-- 185
E+ ++ + +I G V + F I +V + + D L+K
Sbjct: 60 MCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF-----INLVMDIMA---SD-LKKVV 110
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
+ V+ + Q+L + +H+ +H DL P NI + S K+ D+ L+R
Sbjct: 111 DRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG-LARRY 169
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSV 304
Y L K ++ ++ + V T YRAPE+++G +++ D+WSV
Sbjct: 170 GYPPYSDTLSKDETMQR---------REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSV 220
Query: 305 GCILVELCS 313
GCI EL +
Sbjct: 221 GCIFAELLT 229
|
Length = 335 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-19
Identities = 65/229 (28%), Positives = 105/229 (45%), Gaps = 38/229 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLAR 147
+Y ++++GEG +G+V + D VA+K VR + E + + E+ VL+ L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLET 60
Query: 148 HDIGGTR-----CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
+ C R D + +VFE + L +L K P + ++++ Q
Sbjct: 61 FEHPNVVRLFDVCTVSRT--DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
LL + F+H R++H DLKP+NIL+ S+ +K+ D+ ++
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL-------------------ARI 159
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
F + VV T YRAPEV+L + P DLWSVGCI E+
Sbjct: 160 YSFQMAL------TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 3e-19
Identities = 59/232 (25%), Positives = 99/232 (42%), Gaps = 55/232 (23%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR----LARH 148
+ +L +G+G+FG+V + D ++VAIK++ E A EI+ +Q+ L+
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-----LEEAEDEIEDIQQEIQFLS-- 54
Query: 149 DIGGTRCVQIRNWF-----DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
R I ++ + + I+ E G S D L+ + + R+
Sbjct: 55 ---QCRSPYITKYYGSFLKGSK--LWIIMEYCGGGSCLDLLK---PGKLDETYIAFILRE 106
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+L + ++HE IH D+K NILL S++G +KL
Sbjct: 107 VLLGLEYLHEEGKIHRDIKAANILL-----------------SEEGD----------VKL 139
Query: 263 IDFGST---TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
DFG + T + V T + APEVI G++ D+WS+G +EL
Sbjct: 140 ADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIEL 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-19
Identities = 65/238 (27%), Positives = 106/238 (44%), Gaps = 44/238 (18%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
++I K+G+G F V + +VA+K V+ K R+ + EID+L++L +
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLR-----KNSYRSFPIDLVRELGRQLL 204
+ ++ F N + IV E L + D R K R P + + QL
Sbjct: 64 V-----IKYLASFIENNELNIVLE-LADA-GDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
++ MH R++H D+KP N+ + + VK+ D G +F SS
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGL-------GRFF-----SS------ 158
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
TT H +V T +Y +PE I G+N+ D+WS+GC+L E+ +PF
Sbjct: 159 --KTTAAHS----LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA----ALQSPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-19
Identities = 72/235 (30%), Positives = 116/235 (49%), Gaps = 50/235 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMI--EIDVLQRLARH- 148
RY+I +G+G++G V D E VAIK + + ++ +A I EI +L RL RH
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLL-RLLRHP 59
Query: 149 DIGGTRCVQIRNWF------DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGR- 201
DI V+I++ ++++ I +VFE + L+ ++ N DL E +
Sbjct: 60 DI-----VEIKHIMLPPSRREFKD-IYVVFELMESDLHQVIKAND------DLTPEHHQF 107
Query: 202 ---QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
QLL ++ ++H + H DLKP+NIL + +K+ D+ L+R + F + P +
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFG-LARVA-----FNDTP--T 159
Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVEL 311
AI D+ V+TR YRAPE+ Y D+WS+GCI E+
Sbjct: 160 AIFWTDY-------------VATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 201
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 9e-19
Identities = 57/224 (25%), Positives = 95/224 (42%), Gaps = 44/224 (19%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI------EIDVLQRLARHDIGGT 153
+G G+FG V E + + + A+K V + + EI +L +L +I
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI--- 64
Query: 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
VQ +++ I E + G SL L+K Y SFP ++R RQ+L + ++H+
Sbjct: 65 --VQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST--TF 270
+H D+K NIL+ +G +KL DFG
Sbjct: 121 RNTVHRDIKGANILV-----------------DTNG----------VVKLADFGMAKQVV 153
Query: 271 EHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCS 313
E + ++ APEVI G + D+WS+GC ++E+ +
Sbjct: 154 EFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT 197
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 72/241 (29%), Positives = 111/241 (46%), Gaps = 47/241 (19%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVL 142
G+ ++ I+ ++GEGT+GQV + D + ELVA+K VR N+ +E A+ EI +L
Sbjct: 2 GKRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKIL 60
Query: 143 QRLARHDIGGTRCVQI----RNWFDYRNH---ICIVFEKLGPSLYDFLRKNSYRSFPIDL 195
++L +I +I ++ D++ +VFE + L L ++ F D
Sbjct: 61 RQLNHRNI--VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL-ESGLVHFSEDH 117
Query: 196 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255
++ +QLLE + + H+ +H D+K NILL
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---------------------------N 150
Query: 256 KSSAIKLIDFGSTTFEHQDHS--YV--VSTRHYRAPEVILGLGWNYPC-DLWSVGCILVE 310
IKL DFG + + S Y V T YR PE++LG P D+WS GCIL E
Sbjct: 151 NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGE 210
Query: 311 L 311
L
Sbjct: 211 L 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-18
Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 46/226 (20%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ IL K+GEG++G V + E ++VAIK+V + + + + EI +L++
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQ--------C 55
Query: 154 RCVQIRNWFD---YRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I ++ + IV E G S+ D ++ + ++ + + + Q L+ +
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAG-SVSDIMKITN-KTLTEEEIAAILYQTLKGLE 113
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 267
++H + IH D+K NILL +++G KL DFG S
Sbjct: 114 YLHSNKKIHRDIKAGNILL-----------------NEEG----------QAKLADFGVS 146
Query: 268 TTFEH--QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ V+ T + APEVI +G+N D+WS+G +E+
Sbjct: 147 GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-18
Identities = 66/232 (28%), Positives = 110/232 (47%), Gaps = 50/232 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
+Y + K+GEGT+G V + D E +A+K +R + + E A+ EI +L+ +
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIR-LEQEDEGVPSTAIREISLLKEMQHG 61
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+I V++++ + +VFE L L + + + L++ Q+L +A
Sbjct: 62 NI-----VRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+ H R++H DLKP+N+L + R ++A+KL DFG
Sbjct: 117 YCHSHRVLHRDLKPQNLL--------------IDRR------------TNALKLADFGLA 150
Query: 269 --------TFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVEL 311
TF H+ V T YRAPE++LG ++ P D+WSVGCI E+
Sbjct: 151 RAFGIPVRTFTHE-----VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEM 197
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 67/228 (29%), Positives = 106/228 (46%), Gaps = 44/228 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+Y L K+GEGT+G V + + E E+VA+K VR ++ E +A+ EI +L+ L
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKHK 59
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK-NSYRSFPIDLVRELGRQLLESV 207
+I V++ + + +VFE L + N I V+ QLL+ +
Sbjct: 60 NI-----VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI--VKSFMFQLLKGL 112
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
AF H ++H DLKP+N+L+ +K+G +KL DFG
Sbjct: 113 AFCHSHNVLHRDLKPQNLLI-----------------NKNGE----------LKLADFGL 145
Query: 267 --STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVEL 311
+ + +S V T YR P+V+ G ++ D+WS GCI EL
Sbjct: 146 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 63/243 (25%), Positives = 105/243 (43%), Gaps = 55/243 (22%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
Y IL K+GEGTFG+V + + +VA+K + ++ ++ A+ EI +L++L
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKI-LMHNEKDGFPITALREIKILKKLKHP 67
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI---DLVRELG----- 200
++ V + I + E+ P R + Y P DL L
Sbjct: 68 NV-----VPL---------IDMAVER--PDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK 111
Query: 201 ----------RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250
QLLE + ++HE ++H D+K NIL+ + +K+ D+ L+R
Sbjct: 112 LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG-LARPYDGPPP 170
Query: 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCIL 308
N G T ++ +V TR YR PE++LG Y D+W +GC+
Sbjct: 171 --NPKGGGG------GGTR----KYTNLVVTRWYRPPELLLGER-RYTTAVDIWGIGCVF 217
Query: 309 VEL 311
E+
Sbjct: 218 AEM 220
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-17
Identities = 56/225 (24%), Positives = 100/225 (44%), Gaps = 43/225 (19%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKI--VRSINKYREAAMIEIDVLQRLARHDIGG 152
+ +G+G+ G V + ++ A+K V ++R+ + E+ L+ +
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV-- 61
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V+ F I IV E + G SL D L+K P ++ + RQ+L+ + ++H
Sbjct: 62 ---VKCYGAFYKEGEISIVLEYMDGGSLADLLKK--VGKIPEPVLAYIARQILKGLDYLH 116
Query: 212 -ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STT 269
+ +IH D+KP N+L+ + G +K+ DFG S
Sbjct: 117 TKRHIIHRDIKPSNLLI-----------------NSKGE----------VKIADFGISKV 149
Query: 270 FEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
E+ Q +++ V T Y +PE I G ++Y D+WS+G L+E
Sbjct: 150 LENTLDQCNTF-VGTVTYMSPERIQGESYSYAADIWSLGLTLLEC 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-17
Identities = 64/228 (28%), Positives = 108/228 (47%), Gaps = 44/228 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---EAAMIEIDVLQRLARHDI 150
Y + K+GEGT+G V + + + ++VA+K +R ++ A+ EI +L+ L +I
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSL---YDFLRKNSYRSFPIDLVRELGRQLLESV 207
V +++ + + ++FE L L D L K Y +LV+ Q+L+ +
Sbjct: 62 -----VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQY--MDAELVKSYLYQILQGI 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
F H R++H DLKP+N+L+ IKL DFG
Sbjct: 115 LFCHSRRVLHRDLKPQNLLI---------------------------DNKGVIKLADFGL 147
Query: 267 --STTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVEL 311
+ + +++ V T YRAPEV+LG ++ P D+WS+G I E+
Sbjct: 148 ARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEM 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 9e-17
Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 33/229 (14%)
Query: 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAI-KIVRSINKYREA--AMIEIDVLQRLA 146
+ RY+ + +G G +G V D + VAI KI + + A + E+ +L+
Sbjct: 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK 62
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+I R + D++ + +V + + L+ + + + + +R QLL
Sbjct: 63 HDNIIAIRDILRPPGADFK-DVYVVMDLMESDLHHIIHSD--QPLTEEHIRYFLYQLLRG 119
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLI 263
+ ++H +IH DLKP N+L+ +++ D+ + LS S + YF
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT---------- 169
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVEL 311
E+ V+TR YRAPE++L L + D+WSVGCI E+
Sbjct: 170 -------EY------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-16
Identities = 71/253 (28%), Positives = 107/253 (42%), Gaps = 66/253 (26%)
Query: 81 HYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSIN 129
Y +G++ + RY+ L +G G G V +D + VAIK + +
Sbjct: 2 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKR 61
Query: 130 KYREAAMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS 187
YRE VL +L H IG + + + +V E + +L ++
Sbjct: 62 AYREL------VLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ--- 112
Query: 188 YRSFPIDLVRE----LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243
+DL E L Q+L + +H +IH DLKP NI++ S
Sbjct: 113 -----MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS-------------- 153
Query: 244 SSKDGSYFKNLPKSSAIKLIDFG-----STTFEHQDHSYVVSTRHYRAPEVILGLGWNYP 298
+K++DFG T+F YVV TR+YRAPEVILG+G+
Sbjct: 154 -------------DCTLKILDFGLARTAGTSFMMTP--YVV-TRYYRAPEVILGMGYKEN 197
Query: 299 CDLWSVGCILVEL 311
D+WSVGCI+ E+
Sbjct: 198 VDIWSVGCIMGEM 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 65/249 (26%), Positives = 99/249 (39%), Gaps = 85/249 (34%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
RY+ LS +G G +GQV FD + VAIK + + YRE R
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYREL---------R 66
Query: 145 LARHDIGGTRCVQIRNWFDYRNHIC------------------IVFEKLGPSLYDFLRKN 186
L +H D+ N I +V +G L + ++
Sbjct: 67 LLKH-------------MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC- 112
Query: 187 SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
+ D ++ L Q+L + ++H +IH DLKP NI
Sbjct: 113 --QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNI--------------------- 149
Query: 247 DGSYFKNLPKSSAIKLIDFG---STTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLW 302
+ + +K++DFG T E + V+TR YRAPE++L + +N D+W
Sbjct: 150 ------AVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYNQTVDIW 200
Query: 303 SVGCILVEL 311
SVGCI+ EL
Sbjct: 201 SVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 61/230 (26%), Positives = 106/230 (46%), Gaps = 41/230 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVLQRLARHDIGG 152
+ I+ ++G+G FG+V + + E L A K++ + ++ E M+EID+L +I
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI-- 64
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
V++ + F Y N++ I+ E D + R +R + +Q LE++ ++HE
Sbjct: 65 ---VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---STT 269
++IH DLK NIL + DG IKL DFG T
Sbjct: 122 NKIIHRDLKAGNILF-----------------TLDGD----------IKLADFGVSAKNT 154
Query: 270 FEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSV 314
Q + T ++ APEV++ ++Y D+WS+G L+E+ +
Sbjct: 155 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQI 204
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 67/238 (28%), Positives = 105/238 (44%), Gaps = 49/238 (20%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKI-----VRSINKYREAAMIEIDVLQRLARH 148
++IL+++G+G +GQV + E+VA+K + +N+ R + E D+L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHV-LTERDILTT-TKS 60
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ V++ F ++ + E + G L N+ D R ++ E+V
Sbjct: 61 EW----LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAV 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
+HEL IH DLKPEN L+ G IKL DFG
Sbjct: 115 DALHELGYIHRDLKPENFLI-----------------DASGH----------IKLTDFGL 147
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE-LCSVSNCYLTPFA 323
S +S VV + Y APEV+ G G+++ D WS+GC+L E LC PF+
Sbjct: 148 SKGIVTYANS-VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGF-----PPFS 199
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-16
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 33/224 (14%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVLQRLARHD 149
Y + +G+G FG+ E LV K V R K R A+ EI +L L +
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I + N F N + I E G +LYD + + + F ++V Q++ +V+
Sbjct: 61 I-----IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS 115
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++H+ ++H D+K NI L A +K+ D+ S GS + +
Sbjct: 116 YIHKAGILHRDIKTLNIFLTKAGLIKLGDFGI---SKILGSEYS-------------MAE 159
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
T VV T +Y +PE+ G+ +N+ D+W++GC+L EL
Sbjct: 160 T--------VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 57/232 (24%), Positives = 107/232 (46%), Gaps = 45/232 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVLQRLARHDIGG 152
+ I+ ++G+G FG+V + + E L A K++ + ++ E M+EI++L I
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI-- 71
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
V++ F + + I+ E D + R ++ + RQ+LE++ ++H
Sbjct: 72 ---VKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST---- 268
+++IH DLK N+LL + DG IKL DFG +
Sbjct: 129 MKIIHRDLKAGNVLL-----------------TLDGD----------IKLADFGVSAKNV 161
Query: 269 -TFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSV 314
T + +D + T ++ APEV++ ++Y D+WS+G L+E+ +
Sbjct: 162 KTLQRRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 211
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-16
Identities = 60/235 (25%), Positives = 107/235 (45%), Gaps = 43/235 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
+Y + K+GEG+FG+ + E + IK I + K RE + E+ VL + +
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I VQ + F+ ++ IV + G LY + FP D + + Q+ ++
Sbjct: 61 I-----VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK 115
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
+H+ +++H D+K +NI L +KDG IKL DFG
Sbjct: 116 HVHDRKILHRDIKSQNIFL-----------------TKDG----------TIKLGDFGIA 148
Query: 267 ---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318
++T E + T +Y +PE+ +N D+W++GC+L E+C++ + +
Sbjct: 149 RVLNSTVELA--RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 9e-16
Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 37/227 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR------SINKYREAAMIEIDVLQRLAR 147
+R+ +G+G FG+V C+D + +A+K V+ +K A EI +L+ L
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 148 HDIGGTRCVQIRNWF-DYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLL 204
R VQ D +F + P S+ D L+ SY + ++ R+ RQ+L
Sbjct: 64 E-----RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK--SYGALTENVTRKYTRQIL 116
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
E V+++H ++H D+K NIL S VK+ D+ S ++ I
Sbjct: 117 EGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFG----------------ASKRLQTIC 160
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T + V T ++ +PEVI G G+ D+WSVGC +VE+
Sbjct: 161 LSGTGMKS-----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-16
Identities = 64/246 (26%), Positives = 106/246 (43%), Gaps = 61/246 (24%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREA--AMIEIDVLQRLA 146
RY + ++G+G+FG V D + +K+++ I E A E +L +L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR--KNSYRSFPIDLVRELGRQL 203
I V+ F R+ CI+ E G L L K++ ++ + V E QL
Sbjct: 61 HPAI-----VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
L V +MH+ R++H DLK +NI L K++ +K+
Sbjct: 116 LLGVHYMHQRRILHRDLKAKNIFL----------------------------KNNLLKIG 147
Query: 264 DFG-----------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
DFG +TTF T +Y +PE + G++ D+WS+GCIL E+C
Sbjct: 148 DFGVSRLLMGSCDLATTF--------TGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMC 199
Query: 313 SVSNCY 318
+++ +
Sbjct: 200 CLAHAF 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-15
Identities = 63/234 (26%), Positives = 99/234 (42%), Gaps = 43/234 (18%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA--MIEIDVLQRL 145
N + I+ ++G+G FG+V + E A KI++ I E M+EID+L
Sbjct: 1 VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQ-IESEEELEDFMVEIDILSEC 59
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+H V + + Y N + I+ E D + R +R + RQ+LE
Sbjct: 60 -KHP----NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
++ F+H ++IH DLK NILL DG +KL DF
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTL-----------------DGD----------VKLADF 147
Query: 266 GST---TFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVEL 311
G + Q + T ++ APEV+ ++Y D+WS+G L+EL
Sbjct: 148 GVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 61/226 (26%), Positives = 102/226 (45%), Gaps = 42/226 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVR-----SINKYREAAMI-----EIDVLQRLARHD 149
+G G+FG V + EL+A+K V + +K R+ +M+ EI +L+ L +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I VQ +H+ I E + G S+ L N+Y +F LVR RQ+L+ +
Sbjct: 68 I-----VQYLGSSLDADHLNIFLEYVPGGSVAALL--NNYGAFEETLVRNFVRQILKGLN 120
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY---KFLSRSSKDGSYFKNLPKSSAIKLIDF 265
++H +IH D+K NIL+ + +K+ D+ K L +S P
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS--------L 172
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ F + APEV+ + D+WS+GC++VE+
Sbjct: 173 QGSVF-------------WMAPEVVKQTSYTRKADIWSLGCLVVEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 3e-15
Identities = 53/233 (22%), Positives = 90/233 (38%), Gaps = 49/233 (21%)
Query: 95 RILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARH 148
+ K+GEG FG+V + + K+ VA+K ++ ++ E ++++L H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DH 60
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+G C + + IV E G L D+LRKN + + +
Sbjct: 61 PNIVKLLGV--CTE-------EEPLMIVMEYMPGG-DLLDYLRKNRPKELSLSDLLSFAL 110
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAI 260
Q+ + ++ IH DL N L+ VK+ D F LSR D Y+K I
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISD--FGLSRDLYDDDYYKVKGGKLPI 168
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ + APE + + D+WS G +L E+ +
Sbjct: 169 R----------------------WMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 58/233 (24%), Positives = 105/233 (45%), Gaps = 53/233 (22%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
RY+ L+ +G G +G V +D ++ VA+K ++ + YRE + +L+
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRE-----LRLLKH 70
Query: 145 LARHDIGG-----TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL 199
+ ++ G T I N+ N + +V +G L + ++ + + V+ L
Sbjct: 71 MKHENVIGLLDVFTPATSIENF----NEVYLVTNLMGADLNNIVK---CQKLSDEHVQFL 123
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
QLL + ++H +IH DLKP N+ + +
Sbjct: 124 IYQLLRGLKYIHSAGIIHRDLKPSNVAV---------------------------NEDCE 156
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVEL 311
++++DFG + + V+TR YRAPE++L + +N D+WSVGCI+ EL
Sbjct: 157 LRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 5e-15
Identities = 58/242 (23%), Positives = 107/242 (44%), Gaps = 46/242 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDI 150
Y +L +G+G+FG V + +++ K + N K ++ + E+++L+ L +I
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 151 GGTRCVQIRNWF-DYRNH-ICIVFEKL-GPSLYDFLRK--NSYRSFPIDLVRELGRQLLE 205
V+ + D N + IV E G L ++K + + + + QLL
Sbjct: 62 -----VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 206 SVAFMHEL-----RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
++ H ++H DLKP NI L + VK+ D+ L++ S F
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG-LAKILGHDSSF--------- 166
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320
+ T+ V T +Y +PE + + ++ D+WS+GC++ ELC++S
Sbjct: 167 ------AKTY--------VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS----P 208
Query: 321 PF 322
PF
Sbjct: 209 PF 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 5e-15
Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 47/230 (20%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK--------IVRSINKYREAAMIEIDVLQR 144
RY+ LS +G G +G V FD + VA+K I+ + YRE ++ +
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL------K 71
Query: 145 LARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
+H+ IG + N + +V +G L + ++ + D V+ L Q
Sbjct: 72 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQ 128
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+L + ++H +IH DLKP N+ + + +K+
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAV---------------------------NEDCELKI 161
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVEL 311
+DFG + + V+TR YRAPE++L + +N D+WSVGCI+ EL
Sbjct: 162 LDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 8e-15
Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 47/230 (20%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDI 150
Y ++ ++G GT+G V + D ELVAIK++ + + +I EI +L+ RH
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI-KLEPGDDFEIIQQEISMLKE-CRHP- 60
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
V + R+ + IV E G SL D + + + R+ L+ +A+
Sbjct: 61 ---NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAY 116
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--- 266
+HE IH D+K NILL ++DG +KL DFG
Sbjct: 117 LHETGKIHRDIKGANILL-----------------TEDGD----------VKLADFGVSA 149
Query: 267 --STTFEHQDHSYVVSTRHYRAPEVI---LGLGWNYPCDLWSVGCILVEL 311
+ T + T ++ APEV G++ CD+W++G +EL
Sbjct: 150 QLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-15
Identities = 66/228 (28%), Positives = 109/228 (47%), Gaps = 39/228 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV------RSINKYREAAMIEIDVLQRLAR 147
+R+ +G G FG+V C+D + +A+K V + +K A EI +L+ L R
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-R 62
Query: 148 HDIGGTRCVQ----IRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
HD R VQ +R+ + + I + + G S+ D L+ +Y + ++ R RQ+
Sbjct: 63 HD----RIVQYYGCLRDPEEKKLSIFVEYMP-GGSIKDQLK--AYGALTENVTRRYTRQI 115
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
L+ V+++H ++H D+K NIL SA VK+ D+ S I+ I
Sbjct: 116 LQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFG----------------ASKRIQTI 159
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T + V T ++ +PEVI G G+ D+WSV C +VE+
Sbjct: 160 CMSGTGIKS-----VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 40/229 (17%)
Query: 93 RYRILSKMGEGTFGQ---VVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
+Y +L +GEG+FG+ V ++K + I++ +S + E + E +L ++ +
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAV-EDSRKEAVLLAKMKHPN 59
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I V + F+ H+ IV E G L ++ + FP D + + Q+ V
Sbjct: 60 I-----VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ 114
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+HE R++H D+K +NI FL+++ K +KL DFGS
Sbjct: 115 HIHEKRVLHRDIKSKNI--------------FLTQNGK-------------VKLGDFGSA 147
Query: 269 TFEHQDHSYV---VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSV 314
+Y V T +Y PE+ + +N D+WS+GCIL ELC++
Sbjct: 148 RLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 61/249 (24%), Positives = 98/249 (39%), Gaps = 70/249 (28%)
Query: 93 RYRILSKMGEGTFGQVVECF--DNEKKELVAIKIVRSINK---------YREAAMI-EID 140
+Y I +G GT+G+V + + + + AIK + + RE A++ E+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 141 -----VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFL------RKNSYR 189
L + + V + FDY H D R+
Sbjct: 61 HENVVSLVEVFLEH--ADKSVYLL--FDYAEH-------------DLWQIIKFHRQAKRV 103
Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
S P +V+ L Q+L V ++H ++H DLKP NIL++ +G
Sbjct: 104 SIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMG-----------------EG- 145
Query: 250 YFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGLG-WNYPCDLW 302
P+ +K+ D G + D VV T YRAPE++LG + D+W
Sbjct: 146 -----PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIW 200
Query: 303 SVGCILVEL 311
++GCI EL
Sbjct: 201 AIGCIFAEL 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 63/225 (28%), Positives = 109/225 (48%), Gaps = 37/225 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA----MIEIDVLQRLARHD 149
Y L K+GEGT+ V + + LVA+K +R ++ E A + E+ +L+ L +
Sbjct: 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRL--EHEEGAPCTAIREVSLLKNLKHAN 64
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V + + + +VFE L L +L N + V+ QLL +++
Sbjct: 65 I-----VTLHDIIHTERCLTLVFEYLDSDLKQYL-DNCGNLMSMHNVKIFMFQLLRGLSY 118
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
H+ +++H DLKP+N+L+ +K+ D+ L+R+ K++P +
Sbjct: 119 CHKRKILHRDLKPQNLLINEKGELKLADFG-LARA-------KSVPTKT----------- 159
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
+S V T YR P+V+LG ++ P D+W VGCIL E+ +
Sbjct: 160 -----YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-14
Identities = 61/232 (26%), Positives = 101/232 (43%), Gaps = 37/232 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVLQRLARHD 149
+Y + +G G FG V C ++LV IK + + R AA E VL+ L+ +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I ++ F + IV E G +L ++++K D + Q+L ++
Sbjct: 61 I-----IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 267
+H ++H DLK +NILL + V +K+ DFG S
Sbjct: 116 HVHTKLILHRDLKTQNILLDKHKMV--------------------------VKIGDFGIS 149
Query: 268 TTFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318
+ +Y VV T Y +PE+ G +N D+W++GC+L EL S+ +
Sbjct: 150 KILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 57/224 (25%), Positives = 101/224 (45%), Gaps = 33/224 (14%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSIN-KYREAAMIEIDVLQRLARHDI 150
+ IL+K+G+G+FG V + K + A+K + +N + RE A+ E VL +L I
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 151 GGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
++ F + + IV E L+ L+ R P D V Q+L +A
Sbjct: 62 -----IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAH 116
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
+H +++H D+K N+ L + + VK+ D +++ D + F N
Sbjct: 117 LHSKKILHRDIKSLNLFLDAYDNVKIGDLG-VAKLLSDNTNFANT--------------- 160
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+V T +Y +PE+ +N D+W++G +L E C+
Sbjct: 161 --------IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 65/233 (27%), Positives = 109/233 (46%), Gaps = 51/233 (21%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR------ 147
Y++ + +G G+FG V E + E VAIK V +Y+ E+ +++ L
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR---ELLIMKNLNHINIIFL 124
Query: 148 HDIGGTRCVQI--RNWFDYRNHICIVFEKLGPSLYDFLRKNSY--RSFPIDLVRELGRQL 203
D T C + +N F + +V E + +++ +++ + + P+ LV+ QL
Sbjct: 125 KDYYYTECFKKNEKNIF-----LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
++A++H + H DLKP+N+L+ P + +KL
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLID--------------------------PNTHTLKLC 213
Query: 264 DFGSTT---FEHQDHSYVVSTRHYRAPEVILGLGWNYPC--DLWSVGCILVEL 311
DFGS + SY+ S R YRAPE++LG NY DLWS+GCI+ E+
Sbjct: 214 DFGSAKNLLAGQRSVSYICS-RFYRAPELMLG-ATNYTTHIDLWSLGCIIAEM 264
|
Length = 440 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 2e-14
Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 44/228 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINK--YREAAMIEIDVLQRLARHD 149
RY L ++G G +G V D E VAIK + R + + A E+ +L+ + +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN 75
Query: 150 IGGTRCVQI-----RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+ G V + D F + P + L+K D V+ L Q+L
Sbjct: 76 VIGLLDVFTSAVSGDEFQD--------FYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQML 127
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+ ++H +IH DLKP N+ + + +K++D
Sbjct: 128 CGLKYIHSAGIIHRDLKPGNLAV---------------------------NEDCELKILD 160
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVEL 311
FG + + V TR YRAPEVIL + +N D+WSVGCI+ E+
Sbjct: 161 FGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEM 208
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 72/246 (29%), Positives = 111/246 (45%), Gaps = 38/246 (15%)
Query: 74 RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
R + Y IG++ + RY+ L +G G G V +D + VAIK + R
Sbjct: 3 RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 62
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
A A E+ VL + H IG + + + IV E + +L ++
Sbjct: 63 NQTHAKRAYREL-VLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM 121
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
+ + L Q+L + +H +IH DLKP NI++ S +K+ D+ L+R++
Sbjct: 122 ----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA 176
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
G+ F P YVV TR+YRAPEVILG+G+ D+WSVG
Sbjct: 177 --GTSFMMTP---------------------YVV-TRYYRAPEVILGMGYKENVDIWSVG 212
Query: 306 CILVEL 311
CI+ E+
Sbjct: 213 CIMGEM 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-14
Identities = 61/221 (27%), Positives = 109/221 (49%), Gaps = 33/221 (14%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE--AAMIEIDVLQRLARHDIG 151
Y L K+GEG++ V + +LVA+K++R + A+ E +L+ L +I
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI- 65
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V + + + + +VFE + L ++ K+ P + V+ QLL ++++H
Sbjct: 66 ----VLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHP-ENVKLFLFQLLRGLSYIH 120
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
+ ++H DLKP+N+L+ +K+ D+ L+R+ K++P S T+
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFG-LARA-------KSVP-----------SHTYS 161
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPC-DLWSVGCILVEL 311
++ V T YR P+V+LG C D+W VGCI VE+
Sbjct: 162 NE-----VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-14
Identities = 63/238 (26%), Positives = 107/238 (44%), Gaps = 44/238 (18%)
Query: 94 YRILSKMGEGTFGQVVEC---FDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHD 149
++I K+G G F +V D + L ++I ++ K R+ + EID+L++L +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-----KLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+ ++ + F N + IV E L + F K R P V + QL
Sbjct: 64 V-----IKYLDSFIEDNELNIVLELADAGDLSQMIKYF--KKQKRLIPERTVWKYFVQLC 116
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+V MH R++H D+KP N+ + + VK+ D G +F +
Sbjct: 117 SAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL-------GRFFSS----------- 158
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
TT H +V T +Y +PE I G+N+ D+WS+GC+L E+ ++ +PF
Sbjct: 159 --KTTAAHS----LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ----SPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 5e-14
Identities = 34/117 (29%), Positives = 58/117 (49%), Gaps = 14/117 (11%)
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDGSYFKNLPKSSAIKLIDFG 266
+H+L IH D+KP+N+LL + ++K+ D+ + + S +++ L + +DF
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 267 STTFEHQD--HSY----------VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
S + ++ V T Y APEV L G+N CD WS+G I+ E+
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 6e-14
Identities = 62/221 (28%), Positives = 102/221 (46%), Gaps = 37/221 (16%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVR------SINKYREAAMIEIDVLQRLARHDIGGT 153
+G+G FG+V C+D + +A K V+ +K A EI +L+ L +H+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHE---- 64
Query: 154 RCVQIRNWF-DYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
R VQ D +F + P S+ D L+ +Y + + R+ RQ+LE ++++
Sbjct: 65 RIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK--AYGALTESVTRKYTRQILEGMSYL 122
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H ++H D+K NIL SA VK+ D+ S ++ I T
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFG----------------ASKRLQTICMSGTGI 166
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
V T ++ +PEVI G G+ D+WS+GC +VE+
Sbjct: 167 RS-----VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEM 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 6e-14
Identities = 55/241 (22%), Positives = 104/241 (43%), Gaps = 48/241 (19%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLAR 147
+L RY L +G G+ G V D++ + VA+K IV + + + A+ EI +++RL
Sbjct: 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDH 61
Query: 148 HDI---------GGTRCVQ-IRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVR 197
+I G+ + + + + + + IV E + L + L + + R
Sbjct: 62 DNIVKVYEVLGPSGSDLTEDVGSLTELNS-VYIVQEYMETDLANVLEQGP---LSEEHAR 117
Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
QLL + ++H ++H DLKP N+ + + + V
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLV------------------------ 153
Query: 258 SAIKLIDFG-----STTFEHQDH-SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVE 310
+K+ DFG + H+ + S + T+ YR+P ++L + D+W+ GCI E
Sbjct: 154 --LKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAE 211
Query: 311 L 311
+
Sbjct: 212 M 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 8e-14
Identities = 55/233 (23%), Positives = 93/233 (39%), Gaps = 50/233 (21%)
Query: 95 RILSKMGEGTFGQVVECF----DNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+ K+GEG FG+V + +KK VA+K ++ + + E + E ++++L H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DH 60
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+G C + + IV E + G L +LRKN + DL+
Sbjct: 61 PNVVKLLGV--CTE-------EEPLYIVMEYMEGG-DLLSYLRKNRPKLSLSDLL-SFAL 109
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAI 260
Q+ + ++ IH DL N L+ VK+ D F LSR D Y++ I
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISD--FGLSRDLYDDDYYRKRGGKLPI 167
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ + APE + + D+WS G +L E+ +
Sbjct: 168 R----------------------WMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 2e-13
Identities = 59/224 (26%), Positives = 103/224 (45%), Gaps = 41/224 (18%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHD 149
+ + +G G+FG+V+ + A+KI+ I K ++ + E +LQ + RH
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHP 61
Query: 150 IGGTRCVQIRNWF-DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
V + F D N + +V E + G L+ LRK+ FP + R Q++ ++
Sbjct: 62 F----LVNLYGSFQDDSN-LYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLAL 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++H L +++ DLKPEN+LL S Y+K+ D+ F K + +
Sbjct: 115 EYLHSLDIVYRDLKPENLLLDSDGYIKITDFGF-------------------AKRVKGRT 155
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T + T Y APE+IL G+ D W++G ++ E+
Sbjct: 156 YT--------LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 55/243 (22%), Positives = 106/243 (43%), Gaps = 62/243 (25%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+ ++ +GEGT+G+V + + +LVAIKI+ I E E ++L++ + H
Sbjct: 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNH---- 62
Query: 153 TRCVQIRNWFDY------RNHIC------IVFEKL-GPSLYDFLR--KNSYRSFPIDLVR 197
N + +N +V E G S+ D ++ + + + +
Sbjct: 63 ------PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116
Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
+ R+ L +A++HE ++IH D+K +NILL K+
Sbjct: 117 YILRETLRGLAYLHENKVIHRDIKGQNILLT---------------------------KN 149
Query: 258 SAIKLIDFG----STTFEHQDHSYVVSTRHYRAPEVI-----LGLGWNYPCDLWSVGCIL 308
+ +KL+DFG + + +++ + T ++ APEVI ++ D+WS+G
Sbjct: 150 AEVKLVDFGVSAQLDSTLGRRNTF-IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITA 208
Query: 309 VEL 311
+EL
Sbjct: 209 IEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 3e-13
Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 44/227 (19%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSI-------NKYREAAMIEIDVLQRLARHDI-- 150
+G G F + D + L+A+K V + + EA EI ++ RL I
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 151 --GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
G T +H + E + G S+ L K Y +F ++ QLL +
Sbjct: 68 MLGATC---------EDSHFNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGL 116
Query: 208 AFMHELRLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+++HE ++IH D+K N+L+ S + +++ D+ +A +L G
Sbjct: 117 SYLHENQIIHRDVKGANLLIDSTGQRLRIADF------------------GAAARLAAKG 158
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ E Q ++ T + APEV+ G + CD+WSVGC+++E+ +
Sbjct: 159 TGAGEFQGQ--LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 3e-13
Identities = 53/234 (22%), Positives = 93/234 (39%), Gaps = 51/234 (21%)
Query: 95 RILSKMGEGTFGQVVECF----DNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+ K+GEG FG+V + + VA+K ++ + + RE + E ++++L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SH 60
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+G C Q + IV E G L DFLRK+ + + ++
Sbjct: 61 PNIVRLLGV--CTQ-------GEPLYIVTEYMPGG-DLLDFLRKHG-EKLTLKDLLQMAL 109
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKS-SA 259
Q+ + + ++ +H DL N L+ VK+ D F LSR + Y++
Sbjct: 110 QIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISD--FGLSRDIYEDDYYRKRGGGKLP 167
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
IK + APE + + D+WS G +L E+ +
Sbjct: 168 IK----------------------WMAPESLKDGKFTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 3e-13
Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 30/226 (13%)
Query: 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREA--AMIEIDVLQRLA 146
+ +Y + +G G +G V ++E E VAIK I + + +A + EI +L+ L
Sbjct: 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD 62
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
++ + + + N + IV+E + L+ +R + ++ D + QLL
Sbjct: 63 HENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLYQLLRG 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++H ++H DLKP N+LL + +K+ D+ L+R++ + F
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFG-LARTTSEKGDFMT------------- 166
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVEL 311
YVV TR YRAPE++L + D+WSVGCI EL
Sbjct: 167 ---------EYVV-TRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 41/225 (18%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRLARHDI 150
Y L K+GEG++ V + +LVA+K++ S+ A+ E +L+ L +I
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVI-SMKTEEGVPFTAIREASLLKGLKHANI 65
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V + + + + VFE + L ++ ++ P + VR QLL +A++
Sbjct: 66 -----VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYN-VRLFMFQLLRGLAYI 119
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---S 267
H ++H DLKP+N+L+ SY L KL DFG +
Sbjct: 120 HGQHILHRDLKPQNLLI---------------------SYLGEL------KLADFGLARA 152
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVEL 311
+ Q +S V T YR P+V+LG ++ D+W GCI +E+
Sbjct: 153 KSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 40/236 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHD 149
+RI K+G G F +V VA+K V+ + K R + EID+L++L +
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR--KNSYRSFPIDLVRELGRQLLES 206
+ ++ F N + IV E L ++ K R P V + QL +
Sbjct: 64 V-----IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ MH R++H D+KP N+ + + VK+ D G +F +
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL-------GRFFSS------------- 158
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
TT H +V T +Y +PE I G+N+ D+WS+GC+L E+ ++ +PF
Sbjct: 159 KTTAAHS----LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ----SPF 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (170), Expect = 4e-13
Identities = 75/258 (29%), Positives = 122/258 (47%), Gaps = 44/258 (17%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVL 142
GE+ Y ++ K+G G FG+V +E K + R + K RE + +IE++V+
Sbjct: 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVM 66
Query: 143 QRLARHDIGGTRCV-QIRNWFDYRNHICIVFEKLGPSLYDFLR--KNSYRSF-PID--LV 196
+ L +I R + + N + + +I + F G D R + Y+ F I+ +
Sbjct: 67 RELKHKNI--VRYIDRFLNKANQKLYILMEFCDAG----DLSRNIQKCYKMFGKIEEHAI 120
Query: 197 RELGRQLLESVAFMHEL-------RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
++ RQLL ++A+ H L R++H DLKP+NI L + + K +
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG----------IRHIGKITA 170
Query: 250 YFKNLPKSSAIKLIDFG---STTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSV 304
NL K+ DFG + E HS V T +Y +PE++L +Y D+W++
Sbjct: 171 QANNLNGRPIAKIGDFGLSKNIGIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWAL 229
Query: 305 GCILVELCSVSNCYLTPF 322
GCI+ ELCS TPF
Sbjct: 230 GCIIYELCSGK----TPF 243
|
Length = 1021 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-13
Identities = 62/229 (27%), Positives = 97/229 (42%), Gaps = 44/229 (19%)
Query: 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQR 144
+T RY L +G G FG V D + VAIK + + + + E+ +L+
Sbjct: 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIK--KIMKPFSTPVLAKRTYRELKLLKH 65
Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
L +I + I D I V E LG L+ L R ++ Q+L
Sbjct: 66 LRHENIISLSDIFISPLED----IYFVTELLGTDLHRLLTS---RPLEKQFIQYFLYQIL 118
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+ ++H ++H DLKP NIL+ ++ +K+ D
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILI---------------------------NENCDLKICD 151
Query: 265 FG-STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVEL 311
FG + + Q YV STR+YRAPE++L ++ D+WS GCI E+
Sbjct: 152 FGLARIQDPQMTGYV-STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEM 199
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-13
Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 45/227 (19%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKY-------REAAMI-----EIDVLQRLAR 147
+G+GT+G+V + E++A+K V + R+ M+ EI+ L+ L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVE-LPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+I VQ + ++ I E + G S+ LR Y F LVR Q+LE
Sbjct: 68 LNI-----VQYLGFETTEEYLSIFLEYVPGGSIGSCLRT--YGRFEEQLVRFFTEQVLEG 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+A++H ++H DLK +N+L+ + K+ D+ +S+ S D + N S
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGICKISDFG-ISKKSDD--IYDNDQNMS------MQ 171
Query: 267 STTFEHQDHSYVVSTRHYRAPEVI--LGLGWNYPCDLWSVGCILVEL 311
+ F + APEVI G++ D+WS+GC+++E+
Sbjct: 172 GSVF-------------WMAPEVIHSYSQGYSAKVDIWSLGCVVLEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 6e-13
Identities = 47/149 (31%), Positives = 76/149 (51%), Gaps = 10/149 (6%)
Query: 162 FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221
F+ + H+C+V E + L KN + P+D+ R + + ++ ++H ++H DLK
Sbjct: 70 FETKRHLCMVMEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLK 128
Query: 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVST 281
P+N+L+ S ++K+ D+ SK G +L + I+ T E D V T
Sbjct: 129 PDNLLITSMGHIKLTDFGL----SKIG--LMSLTTNLYEGHIE--KDTREFLDKQ-VCGT 179
Query: 282 RHYRAPEVILGLGWNYPCDLWSVGCILVE 310
Y APEVIL G+ P D W++G IL E
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYE 208
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 40/221 (18%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTR 154
L ++G G G V + +++A+K +R ++ + E+D+L +
Sbjct: 6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK--------CN 57
Query: 155 C---VQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V F I I E + D + K P ++ ++ +L+ + ++H
Sbjct: 58 SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 212 E-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
E ++IH D+KP NIL+ S +K+ D+ +S +L++ + TF
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFG-VSG-----------------QLVNSLAKTF 159
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
V T Y APE I G ++ D+WS+G L+EL
Sbjct: 160 --------VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 39/151 (25%), Positives = 68/151 (45%), Gaps = 31/151 (20%)
Query: 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 220
F ++++ +V E L G ++ P D ++ +++ V +H+ +IH D+
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 221 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS 280
KPEN+L+ ++K+ D+ LSR+ + F V
Sbjct: 124 KPENLLIDQTGHLKLTDFG-LSRNGLENKKF---------------------------VG 155
Query: 281 TRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T Y APE ILG+G + D WS+GC++ E
Sbjct: 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEF 186
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-12
Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 37/225 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINK--YREAAMIEIDVLQRLARHD 149
RYR L ++G G +G V D VAIK + R + + A E+ +L+ + +H+
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHE 74
Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
IG D + +V +G L ++ + D ++ L Q+L+ +
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK---HEKLSEDRIQFLVYQMLKGL 131
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++H +IH DLKP N L V+ + +K++DFG
Sbjct: 132 KYIHAAGIIHRDLKPGN-LAVNED--------------------------CELKILDFGL 164
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVEL 311
+ + V TR YRAPEVIL + + D+WSVGCI+ E+
Sbjct: 165 ARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEM 209
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 3e-12
Identities = 42/110 (38%), Positives = 61/110 (55%), Gaps = 25/110 (22%)
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
Q+L + +H +IH DLKP NI++ S +K+ D+ L+R++ G+ F P
Sbjct: 127 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA--GTSFMMTP------ 177
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
YVV TR+YRAPEVILG+G+ D+WSVGCI+ E+
Sbjct: 178 ---------------YVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 60/225 (26%), Positives = 105/225 (46%), Gaps = 37/225 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA----MIEIDVLQRLARHD 149
Y L K+GEGT+ V + LVA+K +R ++ E A + E+ +L+ L +
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRL--EHEEGAPCTAIREVSLLKDLKHAN 65
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V + + + +VFE L L +L + S + V+ QLL + +
Sbjct: 66 I-----VTLHDIIHTEKSLTLVFEYLDKDLKQYL-DDCGNSINMHNVKLFLFQLLRGLNY 119
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
H +++H DLKP+N+L+ +K+ D+ L+R+ K++P +
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFG-LARA-------KSIPTKT----------- 160
Query: 270 FEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
+S V T YR P+++LG ++ D+W VGCI E+ +
Sbjct: 161 -----YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 64/230 (27%), Positives = 107/230 (46%), Gaps = 47/230 (20%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA---AMIEIDVLQRLAR--- 147
Y+ L K+GEG++ V + +LVA+K +R + A A+ E +L+ L
Sbjct: 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR-LEHEEGAPFTAIREASLLKDLKHANI 65
Query: 148 ---HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
HDI T + + +VFE L L ++ + VR QLL
Sbjct: 66 VTLHDIIHT-----------KKTLTLVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLL 113
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+A+ H+ R++H DLKP+N+L+ +K+ D+ L+R+ K++P
Sbjct: 114 RGLAYCHQRRVLHRDLKPQNLLISERGELKLADFG-LARA-------KSVP--------- 156
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
S T+ ++ V T YR P+V+LG ++ D+W VGCI E+ +
Sbjct: 157 --SKTYSNE-----VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 5e-12
Identities = 42/110 (38%), Positives = 59/110 (53%), Gaps = 25/110 (22%)
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
Q+L + +H +IH DLKP NI++ S +K+ D+ L+R++
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-LARTA---------------- 173
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T F YVV TR+YRAPEVILG+G+ D+WSVGCI+ EL
Sbjct: 174 -----CTNFMMT--PYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 60/225 (26%), Positives = 106/225 (47%), Gaps = 37/225 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA----MIEIDVLQRLARHD 149
Y L K+GEGT+ V + + LVA+K +R ++ E A + E+ +L+ L +
Sbjct: 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRL--EHEEGAPCTAIREVSLLKDLKHAN 65
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V + + + +VFE L L ++ + + V+ Q+L +A+
Sbjct: 66 I-----VTLHDIVHTDKSLTLVFEYLDKDLKQYM-DDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
H +++H DLKP+N+L+ +K+ D+ L+R+ K++P +
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFG-LARA-------KSVPTKT----------- 160
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCS 313
+S V T YR P+V+LG ++ D+W VGCI E+ S
Sbjct: 161 -----YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 56/230 (24%), Positives = 99/230 (43%), Gaps = 44/230 (19%)
Query: 97 LSKMGEGTFGQVVEC----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDI 150
+ ++GEG FG+V C + E VA+K + ++R EI++L+ L +I
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 151 GGTRCVQIRNWFD--YRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVREL--GRQLLE 205
V+ + + + ++ E L SL D+L+++ + I+L R L Q+ +
Sbjct: 69 -----VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ---INLKRLLLFSSQICK 120
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR--SSKDGSYFKNLPKSSAIKLI 263
+ ++ R IH DL NIL+ S + VK+ D+ L++ Y+ P S I
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDLVKISDFG-LAKVLPEDKDYYYVKEPGESPIF-- 177
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ APE + ++ D+WS G L EL +
Sbjct: 178 --------------------WYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 49/220 (22%), Positives = 90/220 (40%), Gaps = 40/220 (18%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
Y ++ + G+ G+V + + V +KI + + +IE +LQ + +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQ-----KGTTLIEAMLLQNVNHPSV--- 119
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
+++++ C+V LY +L K S R PID + +Q+LE + ++H
Sbjct: 120 --IRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ 176
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
R+IH D+K ENI + + + D G+ F
Sbjct: 177 RIIHRDVKTENIFINDV---------------------------DQVCIGDLGAAQFPVV 209
Query: 274 DHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
++ + T APEV+ +N D+WS G +L E+
Sbjct: 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 38/229 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHD 149
RY I+ K+GEG+FG++ E IK + + K +EA+ E+ +L ++ +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I V F + IV E G L + + F D + Q+ +
Sbjct: 61 I-----VTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLK 115
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+H+ +++H D+K +NI FLS++ KL DFG
Sbjct: 116 HIHDRKILHRDIKSQNI--------------FLSKNGM------------VAKLGDFGIA 149
Query: 269 TFEHQDHSYV---VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSV 314
+ V T +Y +PE+ +N D+WS+GC+L ELC++
Sbjct: 150 RQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 61/234 (26%), Positives = 101/234 (43%), Gaps = 58/234 (24%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEIDVLQRLARHDIG- 151
+G+G +G V C + +L+A+K V + K E E+D+L+ L +I
Sbjct: 8 LGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 152 --GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
GT C+ N I I E + G S+ L N + P + + +Q+L+ VA
Sbjct: 67 YLGT-CLD-------DNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVA 116
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++H ++H D+K N++L+ + IKLIDFG
Sbjct: 117 YLHNNCVVHRDIKGNNVMLMP---------------------------NGIIKLIDFGCA 149
Query: 269 -----TFEHQDHSYVVSTRH----YRAPEVILGLGWNYPCDLWSVGCILVELCS 313
H HS ++ + H + APEVI G+ D+WS+GC + E+ +
Sbjct: 150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMAT 203
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 36/217 (16%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAA--MIEIDVLQRLARHDIGGTRC 155
+G+GTFG+V+ + + A+KI++ I E A + E VLQ RH
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPF----L 57
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
++ F + +C V E G L+ L + R F D R G +++ ++ ++H
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCD 115
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+++ DLK EN++L ++K+ D+ K+G I G+T
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGL----CKEG--------------ISDGATM----- 152
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T Y APEV+ + D W +G ++ E+
Sbjct: 153 -KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEM 188
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 56/218 (25%), Positives = 89/218 (40%), Gaps = 41/218 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRC 155
+G G+FG+V E AIK ++ K + E +L L+ I
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI----- 80
Query: 156 VQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V + F N + + E +G L+ LRK FP D+ + +L+ + ++H
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD 138
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+I+ DLKPEN+LL + +VKV D+ F + D
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP----------------------------D 170
Query: 275 HSYVV-STRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
++ + T Y APEVI G D W++G +L E
Sbjct: 171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEF 208
|
Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 94 YRILSKMGEGTFGQVV-ECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+ + +G G+FG+V+ + NE VAIK ++ + + +++ + I
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNY-INH 90
Query: 153 TRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
CV + F +++ +V E +G + FLR+N + FP D+ Q++ ++
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQ 148
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
L +++ DLKPEN+LL KDG IK+ DFG
Sbjct: 149 SLNIVYRDLKPENLLL-----------------DKDG----------FIKMTDFGFAKVV 181
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ T Y APE++L +G D W++G + E+
Sbjct: 182 DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221
|
Length = 340 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 51/228 (22%), Positives = 95/228 (41%), Gaps = 45/228 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIG 151
Y+ L +G G +G V +VA+KI+ + + I E+ +L +L +
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 152 GTRCVQIRNWFDYRN--HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ + Y + I+ E G S+ ++ I ++ R++L ++
Sbjct: 63 NI----TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVII---REVLVALK 115
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDY----KFLSRSSKDGSYFKNLPKSSAIKLID 264
++H++ +IH D+K NIL+ + VK+ D+ SSK
Sbjct: 116 YIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK------------------ 157
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVEL 311
+TF V T ++ APEVI G ++ D+WS+G + E+
Sbjct: 158 --RSTF--------VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEM 195
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-11
Identities = 60/230 (26%), Positives = 95/230 (41%), Gaps = 55/230 (23%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
+G+GT+G V D + +AIK I ++Y + EI + L +I VQ
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI-----VQY 70
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLR-KNSYRSFPIDLVRELGRQLLESVAFMHELRLI 216
I E++ G SL LR K + +Q+LE + ++H+ +++
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130
Query: 217 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-------- 268
H D+K +N+L V Y S +K+ DFG++
Sbjct: 131 HRDIKGDNVL--------VNTY------------------SGVVKISDFGTSKRLAGINP 164
Query: 269 ---TFEHQDHSYVVSTRHYRAPEVI-LGL-GWNYPCDLWSVGCILVELCS 313
TF T Y APEVI G G+ P D+WS+GC +VE+ +
Sbjct: 165 CTETF--------TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT 206
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 58/220 (26%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR----LARHDIGG 152
L ++G+G+FG+V + DN +++VAIKI+ E A EI+ +Q+ L++ D
Sbjct: 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD--S 61
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
+ + + I+ E L G S D LR + F I + +++L+ + ++H
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI---ATMLKEILKGLDYLH 118
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
+ IH D+K N+LL VK+ D+ + + + IK F T F
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-----------DTQIKRNTFVGTPF- 166
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ APEVI ++ D+WS+G +EL
Sbjct: 167 ------------WMAPEVIQQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 57/237 (24%), Positives = 96/237 (40%), Gaps = 50/237 (21%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRC 155
LS++GEG G V +C + A+K + + ++ +L+ L
Sbjct: 6 LSRLGEGAGGSVTKCRLKNTGMIFALKTITT----DPNPDLQKQILRELEINKSCKSPYI 61
Query: 156 VQIRNWF--DYRNHICIVFEKLG----PSLYDFLRKNSYRSFPIDLVRELGR---QLLES 206
V+ F + + I I E S+Y ++K R + LG+ +L+
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE----KVLGKIAESVLKG 117
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
++++H ++IH D+KP NILL ++ G +KL DFG
Sbjct: 118 LSYLHSRKIIHRDIKPSNILL-----------------TRKG----------QVKLCDFG 150
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
S + T Y APE I G ++ D+WS+G L+E+ N + PF
Sbjct: 151 VSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV--AQNRF--PF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-11
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 41/221 (18%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIG--- 151
L ++G+G+FG+V + DN KE+VAIKI+ E I EI VL + I
Sbjct: 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
G+ + W I+ E L G S D L+ I + R++L+ + ++
Sbjct: 69 GSYLKGTKLW--------IIMEYLGGGSALDLLKPGPLEETYIATIL---REILKGLDYL 117
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H R IH D+K N+LL VK+ D+ + + + IK F T F
Sbjct: 118 HSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT-----------DTQIKRNTFVGTPF 166
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ APEVI +++ D+WS+G +EL
Sbjct: 167 -------------WMAPEVIKQSAYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 7e-11
Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 35/217 (16%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ + A+K++ ++I K +E M E +VL + +H
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V + F + + V + + G L+ L++ RSFP R ++ ++ ++H L
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLN 116
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+I+ DLKPENILL S +V + D+ K+G I+ TT
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGL----CKEG--------------IEHSKTT----- 153
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
S T Y APEV+ ++ D W +G +L E+
Sbjct: 154 -STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 9e-11
Identities = 51/223 (22%), Positives = 94/223 (42%), Gaps = 39/223 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKI--VRSINKYREAAMI--EIDVLQRLARHD 149
+ +G GTFG+V D + A+K+ + + + ++ + E VL+ ++
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I D + + ++ E + G L+ +LR + F +++ ++
Sbjct: 63 IIRLFW----TEHD-QRFLYMLMEYVPGGELFSYLR--NSGRFSNSTGLFYASEIVCALE 115
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++H +++ DLKPENILL ++K+ D+ F A KL D T
Sbjct: 116 YLHSKEIVYRDLKPENILLDKEGHIKLTDFGF------------------AKKLRDRTWT 157
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ T Y APEVI G N D W++G ++ E+
Sbjct: 158 ---------LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 43/141 (30%), Positives = 71/141 (50%), Gaps = 21/141 (14%)
Query: 191 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDG 248
F DL R +L ++ +H++ IH D+KP+NIL+ ++K+ D+ + R + D
Sbjct: 98 FEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157
Query: 249 SYFK--NLPKSSAIKLIDFGS-------TTFE------HQD---HSYVVSTRHYRAPEVI 290
Y++ + + +++ + S E HQ HS +V T +Y APEV+
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHS-LVGTPNYIAPEVL 216
Query: 291 LGLGWNYPCDLWSVGCILVEL 311
L G+ CD WSVG IL E+
Sbjct: 217 LRTGYTQLCDWWSVGVILYEM 237
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 53/239 (22%), Positives = 103/239 (43%), Gaps = 58/239 (24%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ ++ +G GT+GQV + + +L AIK++ E +EI++L++ + H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHH----- 72
Query: 154 RCVQIRNWFDY------------RNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELG 200
RN Y + + +V E G S+ D ++ + D + +
Sbjct: 73 -----RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
R++L +A +H ++IH D+K +N+LL +++ +
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLT---------------------------ENAEV 160
Query: 261 KLIDFG-STTFEHQ--DHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVEL 311
KL+DFG S + + + T ++ APEVI ++Y D+WS+G +E+
Sbjct: 161 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-10
Identities = 59/229 (25%), Positives = 101/229 (44%), Gaps = 34/229 (14%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHDIG 151
+Y K+G+G G V D + VAIK + + ++ +I EI V++ L +I
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI- 78
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V + F + + +V E L G SL D + + I V R+ L+++ F+
Sbjct: 79 ----VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFL 131
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H ++IH D+K +N+LL VK+ D+ F ++ T
Sbjct: 132 HANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ------------------------ITP 167
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYL 319
E S +V T ++ APEV+ + D+WS+G + +E+ YL
Sbjct: 168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 64/247 (25%), Positives = 111/247 (44%), Gaps = 39/247 (15%)
Query: 94 YRILSKMGEGTFGQV--VECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLAR 147
+ + +G+G FG+V V+ D K + A+K + +++ + E DVL A
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGK--IYAMKTLLKSEMFKKDQLAHVKAERDVL---AE 57
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
D V + F ++ ++ E L G L L K Y +F D+ R + + +
Sbjct: 58 SD--SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLA 113
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK--DGSYFKNLPKSSAIK--- 261
+ +H+L IH D+KP+NIL+ ++K+ D+ + K D +Y++ L + + K
Sbjct: 114 IEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173
Query: 262 ------LIDFGSTTFEHQDH-----------SY-VVSTRHYRAPEVILGLGWNYPCDLWS 303
+D + T +D +Y V T Y APE+ L G+ CD WS
Sbjct: 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233
Query: 304 VGCILVE 310
+G I+ E
Sbjct: 234 LGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 49/230 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV-----RSINKYREAAMIEIDVLQRLAR 147
+ L ++G G+FG V D E+VAIK + +S K+++ + E+ LQ+L R
Sbjct: 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVRFLQQL-R 73
Query: 148 HDIGGTRCVQIRNWFDYRNHIC-IVFEKLGPSLYDFL--RKNSYRSFPIDLVRELGRQLL 204
H ++ + + R H +V E S D L K + I + L
Sbjct: 74 H----PNTIEYKGCY-LREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICH---GAL 125
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+ +A++H IH D+K NILL ++ G+ +KL D
Sbjct: 126 QGLAYLHSHERIHRDIKAGNILL-----------------TEPGT----------VKLAD 158
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVEL 311
FGS + +S+ V T ++ APEVIL + ++ D+WS+G +EL
Sbjct: 159 FGSASLVSPANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 54/238 (22%), Positives = 106/238 (44%), Gaps = 33/238 (13%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSI---NKYREAAMIEIDVLQRLAR 147
++ + +G+G G+V +L A+K++ + + NK + E ++L L
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL-TEQEILATL-D 59
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
H + F ++C+V + G L+ L++ + ++ R ++L +
Sbjct: 60 HPF----LPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDY----------KFLSRSSKDGSYFKNLPK 256
+ ++H L +++ DLKPENILL + ++ + D+ +S++ + GS ++
Sbjct: 116 LEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 257 SS---AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ F S +F V T Y APEVI G G D W++G +L E+
Sbjct: 176 IPSETFSEEPSFRSNSF--------VGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 44/234 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+Y K+G+G G V D + VAIK + + ++ +I ++ R +H
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHP--- 76
Query: 153 TRCVQIRNWFD---YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I N+ D + + +V E L G SL D + + I V R+ L+++
Sbjct: 77 ----NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALE 129
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-- 266
F+H ++IH D+K +NILL DGS +KL DFG
Sbjct: 130 FLHSNQVIHRDIKSDNILL-----------------GMDGS----------VKLTDFGFC 162
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYL 319
T E S +V T ++ APEV+ + D+WS+G + +E+ YL
Sbjct: 163 AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 51/233 (21%), Positives = 93/233 (39%), Gaps = 50/233 (21%)
Query: 94 YRILSKMGEGTFGQV--VECFDNEKKELVAIKIVRSINKYR---EAAMIEIDVLQRLARH 148
Y ++ +G G V C N E VAIK + + K + + E+ + +
Sbjct: 3 YELIEVIGVGATAVVYAAICLPN--NEKVAIKRI-DLEKCQTSVDELRKEVQAMSQCNHP 59
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR-KNSYRSFPIDLVRELGRQLLES 206
++ F + + +V L G SL D ++ ++ + +++L+
Sbjct: 60 NVVKYYTS-----FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKG 114
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++H IH D+K NILL +DGS +K+ DFG
Sbjct: 115 LEYLHSNGQIHRDIKAGNILL-----------------GEDGS----------VKIADFG 147
Query: 267 --STTFEHQDHSY-----VVSTRHYRAPEVI-LGLGWNYPCDLWSVGCILVEL 311
++ + D + V T + APEV+ G+++ D+WS G +EL
Sbjct: 148 VSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIEL 200
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 59/229 (25%), Positives = 107/229 (46%), Gaps = 38/229 (16%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHDIGGTRC 155
+G+GTFGQV + + + + A+K++ + I +E A E ++L R +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDE--SPFI 58
Query: 156 VQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V ++ F + + +V + G L+ L+K F D + +L+ ++ +H+
Sbjct: 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD 116
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+++ DLKPENILL + ++ + D+ LS++ NL + + TF
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFG-LSKA--------NLTDNKT-------TNTF---- 156
Query: 275 HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
T Y APEV+L G+ D WS+G ++ E+C C +PF
Sbjct: 157 ----CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMC----CGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 46/235 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHDIG 151
+Y K+G+G G V D + VAIK + + ++ +I EI V++
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE------- 72
Query: 152 GTRCVQIRNWFDYR---NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ I N+ D + + +V E L G SL D + + I V R+ L+++
Sbjct: 73 -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 128
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
F+H ++IH D+K +NILL DGS +KL DFG
Sbjct: 129 DFLHSNQVIHRDIKSDNILL-----------------GMDGS----------VKLTDFGF 161
Query: 267 --STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYL 319
T E S +V T ++ APEV+ + D+WS+G + +E+ YL
Sbjct: 162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 64/247 (25%), Positives = 111/247 (44%), Gaps = 43/247 (17%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI----GG 152
+ +G G FG+V + K L A+K +R ++ ++ V A DI
Sbjct: 6 IKTLGIGAFGEVCLARKVDTKALYAMKTLR-----KKDVLLRNQVAHVKAERDILAEADN 60
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V++ F ++++ V + + G + L + FP DL R +L +V +H
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI--FPEDLARFYIAELTCAVESVH 118
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDGSYFK--NLPKSSAIKLIDFGS 267
++ IH D+KP+NIL+ ++K+ D+ + R + D Y++ + + + +DF +
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS---MDFSN 175
Query: 268 --------------------TTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSV 304
+HQ HS +V T +Y APEV+L G+ CD WSV
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHS-LVGTPNYIAPEVLLRTGYTQLCDWWSV 234
Query: 305 GCILVEL 311
G IL E+
Sbjct: 235 GVILYEM 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 61/244 (25%), Positives = 109/244 (44%), Gaps = 43/244 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDI-- 150
+ L +G G FG+V + + A+KI+R +A M+E + + + A DI
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR------KADMLEKEQVAHIRAERDILV 56
Query: 151 --GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES- 206
G V++ F + ++ ++ E L G + L K D + E Q +
Sbjct: 57 EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-------DTLSEEATQFYIAE 109
Query: 207 ----VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDGSYFKNL---PKS 257
+ +H+L IH D+KP+N+LL + +VK+ D+ + + + +++NL P S
Sbjct: 110 TVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169
Query: 258 SAIKLIDFGSTTFEHQDHSY----------VVSTRHYRAPEVILGLGWNYPCDLWSVGCI 307
F + + + ++ V T Y APEV + G+N CD WS+G I
Sbjct: 170 D----FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225
Query: 308 LVEL 311
+ E+
Sbjct: 226 MYEM 229
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 5e-10
Identities = 62/235 (26%), Positives = 101/235 (42%), Gaps = 46/235 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHDIG 151
+Y K+G+G G V D + VAI+ + + ++ +I EI V++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE------- 73
Query: 152 GTRCVQIRNWFDYR---NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ I N+ D + + +V E L G SL D + + I V R+ L+++
Sbjct: 74 -NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQAL 129
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
F+H ++IH D+K +NILL DGS +KL DFG
Sbjct: 130 EFLHSNQVIHRDIKSDNILL-----------------GMDGS----------VKLTDFGF 162
Query: 267 --STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYL 319
T E S +V T ++ APEV+ + D+WS+G + +E+ YL
Sbjct: 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 6e-10
Identities = 60/247 (24%), Positives = 110/247 (44%), Gaps = 55/247 (22%)
Query: 93 RY-RILSKMGEGTFGQV-VECFD---NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL 145
RY + + +GEG FG+V + C+D + E+VA+K ++ + EI++L+ L
Sbjct: 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL 63
Query: 146 ARHDI---------GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLV 196
+I G + +Q+ + + LG SL D+L K+ ++L
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQL----------IMEYVPLG-SLRDYLPKHK-----LNLA 107
Query: 197 REL--GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
+ L +Q+ E +A++H IH DL N+LL + VK+ D+ L+++ +G + +
Sbjct: 108 QLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFG-LAKAVPEGHEYYRV 166
Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSV 314
+ D S F + A E + ++Y D+WS G L EL +
Sbjct: 167 RE-------DGDSPVF-------------WYAVECLKENKFSYASDVWSFGVTLYELLTH 206
Query: 315 SNCYLTP 321
+ +P
Sbjct: 207 CDSKQSP 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 52/238 (21%), Positives = 100/238 (42%), Gaps = 45/238 (18%)
Query: 94 YRILSKMGEGTFGQVVEC-FDNEKKELVAIKIV-----------RSINKYREAAMIEIDV 141
Y +L +G G FG V + N + L+A+K + R +K + E+ +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR--KNSYRSFPIDLVRE 198
++ RH V+ F + + IV + + G L + K + F + +
Sbjct: 62 IKEQLRH----PNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 199 LGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
+ Q++ ++ ++H E R++H DL P NI+L + V + D+ L++ + S +
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG-LAKQKQPESKLTS---- 172
Query: 258 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVS 315
VV T Y PE++ + D+W+ GCIL ++C++
Sbjct: 173 --------------------VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 50/220 (22%), Positives = 93/220 (42%), Gaps = 41/220 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-------EAAMIEIDVLQRLARHDIGG 152
+G+G FG+V C ++ A K ++K R + A+ E +L++++ I
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACK---KLDKKRLKKRKGEQMALNEKKILEKVSSRFI-- 55
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V + F+ ++ +C+V + G L + FP Q++ + +H
Sbjct: 56 ---VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
+ R+++ DLKPEN+LL V++ D A++L G
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVRISDLGL------------------AVELKG-GKKI-- 151
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T Y APEV+ G +++ D +++GC L E+
Sbjct: 152 ---KGR-AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 36/125 (28%), Positives = 56/125 (44%), Gaps = 32/125 (25%)
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
D V+ Q+L + ++H ++H D+KP N+L+ S
Sbjct: 103 DHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS------------------------ 138
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYV----VSTRHYRAPEVILGLG-WNYPCDLWSVGCIL 308
+ +K+ DFG E D S V T++YRAPE+++G + D+WSVGCI
Sbjct: 139 ---NCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIF 195
Query: 309 VELCS 313
EL
Sbjct: 196 AELLG 200
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 63/235 (26%), Positives = 105/235 (44%), Gaps = 48/235 (20%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKK--ELVAIK-IVRSINKYREA--AMIEIDVLQRLAR 147
RY ++ ++G+G +G V + E E VAIK I +K A A+ E+ +L+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 148 HD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS------YRSFPIDLVRELG 200
H I + I + N + + E + L+ +R ++SF
Sbjct: 61 HKNITCLYDMDIV-FPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIY------- 112
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
Q+L + ++H ++H DLKP N+L+ + +K+ D+ L+R F P +A
Sbjct: 113 -QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFG-LARG------FSENPGENAG 164
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPC----DLWSVGCILVEL 311
+ ++ V+TR YRAPE++L D+WSVGCIL EL
Sbjct: 165 FMTEY-------------VATRWYRAPEIMLS---FQSYTKAIDVWSVGCILAEL 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-09
Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 43/222 (19%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR----LARHDIGG 152
L K+G+G+FG+V + DN +++VAIKI+ E A EI+ +Q+ L++ D
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIID-----LEEAEDEIEDIQQEITVLSQCD--S 61
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID--LVRELGRQLLESVAF 209
+ + + I+ E L G S D L P+D + + R++L+ + +
Sbjct: 62 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDY 116
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
+H + IH D+K N+LL VK+ D+ G T
Sbjct: 117 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVA------------------------GQLT 152
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ V T + APEVI ++ D+WS+G +EL
Sbjct: 153 DTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-09
Identities = 50/229 (21%), Positives = 105/229 (45%), Gaps = 38/229 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIGG 152
+ ++ +G GT+GQV + + +L AIK++ E EI++L++ + H +I
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 153 TRCVQIR-NWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
I+ N + + +V E G S+ D ++ + + + + R++L ++ +
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H+ ++IH D+K +N+LL +++ +KL+DFG +
Sbjct: 128 HQHKVIHRDIKGQNVLLT---------------------------ENAEVKLVDFGVSAQ 160
Query: 271 EHQD---HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVEL 311
+ + + T ++ APEVI +++ DLWS+G +E+
Sbjct: 161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 32/214 (14%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
K+GEG+ G V + + VA+K + + R + V+ R H+ V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHE----NVVDM 84
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
N + + + +V E L G +L D + I V +L +++++H +IH
Sbjct: 85 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV---CLSVLRALSYLHNQGVIH 141
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
D+K ++ILL S +K+ D+ F ++ SK+ +PK ++
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKE------VPKRKSL----------------- 178
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
V T ++ APEVI L + D+WS+G +++E+
Sbjct: 179 -VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 56/223 (25%), Positives = 102/223 (45%), Gaps = 34/223 (15%)
Query: 92 PRYRI--LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
PR + K+GEG+ G V D VA+K + + R + V+ R +H
Sbjct: 17 PRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHP 76
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V++ + + + + +V E L G +L D + I V +L++++
Sbjct: 77 ----NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATV---CLAVLKALS 129
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
F+H +IH D+K ++ILL S VK+ D+ F ++ SK+ +P+ ++
Sbjct: 130 FLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE------VPRRKSL-------- 175
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
V T ++ APEVI L + D+WS+G +++E+
Sbjct: 176 ----------VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 36/221 (16%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
++ K+G G FG+V N + VA+K ++ EA + E ++++L RHD +
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKL-RHD----K 62
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
VQ+ I IV E + SL DFL+ + + + ++ Q+ E +A++
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA---IKLIDFGSTTF 270
IH DL NIL+ K+ D+ L+R +D Y + A IK
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFG-LARLIEDDEY---TAREGAKFPIK--------- 169
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ APE + D+WS G +L E+
Sbjct: 170 -------------WTAPEAANYGRFTIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-09
Identities = 52/242 (21%), Positives = 99/242 (40%), Gaps = 46/242 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ + S +G G FG+V + ++ A+K+++ + + + V DI
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMK-----KSVLLAQETVSFFEEERDILSI 57
Query: 154 R----CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRS-FPIDLVRELGRQLLESV 207
Q++ F ++++ +V E G L L N Y F D+ + +L+ ++
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL--NRYEDQFDEDMAQFYLAELVLAI 115
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
+H++ +H D+KPEN+L+ ++K+ D+ +R + + LP
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLP------------ 163
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLG------WNYPCDLWSVGCILVELCSVSNCYLTP 321
V T Y APEV+ + + CD WS+G I E+ +P
Sbjct: 164 -----------VGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI----YGRSP 208
Query: 322 FA 323
F
Sbjct: 209 FH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 55/227 (24%), Positives = 91/227 (40%), Gaps = 43/227 (18%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ IL G G C DN+ E V IK + R E +L+ + I
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSI--- 145
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
+Q++ F Y C++ + LY +L + R+ I + + R +L ++ ++HE
Sbjct: 146 --IQLKGTFTYNKFTCLILPRYKTDLYCYL--AAKRNIAICDILAIERSVLRAIQYLHEN 201
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE-- 271
R+IH D+K ENI F N P + L DFG+ F
Sbjct: 202 RIIHRDIKAENI-------------------------FINHPGD--VCLGDFGAACFPVD 234
Query: 272 -HQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSN 316
+ + Y T APE++ + D+WS G +L E+ + +
Sbjct: 235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281
|
Length = 391 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 53/229 (23%), Positives = 92/229 (40%), Gaps = 49/229 (21%)
Query: 99 KMGEGTFGQVVEC-FDNEKKEL--VAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGT 153
K+G+G+FG V + ++ VA+K ++S + + E ++ L ++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL--- 58
Query: 154 RCVQIRNWFDYRNH-ICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
IR + H + +V E L P SL D LRK++ F I + + Q+ + ++
Sbjct: 59 ----IRLYGVVLTHPLMMVTE-LAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
R IH DL NILL S + VK+ D+ L R+
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFG-LMRALPQN---------------------- 150
Query: 271 EHQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVELCS 313
+ V H + APE + +++ D+W G L E+ +
Sbjct: 151 ----EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (136), Expect = 4e-09
Identities = 59/238 (24%), Positives = 95/238 (39%), Gaps = 60/238 (25%)
Query: 99 KMGEGTFGQVVECF---DNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHD---- 149
K+GEG FG+V + + K VA+K ++ + R+ + E V+++L H
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVR 60
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+G C + + +V E + G L D+LRK+ FP L + L S
Sbjct: 61 LLGV--CTE-------EEPLYLVLEYMEGG-DLLDYLRKSR-PVFPSPEKSTLSLKDLLS 109
Query: 207 VA--------FMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKS 257
A ++ + +H DL N L+ VK+ D F LSR D Y++ K
Sbjct: 110 FAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISD--FGLSRDVYDDDYYR---KK 164
Query: 258 SAIKLIDFGSTTFEHQDHSYVVSTRHYR--APEVILGLGWNYPCDLWSVGCILVELCS 313
+ KL R APE + + D+WS G +L E+ +
Sbjct: 165 TGGKL--------------------PIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 50/227 (22%), Positives = 94/227 (41%), Gaps = 38/227 (16%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCV 156
+G+GTFG+V+ + + A+KI++ I K A + + + RH
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPF----LT 58
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
++ F ++ +C V E + G L+ L + R F D R G +++ ++ ++H ++
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKI 116
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
++ DLK EN++L ++K+ D+ D + K
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF--------------------- 155
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
T Y APEV+ + D W +G ++ E+ C PF
Sbjct: 156 ---CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM----CGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 60/241 (24%), Positives = 108/241 (44%), Gaps = 37/241 (15%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDI-- 150
+ L +G G FG+V + + A+KI+R +A M+E + + + A DI
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR------KADMLEKEQVGHIRAERDILV 56
Query: 151 --GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQL---- 203
V++ F + ++ ++ E L G + L K D + E Q
Sbjct: 57 EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-------DTLTEEETQFYIAE 109
Query: 204 -LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDGSYFKNLPKSSAI 260
+ ++ +H+L IH D+KP+N+LL S +VK+ D+ + + + +++NL S
Sbjct: 110 TVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169
Query: 261 KLIDFGSTTFEHQDHSY----------VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
F + + + ++ V T Y APEV + G+N CD WS+G I+ E
Sbjct: 170 DFT-FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
Query: 311 L 311
+
Sbjct: 229 M 229
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 25/155 (16%)
Query: 191 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS--RSSKDG 248
FP L R +L ++ +H++ IH D+KP+NIL+ ++K+ D+ + R + +
Sbjct: 98 FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157
Query: 249 SYFK--NLPKSSAIKLIDF-----------------GSTTFEHQD---HSYVVSTRHYRA 286
Y++ + + +++ D T +HQ HS +V T +Y A
Sbjct: 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHS-LVGTPNYIA 216
Query: 287 PEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321
PEV+L G+ CD WSVG IL E+ +L P
Sbjct: 217 PEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAP 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 31/220 (14%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
+++ K+G G FG+V N + VA+K ++ E+ + E ++++L RHD +
Sbjct: 9 QLIKKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTMSPESFLEEAQIMKKL-RHD----K 62
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
VQ+ I IV E + SL DFL+ R+ + + ++ Q+ +A++ +
Sbjct: 63 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
IH DL+ NIL+ K+ D+ L+R +D Y IK
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFG-LARLIEDNEYTARQGAKFPIK------------ 168
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ APE L + D+WS G +L EL +
Sbjct: 169 ----------WTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 32/214 (14%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
K+GEG+ G V + VA+K++ + R + V+ R +H V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH----QNVVEM 83
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
+ + ++ E L G +L D + + I V E +L+++ ++H +IH
Sbjct: 84 YKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCE---SVLQALCYLHSQGVIH 140
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
D+K ++ILL VK+ D+ F ++ SKD +PK ++
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKD------VPKRKSL----------------- 177
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
V T ++ APEVI + D+WS+G +++E+
Sbjct: 178 -VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 7e-09
Identities = 51/222 (22%), Positives = 104/222 (46%), Gaps = 37/222 (16%)
Query: 93 RYRILSKMGEGTFGQVVECF---DNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
+Y ILS + G+ G+V C D ++K++ IV+++ + EID+L+ ++
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKV----IVKAVTGGKTPGR-EIDILKTISHRA 147
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I + + + + +++ +C+V K L+ ++ ++ P++ + R+LLE++A+
Sbjct: 148 I-----INLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRRLLEALAY 200
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
+H +IH D+K ENI L E + D+ +A KL +
Sbjct: 201 LHGRGIIHRDVKTENIFLDEPENAVLGDF------------------GAACKL---DAHP 239
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
Q + + T +PE++ + D+WS G +L E+
Sbjct: 240 DTPQCYGW-SGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 9e-09
Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 43/223 (19%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIV-----RSINKYREAAMIEIDVLQRLARHDIG 151
L ++G G+FG V D E+VAIK + +S K+++ + E+ LQR+ +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-IKEVKFLQRIKHPN-- 86
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
++ + + + +V E S D L + +++ + L+ +A++H
Sbjct: 87 ---SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLH 142
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
+IH D+K NILL + +KL DFGS +
Sbjct: 143 SHNMIHRDIKAGNILLT---------------------------EPGQVKLADFGSASIA 175
Query: 272 HQDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVEL 311
+S+ V T ++ APEVIL + ++ D+WS+G +EL
Sbjct: 176 SPANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 1e-08
Identities = 64/252 (25%), Positives = 106/252 (42%), Gaps = 60/252 (23%)
Query: 93 RYRILSKMGEGTFGQVVECF------DNEKKELVAI------KIVRSINKY-----REAA 135
+R++ + G FG++ C + E + V K R I K R A
Sbjct: 149 HFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAI 208
Query: 136 MIE--IDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS--YRSF 191
+E I L RL +I ++I + ++ +K LY F+ + ++
Sbjct: 209 QLENEILALGRLNHENI-----LKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDR 263
Query: 192 P-IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250
P + R + +QLL +V ++H+ +LIH D+K ENI L + DG
Sbjct: 264 PLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL-----------------NCDGK- 305
Query: 251 FKNLPKSSAIKLIDFGS-TTFEHQ----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
I L DFG+ FE + D+ +V T +PE++ G G+ D+WS G
Sbjct: 306 ---------IVLGDFGTAMPFEKEREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCG 355
Query: 306 CILVELCSVSNC 317
IL+++ S C
Sbjct: 356 LILLDMLSHDFC 367
|
Length = 501 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 37/218 (16%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS--INKYR--EAAMIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ EL A+K+++ I + E M E VL +H
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
Q+ + F ++ + V E + G ++ R F R +++ + F+HE
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHER 115
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+I+ DLK +N+LL S ++K+ D+ K+G I G TT
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGM----CKEG--------------ILGGVTT---- 153
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
S T Y APE++ + D W++G +L E+
Sbjct: 154 --STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 49/220 (22%), Positives = 96/220 (43%), Gaps = 35/220 (15%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGG 152
+S +G G G V + ++A K+V + + R+ + E+ ++ H+
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIM-----HECRS 62
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH- 211
V F N+IC+ E + D + K P++++ ++ ++E + +++
Sbjct: 63 PYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK-KGGPIPVEILGKIAVAVVEGLTYLYN 121
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
R++H D+KP NIL+ S +K+ D+ + +LI+ + TF
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDF------------------GVSGELINSIADTF- 162
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
V T Y +PE I G + D+WS+G ++EL
Sbjct: 163 -------VGTSTYMSPERIQGGKYTVKSDVWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 57/222 (25%), Positives = 96/222 (43%), Gaps = 41/222 (18%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIV----RSINKYREAAMIEIDVLQRLARHDIGG 152
L ++G G+FG V D E+VAIK + + N+ + + E+ LQ+L RH
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RH---- 74
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
+Q R + + +V E S D L + +++ + L+ +A++H
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AVTHGALQGLAYLHS 133
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
+IH D+K NILL + +KL DFGS +
Sbjct: 134 HNMIHRDVKAGNILLS---------------------------EPGLVKLGDFGSASIMA 166
Query: 273 QDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVEL 311
+ + V T ++ APEVIL + ++ D+WS+G +EL
Sbjct: 167 PANXF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 52/224 (23%), Positives = 93/224 (41%), Gaps = 39/224 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMI--EIDVLQRLARHD 149
+ +L +G+G FG+V + K++ A+K + + + E +LQ L H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHP 60
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-KLGPSL-YDFLRKNSYRSFPIDLVRELGRQLLESV 207
V + F ++ +V + LG L Y +K F + V+ +++ ++
Sbjct: 61 F----LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLAL 113
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++H +IH D+KP+NILL +V + D+ N+ A K+ +
Sbjct: 114 EYLHSKGIIHRDIKPDNILLDEQGHVHITDF--------------NI----ATKVTP-DT 154
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T T Y APEV+ G++ D WS+G E
Sbjct: 155 LTTS------TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYEC 192
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 53/230 (23%), Positives = 104/230 (45%), Gaps = 34/230 (14%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIK---IVRSINKYREAAMIEIDVLQRLARHDI 150
Y + +G+G++G+V + IK + + + R+AA E +L +L +I
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 151 GGTRCVQIRNW--FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
R +W D +I + F + G LY L++ + P + V E Q+ ++
Sbjct: 62 VAYR----ESWEGEDGLLYIVMGFCE-GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++HE ++H DLK +N+ L +KV D ++R ++ D ST
Sbjct: 117 YLHEKHILHRDLKTQNVFLTRTNIIKVGDLG-IARVLENQC--------------DMAST 161
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318
++ T +Y +PE+ +NY D+W++GC + E+ ++ + +
Sbjct: 162 ---------LIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 33/221 (14%)
Query: 95 RILSKMGEGTFGQV-VECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
R+ K+G+G FG+V + ++ K VAIK ++ EA + E ++++L RHD
Sbjct: 9 RLDVKLGQGCFGEVWMGTWNGTTK--VAIKTLKPGTMMPEAFLQEAQIMKKL-RHD---- 61
Query: 154 RCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
+ V + I IV E +G SL DFL++ + + + ++ Q+ + +A++
Sbjct: 62 KLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
+ IH DL+ NIL+ K+ D+ L+R +D Y IK
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFG-LARLIEDNEYTARQGAKFPIK----------- 168
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ APE L + D+WS G +L EL +
Sbjct: 169 -----------WTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 59/229 (25%), Positives = 98/229 (42%), Gaps = 41/229 (17%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAA--MIEIDVLQRLARHDIGGTRC 155
+G+GTFG+V+ + A+KI++ I E A + E VLQ +RH
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPF----L 57
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-EL 213
++ F + +C V E G L+ L + R F D R G +++ ++ ++H E
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK 115
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+++ DLK EN++L ++K+ D+ KDG+ K TF
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK----------------TF--- 156
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
T Y APEV+ + D W +G ++ E+ C PF
Sbjct: 157 -----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM----CGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 40/228 (17%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMI-EIDVLQRLARHDIGGTRC 155
+G+GTFG+V+ + A+KI+R I K A + E VLQ RH
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA-- 59
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
++ F + +C V E G L+ L + R F + R G +++ ++ ++H
Sbjct: 60 --LKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRD 115
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+++ D+K EN++L ++K+ D+ DG+ K TF
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK----------------TF---- 155
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
T Y APEV+ + D W +G ++ E+ C PF
Sbjct: 156 ----CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM----CGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 35/217 (16%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS---IN-KYREAAMIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ + A+K+++ +N K ++ M E +VL + +H
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V + F + V + + G L+ L++ RSFP R ++ ++ ++H +
Sbjct: 59 VGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSIN 116
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+++ DLKPENILL S +V + D+ K+G I D +TTF
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGL----CKEG-----------IAQSD-TTTTF---- 156
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T Y APEVI ++ D W +G +L E+
Sbjct: 157 ----CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 54/227 (23%), Positives = 98/227 (43%), Gaps = 37/227 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ I+ +G G FG+V + + A+KI +NK+ E R R+ +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKI---LNKWEMLKRAETACF-REERNVLVNG 58
Query: 154 RCVQIRNW---FDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
C I F N++ +V + +G L L K R P D+ R +++ ++
Sbjct: 59 DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHS 117
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
+H+L +H D+KP+N+LL ++++ D+ + ++DG+
Sbjct: 118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV------------------- 158
Query: 270 FEHQDHSYVVSTRHYRAPEVIL----GLGWNYP-CDLWSVGCILVEL 311
S V T Y +PE++ G+G P CD WS+G + E+
Sbjct: 159 ----QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 18/162 (11%)
Query: 99 KMGEGTFGQVVECFDNEKK--ELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGT 153
++G G FG V + KK + VA+KI+++ N ++ + E +V+Q+L I
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYI--V 59
Query: 154 RCVQI---RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
R + I +W + + +LGP L FL+KN + + EL Q+ + ++
Sbjct: 60 RMIGICEAESWM-----LVMELAELGP-LNKFLQKN--KHVTEKNITELVHQVSMGMKYL 111
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252
E +H DL N+LLV+ Y K+ D+ D +Y+K
Sbjct: 112 EETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 46/222 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEID--VLQRLARHDIGGTRCVQ 157
+G+G+FG+V++ K++ I +++I K + E+ + +R + V
Sbjct: 1 IGKGSFGKVMQV---RKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVP 57
Query: 158 IRNWFDYRNHICIVFEKL-GPSLYDFLRK----NSYRSFPIDLVRELGRQLLESVAFMHE 212
++ F + +V + G L+ L++ + R+ R +LL ++ +H+
Sbjct: 58 LKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA------RFYTAELLCALENLHK 111
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
+I+ DLKPENILL DY I L DFG
Sbjct: 112 FNVIYRDLKPENILL---------DY------------------QGHIALCDFGLCKLNM 144
Query: 273 QDHSYV---VSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+D T Y APE++LG G+ D W++G +L E+
Sbjct: 145 KDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEM 186
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 58/236 (24%), Positives = 100/236 (42%), Gaps = 51/236 (21%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ I+ +G+GT+G+V + + + A+KI+ I+ E E ++L+ L+ H
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDH----P 75
Query: 154 RCVQIRNWF---DYRN--HICIVFEKL-GPSLYD----FLRKNSYRSFPIDLVRELGRQL 203
V+ + D +N + +V E G S+ D FL++ PI + + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI--IAYILHEA 133
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
L + +H + IH D+K NILL + +KL+
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTT---------------------------EGGVKLV 166
Query: 264 DFGST---TFEHQDHSYVVSTRHYRAPEVI-----LGLGWNYPCDLWSVGCILVEL 311
DFG + T + V T + APEVI L ++ CD+WS+G +EL
Sbjct: 167 DFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 31/220 (14%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
R+ K+G+G FG+V N VAIK ++ EA + E V+++L RH+ +
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 62
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
VQ+ I IV E + SL DFL+ + + + ++ Q+ +A++ +
Sbjct: 63 LVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+H DL+ NIL+ KV D+ L+R +D Y IK
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTARQGAKFPIK------------ 168
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ APE L + D+WS G +L EL +
Sbjct: 169 ----------WTAPEAALYGRFTIKSDVWSFGILLTELTT 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 33/223 (14%)
Query: 92 PR--YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
PR +++ K+G G FG+V + N + VAIK ++ + EA + E +++++L +H
Sbjct: 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTK-VAIKSLKQGSMSPEAFLAEANLMKQL-QHP 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
R V++ + I I+ E + SL DFL+ I+ + ++ Q+ E +A
Sbjct: 62 ----RLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
F+ IH DL+ NIL+ K+ D+ L+R +D Y IK
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFG-LARLIEDNEYTAREGAKFPIK------- 168
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ APE I + D+WS G +L E+
Sbjct: 169 ---------------WTAPEAINYGTFTIKSDVWSFGILLTEI 196
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 5e-08
Identities = 56/221 (25%), Positives = 93/221 (42%), Gaps = 41/221 (18%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
++G G FG V + EK++ VAIK +R E + E V+ +L+ + VQ+
Sbjct: 11 EIGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFIEEAQVMMKLSH-----PKLVQL 64
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
R+ IC+VFE + L D+LR F + + + + E +A++ +IH
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIH 123
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
DL N L + ++ +K+ DFG T F D Y
Sbjct: 124 RDLAARNCL---------------------------VGENQVVKVSDFGMTRFVLDDQ-Y 155
Query: 278 VVSTR-----HYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
ST + +PEV ++ D+WS G ++ E+ S
Sbjct: 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 58/234 (24%), Positives = 98/234 (41%), Gaps = 49/234 (20%)
Query: 99 KMGEGTFGQVVECF--DNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
K+G GT+G V + D + ++ A+K + +A EI +L+ L ++ + V
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNVIALQKV 66
Query: 157 QIRN-----W--FDYRNHI---CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+ + W FDY H I F + + P +V+ L Q+L+
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKA------NKKPMQLPRSMVKSLLYQILDG 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++H ++H DLKP NIL++ P+ +K+ D G
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEG-----------------------PERGRVKIADMG 157
Query: 267 STTFEHQ------DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCS 313
+ D VV T YRAPE++LG + D+W++GCI EL +
Sbjct: 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 6e-08
Identities = 57/216 (26%), Positives = 99/216 (45%), Gaps = 31/216 (14%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
K+G G FG+V N K VA+K ++ + EA + E +V++ L +HD + V++
Sbjct: 13 KLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHD----KLVKL 66
Query: 159 RNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
+ + I I+ E + SL DFL+ + P+ + + Q+ E +AF+ + IH
Sbjct: 67 -HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIH 125
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
DL+ NIL+ ++ K+ D+ L+R +D Y IK
Sbjct: 126 RDLRAANILVSASLVCKIADFG-LARVIEDNEYTAREGAKFPIK---------------- 168
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ APE I + D+WS G +L+E+ +
Sbjct: 169 ------WTAPEAINFGSFTIKSDVWSFGILLMEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 7e-08
Identities = 54/219 (24%), Positives = 94/219 (42%), Gaps = 32/219 (14%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
++L K+G G FG+V E N VA+K ++ + + E ++++L RH +
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKL-RH----PK 62
Query: 155 CVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
+Q+ I IV E K G SL ++L+ + R+ + + ++ Q+ +A++
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYG-SLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA 121
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
IH DL N+L+ KV D+ L+R K+ Y IK
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFG-LARVIKEDIYEAREGAKFPIK----------- 169
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ APE L ++ D+WS G +L E+
Sbjct: 170 -----------WTAPEAALYNRFSIKSDVWSFGILLTEI 197
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 8e-08
Identities = 59/235 (25%), Positives = 97/235 (41%), Gaps = 51/235 (21%)
Query: 99 KMGEGTFGQVVECF--DNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
K+G GT+G V + D + A+K + +A EI +L+ L ++ + V
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNVISLQKV 66
Query: 157 QIRN-----W--FDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDL----VRELGRQLLE 205
+ + W FDY H + F R + P+ L V+ L Q+L+
Sbjct: 67 FLSHADRKVWLLFDYAEHDLW-------HIIKFHRASKANKKPVQLPRGMVKSLLYQILD 119
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ ++H ++H DLKP NIL++ P+ +K+ D
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEG-----------------------PERGRVKIADM 156
Query: 266 GSTTFEHQ------DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCS 313
G + D VV T YRAPE++LG + D+W++GCI EL +
Sbjct: 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 53/214 (24%), Positives = 97/214 (45%), Gaps = 32/214 (14%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
K+GEG+ G V +LVA+K + + R + V+ R +H+ V++
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHE----NVVEM 82
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
N + + + +V E L G +L D + I V +L++++ +H +IH
Sbjct: 83 YNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV---CLAVLKALSVLHAQGVIH 139
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
D+K ++ILL VK+ D+ F ++ SK+ K+L
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL----------------------- 176
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
V T ++ APE+I L + D+WS+G +++E+
Sbjct: 177 -VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-08
Identities = 60/235 (25%), Positives = 102/235 (43%), Gaps = 45/235 (19%)
Query: 95 RILSKMGEGTFGQVVEC-FD---NEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
+ + ++G+G FG V C +D + E+VA+K ++ S ++ EI++L+ L +
Sbjct: 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDN 66
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I + V + R ++ +V E L P SL D+L+K+ R L+ Q+ + +
Sbjct: 67 IVKYKGV---CYSAGRRNLRLVMEYL-PYGSLRDYLQKHRERLDHRKLL-LYASQICKGM 121
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++ R +H DL NIL+ S VK+ DFG
Sbjct: 122 EYLGSKRYVHRDLATRNILVESENRVKIG---------------------------DFGL 154
Query: 268 TTFEHQDHSYVV------STRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSN 316
T QD Y S + APE + ++ D+WS G +L EL + S+
Sbjct: 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSD 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 55/223 (24%), Positives = 90/223 (40%), Gaps = 47/223 (21%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ K E A+K ++ I+ E M+E VL +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRE--LGRQLLESVAFMH 211
+ F + H+ V E L G ++ K + DL R +++ + F+H
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRF-----DLYRATFYAAEIVCGLQFLH 113
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG---ST 268
+I+ DLK +N++L +DG IK+ DFG
Sbjct: 114 SKGIIYRDLKLDNVML-----------------DRDGH----------IKIADFGMCKEN 146
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
F S T Y APE++ GL + + D WS G +L E+
Sbjct: 147 VFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 41/222 (18%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIV----RSINKYREAAMIEIDVLQRLARHDIGG 152
L ++G G+FG V ++ E+VA+K + + N+ + + E+ LQ+L +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNT-- 83
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
++ + + + +V E S D L + +++ + L+ +A++H
Sbjct: 84 ---IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-AITHGALQGLAYLHS 139
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
+IH D+K NILL + +KL DFGS +
Sbjct: 140 HNMIHRDIKAGNILLT---------------------------EPGQVKLADFGSASKSS 172
Query: 273 QDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVEL 311
+S+ V T ++ APEVIL + ++ D+WS+G +EL
Sbjct: 173 PANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 51/220 (23%), Positives = 96/220 (43%), Gaps = 30/220 (13%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
+++ K+G G FG+V + N + VA+K ++ +A + E ++++ L +HD +
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTL-QHD----K 62
Query: 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
V++ I I+ E + SL DFL+ + + + + Q+ E +A++
Sbjct: 63 LVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK 122
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
IH DL+ N+L+ + K+ D+ L+R +D Y IK
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFG-LARVIEDNEYTAREGAKFPIK------------ 169
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ APE I + D+WS G +L E+ +
Sbjct: 170 ----------WTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 38/228 (16%)
Query: 92 PR--YRILSKMGEGTFGQVVE-CFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLAR 147
PR + + K+G G FG+V E + N + VAIKI++S + ++ E+ L+RL R
Sbjct: 4 PREEFTLERKLGSGYFGEVWEGLWKNRVR--VAIKILKSDDLLKQQDFQKEVQALKRL-R 60
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLES 206
H + + + I+ E + SL FLR + P+ + ++ Q+ E
Sbjct: 61 HK----HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEG 116
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYV-KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+A++ E IH DL NI LV + V KV D+ L+R K+ Y L I
Sbjct: 117 MAYLEEQNSIHRDLAARNI-LVGEDLVCKVADFG-LARLIKEDVY---LSSDKKIPY--- 168
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ APE ++ D+WS G +L E+ +
Sbjct: 169 -----------------KWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 56/229 (24%), Positives = 100/229 (43%), Gaps = 41/229 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQRLARHD 149
+ IL +G G FG+V ++ A+KI+ + A E DVL
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN----- 57
Query: 150 IGGTRCVQIRNW-FDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
G + + ++ F N++ +V + +G L L K R P D+ R +++ ++
Sbjct: 58 -GDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAI 115
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
+H+L +H D+KP+NIL+ ++++ D+ S +KL++ G+
Sbjct: 116 DSVHQLHYVHRDIKPDNILMDMNGHIRLADF------------------GSCLKLMEDGT 157
Query: 268 TTFEHQDHSYVVSTRHYRAPEVIL----GLGWNYP-CDLWSVGCILVEL 311
S V T Y +PE++ G G P CD WS+G + E+
Sbjct: 158 V-----QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-07
Identities = 52/217 (23%), Positives = 98/217 (45%), Gaps = 35/217 (16%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ +++ A+K++ ++I K +E M E +VL + +H
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V + F + + V + + G L+ L++ R F R ++ ++ ++H L
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLN 116
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+++ DLKPENILL S ++ + D+ + I+ TT
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKEN------------------IEHNGTT----- 153
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
S T Y APEV+ ++ D W +G +L E+
Sbjct: 154 -STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 56/219 (25%), Positives = 86/219 (39%), Gaps = 39/219 (17%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ E AIK ++ + E M+E VL H
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
+ F + H+ V E L F ++S R F R +++ + F+H+ +
Sbjct: 59 THLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLHKKGI 117
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE---H 272
I+ DLK +N+LL KDG IK+ DFG
Sbjct: 118 IYRDLKLDNVLL-----------------DKDGH----------IKIADFGMCKENMNGE 150
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
S T Y APE++ G +N D WS G +L E+
Sbjct: 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 57/234 (24%), Positives = 94/234 (40%), Gaps = 48/234 (20%)
Query: 13 NMDKRPRKRPRLTWDVP---PPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTG 69
RPR+RP LT +P P L P LP P + SS +
Sbjct: 19 TTKSRPRRRPDLTLPLPQRDPSLAVPLPLP-------------PPSSSSSSSSSSSASGS 65
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RS 127
+P +L+ R+ +++G G G V + L A+K++
Sbjct: 66 APSAAK-------------SLSELERV-NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111
Query: 128 INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS 187
+ R EI++L R H V+ + FD+ I ++ E F+ S
Sbjct: 112 EDTVRRQICREIEIL-RDVNH----PNVVKCHDMFDHNGEIQVLLE--------FMDGGS 158
Query: 188 YRSFPIDLVREL---GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
I + L RQ+L +A++H ++H D+KP N+L+ SA+ VK+ D+
Sbjct: 159 LEGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADF 212
|
Length = 353 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 49/227 (21%), Positives = 100/227 (44%), Gaps = 38/227 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
+ ++ ++G GT+G V + + EL AIK+++ + + A+++ +++ D +
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIK-LEPGEDFAVVQQEIIMM---KDCKHS 66
Query: 154 RCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPID--LVRELGRQLLESVAFM 210
V + R+ + I E G SL D + + P+ + + R+ L+ + ++
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIY----HVTGPLSESQIAYVSRETLQGLYYL 122
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H +H D+K NILL +VK+ D+ ++ + + K+
Sbjct: 123 HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF---------------- 166
Query: 271 EHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSV 314
+ T ++ APEV G+N CD+W+VG +EL +
Sbjct: 167 --------IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAEL 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 55/224 (24%), Positives = 95/224 (42%), Gaps = 46/224 (20%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-------EAAMIEIDVLQRLARHDIGG 152
+G+G FG+V C +L A K +NK R E AM+E +L ++ I
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACK---KLNKKRLKKRKGYEGAMVEKRILAKVHSRFI-- 55
Query: 153 TRCVQIRNWFDYRNHICIVFE-----KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
V + F + +C+V L +Y+ +N FP Q++ +
Sbjct: 56 ---VSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP--GFPEPRACFYTAQIISGL 110
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
+H+ R+I+ DLKPEN+LL + V++ D A++L D S
Sbjct: 111 EHLHQRRIIYRDLKPENVLLDNDGNVRISDLGL------------------AVELKDGQS 152
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T + T + APE++ G +++ D +++G L E+
Sbjct: 153 KTKGY------AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEM 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 70/238 (29%)
Query: 97 LSKMGEGTFGQVV---ECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDI 150
L +G+G+FG+V + + +L A+K+++ + R +E D+L
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDIL-------- 52
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLY---DFLRKNSYRSFPIDLVRELGRQLL--- 204
++ + F + H F+ G LY DFLR DL L ++++
Sbjct: 53 -----AEVNHPFIVKLHY--AFQTEG-KLYLILDFLRGG-------DLFTRLSKEVMFTE 97
Query: 205 ESVAF-----------MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
E V F +H L +I+ DLKPENILL ++K+ D+ LS+ S D
Sbjct: 98 EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG-LSKESIDH----- 151
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
E + +S+ T Y APEV+ G D WS G ++ E+
Sbjct: 152 -----------------EKKAYSF-CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEM 191
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 66/258 (25%), Positives = 94/258 (36%), Gaps = 65/258 (25%)
Query: 64 AIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK 123
AI R PP FAI LTP G+ G V E + + V +K
Sbjct: 151 AISRGCKPPSEVAKVVAGLGFAIHRALTP----------GSEGCVFESSHPDYPQRVVVK 200
Query: 124 IVRSINKYREAAMIE----IDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSL 179
+ EA ++ VL L +GG C+V K L
Sbjct: 201 AGWYASSVHEARLLRRLSHPAVLALLDVRVVGGL--------------TCLVLPKYRSDL 246
Query: 180 YDFLRKNSYRSFPIDL--VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
Y +L R P+ L V + RQLL ++ ++H +IH D+K EN+L+
Sbjct: 247 YTYL---GARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---------- 293
Query: 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY-----VVSTRHYRAPEVILG 292
N P+ I L DFG+ F S + T APEV+ G
Sbjct: 294 ---------------NGPED--ICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG 336
Query: 293 LGWNYPCDLWSVGCILVE 310
+ D+WS G ++ E
Sbjct: 337 DPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 55/217 (25%), Positives = 96/217 (44%), Gaps = 35/217 (16%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAA--MIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ A+K++ ++I K +E M E +VL + +H
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V + F + V + + G L+ L++ R F R ++ ++ ++H L
Sbjct: 59 VGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+I+ DLKPENILL S +V + D+ K+G ++ TT
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGL----CKEG--------------VEPEETT----- 153
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
S T Y APEV+ ++ D W +G +L E+
Sbjct: 154 -STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEM 189
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 61/244 (25%), Positives = 100/244 (40%), Gaps = 61/244 (25%)
Query: 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150
T + I+ +G+GT+G+V + + + L A+KI+ I+ E E ++LQ L H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNH-- 78
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVREL---GRQLLESV 207
V+ F Y+ + G L+ L + S +LV+ L G++L E++
Sbjct: 79 --PNVVKFYGMF-YKADKLV-----GGQLWLVLELCNGGSV-TELVKGLLICGQRLDEAM 129
Query: 208 ------------AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255
+H R+IH D+K NILL +
Sbjct: 130 ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT-------------------------- 163
Query: 256 KSSAIKLIDFGST---TFEHQDHSYVVSTRHYRAPEVI-----LGLGWNYPCDLWSVGCI 307
+KL+DFG + T + V T + APEVI ++ CD+WS+G
Sbjct: 164 -EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGIT 222
Query: 308 LVEL 311
+EL
Sbjct: 223 AIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 46/175 (26%)
Query: 100 MGEGTFGQVVECFDNEK--KEL-VAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTR 154
+G G FG VV+ K KE+ VA+K ++ I ++ + E V+ +L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL--------- 53
Query: 155 CVQIRNWFDYRNHICIV----------------FEKLGPSLYDFLRKNSYRSFPIDLVRE 198
+H CIV LGP L +L+K R P+ ++E
Sbjct: 54 -----------DHPCIVRLIGVCKGEPLMLVMELAPLGP-LLKYLKKR--REIPVSDLKE 99
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS-YFK 252
L Q+ +A++ +H DL N+LLV+ K+ D+ +SR+ GS Y++
Sbjct: 100 LAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFG-MSRALGAGSDYYR 153
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-07
Identities = 47/220 (21%), Positives = 94/220 (42%), Gaps = 41/220 (18%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-------EAAMIEIDVLQRLARHDIGG 152
+G+G FG+V ++ A K ++K R + A++E ++L+++ I
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACK---KLDKKRLKKKSGEKMALLEKEILEKVNSPFI-- 55
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
V + F+ + H+C+V + G L + R ++ V Q+ + +H
Sbjct: 56 ---VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
+ +++ D+KPEN+LL ++ D A++L D + T
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLSDLGL------------------AVELKDGKTITQR 154
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T Y APE++ ++YP D +++GC + E+
Sbjct: 155 -------AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEM 187
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 57/240 (23%), Positives = 97/240 (40%), Gaps = 70/240 (29%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA--MIEIDVLQRLARHDIGGTR 154
L ++G G FG V + ++A+K +RS +E ++++DV+ R +
Sbjct: 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMR-------SSD 61
Query: 155 CVQIRNWFDYRNH-----IC-----IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
C I ++ IC I +K +Y+ L+ P ++ LG+ +
Sbjct: 62 CPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSV----IPEEI---LGKIAV 114
Query: 205 ESVAFMH----ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
+V ++ EL++IH D+KP NILL ++ I
Sbjct: 115 ATVKALNYLKEELKIIHRDVKPSNILL---------------------------DRNGNI 147
Query: 261 KLIDFG------STTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVEL 311
KL DFG + + +D R Y APE I G++ D+WS+G L E+
Sbjct: 148 KLCDFGISGQLVDSIAKTRD----AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 51/218 (23%), Positives = 90/218 (41%), Gaps = 37/218 (16%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V + AIK ++ ++ E M+E VL H
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE--LGRQLLESVAFMHEL 213
+ F + ++ V E L F ++ ++ DL R +++ + F+H
Sbjct: 59 THLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSK 115
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+++ DLK +NILL + ++K+ D+ + L D + TF
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKEN----------------MLGDAKTCTF--- 156
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T Y APE++LG +N D WS G +L E+
Sbjct: 157 -----CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 9e-07
Identities = 53/226 (23%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIG 151
Y ++ ++G GT+G V + + EL A+KI++ + + ++I EI +++ +I
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIK-LEPGDDFSLIQQEIFMVKECKHCNI- 68
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPID--LVRELGRQLLESVA 208
V + R + I E G SL D + + P+ + + R+ L+ +A
Sbjct: 69 ----VAYFGSYLSREKLWICMEYCGGGSLQDIY----HVTGPLSELQIAYVCRETLQGLA 120
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++H +H D+K NILL VK+ D+ ++ + + K+
Sbjct: 121 YLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF-------------- 166
Query: 269 TFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVEL 311
+ T ++ APEV G+N CD+W+VG +EL
Sbjct: 167 ----------IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 48/218 (22%), Positives = 99/218 (45%), Gaps = 37/218 (16%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMIEID--VLQRLARHD--IGGT 153
+G G++ +V+ + + + A+K+V+ +N + ++ + V ++ + H +G
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
C Q + R I + G ++ R+ R P + R ++ ++ ++HE
Sbjct: 63 SCFQTES----RLFFVIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHER 115
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+I+ DLK +N+LL S ++K+ DY K+G + G TT
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGM----CKEG--------------LRPGDTT---- 153
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
S T +Y APE++ G + + D W++G ++ E+
Sbjct: 154 --STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 189
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 51/224 (22%), Positives = 97/224 (43%), Gaps = 38/224 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
+YR+L G+G FG+V C ++ A K + + I K + +M E +L+++
Sbjct: 4 QYRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSR 60
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ V + ++ ++ +C+V + G L + F ++ +
Sbjct: 61 FV-----VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGL 115
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
+H+ R+++ DLKPENILL ++++ D ++P+ IK G
Sbjct: 116 EDLHQERIVYRDLKPENILLDDHGHIRISDLGLAV----------HVPEGQTIK----GR 161
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
V T Y APEV+ + + D W++GC+L E+
Sbjct: 162 -----------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 62/230 (26%), Positives = 94/230 (40%), Gaps = 51/230 (22%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
L ++G GT GQV + + ++A+K + R+ NK E I +D+ L HD
Sbjct: 19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHD----- 72
Query: 155 C---VQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
C V+ +F + + I E + L D L K P D+ LG+ + V +H
Sbjct: 73 CPYIVKCYGYFITDSDVFICMELMSTCL-DKLLKRIQGPIPEDI---LGKMTVAIVKALH 128
Query: 212 ELR----LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
L+ +IH D+KP NILL S +KL DFG
Sbjct: 129 YLKEKHGVIHRDVKPSNILL---------------------------DASGNVKLCDFGI 161
Query: 268 TTF--EHQDHSYVVSTRHYRAPEVI----LGLGWNYPCDLWSVGCILVEL 311
+ + + + Y APE I ++ D+WS+G LVEL
Sbjct: 162 SGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 50/223 (22%), Positives = 91/223 (40%), Gaps = 42/223 (18%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDIGG 152
+ +G G G V + + + ++A+K++ + ++ M E+++L + I
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI-- 61
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
+ F N I I E + G SL + YR P ++ + +++ + ++
Sbjct: 62 ---IGFYGAFFVENRISICTEFMDGGSL------DVYRKIPEHVLGRIAVAVVKGLTYLW 112
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTF 270
L+++H D+KP N+L+ + V KL DFG ST
Sbjct: 113 SLKILHRDVKPSNMLVNTRGQV---------------------------KLCDFGVSTQL 145
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ V T Y APE I G + D+WS+G +EL
Sbjct: 146 VNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELAL 188
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 56/234 (23%), Positives = 98/234 (41%), Gaps = 50/234 (21%)
Query: 94 YRILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQRL 145
+ +L +G G +G+V + ++ +L A+K+++ K E E VL+ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
R V + F + ++ + + G L+ L + + F VR +++
Sbjct: 62 RRCPF----LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREH--FTESEVRVYIAEIV 115
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
++ +H+L +I+ D+K ENILL +G + L D
Sbjct: 116 LALDHLHQLGIIYRDIKLENILL-----------------DSEGH----------VVLTD 148
Query: 265 FG-STTF----EHQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVEL 311
FG S F E + +S+ T Y APEVI G G + D WS+G + EL
Sbjct: 149 FGLSKEFLAEEEERAYSF-CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR 154
+S++G G G V + ++A K++ K R + E+ VL H+
Sbjct: 10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPY 64
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
V F I I E + G SL L++ + P +++ ++ +L +A++ E
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREK 122
Query: 214 -RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
+++H D+KP NIL+ S +K+ D+ + +LID + +F
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDF------------------GVSGQLIDSMANSF-- 162
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
V TR Y +PE + G ++ D+WS+G LVEL
Sbjct: 163 ------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 55/240 (22%)
Query: 100 MGEGTFGQVVE--CFDNEKKEL---VAIKIVRSINKY--REAAMIEIDVLQRLARHDIGG 152
+G G FG+VVE + K + VA+K+++ REA M E+ ++ L H+
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHE--- 99
Query: 153 TRCVQIRNWFDYRNH---ICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I N I ++ E G L +FLR+ ++ + Q+ + +
Sbjct: 100 ----NIVNLLGACTIGGPILVITEYCCYG-DLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
AF+ IH DL N+LL + VK+ D+ L+R +
Sbjct: 155 AFLASKNCIHRDLAARNVLLTHGKIVKICDFG-LARDIMN-------------------- 193
Query: 268 TTFEHQDHSYVV--STR---HYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
D +YVV + R + APE I + + D+WS G +L E+ S+ P+
Sbjct: 194 ------DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLG---SNPY 244
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 5e-06
Identities = 35/136 (25%), Positives = 56/136 (41%), Gaps = 29/136 (21%)
Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
L+D L+K V+++ RQL+E++ +H+ +IH D+K EN+L
Sbjct: 93 DGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL--------- 141
Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
Y + + I L D+G Y T Y +PE I G +
Sbjct: 142 --------------YDRAKDR---IYLCDYGLCKIIGTPSCY-DGTLDYFSPEKIKGHNY 183
Query: 296 NYPCDLWSVGCILVEL 311
+ D W+VG + EL
Sbjct: 184 DVSFDWWAVGVLTYEL 199
|
Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 44/214 (20%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159
+G G++ +V+ + ++ A+K+V+ + + + + + + V +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 160 NWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
+ F + + +V E + G ++ R+ R P + R ++ ++ F+HE +I+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERGIIY 119
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY 277
DLK +N+LL + ++K+ DY K+G + G TT S
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGM----CKEG--------------LGPGDTT------ST 155
Query: 278 VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T +Y APE++ G + + D W++G ++ E+
Sbjct: 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEM 189
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 51/224 (22%), Positives = 91/224 (40%), Gaps = 36/224 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRL--AR 147
+R L+ +G G FG+V+ + EL AIK ++ E+ M E + + R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
H V + F +H+C V E + D + F ++ +
Sbjct: 61 HPF----LVNLFACFQTEDHVCFVMEYA--AGGDLMMHIHTDVFSEPRAVFYAACVVLGL 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++HE ++++ DLK +N+LL + +VK+ D+ K+G + FG
Sbjct: 115 QYLHENKIVYRDLKLDNLLLDTEGFVKIADFGL----CKEG--------------MGFGD 156
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T S T + APEV+ + D W +G ++ E+
Sbjct: 157 RT------STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEM 194
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-06
Identities = 40/158 (25%), Positives = 73/158 (46%), Gaps = 10/158 (6%)
Query: 99 KMGEGTFGQVVE-CFDNEKKEL-VAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR 154
++G G FG V + + KK++ VAIK++++ N+ R+ M E +++ +L I
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI---- 57
Query: 155 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
V++ + + ++ G L FL + V EL Q+ + ++
Sbjct: 58 -VRMIGVCEAEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252
+H DL N+LLV+ Y K+ D+ D SY+K
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 49/223 (21%), Positives = 92/223 (41%), Gaps = 38/223 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHD 149
YR+L G+G FG+V C ++ A K + + I K + AM E +L++
Sbjct: 5 YRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK----- 56
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ V + ++ ++ +C+V + G L + F + ++ +
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE 116
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+H R+++ DLKPENILL ++++ D L+ +G +
Sbjct: 117 DLHRERIVYRDLKPENILLDDYGHIRISDLG-LAVEIPEGETIRGR-------------- 161
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
V T Y APEV+ + + D W +GC++ E+
Sbjct: 162 ----------VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 1e-05
Identities = 59/235 (25%), Positives = 103/235 (43%), Gaps = 40/235 (17%)
Query: 100 MGEGTFGQVVEC-FDNE---KKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIGGT 153
+GEG FG+V C +D E E VA+K ++ + A + EI++L+ L +I
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 154 R--CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL--GRQLLESVA 208
+ C + D N I ++ E L SL ++L +N + I+L ++L Q+ + +
Sbjct: 72 KGICTE-----DGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMD 123
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++ + +H DL N+L+ S VK+ D+ D Y+ +K D S
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY-------TVK-DDLDSP 175
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPFA 323
F + APE ++ + D+WS G L EL + + +P
Sbjct: 176 VF-------------WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 28/114 (24%), Positives = 50/114 (43%), Gaps = 27/114 (23%)
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
+++ ++ +H + IH D+KP+N+LL + ++K+ D+ + +G
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV----------- 198
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVEL 311
D + V T Y +PEV+ G + CD WSVG L E+
Sbjct: 199 ----------RCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 53/220 (24%), Positives = 98/220 (44%), Gaps = 31/220 (14%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRC 155
L ++G G FG VV+ + VAIK+++ + + + E V+ +L+ +
Sbjct: 8 FLKELGTGQFG-VVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKL----- 61
Query: 156 VQIRNWFDYRNHICIVFEKLGPS-LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
VQ+ + I IV E + L ++LR++ R P L+ E+ + + E +A++ +
Sbjct: 62 VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL-EMCKDVCEGMAYLESKQ 120
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
IH DL N L+ VKV D+ LSR D Y ++ ++
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFG-LSRYVLDDEYTSSVGSKFPVR------------- 166
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSV 314
+ PEV+L ++ D+W+ G ++ E+ S+
Sbjct: 167 ---------WSPPEVLLYSKFSSKSDVWAFGVLMWEVYSL 197
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 24/102 (23%)
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
+H+ +I+ DLKPENILL + +VK+ D+ L K S I G+ T
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDF--------------GLCKES----IHEGTVT 157
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
H++ T Y APE+++ G D WS+G ++ ++
Sbjct: 158 -----HTF-CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDM 193
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 39/148 (26%), Positives = 68/148 (45%), Gaps = 30/148 (20%)
Query: 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPE 223
I I E + G SL L+K P +++ ++ +L + ++ E +++H D+KP
Sbjct: 72 GEISICMEHMDGGSLDQVLKK--AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPS 129
Query: 224 NILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRH 283
NIL+ S +K+ D+ + +LID + +F V TR
Sbjct: 130 NILVNSRGEIKLCDF------------------GVSGQLIDSMANSF--------VGTRS 163
Query: 284 YRAPEVILGLGWNYPCDLWSVGCILVEL 311
Y +PE + G + D+WS+G LVE+
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 49/224 (21%), Positives = 95/224 (42%), Gaps = 38/224 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
+YR+L G+G FG+V C ++ A K + + I K + +M E +L+++
Sbjct: 4 QYRVL---GKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ V + ++ ++ +C+V + G L + F + ++L +
Sbjct: 61 FV-----VNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGL 115
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
+H ++ DLKPENILL ++++ D + +P+ +I+ G
Sbjct: 116 EDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVK----------IPEGESIR----GR 161
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
V T Y APEV+ + D W +GC++ E+
Sbjct: 162 -----------VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 55/231 (23%), Positives = 99/231 (42%), Gaps = 45/231 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-----EAAMI--EIDVLQRLA 146
+ IL +G G FG+V ++ A+KI +NK+ E A E DVL
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKI---LNKWEMLKRAETACFREERDVLVNGD 59
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
R I + F N++ +V + +G L L K R P D+ R +++
Sbjct: 60 RRWI-----TNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVL 113
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
++ +H+L +H D+KP+N+LL ++++ D+ S ++L+
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADF------------------GSCLRLLAD 155
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLG-----WNYPCDLWSVGCILVEL 311
G+ + V T Y +PE++ + + CD WS+G + E+
Sbjct: 156 GTV-----QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEM 201
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-05
Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 37/219 (16%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTR 154
+S++G G G V + ++A K++ K R + E+ VL H+
Sbjct: 10 ISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL-----HECNSPY 64
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
V F I I E + G SL L+K P ++ ++ +++ + ++ E
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK 122
Query: 214 -RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
+++H D+KP NIL+ S +K+ D+ + +LID + +F
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDF------------------GVSGQLIDSMANSF-- 162
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
V TR Y +PE + G ++ D+WS+G LVE+
Sbjct: 163 ------VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 29/123 (23%), Positives = 56/123 (45%), Gaps = 24/123 (19%)
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
R P + R ++ ++ F+HE +I+ DLK +N+LL + ++K+ DY + G
Sbjct: 91 RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG 150
Query: 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
++TF T +Y APE++ G + + D W++G ++
Sbjct: 151 DT----------------TSTF--------CGTPNYIAPEILRGEDYGFSVDWWALGVLM 186
Query: 309 VEL 311
E+
Sbjct: 187 FEM 189
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 46/191 (24%), Positives = 85/191 (44%), Gaps = 37/191 (19%)
Query: 92 PRYRIL--SKMGEGTFGQVVEC---------------FDNEKKELVAIKIVRS-INKY-R 132
PR ++ K+GEG FG+V C FD + LVA+K++R+ + K R
Sbjct: 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDG-QPVLVAVKMLRADVTKTAR 61
Query: 133 EAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK------ 185
+ EI ++ RL +I V + + + +C++ E + L FL +
Sbjct: 62 NDFLKEIKIMSRLKNPNIIRLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIEST 116
Query: 186 ----NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241
N+ S I + + Q+ + ++ L +H DL N L+ + +K+ D+ +
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFG-M 175
Query: 242 SRSSKDGSYFK 252
SR+ G Y++
Sbjct: 176 SRNLYSGDYYR 186
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 6e-05
Identities = 39/149 (26%), Positives = 67/149 (44%), Gaps = 32/149 (21%)
Query: 170 IVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENIL 226
I E + SL F +K + + P D++ ++ +++++ ++H L +IH D+KP N+L
Sbjct: 77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVL 136
Query: 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRA 286
+ VK+ D+ L S A K ID G + Y A
Sbjct: 137 INRNGQVKLCDF----------GISGYLVDSVA-KTIDAGC--------------KPYMA 171
Query: 287 PEVILG----LGWNYPCDLWSVGCILVEL 311
PE I G++ D+WS+G ++EL
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-05
Identities = 37/139 (26%), Positives = 59/139 (42%), Gaps = 26/139 (18%)
Query: 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
+L FLR+N + I LV L R + + ++ E+ +H DL NIL+ S KV D
Sbjct: 91 ALDSFLRQNDGQFTVIQLVGML-RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSD 149
Query: 238 Y---KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG 294
+ +FL + D +Y +L I+ + APE I
Sbjct: 150 FGLSRFLEDDTSDPTYTSSLGGKIPIR----------------------WTAPEAIAYRK 187
Query: 295 WNYPCDLWSVGCILVELCS 313
+ D+WS G ++ E+ S
Sbjct: 188 FTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 50/227 (22%), Positives = 94/227 (41%), Gaps = 40/227 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMI--EIDVLQRLARHD 149
Y ++ +G G FG+V +++ A+K++ K ++A E D++
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF----- 99
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
VQ+ F ++ +V E + G L + + S P R +++ ++
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVLALD 156
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+H + IH D+KP+N+LL + ++K+ D+ + +K+G +
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-------------- 202
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVEL 311
V T Y +PEV+ G + CD WSVG L E+
Sbjct: 203 ---------AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 54/233 (23%), Positives = 93/233 (39%), Gaps = 52/233 (22%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMI--EIDVLQRLARHD 149
Y ++ +G G FG+V +++ A+K++ K ++A E D++
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF----- 99
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
VQ+ F ++ +V E + G L + + S P + +++ ++
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKWAKFYTAEVVLALD 156
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS- 267
+H + LIH D+KP+N+LL K +KL DFG+
Sbjct: 157 AIHSMGLIHRDVKPDNMLL---------------------------DKHGHLKLADFGTC 189
Query: 268 -----TTFEHQDHSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVEL 311
T D + V T Y +PEV+ G + CD WSVG L E+
Sbjct: 190 MKMDETGMVRCDTA--VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 61/244 (25%), Positives = 102/244 (41%), Gaps = 55/244 (22%)
Query: 100 MGEGTFGQVVECF--DNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGTR 154
+GEG FGQV+ + K AIK+++ S N +R+ A E++VL +L H
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAG-ELEVLCKLGHH----PN 64
Query: 155 CVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELG-------RQLLE 205
+ + + R ++ I E P +L DFLRK+ +E G +QLL+
Sbjct: 65 IINLLGACENRGYLYIAIE-YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123
Query: 206 -------SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
+ ++ E + IH DL N+L+ K+ D+ LSR + Y K
Sbjct: 124 FASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFG-LSRGEE--VYVKKTMGRL 180
Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318
++ + S + V +T+ D+WS G +L E+ S+
Sbjct: 181 PVRWMAIESLNYS------VYTTK----------------SDVWSFGVLLWEIVSLGG-- 216
Query: 319 LTPF 322
TP+
Sbjct: 217 -TPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 53/249 (21%), Positives = 98/249 (39%), Gaps = 65/249 (26%)
Query: 100 MGEGTFGQVVECFDNEKKEL-----VAIKIVR---SINKYREAAMIEIDVLQRLARHDI- 150
+GEG FG+VV+ K VA+K+++ S ++ R + E ++L+++ +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELR-DLLSEFNLLKQVNHPHVI 66
Query: 151 ---GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLR---------------KNSY---- 188
G C Q D + + + K G SL FLR +NS
Sbjct: 67 KLYGA--CSQ-----DGPLLLIVEYAKYG-SLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 189 ---RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
R+ + + Q+ + ++ E++L+H DL N+L+ +K+ D+
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
++ SY K +K + S DH Y + D+WS G
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLF----DHIYTTQS------------------DVWSFG 216
Query: 306 CILVELCSV 314
+L E+ ++
Sbjct: 217 VLLWEIVTL 225
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 1e-04
Identities = 56/244 (22%), Positives = 98/244 (40%), Gaps = 55/244 (22%)
Query: 100 MGEGTFGQVVECFDNEK--KELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGTR 154
+GEG FGQV++ + + AIK ++ S + +R+ A E++VL +L H
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG-ELEVLCKLGHH----PN 57
Query: 155 CVQIRNWFDYRNHICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELG-------RQLLE 205
+ + ++R ++ + E P +L DFLRK+ +QLL
Sbjct: 58 IINLLGACEHRGYLYLAIE-YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 116
Query: 206 -------SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
+ ++ + + IH DL NIL+ K+ D+ LSR + Y K
Sbjct: 117 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG-LSRGQE--VYVKKTMGRL 173
Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318
++ + S + V +T D+WS G +L E+ S+
Sbjct: 174 PVRWMAIESLNYS------VYTTN----------------SDVWSYGVLLWEIVSLGG-- 209
Query: 319 LTPF 322
TP+
Sbjct: 210 -TPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 51/234 (21%), Positives = 94/234 (40%), Gaps = 60/234 (25%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARHD 149
YR+L G+G FG+V C ++ A K + + I K + AM E +L++
Sbjct: 5 YRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEK----- 56
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE------------KLGPSLYDFLRKNSYRSFPIDLVR 197
+ V + ++ ++ +C+V +G +D R Y +
Sbjct: 57 VNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA------- 109
Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
+L + + R+++ DLKPENILL ++++ D + +P+
Sbjct: 110 ----ELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQ----------IPEG 155
Query: 258 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
++ G V T Y APEVI + + D W +GC++ E+
Sbjct: 156 ETVR----GR-----------VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 55/225 (24%), Positives = 91/225 (40%), Gaps = 45/225 (20%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEID------VLQRLARHDI 150
L ++G G FG VV K VAIK++R E AM E D V+ +L+ ++
Sbjct: 9 LKELGSGQFG-VVHLGKWRGKIDVAIKMIR------EGAMSEDDFIEEAKVMMKLSHPNL 61
Query: 151 GGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
VQ+ + I IV E G L ++LR+ + + + ++ + E++
Sbjct: 62 -----VQLYGVCTKQRPIFIVTEYMANG-CLLNYLRERKGK-LGTEWLLDMCSDVCEAME 114
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++ IH DL N L+ VKV D+ L+R D Y + +K
Sbjct: 115 YLESNGFIHRDLAARNCLVGEDNVVKVSDFG-LARYVLDDQYTSSQGTKFPVK------- 166
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ PEV ++ D+WS G ++ E+ S
Sbjct: 167 ---------------WAPPEVFDYSRFSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 37/218 (16%)
Query: 98 SKMGEGTFGQVVE-CFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
+ +G+G FG V+ + +K VA+K ++ + +A + E V+ L RH V
Sbjct: 12 ATIGKGEFGDVMLGDYRGQK---VAVKCLKDDSTAAQAFLAEASVMTTL-RHP----NLV 63
Query: 157 QIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
Q+ N + IV E + SL D+LR + + E + ++ E
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
+H DL N+L+ KV D+ L++ + G LP +K
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFG-LAKEASQGQDSGKLP----VK-------------- 164
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ APE + ++ D+WS G +L E+ S
Sbjct: 165 --------WTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 53/228 (23%), Positives = 99/228 (43%), Gaps = 39/228 (17%)
Query: 94 YRILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR-LARHD 149
+ +L +G G +G+V + ++ +L A+K+++ ++A +E +R + H
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V + F + ++ + + G ++ L + F D VR +++ ++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN--FSEDEVRFYSGEIILALE 119
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 267
+H+L +++ D+K ENILL S +V L DFG S
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHV---------------------------VLTDFGLS 152
Query: 268 TTF--EHQDHSY-VVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVEL 311
F E ++ +Y T Y APE+I G G D WS+G ++ EL
Sbjct: 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFEL 200
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 2e-04
Identities = 50/221 (22%), Positives = 89/221 (40%), Gaps = 37/221 (16%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGG 152
L +G+G+FG+V+ EL AIKI++ + E M+E VL +
Sbjct: 5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF-- 62
Query: 153 TRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
Q+ + F + + V E + G +Y + ++ P + ++ + F+
Sbjct: 63 --LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE-PQAVF--YAAEISVGLFFL 117
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H +I+ DLK +N++L S ++K+ D+ DG + TF
Sbjct: 118 HRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----------------VTTRTF 161
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T Y APE+I + D W+ G +L E+
Sbjct: 162 --------CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEM 194
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 48/218 (22%), Positives = 90/218 (41%), Gaps = 37/218 (16%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----EAAMIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ E+ AIK+++ + + M E +L A+H
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
+ F ++ + V E + G ++ R R F R ++ ++ F+H
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRH 115
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+I+ DLK +NILL + + K+ D+ +G +TTF
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT----------------TTTF--- 156
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T Y APE++ L + D W++G ++ E+
Sbjct: 157 -----CGTPDYIAPEILQELEYGPSVDWWALGVLMYEM 189
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 3e-04
Identities = 64/230 (27%), Positives = 93/230 (40%), Gaps = 48/230 (20%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHD-----IG 151
K+G+G FG V + E VA+K RS + + E ++L++ H IG
Sbjct: 2 KIGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIG 59
Query: 152 GTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
CVQ + I IV E G SL FLRK R V++L + L++ A M
Sbjct: 60 --VCVQ-------KQPIYIVMELVPGGSLLTFLRKKKNRL----TVKKLLQMSLDAAAGM 106
Query: 211 HELR---LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
L IH DL N L+ +K+ D+ +SR + G Y S +K I
Sbjct: 107 EYLESKNCIHRDLAARNCLVGENNVLKISDFG-MSREEEGGIY----TVSDGLKQIPIKW 161
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNC 317
T APE + + D+WS G +L E S+ +
Sbjct: 162 T-----------------APEALNYGRYTSESDVWSYGILLWETFSLGDT 194
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 30/120 (25%), Positives = 54/120 (45%), Gaps = 22/120 (18%)
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
Q++ ++ +H +++H DLK NI L+ +K+ D+ F + S S
Sbjct: 177 QIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS------------ 224
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321
+D S+ T +Y APE+ ++ D+WS+G IL EL ++ + P
Sbjct: 225 -LDVASS---------FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274
|
Length = 478 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 35/219 (15%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
+G+G+FG+V+ E L A+K+++ + E M E +L H
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF----L 58
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
Q+ F + + V E + G L ++K+ R F R ++ ++ F+H+
Sbjct: 59 TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKG 116
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+I+ DLK +N+LL + K+ D+ K+G I G TT
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGM----CKEG--------------IFNGKTT----- 153
Query: 275 HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
S T Y APE++ + + D W++G +L E+
Sbjct: 154 -STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 36/133 (27%), Positives = 61/133 (45%), Gaps = 23/133 (17%)
Query: 179 LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
L D++R+N R DL+ Q+ + ++++ E+RL+H DL N+L+ S +VK+ D+
Sbjct: 95 LLDYVRENKDRIGSQDLL-NWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDF 153
Query: 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP 298
+L+D T + H D V + A E IL + +
Sbjct: 154 GL-------------------ARLLDIDETEY-HADGGKV--PIKWMALESILHRRFTHQ 191
Query: 299 CDLWSVGCILVEL 311
D+WS G + EL
Sbjct: 192 SDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 50/218 (22%), Positives = 91/218 (41%), Gaps = 36/218 (16%)
Query: 100 MGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRC 155
+G G FG+V C + ++ A+K + + + A+ E +L ++ D C
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214
+ F + +C + + + G L+ L ++ F +R +++ + MH
Sbjct: 62 MTYA--FHTPDKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMHNRF 117
Query: 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD 274
+++ DLKP NILL +V++ D SK P +S
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK------PHAS---------------- 155
Query: 275 HSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVEL 311
V T Y APEV+ G ++ D +S+GC+L +L
Sbjct: 156 ----VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 33/110 (30%), Positives = 49/110 (44%), Gaps = 22/110 (20%)
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
Q+L +V +H +IH D+K NILL S VK+ D+ F K A
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF--------------SKMYAAT 196
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ D TF T +Y APE+ ++ D++S+G +L EL
Sbjct: 197 VSDDVGRTF--------CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYEL 238
|
Length = 496 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 29/87 (33%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 168 ICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225
+ IV E LG L +L+ N Y S + + QL ++A++ R +H D+ N+
Sbjct: 81 VWIVMELAPLG-ELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNV 138
Query: 226 LLVSAEYVKVPDYKFLSRSSKDGSYFK 252
L+ S + VK+ D+ LSR +D SY+K
Sbjct: 139 LVSSPDCVKLGDFG-LSRYLEDESYYK 164
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 9e-04
Identities = 49/230 (21%), Positives = 95/230 (41%), Gaps = 48/230 (20%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGG 152
+L ++G+G +G V + +A+K +R +K+ + M E+D+L + I
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIM-ELDILHKAVSPYI-- 61
Query: 153 TRCVQIRNWFDYRN--HICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V F ++C+ + G LY + P D++R + +++ +
Sbjct: 62 ---VDFYGAFFIEGAVYMCMEYMDAGSLDKLYA--GGVATEGIPEDVLRRITYAVVKGLK 116
Query: 209 FMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
F+ E +IH D+KP N+L+ VK+ D+ G+ +L K++
Sbjct: 117 FLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGV------SGNLVASLAKTN--------- 161
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLG------WNYPCDLWSVGCILVEL 311
+ + Y APE I G + D+WS+G ++E+
Sbjct: 162 -----------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 9e-04
Identities = 50/220 (22%), Positives = 86/220 (39%), Gaps = 33/220 (15%)
Query: 100 MGEGTFGQVVEC---FDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTR 154
+G G FG+V K+ VAIK ++ K R+ + E ++ + + H+I
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI---- 68
Query: 155 CVQIRNWFDYRNHICIVFEKLGPSLYD-FLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
+++ I+ E + D +LR + LV L R + + ++ ++
Sbjct: 69 -IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGML-RGIAAGMKYLSDM 126
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+H DL NIL+ S KV D+ LSR L D T+
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFG-LSRV-----------------LEDDPEGTYTTS 168
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ + APE I + D+WS G ++ E+ S
Sbjct: 169 GGKIPI---RWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 36/148 (24%), Positives = 69/148 (46%), Gaps = 12/148 (8%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMI-EIDVLQRLARHDIG 151
I+ + G FG+V +L A+K+V+ INK + E D L L++
Sbjct: 8 IVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSKSPF- 65
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V + N++ +V E L G + L Y F ++ + ++ ++ ++
Sbjct: 66 ---IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYL 120
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDY 238
H +IH DLKP+N+L+ + ++K+ D+
Sbjct: 121 HRHGIIHRDLKPDNMLISNEGHIKLTDF 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.001
Identities = 24/67 (35%), Positives = 33/67 (49%), Gaps = 8/67 (11%)
Query: 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 220
D N I IV E + G L D + NS ++L RE+GR V +H +IH DL
Sbjct: 69 VDPENFI-IVMEYIEGEPLKDLI--NSNGMEELELSREIGRL----VGKLHSAGIIHGDL 121
Query: 221 KPENILL 227
N++L
Sbjct: 122 TTSNMIL 128
|
Length = 211 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.001
Identities = 21/61 (34%), Positives = 30/61 (49%), Gaps = 10/61 (16%)
Query: 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228
IV E + G L D L + DL+RE+GR V +H+ ++H DL NI+L
Sbjct: 76 IVMEYIEGELLKDALEEARP-----DLLREVGRL----VGKLHKAGIVHGDLTTSNIILS 126
Query: 229 S 229
Sbjct: 127 G 127
|
Length = 204 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 36/138 (26%), Positives = 54/138 (39%), Gaps = 27/138 (19%)
Query: 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
SL FLR+N + LV L R + + ++ E+ +H DL NIL+ S KV D
Sbjct: 91 SLDKFLRENDGKFTVGQLVGML-RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSD 149
Query: 238 YKFLSR--SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW 295
+ LSR + +Y K + APE I +
Sbjct: 150 FG-LSRRLEDSEATYTTKGGKIPI-----------------------RWTAPEAIAYRKF 185
Query: 296 NYPCDLWSVGCILVELCS 313
D+WS G ++ E+ S
Sbjct: 186 TSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 29/103 (28%), Positives = 45/103 (43%), Gaps = 27/103 (26%)
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
MH +++ DLKP NILL +V++ D + K P +S
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHAS----------- 155
Query: 270 FEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVEL 311
V T Y APEV+ G+ ++ D +S+GC+L +L
Sbjct: 156 ---------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.002
Identities = 15/46 (32%), Positives = 31/46 (67%)
Query: 193 IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
I++++ + RQ+L + +H + ++H D+KPEN+L+ VK+ D+
Sbjct: 308 INVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353
|
Length = 507 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 39/225 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHD 149
+ L +G+G+FG+V+ EL AIKI++ + E M+E VL +
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRS-FPIDLVRELGRQLLES 206
Q+ + F + + V E + G +Y + ++ + E+ L
Sbjct: 62 F----LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLF-- 115
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
F+H +I+ DLK +N++L S ++K+ D+ + DG K
Sbjct: 116 --FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK-------------- 159
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
TF T Y APE+I + D W+ G +L E+
Sbjct: 160 --TF--------CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 31/116 (26%), Positives = 57/116 (49%), Gaps = 12/116 (10%)
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
++ ++H ++H DLKP+NILL V + D+ + FK L + + ID
Sbjct: 125 TIEYVHSKGVLHRDLKPDNILLGLFGEVVILDW--------GAAIFKKLEEEDLLD-IDV 175
Query: 266 GSTTFEHQDHSY---VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318
+ + +V T Y APE +LG+ + D++++G IL ++ ++S Y
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 47/216 (21%), Positives = 85/216 (39%), Gaps = 31/216 (14%)
Query: 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156
+ ++G G FG VV + VAIK + E + E V+ +L+ + V
Sbjct: 9 MKELGSGQFG-VVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSH-----PKLV 62
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
Q+ + + IV E + L ++LR+ D++ + + + E + ++
Sbjct: 63 QLYGVCTQQKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
IH DL N L+ S VKV D+ ++R D Y + +K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFG-MTRYVLDDEYTSSSGAKFPVK-------------- 166
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ PEV ++ D+WS G ++ E+
Sbjct: 167 --------WSPPEVFNFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 45/191 (23%), Positives = 80/191 (41%), Gaps = 36/191 (18%)
Query: 92 PRYRIL--SKMGEGTFGQVVEC------------FDNEKKE----LVAIKIVRS-INK-Y 131
PR R+ K+GEG FG+V C F + LVA+K++R NK
Sbjct: 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNA 62
Query: 132 REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRS 190
R + EI ++ RL +I V I + + +C++ E + L FL ++ +
Sbjct: 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQE 117
Query: 191 FPIDL---------VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241
+ + Q+ + ++ L +H DL N L+ +K+ D+ +
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFG-M 176
Query: 242 SRSSKDGSYFK 252
SR+ G Y++
Sbjct: 177 SRNLYSGDYYR 187
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 323 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.69 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.57 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.51 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.48 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.42 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.38 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.31 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.2 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.12 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.09 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.02 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.96 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.92 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.85 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.84 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.81 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.68 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.63 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.58 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.56 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.56 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.46 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.43 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.33 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.32 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.16 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.16 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.12 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.08 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.9 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.79 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.67 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.61 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.6 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.5 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.49 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.44 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.28 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.23 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.14 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.05 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.94 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.91 | |
| PLN02236 | 344 | choline kinase | 96.88 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.87 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.79 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.52 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.4 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.37 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.29 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.25 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.11 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.06 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.82 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 95.66 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.56 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.11 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.93 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.72 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.42 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.35 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.11 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-53 Score=373.32 Aligned_cols=201 Identities=30% Similarity=0.497 Sum_probs=181.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++|.+.++||+|+||+||+|+++.++..||||.+.+. .+..+.+..|+.+|+.++|+|| |.++++.+.++++
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nI-----V~l~d~~~~~~~i 84 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNI-----VRLLDCIEDDDFI 84 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcce-----eeEEEEEecCCeE
Confidence 5799999999999999999999999999999988643 4566778899999999999999 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
||||||| ||+|.+|+++.+ .+++.+++.++.||+.||++||+++||||||||+||||.....
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~--------------- 147 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTAR--------------- 147 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCC---------------
Confidence 9999999 999999999886 7999999999999999999999999999999999999976411
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+....+||+|||+|+...... .+.|||+.|||||++....|+.|+|+||+|+|||++++|+.||..
T Consensus 148 ------~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 148 ------NDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred ------CCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 0112578999999999876553 457999999999999999999999999999999999999999984
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=356.45 Aligned_cols=196 Identities=27% Similarity=0.490 Sum_probs=174.4
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
+.|++++.||+|+||+|++++.+.|++.+|+|++++.. +.......|..||..++||.| |.++..|++..+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFi-----v~l~ysFQt~~k 99 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFI-----VKLIYSFQTEEK 99 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcE-----eeeEEecccCCe
Confidence 46999999999999999999999999999999998543 334567789999999999988 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|||+||+ ||+|...|++.+ .|+++.++.++.+|+.||.|||++|||||||||+|||++.+|++
T Consensus 100 LylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi------------- 164 (357)
T KOG0598|consen 100 LYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHI------------- 164 (357)
T ss_pred EEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcE-------------
Confidence 99999999 999999999876 79999999999999999999999999999999999998776655
Q ss_pred CCCccccCCCCCCceEeeCCCcccc---cCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+|+|||+++.. .....++|||+.|||||++.+.+|+..+|+||||+++|||++|.+||.++
T Consensus 165 --------------~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~ 228 (357)
T KOG0598|consen 165 --------------KLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE 228 (357)
T ss_pred --------------EEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence 55555555432 12334579999999999999999999999999999999999999999875
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-51 Score=356.07 Aligned_cols=249 Identities=62% Similarity=1.081 Sum_probs=227.3
Q ss_pred cCCCCCCCCCCCCCCceeEecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHH
Q 020652 66 PRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL 145 (323)
Q Consensus 66 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l 145 (323)
+....+++.+++..|++++.+++.+.++|.++..+|+|.||.|..|.|..++..||||+++...+.+++.+.|+++|.++
T Consensus 63 ~~~~~~~~~~dD~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki 142 (415)
T KOG0671|consen 63 ARLESRPGRPDDKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKI 142 (415)
T ss_pred ccccCCCCCCCCCCceEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHH
Confidence 55667888899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCC-CCCcceEEEcceeccCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 020652 146 ARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN 224 (323)
Q Consensus 146 ~~~~-i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~N 224 (323)
++.. -+...|+++.+||+..+++|||+|.+|.++++++..++...++...++.++.|++.++++||+.+++|-||||+|
T Consensus 143 ~~~DP~g~~rcv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPEN 222 (415)
T KOG0671|consen 143 NESDPNGKFRCVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPEN 222 (415)
T ss_pred HhcCCCCceEEEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChhe
Confidence 7655 455788999999999999999999999999999999998999999999999999999999999999999999999
Q ss_pred EEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHH
Q 020652 225 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSV 304 (323)
Q Consensus 225 Ili~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 304 (323)
||+.+..+.+..+.+-. ..+....++..++++|||.|++.++.++.++.|.+|.|||++.+.+++.++||||+
T Consensus 223 ILfvss~~~~~~~~k~~-------~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSi 295 (415)
T KOG0671|consen 223 ILFVSSEYFKTYNPKKK-------VCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSI 295 (415)
T ss_pred EEEeccceEEEeccCCc-------cceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceee
Confidence 99988877766554431 11223445678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCCC
Q 020652 305 GCILVELCSVSNCYLTP 321 (323)
Q Consensus 305 G~il~el~tg~~pf~~~ 321 (323)
||||+||+||...|+++
T Consensus 296 GCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 296 GCILVELYTGETLFQTH 312 (415)
T ss_pred eeEEEEeeccceecccC
Confidence 99999999999999874
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-50 Score=369.76 Aligned_cols=221 Identities=43% Similarity=0.809 Sum_probs=206.4
Q ss_pred CCCCCceeEecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCcc
Q 020652 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTR 154 (323)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~-~~~i~~~~ 154 (323)
++.++.+.+..++.+..+|.+++.||+|+||+|.+|.|..|++.||||+++.......+...|+.+|..|+ |-+-...+
T Consensus 170 ~~~~~dY~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n 249 (586)
T KOG0667|consen 170 DDEDGDYQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYN 249 (586)
T ss_pred CCCCCceeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCee
Confidence 44566789999999999999999999999999999999999999999999988888888999999999999 66666788
Q ss_pred eEEEcceeccCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCcee
Q 020652 155 CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~k 234 (323)
+|+++++|...+|+|||+|.++.+|.++++.+....|+...++.++.||+.||.+||+.||||+||||+|||+...
T Consensus 250 ~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~---- 325 (586)
T KOG0667|consen 250 IVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP---- 325 (586)
T ss_pred EEEeeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999653
Q ss_pred ccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcC
Q 020652 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSV 314 (323)
Q Consensus 235 i~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg 314 (323)
.+..+|++|||+|.+..+.....+.+..|+|||+|.|.+|+.+.||||||||++||++|
T Consensus 326 ---------------------~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG 384 (586)
T KOG0667|consen 326 ---------------------KRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTG 384 (586)
T ss_pred ---------------------CcCceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcC
Confidence 34579999999999988888778899999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 020652 315 SNCYLTP 321 (323)
Q Consensus 315 ~~pf~~~ 321 (323)
.+.|+|.
T Consensus 385 ~PLfpG~ 391 (586)
T KOG0667|consen 385 EPLFPGD 391 (586)
T ss_pred ccccCCC
Confidence 9999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-51 Score=357.45 Aligned_cols=203 Identities=31% Similarity=0.532 Sum_probs=179.3
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh--------hHHHHHHHHHHHHHHHhCCCCCcceEEEcc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~--------~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~ 160 (323)
.+.+.|.+.+.||+|+||.|-+|..+.|++.||||++.+... ......+|+++|++|+|||| |++++
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~I-----V~~~d 243 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNI-----VRIKD 243 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCE-----EEEee
Confidence 456779999999999999999999999999999999974321 11235689999999999999 99999
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
+|+.....||||||+ ||+|.+.+..++ .+.+..-+.++.|++.|+.|||++||+||||||+|||+..+.
T Consensus 244 ~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~-------- 313 (475)
T KOG0615|consen 244 FFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDA-------- 313 (475)
T ss_pred eeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCC--------
Confidence 999999999999999 999999999876 788999999999999999999999999999999999997542
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccC--CccccccCCccccchhhcCCC---CCcchhHHHHHHHHHHHhcC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVELCSV 314 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~el~tg 314 (323)
....+||+|||+|+..+. -..++||||.|.|||++.+.+ +..++|||||||+||-+++|
T Consensus 314 ----------------e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG 377 (475)
T KOG0615|consen 314 ----------------EDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSG 377 (475)
T ss_pred ----------------cceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEecc
Confidence 456789999999998753 345689999999999998765 33588999999999999999
Q ss_pred CCCCCCCC
Q 020652 315 SNCYLTPF 322 (323)
Q Consensus 315 ~~pf~~~~ 322 (323)
.+||.+.+
T Consensus 378 ~pPFS~~~ 385 (475)
T KOG0615|consen 378 YPPFSEEY 385 (475)
T ss_pred CCCccccc
Confidence 99999875
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-49 Score=359.09 Aligned_cols=195 Identities=31% Similarity=0.513 Sum_probs=179.5
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc----chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
.+|...+.||+|||+.||++++..+|+.||+|++.+ ....++...+||+|.+.|.|+|| |+++++|++.++
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnI-----V~f~~~FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNI-----VQFYHFFEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcE-----EeeeeEeecCCc
Confidence 579999999999999999999999999999999975 45677888999999999999999 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|||+|+| .++|..++++.. .++|.++++++.||+.||.|||+++|||||||..|+++++
T Consensus 93 VYivLELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~----------------- 153 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNE----------------- 153 (592)
T ss_pred eEEEEEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecC-----------------
Confidence 99999999 899999998654 8999999999999999999999999999999999999754
Q ss_pred CCCccccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+..+||+|||+|.... +...+.||||.|.|||++...+++..+||||+||+||-|++|++||..
T Consensus 154 ----------~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet 220 (592)
T KOG0575|consen 154 ----------NMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET 220 (592)
T ss_pred ----------cCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc
Confidence 4567888888887655 456678999999999999999999999999999999999999999986
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-49 Score=330.50 Aligned_cols=196 Identities=27% Similarity=0.454 Sum_probs=180.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|+.++.||.|+||.|.+++++.++..+|+|++++.. ++.+...+|..+|+.+.||.+ +.+++.+.+.+.
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFl-----v~l~~t~~d~~~ 118 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFL-----VKLYGTFKDNSN 118 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCcee-----EEEEEeeccCCe
Confidence 46999999999999999999999999999999997533 455677889999999999988 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+||||||. ||.|+.++++.+ +|++..++.++.||+.||+|||+++|++|||||+|||++..
T Consensus 119 lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~---------------- 180 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQN---------------- 180 (355)
T ss_pred EEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccC----------------
Confidence 99999999 999999999876 89999999999999999999999999999999999998654
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+.+||+|||.|+......-+.||||.|+|||++...+|+.++|+|||||++|||+.|.+||...
T Consensus 181 -----------G~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 181 -----------GHIKITDFGFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred -----------CcEEEEeccceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 4567888888887777777789999999999999999999999999999999999999999864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-51 Score=339.88 Aligned_cols=198 Identities=33% Similarity=0.529 Sum_probs=173.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEec---cchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcc-eeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN-WFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~---~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~-~~~~~~~ 167 (323)
..|+++++||+|+||+||++.+..+|..+|.|.++ .+.+.++....|+.+|++|+|+|| +++++ .|..++.
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNI-----VqYy~~~f~~~~e 93 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNI-----VQYYAHSFIEDNE 93 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchH-----HHHHHHhhhccch
Confidence 46999999999999999999999999999999886 345677888999999999999999 88887 4555555
Q ss_pred -EEEEEccC-CCCHHHHHH--hcCCCCCCHHHHHHHHHHHHHHHHHHHH--CC--ceecCCCCCcEEEeecCceeccCcc
Q 020652 168 -ICIVFEKL-GPSLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMHE--LR--LIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 168 -~~lv~e~~-~~~L~~~l~--~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~--iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
++||||+| +|+|.+.++ +.+.+.+++..++.++.|++.||.+||+ .+ |+||||||.||+|+..|
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-------- 165 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-------- 165 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC--------
Confidence 89999999 999999987 3445689999999999999999999999 44 99999999999986555
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCCcc---ccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS---YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~ 316 (323)
.+||.|||+++......+ +.+|||+||+||.+.+.+|+.+|||||+||++|||+.-+.
T Consensus 166 -------------------vvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~ 226 (375)
T KOG0591|consen 166 -------------------VVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQS 226 (375)
T ss_pred -------------------ceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCC
Confidence 557777777777655543 4699999999999999999999999999999999999999
Q ss_pred CCCCC
Q 020652 317 CYLTP 321 (323)
Q Consensus 317 pf~~~ 321 (323)
||.+.
T Consensus 227 PF~g~ 231 (375)
T KOG0591|consen 227 PFYGD 231 (375)
T ss_pred Ccccc
Confidence 99874
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=336.90 Aligned_cols=196 Identities=27% Similarity=0.446 Sum_probs=175.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEec--cchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc-eE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN-HI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~--~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~-~~ 168 (323)
.+.+.++.||+|+.|+||+|+++.|++.+|+|++. .....++++.+|+++++..++++| |.+++.|.... .+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyI-----V~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYI-----VGFYGAFYSNGEEI 153 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCe-----eeEeEEEEeCCceE
Confidence 45778899999999999999999999999999984 455677889999999999999888 99999999988 59
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.|+|||| +|+|.++++..+ +++|..+..++.+|++||.|||+ ++||||||||+||||+..|
T Consensus 154 sI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG--------------- 216 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG--------------- 216 (364)
T ss_pred EeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC---------------
Confidence 9999999 999999998775 79999999999999999999995 9999999999999997655
Q ss_pred CCCccccCCCCCCceEeeCCCcccccC-CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
.+||||||.+..... ...+++||..|||||.+.+..|+.++||||||++++|+++|++||..+
T Consensus 217 ------------eVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 217 ------------EVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred ------------CEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 457777777765433 346689999999999999999999999999999999999999999875
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=348.48 Aligned_cols=225 Identities=25% Similarity=0.400 Sum_probs=184.0
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh----hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
-.++|++++.||+|+||.||+|+.+.||+.+|+|++++... ..+....|-.+|.....+.+ |+++..|++.
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~v-----VKLyYsFQD~ 213 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWV-----VKLYYSFQDK 213 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcE-----EEEEEEecCC
Confidence 34679999999999999999999999999999999986543 34556678888888777666 9999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
.++||||||+ ||++..+|.+.+ .|++..++.++.+++.|++-||+.|+|||||||+|+||+..|++|++|||++.-.
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999 999999999876 8999999999999999999999999999999999999999999999999997443
Q ss_pred CCCCCccc------cCCCCCCceEeeCCCc--cccc---------------CCccccccCCccccchhhcCCCCCcchhH
Q 020652 245 SKDGSYFK------NLPKSSAIKLIDFGST--TFEH---------------QDHSYVVSTRHYRAPEVILGLGWNYPCDL 301 (323)
Q Consensus 245 ~~~~~~~~------~~~~~~~~kl~Dfg~a--~~~~---------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 301 (323)
........ ........+..||... .... .-....+|||.|||||++.+.+|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 33211110 0001112344455431 0000 01123699999999999999999999999
Q ss_pred HHHHHHHHHHhcCCCCCCCC
Q 020652 302 WSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 302 wSlG~il~el~tg~~pf~~~ 321 (323)
||||||+|||+.|-+||.+.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~ 391 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSE 391 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999874
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=327.68 Aligned_cols=197 Identities=32% Similarity=0.585 Sum_probs=172.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++|+.+.++|+|+||+||+|+++.||+.||||++... ....+.+++||++|+++.|+|+ |.+.+.|.....+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NL-----VnLiEVFrrkrkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENL-----VNLIEVFRRKRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchH-----HHHHHHHHhccee
Confidence 4688999999999999999999999999999998633 3456778999999999999999 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||+|||..++.+.+.... ..++.+.++.++.|++.|+.|||++++|||||||+||||+..|.+
T Consensus 77 hLVFE~~dhTvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvv--------------- 140 (396)
T KOG0593|consen 77 HLVFEYCDHTVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVV--------------- 140 (396)
T ss_pred EEEeeecchHHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcE---------------
Confidence 9999999989988888876 579999999999999999999999999999999999999766655
Q ss_pred CccccCCCCCCceEeeCCCcccccC-Cc--cccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQ-DH--SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~-~~--~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
||||||.|+.... .. +-.+.|.+|+|||.+.| ..|+..+||||+||++.||++|.+.|+|.
T Consensus 141 ------------KLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~ 205 (396)
T KOG0593|consen 141 ------------KLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR 205 (396)
T ss_pred ------------EeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc
Confidence 5555555554431 11 22478999999999998 58999999999999999999999999984
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=339.82 Aligned_cols=213 Identities=24% Similarity=0.352 Sum_probs=176.0
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh----hHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccC
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~ 165 (323)
..+|.+.+.||+|+|++|++|+++.+++.||||++.+..- ..+-..+|-.+|.+| .||.| ++++..|++.
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgi-----vkLy~TFQD~ 146 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGI-----VKLYFTFQDE 146 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCe-----EEEEEEeecc
Confidence 3579999999999999999999999999999999875322 223456788899999 56655 9999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
..+|+|+||+ +|+|.++|.+.+ .|++..++.++.||+.||+|||++|||||||||+|||++.+++++|+|||-++..
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999 999999999987 8999999999999999999999999999999999999988888877777765544
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
........ .+-...........++||..|.+||++.+...+..+|||+||||||+|+.|++||.+.
T Consensus 225 ~~~~~~~~-----------~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~ 290 (604)
T KOG0592|consen 225 SPSQKSQE-----------NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA 290 (604)
T ss_pred Chhhcccc-----------CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc
Confidence 33211000 0000000111235689999999999999999999999999999999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-47 Score=337.70 Aligned_cols=200 Identities=33% Similarity=0.523 Sum_probs=172.7
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.-.+.|+.+++||+|+||.||+|++..||+.||+|++.... .......+||.||++|+|+|| +++.+.....
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNI-----ikL~eivt~~ 188 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNI-----IKLEEIVTSK 188 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcc-----cceeeEEEec
Confidence 34467999999999999999999999999999999987543 344567899999999999999 8888876654
Q ss_pred --ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 166 --NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 166 --~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
..+|||+|||..+|.-++.... -.|++.+++.++.||+.||+|||++||+|||||.+||||+.+|
T Consensus 189 ~~~siYlVFeYMdhDL~GLl~~p~-vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G------------ 255 (560)
T KOG0600|consen 189 LSGSIYLVFEYMDHDLSGLLSSPG-VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG------------ 255 (560)
T ss_pred CCceEEEEEecccchhhhhhcCCC-cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC------------
Confidence 6899999999999999987654 5799999999999999999999999999999999999986655
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
.+||+|||+|++.... .+..+-|.+|.|||.+.|. .|+.++|+||+||||.||++|++.|
T Consensus 256 ---------------~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~ 320 (560)
T KOG0600|consen 256 ---------------VLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL 320 (560)
T ss_pred ---------------CEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc
Confidence 5567777777643322 2345789999999999987 6999999999999999999999999
Q ss_pred CCC
Q 020652 319 LTP 321 (323)
Q Consensus 319 ~~~ 321 (323)
+|.
T Consensus 321 ~G~ 323 (560)
T KOG0600|consen 321 QGR 323 (560)
T ss_pred CCc
Confidence 874
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-46 Score=342.46 Aligned_cols=199 Identities=24% Similarity=0.387 Sum_probs=169.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceeccC
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~~ 165 (323)
.++|.++++||+|+||+|+++..+.+++.+|||++++. +...+..+.|..|+...+ ||.+ ++++..|++.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL-----~~L~~~fQT~ 441 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFL-----VNLFSCFQTK 441 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeE-----eecccccccC
Confidence 36799999999999999999999999999999999864 345577888999988887 5555 9999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+++|+||||+ ||++..+.+. ..|++..++.|+.+|+.||+|||++|||+||||.+|||++.+|++||+|||+++..
T Consensus 442 ~~l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 442 EHLFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred CeEEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc
Confidence 9999999999 8884444333 36999999999999999999999999999999999999877776655555543322
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
-- .....+++||||.|||||++.+..|+..+|+|||||+||||+.|+.||.+.
T Consensus 519 m~------------------------~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd 571 (694)
T KOG0694|consen 519 MG------------------------QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD 571 (694)
T ss_pred CC------------------------CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 11 223456789999999999999999999999999999999999999999974
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=342.15 Aligned_cols=195 Identities=29% Similarity=0.524 Sum_probs=173.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++|.+.+.||+|+||.||+|+.+.|.+.||||.+.+.. +....+.+|++|++.++|+|| +.++++|+...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpni-----v~m~esfEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNI-----VEMLESFETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcch-----hhHHHhhcccceE
Confidence 46889999999999999999999999999999987533 344567899999999999999 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
|+|.|||-|+|..++...+ .++|+.++.++.|++.||.|||+++|+|||+||.|||++..
T Consensus 77 ~vVte~a~g~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~------------------ 136 (808)
T KOG0597|consen 77 WVVTEYAVGDLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG------------------ 136 (808)
T ss_pred EEEehhhhhhHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC------------------
Confidence 9999999669999999876 79999999999999999999999999999999999998654
Q ss_pred CccccCCCCCCceEeeCCCcccccCCc---cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+.+|+||||+|+...... +.+.|||.|||||++.+.+|+..+|+||||||+|||++|++||..
T Consensus 137 ---------~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 137 ---------GTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred ---------CceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 456777777776554433 335799999999999999999999999999999999999999964
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=335.44 Aligned_cols=200 Identities=33% Similarity=0.490 Sum_probs=174.6
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc-----h-hhHHHHHHHHHHHHHHH-hCCCCCcceEEEcce
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----N-KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNW 161 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-----~-~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~ 161 (323)
...++|++.+.||+|+||+|++|.+..+++.||+|++... . ...+...+|+.+++.+. |+|| ++++++
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI-----~~l~ev 88 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNI-----IRLLEV 88 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCE-----eEEEEE
Confidence 4457899999999999999999999999999999977643 1 23455668999999999 8888 999999
Q ss_pred eccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
+.....+++||||| ||+|.+++.+.+ ++.|..++.+++|++.|++|||++||+||||||+|||++.+
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~---------- 156 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGN---------- 156 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCC----------
Confidence 99999999999999 889999999854 79999999999999999999999999999999999998654
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCC-CC-cchhHHHHHHHHHHHhcCC
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLG-WN-YPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwSlG~il~el~tg~ 315 (323)
...+||+|||++.... ......+||+.|+|||++.+.. |+ .++||||+||+||.|++|.
T Consensus 157 ----------------~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~ 220 (370)
T KOG0583|consen 157 ----------------EGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGR 220 (370)
T ss_pred ----------------CCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCC
Confidence 1456777777776552 2345579999999999999987 86 8899999999999999999
Q ss_pred CCCCCC
Q 020652 316 NCYLTP 321 (323)
Q Consensus 316 ~pf~~~ 321 (323)
.||...
T Consensus 221 ~PF~d~ 226 (370)
T KOG0583|consen 221 LPFDDS 226 (370)
T ss_pred CCCCCc
Confidence 999863
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=323.14 Aligned_cols=225 Identities=24% Similarity=0.341 Sum_probs=187.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++++.||.|.-|+||+|+.+.++..+|+|++.+.. +...++..|.+||+.+.||.+ +.++..|+..+.
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFl-----PTLYa~fet~~~ 151 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFL-----PTLYASFETDKY 151 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCcc-----chhhheeeccce
Confidence 57999999999999999999999999999999997543 334567789999999999988 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.|++|||| ||+|..+++++....|+++.++.++.+|+.||+|||-.|||.|||||+||||.++|++.++||.++.+...
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999 99999999999999999999999999999999999999999999999999999999999999998766643
Q ss_pred CCCccccCC-------CC-CCceE----------------eeCCC--------cccccCCccccccCCccccchhhcCCC
Q 020652 247 DGSYFKNLP-------KS-SAIKL----------------IDFGS--------TTFEHQDHSYVVSTRHYRAPEVILGLG 294 (323)
Q Consensus 247 ~~~~~~~~~-------~~-~~~kl----------------~Dfg~--------a~~~~~~~~~~~gt~~y~aPE~~~~~~ 294 (323)
..+.....+ .. ..+.+ .|++. |.........++||-.|.|||++.|.+
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 222111000 00 00000 12221 011122234579999999999999999
Q ss_pred CCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 295 WNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 295 ~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
.+.++|+|+|||+||||+.|..||.|.
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~ 338 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGS 338 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCC
Confidence 999999999999999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=332.79 Aligned_cols=199 Identities=34% Similarity=0.586 Sum_probs=175.2
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHH--HHHHHHHHHHHH-hCCCCCcceEEEcceeccCc
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA--AMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~--~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~~~ 166 (323)
+.+||.++++||.|+||.||+|+...+++.||||.+++.-...++ -.+|+..|++|+ |+|| +++.+.+.+.+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpni-----ikL~Evi~d~~ 82 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNI-----IKLKEVIRDND 82 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcc-----hhhHHHhhccC
Confidence 457899999999999999999999999999999998754333333 358999999999 9999 99999988877
Q ss_pred -eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 -HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 -~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.+++|||||..+|+++++.. .+.|+++.++.|+.||++||+|+|++|+.|||+||+||||..
T Consensus 83 ~~L~fVfE~Md~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~---------------- 145 (538)
T KOG0661|consen 83 RILYFVFEFMDCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISG---------------- 145 (538)
T ss_pred ceEeeeHHhhhhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecc----------------
Confidence 99999999999999999987 478999999999999999999999999999999999999853
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
...+||+|||+|+...... +..+.|.+|+|||++... .|+.++||||+|||++|+.+-++.|+|-
T Consensus 146 -----------~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~ 213 (538)
T KOG0661|consen 146 -----------NDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGA 213 (538)
T ss_pred -----------cceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCC
Confidence 3457888888888765544 335899999999998754 6899999999999999999999999984
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=302.34 Aligned_cols=197 Identities=31% Similarity=0.523 Sum_probs=171.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh---hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.+|..+++||+|.||+||+|++..||+.||||+++..+. ....+.+||..|+.++|+|| +.+.+.|.+.+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nI-----i~LiD~F~~~~~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNI-----IELIDVFPHKSNL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcch-----hhhhhhccCCCce
Confidence 478899999999999999999999999999999975432 24578899999999999999 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
-||+||+..+|...++... ..++...++.++.++++||+|||++.|+||||||.|+||+++|.+
T Consensus 77 ~lVfEfm~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~l--------------- 140 (318)
T KOG0659|consen 77 SLVFEFMPTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQL--------------- 140 (318)
T ss_pred EEEEEeccccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcE---------------
Confidence 9999999999999998765 579999999999999999999999999999999999999877655
Q ss_pred CccccCCCCCCceEeeCCCcccccCCc---cccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
||+|||+|+...... ...+-|.+|.|||.+.|. .|+..+||||.|||+.||+-|.+.|+|.
T Consensus 141 ------------KiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~ 205 (318)
T KOG0659|consen 141 ------------KIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD 205 (318)
T ss_pred ------------EeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC
Confidence 555555555433222 123679999999999886 6999999999999999999999988874
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=311.21 Aligned_cols=197 Identities=29% Similarity=0.487 Sum_probs=170.5
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh---hHHHHHHHHHHHHHHHhCCCCCcceEEEcceec--cCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD--YRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~--~~~ 166 (323)
+.|+.+++|++|+||.||+|+|+.|++.||+|.++...+ ..-...+||.+|.+++|+|| |.+.++.. .-+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NI-----V~vkEVVvG~~~d 150 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNI-----VEVKEVVVGSNMD 150 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCe-----eeeEEEEeccccc
Confidence 569999999999999999999999999999999975432 23456899999999999999 77766644 345
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.+|||||||..+|..++.... +.|...+++.++.|+++||+|||.+.|+|||||++|+|+...|
T Consensus 151 ~iy~VMe~~EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G--------------- 214 (419)
T KOG0663|consen 151 KIYIVMEYVEHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG--------------- 214 (419)
T ss_pred eeeeeHHHHHhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC---------------
Confidence 799999999999999998876 6899999999999999999999999999999999999986655
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
.+|++|||+|+..... .+..+-|.+|.|||.+.|. .|++.+|+||+|||+.||+++++.|+|.
T Consensus 215 ------------~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 215 ------------ILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred ------------cEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence 4566666767665554 3446789999999999986 5999999999999999999999999884
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=311.99 Aligned_cols=204 Identities=24% Similarity=0.363 Sum_probs=177.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+.|++.+.||.|..++||+|+...+++.||||+++..+ ...+.+.+|++.++.++|||| +.++..|..+..+|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNI-----v~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNI-----VTYHCSFVVDSELW 100 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCc-----ceEEEEEEecceeE
Confidence 46999999999999999999999999999999997433 335778899999999999999 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||.|| +|++.++++..-...+.|..+..|++++++||.|||.+|.||||||+.||||+.+|.||++|||.....
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l---- 176 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL---- 176 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee----
Confidence 999999 999999999876678999999999999999999999999999999999999999999999999875433
Q ss_pred CccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC--CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.|-|... ... -.+++||++|||||++.. .+|+.|+||||||++..||++|..||.-
T Consensus 177 --------------~~~G~R~-~~r-f~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k 234 (516)
T KOG0582|consen 177 --------------FDSGDRQ-VTR-FNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK 234 (516)
T ss_pred --------------cccCcee-eEe-eccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc
Confidence 2322110 000 145689999999999654 3799999999999999999999999963
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=310.64 Aligned_cols=198 Identities=33% Similarity=0.562 Sum_probs=170.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh---hHHHHHHHHHHHHHHHhCC-CCCcceEEEcceeccCc-
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRN- 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~Ei~~l~~l~~~~-i~~~~~~~~~~~~~~~~- 166 (323)
..|+.+++||+|+||+||+|+++.+|+.||+|++....+ ......+|+.+|+.++|+| | +.+++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~i-----v~L~dv~~~~~~ 85 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHI-----VRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcce-----EEEEeeeeeccc
Confidence 457888999999999999999999999999999985443 4566789999999999998 6 99999988776
Q ss_pred -----eEEEEEccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 167 -----HICIVFEKLGPSLYDFLRKNSY--RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 167 -----~~~lv~e~~~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
.+++||||+..+|.+++..... ..++...++.+++||+.||+|||+++|+||||||+||||++.|
T Consensus 86 ~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G-------- 157 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG-------- 157 (323)
T ss_pred ccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC--------
Confidence 8999999999999999987653 3688899999999999999999999999999999999997655
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~ 315 (323)
.+||+|||+|+...-. -+..++|.+|.|||++.|. .|+..+||||+|||++||++++
T Consensus 158 -------------------~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~ 218 (323)
T KOG0594|consen 158 -------------------VLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRR 218 (323)
T ss_pred -------------------cEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCC
Confidence 4566666666543322 2335889999999999987 7999999999999999999999
Q ss_pred CCCCCC
Q 020652 316 NCYLTP 321 (323)
Q Consensus 316 ~pf~~~ 321 (323)
..|++.
T Consensus 219 ~LFpG~ 224 (323)
T KOG0594|consen 219 PLFPGD 224 (323)
T ss_pred CCCCCC
Confidence 999985
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=330.49 Aligned_cols=196 Identities=28% Similarity=0.513 Sum_probs=176.1
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
+-|++.+.||.|+-|.|-+|++..||+.+|||++.+.. .......+||-+|+.+.|||+ +++++.|+...+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnV-----l~LydVwe~~~~ 86 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNV-----LRLYDVWENKQH 86 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCe-----eeeeeeeccCce
Confidence 45999999999999999999999999999999997542 233457889999999999998 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+|.||+ ||.|++++.+++ .+++..+.++++||+.|+.|||..+|+||||||+|+|++.
T Consensus 87 lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~----------------- 147 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDV----------------- 147 (786)
T ss_pred EEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhc-----------------
Confidence 99999999 999999999887 7999999999999999999999999999999999999754
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCC-cchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
...+||+|||+|..+..+. .+.||+|+|.|||++.|.+|+ .++||||+|||||.|+||++||+..
T Consensus 148 ----------~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd 215 (786)
T KOG0588|consen 148 ----------KNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD 215 (786)
T ss_pred ----------ccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc
Confidence 3447888899887755443 456999999999999999985 8899999999999999999999864
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=324.93 Aligned_cols=227 Identities=40% Similarity=0.734 Sum_probs=184.3
Q ss_pred ceeEecCcee---CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCC-cceE
Q 020652 81 HYVFAIGENL---TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG-TRCV 156 (323)
Q Consensus 81 ~~~~~~~~~~---~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~-~~~~ 156 (323)
.+....++.+ .++|+++++||+|+||+||+|.+..+++.||||+++...........|+.+++.+.|.++.+ .+++
T Consensus 115 ~~~~~~~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~ 194 (467)
T PTZ00284 115 HFYVVLGEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLM 194 (467)
T ss_pred ceeEecCCccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCccee
Confidence 3344445443 57899999999999999999999999999999999765555566778999999999887543 4567
Q ss_pred EEcceeccC-ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCcee
Q 020652 157 QIRNWFDYR-NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVK 234 (323)
Q Consensus 157 ~~~~~~~~~-~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~~~~~~k 234 (323)
.+.+++... .++|+|||+++++|.+++.+.. .+++..++.++.||+.||+|||+ .|||||||||+|||++.++...
T Consensus 195 ~i~~~~~~~~~~~~iv~~~~g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 195 KIQRYFQNETGHMCIVMPKYGPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred eeEEEEEcCCceEEEEEeccCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccc
Confidence 888887654 5899999999999999998764 69999999999999999999998 5999999999999998765321
Q ss_pred ccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcC
Q 020652 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSV 314 (323)
Q Consensus 235 i~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg 314 (323)
+..... ........+||+|||.+..........+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 273 --~~~~~~---------~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG 341 (467)
T PTZ00284 273 --DPVTNR---------ALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341 (467)
T ss_pred --cccccc---------ccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhC
Confidence 111000 001233468999999887655555667899999999999999999999999999999999999
Q ss_pred CCCCCC
Q 020652 315 SNCYLT 320 (323)
Q Consensus 315 ~~pf~~ 320 (323)
+.||.+
T Consensus 342 ~~pf~~ 347 (467)
T PTZ00284 342 KLLYDT 347 (467)
T ss_pred CCCCCC
Confidence 999975
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=322.49 Aligned_cols=221 Identities=24% Similarity=0.350 Sum_probs=176.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++++.||+|+||+||+|++..+++.||||++.... .....+..|+.++..++|+++ +++++.+.....
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~i-----v~~~~~~~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWV-----VKMFYSFQDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCc-----ceEEEEEecCCe
Confidence 36999999999999999999999999999999987432 233566789999999999988 899999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+||||+ +++|.+++.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999 899999998764 799999999999999999999999999999999999999999999999998765432
Q ss_pred CCCccccCCCCCCceEeeCCCcccc------------cCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFE------------HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSV 314 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg 314 (323)
...... ..........|+...... .......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 154 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 154 AHRTEF-YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred cccccc-cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 111000 000000011122111000 0011235899999999999999999999999999999999999
Q ss_pred CCCCCC
Q 020652 315 SNCYLT 320 (323)
Q Consensus 315 ~~pf~~ 320 (323)
+.||.+
T Consensus 233 ~~Pf~~ 238 (363)
T cd05628 233 YPPFCS 238 (363)
T ss_pred CCCCCC
Confidence 999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=315.53 Aligned_cols=198 Identities=31% Similarity=0.516 Sum_probs=178.3
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
++..+|++.+.||+|.||.|-+|++...|+.||||.+++.. ...-.+.+||+||..|+|||| +++++.|+.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhI-----I~IyEVFEN 124 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHI-----IQIYEVFEN 124 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCce-----eehhhhhcC
Confidence 45678999999999999999999999999999999987543 223356789999999999999 999999999
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
.+.+.|||||. +|+|+||+...+ .+++..++.+++||..|+.|||.++++|||||.+|||++
T Consensus 125 kdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD--------------- 187 (668)
T KOG0611|consen 125 KDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD--------------- 187 (668)
T ss_pred CceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec---------------
Confidence 99999999999 999999999876 799999999999999999999999999999999999975
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCC-cchhHHHHHHHHHHHhcCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.++.+||+|||++....+.. .++||+|-|.+||++.|.+|. +.+|-|||||+||-|+.|..||+|
T Consensus 188 ------------~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 188 ------------QNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred ------------CCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 45567888888887655543 568999999999999999884 889999999999999999999998
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=326.42 Aligned_cols=200 Identities=28% Similarity=0.444 Sum_probs=174.9
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhh-HHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
+....|...++||+|+.|.||.|+...+++.||||.+...... ++-+.+|+.+|+..+|+|| |.+++.|-.++.
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~Ni-----Vnfl~Sylv~de 344 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNI-----VNFLDSYLVGDE 344 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHH-----HHHHHHhcccce
Confidence 4456799999999999999999999999999999999855443 4556799999999999999 999998888899
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+||||+ ||+|.|.+... .++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+||||+.....
T Consensus 345 LWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred eEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 99999999 99999999875 499999999999999999999999999999999999998877666666665444332
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.. ....+.+|||+|||||++....|++++||||||++++||+-|++||..
T Consensus 422 ~~------------------------~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln 471 (550)
T KOG0578|consen 422 EQ------------------------SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN 471 (550)
T ss_pred cc------------------------CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC
Confidence 21 134567999999999999999999999999999999999999999974
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=313.54 Aligned_cols=208 Identities=23% Similarity=0.356 Sum_probs=166.9
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh---------------hHHHHHHHHHHHHHHHhCCCCC
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---------------YREAAMIEIDVLQRLARHDIGG 152 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~---------------~~~~~~~Ei~~l~~l~~~~i~~ 152 (323)
....+.|++++.||+|.||.|.+|++..+++.||||++.+... ..+...+||.||+++.|+|+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV-- 170 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV-- 170 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe--
Confidence 3556789999999999999999999999999999999964321 12567889999999999998
Q ss_pred cceEEEcceeccC--ceEEEEEccC-CCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEe
Q 020652 153 TRCVQIRNWFDYR--NHICIVFEKL-GPSLYDFLRKNSYRS-FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (323)
Q Consensus 153 ~~~~~~~~~~~~~--~~~~lv~e~~-~~~L~~~l~~~~~~~-l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~ 228 (323)
|+++++.++. +.+|||+||| .|.+...- .... +++.+++.|+++++.||+|||.+|||||||||+|+||+
T Consensus 171 ---V~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 171 ---VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS 244 (576)
T ss_pred ---eEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc
Confidence 9999998874 5899999999 66654322 1223 89999999999999999999999999999999999999
Q ss_pred ecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCC----CCcchhHHHH
Q 020652 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG----WNYPCDLWSV 304 (323)
Q Consensus 229 ~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSl 304 (323)
++|.|||+|||.+........ . .........+|||.|+|||.+.++. .+.+.||||+
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~------~-------------~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWal 305 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSD------E-------------GSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWAL 305 (576)
T ss_pred CCCcEEeeccceeeecccCCc------c-------------ccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhh
Confidence 888877777775443321100 0 0001112258999999999998732 3588999999
Q ss_pred HHHHHHHhcCCCCCCCCC
Q 020652 305 GCILVELCSVSNCYLTPF 322 (323)
Q Consensus 305 G~il~el~tg~~pf~~~~ 322 (323)
||+||.|+.|+.||.+.|
T Consensus 306 GVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 306 GVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred hhhHHHhhhccCCcccch
Confidence 999999999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=313.20 Aligned_cols=196 Identities=33% Similarity=0.464 Sum_probs=164.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc--eE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN--HI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~--~~ 168 (323)
.+|...+.||+|+||.||++.+..+++.+|||.+...+ ...+.+.+|+.+|++++|+|| |++++...... .+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~I-----V~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNI-----VQYYGSSSSRENDEY 91 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCE-----EeeCCccccccCeee
Confidence 35888999999999999999999999999999886432 224668899999999999988 99999755444 69
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEee-cCceeccCcccccccCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~-~~~~ki~d~~~~~~~~~ 246 (323)
+++|||+ +|+|.+++.+.++ .+++..++.+.+||+.||.|||++|||||||||+|||++. ++.+|
T Consensus 92 ~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~K------------ 158 (313)
T KOG0198|consen 92 NIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVK------------ 158 (313)
T ss_pred EeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEE------------
Confidence 9999999 9999999999876 7999999999999999999999999999999999999977 45554
Q ss_pred CCCccccCCCCCCceEeeCCCccccc------CCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEH------QDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
|+|||++.... .......||+.|||||++.+. ..+.++|||||||++.||+||+.||.
T Consensus 159 ---------------laDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~ 223 (313)
T KOG0198|consen 159 ---------------LADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWS 223 (313)
T ss_pred ---------------eccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcch
Confidence 55555443322 112346899999999999963 33459999999999999999999997
Q ss_pred C
Q 020652 320 T 320 (323)
Q Consensus 320 ~ 320 (323)
.
T Consensus 224 ~ 224 (313)
T KOG0198|consen 224 E 224 (313)
T ss_pred h
Confidence 5
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=319.27 Aligned_cols=196 Identities=28% Similarity=0.396 Sum_probs=166.4
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc-eE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN-HI 168 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~-~~ 168 (323)
...+.+.||+|+||+||++.++.+.. ||||++.... ...+.+.+|+.+|.+++|||| +++++.+.... ..
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~-vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNI-----V~f~G~~~~~~~~~ 115 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDV-VAVKIISDPDFDDESRKAFRREASLLSRLRHPNI-----VQFYGACTSPPGSL 115 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCcee-EEEEEecchhcChHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEcCCCCce
Confidence 34556779999999999998764433 9999987432 225689999999999999999 99999998877 79
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR-LIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
++||||+ +|+|.+++.+.....++...+..++.||++|++|||+++ ||||||||+|||++.+.
T Consensus 116 ~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~--------------- 180 (362)
T KOG0192|consen 116 CIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG--------------- 180 (362)
T ss_pred EEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC---------------
Confidence 9999999 999999998843458999999999999999999999999 99999999999986543
Q ss_pred CCCccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhc--CCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVIL--GLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.++||+|||+++.... ..+...||+.|||||++. ...|+.|+||||||++||||+||+.||.+
T Consensus 181 -----------~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~ 248 (362)
T KOG0192|consen 181 -----------KTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFED 248 (362)
T ss_pred -----------CEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCC
Confidence 2567777777765442 333368999999999999 55899999999999999999999999986
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=306.76 Aligned_cols=201 Identities=28% Similarity=0.473 Sum_probs=170.7
Q ss_pred CceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEec---cchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 87 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~---~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
...+..+|..++.||+|+||.|+.|.++.+|+.||||++. ......++..+|+.+|+.++|+|| +.+.+.+.
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNI-----i~l~di~~ 91 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENI-----IGLLDIFR 91 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCc-----ceEEeecc
Confidence 3455677888999999999999999999999999999886 234456778899999999999999 66666654
Q ss_pred c-----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCc
Q 020652 164 Y-----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (323)
Q Consensus 164 ~-----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~ 238 (323)
. -+.+|+|+|+|+.+|.+.++.++ .++.+.+..++.|+++||+|+|+.+|+||||||.|++++.+..
T Consensus 92 p~~~~~f~DvYiV~elMetDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~------ 163 (359)
T KOG0660|consen 92 PPSRDKFNDVYLVFELMETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD------ 163 (359)
T ss_pred cccccccceeEEehhHHhhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC------
Confidence 4 46799999999999999999875 6999999999999999999999999999999999999876554
Q ss_pred ccccccCCCCCccccCCCCCCceEeeCCCccccc-----CCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHh
Q 020652 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH-----QDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELC 312 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~ 312 (323)
+||+|||+|+... ...+..+.|.+|.|||++.. ..|+.++||||+||||.||+
T Consensus 164 ---------------------lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL 222 (359)
T KOG0660|consen 164 ---------------------LKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEML 222 (359)
T ss_pred ---------------------EEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHH
Confidence 4666666666552 22244588999999999865 47999999999999999999
Q ss_pred cCCCCCCCC
Q 020652 313 SVSNCYLTP 321 (323)
Q Consensus 313 tg~~pf~~~ 321 (323)
+|++.|.|.
T Consensus 223 ~gkplFpG~ 231 (359)
T KOG0660|consen 223 TGKPLFPGK 231 (359)
T ss_pred cCCCCCCCC
Confidence 999999873
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=311.35 Aligned_cols=196 Identities=25% Similarity=0.376 Sum_probs=171.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.+.|+|| +++++++.+.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFI-----IRLFWTEHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcH-----hhhHhhhccCCe
Confidence 36999999999999999999999999999999986432 234567789999999999998 888999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+++||||+ +++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~--------------- 138 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG--------------- 138 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC---------------
Confidence 99999999 899999998765 689999999999999999999999999999999999986544
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 139 ------------~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 139 ------------HIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred ------------CEEEEecCcchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 457777777665544444567999999999999999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=315.52 Aligned_cols=195 Identities=28% Similarity=0.436 Sum_probs=172.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++.++|+|| +++++.+...+.
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~ 92 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI-----VNMMCSFQDENR 92 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCC-----CcEEEEEEcCCE
Confidence 56999999999999999999999999999999987432 234567889999999999998 899999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+||||+ +++|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 93 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~--------------- 155 (329)
T PTZ00263 93 VYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG--------------- 155 (329)
T ss_pred EEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC---------------
Confidence 99999999 899999998764 689999999999999999999999999999999999986554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 156 ------------~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 217 (329)
T PTZ00263 156 ------------HVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217 (329)
T ss_pred ------------CEEEeeccCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence 45677777666554444456899999999999999999999999999999999999999965
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=320.11 Aligned_cols=222 Identities=25% Similarity=0.416 Sum_probs=175.9
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.|++++.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.++|+|+ +++++.+...+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~i-----v~l~~~~~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWV-----VKLYYSFQDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCe-----eeeEEEEecCCEE
Confidence 5899999999999999999999999999999986432 334567889999999999988 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
|+||||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+|++|||++......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999 899999998764 6899999999999999999999999999999999999999999999999986533211
Q ss_pred CC--ccc------cCCCCC-----CceEeeCCCc-------cc-c--cCCccccccCCccccchhhcCCCCCcchhHHHH
Q 020652 248 GS--YFK------NLPKSS-----AIKLIDFGST-------TF-E--HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSV 304 (323)
Q Consensus 248 ~~--~~~------~~~~~~-----~~kl~Dfg~a-------~~-~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 304 (323)
.. ... ...... ....+.++.. .. . .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 000 000000 0000111100 00 0 001123579999999999999899999999999
Q ss_pred HHHHHHHhcCCCCCCCC
Q 020652 305 GCILVELCSVSNCYLTP 321 (323)
Q Consensus 305 G~il~el~tg~~pf~~~ 321 (323)
||++|||++|..||...
T Consensus 235 G~il~elltG~~Pf~~~ 251 (381)
T cd05626 235 GVILFEMLVGQPPFLAP 251 (381)
T ss_pred hhHHHHHHhCCCCCcCC
Confidence 99999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=319.18 Aligned_cols=222 Identities=25% Similarity=0.391 Sum_probs=176.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++|+|| +++++.+..++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~i-----v~~~~~~~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWV-----VKLYYSFQDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCC-----cceEEEEEcCCe
Confidence 36999999999999999999999999999999987432 233456789999999999998 899999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+||||+ +++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.++++|||++.....
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999 899999998764 699999999999999999999999999999999999999999999999998765432
Q ss_pred CCCcc--ccCCCCCCceEeeCCCccccc------------CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHh
Q 020652 247 DGSYF--KNLPKSSAIKLIDFGSTTFEH------------QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312 (323)
Q Consensus 247 ~~~~~--~~~~~~~~~kl~Dfg~a~~~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 312 (323)
..... .........-..++....... ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 21100 000000000001111110000 0112347999999999999999999999999999999999
Q ss_pred cCCCCCCC
Q 020652 313 SVSNCYLT 320 (323)
Q Consensus 313 tg~~pf~~ 320 (323)
+|..||.+
T Consensus 234 ~G~~Pf~~ 241 (364)
T cd05599 234 VGYPPFCS 241 (364)
T ss_pred cCCCCCCC
Confidence 99999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=306.70 Aligned_cols=195 Identities=28% Similarity=0.543 Sum_probs=167.5
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC--c---e
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--N---H 167 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~--~---~ 167 (323)
.|+-.+.+|+|+||.||+|....+++.||||.+-.+.+.. .+|+++|+.+.|+|| |++.-+|... + .
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k---nrEl~im~~l~HpNI-----V~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK---NRELQIMRKLDHPNI-----VRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC---cHHHHHHHhcCCcCe-----eeEEEEEEecCCCchhH
Confidence 5888999999999999999999999999999887655433 459999999999999 8777766542 2 4
Q ss_pred EEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 168 ICIVFEKLGPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
..+||||+..+|.++++.. .+..++.-.++.++.||++||.|||+.||+||||||+|+|++.
T Consensus 97 lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~---------------- 160 (364)
T KOG0658|consen 97 LNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDP---------------- 160 (364)
T ss_pred HHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcC----------------
Confidence 5799999999999999842 2347889999999999999999999999999999999999964
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
..+.+||||||+|+....+. .....|.+|+|||.+.|. .|+.+.||||.||++.||+-|++.|.|.
T Consensus 161 ----------~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~ 229 (364)
T KOG0658|consen 161 ----------DTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGD 229 (364)
T ss_pred ----------CCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCC
Confidence 45678999999998765443 334679999999999986 6999999999999999999999999984
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=320.54 Aligned_cols=220 Identities=23% Similarity=0.367 Sum_probs=175.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|+++++||+|+||+||+|.+..+++.||||++.... ...+.+.+|+++++.++|+|| +++++++...++
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i-----v~~~~~~~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWV-----VSLYYSFQDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEEcCCe
Confidence 36999999999999999999999999999999886432 233567789999999999988 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+||||+ +++|.+++.... .+++..++.++.|++.||+|||++||+||||||+|||++.++.++++|||++.....
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999 999999998654 689999999999999999999999999999999999999999999999998754322
Q ss_pred CCCc--cccC----------CCCCC-------------ceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhH
Q 020652 247 DGSY--FKNL----------PKSSA-------------IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDL 301 (323)
Q Consensus 247 ~~~~--~~~~----------~~~~~-------------~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 301 (323)
.... +..+ +.... -++.+++..... .....+||+.|+|||++.+..++.++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di 231 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL--MAYSTVGTPDYIAPEIFLQQGYGQECDW 231 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc--cccccCCCccccCHHHHccCCCCCceee
Confidence 1100 0000 00000 001111111000 0113579999999999999999999999
Q ss_pred HHHHHHHHHHhcCCCCCCC
Q 020652 302 WSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 302 wSlG~il~el~tg~~pf~~ 320 (323)
|||||++|||++|..||.+
T Consensus 232 wSlGvil~elltG~~Pf~~ 250 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCS 250 (377)
T ss_pred EecchhhhhhhcCCCCCCC
Confidence 9999999999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=320.16 Aligned_cols=221 Identities=26% Similarity=0.408 Sum_probs=175.5
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
+|+++++||+|+||+||+|++..+++.||+|++.... ...+.+.+|+.+++.+.|+|| +++++.+...+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~i-----v~~~~~~~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWV-----VRLYYSFQDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcC-----CeEEEEEEeCCEE
Confidence 5999999999999999999999999999999987432 234567789999999999998 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
|+||||| +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999 899999998764 6899999999999999999999999999999999999999999999999986533211
Q ss_pred CCc-cccCCCCCCceEeeCCC---------------------ccc-ccCCccccccCCccccchhhcCCCCCcchhHHHH
Q 020652 248 GSY-FKNLPKSSAIKLIDFGS---------------------TTF-EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSV 304 (323)
Q Consensus 248 ~~~-~~~~~~~~~~kl~Dfg~---------------------a~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 304 (323)
... .............+|.. ... ........+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 100 00000000000001100 000 0001123579999999999999999999999999
Q ss_pred HHHHHHHhcCCCCCCC
Q 020652 305 GCILVELCSVSNCYLT 320 (323)
Q Consensus 305 G~il~el~tg~~pf~~ 320 (323)
||++|||++|+.||.+
T Consensus 235 Gvil~elltG~~Pf~~ 250 (382)
T cd05625 235 GVILYEMLVGQPPFLA 250 (382)
T ss_pred hHHHHHHHhCCCCCCC
Confidence 9999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=313.82 Aligned_cols=204 Identities=34% Similarity=0.548 Sum_probs=182.6
Q ss_pred CceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh----hHHHHHHHHHHHHHHH-hCCCCCcceEEEcce
Q 020652 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLA-RHDIGGTRCVQIRNW 161 (323)
Q Consensus 87 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~ 161 (323)
.+.+...|++.+.||+|.||.||+|+++.||+.+|+|++.+... ..+...+|+.+|+++. |+|+ +.+.+.
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpni-----v~l~~~ 104 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNI-----VQLKDA 104 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCE-----EEEEEE
Confidence 35566789999999999999999999999999999999975332 3467889999999999 8888 999999
Q ss_pred eccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
|++...+++|||+| ||+|.+.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+....
T Consensus 105 ~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~--------- 172 (382)
T KOG0032|consen 105 FEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKD--------- 172 (382)
T ss_pred EEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeecccc---------
Confidence 99999999999999 99999999876 399999999999999999999999999999999999986532
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCcccccC--CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
+....+|++|||++..... .....+||+.|+|||++.+..|+..+||||+||++|.|++|..||
T Consensus 173 --------------~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF 238 (382)
T KOG0032|consen 173 --------------EGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPF 238 (382)
T ss_pred --------------CCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCC
Confidence 1235789999999988766 345579999999999999999999999999999999999999999
Q ss_pred CCC
Q 020652 319 LTP 321 (323)
Q Consensus 319 ~~~ 321 (323)
.+.
T Consensus 239 ~~~ 241 (382)
T KOG0032|consen 239 WGE 241 (382)
T ss_pred cCC
Confidence 763
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=320.15 Aligned_cols=222 Identities=24% Similarity=0.392 Sum_probs=175.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++++.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.+.|+|+ +++++.+..++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~i-----v~~~~~~~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWV-----VKLYYSFQDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCc-----ceEEEEEEcCCE
Confidence 36999999999999999999999999999999986432 234557789999999999998 899999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+||||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999 999999998764 689999999999999999999999999999999999999999999999998643211
Q ss_pred C--CCccccCCCCCCceEeeC-------CCc--------c---cccCCccccccCCccccchhhcCCCCCcchhHHHHHH
Q 020652 247 D--GSYFKNLPKSSAIKLIDF-------GST--------T---FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 306 (323)
Q Consensus 247 ~--~~~~~~~~~~~~~kl~Df-------g~a--------~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 306 (323)
. ........ .......+. ... . .........+||+.|||||++.+..++.++|||||||
T Consensus 154 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 154 THDSKYYQKGD-HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccc-ccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 0 00000000 000000000 000 0 0000112357999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCC
Q 020652 307 ILVELCSVSNCYLTP 321 (323)
Q Consensus 307 il~el~tg~~pf~~~ 321 (323)
++|||++|+.||.+.
T Consensus 233 ilyell~G~~Pf~~~ 247 (376)
T cd05598 233 ILYEMLVGQPPFLAD 247 (376)
T ss_pred eeeehhhCCCCCCCC
Confidence 999999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=312.41 Aligned_cols=195 Identities=29% Similarity=0.467 Sum_probs=171.5
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||.||+|++..+++.||||+++... .....+..|+.++..++|+|+ +++++.+...+.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----v~~~~~~~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWL-----VKLLYAFQDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCC-----ccEEEEEEcCCE
Confidence 36999999999999999999999999999999987432 234567789999999999998 889999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~--------------- 138 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG--------------- 138 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC---------------
Confidence 99999999 899999998754 689999999999999999999999999999999999986544
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 139 ------------~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 200 (333)
T cd05600 139 ------------HIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200 (333)
T ss_pred ------------CEEEEeCcCCcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC
Confidence 45777777776554444456899999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=312.27 Aligned_cols=195 Identities=26% Similarity=0.448 Sum_probs=169.4
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCC-cEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~-~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
++|++.+.||+|+||.||+|.+..++ ..||+|++... ....+.+.+|+.+++.++|+|| +++++++...+
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~I-----v~~~~~~~~~~ 104 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFC-----VNLYGSFKDES 104 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCC-----cceEEEEEeCC
Confidence 57999999999999999999876655 68999988643 2334567789999999999998 89999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.+|+||||+ +++|.+++.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-------------- 168 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG-------------- 168 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC--------------
Confidence 999999999 899999998765 699999999999999999999999999999999999986554
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 169 -------------~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 230 (340)
T PTZ00426 169 -------------FIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230 (340)
T ss_pred -------------CEEEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence 45666666665544444456899999999999998899999999999999999999999976
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=301.75 Aligned_cols=195 Identities=24% Similarity=0.383 Sum_probs=167.0
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++|+++ +.+.+.+...+..+
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i-----v~~~~~~~~~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFV-----VSLAYAYETKDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcE-----EEEEEEEccCCeEE
Confidence 889999999999999999999999999999886432 223456789999999999888 89999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++
T Consensus 77 lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~----------------- 139 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG----------------- 139 (285)
T ss_pred EEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-----------------
Confidence 999999 89999888765445699999999999999999999999999999999999986554
Q ss_pred CccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.++|+|||++...... .....||..|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 140 ----------~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 203 (285)
T cd05631 140 ----------HIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK 203 (285)
T ss_pred ----------CEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCC
Confidence 4566666666543221 1234789999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=288.19 Aligned_cols=197 Identities=26% Similarity=0.432 Sum_probs=177.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|-||.||+|+.+.++-.||+|++.+.. ....++.+|++|...|+|||| .+++++|.+...
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpni-----lrlY~~fhd~~r 96 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNI-----LRLYGYFHDSKR 96 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccH-----Hhhhhheeccce
Confidence 56999999999999999999999999999999987543 234567899999999999999 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+||++||. .|+|...|.......+++..+..++.|++.||.|||.++||||||||+|+|++..+
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~--------------- 161 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG--------------- 161 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC---------------
Confidence 99999999 99999999976667899999999999999999999999999999999999986554
Q ss_pred CCCccccCCCCCCceEeeCCCcccc-cCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFE-HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+|++|||.+... .....++|||..|.+||+..+..++..+|+|++|++.||++.|.+||.+
T Consensus 162 ------------~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes 224 (281)
T KOG0580|consen 162 ------------ELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFES 224 (281)
T ss_pred ------------CeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhh
Confidence 4577777776655 3445668999999999999999999999999999999999999999975
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=315.02 Aligned_cols=198 Identities=30% Similarity=0.565 Sum_probs=177.5
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce-
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH- 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~- 167 (323)
++|.+++++|+|+||.+++++++..++.+|+|.+.. ....+..+..|+.+++++.|||| +.+.+.|..++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~i-----v~y~ds~~~~~~~ 78 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNI-----VEYKDSFEEDGQL 78 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCe-----eeeccchhcCCce
Confidence 569999999999999999999999999999999873 34556678999999999999999 999999988877
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+||||+|| ||+|.+.+.+.+...|+++.+..|+.|++.|++|||+++|+|||||+.||+++.++
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~--------------- 143 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK--------------- 143 (426)
T ss_pred EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC---------------
Confidence 99999999 99999999987777899999999999999999999999999999999999976544
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCc---cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
.+||.|||+|+...... .+.+||+.||+||++.+.+|+.|+|||||||++|||++-+.+|.+.
T Consensus 144 ------------~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~ 209 (426)
T KOG0589|consen 144 ------------KVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS 209 (426)
T ss_pred ------------ceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc
Confidence 45777777777655443 4478999999999999999999999999999999999999999864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=311.47 Aligned_cols=195 Identities=29% Similarity=0.430 Sum_probs=170.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
..|..++.||+|+||.||+|.+..+++.||||++.... ..-++..+|+.+|..++++|| .++++.|-.+..+|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~i-----t~yygsyl~g~~Lw 87 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNI-----TEYYGSYLKGTKLW 87 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchH-----HhhhhheeecccHH
Confidence 35888899999999999999999999999999997433 344678899999999999888 88999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
++|||| ||++.+.++... .+.+..+..++++++.||.|||.++.+|||||+.|||+...|.
T Consensus 88 iiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~---------------- 149 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD---------------- 149 (467)
T ss_pred HHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc----------------
Confidence 999999 999999998765 4588889999999999999999999999999999999976554
Q ss_pred CccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+||+|||.+...... ..+++|||.|||||++.+..|+.|+||||||++.+||++|.+||..
T Consensus 150 -----------vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~ 213 (467)
T KOG0201|consen 150 -----------VKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSK 213 (467)
T ss_pred -----------EEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcc
Confidence 566666666443322 2557999999999999999999999999999999999999999864
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=313.88 Aligned_cols=218 Identities=25% Similarity=0.408 Sum_probs=175.4
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.++..++|+++ +++++.+...+.+
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----v~~~~~~~~~~~~ 76 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWV-----VKMFYSFQDKRNL 76 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCE-----eeEEEEEEcCCEE
Confidence 5899999999999999999999999999999986432 234566789999999999888 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
|+||||+ +++|.+++.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.++++|||++......
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred EEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999 899999998754 6999999999999999999999999999999999999999999999999987644322
Q ss_pred CCc--cccCCCCCCceEeeCCCccc------------ccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc
Q 020652 248 GSY--FKNLPKSSAIKLIDFGSTTF------------EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313 (323)
Q Consensus 248 ~~~--~~~~~~~~~~kl~Dfg~a~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t 313 (323)
... ...... ..-.++..... ........+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~t 231 (360)
T cd05627 155 HRTEFYRNLTH---NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231 (360)
T ss_pred ccccccccccc---CCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeeccc
Confidence 110 000000 00011110000 0011123579999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 020652 314 VSNCYLT 320 (323)
Q Consensus 314 g~~pf~~ 320 (323)
|+.||.+
T Consensus 232 G~~Pf~~ 238 (360)
T cd05627 232 GYPPFCS 238 (360)
T ss_pred CCCCCCC
Confidence 9999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=313.33 Aligned_cols=196 Identities=24% Similarity=0.420 Sum_probs=166.6
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
..++|++.+.||+|+||.||+|++..+++.||+|++.+.. ...+.+.+|+.+++.++|+|+ +++++.+..+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~i-----v~~~~~~~~~ 115 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-----VQLFCAFQDD 115 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCE-----eeEEEEEEcC
Confidence 3468999999999999999999999999999999986422 233456789999999999988 9999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+.+|+||||+ +++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~------------ 180 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH------------ 180 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC------------
Confidence 9999999999 89999999754 4899999999999999999999999999999999999976554
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCC----CCcchhHHHHHHHHHHHhcCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~el~tg~~ 316 (323)
+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|||++|+.
T Consensus 181 ---------------~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~ 245 (370)
T cd05621 181 ---------------LKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDT 245 (370)
T ss_pred ---------------EEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCC
Confidence 456666655433211 12357999999999997643 7889999999999999999999
Q ss_pred CCCC
Q 020652 317 CYLT 320 (323)
Q Consensus 317 pf~~ 320 (323)
||.+
T Consensus 246 Pf~~ 249 (370)
T cd05621 246 PFYA 249 (370)
T ss_pred CCCC
Confidence 9975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=307.89 Aligned_cols=189 Identities=24% Similarity=0.412 Sum_probs=161.8
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEc
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 173 (323)
+.||+|+||.||+|++..+++.||||+++... .....+.+|+.+++.++|+|+ +.+++.+...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----~~~~~~~~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL-----TALKYSFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCC-----CCEEEEEEcCCEEEEEEe
Confidence 46999999999999999999999999987432 233456789999999999998 888888999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccc
Q 020652 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252 (323)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~ 252 (323)
|+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~-------------------- 133 (323)
T cd05571 76 YANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH-------------------- 133 (323)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--------------------
Confidence 99 899999998754 7899999999999999999999999999999999999976554
Q ss_pred cCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 253 NLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 253 ~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+||+|||+++... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 134 -------~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 197 (323)
T cd05571 134 -------IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred -------EEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence 4555555554321 112335799999999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=295.61 Aligned_cols=246 Identities=35% Similarity=0.601 Sum_probs=200.9
Q ss_pred CCCCCceeEecCceeC-CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCC---CC
Q 020652 76 DDKDGHYVFAIGENLT-PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD---IG 151 (323)
Q Consensus 76 ~~~~~~~~~~~~~~~~-~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~---i~ 151 (323)
...+|++++.+|+.+. +||.+.++||+|.|++||+|.|..+.+.||+|+.+....+.+..+.||.+|++++... ..
T Consensus 61 Y~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~ 140 (590)
T KOG1290|consen 61 YRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPG 140 (590)
T ss_pred hhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCC
Confidence 3457889999999999 9999999999999999999999999999999999998899999999999999998643 34
Q ss_pred CcceEEEcceecc----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEE
Q 020652 152 GTRCVQIRNWFDY----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENIL 226 (323)
Q Consensus 152 ~~~~~~~~~~~~~----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIl 226 (323)
...+|++++.|.. +.|+|||+|++|.+|..+|....++.++...++.|++||+.||.|||. +||||-||||+|||
T Consensus 141 ~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvL 220 (590)
T KOG1290|consen 141 KKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVL 220 (590)
T ss_pred CceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceee
Confidence 4678999999875 569999999999999999999999999999999999999999999996 69999999999999
Q ss_pred EeecCc-----------e------------ec--------------cCcc------c--------cc--------c----
Q 020652 227 LVSAEY-----------V------------KV--------------PDYK------F--------LS--------R---- 243 (323)
Q Consensus 227 i~~~~~-----------~------------ki--------------~d~~------~--------~~--------~---- 243 (323)
+..... + +- .++. + .. .
T Consensus 221 l~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~ 300 (590)
T KOG1290|consen 221 LCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQ 300 (590)
T ss_pred eeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccc
Confidence 864300 0 00 0000 0 00 0
Q ss_pred --------cCCC----------------C----Cccc-------------------------------------------
Q 020652 244 --------SSKD----------------G----SYFK------------------------------------------- 252 (323)
Q Consensus 244 --------~~~~----------------~----~~~~------------------------------------------- 252 (323)
.... + ...+
T Consensus 301 ~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v 380 (590)
T KOG1290|consen 301 ESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLV 380 (590)
T ss_pred cccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccccccc
Confidence 0000 0 0000
Q ss_pred -----cCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 253 -----NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 253 -----~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
.-.....+||+|||-|...+..-+.-+.|..|+|||++.|.+|++.+||||++|++|||+||-..|..+
T Consensus 381 ~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePh 454 (590)
T KOG1290|consen 381 NPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPH 454 (590)
T ss_pred CCCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCC
Confidence 001123589999999988766666667899999999999999999999999999999999999999764
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=301.80 Aligned_cols=196 Identities=29% Similarity=0.502 Sum_probs=165.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
++|++.++||+|+||.||+|++..+++.||||++.... .....+.+|+.+++.++|+|+ +.+++++......+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~ 79 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI-----VLLHDIIHTKETLT 79 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCc-----CeEEEEEecCCeEE
Confidence 57999999999999999999999999999999987432 223456789999999999998 89999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+||||++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 80 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~---------------- 142 (303)
T cd07869 80 LVFEYVHTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGEL---------------- 142 (303)
T ss_pred EEEECCCcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCE----------------
Confidence 999999889999887654 468999999999999999999999999999999999999766655
Q ss_pred ccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+
T Consensus 143 -----------kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 143 -----------KLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred -----------EECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 4555554432211 11224689999999998764 588999999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=303.50 Aligned_cols=196 Identities=24% Similarity=0.371 Sum_probs=164.9
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
+|++++.||+|+||.||+|++..+++.||||++... ....+.+..|+.++..+.|++. ++.+++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~----i~~~~~~~~~~~~~ 76 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPF----LTQLHSCFQTMDRL 76 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCc----eeeeEEEEEcCCEE
Confidence 489999999999999999999999999999998743 2334566788889988887642 37888888888999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
|+||||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 77 ~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~-------------- 140 (324)
T cd05587 77 YFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHI-------------- 140 (324)
T ss_pred EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCE--------------
Confidence 9999999 899999997654 68999999999999999999999999999999999999766554
Q ss_pred CCccccCCCCCCceEeeCCCcccc---cCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
||+|||++... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||.+.
T Consensus 141 -------------kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 141 -------------KIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred -------------EEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 55555554321 11123357999999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=309.82 Aligned_cols=223 Identities=25% Similarity=0.405 Sum_probs=176.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||+||+|++..+++.||||++.... .....+..|+.++..++|+|+ +++++.+..+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWI-----VKLYYSFQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCc-----cchhhheecCCe
Confidence 36999999999999999999999999999999987432 334567789999999999988 899999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+||||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999 899999998763 799999999999999999999999999999999999999988888888887655433
Q ss_pred CCCccccCCCCCCc-eEeeC----CCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAI-KLIDF----GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~-kl~Df----g~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
.............. ..... ..............||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22110000000000 00000 00000001122347999999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=298.00 Aligned_cols=196 Identities=30% Similarity=0.512 Sum_probs=165.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
++|++.++||+|+||.||+|++..+++.||+|+++... .....+.+|+.+++.++|+|+ +++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI-----VTLHDIIHTERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCE-----eeEEEEEcCCCeEE
Confidence 46999999999999999999999999999999986432 234467789999999999988 99999999989999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+||||+.++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++||
T Consensus 80 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Df----------- 147 (288)
T cd07871 80 LVFEYLDSDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADF----------- 147 (288)
T ss_pred EEEeCCCcCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcC-----------
Confidence 999999779999987654 35889999999999999999999999999999999999976665555555
Q ss_pred ccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
|++..... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.+
T Consensus 148 ----------------G~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 148 ----------------GLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred ----------------cceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 44432211 1122467999999999876 4689999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=309.28 Aligned_cols=196 Identities=24% Similarity=0.430 Sum_probs=166.2
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
..++|++.+.||+|+||.||+|++..+++.||+|++.... .....+.+|+.+++.++|+|+ +++++.+..+
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~i-----v~~~~~~~~~ 115 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-----VQLFYAFQDD 115 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEcC
Confidence 3468999999999999999999999999999999986422 223456789999999999998 8999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
..+|+||||+ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~------------ 180 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH------------ 180 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC------------
Confidence 9999999999 89999998764 4899999999999999999999999999999999999976554
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCC----CCcchhHHHHHHHHHHHhcCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~el~tg~~ 316 (323)
+||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|||++|..
T Consensus 181 ---------------ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~ 245 (371)
T cd05622 181 ---------------LKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245 (371)
T ss_pred ---------------EEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCC
Confidence 466666655433211 12357999999999997643 7899999999999999999999
Q ss_pred CCCC
Q 020652 317 CYLT 320 (323)
Q Consensus 317 pf~~ 320 (323)
||.+
T Consensus 246 Pf~~ 249 (371)
T cd05622 246 PFYA 249 (371)
T ss_pred CCCC
Confidence 9975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=290.86 Aligned_cols=201 Identities=25% Similarity=0.420 Sum_probs=178.5
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+.+.|++.+.||+|.|+.|+++.+..||+.+|+|+++. .....+.+.+|+.|-+.|+|||| +++.+.+...
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~I-----vrL~~ti~~~ 82 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI-----VRLHDSIQEE 82 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcE-----eehhhhhccc
Confidence 456779999999999999999999999999999998863 23355778899999999999999 9999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
...|||+|++ |++|..-+.+. ..++|..+..+++||+.||.|||.+||||||+||+|+|+.+.
T Consensus 83 ~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK-------------- 146 (355)
T KOG0033|consen 83 SFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASK-------------- 146 (355)
T ss_pred ceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeec--------------
Confidence 9999999999 88988766654 368999999999999999999999999999999999999653
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCcc--ccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS--YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++...+||+|||+|........ -++|||+|||||++...+|+..+|||+.|||||-|+.|.+||.+
T Consensus 147 ----------~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 147 ----------AKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred ----------cCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 3566789999999987664433 26899999999999999999999999999999999999999976
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=308.60 Aligned_cols=195 Identities=25% Similarity=0.428 Sum_probs=165.0
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
.++|++.+.||+|+||.||+|++..+++.||+|++.... .....+..|+.+++.++|+|+ +++++++...+
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~i-----v~~~~~~~~~~ 116 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWI-----VQLHYAFQDDK 116 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCc-----ceEEEEEecCC
Confidence 357999999999999999999999999999999986422 223446789999999999998 88999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.+|+||||+ +++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~------------ 181 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL------------ 181 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCE------------
Confidence 999999999 89999998764 48999999999999999999999999999999999999766555
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCC----CCCcchhHHHHHHHHHHHhcCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL----GWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~el~tg~~p 317 (323)
||+|||.+...... ....+||+.|+|||++.+. .++.++|||||||++|||++|+.|
T Consensus 182 ---------------kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P 246 (370)
T cd05596 182 ---------------KLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246 (370)
T ss_pred ---------------EEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCC
Confidence 55555554432211 1235799999999998754 378999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 247 f~~ 249 (370)
T cd05596 247 FYA 249 (370)
T ss_pred cCC
Confidence 975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=301.12 Aligned_cols=195 Identities=25% Similarity=0.355 Sum_probs=161.7
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
+|++.+.||+|+||.||+|++..+++.||||++.+.. ...+....|..++..+.|++ +++.+++++...+.+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~----~i~~~~~~~~~~~~~ 76 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP----FLTQLHSCFQTMDRL 76 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCC----eEeeEEEEEecCCEE
Confidence 4889999999999999999999999999999987432 22334566777777765432 237888899999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 77 ~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~-------------- 140 (323)
T cd05616 77 YFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHI-------------- 140 (323)
T ss_pred EEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcE--------------
Confidence 9999999 899999987764 68999999999999999999999999999999999999766655
Q ss_pred CCccccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.+
T Consensus 141 -------------kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~ 203 (323)
T cd05616 141 -------------KIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203 (323)
T ss_pred -------------EEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCC
Confidence 555555443211 112235799999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=308.43 Aligned_cols=191 Identities=26% Similarity=0.484 Sum_probs=165.2
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
.++|++++.||+|+||.||+|.+..+++.||+|... ...+.+|++++++++|+|| +++++++......++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~~l 160 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSI-----IQLKGTFTYNKFTCL 160 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCC-----CCEeEEEEECCeeEE
Confidence 467999999999999999999999999999999753 2346789999999999999 899999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 161 v~e~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~------------------ 220 (391)
T PHA03212 161 ILPRYKTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD------------------ 220 (391)
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC------------------
Confidence 99999889999987654 6899999999999999999999999999999999999976554
Q ss_pred cccCCCCCCceEeeCCCcccccC----CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQ----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 221 ---------vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 221 ---------VCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ---------EEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 46666666543211 11235799999999999999999999999999999999999988753
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=301.59 Aligned_cols=192 Identities=22% Similarity=0.402 Sum_probs=161.3
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEc
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 173 (323)
+.||+|+||.||++++..+++.||+|++.... .....+.+|+.+++.++|+|+ +++++.+...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----~~~~~~~~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL-----TALKYAFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCC-----cceeeEEecCCEEEEEEe
Confidence 46999999999999999999999999987432 233456689999999999998 889999999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccc
Q 020652 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252 (323)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~ 252 (323)
|+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++......
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~----- 148 (323)
T cd05595 76 YANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD----- 148 (323)
T ss_pred CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC-----
Confidence 99 899999887654 6899999999999999999999999999999999999987766655555543211100
Q ss_pred cCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 253 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 253 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 149 -------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 197 (323)
T cd05595 149 -------------------GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred -------------------CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC
Confidence 0111234689999999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=315.47 Aligned_cols=200 Identities=28% Similarity=0.398 Sum_probs=173.8
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc----
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN---- 166 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~---- 166 (323)
-|...+.||+|+||.||+++++.+|+.||||.++.. ...++...+|+++|++++|+|| |+++++-+...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NI-----Vk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNI-----VKLFDIEETKFLGLV 88 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhh-----hhhcccCCccccCcc
Confidence 477789999999999999999999999999998753 3556788999999999999999 88888765543
Q ss_pred --eEEEEEccC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 167 --HICIVFEKL-GPSLYDFLRKN-SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 167 --~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
...+||||| ||+|...+.+- +..++++..++.++.++..||.|||++||+||||||.||++-...
T Consensus 89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Ge----------- 157 (732)
T KOG4250|consen 89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGE----------- 157 (732)
T ss_pred cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecC-----------
Confidence 568999999 99999999843 225799999999999999999999999999999999999985432
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
+.....||+|||.|+...++. ..++||..|.+||++.. ..|+..+|.|||||++|+.+||..||-
T Consensus 158 ------------dgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 158 ------------DGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred ------------CCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 345567999999999876654 45799999999999994 789999999999999999999999996
Q ss_pred C
Q 020652 320 T 320 (323)
Q Consensus 320 ~ 320 (323)
.
T Consensus 226 p 226 (732)
T KOG4250|consen 226 P 226 (732)
T ss_pred c
Confidence 5
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=302.36 Aligned_cols=196 Identities=27% Similarity=0.427 Sum_probs=165.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||+||++++..+++.||+|++.+.. ...+.+..|+.+++.++|+++ +.+++++..+++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWI-----TNLHYAFQDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCC-----CceEEEEecCCe
Confidence 36999999999999999999999999999999986422 233457789999999999988 889999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+||||+ +++|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~-------------- 140 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH-------------- 140 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--------------
Confidence 99999999 999999997643 46899999999999999999999999999999999999865554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcC-----CCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 141 -------------~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~P 207 (331)
T cd05597 141 -------------IRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207 (331)
T ss_pred -------------EEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCC
Confidence 566666665432211 122469999999999973 3578899999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 208 f~~ 210 (331)
T cd05597 208 FYA 210 (331)
T ss_pred CCC
Confidence 975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=303.72 Aligned_cols=201 Identities=24% Similarity=0.450 Sum_probs=178.9
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+++-|.+.+.||+|.|++|-+|++..||+.||||++.+.. -....+.+|++.|+.++|+|| |++|+..+..
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNi-----VRLYEViDTQ 89 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNI-----VRLYEVIDTQ 89 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCe-----eeeeehhccc
Confidence 45567999999999999999999999999999999997543 234567789999999999999 9999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
..+|||+|.- +|+|+|||-++. ..+.++.++.++.||+.|+.|||+..+|||||||+|+++.+
T Consensus 90 TKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFE--------------- 153 (864)
T KOG4717|consen 90 TKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFE--------------- 153 (864)
T ss_pred ceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEee---------------
Confidence 9999999999 889999998765 57999999999999999999999999999999999999854
Q ss_pred CCCCCccccCCCCCCceEeeCCCccccc--CCccccccCCccccchhhcCCCCC-cchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+.+.+||+|||++.... +...+.||+..|.|||++.|..|+ +++||||||||||-|++|++||+..
T Consensus 154 -----------KlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeA 222 (864)
T KOG4717|consen 154 -----------KLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEA 222 (864)
T ss_pred -----------ecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccc
Confidence 55668888888876543 334567999999999999999997 7899999999999999999999853
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.33 Aligned_cols=187 Identities=27% Similarity=0.485 Sum_probs=160.9
Q ss_pred ecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC
Q 020652 100 MGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (323)
Q Consensus 100 lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (323)
||+|+||.||+|++..+++.||+|++... ......+.+|+.++++++|+|| +++++.+...+..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFI-----VPLKFSFQSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcE-----eceeeEEecCCeEEEEEcCC
Confidence 79999999999999999999999998642 2234556789999999999988 88999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccC
Q 020652 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (323)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~ 254 (323)
+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 76 ~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~---------------------- 131 (312)
T cd05585 76 NGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH---------------------- 131 (312)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc----------------------
Confidence 999999998754 6999999999999999999999999999999999999966554
Q ss_pred CCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 255 PKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 132 -----~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 132 -----IALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred -----EEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 46666665543211 12235799999999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=301.53 Aligned_cols=200 Identities=29% Similarity=0.451 Sum_probs=161.4
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc-----
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----- 164 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~----- 164 (323)
+|++.++||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++|+|+ +++++++..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI-----VEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCE-----eeecceEeccCCCC
Confidence 599999999999999999999999999999988632 2233457789999999999998 777776643
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 165 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
...+|+||||++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 76 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 76 FKDIYVVFELMESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred CceEEEEEecCCCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 23589999999889999998664 6999999999999999999999999999999999999977665555555543221
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC--CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
..... ........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+
T Consensus 154 ~~~~~---------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 154 FNDTP---------------------TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred ccccC---------------------ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 11000 0000122478999999999876 5789999999999999999999999965
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=302.24 Aligned_cols=189 Identities=23% Similarity=0.424 Sum_probs=161.3
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEc
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 173 (323)
+.||+|+||.||+|++..+++.||+|++... ......+.+|+.+++.+.|+|+ +++.+.+...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFL-----TSLKYSFQTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCC-----cceEEEEEcCCEEEEEEe
Confidence 4689999999999999999999999998743 2233566789999999999998 888888999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccc
Q 020652 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252 (323)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~ 252 (323)
|+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 76 y~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~------------------- 134 (328)
T cd05593 76 YVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHI------------------- 134 (328)
T ss_pred CCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcE-------------------
Confidence 99 899999987654 69999999999999999999999999999999999999765544
Q ss_pred cCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 253 NLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 253 ~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 135 --------kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~ 197 (328)
T cd05593 135 --------KITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (328)
T ss_pred --------EEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC
Confidence 5555555543211 12235799999999999998999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=303.24 Aligned_cols=196 Identities=27% Similarity=0.420 Sum_probs=164.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||.||++++..+++.||+|++.... .....+..|+.++..+.|+++ +.+++++...+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~l~~~~~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWI-----TTLHYAFQDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEcCCE
Confidence 46999999999999999999999999999999986422 223446778889988888887 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.|+||||+ +++|.+++.+.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~-------------- 140 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH-------------- 140 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--------------
Confidence 99999999 999999998643 36899999999999999999999999999999999999976554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcC-----CCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 141 -------------~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~P 207 (331)
T cd05624 141 -------------IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207 (331)
T ss_pred -------------EEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCC
Confidence 455566555432221 122479999999999876 4578899999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 208 f~~ 210 (331)
T cd05624 208 FYA 210 (331)
T ss_pred ccC
Confidence 965
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=301.59 Aligned_cols=190 Identities=26% Similarity=0.440 Sum_probs=157.3
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
..|+++++||+|+||.||+|.+..+++.||||++... ....+.+.+|+++++.++|+|| +++++++...+.++
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~ 148 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNV-----VKCHDMFDHNGEIQ 148 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCc-----ceeeeEeccCCeEE
Confidence 4588899999999999999999999999999998643 3345678899999999999998 89999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+. ....+..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 149 lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~--------------- 207 (353)
T PLN00034 149 VLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNV--------------- 207 (353)
T ss_pred EEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCE---------------
Confidence 999999 8887643 246778889999999999999999999999999999999766655
Q ss_pred CccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcC-----CCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
||+|||++...... ....+||..|+|||++.. ...+.++|||||||++|||++|+.||.
T Consensus 208 ------------kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 208 ------------KIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred ------------EEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 55555544432211 123478999999998853 234568999999999999999999996
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=307.03 Aligned_cols=198 Identities=25% Similarity=0.353 Sum_probs=166.4
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEc
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 173 (323)
+++++.||+|.||.||+|.++.+. .||+|.++......+++.+|+++|++|+|++| |++++++..+..+|||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~l-----V~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGSMSPEAFLREAQIMKKLRHEKL-----VKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCC-cccceEEeccccChhHHHHHHHHHHhCcccCe-----EEEEEEEecCCceEEEEE
Confidence 456789999999999999886553 49999998766677889999999999999999 999999999889999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccc
Q 020652 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252 (323)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~ 252 (323)
|+ .|+|.+||+......+...+...++.|||+|++||.++++|||||-..||||+++..|||+|||+++. ..++....
T Consensus 282 ~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~-~~d~~Y~~ 360 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARL-IGDDEYTA 360 (468)
T ss_pred ecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccc-cCCCceee
Confidence 99 99999999986667899999999999999999999999999999999999998877766666666551 11111111
Q ss_pred cCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 253 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 253 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
..+... ...|.|||.+....++.|||||||||+||||+| |+.||.+
T Consensus 361 ~~~~kf----------------------PIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ 407 (468)
T KOG0197|consen 361 SEGGKF----------------------PIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG 407 (468)
T ss_pred cCCCCC----------------------CceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC
Confidence 111111 346999999999999999999999999999998 8888875
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=292.86 Aligned_cols=196 Identities=32% Similarity=0.618 Sum_probs=164.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++.++|+|+ +++++++...+.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI-----VELKEAFRRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccc-----cchhhhEecCCEE
Confidence 4699999999999999999999999999999998643 2334567789999999999998 8999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
++||||+.+++.+.+.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 76 ~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~--------------- 139 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVL--------------- 139 (287)
T ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcE---------------
Confidence 9999999555555554432 369999999999999999999999999999999999999766554
Q ss_pred CccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 140 ------------kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~ 203 (287)
T cd07848 140 ------------KLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG 203 (287)
T ss_pred ------------EEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence 55555555432211 1224689999999999998999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=298.90 Aligned_cols=193 Identities=24% Similarity=0.407 Sum_probs=160.5
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHH---HHHhCCCCCcceEEEcceeccCc
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQ---RLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~---~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
|++++.||+|+||.||+|.+..+++.||||+++... ...+.+..|+.++. .+.|+|+ +++++++...+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i-----~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL-----VNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCCh-----hceeeEEEcCC
Confidence 678999999999999999999999999999987432 22345566766654 4557777 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.+|+||||+ +++|..++... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+|++|
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~D-------- 144 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIAD-------- 144 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCc--------
Confidence 999999999 88999888653 599999999999999999999999999999999999997766555555
Q ss_pred CCCCccccCCCCCCceEeeCCCcccc---cCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
||++... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 145 -------------------fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 145 -------------------FGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred -------------------ccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 4444321 11123357999999999999999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=297.70 Aligned_cols=196 Identities=24% Similarity=0.358 Sum_probs=163.3
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
+|++.+.||+|+||+||+|++..+++.||+|++.... ...+.+..|+.++..+.|+++ ++.+++++...+.+
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~----i~~~~~~~~~~~~~ 76 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF----LTQLHSCFQTVDRL 76 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCc----hhheeeEEecCCEE
Confidence 3788999999999999999999999999999987432 223456678888888876543 36788888888999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
|+||||+ +++|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 77 ~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~i-------------- 140 (323)
T cd05615 77 YFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHI-------------- 140 (323)
T ss_pred EEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCE--------------
Confidence 9999999 899999998764 69999999999999999999999999999999999999766554
Q ss_pred CCccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 141 -------------kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (323)
T cd05615 141 -------------KIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 204 (323)
T ss_pred -------------EEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC
Confidence 5555555443211 122346899999999999989999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=301.98 Aligned_cols=196 Identities=26% Similarity=0.404 Sum_probs=165.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||+||+|++..+++.||+|+++... ...+.+..|+.+++.+.|+++ +.+++.+...+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i-----~~~~~~~~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWI-----PQLQYAFQDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCC-----cceeeEEecCCe
Confidence 36999999999999999999999999999999987532 234567789999999999988 888888988899
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+++||||+ +++|.+++.+.. ..+++..++.++.|++.||+|||+++|+||||||+|||++.++.+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~------------- 141 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHI------------- 141 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCE-------------
Confidence 99999999 999999998763 369999999999999999999999999999999999999766655
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhc------CCCCCcchhHHHHHHHHHHHhcCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVIL------GLGWNYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~el~tg~~ 316 (323)
||+|||++...... .....||+.|+|||++. +..++.++|||||||++|||++|+.
T Consensus 142 --------------kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~ 207 (330)
T cd05601 142 --------------KLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207 (330)
T ss_pred --------------EeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCC
Confidence 55555554432211 11236899999999987 4567899999999999999999999
Q ss_pred CCCC
Q 020652 317 CYLT 320 (323)
Q Consensus 317 pf~~ 320 (323)
||..
T Consensus 208 Pf~~ 211 (330)
T cd05601 208 PFHE 211 (330)
T ss_pred CCCC
Confidence 9965
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=297.22 Aligned_cols=189 Identities=27% Similarity=0.392 Sum_probs=157.3
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
+.||+|+||+||+|++..+++.||||+++... ...+....|..++..+ .|+|| +++++++..+..+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i-----~~~~~~~~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFL-----THLFCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCc-----cceeeEEEcCCEEEEEE
Confidence 46999999999999999999999999987432 2233445566666543 67777 88999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 76 e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~------------------- 134 (316)
T cd05592 76 EYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH------------------- 134 (316)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC-------------------
Confidence 999 899999998754 6999999999999999999999999999999999999976554
Q ss_pred ccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 135 --------~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~ 198 (316)
T cd05592 135 --------IKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred --------EEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC
Confidence 4555666554321 122335799999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=299.98 Aligned_cols=196 Identities=31% Similarity=0.492 Sum_probs=163.8
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++|+|| +++++++...
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~ 92 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI-----ISLLNVFTPQ 92 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCE-----eeeeeeeccC
Confidence 4567899999999999999999999999999999998632 2334567789999999999998 8888877543
Q ss_pred ------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 166 ------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 166 ------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
..+|+||||++++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 93 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~------ 162 (359)
T cd07876 93 KSLEEFQDVYLVMELMDANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL------ 162 (359)
T ss_pred CCccccceeEEEEeCCCcCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCE------
Confidence 35799999998888887753 48899999999999999999999999999999999999766554
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 163 ---------------------kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 221 (359)
T cd07876 163 ---------------------KILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVI 221 (359)
T ss_pred ---------------------EEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence 55555555432211 2234789999999999999999999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 222 f~~ 224 (359)
T cd07876 222 FQG 224 (359)
T ss_pred CCC
Confidence 975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=295.99 Aligned_cols=197 Identities=27% Similarity=0.422 Sum_probs=169.2
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.++|++.+.||+|+||.||++++..++..+|+|++... ....+.+.+|++++++++|+|+ +++++++..++.+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI-----VGFYGAFYSDGEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCC-----CeEEEEEEECCEE
Confidence 46899999999999999999999999999999998743 3345678899999999999998 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
++||||+ +++|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.++
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~k------------ 144 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIK------------ 144 (331)
T ss_pred EEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEE------------
Confidence 9999999 889999998754 689999999999999999999986 699999999999997666554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccC-CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
|+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..+
T Consensus 145 ---------------l~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 145 ---------------LCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ---------------EccCcccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 455554433211 122346899999999999989999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=300.74 Aligned_cols=189 Identities=24% Similarity=0.404 Sum_probs=160.0
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEc
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 173 (323)
+.||+|+||.||+|.+..+++.||+|++.... .....+..|+++++.++|+|| +.+.+.+...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i-----~~~~~~~~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL-----TALKYSFQTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCC-----CceEEEEEcCCEEEEEEe
Confidence 46999999999999999999999999987432 233456779999999999998 888888999999999999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
|+ +++|.+++.... .+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+
T Consensus 76 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~------------------ 135 (325)
T cd05594 76 YANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI------------------ 135 (325)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCE------------------
Confidence 99 899999887654 69999999999999999999997 799999999999999766554
Q ss_pred ccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 136 ---------kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~ 198 (325)
T cd05594 136 ---------KITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198 (325)
T ss_pred ---------EEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCC
Confidence 555555543211 112234799999999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=299.03 Aligned_cols=196 Identities=27% Similarity=0.426 Sum_probs=163.5
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.++||+|+||.||++++..+++.||+|++.+.. .....+..|+.++..+.|+++ +.+++.+...+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWI-----TTLHYAFQDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCE-----eeEEEEEecCCE
Confidence 36999999999999999999999999999999986422 223346778888888888887 899999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+||||+ +++|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~------------- 141 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHI------------- 141 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCE-------------
Confidence 99999999 999999998643 368999999999999999999999999999999999999765544
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcC-----CCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 142 --------------kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~P 207 (332)
T cd05623 142 --------------RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207 (332)
T ss_pred --------------EEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCC
Confidence 55555554332111 123479999999999863 4578999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 208 f~~ 210 (332)
T cd05623 208 FYA 210 (332)
T ss_pred CCC
Confidence 975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=298.38 Aligned_cols=194 Identities=26% Similarity=0.425 Sum_probs=161.0
Q ss_pred cEEEEeeecccCcEEEEEEEEC---CCCcEEEEEEeccch-----hhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceec
Q 020652 93 RYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~ 163 (323)
+|++.+.||+|+||+||+|++. .+++.||+|++.... ...+.+..|+.+++.+. |+++ +.+++++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i-----~~~~~~~~ 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL-----VTLHYAFQ 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCc-----ccEEEEEe
Confidence 4899999999999999999864 478999999986422 22345678999999995 6666 88888999
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
..+.+++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 76 ~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~--------- 144 (332)
T cd05614 76 TEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHV--------- 144 (332)
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCE---------
Confidence 999999999999 899999997654 69999999999999999999999999999999999999765544
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccC----CccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ----DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~p 317 (323)
||+|||++..... .....+||+.|+|||++.+. .++.++|||||||++|||+||+.|
T Consensus 145 ------------------kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~p 206 (332)
T cd05614 145 ------------------VLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206 (332)
T ss_pred ------------------EEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCC
Confidence 5555555543211 11235799999999999875 478999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|..
T Consensus 207 f~~ 209 (332)
T cd05614 207 FTL 209 (332)
T ss_pred CCC
Confidence 963
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=298.80 Aligned_cols=188 Identities=21% Similarity=0.387 Sum_probs=159.5
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
+.||+|+||.||+|++..+++.||+|+++... ...+.+..|+.+++.+ +|+|| +++++++...+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~I-----v~~~~~~~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFL-----VGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCC-----CceEEEEEcCCEEEEEE
Confidence 46899999999999999999999999987432 2334567899999888 58888 88999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus 76 e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~k----------------- 136 (329)
T cd05588 76 EFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIK----------------- 136 (329)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEE-----------------
Confidence 999 899999987654 799999999999999999999999999999999999997666554
Q ss_pred ccCCCCCCceEeeCCCcccc---cCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
|+|||++... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 137 ----------L~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 137 ----------LTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ----------ECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence 4555544321 111233579999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=296.42 Aligned_cols=189 Identities=24% Similarity=0.388 Sum_probs=158.0
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
+.||+|+||.||+|++..+++.||+|+++... ...+....|..++..+ .|+++ +++++++...+++|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i-----~~~~~~~~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFL-----THLYCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCc-----cCeeEEEEeCCEEEEEE
Confidence 47999999999999999999999999987532 2334556677777654 67777 88999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.++.++++|||
T Consensus 76 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg------------ 141 (316)
T cd05620 76 EFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFG------------ 141 (316)
T ss_pred CCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccC------------
Confidence 999 899999988754 68999999999999999999999999999999999999766655555554
Q ss_pred ccCCCCCCceEeeCCCcccc---cCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 142 ---------------~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~ 198 (316)
T cd05620 142 ---------------MCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred ---------------CCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 44321 1122335799999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=296.57 Aligned_cols=190 Identities=25% Similarity=0.367 Sum_probs=159.4
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
+.||+|+||+||+|++..+++.||||++.... ...+.+..|+.++..+ .|+|+ +++++++...+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----v~~~~~~~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL-----TQLYCCFQTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCch-----hceeeEEEcCCEEEEEE
Confidence 46999999999999999999999999987432 2334566788888776 47777 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 76 Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~------------------ 135 (320)
T cd05590 76 EFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHC------------------ 135 (320)
T ss_pred cCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcE------------------
Confidence 999 899999988764 69999999999999999999999999999999999999766555
Q ss_pred ccCCCCCCceEeeCCCcccc---cCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
||+|||++... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 136 ---------kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 136 ---------KLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred ---------EEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 55555554321 11123357999999999999989999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=289.18 Aligned_cols=196 Identities=23% Similarity=0.385 Sum_probs=166.4
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.|++.+.||+|+||+||++.+..+++.||+|++.... .....+.+|+.+++.++|+|+ +.+++.+..++.+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV-----VSLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCE-----eeeeeeecCCCeE
Confidence 4899999999999999999999999999999986432 122446679999999999988 9999999988999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||||+ +++|.+++.......+++..+..++.|++.||.|||++||+||||||+||++++++.
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--------------- 140 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH--------------- 140 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC---------------
Confidence 9999999 899999887654456999999999999999999999999999999999999976554
Q ss_pred CCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++|+|||.+...... ....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+
T Consensus 141 ------------~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~ 203 (285)
T cd05605 141 ------------IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203 (285)
T ss_pred ------------EEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCC
Confidence 455555555433211 1234789999999999988999999999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=296.86 Aligned_cols=189 Identities=23% Similarity=0.358 Sum_probs=158.8
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
+.||+|+||.||+|++..+++.||||++.... ...+.+..|..++..+ .|+++ +.+++++...+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i-----~~~~~~~~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL-----TALHCCFQTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCc-----cceeeEEEcCCeEEEEE
Confidence 46999999999999999999999999987532 2334566788888765 57777 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 76 E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~------------------ 135 (321)
T cd05591 76 EYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHC------------------ 135 (321)
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCE------------------
Confidence 999 899999987654 68999999999999999999999999999999999999766554
Q ss_pred ccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 136 ---------kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 198 (321)
T cd05591 136 ---------KLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198 (321)
T ss_pred ---------EEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC
Confidence 555555544311 112235789999999999998999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=289.92 Aligned_cols=197 Identities=32% Similarity=0.568 Sum_probs=160.4
Q ss_pred CcEEEEeeecccCcEEEEEEEECC-CCcEEEEEEeccch---hhHHHHHHHHHHHHHH---HhCCCCCcceEEEcceec-
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSIN---KYREAAMIEIDVLQRL---ARHDIGGTRCVQIRNWFD- 163 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l---~~~~i~~~~~~~~~~~~~- 163 (323)
++|++.+.||+|+||+||+|++.. +++.||+|++.... .......+|+.+++.+ .|+|| +++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpni-----v~~~~~~~~ 75 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV-----VRLFDVCTV 75 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCc-----ceEEEEEec
Confidence 369999999999999999999864 46889999886422 2234566788887776 47887 88877763
Q ss_pred ----cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 164 ----YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 164 ----~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
....+++||||++++|.+++.......+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~------ 149 (290)
T cd07862 76 SRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI------ 149 (290)
T ss_pred ccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCE------
Confidence 3457899999998899999987655578999999999999999999999999999999999999766555
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccC--CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|++|
T Consensus 150 ---------------------kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~ 208 (290)
T cd07862 150 ---------------------KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 208 (290)
T ss_pred ---------------------EEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCC
Confidence 5555555443221 12234689999999999988999999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 209 f~~ 211 (290)
T cd07862 209 FRG 211 (290)
T ss_pred cCC
Confidence 975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=306.43 Aligned_cols=199 Identities=27% Similarity=0.480 Sum_probs=161.6
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc----
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY---- 164 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~---- 164 (323)
....+|++.+.||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++|+|+ +++.+++..
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~ni-----v~l~~~~~~~~~~ 134 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP---QYKNRELLIMKNLNHINI-----IFLKDYYYTECFK 134 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHhcCCCCC-----cceeeeEeecccc
Confidence 34568999999999999999999999999999999886432 234569999999999999 666665422
Q ss_pred ----CceEEEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCc
Q 020652 165 ----RNHICIVFEKLGPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (323)
Q Consensus 165 ----~~~~~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~ 238 (323)
...+++||||++++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 135 ~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~------- 207 (440)
T PTZ00036 135 KNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT------- 207 (440)
T ss_pred cCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC-------
Confidence 2357899999988998887632 234699999999999999999999999999999999999996432
Q ss_pred ccccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCC
Q 020652 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~ 315 (323)
..+||+|||+++..... .....||+.|+|||++.+. .++.++|||||||++|||++|.
T Consensus 208 -------------------~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~ 268 (440)
T PTZ00036 208 -------------------HTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGY 268 (440)
T ss_pred -------------------CceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 24577777777543222 2235789999999998765 6899999999999999999999
Q ss_pred CCCCCC
Q 020652 316 NCYLTP 321 (323)
Q Consensus 316 ~pf~~~ 321 (323)
+||.+.
T Consensus 269 ~pf~~~ 274 (440)
T PTZ00036 269 PIFSGQ 274 (440)
T ss_pred CCCCCC
Confidence 999763
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=294.11 Aligned_cols=189 Identities=25% Similarity=0.387 Sum_probs=157.9
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
+.||+|+||+||+|++..+++.||||+++... ...+....|..++..+ .|+|+ +++++++...+.+++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i-----v~~~~~~~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL-----THLYCTFQTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcC-----cceEEEEEeCCEEEEEE
Confidence 46999999999999999999999999987532 2234456677777754 78887 89999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 76 ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~------------------ 135 (316)
T cd05619 76 EYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHI------------------ 135 (316)
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCE------------------
Confidence 999 899999998654 68999999999999999999999999999999999999766555
Q ss_pred ccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 136 ---------kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (316)
T cd05619 136 ---------KIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred ---------EEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 555555443211 112235789999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=296.63 Aligned_cols=189 Identities=25% Similarity=0.426 Sum_probs=155.8
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHH-HHHHHHhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~-~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
+.||+|+||+||+|++..+++.||+|++.... .....+..|.. +++.+.|+|| +++++.+...+.+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~I-----v~~~~~~~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL-----VGLHFSFQTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCC-----CceeEEEEcCCeEEEEE
Confidence 47999999999999999999999999987432 11223333443 4677888888 88889999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 76 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~------------------ 135 (325)
T cd05602 76 DYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHI------------------ 135 (325)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCE------------------
Confidence 999 889999998754 68899999999999999999999999999999999999766554
Q ss_pred ccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 136 ---------kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (325)
T cd05602 136 ---------VLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (325)
T ss_pred ---------EEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence 555555543211 112335799999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=296.90 Aligned_cols=188 Identities=22% Similarity=0.399 Sum_probs=159.1
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
+.||+|+||.||+|++..+++.||+|++++. ....+.+..|+.++.++ +|+|+ +++++++...+.+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~i-----v~~~~~~~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL-----VGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcC-----CceeeEEEeCCEEEEEE
Confidence 4699999999999999999999999998743 22334566788888776 68888 89999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 76 E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~------------------ 135 (329)
T cd05618 76 EYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHI------------------ 135 (329)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCE------------------
Confidence 999 899999887654 69999999999999999999999999999999999999765544
Q ss_pred ccCCCCCCceEeeCCCcccc---cCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
||+|||++... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 136 ---------kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 136 ---------KLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ---------EEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 55555555431 111233579999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=290.17 Aligned_cols=200 Identities=25% Similarity=0.442 Sum_probs=171.5
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
-.++|..++.||+|.||+|.+|+.+.+++.+|||++++. .........|-++|+..+||.+ ..+...|+..
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFL-----t~LKYsFQt~ 240 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFL-----TSLKYSFQTQ 240 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHH-----HHhhhhhccC
Confidence 346788999999999999999999999999999998753 2333445678999999999877 7777788999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+++|+||||. ||.|+-.+.+.. .|+++.++.+..+|+.||.|||+++||.||||.+|+|++.+|++||+|||+++..
T Consensus 241 drlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred ceEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999 999998888764 7999999999999999999999999999999999999877776666666654433
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
... .....++||||.|+|||++....|+..+|+|.+||++|||++|++||..
T Consensus 319 I~~------------------------g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 319 IKY------------------------GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred ccc------------------------cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 222 2234567999999999999999999999999999999999999999975
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=300.25 Aligned_cols=191 Identities=26% Similarity=0.421 Sum_probs=161.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
..+|.+.+.||+|+||.||+|.+..+++.||||.... ....+|+++|++++|+|| +++++++..++..++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-----~~~~~E~~iL~~L~HpnI-----v~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-----ASSVHEARLLRRLSHPAV-----LALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-----cCHHHHHHHHHHCCCCCC-----CcEEEEEEECCEEEE
Confidence 4579999999999999999999999999999996432 235679999999999998 889998888899999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||++.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+
T Consensus 238 v~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~v----------------- 299 (461)
T PHA03211 238 VLPKYRSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDI----------------- 299 (461)
T ss_pred EEEccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCE-----------------
Confidence 99999889999987653 369999999999999999999999999999999999999766655
Q ss_pred cccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
||+|||+++..... .....||..|+|||++.+..++.++|||||||+||||++|..++.
T Consensus 300 ----------kL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 300 ----------CLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ----------EEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 45555544332111 112469999999999999999999999999999999999876543
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=295.53 Aligned_cols=188 Identities=22% Similarity=0.397 Sum_probs=159.4
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
+.||+|+||+||+|++..+++.||+|++.... ...+.+..|+.++.++. |+++ +.+++++...+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i-----~~~~~~~~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFL-----VGLHSCFQTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCE-----eeEEEEEEeCCEEEEEE
Confidence 47999999999999999999999999987532 23345678888888884 6666 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 76 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~------------------ 135 (327)
T cd05617 76 EYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHI------------------ 135 (327)
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCE------------------
Confidence 999 899999887654 69999999999999999999999999999999999999766655
Q ss_pred ccCCCCCCceEeeCCCcccc---cCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
||+|||++... .......+||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 136 ---------kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~ 197 (327)
T cd05617 136 ---------KLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197 (327)
T ss_pred ---------EEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCC
Confidence 55555544321 111233579999999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=296.33 Aligned_cols=197 Identities=25% Similarity=0.364 Sum_probs=158.8
Q ss_pred CcEEEEeeecccCcEEEEEEEEC-----CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceec
Q 020652 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~ 163 (323)
++|++.++||+|+||.||+|.+. .+++.||+|+++.. ....+.+.+|+.+++.+ +|+|| +++++.+.
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni-----v~~~~~~~ 81 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNV-----VNLLGACT 81 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcce-----eeEEeEec
Confidence 57999999999999999999752 34578999998643 23345688899999999 78888 88888766
Q ss_pred c-CceEEEEEccC-CCCHHHHHHhcC------------------------------------------------------
Q 020652 164 Y-RNHICIVFEKL-GPSLYDFLRKNS------------------------------------------------------ 187 (323)
Q Consensus 164 ~-~~~~~lv~e~~-~~~L~~~l~~~~------------------------------------------------------ 187 (323)
. ...++++|||+ +|+|.+++....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 5 44689999999 999999997532
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCce
Q 020652 188 ------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261 (323)
Q Consensus 188 ------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~k 261 (323)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~k--------------------------- 214 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVK--------------------------- 214 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEE---------------------------
Confidence 12477888999999999999999999999999999999997666554
Q ss_pred EeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 262 LIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 262 l~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
|+|||+++..... .....++..|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 215 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~ 279 (338)
T cd05102 215 ICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 279 (338)
T ss_pred EeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCC
Confidence 4555544332111 112345678999999999899999999999999999997 9999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=295.34 Aligned_cols=189 Identities=24% Similarity=0.397 Sum_probs=159.2
Q ss_pred eeecccCcEEEEEEEEC---CCCcEEEEEEeccch-----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 98 SKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+.||+|+||.||+|++. .+++.||+|+++... .....+..|+.+++.++|+|| +++++.+..++.+|
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i-----v~~~~~~~~~~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI-----VDLIYAFQTGGKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCch-----hceeeEEecCCeEE
Confidence 68999999999999864 578899999987432 223456789999999999998 88999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 77 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~--------------- 139 (323)
T cd05584 77 LILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHV--------------- 139 (323)
T ss_pred EEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCE---------------
Confidence 999999 889999998765 68899999999999999999999999999999999999766554
Q ss_pred CccccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 140 ------------kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 140 ------------KLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred ------------EEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 555555543211 112234789999999999998899999999999999999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=308.21 Aligned_cols=205 Identities=31% Similarity=0.427 Sum_probs=168.2
Q ss_pred eeEecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc-chhhHHHHHHHHHHHHHHH-hCCCCCcceEEEc
Q 020652 82 YVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS-INKYREAAMIEIDVLQRLA-RHDIGGTRCVQIR 159 (323)
Q Consensus 82 ~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~-~~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~ 159 (323)
..+.+|. .+++|.+.|.+|||+.||+|++...+..||+|++.. +....+...+||++|++|. |+|| |.++
T Consensus 30 ~~~~Vg~---~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nI-----V~yi 101 (738)
T KOG1989|consen 30 QTFTVGS---HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNI-----VSYI 101 (738)
T ss_pred eEEEECC---EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCce-----eeEe
Confidence 3444444 468999999999999999999999989999998764 4456678889999999998 8887 9998
Q ss_pred ce-ecc------CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEee
Q 020652 160 NW-FDY------RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVS 229 (323)
Q Consensus 160 ~~-~~~------~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--iiHrDlKp~NIli~~ 229 (323)
+. ... .-.++|.|||| ||.|.|++......+|++.++++|+.|+++|+.+||.+. |||||||-+||||..
T Consensus 102 dss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~ 181 (738)
T KOG1989|consen 102 DSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSA 181 (738)
T ss_pred ccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcC
Confidence 83 211 23688999999 799999998665567999999999999999999999998 999999999999976
Q ss_pred cCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC------------ccccccCCccccchhh---cCCC
Q 020652 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------------HSYVVSTRHYRAPEVI---LGLG 294 (323)
Q Consensus 230 ~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------------~~~~~gt~~y~aPE~~---~~~~ 294 (323)
+| ..||||||.+...... ......|+.|+|||+| .+.+
T Consensus 182 ~g---------------------------~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~p 234 (738)
T KOG1989|consen 182 DG---------------------------NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLP 234 (738)
T ss_pred CC---------------------------CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCC
Confidence 55 4566677766432111 1123579999999998 4678
Q ss_pred CCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 295 WNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 295 ~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
.+.|+|||+|||+||-||....||...
T Consensus 235 I~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 235 IGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred CcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 999999999999999999999999764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=299.04 Aligned_cols=223 Identities=35% Similarity=0.638 Sum_probs=198.9
Q ss_pred CCCCCCCCceeEecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCC-C
Q 020652 73 WRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI-G 151 (323)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i-~ 151 (323)
...++..|+|.+.+|+.+..+|.+....|+|-|++|..|.|...++.||||++..+....+.-+.|++||++|+...- .
T Consensus 413 DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Ed 492 (752)
T KOG0670|consen 413 DNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPED 492 (752)
T ss_pred cCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchh
Confidence 455778899999999999999999999999999999999999999999999999887777888899999999986543 3
Q ss_pred CcceEEEcceeccCceEEEEEccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeec
Q 020652 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230 (323)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~ 230 (323)
..+|+.++..|.+.+++|||+|.+..+|.+.|++.+ +..|....++.++.|+..||.+|-.+||+|.||||+|||+++.
T Consensus 493 k~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 493 KFHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNES 572 (752)
T ss_pred hhHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccC
Confidence 457889999999999999999999999999998754 3468899999999999999999999999999999999999753
Q ss_pred CceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCc-cccccCCccccchhhcCCCCCcchhHHHHHHHHH
Q 020652 231 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (323)
Q Consensus 231 ~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (323)
...+||||||.|....... +...-+..|.|||++.|.+|+...|+||+||+||
T Consensus 573 --------------------------k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLY 626 (752)
T KOG0670|consen 573 --------------------------KNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLY 626 (752)
T ss_pred --------------------------cceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeE
Confidence 4568999999998765543 3346678899999999999999999999999999
Q ss_pred HHhcCCCCCCCC
Q 020652 310 ELCSVSNCYLTP 321 (323)
Q Consensus 310 el~tg~~pf~~~ 321 (323)
||.||+..|+|.
T Consensus 627 ElYtGkIlFpG~ 638 (752)
T KOG0670|consen 627 ELYTGKILFPGR 638 (752)
T ss_pred EeeccceecCCC
Confidence 999999999874
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=294.72 Aligned_cols=189 Identities=26% Similarity=0.425 Sum_probs=156.5
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHH-HHHHHHhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~-~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
+.||+|+||.||+|++..+++.||+|++.... .....+..|.. +++.++|+|+ +++++.+...+..|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~i-----v~~~~~~~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFL-----VGLHYSFQTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCc-----cceeeEEEcCCEEEEEE
Confidence 47999999999999999999999999986432 22233444544 5777888888 88899999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+||+++.++.+
T Consensus 76 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~------------------ 135 (321)
T cd05603 76 DYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHV------------------ 135 (321)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCE------------------
Confidence 999 889999887654 68999999999999999999999999999999999999766655
Q ss_pred ccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 136 ---------kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (321)
T cd05603 136 ---------VLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (321)
T ss_pred ---------EEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence 555555443211 112235789999999999998999999999999999999999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=295.17 Aligned_cols=189 Identities=27% Similarity=0.447 Sum_probs=156.5
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHH-HHHHHHhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~-~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
+.||+|+||+||+|++..+++.||||++.... .....+..|.. +++.++|+|+ +++++.+...+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~i-----v~~~~~~~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFL-----VGLHYSFQTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCC-----CCeeEEEEeCCEEEEEE
Confidence 46999999999999999999999999986432 12233444444 4567888888 88889999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 76 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~------------------ 135 (323)
T cd05575 76 DYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHV------------------ 135 (323)
T ss_pred cCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcE------------------
Confidence 999 899999998754 68999999999999999999999999999999999999766554
Q ss_pred ccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 136 ---------kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 198 (323)
T cd05575 136 ---------VLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (323)
T ss_pred ---------EEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence 555555544311 112235799999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=300.62 Aligned_cols=201 Identities=30% Similarity=0.476 Sum_probs=177.5
Q ss_pred CCcEEEE--eeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 91 TPRYRIL--SKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 91 ~~~y~~~--~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
..-|++. +.||+|.||+||-|.++.+|+.||||++.+. .+..+.+..|+.||+.+.||.| |.+.-.|++.
T Consensus 561 stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGi-----V~le~M~ET~ 635 (888)
T KOG4236|consen 561 STVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGI-----VNLECMFETP 635 (888)
T ss_pred HHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCe-----eEEEEeecCC
Confidence 3446653 7899999999999999999999999998742 3455778899999999999998 9999999999
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
+.+++|||.+.|+..+.|......++++...+.++.||+.||.|||.++|+|+||||+|||+.+.
T Consensus 636 ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~--------------- 700 (888)
T KOG4236|consen 636 ERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA--------------- 700 (888)
T ss_pred ceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC---------------
Confidence 99999999997777776665555689999999999999999999999999999999999998653
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+....+||||||.|+...+.. ..++|||.|+|||++++.+|+..-|+||.|||+|--++|..||..
T Consensus 701 ---------~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 701 ---------SPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred ---------CCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 345678999999999877653 457999999999999999999999999999999999999999975
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=296.13 Aligned_cols=195 Identities=30% Similarity=0.489 Sum_probs=163.5
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC-
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR- 165 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~- 165 (323)
+.++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++|+|+ +++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~ 89 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI-----ISLLNVFTPQK 89 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCch-----hceeeeeeccc
Confidence 557899999999999999999999999999999988642 2334567789999999999998 7777766432
Q ss_pred -----ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 166 -----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 166 -----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
...|+||||++++|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.
T Consensus 90 ~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~-------- 157 (355)
T cd07874 90 SLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-------- 157 (355)
T ss_pred cccccceeEEEhhhhcccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--------
Confidence 45799999998888888754 4889999999999999999999999999999999999976554
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 158 -------------------~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 218 (355)
T cd07874 158 -------------------LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218 (355)
T ss_pred -------------------EEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 456666655443222 12347899999999999999999999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 219 ~~ 220 (355)
T cd07874 219 PG 220 (355)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=293.33 Aligned_cols=197 Identities=27% Similarity=0.421 Sum_probs=169.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.++|++.++||+|+||.||+|.+..+++.+|+|++... ....+.+.+|+++++.++|+|| +++++++...+.+
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI-----VGFYGAFYSDGEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcc-----cceeEEEEECCEE
Confidence 46899999999999999999999999999999988643 2344678899999999999998 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
++||||+ +++|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~-------------- 142 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE-------------- 142 (333)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--------------
Confidence 9999999 899999998754 689999999999999999999985 7999999999999976554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccC-CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+||+|||++..... ......||..|+|||++.+..++.++|||||||++|||++|+.||..+
T Consensus 143 -------------~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 143 -------------IKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred -------------EEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 46666665543221 122347899999999999988999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=305.22 Aligned_cols=198 Identities=25% Similarity=0.307 Sum_probs=166.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCC-CcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~-~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
..|.+.+.||+|+||.||+|.+..+ ++.||+|.+.... .....+.+|+.+++.++|+|| +++++++...+.+|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpni-----v~~~~~~~~~~~~~ 141 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGI-----VKHFDDFKSDDKLL 141 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCE-----eEEEEEEEECCEEE
Confidence 3599999999999999999998877 7889999765433 334556789999999999998 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 170 IVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+||||+ +++|.+++... ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~-------------- 207 (478)
T PTZ00267 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI-------------- 207 (478)
T ss_pred EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--------------
Confidence 999999 99999988642 2235889999999999999999999999999999999999976554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 208 -------------~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 208 -------------IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred -------------EEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 455566655433221 22357999999999999999999999999999999999999999753
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=295.65 Aligned_cols=189 Identities=26% Similarity=0.420 Sum_probs=156.9
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHH-HHHHHHhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~-~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
+.||+|+||+||+|.+..+++.||+|++.... .....+..|.. +++.++|+|| +++++.+...+..|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~i-----v~~~~~~~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFL-----VGLHYSFQTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCC-----ccEEEEEecCCEEEEEE
Confidence 46999999999999999999999999986432 22234445554 4667888888 88999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 76 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~------------------ 135 (325)
T cd05604 76 DFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHV------------------ 135 (325)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCE------------------
Confidence 999 899999887654 79999999999999999999999999999999999999766554
Q ss_pred ccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 136 ---------kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (325)
T cd05604 136 ---------VLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYC 198 (325)
T ss_pred ---------EEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCC
Confidence 555555544311 112335799999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=296.77 Aligned_cols=197 Identities=27% Similarity=0.511 Sum_probs=164.8
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc-
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~- 164 (323)
.+.++|++++.||+|+||+||+|.+..+++.||||++.... ...+.+.+|+.+++.++|+|| +++++++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 86 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV-----IGLLDVFTPA 86 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCch-----hhhhhhhccc
Confidence 34578999999999999999999999999999999986432 233456789999999999998 777776643
Q ss_pred -----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 165 -----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 165 -----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
....|++|++++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~------- 156 (343)
T cd07878 87 TSIENFNEVYLVTNLMGADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE------- 156 (343)
T ss_pred ccccccCcEEEEeecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC-------
Confidence 2457999999999999888643 5999999999999999999999999999999999999976554
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
+||+|||++..........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||
T Consensus 157 --------------------~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 216 (343)
T cd07878 157 --------------------LRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF 216 (343)
T ss_pred --------------------EEEcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC
Confidence 455666655544444444578999999999987 46899999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 217 ~~ 218 (343)
T cd07878 217 PG 218 (343)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=291.84 Aligned_cols=189 Identities=25% Similarity=0.382 Sum_probs=159.3
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
+.||+|+||+||+|.+..+++.||||++++.. .....+..|+.++..+ .|+|+ +++++++...+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i-----~~~~~~~~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFL-----TQLHSCFQTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCc-----cceeeEEEcCCEEEEEE
Confidence 46999999999999999999999999987432 2334566788888877 57777 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.+.. .+++..+..++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 76 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~------------------ 135 (318)
T cd05570 76 EYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHI------------------ 135 (318)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcE------------------
Confidence 999 899999988764 69999999999999999999999999999999999999766655
Q ss_pred ccCCCCCCceEeeCCCcccc---cCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 136 ---------kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~ 198 (318)
T cd05570 136 ---------KIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198 (318)
T ss_pred ---------EecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC
Confidence 45555544321 1112234789999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=288.66 Aligned_cols=196 Identities=30% Similarity=0.492 Sum_probs=164.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
++|++.++||+|+||.||+|++..+++.||+|.++... .....+.+|+.++++++|+|+ +++++++..++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-----VTLHDIVHTDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCc-----ceEEEEEeeCCeEE
Confidence 56999999999999999999999999999999886432 233456789999999999998 89999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+
T Consensus 81 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~---------------- 143 (309)
T cd07872 81 LVFEYLDKDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGEL---------------- 143 (309)
T ss_pred EEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCE----------------
Confidence 999999889999887654 358999999999999999999999999999999999999766555
Q ss_pred ccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++...... .....+|+.|+|||++.+. .++.++|||||||++|||+||+.||.+
T Consensus 144 -----------kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 207 (309)
T cd07872 144 -----------KLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG 207 (309)
T ss_pred -----------EECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 55555544332111 1223678999999998764 588999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=285.23 Aligned_cols=196 Identities=33% Similarity=0.569 Sum_probs=160.6
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHH---HhCCCCCcceEEEcceecc--
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRL---ARHDIGGTRCVQIRNWFDY-- 164 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l---~~~~i~~~~~~~~~~~~~~-- 164 (323)
+|++.+.||+|+||+||+|++..+++.||+|.++... .......+|+.+++.+ +|+|+ +++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni-----~~~~~~~~~~~ 75 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNI-----VRLMDVCATSR 75 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCe-----eeeeeeecccc
Confidence 5899999999999999999999999999999886422 1223456788887776 47776 888887653
Q ss_pred ---CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 165 ---RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 165 ---~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
...++++||++.++|.+++.......+++..++.++.|++.||+|||++||+||||||+||+++.++.+
T Consensus 76 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~-------- 147 (288)
T cd07863 76 TDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQV-------- 147 (288)
T ss_pred CCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE--------
Confidence 356899999998899999987655569999999999999999999999999999999999999766655
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
||+|||.+...... .....||..|+|||++.+..++.++|||||||++|||++|++||.
T Consensus 148 -------------------kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~ 208 (288)
T cd07863 148 -------------------KLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 208 (288)
T ss_pred -------------------EECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence 55555544432211 123468999999999999899999999999999999999999986
Q ss_pred C
Q 020652 320 T 320 (323)
Q Consensus 320 ~ 320 (323)
+
T Consensus 209 ~ 209 (288)
T cd07863 209 G 209 (288)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=277.69 Aligned_cols=194 Identities=28% Similarity=0.491 Sum_probs=168.1
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---------hhhHHHHHHHHHHHHHHH-hCCCCCcceEEEcce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---------NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNW 161 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---------~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~ 161 (323)
.+|.-.+.||+|..++|.+|.++.+++.+|+|++... ...+++...|+.||+++. ||+| +.+.++
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~I-----I~l~D~ 91 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYI-----IDLQDV 91 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcE-----EEeeee
Confidence 4678889999999999999999999999999998621 234566778999999986 6666 999999
Q ss_pred eccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
|+.+..+++|+|.| .|.|+|++...- .+++...+.|++|++.|++|||.++||||||||+|||+++
T Consensus 92 yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILldd----------- 158 (411)
T KOG0599|consen 92 YESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDD----------- 158 (411)
T ss_pred ccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecc-----------
Confidence 99999999999999 999999998765 7999999999999999999999999999999999999754
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcC------CCCCcchhHHHHHHHHHHHh
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG------LGWNYPCDLWSVGCILVELC 312 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~el~ 312 (323)
+..+||+|||.+.....+. ...||||.|+|||.+.. .+|+..+|+||+|||+|.|+
T Consensus 159 ----------------n~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLL 222 (411)
T KOG0599|consen 159 ----------------NMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLL 222 (411)
T ss_pred ----------------ccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHH
Confidence 4456777777776554443 34799999999999964 36889999999999999999
Q ss_pred cCCCCCC
Q 020652 313 SVSNCYL 319 (323)
Q Consensus 313 tg~~pf~ 319 (323)
.|.+||-
T Consensus 223 aGcpPFw 229 (411)
T KOG0599|consen 223 AGCPPFW 229 (411)
T ss_pred cCCCchh
Confidence 9999983
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=316.16 Aligned_cols=218 Identities=21% Similarity=0.291 Sum_probs=173.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.++||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++|+|+ +++++++..++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNI-----Vkl~~v~~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGI-----VPVYSICSDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCc-----CeEEEEEeeCCE
Confidence 5799999999999999999999999999999998642 2345678899999999999998 889999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNS---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d 237 (323)
.+++|||+ |++|.+++.... ...++...+..++.||+.||+|||++||+||||||+|||++.++.++++|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 99999999 899999986421 12356677889999999999999999999999999999999988888888
Q ss_pred cccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
||++........... ......-+............+||+.|||||++.+..++.++|||||||++|||+||+.|
T Consensus 157 FGLAk~i~~~~~~~~------~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~P 230 (932)
T PRK13184 157 WGAAIFKKLEEEDLL------DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230 (932)
T ss_pred cCcceeccccccccc------ccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCC
Confidence 887665422211000 00000000000001111235799999999999999999999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|..
T Consensus 231 F~~ 233 (932)
T PRK13184 231 YRR 233 (932)
T ss_pred CCC
Confidence 964
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=285.12 Aligned_cols=189 Identities=25% Similarity=0.422 Sum_probs=158.7
Q ss_pred ecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC
Q 020652 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (323)
Q Consensus 100 lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (323)
||+|+||+||+|.+..+++.||+|++.... ...+.+..|+.+++.++|+|+ +.+.+.+......++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i-----~~~~~~~~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFI-----VSLAYAFQTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcE-----eeeeEEEcCCCeEEEEEeCC
Confidence 799999999999999999999999986432 122456789999999999888 88999999999999999999
Q ss_pred -CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccc
Q 020652 176 -GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252 (323)
Q Consensus 176 -~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~ 252 (323)
+++|.+++... ....+++..+..++.||+.||+|||++||+||||||+||+++.++.
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~-------------------- 135 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN-------------------- 135 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--------------------
Confidence 89999887532 2246899999999999999999999999999999999999865554
Q ss_pred cCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 253 NLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 253 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 136 -------~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 136 -------VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred -------EEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 466666655432221 1224689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=295.18 Aligned_cols=195 Identities=30% Similarity=0.478 Sum_probs=163.7
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc--
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-- 164 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~-- 164 (323)
+.++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++|+|+ +.+++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----i~~~~~~~~~~ 96 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI-----IGLLNVFTPQK 96 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCc-----cccceeecccc
Confidence 457899999999999999999999999999999998642 2334567789999999999998 666665543
Q ss_pred ----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 165 ----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 165 ----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
...+|+||||++++|.+++.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.
T Consensus 97 ~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~-------- 164 (364)
T cd07875 97 SLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-------- 164 (364)
T ss_pred cccccCeEEEEEeCCCCCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--------
Confidence 346899999998899888854 4889999999999999999999999999999999999865544
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
+||+|||++...... .....||..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 165 -------------------~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf 225 (364)
T cd07875 165 -------------------LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225 (364)
T ss_pred -------------------EEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCC
Confidence 566666666543322 12347899999999999999999999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 226 ~~ 227 (364)
T cd07875 226 PG 227 (364)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=293.29 Aligned_cols=197 Identities=25% Similarity=0.412 Sum_probs=171.4
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
+.|+.-++||+|+||.||-|+-+.||+.||+|.+.+. .....-.++|-.+|.+++.+.| |.+-..|++.+.
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~Fi-----VslaYAfeTkd~ 259 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFI-----VSLAYAFETKDA 259 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcE-----EEEeeeecCCCc
Confidence 5688999999999999999999999999999988632 2233456789999999988866 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+||..| ||+|.-.|.+.+...|++..++.++.+|+.||++||+.+||.||+||+|||+++.|++
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Ghv------------- 326 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHV------------- 326 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCe-------------
Confidence 99999999 9999999988888899999999999999999999999999999999999998776665
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|+|+|...... ....+||..|||||++.+..|+...|+|||||+||||+.|+.||..
T Consensus 327 --------------RISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 327 --------------RISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred --------------EeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 55555555443322 3335899999999999999999999999999999999999999964
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=296.88 Aligned_cols=206 Identities=25% Similarity=0.339 Sum_probs=173.0
Q ss_pred eeEecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhh-HHHHHHHHHHHHHHHhCCCCCcceEEEcc
Q 020652 82 YVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (323)
Q Consensus 82 ~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~ 160 (323)
+.+......+++|.-...||+|+||.||+|....+ ..||||.+...... ..+|..|+.++.+++|+|+ +++++
T Consensus 65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nl-----v~LlG 138 (361)
T KOG1187|consen 65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNL-----VKLLG 138 (361)
T ss_pred eeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCc-----ccEEE
Confidence 44444556678899999999999999999986544 88999988765543 5569999999999999999 99999
Q ss_pred eeccCc-eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCcEEEeecCceec
Q 020652 161 WFDYRN-HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR---LIHTDLKPENILLVSAEYVKV 235 (323)
Q Consensus 161 ~~~~~~-~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---iiHrDlKp~NIli~~~~~~ki 235 (323)
||...+ +.+||+||+ .|+|.+++.......++|....+|+.++++||+|||+.. |||||||++|||++++
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~----- 213 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED----- 213 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-----
Confidence 999888 599999999 899999998765327899999999999999999999853 9999999999998654
Q ss_pred cCcccccccCCCCCccccCCCCCCceEeeCCCcccccC-Cccc--c-ccCCccccchhhcCCCCCcchhHHHHHHHHHHH
Q 020652 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSY--V-VSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311 (323)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~--~-~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 311 (323)
..+||+|||+|+.... .... . .||..|+|||.+.....+.|+|||||||+|.||
T Consensus 214 ----------------------~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEl 271 (361)
T KOG1187|consen 214 ----------------------FNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLEL 271 (361)
T ss_pred ----------------------CCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHH
Confidence 4556777777755443 2222 2 799999999999988899999999999999999
Q ss_pred hcCCCCCCC
Q 020652 312 CSVSNCYLT 320 (323)
Q Consensus 312 ~tg~~pf~~ 320 (323)
+||+.+.+.
T Consensus 272 itgr~~~d~ 280 (361)
T KOG1187|consen 272 ITGRKAVDQ 280 (361)
T ss_pred HhCCcccCC
Confidence 999988764
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=284.25 Aligned_cols=196 Identities=23% Similarity=0.404 Sum_probs=166.5
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+.+++.++|+++ +.+.+.+...+.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i-----~~~~~~~~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFV-----VSLAYAYETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCe-----eeeeEEEecCCEE
Confidence 3788899999999999999999999999999886432 223446679999999999888 8899888888999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
|+||||+ +++|.+++.......+++..+..++.|++.||.|||+++|+||||||+||+++.++.
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--------------- 140 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--------------- 140 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC---------------
Confidence 9999999 899999987655456999999999999999999999999999999999999865544
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++|+|||++....... ....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 141 ------------~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 141 ------------IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred ------------EEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 5666666654432211 224789999999999998999999999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=300.33 Aligned_cols=182 Identities=26% Similarity=0.408 Sum_probs=159.3
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC-
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~- 175 (323)
++-||+|+.|.||+|+. .++.||||+++. .-..+|+-|++|+|+|| +.|.+++.....+|||||||
T Consensus 129 LeWlGSGaQGAVF~Grl--~netVAVKKV~e------lkETdIKHLRkLkH~NI-----I~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL--HNETVAVKKVRE------LKETDIKHLRKLKHPNI-----ITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhccCcccceeeeec--cCceehhHHHhh------hhhhhHHHHHhccCcce-----eeEeeeecCCceeEEeeeccc
Confidence 56799999999999964 577899997652 23458889999999999 99999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCC
Q 020652 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255 (323)
Q Consensus 176 ~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~ 255 (323)
.|.|...|+... .+.......|..+|+.|+.|||.+.|||||||.-||||..++.
T Consensus 196 ~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~----------------------- 250 (904)
T KOG4721|consen 196 QGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV----------------------- 250 (904)
T ss_pred cccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce-----------------------
Confidence 999999999765 7899999999999999999999999999999999999976654
Q ss_pred CCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 256 KSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 256 ~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+||+|||.++..... ...++||..|||||+|.+.+.+.|+|||||||+||||+||..||..
T Consensus 251 ----VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 251 ----VKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred ----EEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence 466677766654433 2347999999999999999999999999999999999999999964
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=283.00 Aligned_cols=196 Identities=23% Similarity=0.374 Sum_probs=166.3
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.|+..+.||+|+||+||+|.+..+++.||+|.+.... .....+.+|+++++.++|+++ +.+.+.+..++..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i-----~~~~~~~~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFV-----VNLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCc-----eeEEEEEecCCEE
Confidence 3788899999999999999999999999999886432 223446789999999999988 8888888889999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
+++|||+ +++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~--------------- 140 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH--------------- 140 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC---------------
Confidence 9999999 889999887655457999999999999999999999999999999999999865544
Q ss_pred CCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++|+|||++...... .....|+..|+|||++.+..++.++|+|||||++|||++|..||.+
T Consensus 141 ------------~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~ 203 (285)
T cd05632 141 ------------IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203 (285)
T ss_pred ------------EEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 566666655432211 1234689999999999988999999999999999999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=296.97 Aligned_cols=201 Identities=22% Similarity=0.311 Sum_probs=164.2
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
+...+...+.+.||+|.||+||+|++..+ ||||+++. .....+.|.+|+.++++-+|.|| +-+.+++..
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NI-----lLFMG~~~~ 459 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENI-----LLFMGACMN 459 (678)
T ss_pred ccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhh-----eeeehhhcC
Confidence 34445677889999999999999988655 99999974 34577889999999999999999 999999988
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
... .||+.+| |.+|+.+++... ..|.....+.|++|+++|+.|||.++|||||||..||++.+++.|||.|||++..
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceee
Confidence 776 8999999 889999998655 5799999999999999999999999999999999999997766665555554322
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC---CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
...- ...+.....-|...|||||+++. .+|++.+|||||||++|||+||..||..
T Consensus 538 k~~w----------------------~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi 595 (678)
T KOG0193|consen 538 KTRW----------------------SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI 595 (678)
T ss_pred eeee----------------------ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC
Confidence 1100 00111122357788999999975 3799999999999999999999999974
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=304.19 Aligned_cols=199 Identities=26% Similarity=0.312 Sum_probs=163.9
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC-
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR- 165 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~- 165 (323)
..++|++.+.||+|+||+||+|++..+++.||||++... ......+.+|+.++..+.|+|+ ++++..+...
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~i-----v~~~~~~~~~~ 104 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI-----VKCHEDFAKKD 104 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcE-----EEeecceeccc
Confidence 346899999999999999999999999999999998643 2334567789999999988887 7766655332
Q ss_pred -------ceEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceec
Q 020652 166 -------NHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235 (323)
Q Consensus 166 -------~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki 235 (323)
..+++||||+ +++|.+++... ....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~v-- 182 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLV-- 182 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCE--
Confidence 1478999999 89999998753 23468999999999999999999999999999999999999765544
Q ss_pred cCcccccccCCCCCccccCCCCCCceEeeCCCcccccC-----CccccccCCccccchhhcCCCCCcchhHHHHHHHHHH
Q 020652 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310 (323)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 310 (323)
||+|||+++.... .....+||+.|+|||++.+..++.++|||||||++||
T Consensus 183 -------------------------kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilye 237 (496)
T PTZ00283 183 -------------------------KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYE 237 (496)
T ss_pred -------------------------EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 5555555543221 1233579999999999999999999999999999999
Q ss_pred HhcCCCCCCC
Q 020652 311 LCSVSNCYLT 320 (323)
Q Consensus 311 l~tg~~pf~~ 320 (323)
|++|+.||.+
T Consensus 238 LltG~~Pf~~ 247 (496)
T PTZ00283 238 LLTLKRPFDG 247 (496)
T ss_pred HHHCCCCCCC
Confidence 9999999975
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=296.29 Aligned_cols=194 Identities=25% Similarity=0.408 Sum_probs=161.9
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc---
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN--- 166 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~--- 166 (323)
.|++.++||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++|+|+ +++++++...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNV-----LSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCc-----CCHhheecCCCccc
Confidence 378899999999999999999999999999988642 2234567889999999999998 88888887665
Q ss_pred --eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 167 --HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 167 --~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
..|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg----- 148 (372)
T cd07853 76 FEEIYVVTELMQSDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFG----- 148 (372)
T ss_pred cceEEEEeeccccCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEecccc-----
Confidence 789999999889999887654 69999999999999999999999999999999999999776655555554
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
++...... .....+|+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 149 ----------------------~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 149 ----------------------LARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred ----------------------ceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 44322111 1223678999999999875 47899999999999999999999997
Q ss_pred C
Q 020652 320 T 320 (323)
Q Consensus 320 ~ 320 (323)
+
T Consensus 207 ~ 207 (372)
T cd07853 207 A 207 (372)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=290.23 Aligned_cols=201 Identities=24% Similarity=0.363 Sum_probs=169.4
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
..+|..+.+||+|+||.|.+|..+.+.+.+|||++++. ....+..+.|-++|.....| +.+++++.+|++-+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kp----pFL~qlHScFQTmD 423 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP----PFLVQLHSCFQTMD 423 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCC----chHHHHHHHhhhhh
Confidence 35689999999999999999999999999999998753 23334456677777765554 34589999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.+|+||||+ ||+|.-.+++.+ .+.+..+..++.+|+.||-+||++|||.||||.+|||++.+|++||+|||++++..
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred heeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999 999999998876 79999999999999999999999999999999999999877766555555443322
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
-+ .....+++|||.|+|||++..++|+..+|+||+||+||||+.|++||.|.
T Consensus 502 ~~------------------------~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 502 FD------------------------GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred cC------------------------CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 21 22334579999999999999999999999999999999999999999974
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=293.16 Aligned_cols=195 Identities=24% Similarity=0.445 Sum_probs=164.1
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEEC--CCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDN--EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
..+..+|+++++||+|+||.||+|... .+++.||+|.+... ....+|+.+++.++|+|+ +++++.+...
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~i-----v~~~~~~~~~ 158 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAI-----INLIHAYRWK 158 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCc-----cceeeeEeeC
Confidence 345678999999999999999999754 45678999987643 234679999999999998 8999999988
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
...|++||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||
T Consensus 159 ~~~~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG------ 230 (392)
T PHA03207 159 STVCMVMPKYKCDLFTYVDRSG--PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG------ 230 (392)
T ss_pred CEEEEEehhcCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCc------
Confidence 9999999999889999996543 79999999999999999999999999999999999999776655555554
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 231 ---------------------~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 231 ---------------------AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred ---------------------cccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 44322111 1234799999999999999999999999999999999999999976
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=293.02 Aligned_cols=189 Identities=29% Similarity=0.432 Sum_probs=160.5
Q ss_pred eeecccCcEEEEEEEE---CCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 98 SKMGEGTFGQVVECFD---NEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~---~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
+.||+|+||.||++++ ..+++.||+|++.... .....+..|++++++++|+|| +++++.+...+.+|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFI-----VKLHYAFQTEGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCc-----ccEEEEEEcCCEEEEE
Confidence 6799999999999986 3578999999987432 233456779999999999998 8899999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||+ +++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 77 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~------------------ 136 (318)
T cd05582 77 LDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH------------------ 136 (318)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc------------------
Confidence 9999 899999997654 6899999999999999999999999999999999999976554
Q ss_pred cccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 137 ---------~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 200 (318)
T cd05582 137 ---------IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200 (318)
T ss_pred ---------EEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence 456666655433221 2235789999999999998899999999999999999999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=281.57 Aligned_cols=189 Identities=23% Similarity=0.430 Sum_probs=159.4
Q ss_pred ecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC
Q 020652 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (323)
Q Consensus 100 lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (323)
||+|+||.||++++..+++.||+|.+.... ........|++++++++|+|+ +++.+.++.+.++++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i-----~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFI-----VNLAYAFESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcE-----EEEEEEEecCCeEEEEEecC
Confidence 799999999999999999999999886322 123345679999999999988 99999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccC
Q 020652 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (323)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~ 254 (323)
+++|.+++.......+++..+..++.|++.||+|||++||+||||||+||+++.++.+
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~--------------------- 134 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNC--------------------- 134 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCE---------------------
Confidence 8999998876655568999999999999999999999999999999999999765544
Q ss_pred CCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 255 PKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||++....... ....||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 135 ------~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~ 196 (277)
T cd05607 135 ------RLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKD 196 (277)
T ss_pred ------EEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 555555544322211 224689999999999998899999999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=288.13 Aligned_cols=195 Identities=26% Similarity=0.502 Sum_probs=158.3
Q ss_pred EeeecccCcEEEEEEEEC--CCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc--CceEEEEE
Q 020652 97 LSKMGEGTFGQVVECFDN--EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNHICIVF 172 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~--~~~~~lv~ 172 (323)
.++||+|+||+||+|++. .+++.||+|.+.... ......+|+.++++++|+|+ +++++.+.. +..+|++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-ISMSACREIALLRELKHPNV-----ISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-CcHHHHHHHHHHHhcCCCCC-----cceeeeEecCCCcEEEEEE
Confidence 368999999999999965 467899999886432 23457789999999999999 888887643 46789999
Q ss_pred ccCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 173 EKLGPSLYDFLRKNS-------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 173 e~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
||++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+...+
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~-------------- 145 (317)
T cd07868 80 DYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG-------------- 145 (317)
T ss_pred eccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCC--------------
Confidence 999889999886321 13589999999999999999999999999999999999995321
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCC------ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
+..+.+||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|||++|++||
T Consensus 146 ---------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f 216 (317)
T cd07868 146 ---------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ---------CCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCc
Confidence 23445778888877653321 1235789999999999874 5899999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 217 ~~ 218 (317)
T cd07868 217 HC 218 (317)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=286.32 Aligned_cols=194 Identities=27% Similarity=0.459 Sum_probs=170.3
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
-|.++++||+|+||.||+|.++.+|+.+|||.+... ...++..+||.|++++..+.+ |++++.|-....+|+||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-sDLQEIIKEISIMQQC~S~yV-----VKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-TDLQEIIKEISIMQQCKSKYV-----VKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-chHHHHHHHHHHHHHcCCchh-----hhhhhhhccCCceEeeh
Confidence 377889999999999999999999999999998764 445678899999999988776 99999988888999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||| .|++.|.++... ..+++..+..+++..+.||+|||...-||||||..|||++.+|.+
T Consensus 108 EYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~A------------------ 168 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIA------------------ 168 (502)
T ss_pred hhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchh------------------
Confidence 999 799999998654 589999999999999999999999999999999999998766655
Q ss_pred ccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||.|..... ...++.|||.|||||++..-+|+.++||||||++..||+.|++||..
T Consensus 169 ---------KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsD 231 (502)
T KOG0574|consen 169 ---------KLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSD 231 (502)
T ss_pred ---------hhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccc
Confidence 5556665544332 23557899999999999999999999999999999999999999974
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=291.92 Aligned_cols=188 Identities=27% Similarity=0.463 Sum_probs=153.6
Q ss_pred ecccCcEEEEEEEECCCCcEEEEEEeccchh----hHHHHHHHHHHHHHH---HhCCCCCcceEEEcceeccCceEEEEE
Q 020652 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRL---ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 100 lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~Ei~~l~~l---~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
||+|+||+||+|++..+++.||||++..... .......|..++... .|+++ +.+++.+...+.+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i-----~~~~~~~~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFI-----VGLKFSFQTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcC-----cceEEEEecCCeEEEEE
Confidence 7999999999999999999999999864321 122334566666655 47776 89999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 76 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~------------------ 135 (330)
T cd05586 76 DYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHI------------------ 135 (330)
T ss_pred cCCCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCE------------------
Confidence 999 899999988654 69999999999999999999999999999999999999765544
Q ss_pred ccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+|+|||++.... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.
T Consensus 136 ---------kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~ 200 (330)
T cd05586 136 ---------ALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE 200 (330)
T ss_pred ---------EEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC
Confidence 555555544321 112235799999999999765 4899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=310.99 Aligned_cols=222 Identities=27% Similarity=0.471 Sum_probs=176.3
Q ss_pred EecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcc
Q 020652 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (323)
Q Consensus 84 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~ 160 (323)
+..++...++|+++++||+|+||+||+|.+..+++.||+|++... ......+..|+.+++.+.|+|| +++++
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNI-----Vrl~d 79 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI-----VRYID 79 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCc-----CeEEE
Confidence 334566678999999999999999999999999999999988632 3345678889999999999998 88888
Q ss_pred eecc--CceEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-------CceecCCCCCcEEEe
Q 020652 161 WFDY--RNHICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHEL-------RLIHTDLKPENILLV 228 (323)
Q Consensus 161 ~~~~--~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~-------~iiHrDlKp~NIli~ 228 (323)
+|.. ...+||||||+ +++|.++|.... ...+++..++.|+.||+.||.|||+. +||||||||+||||+
T Consensus 80 ~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~ 159 (1021)
T PTZ00266 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS 159 (1021)
T ss_pred EEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence 7743 46799999999 899999997531 23699999999999999999999984 499999999999996
Q ss_pred ecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcC--CCCCcchhHHHH
Q 020652 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG--LGWNYPCDLWSV 304 (323)
Q Consensus 229 ~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSl 304 (323)
.... .+.+... .....+....+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||
T Consensus 160 s~~~-~lg~i~~---------~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSL 229 (1021)
T PTZ00266 160 TGIR-HIGKITA---------QANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229 (1021)
T ss_pred cCcc-ccccccc---------cccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHH
Confidence 5321 1111100 0011234556899999998764332 233579999999999965 358899999999
Q ss_pred HHHHHHHhcCCCCCCC
Q 020652 305 GCILVELCSVSNCYLT 320 (323)
Q Consensus 305 G~il~el~tg~~pf~~ 320 (323)
|||||||+||..||..
T Consensus 230 G~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 230 GCIIYELCSGKTPFHK 245 (1021)
T ss_pred HHHHHHHHHCCCCCCc
Confidence 9999999999999964
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=319.42 Aligned_cols=200 Identities=24% Similarity=0.418 Sum_probs=165.5
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh----hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
.++|.+++.||+|+||.|.+++++.|++.||+|++++... ....|..|-.+|..-+. ..+++++-.|++..
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns-----~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNS-----EWIVQLHYAFQDER 148 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCc-----HHHHHHHHHhcCcc
Confidence 4679999999999999999999999999999999876322 23456677777764443 45589999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
++|+||||+ ||+|..++.+.. .++++.+++|+..|+.||+-||+.|+|||||||+||||+..|++|++|||-+-+..
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 999999999 999999999876 79999999999999999999999999999999999999877766555555433222
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-----CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+|. + .....+|||.|.+||++.. +.|+..+|+||+||++|||+.|..||..
T Consensus 227 ~dG~----------V-------------~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 227 ADGT----------V-------------RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred CCCc----------E-------------EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 2211 1 1234589999999999963 4689999999999999999999999964
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=273.16 Aligned_cols=198 Identities=28% Similarity=0.462 Sum_probs=170.0
Q ss_pred eCCcEEEE-eeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceecc---
Q 020652 90 LTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY--- 164 (323)
Q Consensus 90 ~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~--- 164 (323)
++++|++- ++||-|-.|.|..|.++.|++.+|+|++.... .+.+|+++.-.. .|+|| |+++++|+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~----KARrEVeLHw~~s~h~~i-----V~IidVyeNs~~ 129 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP----KARREVELHWMASGHPHI-----VSIIDVYENSYQ 129 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH----HHHhHhhhhhhhcCCCce-----EEeehhhhhhcc
Confidence 45678775 57999999999999999999999999886443 355677664333 36666 999998765
Q ss_pred -CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
...+.+|||.+ ||+|+..++.++...|+|.++..|+.||+.|+.|||+.+|.||||||+|+|....
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t------------ 197 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTT------------ 197 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecC------------
Confidence 45678999999 9999999999988889999999999999999999999999999999999998654
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCccccc--CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
..+..+||+|||.|+... ....+.+-||+|.|||++....|+..+|+||+||++|-|++|-+||.+
T Consensus 198 ------------~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS 265 (400)
T KOG0604|consen 198 ------------SPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_pred ------------CCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc
Confidence 356778999999998765 334556889999999999999999999999999999999999999976
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=293.51 Aligned_cols=198 Identities=29% Similarity=0.436 Sum_probs=175.8
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
-.+.|.+.+.||+|.|++|.+|++..++..||||++.+.. ..++.+.+|+++|+.++|||| ++++.+.+...
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnI-----vkl~~v~~t~~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNI-----VKLFSVIETEA 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcce-----eeeeeeeeecc
Confidence 3467999999999999999999999999999999997543 334557899999999999999 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.+|+||||+ ++.+++++.+++ ++.+..++.++.|+++|++|||+++|||||||.+|||++.
T Consensus 129 ~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~---------------- 190 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDE---------------- 190 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccc----------------
Confidence 999999999 999999999887 7888999999999999999999999999999999999754
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCC-cchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+..+||+|||++.+.... ..+.+|++.|.|||++.+..|+ +.+|+||+|++||-|+.|.+||++.
T Consensus 191 -----------~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 191 -----------NMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred -----------ccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 445677777777665433 3457999999999999998875 8899999999999999999999975
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=300.39 Aligned_cols=196 Identities=27% Similarity=0.391 Sum_probs=170.4
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc----chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
...|.-++.||.|+||.||.|++..+.+.||||.+.. ..+.-+++..|+..|.+++|||+ +.+.++|-...
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPnt-----ieYkgCyLre~ 99 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNT-----IEYKGCYLREH 99 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCc-----ccccceeeccc
Confidence 3458888999999999999999999999999999863 33445678899999999999999 99999999888
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
..|||||||-|+..|++.-.. .++.+-.+..|+.+.+.||.|||+++.||||||..|||+.+.|
T Consensus 100 TaWLVMEYClGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g--------------- 163 (948)
T KOG0577|consen 100 TAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG--------------- 163 (948)
T ss_pred hHHHHHHHHhccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC---------------
Confidence 999999999888888887554 4799999999999999999999999999999999999986655
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC---CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+||+|||.|.... +...++|||+|||||+|.. +.|+-++||||||++..||+-.++|+..
T Consensus 164 ------------~VKLaDFGSAsi~~-PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn 227 (948)
T KOG0577|consen 164 ------------LVKLADFGSASIMA-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 227 (948)
T ss_pred ------------eeeeccccchhhcC-chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC
Confidence 45777777776543 4456799999999999963 4699999999999999999999999864
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=282.36 Aligned_cols=198 Identities=23% Similarity=0.357 Sum_probs=160.1
Q ss_pred CCcEEEEeeecccCcEEEEEEEECC----------------CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCC
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNE----------------KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGG 152 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~----------------~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~ 152 (323)
.++|++.++||+|+||.||+|.+.. ++..||+|++... ......+.+|+.++++++|+||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-- 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI-- 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe--
Confidence 3679999999999999999998543 3457999988743 3345678899999999999988
Q ss_pred cceEEEcceeccCceEEEEEccC-CCCHHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 020652 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY-----------------RSFPIDLVRELGRQLLESVAFMHELR 214 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----------------~~l~~~~~~~i~~qi~~aL~~lH~~~ 214 (323)
+++++++...+..++||||+ +++|.+++..... ..+++..+..++.||+.||.|||++|
T Consensus 82 ---v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ 158 (304)
T cd05096 82 ---IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN 158 (304)
T ss_pred ---eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999999889999999999 8999999865321 24677889999999999999999999
Q ss_pred ceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchh
Q 020652 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEV 289 (323)
Q Consensus 215 iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~ 289 (323)
|+||||||+|||++.++.+|++|||+ +...... .....++..|+|||+
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~---------------------------~~~~~~~~~~~~~~~~~~~~~y~aPE~ 211 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGM---------------------------SRNLYAGDYYRIQGRAVLPIRWMAWEC 211 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCcc---------------------------ceecccCceeEecCcCCCCccccCHHH
Confidence 99999999999997766555555554 4322111 112345788999999
Q ss_pred hcCCCCCcchhHHHHHHHHHHHhc--CCCCCCC
Q 020652 290 ILGLGWNYPCDLWSVGCILVELCS--VSNCYLT 320 (323)
Q Consensus 290 ~~~~~~~~~~DiwSlG~il~el~t--g~~pf~~ 320 (323)
+.+..++.++|||||||++|||++ +..||.+
T Consensus 212 ~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 244 (304)
T cd05096 212 ILMGKFTTASDVWAFGVTLWEILMLCKEQPYGE 244 (304)
T ss_pred HhcCCCCchhhhHHHHHHHHHHHHccCCCCCCc
Confidence 998899999999999999999986 5667753
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=302.26 Aligned_cols=202 Identities=26% Similarity=0.423 Sum_probs=157.7
Q ss_pred ecCceeCCcEEEEeeecccCcEEEEEEEECCCC-cEEEEE------------------EeccchhhHHHHHHHHHHHHHH
Q 020652 85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIK------------------IVRSINKYREAAMIEIDVLQRL 145 (323)
Q Consensus 85 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~vAiK------------------~~~~~~~~~~~~~~Ei~~l~~l 145 (323)
..++.+.++|+++++||+|+||+||+|..+... ...++| .+.........+.+|+.+|+++
T Consensus 141 ~~~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l 220 (501)
T PHA03210 141 KHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL 220 (501)
T ss_pred ccchhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC
Confidence 344566789999999999999999998764332 112222 1222223345678899999999
Q ss_pred HhCCCCCcceEEEcceeccCceEEEEEccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 020652 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSY---RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKP 222 (323)
Q Consensus 146 ~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp 222 (323)
+|+|| +++++++...+..|++|++++++|.+++..... .......++.++.||+.||+|||++|||||||||
T Consensus 221 ~HpnI-----v~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP 295 (501)
T PHA03210 221 NHENI-----LKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKL 295 (501)
T ss_pred CCCCc-----CcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 99998 899999999999999999998899988865321 1234667888999999999999999999999999
Q ss_pred CcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcc
Q 020652 223 ENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYP 298 (323)
Q Consensus 223 ~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~ 298 (323)
+|||++.++. +||+|||++...... ....+||..|+|||++.+..++.+
T Consensus 296 ~NILl~~~~~---------------------------vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 348 (501)
T PHA03210 296 ENIFLNCDGK---------------------------IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI 348 (501)
T ss_pred HHEEECCCCC---------------------------EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH
Confidence 9999966554 566666666543221 122579999999999999999999
Q ss_pred hhHHHHHHHHHHHhcCCCCC
Q 020652 299 CDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 299 ~DiwSlG~il~el~tg~~pf 318 (323)
+|||||||++|||++|..++
T Consensus 349 ~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 349 TDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred HHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999988644
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=274.75 Aligned_cols=197 Identities=27% Similarity=0.473 Sum_probs=167.3
Q ss_pred EEEE-eeecccCcEEEEEEEECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceeccCceEEE
Q 020652 94 YRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 94 y~~~-~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
|++. +.||+|+|+.|--|....++..||||++.+. ...+.+..+|++++...+ |+|| ++++++|+++..+||
T Consensus 79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~ni-----lqLiefFEdd~~FYL 153 (463)
T KOG0607|consen 79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNI-----LQLIEFFEDDTRFYL 153 (463)
T ss_pred HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccH-----HHHHHHhcccceEEE
Confidence 4443 6899999999999999999999999999754 345677889999998876 5666 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
|||.+ ||+|...|.+.. .|++..+..+..+|+.||++||.+||.||||||+|||....+
T Consensus 154 VfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn------------------ 213 (463)
T KOG0607|consen 154 VFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPN------------------ 213 (463)
T ss_pred EEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCC------------------
Confidence 99999 999999998775 799999999999999999999999999999999999986543
Q ss_pred ccccCCCCCCceEeeCCCccccc----------CCccccccCCccccchhhc---C--CCCCcchhHHHHHHHHHHHhcC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEH----------QDHSYVVSTRHYRAPEVIL---G--LGWNYPCDLWSVGCILVELCSV 314 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~----------~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DiwSlG~il~el~tg 314 (323)
.-..+|||||.+..-.. ....+.+|+..|||||+.. + ..|+.++|.||||||||-|++|
T Consensus 214 ------~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsG 287 (463)
T KOG0607|consen 214 ------KVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSG 287 (463)
T ss_pred ------CcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhC
Confidence 33567888887654321 1123358999999999874 2 3589999999999999999999
Q ss_pred CCCCCCC
Q 020652 315 SNCYLTP 321 (323)
Q Consensus 315 ~~pf~~~ 321 (323)
-+||.|.
T Consensus 288 YpPFvG~ 294 (463)
T KOG0607|consen 288 YPPFVGH 294 (463)
T ss_pred CCCccCc
Confidence 9999875
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=291.84 Aligned_cols=197 Identities=25% Similarity=0.366 Sum_probs=160.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCC-----CcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceec
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~ 163 (323)
++|++.+.||+|+||.||+|.+..+ ++.||+|+++.. ....+.+.+|+.+++.+ +|+|| +++++.+.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nI-----v~~~~~~~ 112 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNI-----VNLLGACT 112 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCce-----eeEeeEec
Confidence 4699999999999999999986544 357999998643 23445678899999999 79988 99999999
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcC-------------------------------------------------------
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNS------------------------------------------------------- 187 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~------------------------------------------------------- 187 (323)
..+.+++||||| +++|.+++....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 999999999999 999999986431
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccC
Q 020652 188 -------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (323)
Q Consensus 188 -------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~ 254 (323)
...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGl-------------- 258 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGL-------------- 258 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeecee--------------
Confidence 12478888999999999999999999999999999999998766655555554
Q ss_pred CCCCCceEeeCCCcccccCCc-----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 255 PKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
+....... ....++..|||||++.+..++.++|||||||++|||++ |+.||..
T Consensus 259 -------------a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~ 317 (374)
T cd05106 259 -------------ARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317 (374)
T ss_pred -------------eeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 33221111 11234567999999998899999999999999999997 9999964
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=277.87 Aligned_cols=195 Identities=28% Similarity=0.505 Sum_probs=170.5
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||.||++.+..+++.||+|++.... ...+.+.+|+++++++.|+|+ +++++++..++.
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL-----VNLYGSFQDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCc-----cceeeEEEcCCe
Confidence 36999999999999999999999999999999986432 334567889999999999998 899999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+++||||+ +++|.+++.... .+++..+..++.|++.||.|||++||+|+||||+||+++.++.
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~-------------- 139 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY-------------- 139 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--------------
Confidence 99999999 999999998764 7999999999999999999999999999999999999965544
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+||+|||++...........|++.|+|||.+.+..++.++||||||+++|+|++|+.||..
T Consensus 140 -------------~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 200 (290)
T cd05580 140 -------------IKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200 (290)
T ss_pred -------------EEEeeCCCccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 5666666665544444455789999999999888889999999999999999999999965
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=287.60 Aligned_cols=189 Identities=26% Similarity=0.467 Sum_probs=160.5
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
.+|++++.||+|+||.||+|.+..+++.||+|+.... ....|+.+++.++|+|| +++++++......++|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-----~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv 135 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-----TTLIEAMLLQNVNHPSV-----IRMKDTLVSGAITCMV 135 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-----ccHHHHHHHHhCCCCCC-----cChhheEEeCCeeEEE
Confidence 4799999999999999999999999999999975432 23468999999999998 9999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 172 FEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 172 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||++.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.
T Consensus 136 ~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~------------------- 195 (357)
T PHA03209 136 LPHYSSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ------------------- 195 (357)
T ss_pred EEccCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC-------------------
Confidence 9999889999987654 46899999999999999999999999999999999999876554
Q ss_pred ccCCCCCCceEeeCCCcccccC--CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
+||+|||.+..... ......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 196 --------~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 196 --------VCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --------EEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 45666665543221 112346899999999999999999999999999999999865444
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=279.91 Aligned_cols=196 Identities=28% Similarity=0.477 Sum_probs=164.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
++|++.++||+|+||.||+|.+..+++.||+|.+... ......+.+|+.+++.++|+|| +++++++...+..+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-----~~~~~~~~~~~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-----VTLHDIIHTEKSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCc-----ceEEEEEecCCeEE
Confidence 5699999999999999999999999999999988643 2233456789999999999998 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+||||+.++|.+++.... ..+++..++.++.|++.||+|||++||+|+||||+||+++.++.++++|||+
T Consensus 81 lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~--------- 150 (301)
T cd07873 81 LVFEYLDKDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGL--------- 150 (301)
T ss_pred EEEeccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcc---------
Confidence 999999889999987654 3689999999999999999999999999999999999997766555555554
Q ss_pred ccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+...... .....+++.|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 151 ------------------~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~ 207 (301)
T cd07873 151 ------------------ARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207 (301)
T ss_pred ------------------hhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence 4322111 1123568899999998764 578999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=297.70 Aligned_cols=190 Identities=27% Similarity=0.437 Sum_probs=166.7
Q ss_pred eecccCcEEEEEEEECCCCcEEEEEEec-cchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC-C
Q 020652 99 KMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G 176 (323)
Q Consensus 99 ~lG~G~fg~V~~~~~~~~~~~vAiK~~~-~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~-~ 176 (323)
+||+|.||+||-|+|..|...+|||.+. +.....+.+..||.+.+.++|.|| |++.+.+..++++-|.||.. |
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNI-----VrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNI-----VRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhH-----HHHhhccCCCCeEEEEeecCCC
Confidence 6999999999999999999999999886 445666778899999999999999 99999999999999999999 9
Q ss_pred CCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccC
Q 020652 177 PSLYDFLRKNSYRSF--PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (323)
Q Consensus 177 ~~L~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~ 254 (323)
|+|.++++..= .++ .+.++..+..||+.||.|||++.|||||||-+|+||+.
T Consensus 657 GSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNT------------------------- 710 (1226)
T KOG4279|consen 657 GSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNT------------------------- 710 (1226)
T ss_pred CcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEee-------------------------
Confidence 99999998642 345 78999999999999999999999999999999999964
Q ss_pred CCCCCceEeeCCCcccc---cCCccccccCCccccchhhcCC--CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 255 PKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
-.+.+||+|||.++.. +....++.||..|||||++..+ +|+.++|||||||++.||+||++||..
T Consensus 711 -ySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 711 -YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred -ccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence 3456788888877543 2333457899999999999765 699999999999999999999999953
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=273.80 Aligned_cols=194 Identities=37% Similarity=0.595 Sum_probs=165.1
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHH---HHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE---AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~---~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
|++.+.||+|+||+||++.+..+++.||+|++........ ...+|+.+++.++|+|+ +++.+++......++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNI-----VQILDVFQDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTB-----CHEEEEEEESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccc-----ccccccccccccccc
Confidence 8899999999999999999999999999999986543332 33459999999999998 888999988999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+||++ +++|.+++.... .+++..+..++.|++.||.+||+++|+|+||||+||+++.++.+
T Consensus 76 v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~---------------- 137 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEV---------------- 137 (260)
T ss_dssp EEEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEE----------------
T ss_pred cccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccc----------------
Confidence 99999 669999998443 68999999999999999999999999999999999999766655
Q ss_pred ccccCCCCCCceEeeCCCccc---ccCCccccccCCccccchhhc-CCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTF---EHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~---~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+|+|||.+.. .........+|..|+|||++. +..++.++||||||+++|+|++|..||...
T Consensus 138 -----------~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 138 -----------KLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp -----------EESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred -----------ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 5555555542 112223357899999999998 778999999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=274.79 Aligned_cols=200 Identities=22% Similarity=0.321 Sum_probs=162.7
Q ss_pred CcEEEEeeecccCcEEEEEEEEC---CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
++|++.+.||+|+||.||+|.+. ..+..||+|.++.. ......+.+|+.++++++|+|+ +++++++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~ 79 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNI-----VRLEGVITRGN 79 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCc-----CeEEEEEecCC
Confidence 56999999999999999999765 45678999998753 2334567889999999999998 89999999899
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++++|||......
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999 889999998653 368999999999999999999999999999999999999877766666665432110
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
... ........++..|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 159 ~~~-----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~ 211 (266)
T cd05064 159 SEA-----------------------IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred ccc-----------------------hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 000 000011234678999999999999999999999999999775 9999964
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=279.99 Aligned_cols=195 Identities=26% Similarity=0.510 Sum_probs=157.1
Q ss_pred EeeecccCcEEEEEEEECC--CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec--cCceEEEEE
Q 020652 97 LSKMGEGTFGQVVECFDNE--KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD--YRNHICIVF 172 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~--~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~--~~~~~~lv~ 172 (323)
..+||+|+||+||+|++.. ++..||+|.+.... ....+.+|+.+++.++|+|+ +++++++. .+..+++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-ISMSACREIALLRELKHPNV-----IALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-CcHHHHHHHHHHHhCCCCCe-----eeEEEEEeccCCCeEEEEE
Confidence 3689999999999998654 56889999886533 23457789999999999998 88888774 356789999
Q ss_pred ccCCCCHHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 173 EKLGPSLYDFLRKN-------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 173 e~~~~~L~~~l~~~-------~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
||++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+...+
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~-------------- 145 (317)
T cd07867 80 DYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG-------------- 145 (317)
T ss_pred eeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCC--------------
Confidence 99988999887532 123588999999999999999999999999999999999984321
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCC------ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
+..+.+||+|||+++..... .....||+.|+|||++.+. .++.++|||||||++|||+||++||
T Consensus 146 ---------~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f 216 (317)
T cd07867 146 ---------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ---------CCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence 23445777788777643322 1234789999999999774 5889999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
..
T Consensus 217 ~~ 218 (317)
T cd07867 217 HC 218 (317)
T ss_pred cc
Confidence 64
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=287.87 Aligned_cols=197 Identities=27% Similarity=0.383 Sum_probs=160.8
Q ss_pred CcEEEEeeecccCcEEEEEEEE-----CCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceec
Q 020652 92 PRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~ 163 (323)
++|++.++||+|+||.||+|.+ ..++..||||+++.. ....+.+.+|+.+++.+ +|+|| +++++++.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnI-----v~l~~~~~ 109 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINI-----VNLLGACT 109 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcce-----eeeeeeec
Confidence 4799999999999999999974 346678999998643 23445678899999999 79988 99999999
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcC-------------------------------------------------------
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNS------------------------------------------------------- 187 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~------------------------------------------------------- 187 (323)
.++..++||||| +|+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 999999999999 999999987532
Q ss_pred ------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 188 ------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 188 ------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.+|++||
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Df----------- 258 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDF----------- 258 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecC-----------
Confidence 124678889999999999999999999999999999999976655555555
Q ss_pred ccccCCCCCCceEeeCCCcccccCCc-----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
|++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 259 ----------------G~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~ 319 (375)
T cd05104 259 ----------------GLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319 (375)
T ss_pred ----------------ccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 4443221111 11234567999999999999999999999999999998 8899865
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=272.17 Aligned_cols=197 Identities=21% Similarity=0.308 Sum_probs=167.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
..|++.++||+|+||.||+|.+..+++.||+|++.........+.+|+++++.++|+|+ +++++++...+.++++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv 80 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTREPPFYII 80 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCCh-----hheEEEEcCCCCcEEE
Confidence 45899999999999999999999999999999987655556678899999999999988 8889998888999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||+ +++|.+++.......+++..++.++.|++.||.|||++|++||||||+||+++.++.++++|||++
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~--------- 151 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS--------- 151 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccc---------
Confidence 9999 899999998765556899999999999999999999999999999999999987766655555543
Q ss_pred cccCCCCCCceEeeCCCcccccCCc----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+
T Consensus 152 ------------------~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 208 (263)
T cd05052 152 ------------------RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208 (263)
T ss_pred ------------------cccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 3221111 01123567999999999899999999999999999998 9999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=289.01 Aligned_cols=222 Identities=25% Similarity=0.424 Sum_probs=176.6
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh----hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
-|..++.||-|+||+|.+++...|...||+|.+++.+- .......|-+||......-+ |+++-.|.+.+.+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WV-----VrLyySFQDkdnL 704 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWV-----VRLYYSFQDKDNL 704 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcce-----EEEEEEeccCCce
Confidence 48889999999999999999999999999999875432 22345568888887766554 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC--
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS-- 245 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~-- 245 (323)
|+||||+ ||++..+|.+.+ -|+|+.+++++.++.+|+++.|..|+|||||||+||||+.+|++|+.|||++.-..
T Consensus 705 YFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999 999999998887 79999999999999999999999999999999999999999999999999965432
Q ss_pred CCCCccccCCCC------CCceEeeCCCcc-c-------ccC--CccccccCCccccchhhcCCCCCcchhHHHHHHHHH
Q 020652 246 KDGSYFKNLPKS------SAIKLIDFGSTT-F-------EHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (323)
Q Consensus 246 ~~~~~~~~~~~~------~~~kl~Dfg~a~-~-------~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (323)
-+.+.+.+-+.. ..-...|-+.+- . .++ ....++||+.|+|||++...+|+..+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 122222211100 000111222110 0 011 123469999999999999999999999999999999
Q ss_pred HHhcCCCCCCCC
Q 020652 310 ELCSVSNCYLTP 321 (323)
Q Consensus 310 el~tg~~pf~~~ 321 (323)
||+.|++||..+
T Consensus 863 em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 863 EMLVGQPPFLAD 874 (1034)
T ss_pred HHhhCCCCccCC
Confidence 999999999763
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=282.26 Aligned_cols=202 Identities=19% Similarity=0.250 Sum_probs=165.9
Q ss_pred EEeeeccc--CcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 96 ILSKMGEG--TFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 96 ~~~~lG~G--~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
++++||+| +|++||++.+..+++.||+|++... ....+.+.+|+.+++.++|+|| +++++++..++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpni-----v~~~~~~~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNI-----VPYRATFIADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEEECCEEEE
Confidence 46789999 7899999999999999999998743 2344567789999999999998 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
||||+ +++|.+++.......+++..++.++.|++.||+|||+++|+||||||+|||++.++.+++.||+....
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~------ 150 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS------ 150 (327)
T ss_pred EEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhc------
Confidence 99999 89999999765445689999999999999999999999999999999999999988888888764322
Q ss_pred ccccCCCCCCceEeeCCCccc-ccCCccccccCCccccchhhcC--CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTF-EHQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+.++|.... .........++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 151 ------------~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 151 ------------MINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ------------cccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 122221111 0111122356788999999976 4689999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=251.06 Aligned_cols=196 Identities=31% Similarity=0.519 Sum_probs=168.2
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+|.-.++||+|.||+||+|+++.+++.||+|.++..+ .......+||-+|+.+.|.|| +++++....++.+.
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhkni-----vrl~dvlhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI-----VRLHDVLHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcce-----eehhhhhccCceeE
Confidence 4677789999999999999999999999999987433 334678899999999999999 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+|+|||..+|..+..... ..+..+.++.++.|+++||.++|+++++|||+||+|+||+.+|.
T Consensus 78 lvfe~cdqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge----------------- 139 (292)
T KOG0662|consen 78 LVFEFCDQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE----------------- 139 (292)
T ss_pred EeHHHhhHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc-----------------
Confidence 999999999999998765 46899999999999999999999999999999999999976554
Q ss_pred ccccCCCCCCceEeeCCCcccccCCc---cccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHh-cCCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELC-SVSNCYLTP 321 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~-tg~~pf~~~ 321 (323)
+|++|||+++...-.. +..+-|.+|.+|.++.|. -|++..|+||.|||+.|+. .|++.|+|.
T Consensus 140 ----------lkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~ 206 (292)
T KOG0662|consen 140 ----------LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_pred ----------EEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence 5666666665443332 224679999999999986 4899999999999999998 588888763
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=270.20 Aligned_cols=196 Identities=30% Similarity=0.496 Sum_probs=167.4
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc--chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~--~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
+|++.++||+|+||.||++.+..+++.+|+|.++. .....+.+..|+.+++.++|+|+ +++.+.+..++.+++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI-----VAFKESFEADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEEECCEEEE
Confidence 48999999999999999999999999999998853 23345667789999999999998 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+|||+ +++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++.++.++
T Consensus 76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~--------------- 140 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVK--------------- 140 (255)
T ss_pred EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEE---------------
Confidence 99999 88999998765555689999999999999999999999999999999999997666554
Q ss_pred ccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++|||.+...... .....|++.|+|||++.+..++.++|+||||+++|+|++|..||..
T Consensus 141 ------------l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 202 (255)
T cd08219 141 ------------LGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202 (255)
T ss_pred ------------EcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC
Confidence 4555544332211 1234688999999999998899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=276.58 Aligned_cols=194 Identities=26% Similarity=0.417 Sum_probs=166.2
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
+|++.++||+|+||.||++.+..++..+|+|.+... ......+.+|++++++++|+|+ +++++.+..++.+++
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~l 76 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI-----VGFYGAFYSDGEISI 76 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEeeCCEEEE
Confidence 599999999999999999999999999999988643 2344567889999999999998 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
||||+ +++|.+++.+.. .+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++++
T Consensus 77 v~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~------------ 142 (308)
T cd06615 77 CMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC------------ 142 (308)
T ss_pred EeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEc------------
Confidence 99999 889999998764 68999999999999999999997 699999999999999776655554
Q ss_pred CccccCCCCCCceEeeCCCcccccC-CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
|||.+..... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 143 ---------------dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 143 ---------------DFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred ---------------cCCCcccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 4444432211 12234788999999999888899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=284.49 Aligned_cols=195 Identities=28% Similarity=0.446 Sum_probs=161.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEec---cchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~---~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
..|+++++||+||.+.||++.... .+.||+|.+. .+.....-+..|+..|.+|+.+ ..++++++|--.++++
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~----~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGH----DKIIQLYDYEVTDGYL 435 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCC----ceEEEEeeeeccCceE
Confidence 469999999999999999998644 4456666553 3345566788999999999843 3459999998889999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
|||||+-..+|..+|++... .++.-.++.+..||+.|+.++|++||||.||||.|+|+.
T Consensus 436 YmvmE~Gd~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-------------------- 494 (677)
T KOG0596|consen 436 YMVMECGDIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-------------------- 494 (677)
T ss_pred EEEeecccccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE--------------------
Confidence 99999989999999998763 344348899999999999999999999999999999984
Q ss_pred CccccCCCCCCceEeeCCCcccccCCccc-----cccCCccccchhhcCCC-----------CCcchhHHHHHHHHHHHh
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSY-----VVSTRHYRAPEVILGLG-----------WNYPCDLWSVGCILVELC 312 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~gt~~y~aPE~~~~~~-----------~~~~~DiwSlG~il~el~ 312 (323)
.+.+||+|||.|.......+. .+||+.||+||.+.... .+.++||||||||||+|+
T Consensus 495 --------kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMv 566 (677)
T KOG0596|consen 495 --------KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMV 566 (677)
T ss_pred --------eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHH
Confidence 356899999998876655433 48999999999996432 558899999999999999
Q ss_pred cCCCCCCC
Q 020652 313 SVSNCYLT 320 (323)
Q Consensus 313 tg~~pf~~ 320 (323)
.|+.||..
T Consensus 567 YgktPf~~ 574 (677)
T KOG0596|consen 567 YGKTPFGQ 574 (677)
T ss_pred hcCCchHH
Confidence 99999963
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=273.98 Aligned_cols=199 Identities=24% Similarity=0.422 Sum_probs=165.1
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceecc----
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY---- 164 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~---- 164 (323)
..++|++.+.||+|+||.||+|.+..+++.||+|++.........+..|+.+++++ .|+|+ +++.+.+..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~~~~~~~~~~ 78 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI-----ATYYGAFIKKNPP 78 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCe-----eeEeeEEeecCCC
Confidence 34679999999999999999999999999999999876555556788899999998 58887 888887654
Q ss_pred --CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 165 --RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 165 --~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
...+|++|||+ +++|.+++.......+++..+..++.|++.||.|||+++|+||||||+||+++.++.+
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~-------- 150 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV-------- 150 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCE--------
Confidence 34689999999 8899999987554578999999999999999999999999999999999999765544
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcC-----CCCCcchhHHHHHHHHHHHhc
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCS 313 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~t 313 (323)
+|+|||++..... ......|+..|+|||++.+ ..++.++|||||||++|||++
T Consensus 151 -------------------~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~ 211 (272)
T cd06637 151 -------------------KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 211 (272)
T ss_pred -------------------EEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHh
Confidence 5555555543221 1223468999999999863 358889999999999999999
Q ss_pred CCCCCCC
Q 020652 314 VSNCYLT 320 (323)
Q Consensus 314 g~~pf~~ 320 (323)
|..||..
T Consensus 212 g~~p~~~ 218 (272)
T cd06637 212 GAPPLCD 218 (272)
T ss_pred CCCCccc
Confidence 9999854
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=273.52 Aligned_cols=190 Identities=25% Similarity=0.396 Sum_probs=162.4
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
+|++++.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.++++++|+|+ +++++.+...+..++
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~l 76 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI-----IGFYGAFFVENRISI 76 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEEECCEEEE
Confidence 588999999999999999999999999999988643 3344568889999999999988 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
||||+ +++|..+. .+++..+..++.|++.||+|||++||+|+||||+||+++.++.
T Consensus 77 v~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~----------------- 133 (279)
T cd06619 77 CTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ----------------- 133 (279)
T ss_pred EEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC-----------------
Confidence 99999 78876542 4789999999999999999999999999999999999976554
Q ss_pred ccccCCCCCCceEeeCCCcccccC-CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++|+|||++..... ......||..|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 134 ----------~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 134 ----------VKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred ----------EEEeeCCcceecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 45666665543222 12335789999999999998999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=269.62 Aligned_cols=200 Identities=21% Similarity=0.400 Sum_probs=168.0
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
.++|.++++||+|+|++|.+++.++|.+.||+|++++. ++.-+..+.|..+..+..+ ++.+|-++.+|++..
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn----~pflvglhscfqtes 324 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN----NPFLVGLHSCFQTES 324 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccC----CCeEEehhhhhcccc
Confidence 35799999999999999999999999999999998742 2233344556666655432 244599999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.+++|.||. ||+|.-.++++. .++++.++.+..+|+.||.|||++|||.||||.+|+|++..|++|+.|+|.+++..
T Consensus 325 rlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred eEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 999999999 999988887764 79999999999999999999999999999999999999887777666666554433
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.++ ...++++|||.|.|||++.|..|+..+|+|+|||+++||+.|+.||+-
T Consensus 403 ~~g------------------------d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 403 GPG------------------------DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CCC------------------------cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 322 234567999999999999999999999999999999999999999973
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=276.28 Aligned_cols=224 Identities=21% Similarity=0.367 Sum_probs=176.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+..|+++++.+.|+|+ +++++.+.....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFL-----PTLYASFQTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCc-----hhheeeeecCCE
Confidence 36999999999999999999999999999999886432 234567789999999999988 888999988999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.|+||||+ +++|.+++.+.....+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+++.|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999 88999999876556799999999999999999999999999999999999999999999999998665433
Q ss_pred CCCccccCCCCCCce--EeeCCCc---ccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIK--LIDFGST---TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~k--l~Dfg~a---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
............... ....... ...........||..|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 222110000000000 0000000 0011112235789999999999998899999999999999999999999965
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=270.71 Aligned_cols=196 Identities=22% Similarity=0.359 Sum_probs=164.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
++|++.++||+|+||.||+|.+. ++..||+|.+.......+.+.+|+.+++.++|+|+ +++++.+...+..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv 79 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKL-----VRLYAVVTKEEPIYII 79 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCe-----eeEEEEEcCCCCcEEE
Confidence 57999999999999999999865 55679999887655556778899999999999988 8899988888999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||+ +++|.+++.......+++..+..++.|++.||+|||+++++||||||+||+++.++.++++|||
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg----------- 148 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFG----------- 148 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCc-----------
Confidence 9999 8999999987655578999999999999999999999999999999999999776655555554
Q ss_pred cccCCCCCCceEeeCCCcccccCCc----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
.+....... ....++..|+|||++.+..++.++|||||||++|+|+| |..||.+
T Consensus 149 ----------------~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 149 ----------------LARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred ----------------cceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 443322111 11235668999999998889999999999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=274.28 Aligned_cols=198 Identities=30% Similarity=0.508 Sum_probs=163.0
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+|++.+.||+|+||.||+|.+..+|+.||+|.+.... .....+.+|+.+++.++|+|+ +++++++...+..+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i-----~~~~~~~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI-----VRLYDVLHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCe-----eeHHHHhccCCceE
Confidence 5899999999999999999999999999999886432 223456789999999999988 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
++|||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++++|||++......
T Consensus 76 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~-- 152 (284)
T cd07839 76 LVFEYCDQDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-- 152 (284)
T ss_pred EEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--
Confidence 999999889999887643 36899999999999999999999999999999999999987766655555543221100
Q ss_pred ccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
........++..|+|||++.+. .++.++|||||||++|||+||..||..
T Consensus 153 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 153 ----------------------VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred ----------------------CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 0011123568899999998775 478999999999999999999988643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=266.15 Aligned_cols=197 Identities=27% Similarity=0.429 Sum_probs=168.1
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
.|.+.+.||+|++|.||+|.+..+++.|++|.+... ....+.+..|+++++.++|+|+ +++++.+...+..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI-----IRYYESFLDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCe-----ehheeeeccCCEEE
Confidence 388899999999999999999999999999988632 3455678889999999999998 88999999889999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++.++.++++|||
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~--------- 146 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLG--------- 146 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccc---------
Confidence 999999 8999999987644579999999999999999999999999999999999999876655555554
Q ss_pred CccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
.+...... .....|++.|+|||++.+..++.++|+|||||++|||++|+.||...
T Consensus 147 ------------------~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 204 (256)
T cd08529 147 ------------------VAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN 204 (256)
T ss_pred ------------------cceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 43322111 12246788999999999988999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=272.03 Aligned_cols=200 Identities=29% Similarity=0.487 Sum_probs=164.3
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+|++.+.||+|++|.||+|++..+++.||+|++.... ...+.+.+|+.+++.+.|+|+ +++++++..++..|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI-----VCLQDVLMQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCE-----eeeEEEEeeCCeEE
Confidence 4889999999999999999999999999999886432 233567789999999999988 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKLGPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+.++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++++|||++......
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 154 (285)
T cd07861 76 LIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP- 154 (285)
T ss_pred EEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC-
Confidence 999999879999887533 246899999999999999999999999999999999999987776666666543221100
Q ss_pred CccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
........+++.|+|||++.+. .++.++|||||||++|||+||+.||.+.
T Consensus 155 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 155 -----------------------VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred -----------------------cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 0001123568899999998764 5789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=291.19 Aligned_cols=196 Identities=29% Similarity=0.427 Sum_probs=171.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
.+++++..||-|+||.|-++........+|+|++++. .+..+....|-.||...+.+.| |++|..|.+..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fI-----vrLYrTfrd~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFI-----VRLYRTFRDSKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHH-----HHHHHHhccchh
Confidence 4577788999999999999987776667899988753 3555677789999999887777 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|++||-| ||.|+..+++.+ .|.+.+++.++..++.|++|||++|||.|||||+|+|++.+|.+
T Consensus 495 vYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~------------- 559 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYL------------- 559 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCce-------------
Confidence 99999999 999999999887 79999999999999999999999999999999999999887766
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
||.|||.|+..... .-++||||.|.|||++.+.+.+.++|.||||+++|||++|++||.++
T Consensus 560 --------------KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 560 --------------KLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred --------------EEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 55555555544333 23479999999999999999999999999999999999999999986
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=280.63 Aligned_cols=203 Identities=30% Similarity=0.500 Sum_probs=166.2
Q ss_pred eeEecCc---eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcce
Q 020652 82 YVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRC 155 (323)
Q Consensus 82 ~~~~~~~---~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~ 155 (323)
+.+.+++ .+.++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++|+|+
T Consensus 3 ~~~~~~~~~~~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i----- 77 (353)
T cd07850 3 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNI----- 77 (353)
T ss_pred eeecccchhhhhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCC-----
Confidence 3444444 4568899999999999999999999999999999988632 2334556789999999999998
Q ss_pred EEEcceeccC------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEee
Q 020652 156 VQIRNWFDYR------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (323)
Q Consensus 156 ~~~~~~~~~~------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~ 229 (323)
+++++++... ...|+||||+.++|.+.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.
T Consensus 78 v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~ 153 (353)
T cd07850 78 IGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 153 (353)
T ss_pred cceeeeeccCCCccccCcEEEEEeccCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECC
Confidence 7777766432 46799999998899998864 3889999999999999999999999999999999999976
Q ss_pred cCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCCcchhHHHHHHH
Q 020652 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 307 (323)
Q Consensus 230 ~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 307 (323)
++.+ ||+|||.+....... ....||..|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~---------------------------kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~ 206 (353)
T cd07850 154 DCTL---------------------------KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCI 206 (353)
T ss_pred CCCE---------------------------EEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHH
Confidence 5554 555555554332211 22367889999999999999999999999999
Q ss_pred HHHHhcCCCCCCC
Q 020652 308 LVELCSVSNCYLT 320 (323)
Q Consensus 308 l~el~tg~~pf~~ 320 (323)
+|+|++|+.||.+
T Consensus 207 l~~l~~g~~pf~~ 219 (353)
T cd07850 207 MGEMIRGTVLFPG 219 (353)
T ss_pred HHHHHHCCCCCCC
Confidence 9999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=285.71 Aligned_cols=198 Identities=25% Similarity=0.335 Sum_probs=161.8
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCC-----CcEEEEEEeccc--hhhHHHHHHHHHHHHHHH-hCCCCCcceEEEccee
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSI--NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWF 162 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~ 162 (323)
.++|++.++||+|+||.||+|.+... +..||||++... ....+.+.+|+.+++++. |+|| +++++++
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnI-----v~l~~~~ 110 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNI-----VNLLGAC 110 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCe-----eeEEEEE
Confidence 45789999999999999999987543 346999998643 234567889999999996 9888 9999999
Q ss_pred ccCceEEEEEccC-CCCHHHHHHhcC------------------------------------------------------
Q 020652 163 DYRNHICIVFEKL-GPSLYDFLRKNS------------------------------------------------------ 187 (323)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~------------------------------------------------------ 187 (323)
...+.+|+||||| +++|.+++.+..
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 9999999999999 999999986531
Q ss_pred ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 020652 188 ----------------------------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227 (323)
Q Consensus 188 ----------------------------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli 227 (323)
...+++..+..++.|++.||+|||+++|+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 1247788889999999999999999999999999999999
Q ss_pred eecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHH
Q 020652 228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLW 302 (323)
Q Consensus 228 ~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Diw 302 (323)
+.++.+ ||+|||++...... .....++..|+|||++.+..++.++|||
T Consensus 271 ~~~~~~---------------------------kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 323 (400)
T cd05105 271 AQGKIV---------------------------KICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVW 323 (400)
T ss_pred eCCCEE---------------------------EEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHH
Confidence 766555 55555554432111 1123567889999999998999999999
Q ss_pred HHHHHHHHHhc-CCCCCCC
Q 020652 303 SVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 303 SlG~il~el~t-g~~pf~~ 320 (323)
||||++|||++ |..||..
T Consensus 324 SlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 324 SYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred HHHHHHHHHHHCCCCCCcc
Confidence 99999999997 9999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=269.54 Aligned_cols=201 Identities=26% Similarity=0.515 Sum_probs=170.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCC----cEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~----~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
..|+++.+||+|.||.||+|....++ +.+|||.++... .....+.+|+.+++.+.|+|+ +.+..+|-.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nv-----i~Lv~Vfl~ 98 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNV-----ISLVKVFLS 98 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcc-----hhHHHHHhc
Confidence 46999999999999999999655543 378999887432 334678899999999999999 777777765
Q ss_pred -CceEEEEEccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 165 -RNHICIVFEKLGPSLYDFLRKN---SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 165 -~~~~~lv~e~~~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
+..+++++||...+|+..|+-. ..+.++...++.|+.||+.|+.|||++=|+||||||.|||+..+|
T Consensus 99 ~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdg--------- 169 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDG--------- 169 (438)
T ss_pred cCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccC---------
Confidence 7889999999999999998732 224689999999999999999999999999999999999998764
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCcccccCCc------cccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhc
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCS 313 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~t 313 (323)
+..+.+||+|||+++...... ..++-|.+|.|||.+.|. .|+.+.||||.|||+.||+|
T Consensus 170 --------------perG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt 235 (438)
T KOG0666|consen 170 --------------PERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT 235 (438)
T ss_pred --------------CccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc
Confidence 456778888888887655443 235779999999999987 58999999999999999999
Q ss_pred CCCCCCC
Q 020652 314 VSNCYLT 320 (323)
Q Consensus 314 g~~pf~~ 320 (323)
-++.|.+
T Consensus 236 l~PlF~g 242 (438)
T KOG0666|consen 236 LEPLFKG 242 (438)
T ss_pred cCccccc
Confidence 9999976
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=274.76 Aligned_cols=187 Identities=14% Similarity=0.151 Sum_probs=156.4
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccchhh----HHHHHHHHHHHHHHHhCCCCCcceEEEcceecc----CceEE
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY----REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----RNHIC 169 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~----~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~----~~~~~ 169 (323)
..||+|++|.||+|.+ +++.||||+++..... .+.+.+|+.+|++++|+|| +++++++.. ...++
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-----v~~~g~~~~~~~~~~~~~ 98 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNI-----LKIYGFIIDIVDDLPRLS 98 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCE-----EEEeeeEEecccCCCceE
Confidence 5789999999999976 6889999998754322 3567799999999999988 999998765 45789
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
+||||+ +|+|.+++.+.. .+++.....++.|++.||.|||+ .+++||||||+|||++.++.+
T Consensus 99 lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~-------------- 162 (283)
T PHA02988 99 LILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKL-------------- 162 (283)
T ss_pred EEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcE--------------
Confidence 999999 899999998754 68999999999999999999998 599999999999999766554
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC--CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++...........||..|+|||++.+ ..++.++|||||||++|||++|+.||.+
T Consensus 163 -------------kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~ 224 (283)
T PHA02988 163 -------------KIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224 (283)
T ss_pred -------------EEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC
Confidence 55555555443333333468899999999976 6799999999999999999999999975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=250.58 Aligned_cols=198 Identities=23% Similarity=0.414 Sum_probs=158.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc--chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~--~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+....+..||+|++|.|-+.++..+|+..|+|.+.. .++......+|+.+..+.. .++..|.+++.+.....+|
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~----~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTV----DCPFTVHFYGALFREGDVW 121 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCC----CCCeEEEeehhhhccccEE
Confidence 345567899999999999999999999999998873 3344455666776654432 3356699999888888999
Q ss_pred EEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 170 IVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 170 lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+.||.+..+|..+.++ ..+..++|..+-+|+..++.||.|||++ .|||||+||+||||+.+|.
T Consensus 122 IcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq-------------- 187 (282)
T KOG0984|consen 122 ICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ-------------- 187 (282)
T ss_pred EeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc--------------
Confidence 9999999898887652 2235799999999999999999999975 8999999999999976665
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccc--cccCCccccchhhcC----CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILG----LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+||||.+.+..+.... -.|...|||||.+.. ..|+.++||||||++++||++++.||..
T Consensus 188 -------------VKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 188 -------------VKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred -------------EEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 466666666654443322 368889999999864 3799999999999999999999999875
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=257.68 Aligned_cols=200 Identities=24% Similarity=0.284 Sum_probs=164.9
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec-----c
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD-----Y 164 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~-----~ 164 (323)
.+||++.+.||+|||+.||+++...+++.||+|++.... +..+..++|++..++++|+|+ ++++++.- .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~v-----l~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNV-----LRLVDHQLREEKDG 94 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcch-----HHHHHHHHHhhccC
Confidence 368999999999999999999999999999999887544 667888999999999999988 66666543 2
Q ss_pred CceEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEeecCceeccCcc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~--iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
....||+++|. .|+|.+.+... .+..+++.++..|+.+|++||++||+.. ..||||||.|||+.+.
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~--------- 165 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS--------- 165 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC---------
Confidence 44699999999 99999998743 3346999999999999999999999998 9999999999998654
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCC------------ccccccCCccccchhhcCC---CCCcchhHHHH
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------------HSYVVSTRHYRAPEVILGL---GWNYPCDLWSV 304 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------------~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSl 304 (323)
+.++|.|||++....-. ......|..|.|||.+.-. ..+.++|||||
T Consensus 166 ------------------~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSL 227 (302)
T KOG2345|consen 166 ------------------GLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSL 227 (302)
T ss_pred ------------------CceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhh
Confidence 34577777776542111 1112468899999998654 46799999999
Q ss_pred HHHHHHHhcCCCCCCCCC
Q 020652 305 GCILVELCSVSNCYLTPF 322 (323)
Q Consensus 305 G~il~el~tg~~pf~~~~ 322 (323)
||+||+|+.|..||..-|
T Consensus 228 GCtLYa~mf~~sPfe~~~ 245 (302)
T KOG2345|consen 228 GCTLYAMMFGESPFERIY 245 (302)
T ss_pred hHHHHHHHHcCCcchHHh
Confidence 999999999999997544
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=273.01 Aligned_cols=196 Identities=28% Similarity=0.430 Sum_probs=166.2
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
..+|++.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.+++.+.|+|+ +++.+.+..+.+.|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v-----~~~~~~~~~~~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI-----VNYLDSYLVGDELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCE-----eeEEEEEEeCCEEE
Confidence 368999999999999999999999999999999886432 334567789999999999988 99999998889999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~--------------- 155 (296)
T cd06654 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSV--------------- 155 (296)
T ss_pred EeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCE---------------
Confidence 999999 89999998754 48899999999999999999999999999999999999766555
Q ss_pred CccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+|+|||.+...... .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 156 ------------kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~ 219 (296)
T cd06654 156 ------------KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (296)
T ss_pred ------------EECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 45555544322111 12246889999999999888999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=297.12 Aligned_cols=196 Identities=27% Similarity=0.497 Sum_probs=168.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEec-cchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~-~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
.+.|.++..||.|+||.||+|.++.++-..|.|++. +..+..++++.||+||..+.||+| +.+++.|...+.+|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~i-----vkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVI-----VKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHH-----HHHHHHHhccCceE
Confidence 356899999999999999999999999989999887 445667889999999999999998 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
|+.||| ||-+..++...+ +.+.+.++..+++|++.||.|||+++|||||||..|||++-+|.+
T Consensus 106 iliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdi--------------- 169 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDI--------------- 169 (1187)
T ss_pred EEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcE---------------
Confidence 999999 666666666554 689999999999999999999999999999999999999877765
Q ss_pred CccccCCCCCCceEeeCCCcccc---cCCccccccCCccccchhhcC-----CCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
+|+|||.+... .+....+.|||+|||||++.. .+|+.++||||||++|.||+.+.+|-.
T Consensus 170 ------------rLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh 236 (1187)
T KOG0579|consen 170 ------------RLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH 236 (1187)
T ss_pred ------------eeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc
Confidence 55555554332 223456799999999999864 579999999999999999999999865
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=267.83 Aligned_cols=195 Identities=32% Similarity=0.474 Sum_probs=165.1
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch------hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
+.|++.+.||+|++|.||+|.+..+++.||+|.+.... .....+.+|+.++++++|+|+ +++++++...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI-----VQYYGCLRDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCe-----eeeEEEEccC
Confidence 46899999999999999999999999999999876321 123467789999999999988 9999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
...+++|||+ +++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.+++
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l--------- 145 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKL--------- 145 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEE---------
Confidence 9999999999 889999998764 6899999999999999999999999999999999999976665555
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCC------ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
+|||.+...... .....|+..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 146 ------------------~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~ 207 (263)
T cd06625 146 ------------------GDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPW 207 (263)
T ss_pred ------------------eecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence 455444322110 02245788999999999988999999999999999999999998
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
..
T Consensus 208 ~~ 209 (263)
T cd06625 208 AE 209 (263)
T ss_pred cc
Confidence 65
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=267.38 Aligned_cols=201 Identities=30% Similarity=0.475 Sum_probs=163.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc------hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc-
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~------~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~- 164 (323)
.+|++.+.||+|+||.||++.+..+++.||||.+... ....+.+.+|+.+++++.|+|+ +++++++..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~ 76 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERI-----VQYYGCLRDP 76 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCe-----eeEEeEeccC
Confidence 4699999999999999999999999999999987532 1234567789999999999988 888887765
Q ss_pred -CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
...++++|||+ +++|.+++.+.. .+++..+..++.|++.||+|||+++|+|+||||+||+++.++.++++|||+..
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 77 MERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred CCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 35688999999 889999998654 58899999999999999999999999999999999999877666666665433
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
...... ..........|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 155 ~~~~~~---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 155 RLQTIC---------------------LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred cccccc---------------------ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 211000 000111224588899999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=269.35 Aligned_cols=196 Identities=27% Similarity=0.373 Sum_probs=161.0
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
.++|++.++||+|+||.||+|.+..++ .||+|++.......+.+.+|+++++.+.|+|+ +++++.+.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i-----~~~~~~~~~-~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-----VQLYAVVSE-EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCHHHHHHHHHHHHhCCCCCc-----ceEEEEECC-CCcEE
Confidence 367999999999999999999887664 59999987644445678899999999999988 777776644 56899
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
||||+ +++|.+++.+.....+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++++||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~df----------- 146 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADF----------- 146 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccC-----------
Confidence 99999 889999998654456899999999999999999999999999999999999976665555555
Q ss_pred ccccCCCCCCceEeeCCCcccccCCc----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
|.+....... ....++..|+|||++.+..++.++|||||||++|||+| |..||.+
T Consensus 147 ----------------g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~ 206 (262)
T cd05071 147 ----------------GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206 (262)
T ss_pred ----------------CceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 4443222111 11245678999999988889999999999999999999 8888865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=269.52 Aligned_cols=196 Identities=27% Similarity=0.409 Sum_probs=163.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
..+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.++++++|+|+ +++++.+...+.++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----i~~~~~~~~~~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI-----VAYFGSYLSREKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCe-----eeeeEEEEeCCEEE
Confidence 357999999999999999999999999999999986432 334457789999999999998 89999998889999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+
T Consensus 83 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~--------------- 145 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDV--------------- 145 (267)
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCE---------------
Confidence 999999 789999987654 68999999999999999999999999999999999999766555
Q ss_pred CccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||++...... .....|+..|+|||.+. ...++.++|||||||++|||++|..||..
T Consensus 146 ------------~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~ 211 (267)
T cd06646 146 ------------KLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred ------------EECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 45555544332111 12346889999999985 34578899999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=276.70 Aligned_cols=195 Identities=22% Similarity=0.318 Sum_probs=159.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcE----EEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKEL----VAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~----vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+|++.+.||+|+||.||+|.+..+++. ||+|+++.. ....+.+..|+.+++.+.|+|+ +++++++...
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----v~~~g~~~~~ 81 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV-----CRLLGICLTS 81 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEcCC
Confidence 4699999999999999999988666553 899988642 3445678889999999999998 8888877664
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
..++++||+ +|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~Df------ 153 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDF------ 153 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccc------
Confidence 467899999 999999998754 35889999999999999999999999999999999999976665555554
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCcc-----ccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCY 318 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf 318 (323)
|++........ ...++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 154 ---------------------G~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~ 212 (316)
T cd05108 154 ---------------------GLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212 (316)
T ss_pred ---------------------cccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 44443221111 1134668999999999999999999999999999997 99999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 213 ~~ 214 (316)
T cd05108 213 DG 214 (316)
T ss_pred CC
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=267.67 Aligned_cols=197 Identities=23% Similarity=0.374 Sum_probs=164.7
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
.++|++.+.||+|+||.||+|.+.. ++.||+|.++......+.+.+|+.++++++|+|+ +++++++...+..++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~l 78 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKL-----IQLYAVCTLEEPIYI 78 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCc-----cceeEEEecCCCeee
Confidence 3579999999999999999998754 5679999987655556678899999999999988 888899988899999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+|||+ +++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||+
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~--------- 149 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGL--------- 149 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcce---------
Confidence 99999 99999999875545789999999999999999999999999999999999998766665555554
Q ss_pred ccccCCCCCCceEeeCCCcccccCCc-cc---cccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQDH-SY---VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~---~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
+....... .. ...+..|+|||++.+..++.++|||||||++|||+| |+.||.+
T Consensus 150 ------------------~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 207 (261)
T cd05068 150 ------------------ARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207 (261)
T ss_pred ------------------EEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 33221110 00 112357999999998899999999999999999999 9999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=271.69 Aligned_cols=200 Identities=29% Similarity=0.489 Sum_probs=164.1
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
++|++.+.||+|++|.||+|.+..+++.||||.+.... .....+.+|+.+++.++|+|+ +++++++...+..+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI-----VTLHDIIHTKKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcce-----eeEEEEEecCCeEE
Confidence 57999999999999999999999999999999886432 223446689999999999988 89999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+||||+.++|.+++.+.. ..+++..++.++.|++.||.|||+++|+||||||+||+++.++.++++|||++......
T Consensus 80 lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 156 (291)
T cd07844 80 LVFEYLDTDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP-- 156 (291)
T ss_pred EEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC--
Confidence 999999779999987654 36899999999999999999999999999999999999977666655555543211100
Q ss_pred ccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
........++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 157 ----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 157 ----------------------SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred ----------------------CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 000111246788999999876 45889999999999999999999999653
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=269.98 Aligned_cols=201 Identities=23% Similarity=0.318 Sum_probs=165.8
Q ss_pred CCcEEEEeeecccCcEEEEEEEECC-----CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+... ......+..|+.+++.++|+|+ +++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~ 79 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI-----VRLIGVSF 79 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEc
Confidence 3579999999999999999999877 7788999987633 2334567889999999999988 89999888
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccC
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNSY-----RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d 237 (323)
.....++||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++++||||||+||+++..+
T Consensus 80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~------ 153 (277)
T cd05036 80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG------ 153 (277)
T ss_pred cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC------
Confidence 888899999999 8999999976531 2588999999999999999999999999999999999997543
Q ss_pred cccccccCCCCCccccCCCCCCceEeeCCCcccccCCcc-----ccccCCccccchhhcCCCCCcchhHHHHHHHHHHHh
Q 020652 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 312 (323)
....+||+|||.+........ ...++..|+|||++.+..++.++|||||||++|||+
T Consensus 154 ------------------~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 215 (277)
T cd05036 154 ------------------PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIF 215 (277)
T ss_pred ------------------CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHH
Confidence 123457777777654322111 123356799999999889999999999999999999
Q ss_pred c-CCCCCCC
Q 020652 313 S-VSNCYLT 320 (323)
Q Consensus 313 t-g~~pf~~ 320 (323)
+ |..||.+
T Consensus 216 ~~g~~pf~~ 224 (277)
T cd05036 216 SLGYMPYPG 224 (277)
T ss_pred cCCCCCCCC
Confidence 7 9999975
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=264.09 Aligned_cols=196 Identities=25% Similarity=0.442 Sum_probs=163.8
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc-CceE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHI 168 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~-~~~~ 168 (323)
+|++.+.||+|++|.||++.+..+++.||+|.+... ....+.+.+|+.++++++|+|+ +.+.+.+.. ...+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI-----VAYRESWEGEDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCe-----eeeeeeecCCCCEE
Confidence 489999999999999999999999999999998642 2334567889999999999988 888777654 4578
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
+++|||+ +++|.+++.......+++.++..++.|++.||.+||++||+||||||+||+++.++.++
T Consensus 76 ~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~------------- 142 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIK------------- 142 (257)
T ss_pred EEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEE-------------
Confidence 9999999 88999999875545689999999999999999999999999999999999997666554
Q ss_pred CCccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
|+|||++..... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 143 --------------l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 204 (257)
T cd08223 143 --------------VGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA 204 (257)
T ss_pred --------------EecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 455554433211 11234688999999999998999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=271.91 Aligned_cols=195 Identities=25% Similarity=0.407 Sum_probs=163.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
++|++.+.||+|+||.||+|++..+++.||+|+++... .....+.+|+.+++.++|+|+ +++++.+...+.+++
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~i-----i~~~~~~~~~~~~~l 83 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNI-----VAYFGSYLRRDKLWI 83 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCe-----eeEEEEEEeCCEEEE
Confidence 47899999999999999999999999999999987432 233456789999999999988 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+|||+ +++|.+++...+ .+++.+++.++.|++.||.|||++||+|+||||+||+++.++.++++|||
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg---------- 151 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFG---------- 151 (267)
T ss_pred EEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcce----------
Confidence 99999 889999987665 69999999999999999999999999999999999999766655555554
Q ss_pred ccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+..... ......|+..|+|||++. ...++.++|+|||||++|||++|..||..
T Consensus 152 -----------------~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 152 -----------------VSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred -----------------eeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 4332211 112346899999999985 44688999999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=270.29 Aligned_cols=196 Identities=28% Similarity=0.479 Sum_probs=162.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++|+|+ +++.+++..+...|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~~~~~~~~~~~ 79 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANI-----VLLHDIIHTKETLT 79 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCE-----eEEEEEEecCCeEE
Confidence 57999999999999999999999999999999986432 223356789999999999988 89999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+||||++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.+
T Consensus 80 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~---------------- 142 (291)
T cd07870 80 FVFEYMHTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGEL---------------- 142 (291)
T ss_pred EEEecccCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcE----------------
Confidence 999999888888876543 357888999999999999999999999999999999999766555
Q ss_pred ccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+..... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 143 -----------~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 143 -----------KLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred -----------EEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 5555554433211 11223578899999998764 578899999999999999999999964
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=271.81 Aligned_cols=202 Identities=24% Similarity=0.338 Sum_probs=163.1
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCC-----cEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKK-----ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
++|++.+.||+|+||.||+|.+...+ +.||+|.+... ......+.+|+.+++.+.|+|+ +++++++..
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i-----~~~~~~~~~ 79 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI-----VCLLGVCTK 79 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCccc-----ceEEEEEcC
Confidence 46899999999999999999876555 67999988643 2345668899999999999998 899999888
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEee
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~ 229 (323)
....+++|||+ +++|.+++..... ..+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 88999999999 8999999976421 35788999999999999999999999999999999999977
Q ss_pred cCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHH
Q 020652 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (323)
Q Consensus 230 ~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (323)
++.++++|||++....... .........+++.|+|||.+.+..++.++|||||||++|
T Consensus 160 ~~~~~L~dfg~~~~~~~~~----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~ 217 (283)
T cd05048 160 GLTVKISDFGLSRDIYSAD----------------------YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLW 217 (283)
T ss_pred CCcEEECCCcceeeccccc----------------------cccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHH
Confidence 6655555555432111000 000111235678899999999889999999999999999
Q ss_pred HHhc-CCCCCCC
Q 020652 310 ELCS-VSNCYLT 320 (323)
Q Consensus 310 el~t-g~~pf~~ 320 (323)
||++ |..||.+
T Consensus 218 el~~~g~~p~~~ 229 (283)
T cd05048 218 EIFSYGLQPYYG 229 (283)
T ss_pred HHHcCCCCCCCC
Confidence 9998 9999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=266.97 Aligned_cols=197 Identities=29% Similarity=0.470 Sum_probs=165.1
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc----chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||.||+|++..+++.||||.+.. .......+..|+.+++.++|+|+ +++++++...+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNV-----IKYLDSFIEDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcce-----eeeeeeEEECCe
Confidence 469999999999999999999999999999998753 22334567889999999999988 899999988899
Q ss_pred EEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
.+++|||+ +++|.+++... ....+++..+..++.|++.||.|||+++|+|+||||+||+++.++.+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~----------- 145 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVV----------- 145 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCE-----------
Confidence 99999999 78999888632 22358999999999999999999999999999999999999766555
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCc---cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+....... ....|++.|+|||.+.+..++.++|+||||+++|||++|..||..
T Consensus 146 ----------------~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~ 208 (267)
T cd08228 146 ----------------KLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred ----------------EECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 555555444322111 124688899999999988899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=265.92 Aligned_cols=195 Identities=23% Similarity=0.336 Sum_probs=162.1
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
+.|++.+.||+|+||.||++... .+..+|+|.+.......+.+.+|+.+++.++|+|+ +++++++......++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKL-----VQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCc-----eeEEEEEccCCCEEEE
Confidence 35899999999999999999875 45579999887555455678889999999999998 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g----------- 145 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFG----------- 145 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCC-----------
Confidence 9999 899999987644 258999999999999999999999999999999999999776655555555
Q ss_pred cccCCCCCCceEeeCCCcccccCCc----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
.+....... ....++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 146 ----------------~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~ 204 (256)
T cd05114 146 ----------------MTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204 (256)
T ss_pred ----------------CccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence 433221110 11234567999999998889999999999999999999 9999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=264.37 Aligned_cols=196 Identities=29% Similarity=0.479 Sum_probs=168.2
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+|++++.||+|+||.||.+++..+++.+++|.+... ......+.+|++++++++|+|+ +++++++...+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI-----IAYYNHFMDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCe-----eEEEeEEecCCeEE
Confidence 599999999999999999999999999999987632 3445567899999999999988 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
++|||+ +++|.+++.+.....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+|++|||+
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~-------- 147 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGI-------- 147 (256)
T ss_pred EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcc--------
Confidence 999999 89999999876445789999999999999999999999999999999999998766665555554
Q ss_pred CccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+...... .....|++.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 148 -------------------~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08221 148 -------------------SKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203 (256)
T ss_pred -------------------eEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence 3322111 1234689999999999988889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=266.73 Aligned_cols=197 Identities=25% Similarity=0.394 Sum_probs=163.2
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
..++|+++++||+|+||.||+|.+. +++.||+|.+.......+.+.+|+.++++++|+|+ +++++++. .+..+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~-~~~~~ 76 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRL-----VRLYAVVT-QEPIY 76 (260)
T ss_pred chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCe-----eeEEEEEc-cCCcE
Confidence 4567999999999999999999864 56779999988655556678899999999999988 77877764 45689
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
++|||+ +++|.+++.......+++..+..++.|++.||+|||++|++||||||+||+++.++.++++||
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~df---------- 146 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADF---------- 146 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccC----------
Confidence 999999 899999998765567899999999999999999999999999999999999976665555555
Q ss_pred CccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
|.+...... .....++..|+|||++.+..++.++|||||||++|||++ |+.||.+
T Consensus 147 -----------------g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 206 (260)
T cd05067 147 -----------------GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206 (260)
T ss_pred -----------------cceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 444332211 111245678999999998889999999999999999999 9999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=273.11 Aligned_cols=197 Identities=22% Similarity=0.308 Sum_probs=159.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcE--EEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKEL--VAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~--vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~ 166 (323)
++|++.+.||+|+||.||+|.+..++.. +|+|.++.. ......+.+|+.++.++ .|+|+ +++++++..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~i-----v~~~~~~~~~~ 81 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI-----INLLGACEHRG 81 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCc-----ceEEEEECCCC
Confidence 4699999999999999999998877754 577766532 23445678899999999 78888 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~ 231 (323)
.+++||||+ +++|.+++.+.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 999999999 899999997542 12578999999999999999999999999999999999997665
Q ss_pred ceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCCcchhHHHHHHHHH
Q 020652 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (323)
Q Consensus 232 ~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (323)
.++ |+|||++....... ....++..|+|||++.+..++.++|||||||++|
T Consensus 162 ~~k---------------------------l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 214 (303)
T cd05088 162 VAK---------------------------IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 214 (303)
T ss_pred cEE---------------------------eCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHH
Confidence 554 45555443211111 1112356799999998888999999999999999
Q ss_pred HHhc-CCCCCCC
Q 020652 310 ELCS-VSNCYLT 320 (323)
Q Consensus 310 el~t-g~~pf~~ 320 (323)
||+| |..||.+
T Consensus 215 ellt~g~~p~~~ 226 (303)
T cd05088 215 EIVSLGGTPYCG 226 (303)
T ss_pred HHHhcCCCCccc
Confidence 9998 9999864
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=264.24 Aligned_cols=196 Identities=29% Similarity=0.446 Sum_probs=166.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
++|++.+.||+|+||.||+|.+..+++.+|+|++.... ...+.+.+|+.+++.++|+|+ +++++.+...+.+|+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~~l 77 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI-----VAYFGSYLRRDKLWI 77 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCCh-----hceEEEEEeCCEEEE
Confidence 57999999999999999999999999999999987432 345678899999999999998 889999998999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+|||+ +++|.+++.... ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++++
T Consensus 78 ~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~------------- 143 (262)
T cd06613 78 VMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLA------------- 143 (262)
T ss_pred EEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEEC-------------
Confidence 99999 789999987652 369999999999999999999999999999999999999766655554
Q ss_pred ccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCC---CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
|||.+..... ......++..|+|||.+.+. .++.++|+|||||++|||++|..||..
T Consensus 144 --------------d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~ 206 (262)
T cd06613 144 --------------DFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206 (262)
T ss_pred --------------ccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 5544432221 11234688899999999877 789999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=269.07 Aligned_cols=198 Identities=25% Similarity=0.443 Sum_probs=164.9
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceec------
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD------ 163 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~------ 163 (323)
.+.|++.+.||+|+||.||+|.+..+++.+|+|++.........+..|+.+++++ .|+|+ +++++++.
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~~~~~~~~~~~ 89 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNI-----ATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcE-----EEEeeehhcccccC
Confidence 3679999999999999999999999999999999876655556788899999998 57877 88888874
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
....+|++|||+ +++|.+++.......+++..+..++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~---------- 159 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE---------- 159 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC----------
Confidence 346789999999 789999998755556899999999999999999999999999999999999976554
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhc-----CCCCCcchhHHHHHHHHHHHhcC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSV 314 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg 314 (323)
++|+|||.+..... ......|+..|+|||++. +..++.++|||||||++|||++|
T Consensus 160 -----------------~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g 222 (282)
T cd06636 160 -----------------VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222 (282)
T ss_pred -----------------EEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhC
Confidence 46666665543221 122346899999999986 34578899999999999999999
Q ss_pred CCCCCC
Q 020652 315 SNCYLT 320 (323)
Q Consensus 315 ~~pf~~ 320 (323)
..||..
T Consensus 223 ~~p~~~ 228 (282)
T cd06636 223 APPLCD 228 (282)
T ss_pred CCCccc
Confidence 999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=267.04 Aligned_cols=205 Identities=25% Similarity=0.418 Sum_probs=165.7
Q ss_pred EecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceEEEccee
Q 020652 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 84 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~ 162 (323)
+.......++|++.+.||+|+||.||+|.+..+++.+|+|++.......+.+..|+.+++.+ +|+|+ +++++++
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~~~~~~ 84 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV-----VKFYGMY 84 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCe-----eeeeeee
Confidence 33344566889999999999999999999999999999998875444456678899999999 58888 8888876
Q ss_pred -----ccCceEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCcee
Q 020652 163 -----DYRNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (323)
Q Consensus 163 -----~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~k 234 (323)
..++..++||||+ +++|.+++... ....+++..+..++.|++.||.|||+++|+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~- 163 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGV- 163 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCE-
Confidence 3456799999999 89999987632 22468899999999999999999999999999999999999766554
Q ss_pred ccCcccccccCCCCCccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcC-----CCCCcchhHHHHHH
Q 020652 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGC 306 (323)
Q Consensus 235 i~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~ 306 (323)
+|+|||.+..... ......|++.|+|||++.. ..++.++|||||||
T Consensus 164 --------------------------kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv 217 (286)
T cd06638 164 --------------------------KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGI 217 (286)
T ss_pred --------------------------EEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHH
Confidence 5555555433221 1123468999999999853 35788999999999
Q ss_pred HHHHHhcCCCCCCC
Q 020652 307 ILVELCSVSNCYLT 320 (323)
Q Consensus 307 il~el~tg~~pf~~ 320 (323)
++|||++|+.||..
T Consensus 218 i~~el~~g~~p~~~ 231 (286)
T cd06638 218 TAIELGDGDPPLAD 231 (286)
T ss_pred HHHHHhcCCCCCCC
Confidence 99999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=270.75 Aligned_cols=196 Identities=27% Similarity=0.408 Sum_probs=166.8
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
...+|++.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+.+|+.+++.++|+|+ +++++.+..+...
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~ 91 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI-----VNYLDSYLVGDEL 91 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCE-----eeEEEEEecCCEE
Confidence 3468999999999999999999999999999999886432 334567789999999999988 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||||+ +++|.+++.+. .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++++|||
T Consensus 92 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg-------- 160 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG-------- 160 (297)
T ss_pred EEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCc--------
Confidence 9999999 89999998764 48999999999999999999999999999999999999776655555555
Q ss_pred CCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+...... .....|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+
T Consensus 161 -------------------~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 161 -------------------FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred -------------------cceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 43322111 1224678899999999998899999999999999999999999965
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=271.26 Aligned_cols=213 Identities=19% Similarity=0.234 Sum_probs=148.5
Q ss_pred CceeCCcEEEEeeecccCcEEEEEEEECCC---CcEEEEEEeccchhh--HHHH-------HHHHHHHHHHHhCCCCCcc
Q 020652 87 GENLTPRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSINKY--REAA-------MIEIDVLQRLARHDIGGTR 154 (323)
Q Consensus 87 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAiK~~~~~~~~--~~~~-------~~Ei~~l~~l~~~~i~~~~ 154 (323)
.+...++|++.++||+|+||+||+|.+..+ +..+|+|+....... .+.. ..++..+.. ..++.+.+
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~--~~~~~h~~ 84 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN--IHNIDHLG 84 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHH--hccCCCCC
Confidence 345567899999999999999999998877 677888865422211 0000 011111111 12233344
Q ss_pred eEEEcceeccC----ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeec
Q 020652 155 CVQIRNWFDYR----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230 (323)
Q Consensus 155 ~~~~~~~~~~~----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~ 230 (323)
++.+++..... ...+++||++..++.+.+.... ..++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 85 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 85 IPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN 162 (294)
T ss_pred CCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 47776654332 2457889988778888776543 46888999999999999999999999999999999999766
Q ss_pred CceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHH
Q 020652 231 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310 (323)
Q Consensus 231 ~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 310 (323)
+.++++|||++.....++... ...........||+.|+|||++.+..++.++|||||||++||
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~-----------------~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~e 225 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHI-----------------EYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225 (294)
T ss_pred CcEEEEEcCCceeeccCCccc-----------------ccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 655555555433222111000 000011122469999999999999999999999999999999
Q ss_pred HhcCCCCCCC
Q 020652 311 LCSVSNCYLT 320 (323)
Q Consensus 311 l~tg~~pf~~ 320 (323)
|++|+.||.+
T Consensus 226 l~~g~~P~~~ 235 (294)
T PHA02882 226 WAGIKLPWKG 235 (294)
T ss_pred HHhCCCCCCc
Confidence 9999999975
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=272.70 Aligned_cols=200 Identities=28% Similarity=0.511 Sum_probs=162.8
Q ss_pred cEEEEeeecccCcEEEEEEEECC--CCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC-
Q 020652 93 RYRILSKMGEGTFGQVVECFDNE--KKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR- 165 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~--~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~- 165 (323)
+|++.++||+|+||.||+|.+.. +++.||+|.+... ....+...+|+.+++.++|+|+ +++++++...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENV-----VSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCc-----cceEEEEeCCC
Confidence 58999999999999999999988 8999999998752 2334567789999999999998 8888988877
Q ss_pred -ceEEEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 166 -NHICIVFEKLGPSLYDFLRKNS---YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 166 -~~~~lv~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
..+++||||++++|.+++.... ...+++..++.++.|++.||.|||+++|+||||||+||+++.++
T Consensus 76 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~---------- 145 (316)
T cd07842 76 DKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEG---------- 145 (316)
T ss_pred CceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCC----------
Confidence 7899999999888888876332 12689999999999999999999999999999999999998711
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccCC------ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSV 314 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg 314 (323)
+..+.+||+|||++...... .....+|..|+|||++.+. .++.++|||||||++|||++|
T Consensus 146 -------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~ 212 (316)
T cd07842 146 -------------PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTL 212 (316)
T ss_pred -------------CccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhc
Confidence 11334455555554432211 1224678899999998764 578999999999999999999
Q ss_pred CCCCCC
Q 020652 315 SNCYLT 320 (323)
Q Consensus 315 ~~pf~~ 320 (323)
+.||.+
T Consensus 213 ~~~~~~ 218 (316)
T cd07842 213 EPIFKG 218 (316)
T ss_pred CCCCcC
Confidence 999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=270.40 Aligned_cols=197 Identities=25% Similarity=0.491 Sum_probs=163.7
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
.+.|+++++||+|+||.||+|++..+++.+|+|++.... ...+.+.+|+.+++.++|+|+ +++++.+..++..+
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 85 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYI-----VKLLGAFYWDGKLW 85 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcE-----eeeEEEEEeCCeEE
Confidence 356999999999999999999999999999999987433 345667889999999999988 99999988889999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|..++.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+||
T Consensus 86 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~df---------- 154 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADF---------- 154 (292)
T ss_pred EEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccC----------
Confidence 999999 888888876543 36899999999999999999999999999999999999976665555554
Q ss_pred CccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcC-----CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
|.+..... ......++..|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 155 -----------------g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 155 -----------------GVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred -----------------ccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 44332111 1123467889999999853 3478899999999999999999999854
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=270.82 Aligned_cols=202 Identities=21% Similarity=0.314 Sum_probs=163.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECC-----CCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
++|.+.+.||+|+||.||+|.+.. +++.||+|++.... ...+.+.+|+++++.+.|+|+ +++++++..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~ 79 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI-----VKFYGVCTE 79 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCc-----hheeeEEec
Confidence 468899999999999999998743 46789999987432 245678899999999999988 889999998
Q ss_pred CceEEEEEccC-CCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNS------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~ 231 (323)
....+++|||+ +++|.+++...+ ...+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~ 159 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL 159 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence 89999999999 999999997543 13578899999999999999999999999999999999998776
Q ss_pred ceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHH
Q 020652 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311 (323)
Q Consensus 232 ~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 311 (323)
.++++|||++....... .........++..|+|||++.+..++.++|||||||++|||
T Consensus 160 ~~kl~d~g~~~~~~~~~----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~ 217 (280)
T cd05049 160 VVKIGDFGMSRDVYTTD----------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217 (280)
T ss_pred eEEECCcccceecccCc----------------------ceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHH
Confidence 66555555432111000 00001122457789999999999999999999999999999
Q ss_pred hc-CCCCCCC
Q 020652 312 CS-VSNCYLT 320 (323)
Q Consensus 312 ~t-g~~pf~~ 320 (323)
++ |..||..
T Consensus 218 ~~~g~~p~~~ 227 (280)
T cd05049 218 FTYGKQPWYG 227 (280)
T ss_pred HhcCCCCCCC
Confidence 98 9999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=267.43 Aligned_cols=199 Identities=19% Similarity=0.314 Sum_probs=161.1
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECC-----CCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEccee
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~ 162 (323)
.+++|++.+.||+|+||.||+|.+.. ++..||+|++.... .....+.+|+.+++.++|+|+ +++++++
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----v~~~~~~ 78 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV-----VRLLGVV 78 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEE
Confidence 45789999999999999999998653 35679999876422 334567889999999999988 9999999
Q ss_pred ccCceEEEEEccC-CCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCce
Q 020652 163 DYRNHICIVFEKL-GPSLYDFLRKNSY--------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (323)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~--------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ 233 (323)
..+...++||||+ +++|.+++.+... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 79 SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred cCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence 9889999999999 8999999975321 235778889999999999999999999999999999999776655
Q ss_pred eccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCc-----cccccCCccccchhhcCCCCCcchhHHHHHHHH
Q 020652 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308 (323)
Q Consensus 234 ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 308 (323)
+++||| ++....... ....++..|+|||++.+..++.++|||||||++
T Consensus 159 ~l~dfg---------------------------~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 211 (277)
T cd05062 159 KIGDFG---------------------------MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 211 (277)
T ss_pred EECCCC---------------------------CccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHH
Confidence 555555 443221111 112457789999999988899999999999999
Q ss_pred HHHhc-CCCCCCC
Q 020652 309 VELCS-VSNCYLT 320 (323)
Q Consensus 309 ~el~t-g~~pf~~ 320 (323)
|||++ |..||.+
T Consensus 212 ~el~~~~~~p~~~ 224 (277)
T cd05062 212 WEIATLAEQPYQG 224 (277)
T ss_pred HHHHcCCCCCCCC
Confidence 99999 7888865
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=269.17 Aligned_cols=202 Identities=21% Similarity=0.326 Sum_probs=162.9
Q ss_pred CcEEEEeeecccCcEEEEEEEE-----CCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 92 PRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+|.+.+.||+|+||.||++.+ ..++..+|+|.+... ....+.+.+|+++++++.|+|+ +++++++...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~ 79 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI-----VKFYGVCVEG 79 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEecC
Confidence 4699999999999999999985 335567999988643 3445678899999999999998 8999999988
Q ss_pred ceEEEEEccC-CCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCce
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNS-----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ 233 (323)
+..++||||+ +++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 9999999999 899999997543 1248999999999999999999999999999999999999876666
Q ss_pred eccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc
Q 020652 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313 (323)
Q Consensus 234 ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t 313 (323)
+++|||++........ ........++..|+|||++.+..++.++|||||||++|||++
T Consensus 160 kl~dfg~~~~~~~~~~----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t 217 (288)
T cd05093 160 KIGDFGMSRDVYSTDY----------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217 (288)
T ss_pred EeccCCccccccCCce----------------------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 5555554322111000 000112345778999999999899999999999999999998
Q ss_pred -CCCCCCC
Q 020652 314 -VSNCYLT 320 (323)
Q Consensus 314 -g~~pf~~ 320 (323)
|..||.+
T Consensus 218 ~g~~p~~~ 225 (288)
T cd05093 218 YGKQPWYQ 225 (288)
T ss_pred CCCCCCCC
Confidence 9999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=269.23 Aligned_cols=195 Identities=28% Similarity=0.445 Sum_probs=166.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
.+|++.+.||.|+||.||+|.+..+++.||+|.+... ....+.+.+|+.+++.++|+|+ +.+++++...+.+++
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~l 93 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI-----VNFLDSFLVGDELFV 93 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCce-----eeeeeeEecCceEEE
Confidence 5699999999999999999999999999999988643 2334567889999999999988 999999998999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
||||+ +++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++++||
T Consensus 94 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~df----------- 159 (296)
T cd06655 94 VMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDF----------- 159 (296)
T ss_pred EEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccC-----------
Confidence 99999 89999988754 4899999999999999999999999999999999999976665555555
Q ss_pred ccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
|++...... .....|+..|+|||.+.+..++.++|||||||++|+|++|..||...
T Consensus 160 ----------------g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~ 218 (296)
T cd06655 160 ----------------GFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (296)
T ss_pred ----------------ccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 443322111 12246888999999999888999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=266.51 Aligned_cols=197 Identities=24% Similarity=0.376 Sum_probs=162.0
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
..++|++.++||+|+||.||+|.+. ++..+|+|.+.......+.+.+|+.++++++|+++ +++++++.. ...+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i-----~~~~~~~~~-~~~~ 76 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKL-----VQLYAVVSE-EPIY 76 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCce-----EEEEeEECC-CCcE
Confidence 3467999999999999999999865 55669999987655555678899999999999988 888887754 5689
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
++|||+ +++|.+++.......+++..++.++.|++.||.|||+++|+||||||+||++++++.++++|||+
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~-------- 148 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGL-------- 148 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCcee--------
Confidence 999999 88999999875555689999999999999999999999999999999999998766665555554
Q ss_pred CccccCCCCCCceEeeCCCcccccCCc----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
+....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 149 -------------------~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 206 (260)
T cd05070 149 -------------------ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred -------------------eeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 33221111 11234567999999988889999999999999999999 8999865
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=277.89 Aligned_cols=197 Identities=23% Similarity=0.352 Sum_probs=158.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECC-----CCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceec
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~ 163 (323)
++|++.+.||+|+||.||+|.+.. +++.||+|+++.. ....+.+..|+.++.++ .|+|+ +++++++.
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~ni-----v~~~~~~~ 81 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNV-----VNLLGACT 81 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcch-----hheeeeEe
Confidence 579999999999999999997543 4578999988643 23345677899999999 78888 88888664
Q ss_pred -cCceEEEEEccC-CCCHHHHHHhcCC-----------------------------------------------------
Q 020652 164 -YRNHICIVFEKL-GPSLYDFLRKNSY----------------------------------------------------- 188 (323)
Q Consensus 164 -~~~~~~lv~e~~-~~~L~~~l~~~~~----------------------------------------------------- 188 (323)
.+..++++|||+ +++|.+++.....
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 356789999999 8999999864321
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceE
Q 020652 189 ------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262 (323)
Q Consensus 189 ------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl 262 (323)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+++
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL--------------------------- 214 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKI--------------------------- 214 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEE---------------------------
Confidence 25789999999999999999999999999999999999976665554
Q ss_pred eeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 263 IDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 263 ~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
+|||++...... .....++..|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 215 ~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 215 CDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred eccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 455544332111 112345678999999999999999999999999999997 9999965
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=267.88 Aligned_cols=195 Identities=31% Similarity=0.559 Sum_probs=160.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++|+|+ +++++++......
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNL-----VNLIEVFRRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCE-----eeeeeEEeeCCEE
Confidence 46999999999999999999999999999999876322 233567789999999999988 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||||+ ++.|..++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++++|||
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg-------- 145 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFG-------- 145 (286)
T ss_pred EEEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccc--------
Confidence 9999999 556665554433 68999999999999999999999999999999999999776655555554
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCc---cccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+....... ....++..|+|||++.+ ..++.++|||||||++|||++|..||.+
T Consensus 146 -------------------~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~ 203 (286)
T cd07847 146 -------------------FARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203 (286)
T ss_pred -------------------cceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 443322111 12357889999999876 4578999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=269.65 Aligned_cols=212 Identities=24% Similarity=0.409 Sum_probs=169.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||.||++.+..+++.||+|.+.... ...+.+..|+.+++.++|+|+ +++++.+..+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFV-----VSMFCSFETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCe-----eeeEEEEecCCE
Confidence 36999999999999999999999999999999886432 233466789999999999988 899999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+++||||+ +++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+||+++..+.++++|||++.....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999 889999997764 689999999999999999999999999999999999998888887777776432111
Q ss_pred CCCccccCCCCCCceEeeCCCcccc-cCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFE-HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
... ..+.+....... ........|+..|+|||.+.+..++.++|+|||||++|||++|..||.+
T Consensus 154 ~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~ 218 (305)
T cd05609 154 SLT----------TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218 (305)
T ss_pred Ccc----------ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 000 000000000000 0011124578899999999988899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=274.50 Aligned_cols=202 Identities=30% Similarity=0.524 Sum_probs=162.1
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec----
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD---- 163 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~---- 163 (323)
+.++|++.++||+|+||.||+|.+..+++.||||++... ......+.+|+.++++++|+|+ +++++++.
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~ 77 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI-----IGILDIIRPPSF 77 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCc-----Cchhheeecccc
Confidence 457899999999999999999999999999999988632 2344567789999999999998 66666543
Q ss_pred -cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 164 -YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 164 -~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
.....+++|||++++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++++|||++.
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 78 ESFNDVYIVQELMETDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred cccceEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECccccee
Confidence 33468999999988999888653 59999999999999999999999999999999999999877776666666543
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 155 ~~~~~~~---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 155 IADPEHD---------------------HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred ecccccc---------------------ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2211100 0001112468899999998765 4688999999999999999999999965
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=264.07 Aligned_cols=194 Identities=24% Similarity=0.365 Sum_probs=159.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEccee-ccCceEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF-DYRNHICI 170 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~-~~~~~~~l 170 (323)
.+|++.+.||+|+||.||++... +..+|+|.++... ..+.+.+|+.++++++|+++ +++++++ ..++..++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~l 77 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNL-----VQLLGVIVEEKGGLYI 77 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCe-----eeEEEEEEcCCCceEE
Confidence 46899999999999999999654 6779999886433 34568889999999999988 8888764 45667999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+|||+ +++|.+++.+.....+++..+..++.|++.||+|||++||+||||||+||+++.++.+
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~---------------- 141 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVA---------------- 141 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcE----------------
Confidence 99999 8899999987665568999999999999999999999999999999999999766655
Q ss_pred ccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
||+|||.+...........++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 142 -----------kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 142 -----------KVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred -----------EecCCccceeccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 45555544433222223344667999999998889999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=265.37 Aligned_cols=194 Identities=25% Similarity=0.352 Sum_probs=160.9
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
+|++.+.||+|+||.||++.+. ++..+|+|++.......+.+.+|+.+++.++|+|+ +++++++...+..++||
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNL-----VQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCE-----EEEEEEEcCCCceEEEE
Confidence 5889999999999999999876 46679999987544445667889999999999888 89999998889999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+|++
T Consensus 79 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~--------------- 142 (256)
T cd05059 79 EYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVS--------------- 142 (256)
T ss_pred ecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEEC---------------
Confidence 999 899999998654 368999999999999999999999999999999999999766655554
Q ss_pred ccCCCCCCceEeeCCCcccccCCcc-c---cccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEHQDHS-Y---VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~~-~---~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
|||.++....... . ..++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 143 ------------dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 204 (256)
T cd05059 143 ------------DFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204 (256)
T ss_pred ------------CcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence 5544433221111 1 123457999999999899999999999999999999 8999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=263.85 Aligned_cols=190 Identities=22% Similarity=0.348 Sum_probs=158.0
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (323)
+.||+|+||.||+|.+..+++.||+|.+... ......+.+|+++++.++|+|+ +++++++......++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI-----VRLIGVCTQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEcCCCCeEEEEeec
Confidence 4699999999999999999999999987532 3445678899999999999998 99999999889999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccC
Q 020652 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (323)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~ 254 (323)
+++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++++|||++.
T Consensus 76 ~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~------------ 142 (252)
T cd05084 76 QGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSR------------ 142 (252)
T ss_pred cCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCc------------
Confidence 889999997644 358999999999999999999999999999999999999877766666665432
Q ss_pred CCCCCceEeeCCCcccccCCc-----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 255 PKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
...... ....++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 143 ---------------~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 143 ---------------EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred ---------------ccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 211110 00122456999999998889999999999999999997 8888853
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=267.79 Aligned_cols=198 Identities=31% Similarity=0.521 Sum_probs=165.1
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++|++.+.||+|++|+||+|.+..+++.||+|.+.... ...+.+.+|+++++.++|+|+ +++++++......
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI-----VRLQDVVHSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCE-----eeEEEEEecCCeE
Confidence 46999999999999999999999999999999886432 233567789999999999988 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
|+||||++++|.+++.......+++..++.++.||+.||+|||+++|+||||||+||+++..+
T Consensus 77 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~----------------- 139 (294)
T PLN00009 77 YLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRT----------------- 139 (294)
T ss_pred EEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCC-----------------
Confidence 999999988999988766545578899999999999999999999999999999999997432
Q ss_pred CccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
..+||+|||.+...... .....+++.|+|||++.+. .++.++|||||||++|+|+||+.||.+
T Consensus 140 ---------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 140 ---------NALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred ---------CEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 23466666665433221 1223578899999998764 578999999999999999999999964
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=264.58 Aligned_cols=196 Identities=26% Similarity=0.387 Sum_probs=161.0
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
.++|++.++||+|+||.||+|.+..+. .+|+|.+.......+.+.+|+.+++.+.|+|+ +.+++++. .+..++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~-~~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKL-----VPLYAVVS-EEPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCe-----eeEEEEEc-CCCcEE
Confidence 357999999999999999999876654 58999887655555678899999999999988 77777765 456889
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+|||+ +++|.+++.......+++..+..++.|++.||.|||+.||+|+||||+||+++.++.+
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~---------------- 141 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVC---------------- 141 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeE----------------
Confidence 99999 7899999987554568999999999999999999999999999999999999766555
Q ss_pred ccccCCCCCCceEeeCCCcccccCCc----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
+|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|||+| |..||.+
T Consensus 142 -----------~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 206 (260)
T cd05069 142 -----------KIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred -----------EECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 455555443322111 11235678999999998889999999999999999999 9999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=268.15 Aligned_cols=197 Identities=23% Similarity=0.341 Sum_probs=160.4
Q ss_pred CcEEEEeeecccCcEEEEEEEEC----CCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 92 PRYRILSKMGEGTFGQVVECFDN----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~----~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
..|++.+.||+|+||+||+|.+. .+++.||+|.+.... .....+.+|+.+++.+.|+|+ +++++++..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~ 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI-----VCLLGVVTQE 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCe-----eeEEEEEecC
Confidence 46899999999999999999853 456789999886322 233567889999999999998 9999999888
Q ss_pred ceEEEEEccC-CCCHHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEee
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNS---------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~---------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~ 229 (323)
...|++|||+ +++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~ 159 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence 9999999999 889999986332 124788899999999999999999999999999999999977
Q ss_pred cCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHHHH
Q 020652 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSV 304 (323)
Q Consensus 230 ~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 304 (323)
++.++++||| ++...... .....++..|+|||++.+..++.++|||||
T Consensus 160 ~~~~kl~dfg---------------------------~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 212 (283)
T cd05090 160 QLHVKISDLG---------------------------LSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSF 212 (283)
T ss_pred CCcEEecccc---------------------------ccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHH
Confidence 6655555554 44322111 122345678999999988889999999999
Q ss_pred HHHHHHHhc-CCCCCCC
Q 020652 305 GCILVELCS-VSNCYLT 320 (323)
Q Consensus 305 G~il~el~t-g~~pf~~ 320 (323)
||++|||++ |..||.+
T Consensus 213 G~il~el~~~g~~p~~~ 229 (283)
T cd05090 213 GVVLWEIFSFGLQPYYG 229 (283)
T ss_pred HHHHHHHHcCCCCCCCC
Confidence 999999998 9999865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=269.98 Aligned_cols=197 Identities=30% Similarity=0.499 Sum_probs=165.2
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
.++|++.++||+|+||.||++.+..+++.+|+|++... ....+.+..|+.++++++|+|+ +++++.+..+...|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 78 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNI-----VGLYEAYFYENKLW 78 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCce-----eEEEEEEecCCeEE
Confidence 35799999999999999999999989999999998643 2344568889999999999988 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+++.+.. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.+
T Consensus 79 lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~--------------- 142 (280)
T cd06611 79 ILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDV--------------- 142 (280)
T ss_pred EEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCE---------------
Confidence 999999 889999987644 369999999999999999999999999999999999999766555
Q ss_pred CccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhc-----CCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+..... ......||+.|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 143 ------------~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~ 210 (280)
T cd06611 143 ------------KLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210 (280)
T ss_pred ------------EEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence 4555554432211 112346899999999985 34577899999999999999999999964
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=268.17 Aligned_cols=194 Identities=26% Similarity=0.409 Sum_probs=157.8
Q ss_pred CcE-EEEeeecccCcEEEEEEE----ECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 92 PRY-RILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 92 ~~y-~~~~~lG~G~fg~V~~~~----~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
++| ++++.||+|+||+||++. ...+++.||+|++.... .....+.+|+++++.++|+|+ +++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~ 77 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI-----VKYKGCCSE 77 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEec
Confidence 456 999999999999998765 34567889999987532 345667889999999999988 888887654
Q ss_pred --CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 165 --RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 165 --~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
...++++|||+ +++|.+++... .+++..++.++.|++.||.|||++||+||||||+||+++.++.++++|||
T Consensus 78 ~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg-- 152 (283)
T cd05080 78 QGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFG-- 152 (283)
T ss_pred CCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecc--
Confidence 34689999999 89999999764 49999999999999999999999999999999999999766655555554
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccCCc------cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~ 315 (323)
++....... ....++..|+|||++.+..++.++|||||||++|||+||.
T Consensus 153 -------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~ 207 (283)
T cd05080 153 -------------------------LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC 207 (283)
T ss_pred -------------------------cccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCC
Confidence 443322111 1123566799999998888999999999999999999999
Q ss_pred CCCCC
Q 020652 316 NCYLT 320 (323)
Q Consensus 316 ~pf~~ 320 (323)
.||..
T Consensus 208 ~p~~~ 212 (283)
T cd05080 208 DSKQS 212 (283)
T ss_pred CCCCC
Confidence 99864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=262.68 Aligned_cols=197 Identities=28% Similarity=0.476 Sum_probs=165.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||.||+|.+..+++.||+|.++.. ....+.+.+|++++++++|+++ +.+++.+...+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i-----~~~~~~~~~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNV-----IKYLASFIENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCe-----eeeeeeeecCCe
Confidence 5799999999999999999999999999999987531 2335678899999999999988 999999998899
Q ss_pred EEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
.+++|||+ +++|.+++... ....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++++||
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~------ 150 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDL------ 150 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEecc------
Confidence 99999999 88999998742 2245899999999999999999999999999999999999976665555554
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
|.+...... .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||..
T Consensus 151 ---------------------~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 151 ---------------------GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred ---------------------ceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 444322111 1223678899999999988899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=264.21 Aligned_cols=195 Identities=24% Similarity=0.373 Sum_probs=161.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
++|++.+.||+|+||+||++.+.. +..+|+|.+.......+.+.+|+.+++++.|+|+ +++++++......+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKL-----VQLYGVCTKQRPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCe-----eeEEEEEccCCCcEEE
Confidence 469999999999999999997654 4459999887554445678899999999999988 9999999888889999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.+|++|||.
T Consensus 78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~---------- 146 (256)
T cd05113 78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGL---------- 146 (256)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCcc----------
Confidence 9999 889999998654 2689999999999999999999999999999999999997766665555554
Q ss_pred cccCCCCCCceEeeCCCcccccCCc----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
+....... ....++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 147 -----------------~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 204 (256)
T cd05113 147 -----------------SRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER 204 (256)
T ss_pred -----------------ceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 33211111 01234567999999998889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=268.88 Aligned_cols=197 Identities=23% Similarity=0.325 Sum_probs=159.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCc--EEEEEEecc--chhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKE--LVAIKIVRS--INKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~--~vAiK~~~~--~~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~ 166 (323)
++|++.+.||+|+||.||+|.+..++. .+++|.++. .....+.+.+|+.++.++ .|+|+ +++++++...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~~~~~~~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI-----INLLGACENRG 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCch-----hheEEEEccCC
Confidence 469999999999999999999877664 468887763 233446688899999999 68888 88999998888
Q ss_pred eEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~ 231 (323)
.++++|||+ +++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||++.++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL 156 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC
Confidence 999999999 889999997542 12488899999999999999999999999999999999997666
Q ss_pred ceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCCcchhHHHHHHHHH
Q 020652 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (323)
Q Consensus 232 ~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (323)
.+|++|| |++....... .....+..|+|||++.+..++.++|||||||++|
T Consensus 157 ~~kl~df---------------------------g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ 209 (297)
T cd05089 157 ASKIADF---------------------------GLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLW 209 (297)
T ss_pred eEEECCc---------------------------CCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHH
Confidence 5555555 4443211111 1112245799999999888999999999999999
Q ss_pred HHhc-CCCCCCC
Q 020652 310 ELCS-VSNCYLT 320 (323)
Q Consensus 310 el~t-g~~pf~~ 320 (323)
||++ |..||.+
T Consensus 210 el~t~g~~pf~~ 221 (297)
T cd05089 210 EIVSLGGTPYCG 221 (297)
T ss_pred HHHcCCCCCCCC
Confidence 9997 9999965
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=262.86 Aligned_cols=197 Identities=25% Similarity=0.357 Sum_probs=165.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
.++|++.++||+|+||.||+|.+. .++.+|||.+.......+.+.+|+.++++++|+|+ +++++++......++
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~~ 78 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKL-----VQLYAVCSEEEPIYI 78 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCE-----eeeeeeeecCCceEE
Confidence 467999999999999999999875 45779999988655556778899999999999988 899999888889999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+|||+ +++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||+++.++.++++||
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~----------- 147 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADF----------- 147 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECcc-----------
Confidence 99999 889999998765557999999999999999999999999999999999999977665555555
Q ss_pred ccccCCCCCCceEeeCCCcccccCCc----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
|.+....... ....++..|+|||.+.+..++.++|||||||++|||++ |+.||.+
T Consensus 148 ----------------g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 207 (261)
T cd05034 148 ----------------GLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207 (261)
T ss_pred ----------------ccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 4443322110 11224567999999998889999999999999999998 9999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=261.28 Aligned_cols=197 Identities=29% Similarity=0.462 Sum_probs=168.5
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+|++.+.||+|+||.||+|.+..+++.+|+|.+... ....+.+..|+.+++.++|+|+ +++++.+...+..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI-----IEYYENFLEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCch-----hheeeeEecCCEEE
Confidence 589999999999999999999999999999988643 2345678889999999999988 88888888889999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+++.......+++..+..++.|++.||+|||++||+|+||||+||+++.++
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~----------------- 138 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK----------------- 138 (256)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-----------------
Confidence 999999 88999999876545689999999999999999999999999999999999996432
Q ss_pred CccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
..++|+|||.+....... ....|+..|+|||.+.+..++.++||||||+++|+|++|..||.+
T Consensus 139 ---------~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 203 (256)
T cd08220 139 ---------MVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203 (256)
T ss_pred ---------CEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc
Confidence 235667777665433221 224688999999999988889999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=265.71 Aligned_cols=195 Identities=24% Similarity=0.322 Sum_probs=157.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCc----EEEEEEecc--chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vAiK~~~~--~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+|++.++||+|+||+||+|.+..+++ .||+|+++. .......+.+|+.+++.+.|+|+ +.+++++..
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~- 80 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYV-----CRLLGICLT- 80 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCC-----ceEEEEEcC-
Confidence 579999999999999999999877766 489998863 23345667889999999999988 777777654
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
...+++|||+ +++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+|
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~k---------- 149 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVK---------- 149 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEE----------
Confidence 4577999999 899999997643 3689999999999999999999999999999999999997665554
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCcc-----ccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCY 318 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf 318 (323)
|+|||+++....... ...++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 150 -----------------L~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 212 (279)
T cd05109 150 -----------------ITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY 212 (279)
T ss_pred -----------------ECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence 455554433221111 1134678999999998899999999999999999998 99998
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
..
T Consensus 213 ~~ 214 (279)
T cd05109 213 DG 214 (279)
T ss_pred CC
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=264.32 Aligned_cols=194 Identities=26% Similarity=0.407 Sum_probs=166.8
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|++++++++|+|+ +.+++.+..+...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFL-----VNLWYSFQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCCh-----HHHHHhhcCCCeE
Confidence 4899999999999999999999999999999986432 344678889999999999998 8899999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||||+ +++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~-------------- 139 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHV-------------- 139 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCE--------------
Confidence 9999999 899999998763 68999999999999999999999999999999999999766555
Q ss_pred CCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 140 -------------~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 201 (258)
T cd05578 140 -------------HITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201 (258)
T ss_pred -------------EEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCC
Confidence 55555544332221 1224678899999999988899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=269.29 Aligned_cols=203 Identities=26% Similarity=0.388 Sum_probs=163.5
Q ss_pred CCcEEEEeeecccCcEEEEEEEE-----CCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEccee
Q 020652 91 TPRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~ 162 (323)
.++|++.+.||+|+||.||+|.+ ..++..||+|+++.. ....+.+.+|+.+++++ +|+|+ +++++++
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~~ 108 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI-----VNLLGAC 108 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCc-----ceEEEEE
Confidence 35799999999999999999975 334568999988643 23345688899999999 79988 9999999
Q ss_pred ccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
...+..+++|||+ +++|.+++.......+++.++..++.|++.||+|||+++|+|+||||+|||++.++.++++|||++
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence 8889999999999 899999998654345899999999999999999999999999999999999977666555555543
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
........ ........++..|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 189 ~~~~~~~~----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~ 246 (302)
T cd05055 189 RDIMNDSN----------------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246 (302)
T ss_pred ccccCCCc----------------------eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence 22111000 000011245678999999999899999999999999999998 9999865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=266.04 Aligned_cols=195 Identities=35% Similarity=0.567 Sum_probs=164.9
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.++|+|+ +++++++..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV-----VKLLDVFPHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCC-----cceeeEEecCCeeE
Confidence 589999999999999999999999999999998743 2334678899999999999998 89999999899999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+||||++++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+
T Consensus 76 ~v~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~---------------- 138 (286)
T cd07832 76 LVMEYMPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVL---------------- 138 (286)
T ss_pred EEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcE----------------
Confidence 999999999999987654 469999999999999999999999999999999999999766555
Q ss_pred ccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+...... .....|+..|+|||++.+. .++.++|||||||++|||++|.+||.+
T Consensus 139 -----------~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 139 -----------KIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred -----------EEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 45555544332221 1224688999999998765 468999999999999999999888865
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=267.53 Aligned_cols=197 Identities=26% Similarity=0.375 Sum_probs=166.4
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh-hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
..+|++.++||+|+||.||+|.+.. ++.+|+|++..... ..+.+..|+.+++.++|+|+ +++++++......+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 78 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHL-----ISLFAVCSVGEPVY 78 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcch-----hheeeeEecCCCeE
Confidence 3569999999999999999999887 88899999875443 45678889999999999988 88999999899999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+++.+.....+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||++.
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~------ 152 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLAR------ 152 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchh------
Confidence 999999 8899999987655678999999999999999999999999999999999999877766666655432
Q ss_pred CccccCCCCCCceEeeCCCcccccCCc---cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
...... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||.+
T Consensus 153 ---------------------~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~ 207 (261)
T cd05148 153 ---------------------LIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207 (261)
T ss_pred ---------------------hcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Confidence 221110 11234668999999998889999999999999999998 8999964
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=264.32 Aligned_cols=195 Identities=26% Similarity=0.470 Sum_probs=165.5
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-------hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
+|+..+.||+|+||.||++.+..+++.||+|++.... ...+.+..|+.+++.++|+|+ +++++++...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI-----IRMLGATCED 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCce-----ehhhceeccC
Confidence 4788899999999999999999999999999886322 234678889999999999988 9999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+..++||||+ +++|.+++.+.. .+++..+..++.|++.||.|||++|++|+||||+||+++.++.
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~------------ 141 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ------------ 141 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC------------
Confidence 9999999999 899999998654 6899999999999999999999999999999999999965432
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCC-------ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
.++|+|||.+...... .....||..|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 142 --------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 207 (268)
T cd06630 142 --------------RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207 (268)
T ss_pred --------------EEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 2455566555432211 1234688899999999888899999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|..
T Consensus 208 ~~~ 210 (268)
T cd06630 208 WNA 210 (268)
T ss_pred CCC
Confidence 963
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=267.09 Aligned_cols=197 Identities=27% Similarity=0.509 Sum_probs=162.4
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEE
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
|++.+.||+|+||.||+|.+..++..+|+|.+... ....+.+.+|+++++.+.|+|+ +++++.+...+..++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----i~~~~~~~~~~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI-----VKLLDAFYYENNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCe-----eeEEEEEeeCCEEEEEE
Confidence 78889999999999999999999999999988643 3445667889999999999988 89999988889999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|..++.+.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++++|||++......
T Consensus 82 e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~---- 156 (282)
T cd06643 82 EFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---- 156 (282)
T ss_pred EecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc----
Confidence 999 889988876533 36899999999999999999999999999999999999977666655555543221100
Q ss_pred ccCCCCCCceEeeCCCcccccCCccccccCCccccchhhc-----CCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
........||..|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 157 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 210 (282)
T cd06643 157 --------------------IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210 (282)
T ss_pred --------------------ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence 01112346889999999984 34578899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=261.52 Aligned_cols=195 Identities=24% Similarity=0.332 Sum_probs=164.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
++|++.+.||+|+||.||+|.+. ++.||+|.+.......+.+..|+.+++.++|+|+ +++++++......++|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~v 78 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNL-----VQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcce-----eeeEEEEcCCCCeEEE
Confidence 46899999999999999999764 7889999998655556678899999999999988 9999998888899999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||+ +++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~----------------- 141 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVA----------------- 141 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCE-----------------
Confidence 9999 7899999987654568999999999999999999999999999999999999765544
Q ss_pred cccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
+|+|||.+...........++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 142 ----------~l~d~g~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 202 (256)
T cd05039 142 ----------KVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred ----------EEcccccccccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 55555555443322222334567999999988889999999999999999997 9999854
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=266.14 Aligned_cols=194 Identities=28% Similarity=0.417 Sum_probs=166.5
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
++|++.+.||.|+||.||+|.+..+++.||+|++.... .....+.+|+++++.+.|+|+ +++.+.+..+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYI-----TKYYGSFLKGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCe-----eeeeEEEEECCeEE
Confidence 36899999999999999999999999999999986432 334567789999999999988 88999888889999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+|+||+ +++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~--------------- 137 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDV--------------- 137 (274)
T ss_pred EEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCE---------------
Confidence 999999 88999998764 68999999999999999999999999999999999999766544
Q ss_pred CccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+...... .....|++.|+|||.+.+..++.++|||||||++|+|+||+.||.+
T Consensus 138 ------------~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~ 200 (274)
T cd06609 138 ------------KLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200 (274)
T ss_pred ------------EEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 55555555433221 2234688899999999998899999999999999999999999965
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=261.60 Aligned_cols=195 Identities=28% Similarity=0.461 Sum_probs=168.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
++|++.+.||+|+||.||+|.+..+++.+|+|.+..... .+.+.+|++++++++|+|+ +++++.+......|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYI-----VKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcE-----eeeeeeeecCCcEEEE
Confidence 579999999999999999999998899999999875443 6778899999999999988 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
+||+ +++|.+++.... ..+++..+..++.|++.||.|||+.+|+|+||+|+||+++.++.+
T Consensus 77 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~----------------- 138 (256)
T cd06612 77 MEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQA----------------- 138 (256)
T ss_pred EecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcE-----------------
Confidence 9999 889999987544 468999999999999999999999999999999999999766555
Q ss_pred cccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+...... .....|+..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 139 ----------~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~ 201 (256)
T cd06612 139 ----------KLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201 (256)
T ss_pred ----------EEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 55555544432221 1234578899999999998999999999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=261.74 Aligned_cols=201 Identities=25% Similarity=0.366 Sum_probs=162.8
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
..++|++.++||+|+||.||++.+. .+..+|+|.+.......+.+.+|+.+++.++|+|+ +++++.+.. ...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~-~~~~ 76 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKL-----VKLHAVVTK-EPIY 76 (260)
T ss_pred cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCc-----ceEEEEEcC-CCeE
Confidence 4578999999999999999999865 44569999887655556778899999999999998 788777776 6789
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
++|||+ +++|.+++.+.....+++..+..++.|++.||.|||++|++||||||+||+++..+.++++|||+........
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999 8899999987655578899999999999999999999999999999999999776666555555432211000
Q ss_pred CccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
........++..|+|||++.+..++.++|+|||||++|+|+| |..||.+
T Consensus 157 -----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 206 (260)
T cd05073 157 -----------------------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206 (260)
T ss_pred -----------------------cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence 000011234567999999998889999999999999999998 9999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=261.89 Aligned_cols=201 Identities=29% Similarity=0.448 Sum_probs=163.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc------hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc-
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~------~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~- 164 (323)
.+|++.+.||+|+||.||+|.+..+++.||+|.+... ......+.+|+.++++++|+|+ +++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i-----~~~~~~~~~~ 76 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRI-----VQYYGCLRDP 76 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCc-----ceEEEEEEcC
Confidence 4699999999999999999999999999999987421 2233567889999999999998 888887755
Q ss_pred -CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
...++++|||+ +++|.+++.... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++++|||+..
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 77 EEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 35688999999 889999998654 58899999999999999999999999999999999999877766666666543
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
...... ..........|+..|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus 155 ~~~~~~---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 155 RIQTIC---------------------MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred cccccc---------------------ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 221000 000011224588899999999988899999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=266.23 Aligned_cols=196 Identities=32% Similarity=0.553 Sum_probs=164.0
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+|++++.||+|++|.||+|++..+++.||||++.... .....+.+|++++++++|+|+ +++++++...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI-----VKLLDVIHTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCC-----cchhhhcccCCcEE
Confidence 4889999999999999999999999999999886432 223567889999999999998 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+||||+.++|.+++.......+++..+..++.|++.||+|||+++++||||||+||+++.++.+
T Consensus 76 ~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~---------------- 139 (284)
T cd07860 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAI---------------- 139 (284)
T ss_pred EEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCE----------------
Confidence 9999997799999877555678999999999999999999999999999999999999766655
Q ss_pred ccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||.+...... .....++..|+|||++.+.. ++.++|||||||++|||+||+.||.+
T Consensus 140 -----------~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 140 -----------KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred -----------EEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 45555544322211 11235688999999987654 68899999999999999999999965
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=268.80 Aligned_cols=198 Identities=20% Similarity=0.322 Sum_probs=159.9
Q ss_pred CCcEEEEeeecccCcEEEEEEEECC-------CCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN 160 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~ 160 (323)
.++|.+.+.||+|+||.||+|++.. +...+|+|.+... ......+..|+.+++.+ +|+|+ +++++
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~~~~ 91 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI-----INLLG 91 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCE-----eeEEE
Confidence 3679999999999999999998643 2356999998743 23345677899999999 68887 99999
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NI 225 (323)
++...+..|+||||+ +++|.+++..... ..+++.++..++.|++.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 999989999999999 8899999976421 2478899999999999999999999999999999999
Q ss_pred EEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchh
Q 020652 226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCD 300 (323)
Q Consensus 226 li~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D 300 (323)
+++.++.++++||| .+...... .....++..|+|||++.+..++.++|
T Consensus 172 ll~~~~~~kL~dfg---------------------------~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 224 (307)
T cd05098 172 LVTEDNVMKIADFG---------------------------LARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224 (307)
T ss_pred EEcCCCcEEECCCc---------------------------ccccccccchhhccccCCCccceeChHHhccCCCCcHHH
Confidence 99766655555554 44322111 01112356899999999988999999
Q ss_pred HHHHHHHHHHHhc-CCCCCCC
Q 020652 301 LWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 301 iwSlG~il~el~t-g~~pf~~ 320 (323)
||||||++|||++ |..||.+
T Consensus 225 vwslG~~l~el~~~g~~p~~~ 245 (307)
T cd05098 225 VWSFGVLLWEIFTLGGSPYPG 245 (307)
T ss_pred HHHHHHHHHHHHcCCCCCCCc
Confidence 9999999999998 8888864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=265.28 Aligned_cols=197 Identities=28% Similarity=0.452 Sum_probs=165.1
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||.||+|.+..+++.+|||.+... ....+.+.+|+.+++.+.|+|+ +++++++..++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV-----IKYYASFIEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCch-----hhhhheeEeCCe
Confidence 3688999999999999999999999999999987532 2344577889999999999998 889999988899
Q ss_pred EEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
.+++|||+ +++|.+++... ....+++..++.++.|++.||.|||++|++|+||||+||+++.++.++++|||
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg----- 151 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLG----- 151 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcch-----
Confidence 99999999 88999988742 22468999999999999999999999999999999999999776655555554
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+
T Consensus 152 ----------------------~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 152 ----------------------LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred ----------------------hhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence 43322111 1124688899999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=264.98 Aligned_cols=203 Identities=19% Similarity=0.329 Sum_probs=162.7
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCC-----CcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
.++|++.+.||+|+||.||+|.+... +..||+|.+.... .....+.+|+.+++.+.|+|+ +++++++.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~ 79 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV-----VRLLGVVS 79 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCce-----eEEEEEEc
Confidence 46799999999999999999988654 4789999986432 334567789999999999988 99999999
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCcee
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNS--------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~k 234 (323)
.....++||||+ +++|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 999999999999 899999997532 12367889999999999999999999999999999999997766655
Q ss_pred ccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-
Q 020652 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS- 313 (323)
Q Consensus 235 i~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t- 313 (323)
++|||++....... .........++..|+|||++.+..++.++|||||||++|||+|
T Consensus 160 l~dfg~~~~~~~~~----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 217 (277)
T cd05032 160 IGDFGMTRDIYETD----------------------YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATL 217 (277)
T ss_pred ECCcccchhhccCc----------------------ccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhcc
Confidence 55555432211100 0001122356788999999988889999999999999999998
Q ss_pred CCCCCCC
Q 020652 314 VSNCYLT 320 (323)
Q Consensus 314 g~~pf~~ 320 (323)
|..||.+
T Consensus 218 g~~p~~~ 224 (277)
T cd05032 218 AEQPYQG 224 (277)
T ss_pred CCCCCcc
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=263.94 Aligned_cols=203 Identities=26% Similarity=0.421 Sum_probs=166.8
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----------hhHHHHHHHHHHHHHHHhCCCCCcceEEEccee
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----------~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~ 162 (323)
+|.+...||+|+||.||+|.+..+++.+|+|.+.... ...+.+.+|+.+++++.|+|+ +++++++
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~ 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENI-----VQYLGSS 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCe-----eeEEEEE
Confidence 4788899999999999999999999999999875321 122567789999999999988 9999999
Q ss_pred ccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
...+..+++|||+ +++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||++
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 76 LDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred EeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999 889999998754 6899999999999999999999999999999999999987777766666654
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
......... ...........|+..|+|||.+.+..++.++|+|||||++|+|++|+.||..
T Consensus 154 ~~~~~~~~~------------------~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 154 KKLEANSLS------------------TKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred ccccccccc------------------CCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 433211100 0000111224578899999999988899999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=272.47 Aligned_cols=197 Identities=28% Similarity=0.517 Sum_probs=164.9
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+.++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++|+|+ +++.+++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 86 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV-----IGLLDVFTPD 86 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCc-----cceeeeecCC
Confidence 3567899999999999999999999999999999988532 2234567789999999999998 7777776553
Q ss_pred c------eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 166 N------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 166 ~------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
. .+++||||++++|.+++... .+++..++.++.|++.||+|||++||+||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~------- 156 (343)
T cd07880 87 LSLDRFHDFYLVMPFMGTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE------- 156 (343)
T ss_pred ccccccceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-------
Confidence 3 46999999988999888753 5899999999999999999999999999999999999865544
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
++|+|||.+...........+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||
T Consensus 157 --------------------~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf 216 (343)
T cd07880 157 --------------------LKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLF 216 (343)
T ss_pred --------------------EEEeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 566666666554444444567899999999876 35889999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 217 ~~ 218 (343)
T cd07880 217 KG 218 (343)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=272.25 Aligned_cols=197 Identities=28% Similarity=0.516 Sum_probs=163.2
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc-
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~- 164 (323)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.++++++|+|+ +++.+++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i-----v~~~~~~~~~ 88 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV-----IGLLDVFTPA 88 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcc-----cceeeeeeec
Confidence 45678999999999999999999999999999999886432 234567789999999999998 777766543
Q ss_pred -----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 165 -----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 165 -----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
....++++++++++|.+++... .+++..++.++.|++.||+|||++||+||||||+||+++.++.
T Consensus 89 ~~~~~~~~~~lv~~~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~------- 158 (345)
T cd07877 89 RSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE------- 158 (345)
T ss_pred ccccccccEEEEehhcccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC-------
Confidence 3457899999999999888653 5899999999999999999999999999999999999976554
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
++|+|||++...........||..|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 159 --------------------~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf 218 (345)
T cd07877 159 --------------------LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218 (345)
T ss_pred --------------------EEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 455666655544333334578899999999876 46889999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
..
T Consensus 219 ~~ 220 (345)
T cd07877 219 PG 220 (345)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=266.26 Aligned_cols=202 Identities=21% Similarity=0.325 Sum_probs=162.8
Q ss_pred CcEEEEeeecccCcEEEEEEEEC-----CCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+|.+.+.||+|+||.||+|.+. .++..+++|.+.... ...+.+.+|+.++++++|+|+ +++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~ 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI-----VKFYGVCGDG 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCc-----ceEEEEEccC
Confidence 46899999999999999999854 345678999886433 334568899999999999998 9999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeec
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~ 230 (323)
...++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+||+++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 9999999999 8999999976431 247899999999999999999999999999999999999876
Q ss_pred CceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHH
Q 020652 231 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310 (323)
Q Consensus 231 ~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 310 (323)
+.++++|||++........ ........++..|+|||++.+..++.++|||||||++||
T Consensus 160 ~~~~l~dfg~a~~~~~~~~----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 217 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDY----------------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 217 (291)
T ss_pred CcEEECCCCcccccCCCce----------------------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHH
Confidence 6665555554322111000 001112356788999999999999999999999999999
Q ss_pred Hhc-CCCCCCC
Q 020652 311 LCS-VSNCYLT 320 (323)
Q Consensus 311 l~t-g~~pf~~ 320 (323)
|+| |..||..
T Consensus 218 l~t~g~~p~~~ 228 (291)
T cd05094 218 IFTYGKQPWFQ 228 (291)
T ss_pred HHhCCCCCCCC
Confidence 998 9999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=262.01 Aligned_cols=200 Identities=30% Similarity=0.444 Sum_probs=161.8
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc------hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc--
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-- 164 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~------~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~-- 164 (323)
+|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.++|+|+ +.+++++..
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 77 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI-----VQYYGCLRDRA 77 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCe-----eeEEEEEEcCC
Confidence 589999999999999999999999999999987532 1233567789999999999998 888887754
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
...++++|||+ +++|.+++.+.. .+++..++.++.|++.||.|||+++|+||||||+||+++.++.++++|||++..
T Consensus 78 ~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 78 EKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 46789999999 889999998754 589999999999999999999999999999999999997666555555544322
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
..... ..........++..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~~~~---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 156 LQTIC---------------------MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred ccccc---------------------ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 11000 000011123578899999999998899999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=259.32 Aligned_cols=196 Identities=27% Similarity=0.490 Sum_probs=167.1
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+|++.+.||+|+||.||++.+..+++.||+|.+... ....+.+.+|+.++++++|+|+ +++.+++...++.+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI-----VQYQESFEENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCe-----eeeEeeecCCCeEE
Confidence 589999999999999999999999999999988632 2344578889999999999988 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~--------------- 140 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTI--------------- 140 (256)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCE---------------
Confidence 999999 8899999987554568999999999999999999999999999999999999765544
Q ss_pred CccccCCCCCCceEeeCCCcccccCCc---cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+++|||.+....... ....|++.|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 141 ------------~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08218 141 ------------KLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203 (256)
T ss_pred ------------EEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccC
Confidence 555555554332211 123578899999999988899999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=264.08 Aligned_cols=197 Identities=22% Similarity=0.426 Sum_probs=158.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHH-HHHHHhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDV-LQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~-l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++|++.+.||+|+||.||+|.+..+++.||||+++... ........|+.+ ++.+.|+|+ +++++++...+.+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i-----v~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYT-----VTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCe-----eeeeEEEecCCcE
Confidence 36999999999999999999999999999999887432 223345556665 555667777 9999999888999
Q ss_pred EEEEccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 169 CIVFEKLGPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~-~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
|++|||+.++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+
T Consensus 76 ~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~------------ 143 (283)
T cd06617 76 WICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQV------------ 143 (283)
T ss_pred EEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCE------------
Confidence 999999988998888642 224689999999999999999999997 99999999999998765544
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcC----CCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG----LGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
||+|||.+...... .....|+..|+|||++.+ ..++.++|+|||||++|||++|+.||.
T Consensus 144 ---------------kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 208 (283)
T cd06617 144 ---------------KLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD 208 (283)
T ss_pred ---------------EEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCC
Confidence 55555555432221 122468889999999865 456889999999999999999999996
Q ss_pred C
Q 020652 320 T 320 (323)
Q Consensus 320 ~ 320 (323)
.
T Consensus 209 ~ 209 (283)
T cd06617 209 S 209 (283)
T ss_pred c
Confidence 3
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=266.54 Aligned_cols=196 Identities=23% Similarity=0.303 Sum_probs=161.9
Q ss_pred eeecccCcEEEEEEEECCCCc-------EEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 98 SKMGEGTFGQVVECFDNEKKE-------LVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~-------~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+.||+|+||.||+|.+..++. .+|+|.+.... ...+.+..|+.+++.+.|+|+ +.+++++..+...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----v~~~~~~~~~~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHL-----VLNYGVCVCGDESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCCh-----hheeeEEEeCCCcE
Confidence 469999999999998865543 48888775432 334567889999999999998 88999988888899
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++..++.+++
T Consensus 76 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~--------- 145 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPP--------- 145 (258)
T ss_pred EEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCc---------
Confidence 999999 889999998654 368999999999999999999999999999999999999888766555443
Q ss_pred CccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCC-CCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVS-NCYL 319 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~-~pf~ 319 (323)
.++++|||.+..... .....++..|+|||++.+. .++.++|||||||++|||++|. .||.
T Consensus 146 ----------~~~l~d~g~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~ 207 (258)
T cd05078 146 ----------FIKLSDPGISITVLP-KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS 207 (258)
T ss_pred ----------eEEecccccccccCC-chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChh
Confidence 368999998765432 2335688999999999874 5789999999999999999995 5543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=267.33 Aligned_cols=196 Identities=23% Similarity=0.398 Sum_probs=163.2
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
+|++++.||+|+||.||+|.+..+++.||+|.+... ......+.+|+.++++++|+|+ +++++.+...+.+++
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~l 76 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYI-----VDFYGAFFIEGAVYM 76 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcH-----HhhhhheecCCeEEE
Confidence 589999999999999999999999999999988642 2334567889999999999998 899999998999999
Q ss_pred EEccC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 171 VFEKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
||||+ +++|.+++.... ...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.
T Consensus 77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--------------- 141 (286)
T cd06622 77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQ--------------- 141 (286)
T ss_pred EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCC---------------
Confidence 99999 889999887641 2368999999999999999999997 59999999999999865544
Q ss_pred CCccccCCCCCCceEeeCCCcccccCC-ccccccCCccccchhhcCC------CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGL------GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++|+|||.+...... .....|+..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 142 ------------~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 142 ------------VKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred ------------EEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 566666655433221 2234678899999998654 357899999999999999999999954
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=283.74 Aligned_cols=196 Identities=25% Similarity=0.423 Sum_probs=169.6
Q ss_pred CCcE-EEEeeecccCcEEEEEEEECCCCcEEEEEEec-----cchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 91 TPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVR-----SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 91 ~~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~-----~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
.+|| +....||+|+|-+||+|.|..+|..||--.++ +.....+.+..|+.+|+.|+|+|| ++++++|.+
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NI-----irfy~SW~d 112 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNI-----IRFYDSWVD 112 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCce-----eeeeeheec
Confidence 3455 45678999999999999999999988843332 334556889999999999999999 999999877
Q ss_pred Cc--eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEeecCceeccCcc
Q 020652 165 RN--HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 165 ~~--~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
.. .+.+|+|.+ .|+|..|+++.+ .+..+.++.|++||+.||.|||++. |||||||-+||+|+.
T Consensus 113 ~~n~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG---------- 180 (632)
T KOG0584|consen 113 TDNKTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG---------- 180 (632)
T ss_pred CCCceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC----------
Confidence 54 488999999 999999999876 7999999999999999999999985 999999999999953
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCCccc-cccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
..+.+||.|+|+|+........ ++|||.|||||+.. ..|+..+||||||+.+.||+|+.+||
T Consensus 181 ----------------~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPY 243 (632)
T KOG0584|consen 181 ----------------NLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPY 243 (632)
T ss_pred ----------------CcCceeecchhHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCCh
Confidence 4577899999999876665443 68999999999987 68999999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
..
T Consensus 244 sE 245 (632)
T KOG0584|consen 244 SE 245 (632)
T ss_pred hh
Confidence 63
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=263.07 Aligned_cols=198 Identities=27% Similarity=0.435 Sum_probs=163.7
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceecc-----
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY----- 164 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~----- 164 (323)
.++|++.+.||+|+||.||+|.+..+++.+++|++.......+.+.+|+.+++++ .|+|+ +++++++..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~~~~~~~~~~~ 79 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI-----ATFYGAFIKKNPPG 79 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCCh-----heEEEEEEecCCCC
Confidence 4789999999999999999999999999999999886665567788999999999 68888 888888754
Q ss_pred -CceEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 165 -RNHICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
...+++||||+ +++|.+++.... ...+++..++.++.|++.||.|||+++++|+||+|+||+++.++.+++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l----- 154 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKL----- 154 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEE-----
Confidence 34589999999 889999887532 357899999999999999999999999999999999999976665544
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCC-----CCCcchhHHHHHHHHHHHh
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELC 312 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~el~ 312 (323)
+|||.+..... ......|+..|+|||++... .++.++|||||||++|+|+
T Consensus 155 ----------------------~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~ 212 (275)
T cd06608 155 ----------------------VDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA 212 (275)
T ss_pred ----------------------CCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHH
Confidence 45544432211 11224688999999998642 4678999999999999999
Q ss_pred cCCCCCCC
Q 020652 313 SVSNCYLT 320 (323)
Q Consensus 313 tg~~pf~~ 320 (323)
+|+.||..
T Consensus 213 ~g~~p~~~ 220 (275)
T cd06608 213 DGKPPLCD 220 (275)
T ss_pred hCCCCccc
Confidence 99999964
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=292.23 Aligned_cols=144 Identities=22% Similarity=0.380 Sum_probs=130.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|+++++||+|+||+||+|.+..+++.||||+++... .....+..|+.+++.++|+|| ++++..+....+
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~I-----v~~~~~~~~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFI-----VHLYYSLQSANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCc-----CeEEEEEEECCE
Confidence 57999999999999999999999999999999986432 234567889999999999998 888888888899
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||+++|+||||||+||||+.++.++|+|||++.
T Consensus 79 ~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999 999999998654 68999999999999999999999999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=263.36 Aligned_cols=200 Identities=27% Similarity=0.441 Sum_probs=162.9
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccC--
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR-- 165 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~-- 165 (323)
...++|++.+.||+|+||.||+|.+..+++.+|+|++.......+.+..|+.+++++ +|+|+ +++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni-----~~~~~~~~~~~~ 93 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNV-----VKFYGMFYKADK 93 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCe-----EEEEEEEEeccc
Confidence 345789999999999999999999999999999999876544556677899999998 68887 8888876542
Q ss_pred ---ceEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 166 ---NHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 166 ---~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
...++||||+ +++|.+++... ....+++..++.++.|++.||+|||+++|+||||||+||+++.++.+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~------ 167 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGV------ 167 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCE------
Confidence 4689999999 88999988632 22468999999999999999999999999999999999999765544
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCC-----CCCcchhHHHHHHHHHHH
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVEL 311 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~el 311 (323)
||+|||.+..... ......|+..|+|||++... .++.++|||||||++|||
T Consensus 168 ---------------------kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el 226 (291)
T cd06639 168 ---------------------KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226 (291)
T ss_pred ---------------------EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHH
Confidence 5555555443221 11224678899999998653 368899999999999999
Q ss_pred hcCCCCCCC
Q 020652 312 CSVSNCYLT 320 (323)
Q Consensus 312 ~tg~~pf~~ 320 (323)
++|+.||..
T Consensus 227 ~~g~~p~~~ 235 (291)
T cd06639 227 GDGDPPLFD 235 (291)
T ss_pred hhCCCCCCC
Confidence 999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=271.51 Aligned_cols=197 Identities=29% Similarity=0.515 Sum_probs=162.3
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC-
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR- 165 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~- 165 (323)
+.++|++.+.||+|+||+||+|.+..+++.||||.+... ......+.+|+.+++.++|+|+ +++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----~~~~~~~~~~~ 77 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV-----IAIKDIMPPPH 77 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCc-----cchHHheeccc
Confidence 456899999999999999999999999999999988642 2234456789999999999998 7787766543
Q ss_pred ----ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 166 ----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 166 ----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
...|++|||++++|.+++.... .+++..+..++.|++.||.|||+++++||||||+||+++.++.+++
T Consensus 78 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL------ 149 (337)
T cd07858 78 REAFNDVYIVYELMDTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKI------ 149 (337)
T ss_pred ccccCcEEEEEeCCCCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEE------
Confidence 3589999999889999987654 6999999999999999999999999999999999999976665555
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
+|||++...... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.|
T Consensus 150 ---------------------~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 208 (337)
T cd07858 150 ---------------------CDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPL 208 (337)
T ss_pred ---------------------CcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCC
Confidence 455544332211 122357889999999875 4688999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 209 f~~ 211 (337)
T cd07858 209 FPG 211 (337)
T ss_pred CCC
Confidence 975
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=267.97 Aligned_cols=196 Identities=32% Similarity=0.476 Sum_probs=160.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC--c
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--N 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~--~ 166 (323)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .......+|+.++++++|+|+ +++++++... +
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~ 81 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI-----VELKEVVVGKHLD 81 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCC-----cceEEEEecCCCC
Confidence 57999999999999999999999999999999886432 122345679999999999998 8888877543 5
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.+++||||++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++++|||+
T Consensus 82 ~~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~------ 154 (309)
T cd07845 82 SIFLVMEYCEQDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGL------ 154 (309)
T ss_pred eEEEEEecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccce------
Confidence 689999999889999987643 4689999999999999999999999999999999999997766555555554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+...... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+
T Consensus 155 ---------------------~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~ 211 (309)
T cd07845 155 ---------------------ARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPG 211 (309)
T ss_pred ---------------------eeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 4332211 112245788999999876 4578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=264.84 Aligned_cols=200 Identities=23% Similarity=0.249 Sum_probs=156.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCc----EEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
++|++.+.||+|+||+||+|.+..+++ .+++|.+.... .....+..|+.+++.+.|+|+ +++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~i-----v~~~~~~~~- 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI-----VRLLGICPG- 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCc-----ceEEEEECC-
Confidence 468999999999999999999877776 46777765322 233456678888888899988 888887654
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
...++++||+ +++|.+++.... ..+++..+..++.||+.||.|||+++++||||||+||+++.++.+|++|||++...
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 4578899999 899999998654 36899999999999999999999999999999999999977665555555543221
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
..... ........++..|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 160 ~~~~~----------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 214 (279)
T cd05111 160 YPDDK----------------------KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214 (279)
T ss_pred cCCCc----------------------ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 11000 000112346778999999998899999999999999999998 9999975
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=263.63 Aligned_cols=188 Identities=25% Similarity=0.393 Sum_probs=149.3
Q ss_pred eecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH---HhCCCCCcceEEEcceeccCceEEEE
Q 020652 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL---ARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 99 ~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l---~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
.||+|+||.||++.+..+++.+|+|.+.... ........|..+++.+ .|+++ +.+++.+...+..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i-----~~~~~~~~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI-----VCMTYAFHTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcE-----eEEEEEEecCCeEEEE
Confidence 4899999999999999999999999886422 1122334455444444 34444 8888988888899999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||+ +++|.+++.... .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+
T Consensus 76 ~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~----------------- 136 (279)
T cd05633 76 LDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHV----------------- 136 (279)
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCE-----------------
Confidence 9999 899999987654 69999999999999999999999999999999999999766655
Q ss_pred cccCCCCCCceEeeCCCcccccC-CccccccCCccccchhhc-CCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||++..... ......||..|+|||++. +..++.++|||||||++|||++|..||..
T Consensus 137 ----------~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 198 (279)
T cd05633 137 ----------RISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (279)
T ss_pred ----------EEccCCcceeccccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCC
Confidence 4555554432211 112236899999999986 45689999999999999999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=267.20 Aligned_cols=195 Identities=25% Similarity=0.402 Sum_probs=166.5
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
++|++.+.||+|+||+||++.+..+++.||+|++... ....+.+.+|+++++.++|+|+ +++++.+...+.++
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYI-----VSFYGAFLNENNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCc-----ceEeeeEecCCEEE
Confidence 4689999999999999999999999999999987643 3345678899999999999998 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
+||||+ +++|.+++.+.+ .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+
T Consensus 80 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~-------------- 143 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQI-------------- 143 (284)
T ss_pred EEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcE--------------
Confidence 999999 889999987754 68999999999999999999997 699999999999999766555
Q ss_pred CCccccCCCCCCceEeeCCCccccc-CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||++.... .......|+..|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 144 -------------~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~ 204 (284)
T cd06620 144 -------------KLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204 (284)
T ss_pred -------------EEccCCcccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence 555555443221 112234789999999999888899999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=261.94 Aligned_cols=202 Identities=26% Similarity=0.387 Sum_probs=164.7
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-------hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
+|++.+.||+|+||.||+|.+ .+++.+|+|.+.... .....+.+|+++++.++|+|+ +++.+++...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI-----VQYLGTCLDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCE-----eeEeeEeecC
Confidence 478899999999999999986 478889999876321 223457789999999999988 9999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+..+++|||+ +++|.+++.+.. .+++..+..++.|++.||+|||+.+|+|+||||+||+++.++.++++|||+....
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999 889999998754 6899999999999999999999999999999999999987777766666654332
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
...+.. ...........|+..|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 153 ~~~~~~------------------~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 153 AWVGLH------------------GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred hhcccc------------------ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 111000 0000011224688999999999998899999999999999999999999964
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=266.09 Aligned_cols=198 Identities=29% Similarity=0.481 Sum_probs=163.0
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh------hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
+|++.+.||+|+||.||+|.+..+++.||||.+..... ....+..|+++++.++|+|+ +++++++...+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI-----IGLLDVFGHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCC-----hhhhheeecCC
Confidence 48899999999999999999999999999999874322 23456789999999999998 99999999999
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
..++||||++++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.++++|||++.....
T Consensus 76 ~~~lv~e~~~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 76 NINLVFEFMETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred EEEEEEcccCCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 999999999889999997654 3699999999999999999999999999999999999998777665555554332211
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.. .......++..|+|||.+.+ ..++.++|||||||++|||++|.+||.+
T Consensus 155 ~~------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 155 PN------------------------RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred CC------------------------ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 10 01112356788999999865 4578999999999999999999887754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=261.08 Aligned_cols=201 Identities=23% Similarity=0.334 Sum_probs=162.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCC---CcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
++|++.+.||+|+||+||+|.+..+ ...||||+++.. ......+.+|+.+++.++|+|+ +++++++...+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 78 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNI-----IRLEGVVTKSR 78 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCc-----ceEeEEEecCC
Confidence 4699999999999999999988644 467999988643 3345567889999999999998 89999998889
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
..+++|||+ +++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++++|||+.....
T Consensus 79 ~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 79 PVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred ceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 999999999 889999997654 368999999999999999999999999999999999999877666555555443322
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
..... . ......++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 158 ~~~~~---------~-------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 158 DSEAT---------Y-------------TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred ccccc---------e-------------eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 00000 0 0001134578999999998899999999999999999998 9999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=265.62 Aligned_cols=201 Identities=24% Similarity=0.382 Sum_probs=159.8
Q ss_pred cEEEEeeecccCcEEEEEEEE----CCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC-
Q 020652 93 RYRILSKMGEGTFGQVVECFD----NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR- 165 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~----~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~- 165 (323)
-|++++.||+|+||.||+|.. ..+++.||+|.++.. ....+.+.+|+.+++.+.|+|+ +++.+++...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 79 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI-----VKYKGICTEDG 79 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCe-----eeeeeEEecCC
Confidence 378999999999999999974 457889999998643 3344678899999999999988 8888877664
Q ss_pred -ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 166 -NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 166 -~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
...++||||+ +++|.+++.+.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||++..
T Consensus 80 ~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 80 GNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred CCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccc
Confidence 5789999999 999999997653 3589999999999999999999999999999999999998776665555554332
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
....... ........|+..|+|||++.+..++.++|||||||++|||+|++.|+..
T Consensus 159 ~~~~~~~---------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~ 214 (284)
T cd05079 159 IETDKEY---------------------YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESS 214 (284)
T ss_pred cccCccc---------------------eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCcc
Confidence 2111000 0001123467789999999988899999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=263.96 Aligned_cols=196 Identities=34% Similarity=0.637 Sum_probs=163.1
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++|++.+.||+|+||.||+|.+..+++.||+|+++.. ....+.+.+|+++++.+.|+|+ +++.+++..++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENI-----VNLKEAFRRKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCe-----eehhheEEECCEE
Confidence 3699999999999999999999999999999988642 2345678899999999999988 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+++|||+++++.+.+.... ..+++..+..++.||+.||.|||+++|+|+||||+||+++.++.+
T Consensus 76 ~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~--------------- 139 (288)
T cd07833 76 YLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVL--------------- 139 (288)
T ss_pred EEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCE---------------
Confidence 9999999555555444333 358999999999999999999999999999999999999765544
Q ss_pred CccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||.+...... .....++..|+|||++.+. .++.++||||||+++|+|++|+.||.+
T Consensus 140 ------------kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 140 ------------KLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred ------------EEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 55555554432221 1224678899999999888 789999999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=262.53 Aligned_cols=197 Identities=31% Similarity=0.527 Sum_probs=163.7
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
+|++.++||.|++|.||+|++..+++.||||+++... ...+.+.+|+.+++.++|+|+ +++++++...+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI-----VRLHDVIHTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCE-----eeeeeeEeeCCcEEE
Confidence 4899999999999999999999999999999887432 234566789999999999988 999999999999999
Q ss_pred EEccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKLGPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
||||+.++|.+++.... ...+++..+..++.|++.||+|||++||+||||||+||++++++.++
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~--------------- 140 (284)
T cd07836 76 VFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELK--------------- 140 (284)
T ss_pred EEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEE---------------
Confidence 99999779999887543 23589999999999999999999999999999999999997666554
Q ss_pred ccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
|+|||.+...... .....+|..|++||++.+. .++.++|||||||++|+|++|+.||.+.
T Consensus 141 ------------l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 141 ------------LADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred ------------EeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4555544322111 1123578899999998764 5789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=277.62 Aligned_cols=194 Identities=27% Similarity=0.483 Sum_probs=170.7
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHH---------HHHHHHHHHHH---hCCCCCcceEEEcc
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA---------MIEIDVLQRLA---RHDIGGTRCVQIRN 160 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~---------~~Ei~~l~~l~---~~~i~~~~~~~~~~ 160 (323)
.|..++.||+|+||.|++|.++.....|+||.+.+..--.+.+ -.||+||..++ |+|| +++++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI-----lKlLd 636 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI-----LKLLD 636 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch-----hhhhh
Confidence 4999999999999999999999999999999987654333333 24999999999 7777 99999
Q ss_pred eeccCceEEEEEccC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCc
Q 020652 161 WFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~--~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~ 238 (323)
+|++++++||+||.. |.+|+++|..+. .++|..+..|+.|++.|+++||++||||||||-+|+.++.+|
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g------- 707 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG------- 707 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC-------
Confidence 999999999999988 669999999876 799999999999999999999999999999999999986554
Q ss_pred ccccccCCCCCccccCCCCCCceEeeCCCcccccCCc-cccccCCccccchhhcCCCC-CcchhHHHHHHHHHHHhcCCC
Q 020652 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-SYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~ 316 (323)
.+||+|||.+.+..... ..++||..|.|||++.|..| +..-|||+||++||.++....
T Consensus 708 --------------------~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyken 767 (772)
T KOG1152|consen 708 --------------------FVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKEN 767 (772)
T ss_pred --------------------eEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccC
Confidence 56888999887765543 45799999999999999887 577899999999999999999
Q ss_pred CCCC
Q 020652 317 CYLT 320 (323)
Q Consensus 317 pf~~ 320 (323)
||..
T Consensus 768 pyyn 771 (772)
T KOG1152|consen 768 PYYN 771 (772)
T ss_pred CCcC
Confidence 9853
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=265.09 Aligned_cols=197 Identities=22% Similarity=0.348 Sum_probs=160.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCC-----cEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceec
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKK-----ELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~ 163 (323)
++|++.+.||+|+||.||++.+.... ..+|+|.+... ......+.+|+.+++++ +|+|+ +++++++.
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----~~~~~~~~ 86 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI-----INLLGVCT 86 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCe-----eeEEEEEc
Confidence 57999999999999999999876443 78999988643 23345677899999999 78888 99999999
Q ss_pred cCceEEEEEccC-CCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEe
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKN--------------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~ 228 (323)
.+..++++|||+ +++|.+++... ....+++..+..++.|++.||+|||+++|+||||||+||+++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 889999999999 89999999752 234688999999999999999999999999999999999997
Q ss_pred ecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCc-----cccccCCccccchhhcCCCCCcchhHHH
Q 020652 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWS 303 (323)
Q Consensus 229 ~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwS 303 (323)
.++.++++||| .+....... ....++..|+|||++.+..++.++||||
T Consensus 167 ~~~~~kL~Dfg---------------------------~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 219 (293)
T cd05053 167 EDHVMKIADFG---------------------------LARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 219 (293)
T ss_pred CCCeEEeCccc---------------------------cccccccccceeccCCCCCCccccCHHHhccCCcCcccceee
Confidence 76655555554 443322111 1113456799999999889999999999
Q ss_pred HHHHHHHHhc-CCCCCCC
Q 020652 304 VGCILVELCS-VSNCYLT 320 (323)
Q Consensus 304 lG~il~el~t-g~~pf~~ 320 (323)
|||++|||++ |..||.+
T Consensus 220 lG~il~el~~~g~~p~~~ 237 (293)
T cd05053 220 FGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred hhhHHHHHhcCCCCCCCC
Confidence 9999999997 9898864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=261.09 Aligned_cols=202 Identities=23% Similarity=0.314 Sum_probs=161.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCC---cEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~---~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
.+|++.+.||+|+||.||+|.+..++ ..+|+|.++.. ....+.+..|+.+++.++|+|+ +++++++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 78 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNI-----IHLEGVVTKSK 78 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEecCC
Confidence 47999999999999999999886544 37999988642 3345678889999999999998 89999998889
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++++|||++....
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 79 PVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred ccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999 889999998654 368999999999999999999999999999999999999776665555555433221
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
..... ........++..|+|||.+.+..++.++|+|||||++||+++ |..||..
T Consensus 158 ~~~~~---------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~ 212 (267)
T cd05066 158 DDPEA---------------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE 212 (267)
T ss_pred cccce---------------------eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc
Confidence 10000 000001123567999999998889999999999999999886 9999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=262.83 Aligned_cols=189 Identities=25% Similarity=0.421 Sum_probs=158.8
Q ss_pred ecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC
Q 020652 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (323)
Q Consensus 100 lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (323)
||+|+||+||+|.+..+++.||+|++.... .....+..|+.+++.++|+|+ +.+++.+...+..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFI-----VSLAYAFETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCE-----eeeeeEEecCCeEEEEEecC
Confidence 699999999999999999999999886422 223455679999999999887 88999999889999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccC
Q 020652 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (323)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~ 254 (323)
+++|.+++.+.....+++..+..++.|++.||.|||++|++||||||+||+++.++.+
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~--------------------- 134 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNV--------------------- 134 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCE---------------------
Confidence 8999999987655579999999999999999999999999999999999999766555
Q ss_pred CCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 255 PKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+...... .....++..|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 135 ------~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 196 (277)
T cd05577 135 ------RISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196 (277)
T ss_pred ------EEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 55555544332211 1223578899999999888899999999999999999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=279.35 Aligned_cols=194 Identities=24% Similarity=0.345 Sum_probs=161.7
Q ss_pred EEEEeeecccCcEEEEEEEECCCCc---E-EEEEEecc----chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKE---L-VAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~---~-vAiK~~~~----~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
-.+.++||+|+||.||+|..+..+. . ||||..+. ......++.+|.++++.++|+|| ++++++....
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NV-----Vr~yGVa~~~ 233 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNV-----VRFYGVAVLE 233 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEcCC
Confidence 3456899999999999998765432 3 89998873 24566788999999999999999 9999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
..+++|||+| ||+|.++|++.+. .++..+...++.+.+.||+|||++++|||||-.+|+|+..++.+||+|||+
T Consensus 234 ~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL---- 308 (474)
T KOG0194|consen 234 EPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL---- 308 (474)
T ss_pred CccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc----
Confidence 9999999999 9999999998763 699999999999999999999999999999999999998777666666655
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCc--c-ccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--S-YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
++....-. . ...-...|+|||.+....|+.++|||||||++||+.+ |..||.+
T Consensus 309 -----------------------s~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g 365 (474)
T KOG0194|consen 309 -----------------------SRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG 365 (474)
T ss_pred -----------------------ccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC
Confidence 33221000 0 0012357999999999999999999999999999998 7889876
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=263.64 Aligned_cols=197 Identities=34% Similarity=0.527 Sum_probs=158.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHh-CCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLAR-HDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~-~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+.| +|+ +++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i-----~~~~~~~~~~~~ 75 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI-----VRLLDVEHVEEK 75 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCc-----cceeeeEeecCC
Confidence 36999999999999999999999999999999876432 123567789999999965 777 788877766554
Q ss_pred -----EEEEEccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEee-cCceeccCc
Q 020652 168 -----ICIVFEKLGPSLYDFLRKNS---YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDY 238 (323)
Q Consensus 168 -----~~lv~e~~~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~-~~~~ki~d~ 238 (323)
.|++|||+.++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||+++. ++.
T Consensus 76 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~------ 149 (295)
T cd07837 76 NGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGL------ 149 (295)
T ss_pred CCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCe------
Confidence 89999999779999887542 235899999999999999999999999999999999999976 444
Q ss_pred ccccccCCCCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcC
Q 020652 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSV 314 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg 314 (323)
+||+|||.+...... .....+++.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 150 ---------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 208 (295)
T cd07837 150 ---------------------LKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208 (295)
T ss_pred ---------------------EEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcC
Confidence 456666655432111 111256888999998875 4578999999999999999999
Q ss_pred CCCCCC
Q 020652 315 SNCYLT 320 (323)
Q Consensus 315 ~~pf~~ 320 (323)
..||.+
T Consensus 209 ~~~~~~ 214 (295)
T cd07837 209 QPLFPG 214 (295)
T ss_pred CCCCCC
Confidence 999964
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=268.36 Aligned_cols=197 Identities=29% Similarity=0.483 Sum_probs=165.0
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc-
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~- 164 (323)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+..|+.+++.++|+|+ +++.+++..
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~ 81 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI-----ISLSDIFISP 81 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCe-----eeEeeeEecC
Confidence 3567899999999999999999999999999999987532 2334567789999999999998 888888755
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 165 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
....+++|||++++|.+++... .+++..+..++.|++.||.|||+++|+||||||+||+++.++.
T Consensus 82 ~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~------------ 146 (328)
T cd07856 82 LEDIYFVTELLGTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD------------ 146 (328)
T ss_pred CCcEEEEeehhccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC------------
Confidence 5678999999988999888753 4889999999999999999999999999999999999865554
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++|+|||.+...........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 147 ---------------~~l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 147 ---------------LKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred ---------------EEeCccccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 456666655543333334467889999999866 5689999999999999999999999965
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=254.37 Aligned_cols=196 Identities=26% Similarity=0.395 Sum_probs=160.5
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
..+.+..||.|+-|+||+++.+.+|...|||.+.... +..+++.+.++++.+-. ..+++|+.+++|..+..+++
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~----dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSH----DCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhcc----CCCeeeeeeeEEeeCchHHH
Confidence 4566788999999999999999999999999997543 34455666777665443 22455999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
.||.|+..+..++++-. ..++|..+-.+...++.||.||-+ +||||||+||+|||+++.|
T Consensus 169 cMelMs~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G------------------ 229 (391)
T KOG0983|consen 169 CMELMSTCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG------------------ 229 (391)
T ss_pred HHHHHHHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC------------------
Confidence 99999877788777655 469999999999999999999985 6899999999999986554
Q ss_pred ccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCC---CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+||||||.+....+. ++...|.+.|||||.+.-. .|+.++||||||++|+||+||+.||.+
T Consensus 230 ---------niKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 230 ---------NIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred ---------CEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 5677777776543322 3445799999999999643 699999999999999999999999986
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=260.77 Aligned_cols=196 Identities=25% Similarity=0.388 Sum_probs=161.4
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCc---EEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
+.|++.+.||+|+||.||+|.+..+++ .||||++... ....+.+..|+.+++.+.|+|+ +++.+++..+.
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~~~~~~~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI-----IHLEGVVTKSR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCc-----ceEEEEECCCC
Confidence 458999999999999999999877664 6999988642 3445678899999999999998 88999998889
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++++|||+
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~----- 152 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGL----- 152 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcc-----
Confidence 999999999 889999987654 3689999999999999999999999999999999999997666555555554
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCc------ccc--ccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYV--VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSN 316 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~--~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~ 316 (323)
+....... ... ..+..|+|||.+.+..++.++|||||||++|||++ |..
T Consensus 153 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~ 210 (269)
T cd05065 153 ----------------------SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210 (269)
T ss_pred ----------------------ccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCC
Confidence 33221110 001 12457999999998899999999999999999886 999
Q ss_pred CCCC
Q 020652 317 CYLT 320 (323)
Q Consensus 317 pf~~ 320 (323)
||..
T Consensus 211 p~~~ 214 (269)
T cd05065 211 PYWD 214 (269)
T ss_pred CCCC
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=276.23 Aligned_cols=197 Identities=24% Similarity=0.366 Sum_probs=160.6
Q ss_pred CcEEEEeeecccCcEEEEEEEEC-----CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceec
Q 020652 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~ 163 (323)
++|.+.++||+|+||.||+|++. .+++.||+|+++.. ....+.+.+|+.++.++. |+|+ +++++.+.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~ni-----v~~~~~~~ 111 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNI-----VNLLGACT 111 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCe-----EEEEEEEc
Confidence 46888999999999999999864 34568999999743 233456788999999997 8888 99999999
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcCC------------------------------------------------------
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNSY------------------------------------------------------ 188 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~------------------------------------------------------ 188 (323)
..+.+++||||+ +|+|.+++.+...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 989999999999 9999999975421
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 020652 189 ------------------------------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (323)
Q Consensus 189 ------------------------------------------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIl 226 (323)
..+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 23667788899999999999999999999999999999
Q ss_pred EeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccC-----CccccccCCccccchhhcCCCCCcchhH
Q 020652 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDL 301 (323)
Q Consensus 227 i~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di 301 (323)
++..+.+ ||+|||+++.... ......++..|+|||++.+..++.++||
T Consensus 272 l~~~~~~---------------------------kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 324 (401)
T cd05107 272 ICEGKLV---------------------------KICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDV 324 (401)
T ss_pred EeCCCEE---------------------------EEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHH
Confidence 9766555 4555554433211 1112356788999999998889999999
Q ss_pred HHHHHHHHHHhc-CCCCCCC
Q 020652 302 WSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 302 wSlG~il~el~t-g~~pf~~ 320 (323)
|||||++|||++ |..||..
T Consensus 325 wslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 325 WSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred HHHHHHHHHHHHcCCCCCCC
Confidence 999999999998 8899864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=260.64 Aligned_cols=202 Identities=22% Similarity=0.315 Sum_probs=161.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCc---EEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
++|+..+.||+|+||.||+|.+..+++ .+|+|.+... ....+.+..|+.+++.+.|+|+ +++.+++...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 79 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI-----IRLEGVVTKFK 79 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCe-----eEEEEEEccCC
Confidence 568999999999999999999876554 7999988643 3345678889999999999988 99999999989
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||+.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999 889999997653 468999999999999999999999999999999999999776666555555432221
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
..... . ........+..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 159 ~~~~~----------~-----------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~ 213 (268)
T cd05063 159 DDPEG----------T-----------YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213 (268)
T ss_pred ccccc----------c-----------eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence 10000 0 00000123457999999998889999999999999999997 9999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=263.37 Aligned_cols=194 Identities=27% Similarity=0.417 Sum_probs=164.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
..|+.+++||.|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.+.|+|+ +++++.+..++..+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV-----TKYYGSYLKGTKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEECCEEE
Confidence 3588899999999999999999999999999988643 2344667889999999999988 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+++... .+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++++|||
T Consensus 79 lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg--------- 146 (277)
T cd06640 79 IIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFG--------- 146 (277)
T ss_pred EEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccc---------
Confidence 999999 88999998753 58999999999999999999999999999999999999776655555554
Q ss_pred CccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++..... ......++..|+|||++.+..++.++|+|||||++|||++|..||..
T Consensus 147 ------------------~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06640 147 ------------------VAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred ------------------cceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCC
Confidence 4432211 11223578899999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=266.67 Aligned_cols=197 Identities=24% Similarity=0.384 Sum_probs=159.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCC--------------cEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKK--------------ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRC 155 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~--------------~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~ 155 (323)
++|++.++||+|+||.||+|.+..++ ..||+|++... ....+.+.+|++++++++|+|+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i----- 79 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNI----- 79 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCc-----
Confidence 57999999999999999999875432 35899988642 3345678899999999999998
Q ss_pred EEEcceeccCceEEEEEccC-CCCHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 020652 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY----------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN 224 (323)
Q Consensus 156 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~----------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~N 224 (323)
+++++++...+..++||||+ +++|.+++..... ..+++..+..++.|++.||+|||++|++||||||+|
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~N 159 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRN 159 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhh
Confidence 99999999999999999999 8999999865321 236788999999999999999999999999999999
Q ss_pred EEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcch
Q 020652 225 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPC 299 (323)
Q Consensus 225 Ili~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~ 299 (323)
|+++.++.+|++|||+ +...... .....++..|+|||++.+..++.++
T Consensus 160 ill~~~~~~kl~dfg~---------------------------~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 212 (295)
T cd05097 160 CLVGNHYTIKIADFGM---------------------------SRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTAS 212 (295)
T ss_pred EEEcCCCcEEeccccc---------------------------ccccccCcceeccCcCcCceeecChhhhccCCcCchh
Confidence 9997766555555554 3321111 1122456789999999988899999
Q ss_pred hHHHHHHHHHHHhc--CCCCCCC
Q 020652 300 DLWSVGCILVELCS--VSNCYLT 320 (323)
Q Consensus 300 DiwSlG~il~el~t--g~~pf~~ 320 (323)
|||||||++|||++ |..||..
T Consensus 213 DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 213 DVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred hHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999988 6677753
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=261.85 Aligned_cols=202 Identities=26% Similarity=0.408 Sum_probs=158.7
Q ss_pred CcEEEEeeecccCcEEEEEEE----ECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec--c
Q 020652 92 PRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD--Y 164 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~----~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~--~ 164 (323)
.+|++.+.||+|+||.||+|. +..+++.||+|.+.... ...+.+.+|+++++.++|+|+ +++.+++. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~ 78 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI-----VKYKGVCYSAG 78 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCe-----eEEEEEEccCC
Confidence 479999999999999999997 44678899999986433 334577899999999999998 88877653 3
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
...+++||||+ +++|.+++.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||++..
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 79 RRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred CCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccc
Confidence 45689999999 899999997653 3589999999999999999999999999999999999998777666666655432
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
........ . ......++..|+|||++.+..++.++|||||||++|||++|..++..
T Consensus 158 ~~~~~~~~---------~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 158 LPQDKEYY---------K------------VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred ccCCCcce---------e------------ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 21110000 0 00011234569999999988899999999999999999998777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=263.07 Aligned_cols=198 Identities=21% Similarity=0.331 Sum_probs=158.9
Q ss_pred CCcEEEEeeecccCcEEEEEEEECC-----CCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
.++|++.++||+|+||.||+|.++. .+..||+|.+.... .....+.+|+.+++.+.|+|+ +++++++.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~ 79 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV-----VRLLGVVS 79 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEc
Confidence 4689999999999999999997652 34579999876432 233456789999999999988 99999988
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCcee
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNS--------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~k 234 (323)
..+..++||||+ +++|.+++.+.. ...++...+..++.|++.||.|||+++|+||||||+||+++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 888999999999 899999997532 12346678899999999999999999999999999999997766555
Q ss_pred ccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHHHHHHHHH
Q 020652 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (323)
Q Consensus 235 i~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (323)
++||| +++..... .....++..|+|||.+.+..++.++|||||||++|
T Consensus 160 L~Dfg---------------------------~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~ 212 (288)
T cd05061 160 IGDFG---------------------------MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLW 212 (288)
T ss_pred ECcCC---------------------------ccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHH
Confidence 55554 44322111 11124567899999999888999999999999999
Q ss_pred HHhc-CCCCCCC
Q 020652 310 ELCS-VSNCYLT 320 (323)
Q Consensus 310 el~t-g~~pf~~ 320 (323)
||++ |..||.+
T Consensus 213 el~~~~~~p~~~ 224 (288)
T cd05061 213 EITSLAEQPYQG 224 (288)
T ss_pred HHHhCCCCCCCC
Confidence 9998 7888865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=265.19 Aligned_cols=198 Identities=27% Similarity=0.388 Sum_probs=165.6
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
....+|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.++|+|+ +++.+++..
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~ni-----v~~~~~~~~ 86 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNT-----IEYKGCYLR 86 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEEe
Confidence 3446799999999999999999999999999999988632 2333567889999999999988 999999999
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 165 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
.+..++||||+.++|.+++.... ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.
T Consensus 87 ~~~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~------------ 153 (307)
T cd06607 87 EHTAWLVMEYCLGSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT------------ 153 (307)
T ss_pred CCeEEEEHHhhCCCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC------------
Confidence 99999999999888888876543 36899999999999999999999999999999999999865554
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++|+|||.+...... ....|+..|+|||++. ...++.++||||||+++|||+||+.||.+
T Consensus 154 ---------------~kL~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 154 ---------------VKLADFGSASLVSPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred ---------------EEEeecCcceecCCC-CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 566666655443222 2346788999999985 34688999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=259.52 Aligned_cols=193 Identities=23% Similarity=0.345 Sum_probs=158.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
++|++.+.||+|+||.||++. .+++.||+|++.... ..+.+.+|+.+++.++|+|+ +++++++... ..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~-~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-TAQAFLEETAVMTKLHHKNL-----VRLLGVILHN-GLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-hHHHHHHHHHHHHhCCCCCc-----CeEEEEEcCC-CcEEE
Confidence 469999999999999999985 577889999886532 34678889999999999998 7888877654 47999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||+ +++|.+++.......+++..+..++.|++.||.|||++|++||||||+||+++.++.+++
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl--------------- 141 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKV--------------- 141 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEE---------------
Confidence 9999 889999998765556899999999999999999999999999999999999976665555
Q ss_pred cccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
+|||.+............+..|+|||.+.+..++.++|+|||||++|||++ |+.||..
T Consensus 142 ------------~Dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 200 (254)
T cd05083 142 ------------SDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK 200 (254)
T ss_pred ------------CCCccceeccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 455544332222222234567999999988889999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=271.39 Aligned_cols=197 Identities=24% Similarity=0.363 Sum_probs=156.3
Q ss_pred CcEEEEeeecccCcEEEEEEEE-----CCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceec
Q 020652 92 PRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~ 163 (323)
++|++.+.||+|+||+||+|.+ ..+++.||||+++.. ......+.+|+.++.++ +|+|+ +++++++.
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni-----v~~~~~~~ 81 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV-----VNLLGACT 81 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccH-----hhhcceee
Confidence 5799999999999999999985 346788999998743 23345678899999999 46777 88887664
Q ss_pred c-CceEEEEEccC-CCCHHHHHHhcCC-----------------------------------------------------
Q 020652 164 Y-RNHICIVFEKL-GPSLYDFLRKNSY----------------------------------------------------- 188 (323)
Q Consensus 164 ~-~~~~~lv~e~~-~~~L~~~l~~~~~----------------------------------------------------- 188 (323)
. +..++++|||+ +++|.+++.....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 45689999999 9999999875321
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCC
Q 020652 189 ------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256 (323)
Q Consensus 189 ------------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~ 256 (323)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~----------------------- 218 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVV----------------------- 218 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcE-----------------------
Confidence 236778889999999999999999999999999999999766555
Q ss_pred CCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 257 SSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 257 ~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
||+|||++...... .....++..|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 219 ----kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 284 (343)
T cd05103 219 ----KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284 (343)
T ss_pred ----EEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 55555544332111 111234677999999999899999999999999999996 9999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=258.86 Aligned_cols=204 Identities=23% Similarity=0.377 Sum_probs=167.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
++|++.+.||.|+||+||+|.+..++..+|+|++... ......+.+|+.+++.++|+|+ +++++.+...+..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV-----VKYYTSFVVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCE-----EEEEEEEeeCCEEE
Confidence 3699999999999999999999889999999998643 2345677889999999999888 88999888899999
Q ss_pred EEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||++ +++|.+++..... ..+++..+..++.|++.||.|||++||+||||||+||++++++.++++|||++......
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999 8999999976432 46899999999999999999999999999999999999987666555555543322211
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
... .........|+..|+|||++... .++.++|+|||||++|||++|+.||..
T Consensus 156 ~~~--------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 209 (267)
T cd06610 156 GDR--------------------TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK 209 (267)
T ss_pred ccc--------------------cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccc
Confidence 100 00011234688999999999877 789999999999999999999999965
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=258.52 Aligned_cols=194 Identities=29% Similarity=0.470 Sum_probs=164.0
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch------hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
+|+..+.||+|+||+||+|.+..+++.|++|.+.... ...+.+.+|+.+++.++|+|+ +++++++....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI-----VQYLGTEREED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCc-----hheeeeEecCC
Confidence 4788899999999999999998899999999876432 244567889999999999998 88999998889
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.++++|||+ +++|.+++.+.. .+++..+..++.|++.||.|||++||+|+||||+||+++.++.+
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~------------ 141 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVV------------ 141 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE------------
Confidence 999999999 889999998754 58999999999999999999999999999999999999766555
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||.+...... .....|+..|+|||.+.... ++.++|+|||||++|+|++|+.||..
T Consensus 142 ---------------kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~ 204 (258)
T cd06632 142 ---------------KLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ 204 (258)
T ss_pred ---------------EEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 55555544332211 12346889999999998776 89999999999999999999999964
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=263.11 Aligned_cols=202 Identities=22% Similarity=0.328 Sum_probs=161.8
Q ss_pred CcEEEEeeecccCcEEEEEEEEC-----CCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+|++.++||+|+||.||++... .++..+|+|.+... ....+.+.+|+++++.+.|+|+ +++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~ 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI-----VRFYGVCTEG 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCC-----ceEEEEEecC
Confidence 46889999999999999999743 35678999987643 3445678899999999999998 8899998888
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSY-------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~-------------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~ 231 (323)
...+++|||+ +++|.+++..... ..+++..+..++.|++.||+|||++||+||||||+||++++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 8999999999 8999999976431 2478999999999999999999999999999999999997766
Q ss_pred ceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHH
Q 020652 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311 (323)
Q Consensus 232 ~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 311 (323)
.++++|||+........ .........+++.|+|||++.+..++.++|||||||++|||
T Consensus 160 ~~kL~dfg~~~~~~~~~----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 217 (280)
T cd05092 160 VVKIGDFGMSRDIYSTD----------------------YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217 (280)
T ss_pred CEEECCCCceeEcCCCc----------------------eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHH
Confidence 66555555432211000 00001122456789999999999999999999999999999
Q ss_pred hc-CCCCCCC
Q 020652 312 CS-VSNCYLT 320 (323)
Q Consensus 312 ~t-g~~pf~~ 320 (323)
++ |..||..
T Consensus 218 ~~~g~~p~~~ 227 (280)
T cd05092 218 FTYGKQPWYQ 227 (280)
T ss_pred HcCCCCCCcc
Confidence 98 9999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=258.31 Aligned_cols=194 Identities=27% Similarity=0.408 Sum_probs=152.0
Q ss_pred eecccCcEEEEEEEEC--CCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEcc
Q 020652 99 KMGEGTFGQVVECFDN--EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174 (323)
Q Consensus 99 ~lG~G~fg~V~~~~~~--~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~ 174 (323)
.||+|+||.||+|.+. .++..||+|++.... ...+.+.+|+.+++++.|+|+ ++++++++. ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----i~~~~~~~~-~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI-----VRMIGVCEA-EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCe-----EEEEEEEcC-CCeEEEEEe
Confidence 4899999999999765 445679999886432 334568899999999999988 888888764 568999999
Q ss_pred C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcccc
Q 020652 175 L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253 (323)
Q Consensus 175 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~ 253 (323)
+ +++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+|++|||++.....+....
T Consensus 76 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~-- 152 (257)
T cd05115 76 ASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-- 152 (257)
T ss_pred CCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccce--
Confidence 9 899999987543 368999999999999999999999999999999999999776665555555433211111000
Q ss_pred CCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 254 ~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
.......++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 153 -------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 201 (257)
T cd05115 153 -------------------KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKK 201 (257)
T ss_pred -------------------eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCc
Confidence 00001123568999999998889999999999999999996 9999964
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=263.35 Aligned_cols=195 Identities=32% Similarity=0.543 Sum_probs=161.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++|++.++||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+++++.++|+|+ +++++++..+...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL-----VNLIEVFRRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcch-----hhHHHhcccCCeE
Confidence 36999999999999999999999999999999875322 234567789999999999998 8999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||||+ +++|.++..... .+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~-------------- 139 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVV-------------- 139 (286)
T ss_pred EEEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcE--------------
Confidence 9999999 667776655433 58999999999999999999999999999999999999766554
Q ss_pred CCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||++...... .....++..|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 140 -------------~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 140 -------------KLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred -------------EEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 55555554432111 1223578899999998764 478899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=258.32 Aligned_cols=201 Identities=27% Similarity=0.451 Sum_probs=166.5
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh---hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+|++.+.||+|+||.||+|.+..+++.||+|+++.... ..+.+..|+.+++.++|+|+ +++++.+...+.++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNL-----VKYYGVEVHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCCh-----hheeeeEecCCEEE
Confidence 58999999999999999999999999999999875433 55678899999999999998 88888888889999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+|+||+ +++|.+++.... .+++..+..++.|++.||.|||++||+|+||||+||+++.++.++++|||+........
T Consensus 76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred EEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999 899999998754 58899999999999999999999999999999999999877666666665543322211
Q ss_pred CccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCC---CCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
... ........++..|+|||++.+.. ++.++|||||||++|||++|+.||.+
T Consensus 154 ~~~--------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~ 208 (264)
T cd06626 154 TTM--------------------GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208 (264)
T ss_pred Ccc--------------------cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence 100 00011235788999999998766 88999999999999999999999963
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=264.47 Aligned_cols=203 Identities=28% Similarity=0.500 Sum_probs=161.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC---
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--- 165 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~--- 165 (323)
++|++.++||+|+||.||+|.+..+++.||||.+.... .......+|+.+++++.|+|+ +++++++...
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~ 86 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENV-----VNLIEICRTKATP 86 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCc-----cceEEEEeccccc
Confidence 46999999999999999999999999999999885322 223455679999999999998 7777765443
Q ss_pred -----ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 166 -----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 166 -----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
...++||||++++|.+++.... ..+++..++.++.|++.||+|||++|++|+||||+||+++.++.++++|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCEHDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCCcCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 4569999999889998887643 3689999999999999999999999999999999999998777666666665
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
+......... .........++..|+|||.+.+. .++.++||||||+++|||++|..||.
T Consensus 166 ~~~~~~~~~~--------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~ 225 (310)
T cd07865 166 ARAFSLSKNS--------------------KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ 225 (310)
T ss_pred cccccCCccc--------------------CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence 4332211100 00011123578899999998765 47889999999999999999999986
Q ss_pred C
Q 020652 320 T 320 (323)
Q Consensus 320 ~ 320 (323)
+
T Consensus 226 ~ 226 (310)
T cd07865 226 G 226 (310)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=264.63 Aligned_cols=203 Identities=18% Similarity=0.310 Sum_probs=160.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEEC-------CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDN-------EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN 160 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~ 160 (323)
..+|.+.+.||+|+||.||+|++. .++..||+|.+... ......+.+|+.+++.+ .|+|+ +++++
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----~~~~~ 88 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI-----INLLG 88 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCc-----hheeE
Confidence 357999999999999999999753 23457999988642 23445688899999999 79888 89999
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NI 225 (323)
++......+++|||+ +++|.+++.+.. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 999889999999999 889999998642 13578888999999999999999999999999999999
Q ss_pred EEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHH
Q 020652 226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305 (323)
Q Consensus 226 li~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 305 (323)
+++.++.++++|||++........ ........++..|+|||++.+..++.++||||||
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 226 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDY----------------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226 (304)
T ss_pred EEcCCCcEEECCCccceecccccc----------------------cccccCCCCCceeeCchhhccCCCCchhhHHHHH
Confidence 998766665555554332211100 0001112356789999999988899999999999
Q ss_pred HHHHHHhc-CCCCCCC
Q 020652 306 CILVELCS-VSNCYLT 320 (323)
Q Consensus 306 ~il~el~t-g~~pf~~ 320 (323)
|++|||++ |..||.+
T Consensus 227 ~~l~el~~~g~~p~~~ 242 (304)
T cd05101 227 VLMWEIFTLGGSPYPG 242 (304)
T ss_pred HHHHHHHcCCCCCccc
Confidence 99999998 7888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=258.69 Aligned_cols=187 Identities=25% Similarity=0.386 Sum_probs=152.2
Q ss_pred eecccCcEEEEEEEE--CCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEc
Q 020652 99 KMGEGTFGQVVECFD--NEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (323)
Q Consensus 99 ~lG~G~fg~V~~~~~--~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 173 (323)
+||+|+||.||+|.+ ..+++.+|+|+++.. ....+.+..|+.+++.+.|+|+ +++++++.. ...++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~-~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYI-----VRMIGICEA-ESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEcC-CCcEEEEe
Confidence 689999999999964 467789999988643 2345678889999999999998 888887654 56789999
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccc
Q 020652 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252 (323)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~ 252 (323)
|+ +++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||
T Consensus 76 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg------------- 140 (257)
T cd05116 76 LAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFG------------- 140 (257)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCc-------------
Confidence 99 789999997654 68999999999999999999999999999999999999766655555554
Q ss_pred cCCCCCCceEeeCCCcccccCCc------cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 253 NLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 253 ~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
.+....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 141 --------------~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 201 (257)
T cd05116 141 --------------LSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201 (257)
T ss_pred --------------cccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 443322111 11234578999999988889999999999999999998 9999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=264.00 Aligned_cols=202 Identities=22% Similarity=0.378 Sum_probs=162.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCC----------------cEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKK----------------ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGT 153 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~----------------~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~ 153 (323)
++|++.+.||+|+||.||+|.+..++ ..||+|++... ....+.+.+|+++++++.|+|+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i--- 81 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI--- 81 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE---
Confidence 57999999999999999999876544 56899988743 2445678889999999999988
Q ss_pred ceEEEcceeccCceEEEEEccC-CCCHHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 020652 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNS---------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPE 223 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~ 223 (323)
+++++++..+...+++||++ +++|.+++.+.. ...+++..++.++.|++.||.|||++||+||||||+
T Consensus 82 --~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 82 --ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred --eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 89999998889999999999 899999997643 125899999999999999999999999999999999
Q ss_pred cEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHH
Q 020652 224 NILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWS 303 (323)
Q Consensus 224 NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 303 (323)
||+++.++.++++|||++....... .........++..|+|||++.+..++.++||||
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 217 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSD----------------------YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA 217 (296)
T ss_pred ceeecCCCceEEccccceeecccCc----------------------ceeecCcCCCCceecCHHHhhcCCCCccchhhh
Confidence 9999877666555555432211100 000111234677899999999888999999999
Q ss_pred HHHHHHHHhc--CCCCCCC
Q 020652 304 VGCILVELCS--VSNCYLT 320 (323)
Q Consensus 304 lG~il~el~t--g~~pf~~ 320 (323)
|||++|||++ |..||..
T Consensus 218 lG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 218 FGVTLWEILTLCREQPYEH 236 (296)
T ss_pred hHHHHHHHHhcCCCCCCCC
Confidence 9999999998 6777754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=260.47 Aligned_cols=192 Identities=23% Similarity=0.339 Sum_probs=150.1
Q ss_pred eecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEcc
Q 020652 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174 (323)
Q Consensus 99 ~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~ 174 (323)
.||+|+||.||+|.+..+++.||+|.+.... ........|..+++.+.+. .+++++.+.+.+...+..++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG--DCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhC--CCCcEeeeeeeeecCCEEEEEEec
Confidence 4899999999999999999999999886422 1122233444444444321 123448999999999999999999
Q ss_pred C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcccc
Q 020652 175 L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253 (323)
Q Consensus 175 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~ 253 (323)
+ +++|.+++.... .+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+++
T Consensus 79 ~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl------------------ 138 (278)
T cd05606 79 MNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRI------------------ 138 (278)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEE------------------
Confidence 9 899999887654 6999999999999999999999999999999999999976665544
Q ss_pred CCCCCCceEeeCCCcccccC-CccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 254 LPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 254 ~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+|||.+..... ......|+..|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 139 ---------~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 139 ---------SDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred ---------ccCcCccccCccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 45554432211 11234689999999999754 6899999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=264.95 Aligned_cols=197 Identities=22% Similarity=0.355 Sum_probs=158.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECC-------CCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW 161 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~ 161 (323)
++|.+.++||+|+||.||+|++.. ....+|+|.++.. ......+..|+.+++.+ .|+|+ ++++++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~ 86 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNI-----INLLGV 86 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCe-----eeEEEE
Confidence 579999999999999999998642 3457999988743 23345677899999999 58888 999999
Q ss_pred eccCceEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 020652 162 FDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (323)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIl 226 (323)
+...+.++++|||+ +++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+|||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 166 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVL 166 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEE
Confidence 98888999999999 899999997642 135888999999999999999999999999999999999
Q ss_pred EeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhH
Q 020652 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDL 301 (323)
Q Consensus 227 i~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di 301 (323)
++.++.+|+ +|||.++..... .....++..|+|||++.+..++.++||
T Consensus 167 l~~~~~~kL---------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (314)
T cd05099 167 VTEDNVMKI---------------------------ADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDV 219 (314)
T ss_pred EcCCCcEEE---------------------------ccccccccccccccccccccCCCCccccCHHHHccCCcCccchh
Confidence 976665544 455544332211 011123467999999998889999999
Q ss_pred HHHHHHHHHHhc-CCCCCCC
Q 020652 302 WSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 302 wSlG~il~el~t-g~~pf~~ 320 (323)
|||||++|||++ |..||.+
T Consensus 220 wslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 220 WSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred hHHHHHHHHHHhCCCCCCCC
Confidence 999999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=259.49 Aligned_cols=219 Identities=25% Similarity=0.352 Sum_probs=176.1
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~~~ 166 (323)
++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+..|+.+++++. |+|+ +++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i-----~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI-----IKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCc-----hhHHHHhcCCc
Confidence 3699999999999999999999999999999998642 233456778999999998 8888 89999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
..++|||++ +++|.+++.+.. .+++..+..++.|++.||.|||++|++|+||||+||+++.++.++++|||+.....
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999 999999998765 69999999999999999999999999999999999999998988888888765543
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
.......... ....++..............|+..|+|||++.+..++.++|||||||++++|++|..||...
T Consensus 154 ~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 225 (280)
T cd05581 154 PNSSPESNKG----DATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS 225 (280)
T ss_pred CccccccCCC----CCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCc
Confidence 3221110000 00011111111112223356889999999998888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=265.62 Aligned_cols=201 Identities=21% Similarity=0.293 Sum_probs=159.5
Q ss_pred cEEEEeeecccCcEEEEEEEECCC-----CcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
+|++.++||+|+||.||+|.+..+ ++.||+|++.... ...+.+..|+.++..++|+|+ +++++++...
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-----v~~~~~~~~~ 80 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI-----VCLLGVVTKE 80 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCc-----CeEEEEEcCC
Confidence 578889999999999999987543 5789999987432 234667889999999999988 8999999988
Q ss_pred ceEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeec
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~ 230 (323)
...++++||+ +++|.+++.... ...+++..+..++.|++.||+|||++||+||||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 8999999999 889999985321 1247888899999999999999999999999999999999766
Q ss_pred CceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHH
Q 020652 231 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310 (323)
Q Consensus 231 ~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 310 (323)
+.+|++|||++........ ........+++.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 218 (283)
T cd05091 161 LNVKISDLGLFREVYAADY----------------------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWE 218 (283)
T ss_pred CceEecccccccccccchh----------------------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHH
Confidence 6555555554322111000 000112345778999999988889999999999999999
Q ss_pred Hhc-CCCCCCC
Q 020652 311 LCS-VSNCYLT 320 (323)
Q Consensus 311 l~t-g~~pf~~ 320 (323)
|++ |..||.+
T Consensus 219 l~~~g~~p~~~ 229 (283)
T cd05091 219 VFSYGLQPYCG 229 (283)
T ss_pred HHcCCCCCCCC
Confidence 998 8888865
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=267.22 Aligned_cols=194 Identities=24% Similarity=0.408 Sum_probs=162.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
+.|.....||+|+||.||++.+..+++.||||.+... ....+.+.+|+.+++.+.|+|+ +++++.+..++..++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----i~~~~~~~~~~~~~l 96 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV-----VDMYNSYLVGDELWV 96 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcH-----HHHHHheecCCeEEE
Confidence 4466678899999999999999999999999988643 2345567889999999999988 888888888899999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
||||+ +++|.+++... .+++..+..++.||+.||.|||+++|+||||||+||+++.++.++++|||
T Consensus 97 v~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg---------- 163 (292)
T cd06658 97 VMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFG---------- 163 (292)
T ss_pred EEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCc----------
Confidence 99999 88999988643 58999999999999999999999999999999999999766655555554
Q ss_pred ccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++..... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus 164 -----------------~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 220 (292)
T cd06658 164 -----------------FCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN 220 (292)
T ss_pred -----------------chhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4332111 11224688999999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=257.86 Aligned_cols=191 Identities=24% Similarity=0.378 Sum_probs=160.6
Q ss_pred eeecccCcEEEEEEEECCC---CcEEEEEEeccchhh--HHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNEK---KELVAIKIVRSINKY--REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~---~~~vAiK~~~~~~~~--~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
+.||+|+||.||+|.+... +..||+|++...... .+.+..|+.+++.+.|+|+ +++++++.....++++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNV-----VRLLGVCTEEEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCCh-----heeeeeecCCCceEEEE
Confidence 4799999999999999866 889999998754332 5678899999999999988 89999998889999999
Q ss_pred ccC-CCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 173 EKL-GPSLYDFLRKNS-------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
||+ +++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~d------- 148 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISD------- 148 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcc-------
Confidence 999 999999998751 24689999999999999999999999999999999999997766555555
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCY 318 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf 318 (323)
||.+...... .....++..|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus 149 --------------------fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 208 (262)
T cd00192 149 --------------------FGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY 208 (262)
T ss_pred --------------------cccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCC
Confidence 4444332221 122357889999999998889999999999999999999 69998
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
..
T Consensus 209 ~~ 210 (262)
T cd00192 209 PG 210 (262)
T ss_pred CC
Confidence 65
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=270.27 Aligned_cols=203 Identities=25% Similarity=0.468 Sum_probs=163.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec----
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD---- 163 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~---- 163 (323)
..+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++|+|+ +++++++.
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~ 78 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNI-----IAIRDILRPPGA 78 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCc-----cCHHHhccccCC
Confidence 467999999999999999999999999999999886432 234566789999999999998 77777664
Q ss_pred cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 164 YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 164 ~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
....+++||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+|++|||++..
T Consensus 79 ~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 79 DFKDVYVVMDLMESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred CCceEEEEEehhhhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 345789999999889999987654 599999999999999999999999999999999999998777666666654432
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
....... .........|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+
T Consensus 157 ~~~~~~~--------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 214 (334)
T cd07855 157 LSSSPTE--------------------HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG 214 (334)
T ss_pred ecccCcC--------------------CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence 2111000 0000112368899999999866 4588999999999999999999999965
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=264.04 Aligned_cols=196 Identities=22% Similarity=0.375 Sum_probs=159.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECC----------------CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNE----------------KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGT 153 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~----------------~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~ 153 (323)
++|++.++||+|+||.||++.+.. ++..+|+|++... ....+.+.+|+.+++.++|+|+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i--- 81 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNI--- 81 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc---
Confidence 579999999999999999986533 3457999988743 3345678899999999999988
Q ss_pred ceEEEcceeccCceEEEEEccC-CCCHHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCC
Q 020652 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY---------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPE 223 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~ 223 (323)
+++++++......+++|||+ +++|.+++..... ..+++..+..++.|++.||+|||++||+||||||+
T Consensus 82 --~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~ 159 (296)
T cd05095 82 --IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATR 159 (296)
T ss_pred --ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence 89999998889999999999 8899999976431 24677889999999999999999999999999999
Q ss_pred cEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcc
Q 020652 224 NILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYP 298 (323)
Q Consensus 224 NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~ 298 (323)
||+++.++.++++|||+ +...... .....++..|+|||+..+..++.+
T Consensus 160 Nili~~~~~~~l~dfg~---------------------------~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~ 212 (296)
T cd05095 160 NCLVGKNYTIKIADFGM---------------------------SRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA 212 (296)
T ss_pred eEEEcCCCCEEeccCcc---------------------------cccccCCcceeccCcCcCccccCCHHHHhcCCccch
Confidence 99997666555555554 4322111 111234678999999988889999
Q ss_pred hhHHHHHHHHHHHhc--CCCCCC
Q 020652 299 CDLWSVGCILVELCS--VSNCYL 319 (323)
Q Consensus 299 ~DiwSlG~il~el~t--g~~pf~ 319 (323)
+|||||||++|||++ |..||.
T Consensus 213 ~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 213 SDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred hhhhHHHHHHHHHHHhCCCCCcc
Confidence 999999999999998 778875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=264.16 Aligned_cols=196 Identities=31% Similarity=0.494 Sum_probs=162.4
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC--c
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--N 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~--~ 166 (323)
++|++.+.||+|+||.||+|.+..+++.+|+|.++... .....+.+|+.+++++.|+|+ +++.+++... +
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~~~~~~~~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNI-----VTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCE-----EEEEEEEEecCCC
Confidence 46999999999999999999999999999999987432 223345689999999999988 8888887766 8
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
..|+||||++++|.+++.... ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.+
T Consensus 80 ~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~------------- 145 (293)
T cd07843 80 KIYMVMEYVEHDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGIL------------- 145 (293)
T ss_pred cEEEEehhcCcCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcE-------------
Confidence 899999999779999987654 368999999999999999999999999999999999999766555
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+...... .....+++.|+|||.+.+. .++.++|||||||++|||++|..||.+
T Consensus 146 --------------~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~ 209 (293)
T cd07843 146 --------------KICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209 (293)
T ss_pred --------------EEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 55555544432221 1223578899999998765 468999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=269.19 Aligned_cols=197 Identities=26% Similarity=0.471 Sum_probs=159.2
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC---
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--- 165 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~--- 165 (323)
+.++|++.+.||.|+||.||+|.+..+++.||+|++.... ...+.+.+|+++++.++|+|+ +++++.+...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i-----~~~~~~~~~~~~~ 77 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNI-----VKVYEVLGPSGSD 77 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcc-----hhhHhhhcccccc
Confidence 3578999999999999999999999999999999886432 334567889999999999998 7766654432
Q ss_pred -----------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCcee
Q 020652 166 -----------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (323)
Q Consensus 166 -----------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~k 234 (323)
...|+||||++++|.+++... .+++..++.++.||+.||+|||++||+||||||+||+++..+
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~--- 151 (342)
T cd07854 78 LTEDVGSLTELNSVYIVQEYMETDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED--- 151 (342)
T ss_pred cccccccccccceEEEEeecccccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC---
Confidence 368999999988999888653 589999999999999999999999999999999999996432
Q ss_pred ccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC------ccccccCCccccchhhcC-CCCCcchhHHHHHHH
Q 020652 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCI 307 (323)
Q Consensus 235 i~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~i 307 (323)
..++|+|||.+...... .....|+..|+|||++.+ ..++.++|||||||+
T Consensus 152 -----------------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvi 208 (342)
T cd07854 152 -----------------------LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCI 208 (342)
T ss_pred -----------------------ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHH
Confidence 23455555555432111 112357889999998765 468899999999999
Q ss_pred HHHHhcCCCCCCC
Q 020652 308 LVELCSVSNCYLT 320 (323)
Q Consensus 308 l~el~tg~~pf~~ 320 (323)
+|||++|+.||..
T Consensus 209 l~el~~g~~pf~~ 221 (342)
T cd07854 209 FAEMLTGKPLFAG 221 (342)
T ss_pred HHHHHhCCCCCCC
Confidence 9999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=260.00 Aligned_cols=194 Identities=18% Similarity=0.257 Sum_probs=153.9
Q ss_pred EEEeeecccCcEEEEEEEECCCCc--EEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc-----
Q 020652 95 RILSKMGEGTFGQVVECFDNEKKE--LVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----- 164 (323)
Q Consensus 95 ~~~~~lG~G~fg~V~~~~~~~~~~--~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~----- 164 (323)
.+.++||+|+||.||+|.+..+++ .+|+|.++.. ....+.+.+|+.+++.++|+|+ +++++.+..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~ 76 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV-----MRLIGVCLQTVESE 76 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEccCCccc
Confidence 467899999999999999877765 6899987642 3445677889999999999998 777765422
Q ss_pred -CceEEEEEccC-CCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCc
Q 020652 165 -RNHICIVFEKL-GPSLYDFLRKN----SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (323)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~ 238 (323)
....+++|||+ +++|.+++... ....+++..+..++.|++.||+|||+++|+||||||+|||++.++.++++||
T Consensus 77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df 156 (272)
T cd05075 77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADF 156 (272)
T ss_pred CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCC
Confidence 23578999999 89999987532 2235889999999999999999999999999999999999976665555555
Q ss_pred ccccccCCCCCccccCCCCCCceEeeCCCcccccCCc-----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc
Q 020652 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t 313 (323)
|+ +....... ....+++.|+|||.+.+..++.++|||||||++|||++
T Consensus 157 g~---------------------------~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~ 209 (272)
T cd05075 157 GL---------------------------SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209 (272)
T ss_pred Cc---------------------------ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHc
Confidence 54 33221111 11245678999999999899999999999999999999
Q ss_pred -CCCCCCC
Q 020652 314 -VSNCYLT 320 (323)
Q Consensus 314 -g~~pf~~ 320 (323)
|+.||.+
T Consensus 210 ~g~~p~~~ 217 (272)
T cd05075 210 RGQTPYPG 217 (272)
T ss_pred CCCCCCCC
Confidence 8899865
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=256.70 Aligned_cols=195 Identities=28% Similarity=0.477 Sum_probs=167.9
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
+|++.+.||+|++|.||+|.+..+++.||+|++.... ...+.+.+|+.++..++|+|+ +++++++...+..++
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~l 76 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV-----VKCYGAFYKEGEISI 76 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEccCCeEEE
Confidence 5899999999999999999999999999999987543 345678899999999999988 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
||||+ +++|.+++.... .+++..+..++.|++.||+|||+ ++++||||+|+||+++.++.+
T Consensus 77 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~--------------- 139 (264)
T cd06623 77 VLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEV--------------- 139 (264)
T ss_pred EEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCE---------------
Confidence 99999 799999998753 69999999999999999999999 999999999999999766655
Q ss_pred CccccCCCCCCceEeeCCCcccccCCc---cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 140 ------------~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 203 (264)
T cd06623 140 ------------KIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203 (264)
T ss_pred ------------EEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 455555443322111 1346788999999999888999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=259.58 Aligned_cols=200 Identities=16% Similarity=0.226 Sum_probs=155.8
Q ss_pred EEEEeeecccCcEEEEEEEECC---CCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc-
Q 020652 94 YRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN- 166 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~---~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~- 166 (323)
|++.+.||+|+||.||+|.+.. ++..||+|+++.. ....+.+.+|+.+++.+.|+|+ +++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~ 75 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV-----MKLIGVCFEASS 75 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEeeeccCCc
Confidence 5678999999999999998764 3478999988743 2334568889999999999998 88887665433
Q ss_pred -----eEEEEEccC-CCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceecc
Q 020652 167 -----HICIVFEKL-GPSLYDFLRKN----SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (323)
Q Consensus 167 -----~~~lv~e~~-~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~ 236 (323)
..+++|||+ +++|.+++... ....+++..+..++.|++.||.|||+++|+||||||+||+++.++.+|++
T Consensus 76 ~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 155 (273)
T cd05035 76 LQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVA 155 (273)
T ss_pred cccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEEC
Confidence 479999999 89999988543 22368999999999999999999999999999999999999776666555
Q ss_pred CcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CC
Q 020652 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VS 315 (323)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~ 315 (323)
|||++........ ........++..|+|||.+.+..++.++|||||||++|||++ |.
T Consensus 156 dfg~~~~~~~~~~----------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~ 213 (273)
T cd05035 156 DFGLSKKIYSGDY----------------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQ 213 (273)
T ss_pred Cccceeecccccc----------------------ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCC
Confidence 5554332211100 000011234668999999988889999999999999999999 88
Q ss_pred CCCCC
Q 020652 316 NCYLT 320 (323)
Q Consensus 316 ~pf~~ 320 (323)
.||.+
T Consensus 214 ~p~~~ 218 (273)
T cd05035 214 TPYPG 218 (273)
T ss_pred CCCCC
Confidence 98864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=267.24 Aligned_cols=197 Identities=20% Similarity=0.327 Sum_probs=159.5
Q ss_pred CcEEEEeeecccCcEEEEEEEECCC-------CcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEK-------KELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW 161 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~-------~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~ 161 (323)
.+|++.+.||+|+||.||+|++... +..||+|+++.. ....+.+.+|+.+++++ .|+|| ++++++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~ 86 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNI-----INLLGA 86 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCe-----eeeeEE
Confidence 5799999999999999999986432 236899987643 23446788899999999 79988 999999
Q ss_pred eccCceEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 020652 162 FDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (323)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIl 226 (323)
+...+.++++|||+ +++|.+++.+.. ...+++..+..++.|++.||.|||++||+||||||+||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 166 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL 166 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 99888999999999 889999997532 134778889999999999999999999999999999999
Q ss_pred EeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhH
Q 020652 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDL 301 (323)
Q Consensus 227 i~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di 301 (323)
++.++.++++|||+ ++..... .....++..|+|||++.+..++.++||
T Consensus 167 l~~~~~~kL~Dfg~---------------------------~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (334)
T cd05100 167 VTEDNVMKIADFGL---------------------------ARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 219 (334)
T ss_pred EcCCCcEEECCccc---------------------------ceecccccccccccCCCcCceEcCHHHhccCCcCchhhh
Confidence 97766665555554 3322111 011233567999999999999999999
Q ss_pred HHHHHHHHHHhc-CCCCCCC
Q 020652 302 WSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 302 wSlG~il~el~t-g~~pf~~ 320 (323)
|||||++|||++ |..||.+
T Consensus 220 ~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 220 WSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred HHHHHHHHHHHhcCCCCCCC
Confidence 999999999998 8888864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=263.01 Aligned_cols=196 Identities=20% Similarity=0.340 Sum_probs=158.9
Q ss_pred cEEEEeeecccCcEEEEEEEECC-----CCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 93 RYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
+|++.+.||+|+||.||+|.+.. ....+|+|.+.... ...+.+.+|+.+++.+.|+|| +++++.+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV-----IKLYGACSQD 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCE-----eeEEEEEecC
Confidence 47889999999999999998753 23568999876432 334568889999999999988 9999999988
Q ss_pred ceEEEEEccC-CCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNS----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKP 222 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp 222 (323)
+..+++|||+ +++|.+++.... ...+++..+..++.|++.||+|||+++|+||||||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp 155 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA 155 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence 9999999999 899999986421 12478899999999999999999999999999999
Q ss_pred CcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCc
Q 020652 223 ENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNY 297 (323)
Q Consensus 223 ~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~ 297 (323)
+||++++++.++++||| .+...... .....++..|+|||++.+..++.
T Consensus 156 ~nill~~~~~~kl~dfg---------------------------~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~ 208 (290)
T cd05045 156 RNVLVAEGRKMKISDFG---------------------------LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTT 208 (290)
T ss_pred heEEEcCCCcEEecccc---------------------------ccccccCccchhcccCCCCCccccCHHHHccCCcch
Confidence 99999766655555554 44322111 11124567899999998888999
Q ss_pred chhHHHHHHHHHHHhc-CCCCCCC
Q 020652 298 PCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 298 ~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
++|||||||++|||++ |..||.+
T Consensus 209 ~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 209 QSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred HhHHHHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999998 9999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=259.87 Aligned_cols=195 Identities=22% Similarity=0.319 Sum_probs=160.4
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCc----EEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+|++.+.||+|+||+||+|.+..+++ .+|+|.+.... .....+.+|+.+++.+.|+|+ +++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~- 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHV-----VRLLGICLS- 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEec-
Confidence 579999999999999999999876654 58999876432 344677889999999999998 888887776
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
...++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.++++|||+
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~---- 155 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGL---- 155 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcc----
Confidence 7889999999 899999998754 3589999999999999999999999999999999999997766655555554
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCcc-----ccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCY 318 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf 318 (323)
+........ ...++..|+|||.+....++.++|+|||||++|||++ |+.||
T Consensus 156 -----------------------~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 212 (279)
T cd05057 156 -----------------------AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212 (279)
T ss_pred -----------------------cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCC
Confidence 332211111 0123567999999988889999999999999999998 99999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 213 ~~ 214 (279)
T cd05057 213 EG 214 (279)
T ss_pred CC
Confidence 76
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=261.09 Aligned_cols=195 Identities=32% Similarity=0.548 Sum_probs=162.7
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
|++.+.||+|++|.||+|.+..+++.||+|++.... ...+.+.+|+++++.++|+|+ +++++++..++..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i-----v~~~~~~~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI-----VRLLDVVHSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCc-----cCHhheeccCCeEEE
Confidence 677899999999999999999999999999886432 233567789999999999998 899999998999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
+|||++++|.+++.......+++..+..++.|++.||+|||+++++||||+|+||+++.++.+
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~----------------- 138 (283)
T cd07835 76 VFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGAL----------------- 138 (283)
T ss_pred EEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcE-----------------
Confidence 999998899999987654568999999999999999999999999999999999999765554
Q ss_pred cccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+...... .....++..|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 139 ----------~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 202 (283)
T cd07835 139 ----------KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPG 202 (283)
T ss_pred ----------EEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 55555554332111 1123568899999988764 578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=256.25 Aligned_cols=195 Identities=27% Similarity=0.410 Sum_probs=161.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
.+|++.+.||+|+||.||++.+. .+..+|+|.+.........+..|+++++++.|+++ +++++++......+++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~v 77 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKL-----VQLYGVCTERSPICLV 77 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCe-----eeEEEEEccCCceEEE
Confidence 36899999999999999999875 46679999887554445678889999999999988 8999999888899999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||+ +++|.+++.... ..++++.+..++.|++.||.|||+++++||||||+||+++.++.++++|||+
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~---------- 146 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGM---------- 146 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcc----------
Confidence 9999 889999987654 3588999999999999999999999999999999999997666555555554
Q ss_pred cccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
+...... .....++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus 147 -----------------~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 204 (256)
T cd05112 147 -----------------TRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204 (256)
T ss_pred -----------------eeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 3322111 011234568999999998889999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=262.13 Aligned_cols=195 Identities=28% Similarity=0.429 Sum_probs=165.2
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
.++|++.+.||+|+||.||++.+..+++.||+|.+... ....+.+.+|+.+++.+.|+|+ +++++.+...+..|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----~~~~~~~~~~~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNI-----VNYLDSYLVGDELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCe-----eehhheeeeCCcEE
Confidence 36899999999999999999999889999999988642 2334567889999999999988 99999998889999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+|+||+ +++|.+++.+. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++++
T Consensus 93 lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~------------ 157 (293)
T cd06647 93 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLT------------ 157 (293)
T ss_pred EEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEc------------
Confidence 999999 89999998764 48899999999999999999999999999999999999766655554
Q ss_pred CccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
|||.+..... ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||..
T Consensus 158 ---------------dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~ 217 (293)
T cd06647 158 ---------------DFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (293)
T ss_pred ---------------cCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4444332211 11224688899999999888899999999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=264.75 Aligned_cols=194 Identities=29% Similarity=0.451 Sum_probs=163.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
..|+..+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.+.|+|+ +++++.+..++..+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 78 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI-----TRYYGSYLKGTKLW 78 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCcc-----HhhhcccccCCceE
Confidence 3477788999999999999999999999999988633 3344567889999999999988 89999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++++||
T Consensus 79 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~df---------- 145 (277)
T cd06642 79 IIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADF---------- 145 (277)
T ss_pred EEEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccc----------
Confidence 999999 88999988653 5899999999999999999999999999999999999977665555554
Q ss_pred CccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
|++...... .....|+..|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus 146 -----------------g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 146 -----------------GVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred -----------------cccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 444332211 1224578899999999998899999999999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=256.35 Aligned_cols=197 Identities=28% Similarity=0.447 Sum_probs=167.3
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+|++.+.||+|+||.||++.+..++..+|+|.+... ....+.+.+|+.+++.++|+|+ +++++.+......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i-----~~~~~~~~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI-----VTFFASFQENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCCh-----hhhhheeccCCeEE
Confidence 589999999999999999999999999999998643 2344567789999999999998 89999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+++||+ +++|.+++.......+++..+..++.|++.||.|||+++|+|+||||+||+++.++.
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~---------------- 139 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM---------------- 139 (257)
T ss_pred EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC----------------
Confidence 999999 899999998765456899999999999999999999999999999999999975532
Q ss_pred CccccCCCCCCceEeeCCCcccccCCc---cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.++++|||.+....... ....|++.|+|||++.+..++.++|+|||||++|||++|..||..
T Consensus 140 ----------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 204 (257)
T cd08225 140 ----------VAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204 (257)
T ss_pred ----------eEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 24556666554332211 123588899999999888899999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=259.20 Aligned_cols=198 Identities=26% Similarity=0.391 Sum_probs=164.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc--Cce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~--~~~ 167 (323)
++|+..++||.|++|.||+|.+..+++.+|+|.+.... .....+.+|+++++.++|+|| +.+++++.. .+.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~ 75 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI-----VKYYGAFLDESSSS 75 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCe-----eeeeeEEEccCCCe
Confidence 36999999999999999999999999999999887432 345668889999999999998 888887744 447
Q ss_pred EEEEEccC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 168 ICIVFEKL-GPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+++||||+ +++|.+++.. .....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~----------- 144 (287)
T cd06621 76 IGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQV----------- 144 (287)
T ss_pred EEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeE-----------
Confidence 89999999 8899988753 223468999999999999999999999999999999999999766554
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCC-ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+|+|||++...... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 145 ----------------~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 145 ----------------KLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ----------------EEeeccccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 55555554332211 12235788899999999989999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=258.55 Aligned_cols=194 Identities=26% Similarity=0.443 Sum_probs=162.3
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-----------hhHHHHHHHHHHHHHHHhCCCCCcceEEEcce
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-----------~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~ 161 (323)
+|.+.+.||+|+||.||+|.+..+++.+|+|.++... ...+.+..|+.+++.+.|+|+ ++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~ 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNI-----VQYLGF 76 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCc-----ceEEEE
Confidence 5889999999999999999999999999999875311 112456789999999999998 899999
Q ss_pred eccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
+...+.+++||||+ +++|.+++.+.. .+++..+..++.|++.||.|||+++++||||||+||+++.++.++++|||
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~- 153 (272)
T cd06629 77 ETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFG- 153 (272)
T ss_pred eccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecc-
Confidence 99999999999999 999999998764 68999999999999999999999999999999999999766655555554
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCcccccC-----CccccccCCccccchhhcCCC--CCcchhHHHHHHHHHHHhc
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCS 313 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~t 313 (323)
.+..... ......|+..|+|||++.+.. ++.++|+||||+++|||++
T Consensus 154 --------------------------~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~ 207 (272)
T cd06629 154 --------------------------ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA 207 (272)
T ss_pred --------------------------ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHh
Confidence 4432211 112246788999999988754 7899999999999999999
Q ss_pred CCCCCCC
Q 020652 314 VSNCYLT 320 (323)
Q Consensus 314 g~~pf~~ 320 (323)
|..||..
T Consensus 208 g~~p~~~ 214 (272)
T cd06629 208 GRRPWSD 214 (272)
T ss_pred CCCCCcC
Confidence 9999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=304.46 Aligned_cols=198 Identities=32% Similarity=0.465 Sum_probs=167.1
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+.-+|+-..+||.|.||.||-|.+..+|+..|+|-++. ..+......+|..+|..++|+|+ |+++++--++
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNl-----V~YyGVEvHR 1306 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNL-----VRYYGVEVHR 1306 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccc-----cccCceeecH
Confidence 445578888999999999999999999999999997762 23334566789999999999999 8888887788
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+.++|.|||| +|+|.+.+.... ..++...+.+..|++.||.|||++|||||||||+||+++..|
T Consensus 1307 ekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g------------- 1371 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG------------- 1371 (1509)
T ss_pred HHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-------------
Confidence 8999999999 999999998654 577888889999999999999999999999999999986655
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCc-------cccccCCccccchhhcCC---CCCcchhHHHHHHHHHHHhcC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSV 314 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~tg 314 (323)
.+|+.|||.|....... ...+||+-|||||++.+. +...+.|||||||++.||+||
T Consensus 1372 --------------~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tG 1437 (1509)
T KOG4645|consen 1372 --------------LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATG 1437 (1509)
T ss_pred --------------cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecC
Confidence 45666677665443322 236899999999999864 466889999999999999999
Q ss_pred CCCCCC
Q 020652 315 SNCYLT 320 (323)
Q Consensus 315 ~~pf~~ 320 (323)
+.||..
T Consensus 1438 krPW~~ 1443 (1509)
T KOG4645|consen 1438 KRPWAE 1443 (1509)
T ss_pred CCchhh
Confidence 999963
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=265.94 Aligned_cols=192 Identities=24% Similarity=0.421 Sum_probs=161.4
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEE
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
|....+||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.+.|+|+ +++++.+..++..+++|
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNV-----VEMYKSYLVGEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCch-----hhhhhheeeCCeEEEEE
Confidence 45556899999999999999999999999998642 2334567789999999999988 89999998899999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 98 e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~------------------ 156 (297)
T cd06659 98 EFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRV------------------ 156 (297)
T ss_pred ecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcE------------------
Confidence 999 88999887653 58999999999999999999999999999999999999766655
Q ss_pred ccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+..... ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 157 ---------kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 219 (297)
T cd06659 157 ---------KLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS 219 (297)
T ss_pred ---------EEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 5555554432211 11234689999999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=268.32 Aligned_cols=195 Identities=29% Similarity=0.533 Sum_probs=161.8
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC-
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR- 165 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~- 165 (323)
+.++|.+.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.+.|+|+ +++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----v~~~~~~~~~~ 87 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV-----IGLLDVFTSAV 87 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCc-----cchhheecccc
Confidence 456899999999999999999999999999999988642 2234557789999999999998 7777776543
Q ss_pred -----ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 166 -----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 166 -----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
..+++||||+..+|.+++. ..+++..+..++.|++.||+|||+++|+||||||+||+++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~--------- 154 (342)
T cd07879 88 SGDEFQDFYLVMPYMQTDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC--------- 154 (342)
T ss_pred cCCCCceEEEEecccccCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC---------
Confidence 3579999999778877653 2589999999999999999999999999999999999986554
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
.++|+|||++...........+|..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 155 ------------------~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~ 216 (342)
T cd07879 155 ------------------ELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216 (342)
T ss_pred ------------------CEEEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence 4566666666554433344567889999999876 468899999999999999999999997
Q ss_pred C
Q 020652 320 T 320 (323)
Q Consensus 320 ~ 320 (323)
+
T Consensus 217 ~ 217 (342)
T cd07879 217 G 217 (342)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=256.52 Aligned_cols=194 Identities=24% Similarity=0.348 Sum_probs=154.4
Q ss_pred eeecccCcEEEEEEEECCCC---cEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNEKK---ELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~---~~vAiK~~~~~~~--~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
++||+|+||.||+|.+..++ ..+|+|.+..... ..+.+..|+.+++.+.|+|+ +++++++. .+..++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~-~~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCI-----VRLIGVCK-GEPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEc-CCceEEEE
Confidence 47999999999999876655 7899999875433 45678889999999999988 88888765 45689999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.+.. .+++..+..++.|++.||+|||+++++||||||+||+++.++.++++|||++.........
T Consensus 75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~- 151 (257)
T cd05060 75 ELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY- 151 (257)
T ss_pred EeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc-
Confidence 999 889999998765 6899999999999999999999999999999999999987766655555543222111000
Q ss_pred ccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
........++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 152 --------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~ 201 (257)
T cd05060 152 --------------------YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201 (257)
T ss_pred --------------------cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCccc
Confidence 000001123467999999998899999999999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=259.11 Aligned_cols=196 Identities=20% Similarity=0.267 Sum_probs=149.7
Q ss_pred eeecccCcEEEEEEEECC--CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEc
Q 020652 98 SKMGEGTFGQVVECFDNE--KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~--~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 173 (323)
+.||+|+||+||+|.... ....+|+|.+... ......+.+|+.+++.++|+|+ +++++.+......++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~ni-----i~~~~~~~~~~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNV-----LQCLGQCIESIPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCc-----ceEEEEECCCCceEEEEE
Confidence 368999999999996433 4457888876532 2334567789999999999998 999999988899999999
Q ss_pred cC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 174 KL-GPSLYDFLRKNSY---RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 174 ~~-~~~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
|+ +++|.+++..... ...++..+..++.||+.||+|||++||+||||||+||+++.++.+|++|||++......+.
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 155 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY 155 (269)
T ss_pred eCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh
Confidence 99 8999999976432 2346788899999999999999999999999999999997766555555554322111000
Q ss_pred ccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-------CCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-------LGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
........++..|+|||++.. ..++.++|||||||++|||++ |..||..
T Consensus 156 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (269)
T cd05042 156 ----------------------YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212 (269)
T ss_pred ----------------------eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence 000112245678999999753 356789999999999999999 7888864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=258.63 Aligned_cols=191 Identities=22% Similarity=0.311 Sum_probs=154.6
Q ss_pred eeecccCcEEEEEEEECCCCc--EEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNEKKE--LVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~--~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
+.||+|+||.||+|.+..++. .+|+|.++.. ....+.+..|+.++.++ .|+|+ +++++++...+..+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~~~~~~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI-----INLLGACEHRGYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCe-----eeEEEEEecCCCceEEE
Confidence 368999999999999988775 4688877632 34456778899999999 68887 99999999889999999
Q ss_pred ccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccC
Q 020652 173 EKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d 237 (323)
||+ +++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECC
Confidence 999 899999997542 12478999999999999999999999999999999999998776665555
Q ss_pred cccccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-C
Q 020652 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-V 314 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g 314 (323)
||+ +...... ......+..|+|||++.+..++.++|||||||++|||++ |
T Consensus 156 fgl---------------------------~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g 208 (270)
T cd05047 156 FGL---------------------------SRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG 208 (270)
T ss_pred CCC---------------------------ccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCC
Confidence 554 3211110 011123567999999988889999999999999999997 9
Q ss_pred CCCCCC
Q 020652 315 SNCYLT 320 (323)
Q Consensus 315 ~~pf~~ 320 (323)
..||.+
T Consensus 209 ~~pf~~ 214 (270)
T cd05047 209 GTPYCG 214 (270)
T ss_pred CCCccc
Confidence 999964
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=259.05 Aligned_cols=193 Identities=33% Similarity=0.553 Sum_probs=158.4
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceeccC--ceE
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYR--NHI 168 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~~--~~~ 168 (323)
|++.++||+|+||.||+|.+..+++.||+|+++... .......+|+.++.++. |+|+ +++++++... +.+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI-----LRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCc-----cceEEEEecCCCCcE
Confidence 678999999999999999999999999999886432 22223456888888886 8888 8888888877 889
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
++||||+.++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++. +
T Consensus 76 ~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~----------------- 136 (282)
T cd07831 76 ALVFELMDMNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D----------------- 136 (282)
T ss_pred EEEEecCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C-----------------
Confidence 9999999889999887643 36899999999999999999999999999999999999865 4
Q ss_pred CccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+||+|||.+....... ....++..|+|||++.+ ..++.++|||||||++|||++|..||.+
T Consensus 137 ----------~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~ 201 (282)
T cd07831 137 ----------ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPG 201 (282)
T ss_pred ----------CeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCC
Confidence 45666666654432221 22457889999998754 4578899999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=268.72 Aligned_cols=214 Identities=24% Similarity=0.432 Sum_probs=168.3
Q ss_pred eCCcEEE-EeeecccCcEEEEEEEECCCCcEEEEEEeccchhh---------------HHHHHHHHHHHHHHHhCCCCCc
Q 020652 90 LTPRYRI-LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY---------------REAAMIEIDVLQRLARHDIGGT 153 (323)
Q Consensus 90 ~~~~y~~-~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~---------------~~~~~~Ei~~l~~l~~~~i~~~ 153 (323)
+.++|.. .+.||+|+||+||+|.+..+++.||||++...... ...+.+|+.+++.++|+|+
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i--- 82 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENI--- 82 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcce---
Confidence 4567875 46799999999999999999999999988643211 1246789999999999988
Q ss_pred ceEEEcceeccCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCce
Q 020652 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ 233 (323)
+.+++++...+..+++|||+.++|.+++.... .+++..+..++.|++.||+|||++||+|+||||+||+++.++.+
T Consensus 83 --v~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 83 --MGLVDVYVEGDFINLVMDIMASDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred --eeeeEEEecCCcEEEEEeccccCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence 99999999999999999999889999997654 68999999999999999999999999999999999999988888
Q ss_pred eccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHh
Q 020652 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELC 312 (323)
Q Consensus 234 ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~ 312 (323)
+++|||++........... .-.+... ..........+++.|+|||.+.+. .++.++|||||||++|||+
T Consensus 159 kl~dfg~~~~~~~~~~~~~--------~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~ 228 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDT--------LSKDETM--QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228 (335)
T ss_pred EECCccceeeccccccccc--------ccccccc--cccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHH
Confidence 8888887654332111000 0000000 000111223568899999998765 4689999999999999999
Q ss_pred cCCCCCCC
Q 020652 313 SVSNCYLT 320 (323)
Q Consensus 313 tg~~pf~~ 320 (323)
+|..||.+
T Consensus 229 tg~~p~~~ 236 (335)
T PTZ00024 229 TGKPLFPG 236 (335)
T ss_pred hCCCCCCC
Confidence 99999965
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=267.88 Aligned_cols=201 Identities=17% Similarity=0.234 Sum_probs=161.7
Q ss_pred eeeccc--CcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEG--TFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G--~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
..||+| +||+||+|++..+++.||+|++... ....+.+.+|+.+++.++|+|| +++++++..++..++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~ni-----v~~~~~~~~~~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNI-----MTSWTVFTTGSWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc-----ceEeeeEecCCceEEEE
Confidence 456776 9999999999999999999998642 2334667889999999999998 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.+.....+++..+..++.|++.||+|||++||+||||||+||+++.++.++++||+........+.
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~-- 156 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ-- 156 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc--
Confidence 999 88999999876545699999999999999999999999999999999999999888888888764322211110
Q ss_pred ccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC--CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.............++..|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 157 ---------------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 157 ---------------KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred ---------------cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 000000001112356679999999774 478999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=257.00 Aligned_cols=188 Identities=29% Similarity=0.437 Sum_probs=161.2
Q ss_pred ecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC
Q 020652 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (323)
Q Consensus 100 lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (323)
||.|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++|+|+ +++++.+..++..+++|||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFI-----VKLYRTFKDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCE-----eeeeeeEEcCCccEEEEecC
Confidence 699999999999999999999999986432 344668889999999999988 89999999999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccC
Q 020652 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (323)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~ 254 (323)
+++|.+++.+.. .+++..+..++.||+.||.|||+++++|+||||+||+++.++.
T Consensus 76 ~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~---------------------- 131 (262)
T cd05572 76 LGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY---------------------- 131 (262)
T ss_pred CCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC----------------------
Confidence 899999998764 5899999999999999999999999999999999999976554
Q ss_pred CCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 255 PKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
++|+|||.+...... .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus 132 -----~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 195 (262)
T cd05572 132 -----VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGED 195 (262)
T ss_pred -----EEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCC
Confidence 466666655543322 22346889999999998888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=262.32 Aligned_cols=211 Identities=27% Similarity=0.441 Sum_probs=165.8
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc---
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--- 164 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~--- 164 (323)
.++|++.++||+|+||.||+|.+..+++.+|+|++.... .......+|+++++.++|+|+ +++++++..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 81 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV-----VPLIDMAVERPD 81 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCc-----cchhhheecccc
Confidence 468999999999999999999999999999999885322 223456789999999999998 777766532
Q ss_pred -----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 165 -----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 165 -----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
...+++||||++++|...+.... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.++++|||
T Consensus 82 ~~~~~~~~~~lv~~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDHDLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred cccccCceEEEEEecCCcCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 34579999999888888876543 469999999999999999999999999999999999999988888888888
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
++........... .+.. ..........|++.|+|||++.+. .++.++|||||||++|||++|++||
T Consensus 161 ~~~~~~~~~~~~~------------~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 161 LARPYDGPPPNPK------------GGGG-GGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred cchhccCCCcccc------------cCCc-ccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 7654332211000 0000 000111234678999999988764 5789999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 228 ~~ 229 (311)
T cd07866 228 QG 229 (311)
T ss_pred CC
Confidence 65
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=268.32 Aligned_cols=197 Identities=29% Similarity=0.530 Sum_probs=164.1
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+.++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++.+.|+|+ +++.+++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 86 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV-----IGLLDVFTPA 86 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCH-----HHHHHHhhcc
Confidence 3457899999999999999999999999999999987642 2234556789999999999998 7777766554
Q ss_pred c------eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 166 N------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 166 ~------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
+ ..++|+||++++|.+++... .+++..++.++.|++.||.|||+.||+||||||+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~------- 156 (343)
T cd07851 87 SSLEDFQDVYLVTHLMGADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE------- 156 (343)
T ss_pred ccccccccEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC-------
Confidence 4 48999999999999998763 5999999999999999999999999999999999999976554
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
++|+|||.+...........++..|+|||.+.+. .++.++|||||||++|||++|+.||
T Consensus 157 --------------------~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf 216 (343)
T cd07851 157 --------------------LKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLF 216 (343)
T ss_pred --------------------EEEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 4566666555443333345678899999998763 6789999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 217 ~~ 218 (343)
T cd07851 217 PG 218 (343)
T ss_pred CC
Confidence 64
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=257.60 Aligned_cols=195 Identities=21% Similarity=0.271 Sum_probs=158.9
Q ss_pred eeecccCcEEEEEEEECCCC----------cEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 98 SKMGEGTFGQVVECFDNEKK----------ELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~----------~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
+.||+|+||.||+|.+..++ ..+++|++.........+.+|+.+++.+.|+|+ +++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL-----VKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcch-----hheeeEEec-CC
Confidence 46899999999999998776 358888776544436778889999999999998 888887776 67
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.-
T Consensus 75 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~------------- 140 (259)
T cd05037 75 NIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLN------------- 140 (259)
T ss_pred cEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccc-------------
Confidence 89999999 899999998654 268999999999999999999999999999999999999765410
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC--CCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
......+||+|||.+..... .....++..|+|||++.+. .++.++|||||||++|||++ |..||..
T Consensus 141 -------~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~ 209 (259)
T cd05037 141 -------EGYVPFIKLSDPGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST 209 (259)
T ss_pred -------cCCceeEEeCCCCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCccc
Confidence 01223578888888765433 2234577889999999876 78999999999999999999 5777743
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=260.01 Aligned_cols=196 Identities=29% Similarity=0.464 Sum_probs=167.9
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
+|++.+.||+|+||.||+|.+..+++.+|+|.+... ....+.+.+|+++++.+.|+|+ +++++.+...+..++
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~l 76 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYI-----VGFYGAFYNNGDISI 76 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCch-----hhhheeeecCCEEEE
Confidence 588899999999999999999999999999988643 3445667889999999999998 888888888899999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+|||+ +++|.+++.... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++
T Consensus 77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~----------------- 138 (265)
T cd06605 77 CMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG----------------- 138 (265)
T ss_pred EEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-----------------
Confidence 99999 799999998753 478999999999999999999999 9999999999999986544
Q ss_pred CccccCCCCCCceEeeCCCcccccCCc-cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
.++|+|||.+....... ....++..|+|||.+.+..++.++|||||||++|+|++|..||...
T Consensus 139 ----------~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 139 ----------QIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred ----------CEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 45667777654432211 1256888999999999999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=257.95 Aligned_cols=191 Identities=20% Similarity=0.257 Sum_probs=151.6
Q ss_pred eeecccCcEEEEEEEEC--CCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEc
Q 020652 98 SKMGEGTFGQVVECFDN--EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~--~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 173 (323)
+.||+|+||.||+|... .++..+|+|.++... .....+.+|+.+++.++|+|+ +++++++......++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNL-----LQCLGQCTEVTPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEcCCCCcEEEEE
Confidence 36899999999999754 355679999886432 233467789999999999988 899999988888999999
Q ss_pred cC-CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 174 KL-GPSLYDFLRKNS---YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 174 ~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
|+ +++|.+++.... ....++..+..++.|++.||+|||+++++||||||+||+++.++.++++|||+
T Consensus 76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~--------- 146 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGL--------- 146 (269)
T ss_pred CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccc---------
Confidence 99 899999997532 12456778889999999999999999999999999999997766655555554
Q ss_pred ccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCC-------CCCcchhHHHHHHHHHHHhc-CCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGL-------GWNYPCDLWSVGCILVELCS-VSN 316 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlG~il~el~t-g~~ 316 (323)
+...... .....|+..|+|||++.+. .++.++|||||||++|||++ |+.
T Consensus 147 ------------------~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~ 208 (269)
T cd05087 147 ------------------SHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQ 208 (269)
T ss_pred ------------------cccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCC
Confidence 3221111 1123567889999998643 35789999999999999996 999
Q ss_pred CCCC
Q 020652 317 CYLT 320 (323)
Q Consensus 317 pf~~ 320 (323)
||..
T Consensus 209 p~~~ 212 (269)
T cd05087 209 PYRH 212 (269)
T ss_pred CCCC
Confidence 9964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=254.30 Aligned_cols=197 Identities=27% Similarity=0.464 Sum_probs=163.5
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec--cCce
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD--YRNH 167 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~--~~~~ 167 (323)
+|++.+.||.|+||.||+|.+..+++.||+|++... ....+.+..|+++++.++|+|+ +++++++. .+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI-----VRYYDRIIDRSNQT 75 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCcc-----ceeeeeeecCCCCE
Confidence 489999999999999999999999999999988632 3345567889999999999998 88887654 3567
Q ss_pred EEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHH-----HCCceecCCCCCcEEEeecCceeccCcc
Q 020652 168 ICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMH-----ELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH-----~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
.+++|||+ +++|.+++... ....+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~------ 149 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNV------ 149 (265)
T ss_pred EEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCE------
Confidence 89999999 88999998753 2246899999999999999999999 8999999999999999766655
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCCc---cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~ 316 (323)
||+|||.+....... ....|++.|+|||++.+..++.++|+||||+++|+|++|+.
T Consensus 150 ---------------------kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 208 (265)
T cd08217 150 ---------------------KLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSP 208 (265)
T ss_pred ---------------------EEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 555555444332211 22468999999999998889999999999999999999999
Q ss_pred CCCCC
Q 020652 317 CYLTP 321 (323)
Q Consensus 317 pf~~~ 321 (323)
||...
T Consensus 209 p~~~~ 213 (265)
T cd08217 209 PFTAR 213 (265)
T ss_pred cccCc
Confidence 99753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=258.29 Aligned_cols=193 Identities=25% Similarity=0.409 Sum_probs=161.3
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHH---hCCCCCcceEEEcceeccCce
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLA---RHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~---~~~i~~~~~~~~~~~~~~~~~ 167 (323)
.|++.+.||+|+||.||+|.+..+++.||+|.+... ....+.+.+|+.+++.+. |+|+ +++++++..+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~v-----i~~~~~~~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNI-----TKYYGSYLKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCe-----eeEeeeeeeCCE
Confidence 488899999999999999999999999999988643 234456778999999997 6665 999999988899
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.|+||||+ +++|.+++... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~------------- 140 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNV------------- 140 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCE-------------
Confidence 99999999 88999998654 58999999999999999999999999999999999999766555
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+...... .....|+..|+|||.+.+. .++.++|+|||||++|+|++|..||.+
T Consensus 141 --------------~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 204 (277)
T cd06917 141 --------------KLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204 (277)
T ss_pred --------------EEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC
Confidence 55555544332211 1224688899999998754 578999999999999999999999965
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=256.54 Aligned_cols=196 Identities=20% Similarity=0.227 Sum_probs=156.3
Q ss_pred eeecccCcEEEEEEEECC------------CCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 98 SKMGEGTFGQVVECFDNE------------KKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~------------~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
+.||+|+||.||+|.... ....||+|++.... .....+..|+.+++.++|+|+ +++++++..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~i-----v~~~~~~~~ 75 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHI-----VLLYGVCVR 75 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCE-----eeEEEEEec
Confidence 468999999999997532 22358889876433 233466778899999999988 999999888
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
....+++|||+ +++|..++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++..+
T Consensus 76 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~--------- 145 (262)
T cd05077 76 DVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDG--------- 145 (262)
T ss_pred CCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccC---------
Confidence 88899999999 788888887543 3589999999999999999999999999999999999997654210
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhc-CCCCCcchhHHHHHHHHHHHh-cCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELC-SVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~-tg~~pf~~ 320 (323)
.....++++|||.+...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||..
T Consensus 146 -----------~~~~~~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (262)
T cd05077 146 -----------ECGPFIKLSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212 (262)
T ss_pred -----------CCCceeEeCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 12234788899987654322 2346788999999987 456899999999999999997 68888864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=256.82 Aligned_cols=192 Identities=26% Similarity=0.384 Sum_probs=155.9
Q ss_pred CcEEEEeee--cccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKM--GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~l--G~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++|.+.+.+ |+|+||.||++.+..+++.+|+|++....... .|+.+...+ +|+|+ +++++.+...+..
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~----~e~~~~~~~~~h~~i-----v~~~~~~~~~~~~ 84 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA----IEPMVHQLMKDNPNF-----IKLYYSVTTLKGH 84 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch----hhHHHHHHhhcCCCE-----EEEEEEEecCCee
Confidence 456776666 99999999999999999999999986432111 133222222 46666 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||||+ +++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~---------------- 146 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK---------------- 146 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC----------------
Confidence 9999999 899999998764 799999999999999999999999999999999999997654
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
..++|+|||.+...... ....|+..|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 147 ----------~~~~l~dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 209 (267)
T PHA03390 147 ----------DRIYLCDYGLCKIIGTP-SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKED 209 (267)
T ss_pred ----------CeEEEecCccceecCCC-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 13566666655443322 2236889999999999989999999999999999999999999754
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=254.13 Aligned_cols=188 Identities=24% Similarity=0.413 Sum_probs=153.2
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccchh----hHHHHHHHHHHH-HHHHhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVL-QRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~Ei~~l-~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
+.||+|+||.||+|.+..+++.||+|++..... .......|..++ ....|+|+ +++++.+..++.+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i-----~~~~~~~~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYV-----AKLYYSFQSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCe-----eeeeeeEEcCCeEEEEE
Confidence 579999999999999999999999999864321 112233344333 33456766 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.... .+++..+..++.|++.||.|||+.+|+||||+|+||+++.++.
T Consensus 77 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~------------------- 135 (260)
T cd05611 77 EYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH------------------- 135 (260)
T ss_pred eccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc-------------------
Confidence 999 899999998764 6899999999999999999999999999999999999976554
Q ss_pred ccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++|+|||.+..... .....|+..|+|||.+.+..++.++||||||+++|||++|..||..
T Consensus 136 --------~~l~dfg~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 195 (260)
T cd05611 136 --------LKLTDFGLSRNGLE-NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195 (260)
T ss_pred --------EEEeecccceeccc-cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC
Confidence 45666665543322 2234688899999999988889999999999999999999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=255.36 Aligned_cols=194 Identities=24% Similarity=0.346 Sum_probs=161.8
Q ss_pred EEEeeecccCcEEEEEEEECCCC----cEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 95 RILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 95 ~~~~~lG~G~fg~V~~~~~~~~~----~~vAiK~~~~~~~--~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++.+.||+|+||.||+|.+..++ ..||+|++..... ..+.+..|+.+++.+.|+|+ +++++++...+..
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~ 76 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNI-----VKLLGVCTEEEPL 76 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCch-----heEEEEEcCCCee
Confidence 56789999999999999998766 8999999875433 45678889999999999888 8999999888999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
+++|||+ +++|.+++.......+++..+..++.|++.||.|||+++++|+||||+||+++.++.++++|||+
T Consensus 77 ~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~------- 149 (258)
T smart00219 77 MIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGL------- 149 (258)
T ss_pred EEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCC-------
Confidence 9999999 88999999865533389999999999999999999999999999999999998776665555554
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCcc----ccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHS----YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
+........ ...+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+
T Consensus 150 --------------------~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 150 --------------------SRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred --------------------ceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 332221110 1126788999999988889999999999999999998 7888864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=258.26 Aligned_cols=193 Identities=28% Similarity=0.430 Sum_probs=163.5
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
-|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++|+|+ +++++.+..++..++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV-----TKYYGSYLKDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCE-----eEEEEEEEeCCeEEE
Confidence 378889999999999999999999999999987632 2334567889999999999988 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
||||+ +++|.+++... .+++..+..++.|++.||.|||++|++|+||||+||+++.++.+
T Consensus 80 v~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~---------------- 140 (277)
T cd06641 80 IMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEV---------------- 140 (277)
T ss_pred EEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCE----------------
Confidence 99999 88999998753 58999999999999999999999999999999999999765554
Q ss_pred ccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+...... .....|+..|+|||.+.+..++.++|+|||||++|+|++|..||..
T Consensus 141 -----------~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 141 -----------KLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred -----------EEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 55555544332211 1224678899999999888889999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=258.10 Aligned_cols=199 Identities=26% Similarity=0.420 Sum_probs=158.9
Q ss_pred EEEeeecccCcEEEEEEEEC----CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 95 RILSKMGEGTFGQVVECFDN----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 95 ~~~~~lG~G~fg~V~~~~~~----~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.+.+.||.|.||.||+|... ..+..|+||+++.. ....+.+.+|++.+++++|+|| +++++++...+..
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~g~~~~~~~~ 76 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNI-----VKLYGFCIENEPL 76 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTB-----E-EEEEEESSSSE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccc-----ccccccccccccc
Confidence 46789999999999999987 45678999999642 3346788899999999999998 9999999988889
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||||+ +++|.+++.......+++..+..++.|++.||.|||+++|+|+||+++||+++.++.+||+|||+.......
T Consensus 77 ~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 77 FLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp EEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999 789999999874457999999999999999999999999999999999999987776666666554332111
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
.. ........+...|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 157 ~~----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~ 208 (259)
T PF07714_consen 157 SK----------------------YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD 208 (259)
T ss_dssp SS----------------------EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT
T ss_pred cc----------------------cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 00 000111245668999999999889999999999999999999 7888864
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=255.91 Aligned_cols=196 Identities=22% Similarity=0.334 Sum_probs=158.3
Q ss_pred eeecccCcEEEEEEEECC-CC--cEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNE-KK--ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~-~~--~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
++||+|++|.||+|.+.. .+ ..||||.+.... ...+.+.+|+.++++++|+|+ +++++.+.. ...+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~-~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL-----IRLYGVVLT-HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCc-----cceeEEEcC-CeEEEEE
Confidence 468999999999998865 33 368999987543 345678899999999999998 888888777 8899999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++.+.....+++..++.++.|++.||+|||++|++|+||||+||+++.++.+|++|||++..........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999 8999999987543468999999999999999999999999999999999999877776666666543322111000
Q ss_pred ccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
.......++..|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus 155 ---------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 155 ---------------------VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred ---------------------ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 00012346778999999998899999999999999999998 9999853
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=259.45 Aligned_cols=195 Identities=20% Similarity=0.257 Sum_probs=155.8
Q ss_pred eecccCcEEEEEEEECCC------------------------CcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCc
Q 020652 99 KMGEGTFGQVVECFDNEK------------------------KELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGT 153 (323)
Q Consensus 99 ~lG~G~fg~V~~~~~~~~------------------------~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~ 153 (323)
.||+|+||.||+|....+ ...||+|++.... .....+..|+.+++.+.|+|+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~ni--- 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHL--- 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCe---
Confidence 699999999999974321 2458899886432 234567788899999999998
Q ss_pred ceEEEcceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCc
Q 020652 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 232 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~ 232 (323)
+++++++......++||||+ +++|.+++.+.. ..+++..+..++.|++.||+|||+++|+||||||+|||++..+.
T Consensus 79 --v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 79 --AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGL 155 (274)
T ss_pred --eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCc
Confidence 99999999889999999999 889998887543 36899999999999999999999999999999999999976442
Q ss_pred eeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHH
Q 020652 233 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVEL 311 (323)
Q Consensus 233 ~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el 311 (323)
.. .....+|++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|||
T Consensus 156 ~~--------------------~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el 214 (274)
T cd05076 156 AE--------------------GTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214 (274)
T ss_pred cc--------------------CccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence 10 12234788999977543222 22357888999999876 4689999999999999999
Q ss_pred h-cCCCCCCC
Q 020652 312 C-SVSNCYLT 320 (323)
Q Consensus 312 ~-tg~~pf~~ 320 (323)
+ +|..||..
T Consensus 215 ~~~g~~p~~~ 224 (274)
T cd05076 215 CFDGEVPLKE 224 (274)
T ss_pred HhCCCCCccc
Confidence 5 79999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=266.61 Aligned_cols=200 Identities=28% Similarity=0.463 Sum_probs=164.9
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc---
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN--- 166 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~--- 166 (323)
+|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.++|+|+ +++.+++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI-----IGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcch-----hhhhhhhcccCccc
Confidence 589999999999999999999999999999988743 2344568889999999999988 88888876654
Q ss_pred --eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 167 --HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 167 --~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
.+|++|||++++|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+||+++.++.++++|||++...
T Consensus 76 ~~~~~lv~e~~~~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 76 FNDVYIVTELMETDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred ccceEEEecchhhhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 789999999879999987654 7999999999999999999999999999999999999987766655555544322
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
...... ........+|..|+|||++.+. .++.++|+|||||++|+|++|+.||.+
T Consensus 154 ~~~~~~---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~ 209 (330)
T cd07834 154 DPDEDE---------------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPG 209 (330)
T ss_pred cccccc---------------------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCC
Confidence 111000 0011224678899999999888 789999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=259.98 Aligned_cols=203 Identities=20% Similarity=0.328 Sum_probs=161.5
Q ss_pred CCcEEEEeeecccCcEEEEEEEECC-----CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
.++|++.+.||+|+||.||+|.+.. ++..||+|++... ......+.+|+.+++.+.|+|+ +++++++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i-----v~~~~~~~ 78 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI-----VKLLGVCA 78 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCch-----heEEEEEc
Confidence 3579999999999999999998753 6788999988643 2334668889999999999998 89999998
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNS--------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKP 222 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~--------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp 222 (323)
.+...+++|||+ +++|.+++.... ...+++..+..++.|++.||.|||+++++||||||
T Consensus 79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 888999999999 889999997432 12477888999999999999999999999999999
Q ss_pred CcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHH
Q 020652 223 ENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLW 302 (323)
Q Consensus 223 ~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 302 (323)
+||+++.++.++++|||+......... ........++..|+|||++.+..++.++|||
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 216 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADY----------------------YKASENDAIPIRWMPPESIFYNRYTTESDVW 216 (288)
T ss_pred hheEecCCCceEECccccceecccCcc----------------------ccccCCCccChhhcCHHHHhcCCCCchhHHH
Confidence 999997776665555554322111000 0000112345679999999988999999999
Q ss_pred HHHHHHHHHhc-CCCCCCC
Q 020652 303 SVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 303 SlG~il~el~t-g~~pf~~ 320 (323)
||||++|||++ |..||.+
T Consensus 217 slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 217 AYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred HHHHHHHHHHhCCCCCCCC
Confidence 99999999997 8888854
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=257.97 Aligned_cols=193 Identities=26% Similarity=0.447 Sum_probs=159.3
Q ss_pred cEEEEeeecccCcEEEEEEEEC---CCCcEEEEEEeccch-----hhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceec
Q 020652 93 RYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~ 163 (323)
+|++.+.||+|+||.||+|++. .+++.||+|++.... ...+.+.+|+.+++.+. |+++ +.+++.+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i-----~~~~~~~~ 75 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL-----VTLHYAFQ 75 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCCh-----hceeeEee
Confidence 4889999999999999999875 478999999986422 23456778999999995 6777 88888888
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
.+..+++||||+ +++|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.+
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~--------- 144 (290)
T cd05613 76 TDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHV--------- 144 (290)
T ss_pred cCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCE---------
Confidence 889999999999 889999998754 68999999999999999999999999999999999999766555
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCC--CCCcchhHHHHHHHHHHHhcCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~ 316 (323)
+|+|||++...... .....|+..|+|||.+.+. .++.++|||||||++|+|++|..
T Consensus 145 ------------------kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~ 206 (290)
T cd05613 145 ------------------VLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGAS 206 (290)
T ss_pred ------------------EEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCC
Confidence 55555544332211 1124688999999998753 46789999999999999999999
Q ss_pred CCC
Q 020652 317 CYL 319 (323)
Q Consensus 317 pf~ 319 (323)
||.
T Consensus 207 p~~ 209 (290)
T cd05613 207 PFT 209 (290)
T ss_pred CCC
Confidence 985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=260.64 Aligned_cols=200 Identities=31% Similarity=0.547 Sum_probs=162.1
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
+...++|++.+.||+|+||.||+|.+..+++.||+|+++... .....+.+|+++++.++|+|+ +++++++..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-----~~~~~~~~~ 77 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI-----VNLKEIVTD 77 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCe-----eeeeheecC
Confidence 344578999999999999999999999999999999986432 233456789999999999998 888877765
Q ss_pred Cc----------eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCcee
Q 020652 165 RN----------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (323)
Q Consensus 165 ~~----------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~k 234 (323)
.. .+++||||++++|.+++.... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+|
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 78 KQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred cchhhhccccCCcEEEEEcccCccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEE
Confidence 43 799999999778888887653 4689999999999999999999999999999999999997766555
Q ss_pred ccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCc----cccccCCccccchhhcCC-CCCcchhHHHHHHHHH
Q 020652 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILV 309 (323)
Q Consensus 235 i~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ 309 (323)
++||| .+....... ....++..|+|||++.+. .++.++|||||||++|
T Consensus 157 l~dfg---------------------------~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~ 209 (302)
T cd07864 157 LADFG---------------------------LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILG 209 (302)
T ss_pred eCccc---------------------------ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHH
Confidence 55555 443221111 112457789999988754 5789999999999999
Q ss_pred HHhcCCCCCCC
Q 020652 310 ELCSVSNCYLT 320 (323)
Q Consensus 310 el~tg~~pf~~ 320 (323)
||++|+.||..
T Consensus 210 el~~g~~~~~~ 220 (302)
T cd07864 210 ELFTKKPIFQA 220 (302)
T ss_pred HHHhCCCCCCC
Confidence 99999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=255.90 Aligned_cols=195 Identities=35% Similarity=0.581 Sum_probs=160.0
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHH---hCCCCCcceEEEcceeccCce
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLA---RHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~---~~~i~~~~~~~~~~~~~~~~~ 167 (323)
|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++++. |+|+ +++.+++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i-----~~~~~~~~~~~~ 75 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI-----VRLLDVCHGPRT 75 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCc-----ceEEEEEeeccC
Confidence 678999999999999999999889999999986322 22345667888887774 7777 888888877665
Q ss_pred -----EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 168 -----ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 168 -----~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
++++|||+.++|.+++.......+++..++.++.|++.||.|||+.+++|+||||+||+++.++.+
T Consensus 76 ~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~--------- 146 (287)
T cd07838 76 DRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQV--------- 146 (287)
T ss_pred CCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCE---------
Confidence 999999997799999887554469999999999999999999999999999999999999766554
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+...... .....++..|+|||++.+..++.++|||||||++|||++|++||.+
T Consensus 147 ------------------~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~ 208 (287)
T cd07838 147 ------------------KIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRG 208 (287)
T ss_pred ------------------EEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccC
Confidence 55555544332211 1223578899999999998999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=252.48 Aligned_cols=189 Identities=23% Similarity=0.345 Sum_probs=155.5
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (323)
+.||+|+||.||+|... +++.+|+|++... ......+.+|+++++.+.|+|+ +++++++...+..++||||+
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv~e~~ 74 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNI-----VKLIGVCTQRQPIYIVMELV 74 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCc-----CeEEEEEecCCccEEEEECC
Confidence 46899999999999854 6788999987643 2334567889999999999998 88999988888999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccC
Q 020652 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (323)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~ 254 (323)
+++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++++|||+
T Consensus 75 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~-------------- 139 (250)
T cd05085 75 PGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGM-------------- 139 (250)
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCcc--------------
Confidence 899999987654 3588999999999999999999999999999999999998766665555554
Q ss_pred CCCCCceEeeCCCcccccCCc----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 255 PKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
+....... ....++..|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 140 -------------~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~ 197 (250)
T cd05085 140 -------------SRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197 (250)
T ss_pred -------------ceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC
Confidence 32211111 11233567999999988889999999999999999998 9999865
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=281.96 Aligned_cols=204 Identities=24% Similarity=0.368 Sum_probs=165.2
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECC-----CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEccee
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~ 162 (323)
...+-+..+.||+|+||+||+|+... ....||||.++.. ...+++|++|++++..++|+|| |++++.+
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nI-----VrLlGVC 558 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNI-----VRLLGVC 558 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCe-----EEEEEEE
Confidence 34566788999999999999997543 3568999998743 3467899999999999999999 9999999
Q ss_pred ccCceEEEEEccC-CCCHHHHHHhcC--------CCC----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEee
Q 020652 163 DYRNHICIVFEKL-GPSLYDFLRKNS--------YRS----FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (323)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~----l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~ 229 (323)
..++.+|+|+||| .|||.+||+... ... ++..+.+.|+.||+.|++||-++.+|||||-..|+||++
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE 638 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc
Confidence 9999999999999 999999998532 122 788899999999999999999999999999999999987
Q ss_pred cCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHH
Q 020652 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (323)
Q Consensus 230 ~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (323)
.-.|||+|||+++.....+... ......-...||+||.|..+.++++|||||+||+||
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk----------------------~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLW 696 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYK----------------------VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLW 696 (774)
T ss_pred ceEEEecccccchhhhhhhhhc----------------------ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhh
Confidence 6666555555543332221100 000011245899999999999999999999999999
Q ss_pred HHhc-CCCCCCC
Q 020652 310 ELCS-VSNCYLT 320 (323)
Q Consensus 310 el~t-g~~pf~~ 320 (323)
|+++ |+-||.+
T Consensus 697 EIFsyG~QPy~g 708 (774)
T KOG1026|consen 697 EIFSYGKQPYYG 708 (774)
T ss_pred hhhccccCcccc
Confidence 9996 8888865
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=255.37 Aligned_cols=195 Identities=23% Similarity=0.312 Sum_probs=158.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCC---CcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
.+|.+.+.||+|+||.||+|.+... ...||||..... ....+.+.+|+.+++.+.|+|+ +++++++.. .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~-~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI-----VKLIGVITE-N 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCch-----hceeEEEcC-C
Confidence 5689999999999999999987544 456899987643 3455678899999999999998 888887765 4
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
..++||||+ +++|.+++.+.. ..+++..+..++.|++.||+|||++|++||||||+||+++..+.++++|||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g------ 152 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFG------ 152 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCc------
Confidence 578999999 899999998654 368999999999999999999999999999999999999776655555554
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCc----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
.+....... ....++..|+|||.+.+..++.++|||||||++|||++ |..||.+
T Consensus 153 ---------------------~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 211 (270)
T cd05056 153 ---------------------LSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211 (270)
T ss_pred ---------------------eeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 443321111 11234567999999988889999999999999999986 9999965
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=261.33 Aligned_cols=195 Identities=24% Similarity=0.311 Sum_probs=157.5
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCc----EEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+|+..+.||+|+||.||+|.+..+++ .+|+|.+.... .....+.+|+.+++.+.|+|+ +++++++...
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~ni-----v~~~~~~~~~ 81 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL-----VRLLGVCLSP 81 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCc-----ccEEEEEcCC
Confidence 468899999999999999999887776 46888776432 223467789999999999998 8888877653
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
..++++||+ +++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~----------- 148 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHV----------- 148 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCce-----------
Confidence 467899999 899999987654 358999999999999999999999999999999999999766555
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCc-----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCY 318 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf 318 (323)
||+|||++....... ....++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 149 ----------------kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~ 212 (303)
T cd05110 149 ----------------KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212 (303)
T ss_pred ----------------EEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 455555443322111 11235678999999999899999999999999999997 89999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 213 ~~ 214 (303)
T cd05110 213 DG 214 (303)
T ss_pred CC
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=253.77 Aligned_cols=193 Identities=27% Similarity=0.415 Sum_probs=159.6
Q ss_pred EEeeecccCcEEEEEEEECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEcc
Q 020652 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174 (323)
Q Consensus 96 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~ 174 (323)
....||+|+||.||+|.+..++..||+|.+... ....+.+.+|+.+++.++|+|+ +++++++..++..+++|||
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~e~ 86 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNI-----VQYLGSDSENGFFKIFMEQ 86 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCe-----eeeeeeeccCCEEEEEEec
Confidence 346899999999999999999999999987643 3345678899999999999988 9999999999999999999
Q ss_pred C-CCCHHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 175 L-GPSLYDFLRKNSYRSF--PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 175 ~-~~~L~~~l~~~~~~~l--~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
+ +++|.+++.... ..+ ++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 87 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~--------------------- 144 (268)
T cd06624 87 VPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTY--------------------- 144 (268)
T ss_pred CCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCC---------------------
Confidence 9 899999998643 234 788899999999999999999999999999999999642
Q ss_pred ccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCC--CCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
...++|+|||.+...... .....|++.|+|||++.+.. ++.++||||||+++|+|++|..||..
T Consensus 145 -----~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 145 -----SGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred -----CCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 224566666665433211 12235789999999987643 78999999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=258.23 Aligned_cols=200 Identities=28% Similarity=0.439 Sum_probs=170.4
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
+...+.|++.+.||+|+||.||+|.+..+++.||+|++.......+.+..|+++++.++|+|+ +++++.+...+.
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~ 89 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNI-----VDYYDSYLVGDE 89 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCe-----eEEEEEEEECCE
Confidence 345567999999999999999999999899999999987654455678889999999999988 999999998999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.++++||+ +++|.+++.... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++++|||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~------ 162 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGF------ 162 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccch------
Confidence 99999999 799999998764 4699999999999999999999999999999999999997766665555554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+..... ......++..|+|||++.+..++.++|+|||||++|+|++|..||..
T Consensus 163 ---------------------~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~ 218 (286)
T cd06614 163 ---------------------AAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR 218 (286)
T ss_pred ---------------------hhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 322111 11223578899999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=258.67 Aligned_cols=197 Identities=26% Similarity=0.438 Sum_probs=162.0
Q ss_pred CcEEEEeeecccCcEEEEEEEEC----CCCcEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc-
Q 020652 92 PRYRILSKMGEGTFGQVVECFDN----EKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~----~~~~~vAiK~~~~~~~--~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~- 164 (323)
..|++.+.||+|+||.||+|... .+++.+|+|++..... ..+.+.+|+.+++.+.|+|+ +++++++..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i-----~~~~~~~~~~ 78 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI-----VKYKGVCEKP 78 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCCh-----heEEeeeecC
Confidence 45888999999999999999864 3478999999875444 36678899999999999988 888887766
Q ss_pred -CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
+...+++|||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+|+||||+||+++.++.++
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~-------- 149 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVK-------- 149 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEE--------
Confidence 56899999999 889999998654 3589999999999999999999999999999999999997665554
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCCcc------ccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS------YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~ 316 (323)
|+|||.+........ ...++..|+|||.+.+..++.++|||||||++|||+||..
T Consensus 150 -------------------l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~ 210 (284)
T cd05038 150 -------------------ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGD 210 (284)
T ss_pred -------------------EcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCC
Confidence 455554443321110 1134557999999988889999999999999999999999
Q ss_pred CCCCC
Q 020652 317 CYLTP 321 (323)
Q Consensus 317 pf~~~ 321 (323)
||..+
T Consensus 211 p~~~~ 215 (284)
T cd05038 211 PSQSP 215 (284)
T ss_pred Ccccc
Confidence 98764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=249.55 Aligned_cols=195 Identities=31% Similarity=0.520 Sum_probs=168.7
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh-hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
.|++.+.||+|++|.||++.+..+++.+++|++..... ..+.+.+|+.+++.++|+++ +++.+.+......+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNI-----VKYYGSYLKKDELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCE-----eEEEEEEecCCeEEEE
Confidence 38889999999999999999998999999999875443 55678899999999998887 8999999888999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
+||+ +++|.+++.... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~------------------ 136 (253)
T cd05122 76 MEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE------------------ 136 (253)
T ss_pred EecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe------------------
Confidence 9999 799999988753 46899999999999999999999999999999999999965544
Q ss_pred cccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++|+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|+|++|+.||..
T Consensus 137 ---------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 199 (253)
T cd05122 137 ---------VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSE 199 (253)
T ss_pred ---------EEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 5666666655443332 345788999999999988889999999999999999999999865
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=260.80 Aligned_cols=198 Identities=27% Similarity=0.404 Sum_probs=164.1
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
.....|...+.||+|+||.||++.+..+++.+|+|++... ......+..|+++++.++|+|+ +++++++..
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~ 96 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNS-----IEYKGCYLR 96 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEee
Confidence 3445588899999999999999999999999999988632 2233567789999999999988 999999998
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 165 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
++..++||||+.++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.
T Consensus 97 ~~~~~lv~e~~~g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~------------ 163 (317)
T cd06635 97 EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ------------ 163 (317)
T ss_pred CCeEEEEEeCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC------------
Confidence 89999999999778888876543 36899999999999999999999999999999999999866554
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++|+|||.+..... .....|+..|+|||++. +..++.++|||||||++|||++|..||..
T Consensus 164 ---------------~kl~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 164 ---------------VKLADFGSASIASP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred ---------------EEEecCCCccccCC-cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 45566655543222 22346888999999984 34688999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=256.95 Aligned_cols=193 Identities=26% Similarity=0.430 Sum_probs=162.9
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
.|...+.||+|++|.||++.+..+++.+|+|++.... ...+.+.+|+.+++.+.|+|+ +++++++...+..+++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~v-----v~~~~~~~~~~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI-----VEMYSSYLVGDELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCCh-----heEEEEEEcCCeEEEE
Confidence 4666789999999999999999999999999886432 334567889999999999988 8999998888999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
+||+ +++|.+++... .+++..+..++.|++.||+|||++||+||||||+||+++.++.++++|||+
T Consensus 95 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~---------- 161 (285)
T cd06648 95 MEFLEGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGF---------- 161 (285)
T ss_pred EeccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEccccc----------
Confidence 9999 89999998873 589999999999999999999999999999999999997766655555553
Q ss_pred cccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+..... ......|+..|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 162 -----------------~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 162 -----------------CAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred -----------------chhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 322111 11224688999999999988899999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=256.48 Aligned_cols=201 Identities=18% Similarity=0.285 Sum_probs=162.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECC-----CCcEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~~~~~~~--~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
.+|++++.||+|+||.||+|+.+. +.+.||+|.+..... ..+.+.+|+++++++.|+|+ +++++++..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~ 79 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNV-----VRLLGLCRE 79 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcce-----eeeEEEECC
Confidence 469999999999999999999654 356799998764332 35678899999999999988 899999988
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceecc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSY-------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~ 236 (323)
....++||||+ +++|.+++..... ..+++..+..++.|++.||+|||+++|+||||||+||+++.++.++++
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~ 159 (275)
T cd05046 80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS 159 (275)
T ss_pred CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence 88999999999 8999999986541 158999999999999999999999999999999999999887766666
Q ss_pred CcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CC
Q 020652 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VS 315 (323)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~ 315 (323)
|||+........ ........++..|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus 160 ~~~~~~~~~~~~-----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~ 216 (275)
T cd05046 160 LLSLSKDVYNSE-----------------------YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216 (275)
T ss_pred ccccccccCccc-----------------------ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 665432211000 000112245678999999988888999999999999999998 88
Q ss_pred CCCCC
Q 020652 316 NCYLT 320 (323)
Q Consensus 316 ~pf~~ 320 (323)
.||..
T Consensus 217 ~p~~~ 221 (275)
T cd05046 217 LPFYG 221 (275)
T ss_pred CCccc
Confidence 88853
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=256.98 Aligned_cols=198 Identities=32% Similarity=0.540 Sum_probs=162.1
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC--ceE
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--NHI 168 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~--~~~ 168 (323)
|++.+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++.+.|+|+ +++++++... ...
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~ 75 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI-----VRLKEIVTSKGKGSI 75 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCe-----eeheeeEecCCCCcE
Confidence 67899999999999999999999999999998754 2334567789999999999988 8888888877 789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
++||||++++|.+++.... ..+++..++.++.||+.||+|||++|++|+||||+||++++++.++++|||++.......
T Consensus 76 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 76 YMVFEYMDHDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred EEEeccccccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9999999779999987653 368999999999999999999999999999999999999876666555555432221110
Q ss_pred CccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
. .......++..|+|||.+.+. .++.++|||||||++|||++|+.||..
T Consensus 155 ~-----------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~ 204 (287)
T cd07840 155 S-----------------------ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG 204 (287)
T ss_pred c-----------------------ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 0 001223567889999987754 578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=257.11 Aligned_cols=196 Identities=20% Similarity=0.331 Sum_probs=158.0
Q ss_pred eeecccCcEEEEEEEECCCC------cEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 98 SKMGEGTFGQVVECFDNEKK------ELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~------~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+.||+|+||.||+|.+.... +.+|||.+.... .....+.+|+.+++.++|+|+ +++++++......+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI-----VKLLGVCLLNEPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCe-----eeEeeeecCCCCeE
Confidence 36899999999999876544 689999876432 345677889999999999998 99999988888999
Q ss_pred EEEccC-CCCHHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 170 IVFEKL-GPSLYDFLRKNS-----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~-----~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
++|||+ +++|.+++.+.. ...+++..+..++.|++.||.|||+++++|+||||+||+++.++
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~------------ 143 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKG------------ 143 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCC------------
Confidence 999999 899999997532 23478899999999999999999999999999999999997654
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNC 317 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~p 317 (323)
.+....++|+|||++...... .....++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 144 ----------~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p 213 (269)
T cd05044 144 ----------YDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213 (269)
T ss_pred ----------CCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCC
Confidence 012224566666665432211 112245678999999999899999999999999999998 9999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|..
T Consensus 214 ~~~ 216 (269)
T cd05044 214 YPA 216 (269)
T ss_pred Ccc
Confidence 864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=266.00 Aligned_cols=205 Identities=34% Similarity=0.489 Sum_probs=163.7
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceecc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~ 164 (323)
.+.++|++.+.||+|+||.||+|.+..+++.+|+|.+... ......+.+|+.+++++ +|+|+ +++++++..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni-----~~~~~~~~~ 78 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNI-----VKLLNVIKA 78 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCc-----cceeeeecc
Confidence 4567899999999999999999999999999999987532 23344567899999999 99998 888887754
Q ss_pred --CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 165 --RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 165 --~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
....|+||||++++|.+++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++++|||++.
T Consensus 79 ~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 79 ENDKDIYLVFEYMETDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred CCCceEEEEecccccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 3468999999988999998764 58889999999999999999999999999999999999877766666665443
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
........ ..........||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 156 ~~~~~~~~-------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 156 SLSELEEN-------------------PENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred cccccccc-------------------ccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 32211100 00011122468999999998865 4578999999999999999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=287.27 Aligned_cols=198 Identities=21% Similarity=0.332 Sum_probs=164.2
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCc-----EEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKE-----LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
...-++.+.||+|+||.||.|....... .||||.++.. .....+|.+|..+|+.++|+|| +++++++-
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNi-----v~liGv~l 765 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNI-----VSLIGVCL 765 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcce-----eeEEEeec
Confidence 4567788999999999999998765433 4899988754 4556789999999999999999 99999988
Q ss_pred cCceEEEEEccC-CCCHHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccC
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKN-----SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d 237 (323)
.....+|++||| +|+|..||++. +...++......++.||++|++||+++++|||||-..|+|++....|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~V---- 841 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVV---- 841 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcE----
Confidence 889999999999 99999999976 12568899999999999999999999999999999999999766555
Q ss_pred cccccccCCCCCccccCCCCCCceEeeCCCcccccCCcccc-----ccCCccccchhhcCCCCCcchhHHHHHHHHHHHh
Q 020652 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV-----VSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~-----~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 312 (323)
||+|||+|+.......+. .-...|||||.+....++.|+|||||||+|||++
T Consensus 842 -----------------------KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEif 898 (1025)
T KOG1095|consen 842 -----------------------KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIF 898 (1025)
T ss_pred -----------------------EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHH
Confidence 555555554322222111 1134799999999999999999999999999999
Q ss_pred c-CCCCCCC
Q 020652 313 S-VSNCYLT 320 (323)
Q Consensus 313 t-g~~pf~~ 320 (323)
| |..||.+
T Consensus 899 slG~~PY~~ 907 (1025)
T KOG1095|consen 899 SLGATPYPS 907 (1025)
T ss_pred hCCCCCCCC
Confidence 7 8899976
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=255.74 Aligned_cols=203 Identities=19% Similarity=0.244 Sum_probs=161.2
Q ss_pred CCcEEEEeeecccCcEEEEEEEECC----CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNE----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~----~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
.++|++.+.||+|+||.||+|.+.. +++.|++|++... ....+.+.+|+.+++.+.|+|+ +++++++..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----~~~~~~~~~ 79 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI-----LPILHVCIE 79 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEec
Confidence 3679999999999999999999876 3578999988643 3345667889999999999998 888776544
Q ss_pred -CceEEEEEccC-CCCHHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceecc
Q 020652 165 -RNHICIVFEKL-GPSLYDFLRKNSY------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (323)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~ 236 (323)
+...++++||+ +++|.+++..... ..+++..+..++.|++.||+|||+++++||||||+||+++.++.+|++
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence 56789999999 8999999976422 358999999999999999999999999999999999999776666555
Q ss_pred CcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CC
Q 020652 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VS 315 (323)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~ 315 (323)
|||+++....... ........++..|+|||++.+..++.++|||||||++||+++ |+
T Consensus 160 d~g~~~~~~~~~~----------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~ 217 (280)
T cd05043 160 DNALSRDLFPMDY----------------------HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ 217 (280)
T ss_pred CCCCcccccCCce----------------------EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCC
Confidence 5554332211100 000011235667999999998889999999999999999999 99
Q ss_pred CCCCC
Q 020652 316 NCYLT 320 (323)
Q Consensus 316 ~pf~~ 320 (323)
.||..
T Consensus 218 ~p~~~ 222 (280)
T cd05043 218 TPYVE 222 (280)
T ss_pred CCcCc
Confidence 99964
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=259.22 Aligned_cols=196 Identities=27% Similarity=0.425 Sum_probs=160.0
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceeccCceEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+|+..+.||+|+||.||++.+..+++.||+|.+.... .....+.+|+.++.++. |+|+ +++++++...+..+
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i-----v~~~~~~~~~~~~~ 79 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYI-----VKFYGALFREGDCW 79 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCE-----eeeeeEEecCCcEE
Confidence 4677789999999999999999999999999886432 34456788999999986 8887 99999888888999
Q ss_pred EEEccCCCCHHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 170 IVFEKLGPSLYDFLR---KNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 170 lv~e~~~~~L~~~l~---~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
++|||++.+|.++.. ......+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.
T Consensus 80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~------------- 146 (288)
T cd06616 80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN------------- 146 (288)
T ss_pred EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc-------------
Confidence 999999777766543 2223469999999999999999999997 49999999999999976554
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCC---CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++|+|||++...... .....|+..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 147 --------------~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 147 --------------IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred --------------EEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 466666655432211 1223678899999999876 688999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=249.48 Aligned_cols=194 Identities=33% Similarity=0.494 Sum_probs=166.3
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+|++.+.||+|++|.||++.+..+++.||+|.+.... ...+.+.+|+++++++.|+|+ +++.+++...+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI-----VKYIGSIETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCc-----cEEEEEEEeCCEEE
Confidence 4889999999999999999999999999999987543 355678899999999999988 88888888889999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
++||++ +++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 76 ~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~--------------- 138 (254)
T cd06627 76 IILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVV--------------- 138 (254)
T ss_pred EEEecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCE---------------
Confidence 999999 889999998764 69999999999999999999999999999999999999765544
Q ss_pred CccccCCCCCCceEeeCCCcccccCCc---cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+....... ....++..|+|||...+..++.++||||||+++|+|++|..||..
T Consensus 139 ------------~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 139 ------------KLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred ------------EEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 555555544332221 234678899999999888889999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=261.45 Aligned_cols=201 Identities=26% Similarity=0.450 Sum_probs=159.4
Q ss_pred cEEEEeeecccCcEEEEEEEECCC--CcEEEEEEeccc---hhhHHHHHHHHHHHHHHH-hCCCCCcceEEEccee----
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEK--KELVAIKIVRSI---NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWF---- 162 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~--~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~---- 162 (323)
+|++.+.||+|+||.||++.+..+ +..||+|.+... ....+.+.+|+.+++++. |+|+ +++++..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~~~~~~ 75 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNI-----TCLYDMDIVFP 75 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCCh-----heeeeeeeecc
Confidence 489999999999999999999888 899999988632 223456778999999995 8888 6766643
Q ss_pred ccCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 163 DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 163 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
.....++++||+++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.
T Consensus 76 ~~~~~~~~~~e~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 76 GNFNELYLYEELMEADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred ccCCcEEEEEecccCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 2235688999999889999987654 69999999999999999999999999999999999999877766666666543
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
........ .........||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 154 ~~~~~~~~--------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~ 212 (332)
T cd07857 154 GFSENPGE--------------------NAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212 (332)
T ss_pred eccccccc--------------------ccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCC
Confidence 32211100 0001122478999999998876 4689999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=277.14 Aligned_cols=200 Identities=25% Similarity=0.435 Sum_probs=172.4
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceecc---
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDY--- 164 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~--- 164 (323)
+.++.|++.+.||.|.+|.||+++++.+++.+|+|+........++...|..+|+... |||+ +.++++|..
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv-----~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNV-----ATFYGAFIKKDP 90 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCc-----ceEEEEEEEecC
Confidence 3346799999999999999999999999999999999887777788888999998887 4555 888887754
Q ss_pred --CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 165 --RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 165 --~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
++.+||||||| ||+..|+++.-.+.++.|+.+.+|++.++.||.+||.+.++|||||-.|||++..+
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~---------- 160 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA---------- 160 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC----------
Confidence 56899999999 99999999987778999999999999999999999999999999999999987555
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCC-----CCCcchhHHHHHHHHHHHhc
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCS 313 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~el~t 313 (323)
.+||+|||.+..... ...+.+|||.|||||++... .|+..+|+||||++..||.-
T Consensus 161 -----------------~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIElad 223 (953)
T KOG0587|consen 161 -----------------EVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAE 223 (953)
T ss_pred -----------------cEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcC
Confidence 557777776654333 23457899999999999754 37789999999999999999
Q ss_pred CCCCCCC
Q 020652 314 VSNCYLT 320 (323)
Q Consensus 314 g~~pf~~ 320 (323)
|.+|+..
T Consensus 224 G~PPl~D 230 (953)
T KOG0587|consen 224 GAPPLCD 230 (953)
T ss_pred CCCCccC
Confidence 9999865
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=255.60 Aligned_cols=195 Identities=32% Similarity=0.602 Sum_probs=161.7
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh--hHHHHHHHHHHHHHHH-hCCCCCcceEEEcceeccCceEEE
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
|++.+.||+|+||+||+|.+..+++.||||.+..... ......+|+..++++. |+|+ +++++++..++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI-----VKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCc-----hhHHHHhhcCCcEEE
Confidence 6788999999999999999999999999998864322 2223456889999998 8888 899999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
||||++++|.+++.......+++..+..++.|++.+|.|||++|++|+||||+||+++.++.+
T Consensus 76 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~----------------- 138 (283)
T cd07830 76 VFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVV----------------- 138 (283)
T ss_pred EEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCE-----------------
Confidence 999998899999887654578999999999999999999999999999999999999765544
Q ss_pred cccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+...... .....++..|+|||++.+ ..++.++|+||||+++|||++|+.||..
T Consensus 139 ----------~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~ 201 (283)
T cd07830 139 ----------KIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG 201 (283)
T ss_pred ----------EEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCC
Confidence 55555555433221 122467889999998854 4578999999999999999999999964
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=250.81 Aligned_cols=189 Identities=24% Similarity=0.364 Sum_probs=156.4
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (323)
++||+|+||.||+|.+.. ++.||+|++.... ...+.+..|+++++++.|+|+ +.+++++......++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNI-----VKLIGVCVQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCe-----EEEEEEEecCCCeEEEEEcC
Confidence 479999999999999877 8999999876432 345678899999999999988 89999999889999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccC
Q 020652 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (323)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~ 254 (323)
+++|.+++.+.. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.++++|||+
T Consensus 75 ~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~-------------- 139 (251)
T cd05041 75 PGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGM-------------- 139 (251)
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccc--------------
Confidence 899999997653 3688999999999999999999999999999999999997766655555554
Q ss_pred CCCCCceEeeCCCcccccCCc-----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 255 PKSSAIKLIDFGSTTFEHQDH-----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
+....... ....++..|+|||.+.+..++.++|||||||++|||+| |..||.+
T Consensus 140 -------------~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 140 -------------SREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred -------------cccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 33221110 01123557999999988889999999999999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=257.14 Aligned_cols=195 Identities=26% Similarity=0.398 Sum_probs=162.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
+.|...++||+|+||+||+|.+..+++.||+|++... ....+.+..|+.+++.++|+|+ +++++++.....
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~ 95 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNT-----IEYKGCYLKEHT 95 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCC-----ccEEEEEEeCCE
Confidence 4477788999999999999999999999999988632 2233467789999999999998 899999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
.|+||||+.++|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||+++.++.
T Consensus 96 ~~lv~e~~~~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--------------- 159 (313)
T cd06633 96 AWLVMEYCLGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--------------- 159 (313)
T ss_pred EEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC---------------
Confidence 99999999888988887644 46899999999999999999999999999999999999965554
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++|+|||.+..... .....|+..|+|||++. ...++.++|||||||++|||++|..||..
T Consensus 160 ------------~kL~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~ 222 (313)
T cd06633 160 ------------VKLADFGSASKSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222 (313)
T ss_pred ------------EEEeecCCCcccCC-CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 45666665543221 22346889999999985 35688899999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=255.08 Aligned_cols=194 Identities=37% Similarity=0.628 Sum_probs=163.3
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
|++.+.||+|++|.||+|.+..+++.+|+|.+.... .....+..|+.+++.++|+++ +++++++..+...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI-----IKLLDVFRHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCc-----chHHHhhccCCCEEE
Confidence 567899999999999999999999999999886432 234567789999999999988 999999988999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
+|||+.++|.+++.... ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.+
T Consensus 76 v~e~~~~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~----------------- 137 (283)
T cd05118 76 VFEFMDTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVL----------------- 137 (283)
T ss_pred EEeccCCCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcE-----------------
Confidence 99999779999887754 468999999999999999999999999999999999999765544
Q ss_pred cccCCCCCCceEeeCCCcccccCCc---cccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+....... ....++..|+|||.+.+. .++.++|+|||||++|+|+||+.||.+
T Consensus 138 ----------~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 201 (283)
T cd05118 138 ----------KLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG 201 (283)
T ss_pred ----------EEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 555555544332221 123578889999999877 789999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=248.13 Aligned_cols=194 Identities=31% Similarity=0.474 Sum_probs=166.7
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC--ce
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--NH 167 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~--~~ 167 (323)
+|++.+.||+|++|.||+|.+..+++.|++|++.... ...+.+.+|+.++++++|+|+ +++++.+... ..
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNI-----VRYYGSERDEEKNT 75 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCE-----eeEEEEEecCCCCe
Confidence 4888999999999999999999999999999987544 345678899999999999988 8898888887 88
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
++++||++ +++|.+++.+.. .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++++|
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d--------- 144 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLAD--------- 144 (260)
T ss_pred EEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcc---------
Confidence 99999999 999999998765 799999999999999999999999999999999999997666555554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||.+...... .....++..|+|||.+.+...+.++||||||+++|+|++|..||..
T Consensus 145 ------------------~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 205 (260)
T cd06606 145 ------------------FGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSE 205 (260)
T ss_pred ------------------cccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4444332222 1234678899999999888899999999999999999999999965
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=251.38 Aligned_cols=198 Identities=27% Similarity=0.455 Sum_probs=160.5
Q ss_pred ecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC
Q 020652 100 MGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (323)
Q Consensus 100 lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (323)
||+|+||.||++.+..+++.+|+|++.... ...+.+.+|++++++++|+|+ +++++.+..+...|++|||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i-----~~~~~~~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYV-----VKLYYSFQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcch-----hHHHHheecCcEEEEEEecC
Confidence 689999999999999999999999986432 345567889999999999998 88888888899999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccC
Q 020652 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (323)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~ 254 (323)
+++|.+++.+.. .+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++++|||+...........
T Consensus 76 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~--- 150 (265)
T cd05579 76 PGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN--- 150 (265)
T ss_pred CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc---
Confidence 889999998765 68999999999999999999999999999999999999877666555555433221110000
Q ss_pred CCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 255 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
. ...........++..|+|||.+.+..++.++||||||+++|||++|..||..
T Consensus 151 -------~------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 203 (265)
T cd05579 151 -------L------NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203 (265)
T ss_pred -------c------ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 0 0000012234678899999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=248.16 Aligned_cols=196 Identities=30% Similarity=0.514 Sum_probs=165.4
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+|++.++||+|+||.||++.+..+++.+|+|.+... ......+.+|+.+++.++|+|+ +++.+++......+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-----~~~~~~~~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI-----ISYKEAFLDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCc-----hhhhhhhccCCEEE
Confidence 589999999999999999999999999999988643 2334566789999999999988 88888888889999
Q ss_pred EEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 170 IVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+||||+ +++|.+++.+. ....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~-------------- 141 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL-------------- 141 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc--------------
Confidence 999999 88999998762 1246899999999999999999999999999999999999976554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCc-cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+||+|||.+....... ....|+..|+|||.+.+..++.++|+||||+++|||++|+.||..
T Consensus 142 -------------~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~ 203 (256)
T cd08530 142 -------------VKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203 (256)
T ss_pred -------------EEEeeccchhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4555665554432221 123578899999999998899999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=247.64 Aligned_cols=196 Identities=30% Similarity=0.575 Sum_probs=166.4
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+|++.+.||+|+||.||++.+..+++.||+|++.... .....+..|+++++.++|+|+ +++.+.+......+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~-----~~~~~~~~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI-----IKYYESFEEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCCh-----hheEEEEecCCEEE
Confidence 5899999999999999999999999999999987432 445678889999999999988 88888888889999
Q ss_pred EEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 170 IVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
++||++ +++|.+++.+.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++++|||
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~------- 148 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFG------- 148 (258)
T ss_pred EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCcc-------
Confidence 999999 789999998642 3579999999999999999999999999999999999999776655555554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+...... .....|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||..
T Consensus 149 --------------------~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 205 (258)
T cd08215 149 --------------------ISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG 205 (258)
T ss_pred --------------------ceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCC
Confidence 43322211 1224688899999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=250.57 Aligned_cols=196 Identities=19% Similarity=0.265 Sum_probs=150.0
Q ss_pred eeecccCcEEEEEEEECC---CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec-cCceEEEE
Q 020652 98 SKMGEGTFGQVVECFDNE---KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD-YRNHICIV 171 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~---~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~lv 171 (323)
+.||+|+||.||+|.+.. .+..||||.+... ....+.+.+|+.+++.++|+|+ +++++++. .++..+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~~lv 75 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNV-----LSLLGICLPSEGSPLVV 75 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCc-----ceEEEEeecCCCCcEEE
Confidence 468999999999998653 3467999987532 2345677889999999999998 88888653 45668999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||+ +++|.+++.+.. ..+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+|++|||++........
T Consensus 76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~- 153 (262)
T cd05058 76 LPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY- 153 (262)
T ss_pred EecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc-
Confidence 9999 899999997654 3467888889999999999999999999999999999998776666665554332111000
Q ss_pred cccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcC-CCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSV-SNCYL 319 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg-~~pf~ 319 (323)
. .........++..|+|||.+.+..++.++|||||||++|||++| .+||.
T Consensus 154 -----------------~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 154 -----------------Y--SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred -----------------e--eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 0 00001122456789999999888999999999999999999995 56664
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=261.15 Aligned_cols=202 Identities=27% Similarity=0.382 Sum_probs=167.0
Q ss_pred ecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEccee
Q 020652 85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 85 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~ 162 (323)
.+.+-..++..+.++||+|-||.|.+|.-. .+..||+|.++.. ...+.+|.+|+++|.+++|||| +.+.+.+
T Consensus 531 al~EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNI-----veLvGVC 604 (807)
T KOG1094|consen 531 ALVEFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNI-----VELLGVC 604 (807)
T ss_pred chhhcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCe-----eEEEeee
Confidence 344555677889999999999999999743 4688999999843 3456789999999999999999 9999999
Q ss_pred ccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
..++.+|+||||+ .|+|.+|+.++....+.-.....++.||+.|++||.+.++|||||.+.|+|++.+
T Consensus 605 ~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e----------- 673 (807)
T KOG1094|consen 605 VQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGE----------- 673 (807)
T ss_pred ecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCc-----------
Confidence 9999999999999 9999999998754444555667799999999999999999999999999998654
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccCCccc-----cccCCccccchhhcCCCCCcchhHHHHHHHHHHHh--cC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY-----VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC--SV 314 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~--tg 314 (323)
.++||+|||+++.......+ .+-...|||+|.+..++++.++|+|+||+++||++ +.
T Consensus 674 ----------------~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~ 737 (807)
T KOG1094|consen 674 ----------------FTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCR 737 (807)
T ss_pred ----------------ccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHh
Confidence 45566667666644333322 23467899999999999999999999999999985 46
Q ss_pred CCCCC
Q 020652 315 SNCYL 319 (323)
Q Consensus 315 ~~pf~ 319 (323)
..||.
T Consensus 738 e~Py~ 742 (807)
T KOG1094|consen 738 EQPYS 742 (807)
T ss_pred hCchh
Confidence 66664
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=253.84 Aligned_cols=196 Identities=27% Similarity=0.409 Sum_probs=156.6
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCceEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+.+-+..||.|+||+|++..++.+|+..|||.++... +..+++..|.+...+- +.+|| |++++..-.++..|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~I-----VkfyGa~F~EGdcW 139 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNI-----VKFYGALFSEGDCW 139 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHH-----HHHhhhhhcCCcee
Confidence 3455678999999999999999999999999998543 4556677888765443 33455 99999888888999
Q ss_pred EEEccCCCCHHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 170 IVFEKLGPSLYDFLR---KNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 170 lv~e~~~~~L~~~l~---~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
+.||.|..+|..+.+ .-+...++|..+-.|....+.||+||-+ .+|||||+||+|||++..|.
T Consensus 140 iCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~------------- 206 (361)
T KOG1006|consen 140 ICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD------------- 206 (361)
T ss_pred eeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC-------------
Confidence 999999888776543 2333579999999999999999999985 68999999999999876654
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcC--CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+||||||.+....... +.-.|...|||||.+.. .+|+.+||+||||++|||++||..||.+
T Consensus 207 --------------vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 207 --------------VKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred --------------EeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 5666666655433221 22368889999999964 3699999999999999999999999974
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=247.28 Aligned_cols=180 Identities=21% Similarity=0.289 Sum_probs=147.7
Q ss_pred cCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC-CCCHHH
Q 020652 103 GTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYD 181 (323)
Q Consensus 103 G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~ 181 (323)
|.+|.||+|++..+++.||+|.+..... ...|...+....|+|+ +++++++...+..+++|||+ +++|.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~----~~~~~~~~~~~~~~~i-----~~~~~~~~~~~~~~lv~e~~~~~~L~~ 74 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE----YSRERLTIIPHCVPNM-----VCLHKYIVSEDSVFLVLQHAEGGKLWS 74 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh----hhhHHHHHHhcCCCce-----eehhhheecCCeEEEEEecCCCCCHHH
Confidence 8999999999999999999999875432 2234444444556776 99999999999999999999 889999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCce
Q 020652 182 FLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261 (323)
Q Consensus 182 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~k 261 (323)
++.+.. .+++..+..++.|++.||+|||++||+||||||+||+++.++.+ +
T Consensus 75 ~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~---------------------------~ 125 (237)
T cd05576 75 HISKFL--NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHI---------------------------Q 125 (237)
T ss_pred HHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCE---------------------------E
Confidence 997654 58999999999999999999999999999999999999766544 5
Q ss_pred EeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 262 l~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++|||.+...........++..|+|||.+.+..++.++|+||+||++|||++|..||..
T Consensus 126 l~df~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 126 LTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred EecccchhccccccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 55555544333322334567789999999888899999999999999999999987653
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=256.96 Aligned_cols=195 Identities=19% Similarity=0.206 Sum_probs=155.2
Q ss_pred CcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC-CCCH
Q 020652 104 TFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSL 179 (323)
Q Consensus 104 ~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L 179 (323)
++|.||.+++..+++.||+|++... ....+.+..|+.+++.++|+|+ +++++.+...+..+++|||+ +++|
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i-----~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI-----LPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcch-----hhhhheeecCCeEEEEEeccCCCCH
Confidence 4455666666779999999998643 3445678899999999999998 88999999899999999999 8899
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCC
Q 020652 180 YDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259 (323)
Q Consensus 180 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~ 259 (323)
.+++.......+++..+..++.|++.||+|||+++|+||||||+||+++.++.++++||+........+...
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~-------- 158 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ-------- 158 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccc--------
Confidence 999987544578999999999999999999999999999999999999988888777776543322111000
Q ss_pred ceEeeCCCcccccCCccccccCCccccchhhcCC--CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 260 ~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.... .......++..|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 159 RVVH---------DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred cccc---------cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 0000 011223567889999999763 588999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=253.98 Aligned_cols=192 Identities=24% Similarity=0.417 Sum_probs=160.6
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEE
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
|....+||+|+||.||++.+..+++.||||++.... .....+.+|+.+++.++|+|+ +++++.+...+..+++|
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~ 96 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV-----VEMYNSYLVGDELWVVM 96 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcch-----hheeeEEEeCCEEEEEE
Confidence 444578999999999999999999999999876322 344567889999999999988 89999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||+ +++|.+++... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++++|||+
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~----------- 162 (292)
T cd06657 97 EFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGF----------- 162 (292)
T ss_pred ecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEccccc-----------
Confidence 999 88999887543 589999999999999999999999999999999999997766655555554
Q ss_pred ccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+..... ......|+..|+|||.+.+..++.++|+|||||++|||++|..||.+
T Consensus 163 ----------------~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~ 218 (292)
T cd06657 163 ----------------CAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218 (292)
T ss_pred ----------------ceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 322111 11224678999999999888889999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=250.07 Aligned_cols=190 Identities=23% Similarity=0.300 Sum_probs=147.9
Q ss_pred eecccCcEEEEEEEECCC--CcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEcc
Q 020652 99 KMGEGTFGQVVECFDNEK--KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174 (323)
Q Consensus 99 ~lG~G~fg~V~~~~~~~~--~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~ 174 (323)
.||+|+||.||++..... ...+++|.+... ....+.+.+|+.+++.++|+|+ +++++.+......|+||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~i-----v~~~~~~~~~~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNI-----LQCLGQCVEAIPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcch-----hheEEEecCCCccEEEEec
Confidence 699999999999975433 345667766533 2345678899999999999998 9999999888899999999
Q ss_pred C-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 175 L-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 175 ~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
+ +++|.+++.+.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.++++||
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Df------------- 143 (268)
T cd05086 77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDY------------- 143 (268)
T ss_pred CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEeccc-------------
Confidence 9 899999997642 234677788899999999999999999999999999999976665555555
Q ss_pred ccCCCCCCceEeeCCCccccc-----CCccccccCCccccchhhcC-------CCCCcchhHHHHHHHHHHHhc-CCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEH-----QDHSYVVSTRHYRAPEVILG-------LGWNYPCDLWSVGCILVELCS-VSNCY 318 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~-----~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~el~t-g~~pf 318 (323)
|++.... .......|+..|+|||++.. ..++.++|||||||++|||++ |..||
T Consensus 144 --------------g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~ 209 (268)
T cd05086 144 --------------GIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPY 209 (268)
T ss_pred --------------ccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Confidence 4432211 01122467889999999853 245789999999999999996 56777
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
..
T Consensus 210 ~~ 211 (268)
T cd05086 210 SH 211 (268)
T ss_pred CC
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=284.76 Aligned_cols=215 Identities=27% Similarity=0.343 Sum_probs=158.8
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEccee-----
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF----- 162 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~----- 162 (323)
....|+.++.||+||||.||+++++-+|+.||||++... .+......+|+.+|.+|+|+|+ |+++..|
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNV-----VRYysAWVEs~~ 551 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNV-----VRYYSAWVESTA 551 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcce-----eeeehhhhccCC
Confidence 445688899999999999999999999999999999754 3444567789999999999998 2222211
Q ss_pred -------------------------------------------------------c------------------------
Q 020652 163 -------------------------------------------------------D------------------------ 163 (323)
Q Consensus 163 -------------------------------------------------------~------------------------ 163 (323)
.
T Consensus 552 ~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S 631 (1351)
T KOG1035|consen 552 ELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLS 631 (1351)
T ss_pred ccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccc
Confidence 0
Q ss_pred ------c---------------------C--------ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Q 020652 164 ------Y---------------------R--------NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207 (323)
Q Consensus 164 ------~---------------------~--------~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL 207 (323)
. . ..+||-|||| ...|.+++.++. ..-....++++++||+.||
T Consensus 632 ~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~-~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 632 NTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH-FNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred cccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc-cchhhHHHHHHHHHHHHHH
Confidence 0 0 2468999999 445555555543 1114778999999999999
Q ss_pred HHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCccccc-CCccccccCCcccc
Q 020652 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH-QDHSYVVSTRHYRA 286 (323)
Q Consensus 208 ~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~gt~~y~a 286 (323)
.|+|++|||||||||.||++++++.|||+|||++......... ......+.+.-.-.. ...+..+||.-|+|
T Consensus 711 aYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~-------~d~~~~~~~~~~g~~~~~~Ts~VGTalYvA 783 (1351)
T KOG1035|consen 711 AYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLES-------IDQDLSFSTNRAGSNDGDLTSQVGTALYVA 783 (1351)
T ss_pred HHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhh-------HhhccCccccccCCCCcccccccceeeeec
Confidence 9999999999999999999999999999999987552211100 001111111111111 13445699999999
Q ss_pred chhhcCCC---CCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 287 PEVILGLG---WNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 287 PE~~~~~~---~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||++.+.. |+.|+||||||+|||||+. ||..
T Consensus 784 PEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T 817 (1351)
T KOG1035|consen 784 PELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT 817 (1351)
T ss_pred HHHhcccccccccchhhhHHHHHHHHHHhc---cCCc
Confidence 99998765 9999999999999999984 5554
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=256.64 Aligned_cols=196 Identities=29% Similarity=0.405 Sum_probs=161.4
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
...|...+.||+|+||.||+|++..+++.+|+|.+... ....+.+.+|+.+++.+.|+|+ +++.+++....
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 88 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT-----IQYRGCYLREH 88 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCc-----ccEEEEEEcCC
Confidence 35688889999999999999999999999999987632 2233467789999999999988 88888888888
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
..++||||+.++|.+++.... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+
T Consensus 89 ~~~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~------------- 154 (308)
T cd06634 89 TAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLV------------- 154 (308)
T ss_pred eeEEEEEccCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcE-------------
Confidence 999999999778888876543 358999999999999999999999999999999999999765554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC---CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+..... .....|+..|+|||++.+ ..++.++|||||||++|||++|..||..
T Consensus 155 --------------kl~dfg~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 155 --------------KLGDFGSASIMAP-ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred --------------EECCcccceeecC-cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 5555554443222 123467889999999853 4578899999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=252.58 Aligned_cols=196 Identities=26% Similarity=0.412 Sum_probs=158.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
+.|++.+.||+|+||.||+|.+..+++.||||.++... .....+..|+.++.+.. |+|+ +++++++......
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i-----~~~~~~~~~~~~~ 89 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYI-----VKCYGYFITDSDV 89 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCch-----HhhheeeecCCeE
Confidence 56999999999999999999999999999999987432 23345566777666665 7777 8999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
|++|||++++|.+++.... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+
T Consensus 90 ~~v~e~~~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~-------------- 154 (296)
T cd06618 90 FICMELMSTCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNV-------------- 154 (296)
T ss_pred EEEeeccCcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCE--------------
Confidence 9999999888888877644 378999999999999999999997 699999999999999766555
Q ss_pred CCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCC----CCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||.+...... .....++..|+|||.+.+.. ++.++|||||||++|||++|+.||..
T Consensus 155 -------------kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 155 -------------KLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred -------------EECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 55555544332111 11235778899999997654 78999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=249.36 Aligned_cols=196 Identities=24% Similarity=0.508 Sum_probs=159.0
Q ss_pred cEEEEeeecccCcEEEEEEEECC-CCcEEEEEEeccc-----------hhhHHHHHHHHHHHHH-HHhCCCCCcceEEEc
Q 020652 93 RYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSI-----------NKYREAAMIEIDVLQR-LARHDIGGTRCVQIR 159 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~-~~~~vAiK~~~~~-----------~~~~~~~~~Ei~~l~~-l~~~~i~~~~~~~~~ 159 (323)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+... ......+..|+.++.+ ++|+|+ ++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----~~~~ 75 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNI-----VRYY 75 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCe-----eeEE
Confidence 37889999999999999999987 6889999987521 1222445667777765 678877 9999
Q ss_pred ceeccCceEEEEEccC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCceec
Q 020652 160 NWFDYRNHICIVFEKL-GPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKV 235 (323)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~~~~~~ki 235 (323)
+++..++..+++|||+ +++|.+++.. .....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~-- 153 (269)
T cd08528 76 KTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKV-- 153 (269)
T ss_pred eeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcE--
Confidence 9999999999999999 8899998753 223468999999999999999999996 789999999999999765544
Q ss_pred cCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc
Q 020652 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313 (323)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t 313 (323)
+|+|||.+...... .....|+..|+|||.+.+..++.++|+||||+++|||++
T Consensus 154 -------------------------~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~ 208 (269)
T cd08528 154 -------------------------TITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208 (269)
T ss_pred -------------------------EEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHh
Confidence 55555555432222 123468889999999998889999999999999999999
Q ss_pred CCCCCCC
Q 020652 314 VSNCYLT 320 (323)
Q Consensus 314 g~~pf~~ 320 (323)
|+.||..
T Consensus 209 g~~p~~~ 215 (269)
T cd08528 209 LQPPFYS 215 (269)
T ss_pred CCCcccc
Confidence 9999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=251.25 Aligned_cols=204 Identities=25% Similarity=0.469 Sum_probs=163.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc----
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY---- 164 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~---- 164 (323)
+.|+-..+||+|.||.||+|+...+++.||+|++-. .........+|+.+|..+.|+|+ +.+.+.+..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv-----~nliEic~tk~Tp 91 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENV-----VNLIEICRTKATP 91 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhH-----HHHHHHHhhccCC
Confidence 568888999999999999999999999999997643 23345678899999999999998 666555432
Q ss_pred ----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 165 ----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 165 ----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
...+|+||++|..+|.-++.... .+++...+..++.+++.||.|+|...|+|||+|++|+||+.+|.+|++|||+
T Consensus 92 ~~r~r~t~ylVf~~cehDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEHDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred cccccceeeeeHHHhhhhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence 34589999999999999987653 5799999999999999999999999999999999999998777665555555
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
++..+..... ....-+..+-|.+|.+||.+.|. .|+++.|||..|||+.||+||.+-++
T Consensus 171 ar~fs~~~n~--------------------~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq 230 (376)
T KOG0669|consen 171 ARAFSTSKNV--------------------VKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ 230 (376)
T ss_pred ccceeccccc--------------------CCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence 4333221110 00111224669999999999986 69999999999999999999999887
Q ss_pred CC
Q 020652 320 TP 321 (323)
Q Consensus 320 ~~ 321 (323)
+.
T Consensus 231 gn 232 (376)
T KOG0669|consen 231 GN 232 (376)
T ss_pred CC
Confidence 63
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=250.68 Aligned_cols=193 Identities=26% Similarity=0.401 Sum_probs=158.5
Q ss_pred cEEEEeeecccCcEEEEEEEEC---CCCcEEEEEEeccch-----hhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceec
Q 020652 93 RYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~ 163 (323)
+|++.+.||+|+||.||++++. .+++.||||+++... ...+.+..|+.++.++. |+++ +.+.+.+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i-----~~~~~~~~ 75 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL-----VTLHYAFQ 75 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcch-----hhhheeee
Confidence 3889999999999999999864 467889999886422 23345678999999995 7777 88888888
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
.+...++||||+ +++|.+++.... .+++..++.++.|++.||.|||+.+++||||||+||+++.++.
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~---------- 143 (288)
T cd05583 76 TDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH---------- 143 (288)
T ss_pred cCCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC----------
Confidence 889999999999 889999987654 6899999999999999999999999999999999999966554
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCC--CCcchhHHHHHHHHHHHhcCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~tg~~ 316 (323)
++|+|||++...... .....|+..|+|||.+.+.. .+.++||||||+++|||++|..
T Consensus 144 -----------------~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~ 206 (288)
T cd05583 144 -----------------VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGAS 206 (288)
T ss_pred -----------------EEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCC
Confidence 455666655432211 11246889999999987764 7889999999999999999999
Q ss_pred CCC
Q 020652 317 CYL 319 (323)
Q Consensus 317 pf~ 319 (323)
||.
T Consensus 207 p~~ 209 (288)
T cd05583 207 PFT 209 (288)
T ss_pred Ccc
Confidence 985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=250.64 Aligned_cols=194 Identities=34% Similarity=0.553 Sum_probs=163.1
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+..|+.+++.++|+|+ +++++++......++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i-----~~~~~~~~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI-----VKLLDVIHTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCH-----HHHHhhhhcCCceEE
Confidence 56788999999999999999999999999998753 2334567789999999999988 899999988899999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
||||++++|.+++.+.. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.+
T Consensus 76 v~e~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~----------------- 137 (282)
T cd07829 76 VFEYCDMDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVL----------------- 137 (282)
T ss_pred EecCcCcCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCE-----------------
Confidence 99999889999998763 369999999999999999999999999999999999999766555
Q ss_pred cccCCCCCCceEeeCCCcccccCCc---cccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+|+|||.+....... ....++..|+|||.+.+. .++.++|||||||++|||++|..||.+
T Consensus 138 ----------~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 201 (282)
T cd07829 138 ----------KLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPG 201 (282)
T ss_pred ----------EEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 555555444322211 123457789999999876 789999999999999999999999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=264.82 Aligned_cols=194 Identities=27% Similarity=0.440 Sum_probs=163.0
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCceE
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
+...|.+...+|.|+|+.|..|.+..+++..++|++.+. ..+..+|+.++... .|+|+ +++.+.+.++.+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~ni-----v~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNI-----VKSHDVYEDGKEI 391 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcc-----eeecceecCCcee
Confidence 456789999999999999999999999999999998754 22344577665554 46777 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
|+|||.+ |+.|.+.+.... .+. ..+..|+.||+.|+.|||++|||||||||+|||+.
T Consensus 392 ~~v~e~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~------------------- 449 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD------------------- 449 (612)
T ss_pred eeeehhccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec-------------------
Confidence 9999999 888888777654 233 77888999999999999999999999999999983
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+..+.++|+|||.+.........-+-|..|.|||++...+|+.++||||||++||+|++|+.||..
T Consensus 450 -------~~~g~lrltyFG~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~ 515 (612)
T KOG0603|consen 450 -------GSAGHLRLTYFGFWSELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAA 515 (612)
T ss_pred -------CCCCcEEEEEechhhhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCcccc
Confidence 133457888888887766554444668899999999999999999999999999999999999976
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=252.53 Aligned_cols=191 Identities=25% Similarity=0.439 Sum_probs=158.8
Q ss_pred EEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC-----ce
Q 020652 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-----NH 167 (323)
Q Consensus 96 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~-----~~ 167 (323)
-.+.||.|+||+||-+.|..+|+.||+|++... -...+.+-+|+.+|..++|.|+ ....++..-. ..
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNV-----LSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNV-----LSLLDILQPANPSFFQE 131 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccH-----HHHHHhcCCCCchHHHH
Confidence 357899999999999999999999999987632 2334567789999999999987 5555544322 35
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
+|+++|.+..+|..++..-+ .++.+.++-+++||++||+|||+.+|+||||||.|+|+++
T Consensus 132 iYV~TELmQSDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS------------------ 191 (449)
T KOG0664|consen 132 LYVLTELMQSDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS------------------ 191 (449)
T ss_pred HHHHHHHHHhhhhheeccCC--CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc------------------
Confidence 78899999889999887654 7999999999999999999999999999999999999854
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCc----cccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+..+||||||+++..+... +..+-|.+|.|||++.|. .|+.++||||.|||+.||+.++..|+.
T Consensus 192 ---------NCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 192 ---------NCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred ---------CceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 4566888888887655443 234679999999999986 599999999999999999999988864
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=244.10 Aligned_cols=187 Identities=30% Similarity=0.518 Sum_probs=160.5
Q ss_pred ecccCcEEEEEEEECCCCcEEEEEEeccchh----hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC
Q 020652 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (323)
Q Consensus 100 lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (323)
||+|+||.||++.+..+++.+|+|++..... ....+..|+.+++.++|+|+ +++++.++.+...+++|||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI-----VKLHYAFQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcH-----HHHHHHeecCCeeEEEEecC
Confidence 6999999999999998999999999874322 34567889999999999988 88889899999999999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccC
Q 020652 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254 (323)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~ 254 (323)
+++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++.
T Consensus 76 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~---------------------- 131 (250)
T cd05123 76 PGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH---------------------- 131 (250)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc----------------------
Confidence 999999998764 6899999999999999999999999999999999999976554
Q ss_pred CCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 255 PKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 255 ~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++|+|||.+...... .....++..|+|||.+.+...+.++|+||||+++|+|++|..||..
T Consensus 132 -----~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~ 195 (250)
T cd05123 132 -----IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195 (250)
T ss_pred -----EEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 466666655443221 2334678899999999888889999999999999999999999965
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=248.95 Aligned_cols=195 Identities=16% Similarity=0.220 Sum_probs=153.7
Q ss_pred EEEEeeecccCcEEEEEEEEC---CCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC--
Q 020652 94 YRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-- 165 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~---~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~-- 165 (323)
|.+.+.||+|+||.||+|.+. .+++.||||++... ....+.+.+|+.+++.+.|+|+ +++++++...
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~ 75 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNV-----IKLIGVSLRSRA 75 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCc-----ceEEEEEccCCC
Confidence 567889999999999999864 35789999988642 2345567889999999999998 8888876442
Q ss_pred ----ceEEEEEccC-CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceecc
Q 020652 166 ----NHICIVFEKL-GPSLYDFLRKNS----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (323)
Q Consensus 166 ----~~~~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~ 236 (323)
...+++++|+ +++|.+++.... ...+++..+..++.|++.||+|||++||+||||||+||+++.++.++++
T Consensus 76 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~ 155 (273)
T cd05074 76 KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVA 155 (273)
T ss_pred CCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEEC
Confidence 1347889999 899998875321 1257889999999999999999999999999999999999766655555
Q ss_pred CcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHH
Q 020652 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311 (323)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 311 (323)
||| .+...... .....+++.|++||.+.+..++.++|||||||++|||
T Consensus 156 dfg---------------------------~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el 208 (273)
T cd05074 156 DFG---------------------------LSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEI 208 (273)
T ss_pred ccc---------------------------ccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHH
Confidence 555 43322111 1112346789999999988899999999999999999
Q ss_pred hc-CCCCCCC
Q 020652 312 CS-VSNCYLT 320 (323)
Q Consensus 312 ~t-g~~pf~~ 320 (323)
++ |+.||.+
T Consensus 209 ~~~g~~p~~~ 218 (273)
T cd05074 209 MTRGQTPYAG 218 (273)
T ss_pred hhCCCCCCCC
Confidence 99 8898864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=247.57 Aligned_cols=195 Identities=30% Similarity=0.504 Sum_probs=159.6
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc------hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~------~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
+|.+.++||+|+||.||++.+..++..+++|+++.. ......+..|+.+++.++|+|+ +++++++....
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI-----VKFHASFLERD 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcH-----HHHHHHHhcCC
Confidence 589999999999999999999888777777776531 1223456678999999999998 88999888888
Q ss_pred eEEEEEccC-CCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 167 HICIVFEKL-GPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
..++||||+ +++|.+++.. .....+++..++.++.|++.||.|||++|++|+||||+||+++. +.
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~----------- 143 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NL----------- 143 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CC-----------
Confidence 999999999 8899998864 22246899999999999999999999999999999999999853 33
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++|+|||.+...... .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||..
T Consensus 144 ----------------~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 144 ----------------LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred ----------------EeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 455666655432211 1224578899999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=261.42 Aligned_cols=205 Identities=28% Similarity=0.458 Sum_probs=170.0
Q ss_pred cCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--------hhHHHHHHHHHHHHHHHhCCCCCcceEE
Q 020652 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--------KYREAAMIEIDVLQRLARHDIGGTRCVQ 157 (323)
Q Consensus 86 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--------~~~~~~~~Ei~~l~~l~~~~i~~~~~~~ 157 (323)
-...+.++|-++..||+|||+.||+|.|...+++||+|+-..+. .+.+.+.+|..|.+.|.|+.| |+
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRI-----VK 531 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRI-----VK 531 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCccee-----ee
Confidence 34456789999999999999999999999999999999864322 233556789999999999888 99
Q ss_pred EcceeccC-ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--CceecCCCCCcEEEeecCce
Q 020652 158 IRNWFDYR-NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL--RLIHTDLKPENILLVSAEYV 233 (323)
Q Consensus 158 ~~~~~~~~-~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--~iiHrDlKp~NIli~~~~~~ 233 (323)
++++|.-+ +.+|-|+||| |.+|.-||+.+. .+++..++.|+.||+.||.||.+. -|||-||||.|||+.+.
T Consensus 532 lYDyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~G--- 606 (775)
T KOG1151|consen 532 LYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNG--- 606 (775)
T ss_pred eeeeeeeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecC---
Confidence 99998764 5689999999 888988888765 799999999999999999999976 59999999999998653
Q ss_pred eccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCc----------cccccCCccccchhhcCC----CCCcch
Q 020652 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----------SYVVSTRHYRAPEVILGL----GWNYPC 299 (323)
Q Consensus 234 ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~~----~~~~~~ 299 (323)
...+.+||+|||+++...... +...||.+|++||.+.-. ..+.++
T Consensus 607 ---------------------tacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKV 665 (775)
T KOG1151|consen 607 ---------------------TACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKV 665 (775)
T ss_pred ---------------------cccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccce
Confidence 234567888888776644321 224799999999988533 478999
Q ss_pred hHHHHHHHHHHHhcCCCCCCCC
Q 020652 300 DLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 300 DiwSlG~il~el~tg~~pf~~~ 321 (323)
||||+|||+|..+.|+.||...
T Consensus 666 DVWSvGVIFyQClYGrKPFGhn 687 (775)
T KOG1151|consen 666 DVWSVGVIFYQCLYGRKPFGHN 687 (775)
T ss_pred eeEeeehhhhhhhccCCCCCCc
Confidence 9999999999999999999754
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=247.62 Aligned_cols=206 Identities=23% Similarity=0.290 Sum_probs=158.5
Q ss_pred CCceeEecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEE
Q 020652 79 DGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158 (323)
Q Consensus 79 ~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~ 158 (323)
+...++-+...++...++++.||+|.||+||+|.+ .|+.||||++...++..-.-+.||.--..|+|.|| ..+
T Consensus 198 GSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENI-----LgF 270 (513)
T KOG2052|consen 198 GSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENI-----LGF 270 (513)
T ss_pred CCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchh-----hhh
Confidence 33455556667788899999999999999999965 57789999998655433333345555556889998 666
Q ss_pred cceeccC----ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCcE
Q 020652 159 RNWFDYR----NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL--------RLIHTDLKPENI 225 (323)
Q Consensus 159 ~~~~~~~----~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--------~iiHrDlKp~NI 225 (323)
+..-..+ .++|||.+|. .|+|+|||.++ .++.+...+++..++.||++||.. .|.|||||+.||
T Consensus 271 IaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNI 347 (513)
T KOG2052|consen 271 IAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 347 (513)
T ss_pred hhccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccE
Confidence 6544332 3789999999 99999999985 599999999999999999999952 499999999999
Q ss_pred EEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCC----C--Ccch
Q 020652 226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG----W--NYPC 299 (323)
Q Consensus 226 li~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~ 299 (323)
|+..++.+.|+|+|++-+...+.+ ..| ...+..+||..|||||++.... + -..+
T Consensus 348 LVKkn~~C~IADLGLAv~h~~~t~------------~id--------i~~N~rVGTKRYMAPEvLdetin~~~Fesyk~A 407 (513)
T KOG2052|consen 348 LVKKNGTCCIADLGLAVRHDSDTD------------TID--------IPPNPRVGTKRYMAPEVLDETINMKHFESYKRA 407 (513)
T ss_pred EEccCCcEEEeeceeeEEecccCC------------ccc--------CCCCCccceeeccChHHhhhhcChhhhhhhhHH
Confidence 999999888888887654443321 111 1233458999999999997532 1 1568
Q ss_pred hHHHHHHHHHHHhcC
Q 020652 300 DLWSVGCILVELCSV 314 (323)
Q Consensus 300 DiwSlG~il~el~tg 314 (323)
||||||.++||++-+
T Consensus 408 DIYafgLVlWEiarR 422 (513)
T KOG2052|consen 408 DIYAFGLVLWEIARR 422 (513)
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999999999743
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=264.91 Aligned_cols=197 Identities=20% Similarity=0.281 Sum_probs=137.1
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCC----CcEEEEEEeccchhhHHHHHHHHHHHHHHHhC---CCCCcceEEEcc-e-
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEK----KELVAIKIVRSINKYREAAMIEIDVLQRLARH---DIGGTRCVQIRN-W- 161 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~----~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~---~i~~~~~~~~~~-~- 161 (323)
.++|++.++||+|+||.||+|.+..+ +..||+|++...... |+.+...+.+. ++. ..+..+.. .
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~------e~~~~e~l~~~~~~~~~-~~~~~~~~~~~ 203 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV------EIWMNERVRRACPNSCA-DFVYGFLEPVS 203 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh------HHHHHHHHHhhchhhHH-HHHHhhhcccc
Confidence 46899999999999999999999988 899999987642211 22222222221 110 00000000 0
Q ss_pred eccCceEEEEEccC-CCCHHHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 020652 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYR------------------SFPIDLVRELGRQLLESVAFMHELRLIHTDLKP 222 (323)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~------------------~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp 222 (323)
.......++||||+ +++|.+++...... ......+..++.||+.||+|||+++|+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 23456799999999 88999998754311 112345678999999999999999999999999
Q ss_pred CcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCC-----
Q 020652 223 ENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGL----- 293 (323)
Q Consensus 223 ~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~----- 293 (323)
+|||++.+ ...+||+|||++...... ....+||+.|||||++...
T Consensus 284 ~NILl~~~--------------------------~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~ 337 (566)
T PLN03225 284 QNIIFSEG--------------------------SGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPS 337 (566)
T ss_pred HHEEEeCC--------------------------CCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCC
Confidence 99999642 234677777777543221 2345789999999976432
Q ss_pred -----------------CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 294 -----------------GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 294 -----------------~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.++.++|||||||+||||+++..++..
T Consensus 338 ~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~ 381 (566)
T PLN03225 338 APSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS 381 (566)
T ss_pred CccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch
Confidence 234567999999999999998776543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=232.22 Aligned_cols=193 Identities=24% Similarity=0.524 Sum_probs=164.4
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceeccC--c
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYR--N 166 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~~--~ 166 (323)
-.++|++.+++|+|-|++||.|.+..+++.++||+++...+ +...+|+.||..|. ++|| +.+++...+. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk--kKIkREikIL~nL~gg~NI-----i~L~DiV~Dp~Sk 108 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK--KKIKREIKILQNLRGGPNI-----IKLLDIVKDPESK 108 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH--HHHHHHHHHHHhccCCCCe-----eehhhhhcCcccc
Confidence 34679999999999999999999999999999999985433 45789999999998 7777 9999987664 4
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
...||+||. +.+...+. ..++...++.++.|++.||.|||+.||+|||+||.|++|+.
T Consensus 109 tpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh---------------- 167 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDH---------------- 167 (338)
T ss_pred CchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeech----------------
Confidence 577999999 55554443 25888899999999999999999999999999999999964
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCccc--cccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~--~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
....++|+|+|+|.+.+..... .+.+.+|--||.+..- .|+..-|+|||||+|..|+..+-||..
T Consensus 168 ----------~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 168 ----------ELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred ----------hhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 3456899999999987766544 5788999999999765 589999999999999999999988863
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=248.57 Aligned_cols=193 Identities=24% Similarity=0.340 Sum_probs=151.3
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHH--HHHhCCCCCcceEEEcceeccCc---
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQ--RLARHDIGGTRCVQIRNWFDYRN--- 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~--~l~~~~i~~~~~~~~~~~~~~~~--- 166 (323)
...++.+.||+|.||.||+|. -+++.||||++...+ .+.+..|-+|.+ .+.|+|| +++++.-....
T Consensus 210 ~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~~--kqs~~~Ek~Iy~lp~m~h~nI-----l~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQE--KQSFQNEKNIYSLPGMKHENI-----LQFIGAEKRGTADR 280 (534)
T ss_pred CchhhHHHhhcCccceeehhh--ccCceeEEEecCHHH--HHHHHhHHHHHhccCccchhH-----HHhhchhccCCccc
Confidence 346788999999999999995 456999999997543 345555655544 4667777 88877655544
Q ss_pred -eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCcEEEeecCceec
Q 020652 167 -HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL---------RLIHTDLKPENILLVSAEYVKV 235 (323)
Q Consensus 167 -~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---------~iiHrDlKp~NIli~~~~~~ki 235 (323)
.++||+||. .|+|.+||+.+ .+++....+++..+++||+|||+- .|+|||||.+||||.++..+.|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 899999999 99999999986 599999999999999999999972 5999999999999999888877
Q ss_pred cCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCC-CC-----cchhHHHHHHHHH
Q 020652 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WN-----YPCDLWSVGCILV 309 (323)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwSlG~il~ 309 (323)
+|||++-+...... .......+||..|||||++.|.. +. .+.||||+|.+||
T Consensus 358 aDFGLAl~~~p~~~----------------------~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLW 415 (534)
T KOG3653|consen 358 ADFGLALRLEPGKP----------------------QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLW 415 (534)
T ss_pred eccceeEEecCCCC----------------------CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHH
Confidence 77777544332110 01112258999999999998752 22 4689999999999
Q ss_pred HHhcCCCCC
Q 020652 310 ELCSVSNCY 318 (323)
Q Consensus 310 el~tg~~pf 318 (323)
||+++..-+
T Consensus 416 Ei~SRC~~~ 424 (534)
T KOG3653|consen 416 EIASRCTDA 424 (534)
T ss_pred HHHhhcccc
Confidence 999876544
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=253.95 Aligned_cols=196 Identities=22% Similarity=0.336 Sum_probs=169.9
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
+..+..+||-|.||.||.|.+++..-.||||.++.+....++|+.|..+|+.+.|+|+ |++++.|.....+|||+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNL-----VqLLGVCT~EpPFYIiT 342 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTHEPPFYIIT 342 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccH-----HHHhhhhccCCCeEEEE
Confidence 3456789999999999999999988899999999888888999999999999999999 99999999999999999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||| .|+|.+||+......++.-.+.+++.||..|++||..+++|||||-..|+|++++..|||
T Consensus 343 EfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKv---------------- 406 (1157)
T KOG4278|consen 343 EFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKV---------------- 406 (1157)
T ss_pred ecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEe----------------
Confidence 999 999999999887667888888999999999999999999999999999999987665554
Q ss_pred ccCCCCCCceEeeCCCcccccCCccc-ccc---CCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEHQDHSY-VVS---TRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~~~-~~g---t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
+|||++++...+..+ ..| ...|.|||.+....++.|+|||+|||+|||++| |..||+|
T Consensus 407 -----------ADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 407 -----------ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred -----------eccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 555555443332221 122 346999999999999999999999999999986 8899987
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=280.95 Aligned_cols=188 Identities=16% Similarity=0.244 Sum_probs=155.5
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
..|...+.||+|+||.||+|++..+++.||||.+...... ...|++++++++|+|| +++++++...+..|+|
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~l~~l~HpnI-----v~~~~~~~~~~~~~lv 761 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI---PSSEIADMGKLQHPNI-----VKLIGLCRSEKGAYLI 761 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc---cHHHHHHHhhCCCCCc-----ceEEEEEEcCCCCEEE
Confidence 3466678899999999999999999999999988643322 2346888999999998 9999999998999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH---ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
|||+ +++|.++++ .+++..+..++.|++.||+||| +.+|+||||||+||+++.++..++.
T Consensus 762 ~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~----------- 825 (968)
T PLN00113 762 HEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR----------- 825 (968)
T ss_pred EeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-----------
Confidence 9999 999999995 3789999999999999999999 6699999999999999765543321
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
||....... .....||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 826 -----------------~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 826 -----------------LSLPGLLCT-DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred -----------------ecccccccc-CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 332222111 11236789999999999999999999999999999999999998654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=252.77 Aligned_cols=202 Identities=23% Similarity=0.404 Sum_probs=149.5
Q ss_pred CCcEEEEeeecccCcEEEEEEEEC----------------CCCcEEEEEEeccchh-h--------------HHHHHHHH
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDN----------------EKKELVAIKIVRSINK-Y--------------REAAMIEI 139 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~----------------~~~~~vAiK~~~~~~~-~--------------~~~~~~Ei 139 (323)
.++|++.++||+|+||+||+|.+. ..++.||||.+..... . .+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999752 2346799999864221 1 12334577
Q ss_pred HHHHHHHhCCCCCcceEEEcceecc--------CceEEEEEccC-CCCHHHHHHhcCC----------------------
Q 020652 140 DVLQRLARHDIGGTRCVQIRNWFDY--------RNHICIVFEKL-GPSLYDFLRKNSY---------------------- 188 (323)
Q Consensus 140 ~~l~~l~~~~i~~~~~~~~~~~~~~--------~~~~~lv~e~~-~~~L~~~l~~~~~---------------------- 188 (323)
.++.++.|.++....++.+.+++.. ....+|||||+ +++|.+++.....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 8888888888777777777777643 35689999999 8999999874311
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCc
Q 020652 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268 (323)
Q Consensus 189 ~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a 268 (323)
..+++..++.++.|++.||.|||+++|+||||||+|||++.++. +||+|||++
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~---------------------------~kL~DFGla 356 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ---------------------------VKIIDFGAA 356 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCc---------------------------EEEEeCcCc
Confidence 12456778899999999999999999999999999999876554 456666655
Q ss_pred ccccCCc----cccccCCccccchhhcCCC--------------------CC--cchhHHHHHHHHHHHhcCCC-CCC
Q 020652 269 TFEHQDH----SYVVSTRHYRAPEVILGLG--------------------WN--YPCDLWSVGCILVELCSVSN-CYL 319 (323)
Q Consensus 269 ~~~~~~~----~~~~gt~~y~aPE~~~~~~--------------------~~--~~~DiwSlG~il~el~tg~~-pf~ 319 (323)
....... ....+|+.|+|||++.... |+ .+.||||+||++|+|++|.. ||.
T Consensus 357 ~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 357 VDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred cccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 4322111 1123588999999986432 11 34799999999999999875 664
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-33 Score=236.80 Aligned_cols=193 Identities=32% Similarity=0.500 Sum_probs=162.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC--
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-- 165 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~-- 165 (323)
..||.-++.+|.|.- .|..|.|.-+++.||+|.+.. .....+.+.+|..++..++|+|+ +.++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~ni-----i~l~n~ftP~~~ 89 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNI-----ISLLNVFTPQKT 89 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccce-----eeeeeccCcccc
Confidence 357999999999998 788899999999999998753 22334567889999999999999 8888877543
Q ss_pred ----ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 166 ----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 166 ----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
..+|+|||++..+|.+.+.. .+..+.+..++.|+++|++|||+.||+||||||+||++..++.
T Consensus 90 l~~~~e~y~v~e~m~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--------- 156 (369)
T KOG0665|consen 90 LEEFQEVYLVMELMDANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--------- 156 (369)
T ss_pred HHHHHhHHHHHHhhhhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh---------
Confidence 35899999999999999873 4788899999999999999999999999999999999866554
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
+|+.|||+|+..... .+..+.|..|.|||++.+..|...+||||+||++.||++|+..|.
T Consensus 157 ------------------lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 157 ------------------LKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred ------------------eeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 466666666544333 233578999999999999999999999999999999999999998
Q ss_pred C
Q 020652 320 T 320 (323)
Q Consensus 320 ~ 320 (323)
|
T Consensus 219 g 219 (369)
T KOG0665|consen 219 G 219 (369)
T ss_pred C
Confidence 6
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-31 Score=225.54 Aligned_cols=194 Identities=38% Similarity=0.602 Sum_probs=164.0
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
|.+.+.||+|++|.||++.+..+++.+|+|.+..... ..+.+.+|++.++.++|+|+ +++++++......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i-----~~~~~~~~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNI-----VKLYGVFEDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCh-----hhheeeeecCCceEEE
Confidence 5678999999999999999998899999999875432 46678889999999988887 8888888888899999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
+|++ +++|.+++..... .+++..+..++.+++.+|.+||+++++|+||+|+||+++..+
T Consensus 76 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~------------------- 135 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG------------------- 135 (225)
T ss_pred EeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-------------------
Confidence 9999 6699999987541 188999999999999999999999999999999999996544
Q ss_pred cccCCCCCCceEeeCCCcccccCCc----cccccCCccccchhh-cCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVI-LGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.++|+|||.+....... ....++..|++||.+ ....++.++|+||||++++||++|+.||.+
T Consensus 136 --------~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 136 --------LVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --------CEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 45666666655443322 345678899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-33 Score=231.64 Aligned_cols=199 Identities=25% Similarity=0.332 Sum_probs=165.0
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCcceEEEcc-eeccCc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRN-WFDYRN 166 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~-~~~~~~ 166 (323)
.+.+.|.+.+.||+|.||.+.+|+++.++..+|+|.+........+|.+|..---.|. |+|| +.-++ .|+..+
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hI-----i~tY~vaFqt~d 95 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHI-----IDTYEVAFQTSD 95 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhh-----hHHHHHHhhcCc
Confidence 3557799999999999999999999999999999999877777778888886544444 4455 44433 477788
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.+.++|||+ -|+|..-+... .+-|...+.++.|+++|++|||++++||||||.+||||-..
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~--------------- 157 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA--------------- 157 (378)
T ss_pred eEEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC---------------
Confidence 999999999 88998887764 48899999999999999999999999999999999999653
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-----CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
...++||||||.++..+......--+..|.+||+.... ..++.+|+|.||+++|..+||++||+-
T Consensus 158 ----------df~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 158 ----------DFYRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred ----------CccEEEeeecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 23378999999988766555555567789999987542 256889999999999999999999973
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=250.00 Aligned_cols=201 Identities=21% Similarity=0.316 Sum_probs=162.4
Q ss_pred cEEEEeeecccCcEEEEEEEECCC---CcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
...+.++||+|.||+|++|.+... ...||||.++... ....+|.+|+.+|.+|+|+|+ +++|+...+ ..
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hl-----iRLyGvVl~-qp 184 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHL-----IRLYGVVLD-QP 184 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcce-----eEEeeeecc-ch
Confidence 456678999999999999988643 2468999987433 356789999999999999998 999998876 67
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+.||||++ .|+|.+.|.+.....|.......++.||+.|+.||.++++|||||-..|+|+.....|||+|||+.+....
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 88999999 99999999885445788899999999999999999999999999999999997766665555555544433
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
+.+.+.... ...-...|+|||.+.-..++.++|+|++||+||||+| |+-||.|
T Consensus 265 ned~Yvm~p---------------------~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G 318 (1039)
T KOG0199|consen 265 NEDMYVMAP---------------------QRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG 318 (1039)
T ss_pred CCcceEecC---------------------CCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC
Confidence 332221000 0012457999999999999999999999999999997 8899976
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=255.98 Aligned_cols=193 Identities=24% Similarity=0.363 Sum_probs=163.9
Q ss_pred cEEEEeeecccCcEEEEEEEECCCC---cEEEEEEecc--chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~---~~vAiK~~~~--~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
.-.+.++||.|.||.|++|+.+..+ ..||||.++. ..+.+.+|+.|..||-++.|||| +++.+.......
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNI-----IrLEGVVTks~P 704 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNI-----IRLEGVVTKSKP 704 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcE-----EEEEEEEecCce
Confidence 4567889999999999999987665 4699999984 45677889999999999999999 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+.||.||| +|+|..||+.+.+ .|+..++..+++.|+.|++||-+.+.|||||-..|||++.+-.+||+|||
T Consensus 705 vMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFG------- 776 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFG------- 776 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEecccc-------
Confidence 99999999 9999999998875 49999999999999999999999999999999999999776655555555
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCcc----cccc--CCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHS----YVVS--TRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCY 318 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~----~~~g--t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf 318 (323)
+++..+++.. +.-| ...|.|||.|.-..++.++||||+|++|||.++ |..||
T Consensus 777 --------------------LSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 777 --------------------LSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred --------------------ceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 4444332221 1112 358999999999999999999999999999885 88887
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=243.71 Aligned_cols=192 Identities=23% Similarity=0.379 Sum_probs=161.8
Q ss_pred EEEeeecccCcEEEEEEEECCC----CcEEEEEEecc--chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 95 RILSKMGEGTFGQVVECFDNEK----KELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 95 ~~~~~lG~G~fg~V~~~~~~~~----~~~vAiK~~~~--~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.+.+.||.|.||.||+|....- .--||||..+. .....+.|+.|..+++.++|||| +++++++.. ..+
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphI-----ikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHI-----IKLIGVCVE-QPM 465 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcch-----hheeeeeec-cce
Confidence 3457899999999999986533 23588998774 33457889999999999999999 999998875 569
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
|||||.+ -|.|..|++.+. ..++......++.||+.||.|||+.++|||||-..|||+.+..
T Consensus 466 WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~---------------- 528 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ---------------- 528 (974)
T ss_pred eEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc----------------
Confidence 9999999 899999999876 5799999999999999999999999999999999999986543
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCcccc--cc--CCccccchhhcCCCCCcchhHHHHHHHHHHHh-cCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV--VS--TRHYRAPEVILGLGWNYPCDLWSVGCILVELC-SVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~--~g--t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~-tg~~pf~~ 320 (323)
.+||+|||++++......+. .| ...|||||.+.-..++.++|||-|||.+||++ .|.-||.+
T Consensus 529 -----------CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg 595 (974)
T KOG4257|consen 529 -----------CVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG 595 (974)
T ss_pred -----------eeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc
Confidence 56777888777766554321 22 45799999999999999999999999999987 49999987
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=251.84 Aligned_cols=198 Identities=22% Similarity=0.274 Sum_probs=157.1
Q ss_pred EEEEeeecccCcEE-EEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceeccCceEEEE
Q 020652 94 YRILSKMGEGTFGQ-VVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 94 y~~~~~lG~G~fg~-V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
|.-.+.+|.|+.|+ ||+|.. .++.||||.+- .+....+.+||..|+.-. |+|| +++++.-.++.+.||.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll--~e~~~~A~rEi~lL~eSD~H~Nv-----iRyyc~E~d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLL--EEFFDFAQREIQLLQESDEHPNV-----IRYYCSEQDRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHh--hHhHHHHHHHHHHHHhccCCCce-----EEEEeeccCCceEEEE
Confidence 33456789999886 689954 67789999764 344456789999998875 6776 9999988889999999
Q ss_pred EccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 172 FEKLGPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 172 ~e~~~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
.|.|..+|.+++... ..........+.++.|++.||++||+.+||||||||+||||....
T Consensus 582 lELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~------------------ 643 (903)
T KOG1027|consen 582 LELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPS------------------ 643 (903)
T ss_pred ehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccC------------------
Confidence 999999999999874 111112145678899999999999999999999999999997531
Q ss_pred ccccCCCCCCceEeeCCCcccccCCc------cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcC-CCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSV-SNCYLTPF 322 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg-~~pf~~~~ 322 (323)
.+....++|+|||+++....+. ....||-+|+|||++....-+.++||+||||++|+.++| +.||..++
T Consensus 644 ----~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~ 719 (903)
T KOG1027|consen 644 ----ADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL 719 (903)
T ss_pred ----CCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH
Confidence 1234566777777776544332 234799999999999998888899999999999999986 99998765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-30 Score=219.20 Aligned_cols=202 Identities=25% Similarity=0.333 Sum_probs=173.5
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
...|++.++||+|+||++++|.+..+++.||||.-... ....++..|....+.|... ..+.+.+-+...+.+-.|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-S~APQLrdEYr~YKlL~g~----~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-SEAPQLRDEYRTYKLLGGT----EGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEecccc-CCcchHHHHHHHHHHHcCC----CCCCceeeeccccchhhh
Confidence 35699999999999999999999999999999976543 3334577899988888742 333677777778888999
Q ss_pred EEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 171 VFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 171 v~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||.+|.+|.|+..-.+ +.|+..++..++.|++.-++|+|++.+|.|||||+|+||+..+
T Consensus 102 VidLLGPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~------------------- 161 (449)
T KOG1165|consen 102 VIDLLGPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPG------------------- 161 (449)
T ss_pred hhhhhCcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCC-------------------
Confidence 99999999999998776 6899999999999999999999999999999999999997654
Q ss_pred cccCCCCCCceEeeCCCcccccCC----------ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
......+.++|||+|+...+. .....||..||+--...|.+.+.+.|+=|||-++++.+-|.+||+|
T Consensus 162 ---~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 162 ---TKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred ---CCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 234566899999999765443 2346899999999999999999999999999999999999999987
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=216.69 Aligned_cols=183 Identities=36% Similarity=0.573 Sum_probs=155.0
Q ss_pred CcEEEEEEEECCCCcEEEEEEeccchhh--HHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC-CCCHH
Q 020652 104 TFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLY 180 (323)
Q Consensus 104 ~fg~V~~~~~~~~~~~vAiK~~~~~~~~--~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~ 180 (323)
+||.||+|.+..+++.+|+|++...... .+.+.+|++.+++++|+++ +++.+++......+++||++ +++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNI-----VRLYDVFEDEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcH-----HHHHhheeeCCEEEEEEeCCCCCCHH
Confidence 5899999999999999999998753322 5778899999999999888 88888888888999999999 66999
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCc
Q 020652 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260 (323)
Q Consensus 181 ~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~ 260 (323)
+++.... .+++..+..++.+++.+|.+||+.+|+|+||+|+||+++.++. +
T Consensus 76 ~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~---------------------------~ 126 (244)
T smart00220 76 DLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGH---------------------------V 126 (244)
T ss_pred HHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCc---------------------------E
Confidence 9998754 3899999999999999999999999999999999999976554 4
Q ss_pred eEeeCCCcccccC--CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 261 KLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 261 kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+++|||.+..... ......++..|++||.+.+..++.++||||||+++|+|++|..||..
T Consensus 127 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 127 KLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred EEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 5555555544332 22334678899999999888889999999999999999999999965
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=245.63 Aligned_cols=198 Identities=20% Similarity=0.254 Sum_probs=158.9
Q ss_pred EEEEeeecccCcEEEEEEEECCCC----cEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~----~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
.+..++||+|+||+||+|.+...+ .+||||++... .+..+++..|..+|.++.|+|+ +++++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl-----~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNL-----LRLLGVCMLST- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchH-----HHHhhhcccch-
Confidence 455689999999999999886554 46899988643 3446788999999999999999 88888877654
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+.||++|+ .|+|.|+++.+. ..+-....+.|..||++|+.|||+++++||||-..|+|+.+...+||.|||+++-...
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 88999999 999999998765 4688889999999999999999999999999999999998766665555554433332
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
++..+.. ....-.+.|||=|.+....|+.++|||||||++||++| |.-||++
T Consensus 851 d~~ey~~----------------------~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g 903 (1177)
T KOG1025|consen 851 DEKEYSA----------------------PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG 903 (1177)
T ss_pred ccccccc----------------------cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence 2221100 00112457999999999999999999999999999997 8899876
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=225.38 Aligned_cols=205 Identities=28% Similarity=0.344 Sum_probs=166.3
Q ss_pred cEEEEeeecccCcEEEEEEEECCCC-cEEEEEEeccchhh-HHHHHHHHHHHHHHHhCCCCCcceEEEccee-ccCceEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKY-REAAMIEIDVLQRLARHDIGGTRCVQIRNWF-DYRNHIC 169 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~-~~vAiK~~~~~~~~-~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~-~~~~~~~ 169 (323)
+|.+.++||+|+||.||+|.+..++ ..+|+|+....... ...+..|+.++..+.. .....++..+.+.. ....+.|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~-~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEK-KNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhh-hcCCCCCCEEEEeccCCCceeE
Confidence 7999999999999999999988775 67899987653222 2267889999999985 22223457778777 5777899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+||+.+|.+|.++........++..++..++.|++.+|++||+.|++||||||+|++++....
T Consensus 98 iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~----------------- 160 (322)
T KOG1164|consen 98 IVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSR----------------- 160 (322)
T ss_pred EEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCC-----------------
Confidence 999999999999987766678999999999999999999999999999999999999975420
Q ss_pred ccccCCCCCCceEeeCCCcc--cc---------cC-C-ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTT--FE---------HQ-D-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~--~~---------~~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~ 316 (323)
.....+.|.|||+++ .. .. . ...+.||..|+++.+..+...+.+.|+||++.++.||..|..
T Consensus 161 -----~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~L 235 (322)
T KOG1164|consen 161 -----SEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSL 235 (322)
T ss_pred -----cccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCC
Confidence 112346777777776 21 00 0 123569999999999999999999999999999999999999
Q ss_pred CCCC
Q 020652 317 CYLT 320 (323)
Q Consensus 317 pf~~ 320 (323)
||.+
T Consensus 236 PW~~ 239 (322)
T KOG1164|consen 236 PWEA 239 (322)
T ss_pred CCcc
Confidence 9965
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-30 Score=209.99 Aligned_cols=201 Identities=27% Similarity=0.390 Sum_probs=168.8
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
..++|+++++||+|+||.+|+|....+|+.||||+-..... ...+..|..+.+.|++- ..+..+..+.....+-.
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-hpqL~yEskvY~iL~~g----~GiP~i~~y~~e~~ynv 87 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-HPQLLYESKVYRILQGG----VGIPHIRHYGTEKDYNV 87 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-CcchhHHHHHHHHhccC----CCCchhhhhccccccce
Confidence 45789999999999999999999999999999998654332 34577899999998863 22366677777788889
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+|||.+|.+|.+++.-.. +.|+..+++.++-|++.-++|+|.+++|||||||+|+|.+-..
T Consensus 88 lVMdLLGPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgr------------------ 148 (341)
T KOG1163|consen 88 LVMDLLGPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGR------------------ 148 (341)
T ss_pred eeeeccCccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccc------------------
Confidence 999999999999987554 5799999999999999999999999999999999999986432
Q ss_pred ccccCCCCCCceEeeCCCcccccCC----------ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
....+.|+|||+|+...+. .....||..|.+--...+...+.+.|+=|+|.+|.++.-|..||+
T Consensus 149 ------h~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 149 ------HCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred ------ccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccc
Confidence 2345788999988653222 233589999999888888888999999999999999999999998
Q ss_pred C
Q 020652 320 T 320 (323)
Q Consensus 320 ~ 320 (323)
+
T Consensus 223 g 223 (341)
T KOG1163|consen 223 G 223 (341)
T ss_pred c
Confidence 7
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-31 Score=244.95 Aligned_cols=196 Identities=27% Similarity=0.411 Sum_probs=164.5
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
+..++|+++.++|+|+||.||+|+|+.+++..|+|+++... ....-...|+-+++..+|+|| +.+++.+-....
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~ni-----vay~gsylr~dk 86 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNI-----VAYFGSYLRRDK 86 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcCh-----HHHHhhhhhhcC
Confidence 34568999999999999999999999999999999998533 233456679999999999999 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+.|||| ||+|.+.-..-+ .+++.++.+.++..++||+|||++|-+|||||-.|||+++.|++|++|||
T Consensus 87 lwicMEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfg------- 157 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFG------- 157 (829)
T ss_pred cEEEEEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccC-------
Confidence 99999999 889998776544 79999999999999999999999999999999999999877766555555
Q ss_pred CCCccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
.+..... ....+.||++|||||+.. ...|+..+|||++|++..|+.--++|-
T Consensus 158 --------------------vsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 158 --------------------VSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred --------------------chhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 3322211 223468999999999874 457999999999999999997666653
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=239.69 Aligned_cols=197 Identities=23% Similarity=0.391 Sum_probs=158.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECC-------CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHH-hCCCCCcceEEEcce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSI--NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNW 161 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~-------~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~ 161 (323)
++..+.+.||+|.||.|++|.-.. ....||||.++.. ....+.+..|+++|+.+. |+|+ +.+.+.
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~ni-----v~llG~ 370 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNI-----VNLLGA 370 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcch-----hhheee
Confidence 344566799999999999996431 1457999988732 345678889999999987 7777 999999
Q ss_pred eccCceEEEEEccC-CCCHHHHHHhcC------------C--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEE
Q 020652 162 FDYRNHICIVFEKL-GPSLYDFLRKNS------------Y--RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENIL 226 (323)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~------------~--~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIl 226 (323)
+..++.+++|+||+ .|+|.++++... . ..++......++.||+.|++||++.++|||||-..|||
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVL 450 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEE
Confidence 88889999999999 999999998764 0 13888999999999999999999999999999999999
Q ss_pred EeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCcccc----cc--CCccccchhhcCCCCCcchh
Q 020652 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYV----VS--TRHYRAPEVILGLGWNYPCD 300 (323)
Q Consensus 227 i~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~----~g--t~~y~aPE~~~~~~~~~~~D 300 (323)
+..+..+ ||+|||+++.......+. .| ...|||||.+....|+.++|
T Consensus 451 i~~~~~~---------------------------kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSD 503 (609)
T KOG0200|consen 451 ITKNKVI---------------------------KIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSD 503 (609)
T ss_pred ecCCCEE---------------------------EEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccch
Confidence 9766555 555555554322222111 11 23499999999999999999
Q ss_pred HHHHHHHHHHHhc-CCCCCCC
Q 020652 301 LWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 301 iwSlG~il~el~t-g~~pf~~ 320 (323)
||||||+|||++| |..||.+
T Consensus 504 VWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 504 VWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhHHHHHHHHHhhCCCCCCCC
Confidence 9999999999997 8899986
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=253.30 Aligned_cols=146 Identities=21% Similarity=0.224 Sum_probs=123.3
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
..++++||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+..+.+|++|||++....
T Consensus 53 ~~~~~~~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 53 DSIVRALECEDVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred chhhhhhccCCccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 3577889988899999997543 469999999999999999999999999999999999999999999999999876543
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCC-------------------ccccccCCccccchhhcCCCCCcchhHHHHHH
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------------------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 306 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 306 (323)
. +....+|++|||+++..... ....+||+.|||||++.+..|+.++|||||||
T Consensus 132 ~--------~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGv 203 (793)
T PLN00181 132 S--------DEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGV 203 (793)
T ss_pred c--------cccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHH
Confidence 2 23457899999998642210 11246899999999999999999999999999
Q ss_pred HHHHHhcCCCCCCC
Q 020652 307 ILVELCSVSNCYLT 320 (323)
Q Consensus 307 il~el~tg~~pf~~ 320 (323)
+||||++|..|+..
T Consensus 204 iL~ELl~~~~~~~~ 217 (793)
T PLN00181 204 LLFELFCPVSSREE 217 (793)
T ss_pred HHHHHhhCCCchhh
Confidence 99999999888753
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=222.25 Aligned_cols=223 Identities=23% Similarity=0.380 Sum_probs=165.6
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECC---CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+.+.|.++++||+|+|++||++.+.. .++.||+|.+..... ......|+++|..+.-. .+++.+.+++..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~----~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGS----DNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccc----hhhhcchhhhccC
Confidence 455679999999999999999999877 788999998875433 34578899999988632 3348999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeec-CceeccCcccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-EYVKVPDYKFLSR 243 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~-~~~ki~d~~~~~~ 243 (323)
+.+++||||+ ..+-.++.. .++...++.+++.++.||.++|.+|||||||||.|+|.+.. +.-.+.|||++..
T Consensus 108 d~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred CeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 9999999999 666666665 47788999999999999999999999999999999999654 5667899999773
Q ss_pred cCCCC--Cccc-----cCCCCCCceEeeCCCcc---c---c-------cCCccccccCCccccchhhcCC-CCCcchhHH
Q 020652 244 SSKDG--SYFK-----NLPKSSAIKLIDFGSTT---F---E-------HQDHSYVVSTRHYRAPEVILGL-GWNYPCDLW 302 (323)
Q Consensus 244 ~~~~~--~~~~-----~~~~~~~~kl~Dfg~a~---~---~-------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw 302 (323)
..... .... ....-..-..-.+..+. . . ........||++|.|||++... ..++++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 21111 0000 00000000000111110 0 0 0111235899999999999775 478999999
Q ss_pred HHHHHHHHHhcCCCCCCCC
Q 020652 303 SVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 303 SlG~il~el~tg~~pf~~~ 321 (323)
|.|||+.-+++++.||.-+
T Consensus 263 s~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred eccceeehhhccccccccC
Confidence 9999999999999999754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=197.05 Aligned_cols=179 Identities=39% Similarity=0.621 Sum_probs=151.6
Q ss_pred ecccCcEEEEEEEECCCCcEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC-C
Q 020652 100 MGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G 176 (323)
Q Consensus 100 lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~-~ 176 (323)
||+|++|.||++.+..+++.+++|++..... ..+.+.+|++.++.+.|+++ +++++++......+++||++ +
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-----~~~~~~~~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNI-----VKLYGVFEDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCe-----eeEeeeeecCCeEEEEEecCCC
Confidence 6899999999999988899999999875543 25678899999999999777 99999998888999999999 6
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEee-cCceeccCcccccccCCCCCccccCC
Q 020652 177 PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSKDGSYFKNLP 255 (323)
Q Consensus 177 ~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~-~~~~ki~d~~~~~~~~~~~~~~~~~~ 255 (323)
++|.+++.... ..+++..+..++.+++.+|.+||++|++|+||+|.||+++. .+
T Consensus 76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~------------------------ 130 (215)
T cd00180 76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG------------------------ 130 (215)
T ss_pred CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC------------------------
Confidence 99999998753 35899999999999999999999999999999999999975 44
Q ss_pred CCCCceEeeCCCcccccCC---ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHH
Q 020652 256 KSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVEL 311 (323)
Q Consensus 256 ~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el 311 (323)
.++|+|||.+...... .....+...|++||.+... .++.++|+|+||+++++|
T Consensus 131 ---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 131 ---KVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred ---cEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 4566666666544333 2334678899999999887 788999999999999987
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-27 Score=212.33 Aligned_cols=170 Identities=19% Similarity=0.157 Sum_probs=120.0
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECC-CCcEEEEEEeccc------hhhHHHHHHHHHHHHHHHhCCCCCcceEEEccee
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vAiK~~~~~------~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~ 162 (323)
+.++|++.+.||+|+||+||+|++.. +++.+|||++... ....+.+.+|+++|++++|+|+. ..+++.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv----~~l~~~- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVV----PQLLAT- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCC----cEEEEc-
Confidence 44679999999999999999999876 6788899986522 22356688999999999999872 133332
Q ss_pred ccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCcEEEeecCceeccCccc
Q 020652 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL-KPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDl-Kp~NIli~~~~~~ki~d~~~ 240 (323)
+..|+||||+ |++|.. +.. .. ...++.|++.||.|||++||+|||| ||+|||++.++.++|+|||+
T Consensus 91 ---~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred ---CCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 3579999999 888863 211 11 1467899999999999999999999 99999997655555555554
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCccc-ccCCccccccCCccccchhhcCC
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTF-EHQDHSYVVSTRHYRAPEVILGL 293 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~-~~~~~~~~~gt~~y~aPE~~~~~ 293 (323)
++.....+.. +.. ........++++.|+|||.+...
T Consensus 159 A~~~~~~~~~-----------------~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGAL-----------------YRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcch-----------------hhhhhhhhhhhhhccCccCCcccCChh
Confidence 4332211100 000 01112346789999999998643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-24 Score=192.92 Aligned_cols=194 Identities=35% Similarity=0.510 Sum_probs=159.1
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh----hHHHHHHHHHHHHHHHhC-CCCCcceEEEcceeccCceE
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~Ei~~l~~l~~~-~i~~~~~~~~~~~~~~~~~~ 168 (323)
|.+.+.||.|+||.||++.+. ..+++|.+..... ....+.+|+.++..+.|+ ++ +.+.+.+......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i-----~~~~~~~~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI-----VKLYDFFQDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcce-----eeEEEEEecCCEE
Confidence 788999999999999999887 7789998864322 356788899999999988 46 8888888777778
Q ss_pred EEEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+++++++ ++++.+++..... ..++...+..++.|++.++.|+|+.+++|||+||+||+++..+.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-------------- 139 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-------------- 139 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC--------------
Confidence 9999999 8899977765431 15889999999999999999999999999999999999976551
Q ss_pred CCCccccCCCCCCceEeeCCCcccccC---------CccccccCCccccchhhcC---CCCCcchhHHHHHHHHHHHhcC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ---------DHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSV 314 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~---------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~tg 314 (323)
.++++|||.+..... ......||..|+|||.+.+ ..++...|+||+|++++++++|
T Consensus 140 ------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~ 207 (384)
T COG0515 140 ------------VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTG 207 (384)
T ss_pred ------------eEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhC
Confidence 345556665543221 1244689999999999988 5788999999999999999999
Q ss_pred CCCCCCC
Q 020652 315 SNCYLTP 321 (323)
Q Consensus 315 ~~pf~~~ 321 (323)
..||...
T Consensus 208 ~~p~~~~ 214 (384)
T COG0515 208 LPPFEGE 214 (384)
T ss_pred CCCCCCC
Confidence 9997654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.9e-26 Score=197.26 Aligned_cols=205 Identities=17% Similarity=0.190 Sum_probs=149.8
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCC-----cEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcce
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKK-----ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~ 161 (323)
.-..|+++...+-+|.||.||.|.++..+ +.|-+|.++.. ..+...+..|.-.+..+.|+|+ ..+.+.
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nl-----l~V~~V 355 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNL-----LSVLGV 355 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCc-----cceeEE
Confidence 34467889999999999999999765433 33555655432 2334456677777888888888 444443
Q ss_pred e-ccCceEEEEEccC-CCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCce
Q 020652 162 F-DYRNHICIVFEKL-GPSLYDFLRKN------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (323)
Q Consensus 162 ~-~~~~~~~lv~e~~-~~~L~~~l~~~------~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ 233 (323)
. ++....++++.+. -|+|..++... ..+.++..++..++.|++.|++|||++||||.||-..|++|++.-.+
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence 2 2345677888888 68999999832 22456677888999999999999999999999999999999876666
Q ss_pred eccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc
Q 020652 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313 (323)
Q Consensus 234 ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t 313 (323)
|++|-.+++.....+..+..-+.+ ....||+||.+....|+.++|+|||||+||||+|
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEn----------------------RPvkWMslEal~n~~yssasDvWsfGVllWELmt 493 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNEN----------------------RPVKWMSLEALQNSHYSSASDVWSFGVLLWELMT 493 (563)
T ss_pred EeccchhccccCcccccccCCCCC----------------------CcccccCHHHHhhhhhcchhhhHHHHHHHHHHHh
Confidence 666655444333322222111111 1346999999999999999999999999999997
Q ss_pred -CCCCCCC
Q 020652 314 -VSNCYLT 320 (323)
Q Consensus 314 -g~~pf~~ 320 (323)
|+.||..
T Consensus 494 lg~~Pyae 501 (563)
T KOG1024|consen 494 LGKLPYAE 501 (563)
T ss_pred cCCCCccc
Confidence 9999864
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=183.49 Aligned_cols=175 Identities=13% Similarity=0.169 Sum_probs=124.3
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHH------HHHHHHHHHHHHhCCCCCcceEE
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREA------AMIEIDVLQRLARHDIGGTRCVQ 157 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~------~~~Ei~~l~~l~~~~i~~~~~~~ 157 (323)
+.+.++|++++.||.|+||.||++.+ ++..+|||++.... ...+. +.+|+..+.++.|+++..+....
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 34678999999999999999999755 46679999986322 11112 57899999999999985443221
Q ss_pred E---cceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCce
Q 020652 158 I---RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (323)
Q Consensus 158 ~---~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ 233 (323)
. ...+...+..+|+|||+ |.+|.++. .+++. ...+++.+|..||+.|++|||+||+||+++.+|
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-- 172 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-- 172 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhh------hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--
Confidence 1 11122245689999999 77898873 23332 456899999999999999999999999996543
Q ss_pred eccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHH
Q 020652 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311 (323)
Q Consensus 234 ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 311 (323)
++|+|||........... -..+....|+.++|+||||+++.-+
T Consensus 173 --------------------------i~liDfg~~~~~~e~~a~---------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 173 --------------------------LRIIDLSGKRCTAQRKAK---------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred --------------------------EEEEECCCcccccchhhH---------HHHHHHhHhcccccccceeEeehHH
Confidence 577777765443221111 1133445677899999999988654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=175.52 Aligned_cols=122 Identities=23% Similarity=0.222 Sum_probs=94.0
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccchh---h------------------------HHHHHHHHHHHHHHHhCC
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---Y------------------------REAAMIEIDVLQRLARHD 149 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~---~------------------------~~~~~~Ei~~l~~l~~~~ 149 (323)
...||+|+||.||+|.+. +|+.||||+++.... . ......|+.++.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999986 899999999864311 0 122345999999999887
Q ss_pred CCCcceEEEcceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCcEEE
Q 020652 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM-HELRLIHTDLKPENILL 227 (323)
Q Consensus 150 i~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~l-H~~~iiHrDlKp~NIli 227 (323)
+..+.+.. ... .+|||||+ ++++...+... ..+++..+..++.|++.+|.++ |+.||+||||||+|||+
T Consensus 81 v~~p~~~~------~~~-~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPIL------LKS-HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEE------ecC-CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 74444331 112 37999999 55555443333 3689999999999999999999 79999999999999998
Q ss_pred e
Q 020652 228 V 228 (323)
Q Consensus 228 ~ 228 (323)
+
T Consensus 152 ~ 152 (190)
T cd05147 152 H 152 (190)
T ss_pred E
Confidence 5
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=172.64 Aligned_cols=107 Identities=28% Similarity=0.342 Sum_probs=89.2
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCC
Q 020652 177 PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256 (323)
Q Consensus 177 ~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~ 256 (323)
|+|.+++...+ ..+++..++.++.|++.||+|||+++ ||+|||++.++.+
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~----------------------- 50 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLL----------------------- 50 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccce-----------------------
Confidence 68999998644 46999999999999999999999998 9999998766544
Q ss_pred CCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 257 ~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
|+ ||.+....... ..||+.|||||++.+..++.++|||||||++|||+||+.||...
T Consensus 51 ----~~--fG~~~~~~~~~--~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 51 ----KL--DGSVAFKTPEQ--SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred ----ee--ccceEeecccc--CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 44 55554432221 26899999999999999999999999999999999999999753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-23 Score=170.88 Aligned_cols=125 Identities=20% Similarity=0.151 Sum_probs=95.2
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccchhh---------------------------HHHHHHHHHHHHHHHhCC
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY---------------------------REAAMIEIDVLQRLARHD 149 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~---------------------------~~~~~~Ei~~l~~l~~~~ 149 (323)
.+.||+|+||+||+|.+. +|+.||||+++..... ......|...+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 8999999998743110 122357899999999988
Q ss_pred CCCcceEEEcceeccCceEEEEEccC-CCCHHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEE
Q 020652 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDF-LRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENIL 226 (323)
Q Consensus 150 i~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~-l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIl 226 (323)
+..+..... . ..+|||||+ |+++... +.. ..++...+..++.|++.+|.++|+ +||+||||||+|||
T Consensus 81 i~~p~~~~~-----~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIl 150 (190)
T cd05145 81 VPVPEPILL-----K--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNIL 150 (190)
T ss_pred CCCceEEEe-----c--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEE
Confidence 744433221 1 248999999 5544333 333 257888999999999999999999 99999999999999
Q ss_pred EeecCce
Q 020652 227 LVSAEYV 233 (323)
Q Consensus 227 i~~~~~~ 233 (323)
++ ++.+
T Consensus 151 l~-~~~~ 156 (190)
T cd05145 151 YH-DGKP 156 (190)
T ss_pred EE-CCCE
Confidence 96 4433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-22 Score=167.53 Aligned_cols=125 Identities=21% Similarity=0.240 Sum_probs=99.9
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc---e-EEEE
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN---H-ICIV 171 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~---~-~~lv 171 (323)
.+.||+|+||.||. +..++.. +||++... ....+.+.+|+.+++.+.|.+..++++++++++++++. . +.+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 47899999999995 6667665 69987643 23456789999999999776666666799999998863 4 3488
Q ss_pred EccC---CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHHCCceecCCCCCcEEEee
Q 020652 172 FEKL---GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV-AFMHELRLIHTDLKPENILLVS 229 (323)
Q Consensus 172 ~e~~---~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL-~~lH~~~iiHrDlKp~NIli~~ 229 (323)
|||+ +++|.+++.+. .+++. ..++.|++.++ +|||+++|+||||||+|||++.
T Consensus 84 ~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~ 140 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQR 140 (210)
T ss_pred ecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEec
Confidence 9994 48999999763 36666 35678888888 9999999999999999999964
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.3e-22 Score=165.30 Aligned_cols=180 Identities=14% Similarity=0.089 Sum_probs=129.2
Q ss_pred EEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHH-----HHHHHHHHHHHHHh-CCCCCcceEEEcceeccCceE
Q 020652 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE-----AAMIEIDVLQRLAR-HDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 95 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~-----~~~~Ei~~l~~l~~-~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.+...|++|+||+|+++.. .+..++.+.+........ .+.+|+++|+++.| +++ ++++++ +..
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~v-----P~ll~~----~~~ 73 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRT-----PRLLHW----DGR 73 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCC-----CEEEEE----cCE
Confidence 3568999999999998754 677788777664443222 57889999999976 334 566554 346
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC-CCCcEEEeecCceeccCcccccccCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL-KPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDl-Kp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+++|||+ |.+|.+.+.. . ...++.|++.+|+++|++||+|||| ||+|||++.++.+
T Consensus 74 ~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i------------- 131 (218)
T PRK12274 74 HLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSP------------- 131 (218)
T ss_pred EEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCE-------------
Confidence 8999999 7788654321 1 1357789999999999999999999 7999999765554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCc----------------cccccCCccccchhhcCC-CCC-cchhHHHHHHHH
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH----------------SYVVSTRHYRAPEVILGL-GWN-YPCDLWSVGCIL 308 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------------~~~~gt~~y~aPE~~~~~-~~~-~~~DiwSlG~il 308 (323)
+|+|||++....... .....++.|++|+.-.-. ..+ ...++++.|+-+
T Consensus 132 --------------~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~ 197 (218)
T PRK12274 132 --------------AVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPV 197 (218)
T ss_pred --------------EEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchH
Confidence 555555554322111 012468889999876543 333 567888999999
Q ss_pred HHHhcCCCCCCCC
Q 020652 309 VELCSVSNCYLTP 321 (323)
Q Consensus 309 ~el~tg~~pf~~~ 321 (323)
|.++|+..++-+.
T Consensus 198 ~~~~~~~~~~~~~ 210 (218)
T PRK12274 198 YRFVTRRVLHWED 210 (218)
T ss_pred HHHHhccCCcccc
Confidence 9999999987653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.7e-22 Score=196.44 Aligned_cols=199 Identities=25% Similarity=0.376 Sum_probs=150.3
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
...|.|.+.||+|+||.||+|.+.. ++.||+|+-+....+. +..=.+++.+|+ +-+ .+-+..+...+...+.-+|
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE--fYI~~q~~~RLk-~~~-~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE--FYICLQVMERLK-PQM-LPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee--eeehHHHHHhhc-hhh-hcchHHHHHHHccCCccee
Confidence 3579999999999999999999877 9999999876433221 111112233333 110 0111444444555666789
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
|+||. -|+|.+++... ..+++..+..+..|++.-+++||..+|||+||||+|+||...-. .|
T Consensus 772 v~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~---~~------------ 834 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREIC---AD------------ 834 (974)
T ss_pred eeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccC---CC------------
Confidence 99999 89999999844 47999999999999999999999999999999999999965321 11
Q ss_pred ccccCCCCCCceEeeCCCccc---ccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTF---EHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~---~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~ 316 (323)
+....++|+|||.+-. .... -...++|-.+-++|+..|.+++..+|.|.|.-+++-|+.|++
T Consensus 835 -----~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 835 -----SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred -----CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 2255689999998843 2222 223578999999999999999999999999999999999864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-23 Score=194.32 Aligned_cols=185 Identities=25% Similarity=0.362 Sum_probs=147.7
Q ss_pred eecccCcEEEEEEEE---CCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceeccCceEEEE
Q 020652 99 KMGEGTFGQVVECFD---NEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 99 ~lG~G~fg~V~~~~~---~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
.+|+|+||.|++++. ...++.+|+|+.++.. ..+.....|-.++..++ |+.+ +.+...++.+...+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~-----v~lhyafqt~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFL-----VKLHYAFQTDGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCce-----eeeeeeeccccchhHh
Confidence 379999999987643 3457789999876432 11224455777777777 5555 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
+++. +++|...+.+.. .+.+.....+...++.+++++|+.+|+|||+|++||+++.+|++
T Consensus 76 ld~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi----------------- 136 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHI----------------- 136 (612)
T ss_pred hhhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCcc-----------------
Confidence 9999 889988887664 68888999999999999999999999999999999998776655
Q ss_pred cccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++.|||.++..-..... |||..|||||++. +....+|+||||+++|||+||..||.+
T Consensus 137 ----------~~tdfglske~v~~~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 137 ----------KLTDFGLSKEAVKEKIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----------ccCCchhhhHhHhhhhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 55555555443222222 8999999999998 567889999999999999999999986
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-22 Score=196.01 Aligned_cols=196 Identities=23% Similarity=0.343 Sum_probs=145.4
Q ss_pred CcE-EEEeeecccCcEEEEEEEECCCCcEEEEEEec----cchh---hHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 92 PRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINK---YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 92 ~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~----~~~~---~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
..| .....+|.|++|.|+.+......+.++.|.+. .... .......|..+-..+.|+|+ +.....+.
T Consensus 317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~-----~e~l~~~~ 391 (601)
T KOG0590|consen 317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNI-----IETLDIVQ 391 (601)
T ss_pred cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCch-----hhhHHHHh
Confidence 345 45678999999988888777666666666443 1111 11124456666777888887 54444444
Q ss_pred cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 164 YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 164 ~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
......-+||||..+|+.++.... .+....+..++.|++.||+|||+.||.|||+|++|+++...|.+
T Consensus 392 ~~~~~~~~mE~~~~Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~l---------- 459 (601)
T KOG0590|consen 392 EIDGILQSMEYCPYDLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGIL---------- 459 (601)
T ss_pred hcccchhhhhcccHHHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCce----------
Confidence 444444449999449999998763 58888999999999999999999999999999999999766644
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccC-------CccccccCCccccchhhcCCCCC-cchhHHHHHHHHHHHhcCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-------DHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~ 315 (323)
||+|||.+..... ....++|+..|+|||++.+..|+ ...||||.|++++.|++|+
T Consensus 460 -----------------ki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~ 522 (601)
T KOG0590|consen 460 -----------------KIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR 522 (601)
T ss_pred -----------------EEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence 5666665533211 11235899999999999999998 5589999999999999999
Q ss_pred CCCCCC
Q 020652 316 NCYLTP 321 (323)
Q Consensus 316 ~pf~~~ 321 (323)
.||.-+
T Consensus 523 ~~Wk~a 528 (601)
T KOG0590|consen 523 FPWKVA 528 (601)
T ss_pred Cccccc
Confidence 999753
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-21 Score=167.72 Aligned_cols=201 Identities=20% Similarity=0.224 Sum_probs=122.6
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH----------HhCC-CCCcceEEE
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL----------ARHD-IGGTRCVQI 158 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l----------~~~~-i~~~~~~~~ 158 (323)
+...+.||.|+++.||.+.|..|++.+|+|+..... ...+.+.+|......+ .|-. +....++++
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 567789999999999999999999999999875322 1223344444222221 1111 111112333
Q ss_pred cc---eeccC---c-----eEEEEEccCCCCHHHHHH---hcCCC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCC
Q 020652 159 RN---WFDYR---N-----HICIVFEKLGPSLYDFLR---KNSYR--SFPIDLVRELGRQLLESVAFMHELRLIHTDLKP 222 (323)
Q Consensus 159 ~~---~~~~~---~-----~~~lv~e~~~~~L~~~l~---~~~~~--~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp 222 (323)
.+ ++... + ..+++|+.+.++|.+++. ..... .+.......+..|+++.+++||+.||+|+||||
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~ 173 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKP 173 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred cCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccce
Confidence 21 11111 1 247788888889988865 22211 122223345668999999999999999999999
Q ss_pred CcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC--------C
Q 020652 223 ENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL--------G 294 (323)
Q Consensus 223 ~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~--------~ 294 (323)
+|++++.+|.++++||+.+. ..+........+..|.+||..... .
T Consensus 174 ~nfll~~~G~v~Lg~F~~~~---------------------------r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~ 226 (288)
T PF14531_consen 174 ENFLLDQDGGVFLGDFSSLV---------------------------RAGTRYRCSEFPVAFTPPELESCAGQFGQNNAP 226 (288)
T ss_dssp GGEEE-TTS-EEE--GGGEE---------------------------ETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEE
T ss_pred eeEEEcCCCCEEEcChHHHe---------------------------ecCceeeccCCCcccCChhhhhhhcccCcccce
Confidence 99999887776666665332 211111112345679999987442 4
Q ss_pred CCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 295 WNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 295 ~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
++.+.|.|+||+++|.|++|..||...
T Consensus 227 ~t~~~DaW~LG~~ly~lWC~~lPf~~~ 253 (288)
T PF14531_consen 227 YTFATDAWQLGITLYSLWCGRLPFGLS 253 (288)
T ss_dssp E-HHHHHHHHHHHHHHHHHSS-STCCC
T ss_pred eeeccCHHHHHHHHHHHHHccCCCCCC
Confidence 788999999999999999999999853
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.8e-21 Score=163.19 Aligned_cols=126 Identities=25% Similarity=0.193 Sum_probs=96.4
Q ss_pred EEEEeeecccCcEEEEEEE-ECCCCcEEEEEEeccchh-------------------------hHHHHHHHHHHHHHHHh
Q 020652 94 YRILSKMGEGTFGQVVECF-DNEKKELVAIKIVRSINK-------------------------YREAAMIEIDVLQRLAR 147 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~-~~~~~~~vAiK~~~~~~~-------------------------~~~~~~~Ei~~l~~l~~ 147 (323)
|++.+.||+|+||.||+|. +..+|+.||||+++.... ....+.+|+.+++++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 8889999999999999998 667899999999864211 11235689999999987
Q ss_pred CCCCCcceEEEcceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceecCCCCCcE
Q 020652 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR-LIHTDLKPENI 225 (323)
Q Consensus 148 ~~i~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~-iiHrDlKp~NI 225 (323)
..+.. ..++.+ . ..++||||+ +.+|..+..... .+....+..++.|++.+|.+||++| |+||||||+||
T Consensus 110 ~~i~~---p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NI 180 (237)
T smart00090 110 AGVPV---PKPIAW---R-RNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNI 180 (237)
T ss_pred cCCCC---CeeeEe---c-CceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhE
Confidence 54322 222222 2 247999999 656666543322 4566677899999999999999999 99999999999
Q ss_pred EEe
Q 020652 226 LLV 228 (323)
Q Consensus 226 li~ 228 (323)
+++
T Consensus 181 li~ 183 (237)
T smart00090 181 LVH 183 (237)
T ss_pred EEE
Confidence 986
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=190.20 Aligned_cols=178 Identities=26% Similarity=0.472 Sum_probs=124.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
.+|..++.|..|+||.||+++++.+.+.+|+|+-+.+. |++ || ..+- +..+.|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l-----------ilR-----ni-----lt~a------~npfvv 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL-----------ILR-----NI-----LTFA------GNPFVV 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhcccccch-----------hhh-----cc-----cccc------CCccee
Confidence 56999999999999999999999999999996532211 111 01 1111 111222
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 172 FEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 172 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
|+-...++..+ .++.+ ++.+++|||+-||+|||+||+|.+|+.-|++|+.|||+.+.........
T Consensus 136 -----gDc~tllk~~g--~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -----GDCATLLKNIG--PLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -----chhhhhcccCC--CCcch--------hhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 44444555433 33322 2788999999999999999999999999999888888765443322110
Q ss_pred ccCCCCCCceEeeCCCcccccC-CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+ ..+.+ ....++ ....++|||.|.|||++...+|+..+|+|++|+|+||.+-|+.||++.
T Consensus 201 --l-~eg~I-------~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd 261 (1205)
T KOG0606|consen 201 --L-KEGHI-------EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 261 (1205)
T ss_pred --h-hhcch-------HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence 0 00000 011111 122358999999999999999999999999999999999999999997
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.9e-20 Score=162.24 Aligned_cols=129 Identities=24% Similarity=0.381 Sum_probs=102.4
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
..+|+||.....+|.+++..+. .+....+.++.|+++|+.|||++||.|||+|++|||+.-+.
T Consensus 316 ~tlylvMkrY~~tLr~yl~~~~---~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~Eldd-------------- 378 (598)
T KOG4158|consen 316 KTLYLVMKRYRQTLREYLWTRH---RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDD-------------- 378 (598)
T ss_pred ceEEEehhcchhhHHHHHhcCC---CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecC--------------
Confidence 4589999999999999998764 77888899999999999999999999999999999996442
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccC---------CccccccCCccccchhhcCCC-----C-CcchhHHHHHHHHHH
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQ---------DHSYVVSTRHYRAPEVILGLG-----W-NYPCDLWSVGCILVE 310 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---------~~~~~~gt~~y~aPE~~~~~~-----~-~~~~DiwSlG~il~e 310 (323)
|.-..+.++|||++-.... ..-...|...-||||+....+ . -.|+|.|+.|.+.||
T Consensus 379 ---------D~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYE 449 (598)
T KOG4158|consen 379 ---------DEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYE 449 (598)
T ss_pred ---------CCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHH
Confidence 2334567888887633211 111235777899999986432 1 257999999999999
Q ss_pred HhcCCCCCCC
Q 020652 311 LCSVSNCYLT 320 (323)
Q Consensus 311 l~tg~~pf~~ 320 (323)
+++...||.+
T Consensus 450 Ifg~~NPFY~ 459 (598)
T KOG4158|consen 450 IFGRSNPFYK 459 (598)
T ss_pred HhccCCcccc
Confidence 9999999976
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-20 Score=183.03 Aligned_cols=200 Identities=21% Similarity=0.290 Sum_probs=145.9
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
.|...+.||++.|=+|.+|++.+. .|+||++-+.. ....+...|++ ...+++||. +.+..+......
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~-----lPfqk~~~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNC-----LPFQKVLVTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcc-----cchHHHHHhhHH
Confidence 578889999999999999976543 38999875432 11223334555 556667776 777777777778
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
.|||-+|...+|.|.+.... -+..-+.+.|+.|++.||.-||..||+|+|||.+||||+.=+=+.++||.-.+-....
T Consensus 96 AylvRqyvkhnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 96 AYLVRQYVKHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHHHHHHHhhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence 88999999889999998765 4667778889999999999999999999999999999999888888888532211111
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC----------C-CCcchhHHHHHHHHHHHhc-CC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL----------G-WNYPCDLWSVGCILVELCS-VS 315 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwSlG~il~el~t-g~ 315 (323)
.+ .-+||+.-...... -..|.|||.+... . .+++-||||+||+++||++ |+
T Consensus 174 --------eD---NPadf~fFFDTSrR------RtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~ 236 (1431)
T KOG1240|consen 174 --------ED---NPADFTFFFDTSRR------RTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGR 236 (1431)
T ss_pred --------CC---CcccceEEEecCCc------eeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCC
Confidence 11 12355432211111 1259999988542 2 5678899999999999976 78
Q ss_pred CCCC
Q 020652 316 NCYL 319 (323)
Q Consensus 316 ~pf~ 319 (323)
+||.
T Consensus 237 PlF~ 240 (1431)
T KOG1240|consen 237 PLFT 240 (1431)
T ss_pred Cccc
Confidence 8884
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.4e-19 Score=148.27 Aligned_cols=124 Identities=25% Similarity=0.238 Sum_probs=92.9
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-----------------------hhHHHHHHHHHHHHHHHhCCC
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------------------KYREAAMIEIDVLQRLARHDI 150 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-----------------------~~~~~~~~Ei~~l~~l~~~~i 150 (323)
|.+.+.||+|+||.||++... +++.||||++.... ........|+.++..+.+.++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 788899999999999999864 79999999865321 011235678999999988754
Q ss_pred CCcceEEEcceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEee
Q 020652 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (323)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~ 229 (323)
.. ...++ ....++||||+ |++|.+.... .....++.+++.++.++|+.||+||||||+||+++.
T Consensus 96 ~v---~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~ 160 (198)
T cd05144 96 PV---PKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDD 160 (198)
T ss_pred CC---Cceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcC
Confidence 22 22222 13458999999 7787654321 345678899999999999999999999999999965
Q ss_pred cCce
Q 020652 230 AEYV 233 (323)
Q Consensus 230 ~~~~ 233 (323)
++.+
T Consensus 161 ~~~~ 164 (198)
T cd05144 161 DEKI 164 (198)
T ss_pred CCcE
Confidence 4433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.4e-19 Score=149.61 Aligned_cols=118 Identities=22% Similarity=0.236 Sum_probs=93.8
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch---------hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
+.||+|++|.||+|.+ .+..+++|+..... .....+.+|+.++..+.++++..+.+. +......
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~-----~~~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVY-----FVDPENF 74 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEE-----EEeCCCC
Confidence 5799999999999976 66779999764211 112456789999999999887444332 2334567
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEe
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~ 228 (323)
+++|||+ |++|.+++.... . ....++.+++.+|.++|+.|++|+|++|+|||++
T Consensus 75 ~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~ 129 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS 129 (211)
T ss_pred EEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE
Confidence 8999999 889999986532 2 7788999999999999999999999999999996
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=145.69 Aligned_cols=114 Identities=21% Similarity=0.194 Sum_probs=88.1
Q ss_pred eecccCcEEEEEEEECCCCcEEEEEEeccch---------hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 99 ~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
.||+|+||.||++. .++..+++|+..... ...+.+.+|++++..+.++++..+.+ +. ...+..+
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~---~~--~~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVV---YD--VDPDNKT 73 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEE---EE--EECCCCE
Confidence 38999999999997 456779999854211 11245678999999999887643333 22 2344568
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEe
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~ 228 (323)
++|||+ |++|.+++.... . .++.|++.+|.+||+.|++|+|+||+||+++
T Consensus 74 lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~ 124 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR 124 (199)
T ss_pred EEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE
Confidence 999999 889998876532 1 7889999999999999999999999999986
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=165.82 Aligned_cols=134 Identities=22% Similarity=0.198 Sum_probs=96.7
Q ss_pred CceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEe-cc---ch-----hhHHHHHHHHHHHHHHHhCCCCCcceEE
Q 020652 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV-RS---IN-----KYREAAMIEIDVLQRLARHDIGGTRCVQ 157 (323)
Q Consensus 87 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~-~~---~~-----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~ 157 (323)
.+.....|...+.||+|+||+||++.+...+ +++|+. .+ .. ...+.+.+|+++++.++|+++. .
T Consensus 328 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~-----~ 400 (535)
T PRK09605 328 EEEVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVP-----T 400 (535)
T ss_pred ccccccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCC-----e
Confidence 3344455677899999999999999765443 444432 11 11 1235677899999999998873 2
Q ss_pred EcceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceecc
Q 020652 158 IRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (323)
Q Consensus 158 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~ 236 (323)
...+.......++||||+ +++|.+++. ....++.|++.+|.+||++||+||||||+|||+ .++.++++
T Consensus 401 p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~li 469 (535)
T PRK09605 401 PVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLI 469 (535)
T ss_pred eEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEE
Confidence 223333445678999999 889998875 246789999999999999999999999999999 34433333
Q ss_pred Cc
Q 020652 237 DY 238 (323)
Q Consensus 237 d~ 238 (323)
||
T Consensus 470 DF 471 (535)
T PRK09605 470 DF 471 (535)
T ss_pred eC
Confidence 33
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-19 Score=164.09 Aligned_cols=195 Identities=22% Similarity=0.296 Sum_probs=130.0
Q ss_pred cEEEEeeecccCcEEEEEEEECCC---CcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcc-------e
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRN-------W 161 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~-------~ 161 (323)
.+.+.+..+..+++.+...+-... .+.++-|.....+ .......+++..+....|++. ..+.+ .
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~-----s~~~d~~~s~~~~ 319 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNR-----SILEDLRPSLFES 319 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCc-----ccccCCCCchhhh
Confidence 345555566666666554432222 2333333332222 222333455555555555543 11111 1
Q ss_pred e-----ccCceEEEEEccC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCcee
Q 020652 162 F-----DYRNHICIVFEKL-GPSLYDFLRKN-SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (323)
Q Consensus 162 ~-----~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~k 234 (323)
+ ....++|+.|++| ..+|.+||.+. .....+......++.|+..|++| ++.+|||+||.||....++.+|
T Consensus 320 ~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 320 SKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred ccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhh
Confidence 1 1133689999999 88999999733 33456778899999999999999 9999999999999998888777
Q ss_pred ccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc
Q 020652 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313 (323)
Q Consensus 235 i~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t 313 (323)
|.|||+........+ .......++.-+||..||+||++.+..|+.++||||||+||+||+.
T Consensus 397 IgDFgl~ts~~~~~~------------------~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDET------------------VAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhhheeecccCCc------------------ccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 777777554433220 0001112344589999999999999999999999999999999986
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.8e-17 Score=138.01 Aligned_cols=124 Identities=27% Similarity=0.270 Sum_probs=84.4
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccchhh---HH----------------------HHHHHHHHHHHHHhCCCC
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY---RE----------------------AAMIEIDVLQRLARHDIG 151 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~---~~----------------------~~~~Ei~~l~~l~~~~i~ 151 (323)
.+.||+|+||+||+|.+. +++.||||++...... .. ....|...+..+.+..+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 8899999987642211 11 113566777777665432
Q ss_pred CcceEEEcceeccCceEEEEEccC-CCCHH-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEe
Q 020652 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLY-DFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLV 228 (323)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~-~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~ 228 (323)
.+. .+.. ...++||||+ ++++. ..+.... .. ..+..++.+++.++.++|. ++|+||||||+||+++
T Consensus 81 ~~~---~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~ 149 (187)
T cd05119 81 VPK---PIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD 149 (187)
T ss_pred CCc---eEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE
Confidence 222 2221 2358999999 53322 1121111 11 5678899999999999999 9999999999999996
Q ss_pred ecCce
Q 020652 229 SAEYV 233 (323)
Q Consensus 229 ~~~~~ 233 (323)
++.+
T Consensus 150 -~~~~ 153 (187)
T cd05119 150 -DGKV 153 (187)
T ss_pred -CCcE
Confidence 4433
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.6e-18 Score=145.93 Aligned_cols=191 Identities=15% Similarity=0.216 Sum_probs=148.3
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
..++.+|.+...|+.|+|++..++ ++.|+++. ......+|..|.-.|+.+.|||| +.+++.+....++.+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpni-----lpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNI-----LPVLGACNSPPNLVI 264 (448)
T ss_pred hhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCch-----hhhhhhccCCCCceE
Confidence 456778999999999999876554 66777753 23344678889999999999999 899999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
+..|+ -++|+..+...........++.+++.++++|+.|||+.. |..--|....++|+++-.++|+
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris----------- 333 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS----------- 333 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-----------
Confidence 99999 899999999877667788899999999999999999864 3344688889999876554432
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCC---cchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+|--.+. +.. -..-.|.||+||.+...+-+ .++|+|||.+++|||.|...||..
T Consensus 334 --------------mad~kfsf---qe~-gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfad 391 (448)
T KOG0195|consen 334 --------------MADTKFSF---QEV-GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFAD 391 (448)
T ss_pred --------------cccceeee---ecc-ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccccc
Confidence 22211110 110 01237889999999876543 679999999999999999999964
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=4.5e-16 Score=134.44 Aligned_cols=124 Identities=19% Similarity=0.198 Sum_probs=86.9
Q ss_pred eeec-ccCcEEEEEEEECCCCcEEEEEEeccch--------------hhHHHHHHHHHHHHHHHhCCCCCcceEEEccee
Q 020652 98 SKMG-EGTFGQVVECFDNEKKELVAIKIVRSIN--------------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 98 ~~lG-~G~fg~V~~~~~~~~~~~vAiK~~~~~~--------------~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~ 162 (323)
..|| .||.|+||.+... +..++||.+.... .....+.+|+.++..+.+.++..+..+.+.. .
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~-~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV-V 113 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee-e
Confidence 4576 7888888888653 6778999774211 1234577899999999998864333222211 1
Q ss_pred ccC--ceEEEEEccC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC
Q 020652 163 DYR--NHICIVFEKL-G-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (323)
Q Consensus 163 ~~~--~~~~lv~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~ 231 (323)
... ...++|||++ | .+|.+++... .+++.. +.|++.+|.+||++||+||||||+|||++.++
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~ 179 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG 179 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC
Confidence 111 1236999999 5 5899888653 355543 57899999999999999999999999996543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.69 E-value=3e-16 Score=125.18 Aligned_cols=121 Identities=25% Similarity=0.272 Sum_probs=95.2
Q ss_pred EEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC
Q 020652 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (323)
Q Consensus 96 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (323)
+++.||+|.++.||++.... ..+++|....... ...+..|+.+++.+.+.+ ..+++++.+....+..+++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~---~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-GADREREVAILQLLARKG---LPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcC---CCCCeEEEEcCCCCccEEEEEec
Confidence 35789999999999998754 6799998865433 456888999999998862 22367777777777899999999
Q ss_pred -CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCcEEEeecC
Q 020652 176 -GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL---RLIHTDLKPENILLVSAE 231 (323)
Q Consensus 176 -~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~iiHrDlKp~NIli~~~~ 231 (323)
+..+..+ +......++.+++.+|.++|.. +++|+|+||+||+++..+
T Consensus 76 ~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~ 126 (155)
T cd05120 76 EGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK 126 (155)
T ss_pred CCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc
Confidence 5555433 4456677889999999999985 799999999999996543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=9.1e-18 Score=161.91 Aligned_cols=199 Identities=21% Similarity=0.283 Sum_probs=152.4
Q ss_pred cEEEEeeecccCcEEEEEEEECC-CCcEEEEEEeccch---hhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceeccCce
Q 020652 93 RYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSIN---KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~-~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~~~~ 167 (323)
.|.+.+.||+|+|+.|-.+.... ....+|.|.+.... ...+....|..+-+.+. |.|+ +.+++.......
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~-----~~~~~~~~~~~~ 95 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNT-----VHMIEPSSSPRS 95 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccc-----cccCCccCCCcc
Confidence 48888899999999998887643 34556777665332 23334445777777777 7777 899999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.++++++. |+++.+.+........+...+..++.|+..+|.|+| ..++.||||||+|.+++..+.
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~------------- 162 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS------------- 162 (601)
T ss_pred cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-------------
Confidence 99999999 889988883222225777888999999999999999 999999999999999876650
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccC--C----cccccc-CCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQ--D----HSYVVS-TRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~----~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~p 317 (323)
.+++.|||+|..... . ....+| ++.|+|||...+. ......|+||.|+++.-+++|..|
T Consensus 163 -------------~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p 229 (601)
T KOG0590|consen 163 -------------ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELP 229 (601)
T ss_pred -------------cccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCC
Confidence 345555555543322 1 122478 9999999999885 456889999999999999999999
Q ss_pred CCCCC
Q 020652 318 YLTPF 322 (323)
Q Consensus 318 f~~~~ 322 (323)
|..+.
T Consensus 230 ~~~~~ 234 (601)
T KOG0590|consen 230 WDFPS 234 (601)
T ss_pred ccccc
Confidence 98653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=4e-15 Score=138.16 Aligned_cols=207 Identities=21% Similarity=0.253 Sum_probs=153.8
Q ss_pred ceeCCcEEEEeeecc--cCcEEEEEEEE--CCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcc
Q 020652 88 ENLTPRYRILSKMGE--GTFGQVVECFD--NEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~--G~fg~V~~~~~--~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~ 160 (323)
+.+...+.+.+.+|. |.+|.||.+.. ..+...+|+|.-+.. ......-.+|+...+++. .+.+.+..+.
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~----~~~~~v~~~~ 185 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKID----SHENPVRDSP 185 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccC----ccccccccCc
Confidence 345567888999999 99999999988 888999999973311 122222334554444433 1233477788
Q ss_pred eeccCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHHCCceecCCCCCcEEEeec-Cceec
Q 020652 161 WFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE----SVAFMHELRLIHTDLKPENILLVSA-EYVKV 235 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~----aL~~lH~~~iiHrDlKp~NIli~~~-~~~ki 235 (323)
.++.++..++-+|+|+.+|..+...-. ..++...++..+.+... ||.++|+.+++|-|+||+||++..+ ..++.
T Consensus 186 ~~e~~~~lfiqtE~~~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 186 AWEGSGILFIQTELCGESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred ccccCCcceeeeccccchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeec
Confidence 899999999999999999999887654 34888999999999999 9999999999999999999999888 77777
Q ss_pred cCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCC
Q 020652 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~ 315 (323)
.||+++.... |.+.+...... ....|...|++||+..+ .++...||+|||.++.+..++.
T Consensus 265 ~df~~v~~i~------------------~~~~~~~~~~~-~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~ 324 (524)
T KOG0601|consen 265 TDFGLVSKIS------------------DGNFSSVFKVS-KRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGS 324 (524)
T ss_pred CCcceeEEcc------------------CCccccceeee-ecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhc
Confidence 8887654332 22222211111 11246678999998766 6788999999999999998887
Q ss_pred CCCC
Q 020652 316 NCYL 319 (323)
Q Consensus 316 ~pf~ 319 (323)
.+..
T Consensus 325 ~~~~ 328 (524)
T KOG0601|consen 325 HLPS 328 (524)
T ss_pred cccc
Confidence 6543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.5e-15 Score=139.28 Aligned_cols=145 Identities=21% Similarity=0.302 Sum_probs=114.1
Q ss_pred HHHHhCCCCCcceEEEcceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-eecCC
Q 020652 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL-IHTDL 220 (323)
Q Consensus 143 ~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i-iHrDl 220 (323)
+.+.|.|+ .++.+....+...++|.+|| .|+|.|.+.... ..+++-....++++++.||.|||.-.| .|+.+
T Consensus 2 ~~l~h~n~-----~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l 75 (484)
T KOG1023|consen 2 RQLDHDNL-----NKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSPIGYHGAL 75 (484)
T ss_pred cccchhhh-----hhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCcceeeeee
Confidence 45667776 88899888889999999999 899999998743 568888889999999999999998766 99999
Q ss_pred CCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccC-----CccccccCCccccchhhcCCC-
Q 020652 221 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLG- 294 (323)
Q Consensus 221 Kp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~- 294 (323)
++.|++++.. +.+||+|||+...... ......-...|.|||.+.+..
T Consensus 76 ~s~nClvd~~---------------------------w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~ 128 (484)
T KOG1023|consen 76 KSSNCLVDSR---------------------------WVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALS 128 (484)
T ss_pred ccccceeeee---------------------------EEEEechhhhcccccccccccccchhHHHHhccCHHHhccccc
Confidence 9999998654 4455556655544321 111112345699999998742
Q ss_pred ------CCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 295 ------WNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 295 ------~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+.+.||||||++++|+++.+.||..
T Consensus 129 ~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 129 QSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred ccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 35679999999999999999999975
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=5.5e-14 Score=131.64 Aligned_cols=141 Identities=17% Similarity=0.192 Sum_probs=91.5
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccchhh-----------------------------------H------HHHH
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-----------------------------------R------EAAM 136 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~-----------------------------------~------~~~~ 136 (323)
+.||+|++|+||+|+. .+|+.||||+.+..-.. . -++.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 5799999999999986 47899999997532100 0 0234
Q ss_pred HHHHHHHHHHhCCCCCcceEEEccee-ccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHHC
Q 020652 137 IEIDVLQRLARHDIGGTRCVQIRNWF-DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE-SVAFMHEL 213 (323)
Q Consensus 137 ~Ei~~l~~l~~~~i~~~~~~~~~~~~-~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~-aL~~lH~~ 213 (323)
+|...+.++....- +...+.+-..+ +.....+|||||+ |.+|.++..... .... ...++.+++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~-~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFK-NDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-AGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcC-CCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHhC
Confidence 45555666653211 11113333322 2234578999999 888888765321 1222 2345555555 46789999
Q ss_pred CceecCCCCCcEEEeecCceeccCccccccc
Q 020652 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 214 ~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
|++|+|+||.||++..++.+++.|||++...
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9999999999999987777767777665444
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.2e-14 Score=136.14 Aligned_cols=143 Identities=17% Similarity=0.274 Sum_probs=88.5
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-----------------------------------hhHHH---
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------------------------------KYREA--- 134 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-----------------------------------~~~~~--- 134 (323)
.|.. +.||+|++|+||+|+.+.+|+.||||+.+..- +..+.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3555 78999999999999998889999999986321 11111
Q ss_pred ---HHHHHHHHHHHHhCCCCCcceEEEccee-ccCceEEEEEccC-CCCHHHHH--HhcCC--CCCCHHHHHHHHHHHHH
Q 020652 135 ---AMIEIDVLQRLARHDIGGTRCVQIRNWF-DYRNHICIVFEKL-GPSLYDFL--RKNSY--RSFPIDLVRELGRQLLE 205 (323)
Q Consensus 135 ---~~~Ei~~l~~l~~~~i~~~~~~~~~~~~-~~~~~~~lv~e~~-~~~L~~~l--~~~~~--~~l~~~~~~~i~~qi~~ 205 (323)
+.+|...+.++... ..+...+.+-..+ +.....+|||||+ |+++.++- ...+. ..+.+..+..++.|++
T Consensus 200 ElD~~~Ea~N~~~~~~~-f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 200 ELDLMREAANASQLRRN-FEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred hhCHHHHHHHHHHHHHH-ccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 23445455555432 1111123333332 2245678999999 88988753 22220 1233444444455543
Q ss_pred HHHHHHHCCceecCCCCCcEEEeecC----ceeccCccccccc
Q 020652 206 SVAFMHELRLIHTDLKPENILLVSAE----YVKVPDYKFLSRS 244 (323)
Q Consensus 206 aL~~lH~~~iiHrDlKp~NIli~~~~----~~ki~d~~~~~~~ 244 (323)
..|++|+|+||.||+++.++ .+++.|||++...
T Consensus 278 ------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 ------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred ------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 59999999999999998776 5555555544433
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=9.3e-13 Score=109.33 Aligned_cols=121 Identities=20% Similarity=0.226 Sum_probs=86.5
Q ss_pred eeecccCcEEEEEEEECC------CCcEEEEEEeccc-----------------------hhhHH----HHHHHHHHHHH
Q 020652 98 SKMGEGTFGQVVECFDNE------KKELVAIKIVRSI-----------------------NKYRE----AAMIEIDVLQR 144 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~------~~~~vAiK~~~~~-----------------------~~~~~----~~~~Ei~~l~~ 144 (323)
..||.|--+.||.|.... .+..+|||+.+.. ...+. ...+|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997653 3578999987521 00112 23489999999
Q ss_pred HHhCCCCCcceEEEcceeccCceEEEEEccCCCC-HHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCC
Q 020652 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS-LYD-FLRKNSYRSFPIDLVRELGRQLLESVAFM-HELRLIHTDLK 221 (323)
Q Consensus 145 l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~-L~~-~l~~~~~~~l~~~~~~~i~~qi~~aL~~l-H~~~iiHrDlK 221 (323)
+....+..+..+ .+ ..-+|||||++++ +.. .++. ..++.+.+..+..|++.+|..| |+.||||+||+
T Consensus 83 l~~~Gv~vP~pi---~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVV---VL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHcCCCCCeEE---Ee----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 998876444443 32 3457999999542 321 2222 1355667778889999999998 89999999999
Q ss_pred CCcEEEe
Q 020652 222 PENILLV 228 (323)
Q Consensus 222 p~NIli~ 228 (323)
+.|||+.
T Consensus 153 ~~NIL~~ 159 (197)
T cd05146 153 EYNMLWH 159 (197)
T ss_pred HHHEEEE
Confidence 9999985
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.3e-13 Score=111.28 Aligned_cols=114 Identities=18% Similarity=0.153 Sum_probs=82.3
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC-
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~- 175 (323)
++.|+.|.++.||++... ++.|++|+.............|+.+++.+.+.++. ..++.+.. ...++|||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~----P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIG----PKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCC----CceEEEeC--CCCeEEEEecC
Confidence 468899999999999754 67799998764432233467899999999876542 23333332 2347999999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eecCCCCCcEEEe
Q 020652 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL-----IHTDLKPENILLV 228 (323)
Q Consensus 176 ~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~i-----iHrDlKp~NIli~ 228 (323)
|.++.+. . . ....++.+++.+|..||+.++ +|+|++|.||+++
T Consensus 75 G~~l~~~----~---~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~ 122 (170)
T cd05151 75 GSELLTE----D---F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD 122 (170)
T ss_pred CCccccc----c---c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE
Confidence 6665432 0 1 123456789999999999885 9999999999986
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.2e-14 Score=137.08 Aligned_cols=224 Identities=19% Similarity=0.182 Sum_probs=154.1
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHH----HHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~----~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
+.+.+.+.+-+|+++.++.+.-..++...++|+.....+.... ...+-.++.... ++.++.....+.....
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-----~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-----SPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCC-----CCceecccCCCCCCCC
Confidence 3477788999999999999988888877777765543322211 111111111111 1333444444555677
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.+|+|+|. +++|...++..+ ..+++.++.+...+..++++||...++|||+||.|+++...+..+++||+.......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence 89999999 889998888765 577778888889999999999999999999999999999999999999986544332
Q ss_pred CCCccccCCCCCCceEeeCCCcc----ccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTT----FEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~----~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
................-+++... ... ......+||+.|.+||...+......+|+|++|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 21110000000000111111111 011 11233589999999999999999999999999999999999999998
Q ss_pred CCC
Q 020652 320 TPF 322 (323)
Q Consensus 320 ~~~ 322 (323)
.+.
T Consensus 1037 a~t 1039 (1205)
T KOG0606|consen 1037 AET 1039 (1205)
T ss_pred Ccc
Confidence 764
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.6e-11 Score=98.68 Aligned_cols=145 Identities=24% Similarity=0.220 Sum_probs=105.2
Q ss_pred EEeeecccCcEEEEEEEECCCCcEEEEEEec-c--------chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR-S--------INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 96 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~-~--------~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
.+..|-+|+-+.|+++. ..|+.+.||.-. + ..-.+.+..+|+.+|.++..-.|..+.+. +.+..
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~-----~~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI-----FIDTY 83 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE-----EEecC
Confidence 46788899999999995 467777788421 1 11234566789999999988776443332 22334
Q ss_pred eEEEEEccCCC--CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 167 HICIVFEKLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 167 ~~~lv~e~~~~--~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
.-+|+|||+.| ++.+++...............++.+|-..+.-||.++|||+||..+||++..++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~------------- 150 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDG------------- 150 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCC-------------
Confidence 45689999955 899998865533344444478888899999999999999999999999997654
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccc
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFE 271 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~ 271 (323)
....+.++|||++...
T Consensus 151 -----------~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 151 -----------NQITPILIDFGLSSVS 166 (229)
T ss_pred -----------CcCceEEEeecchhcc
Confidence 3445578899887653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-11 Score=116.52 Aligned_cols=182 Identities=17% Similarity=0.255 Sum_probs=132.0
Q ss_pred EEEEeeecccCcEEEE-EEEECCCCcEEEEEEeccchh-hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 94 YRILSKMGEGTFGQVV-ECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~-~~~~~~~~~~vAiK~~~~~~~-~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
|.+ +..+-++.+ +| .|..+.++.+|.|...+.... ..+...+-++.|+.++||+| +++++.++..+.+|||
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~I-----l~yL~t~e~~~~~ylv 87 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNI-----LSYLDTTEEEGTLYLV 87 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchh-----hhhhhhhcccCceEEE
Confidence 444 444444444 44 466677888888888775443 33456778889999999999 9999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
+|.+. .|..++++ +....+..-+.||+.||.+|| +++++|++|.-+.|+|+..|+.|+.+|.++.+....+..
T Consensus 88 TErV~-Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~ 161 (690)
T KOG1243|consen 88 TERVR-PLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP 161 (690)
T ss_pred eeccc-cHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc
Confidence 99983 45666665 336677788999999999997 678999999999999999999999988776544332210
Q ss_pred cccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSV 314 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg 314 (323)
.+ ...--..|..|+.+.... ...|.|-|||+++|++.|
T Consensus 162 ---------~~---------------~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 ---------AK---------------SLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ---------cc---------------cchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 00 000011255666543332 457999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.8e-12 Score=120.75 Aligned_cols=195 Identities=20% Similarity=0.137 Sum_probs=137.2
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEEC-CCCcEEEEEEeccch---hhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceec
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDN-EKKELVAIKIVRSIN---KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~ 163 (323)
....+|..+..||.|.|+.|+.+..+ .++..|++|.+.... ........|+.+...+. |.+. +.....|.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~-----~g~~~~W~ 336 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPS-----VGKNSSWS 336 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhccccc-----CCCCCCcc
Confidence 34567899999999999999988755 678889999765321 12222345666665554 4444 55555566
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
.....|+-.||| ++++...+.-. ..+.+...+.+..|++.++.++|+..++|+|+||+||++..++
T Consensus 337 ~~r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~----------- 403 (524)
T KOG0601|consen 337 QLRQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG----------- 403 (524)
T ss_pred ccccccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccch-----------
Confidence 666677999999 77766665332 2578888999999999999999999999999999999997653
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccc--cchhhcCCCCCcchhHHHHHHHHHHHhcCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYR--APEVILGLGWNYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwSlG~il~el~tg~~ 316 (323)
...++.|||+.....-......++-.++ +++......+..+.|++|||..+.|.+++..
T Consensus 404 ---------------~~~~~~~~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 404 ---------------FFSKLGDFGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred ---------------hhhhccccccccccceecccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 2235666665542111111122233344 5555556678899999999999999998764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=9.2e-11 Score=99.91 Aligned_cols=107 Identities=17% Similarity=0.152 Sum_probs=72.6
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC---ceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR---NHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~---~~~~lv~ 172 (323)
+.|+.|.++.||++.... |+.+++|+...... ....+..|.++++.+.+.++.. .+++.+.... +..++||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~v---p~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPV---PKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCC---CCEEEECCCCCccCCceEEE
Confidence 678999999999997643 57899998764332 3456788999999998765433 3333333332 3568999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH 211 (323)
|++ |.++.+.+.. ..++++....++.+++.+|..||
T Consensus 80 e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH 116 (223)
T cd05154 80 ERVDGRVLRDRLLR---PELSPEERRALARALADTLAALH 116 (223)
T ss_pred EEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHh
Confidence 999 6666554321 13566666666777777777766
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.8e-10 Score=91.90 Aligned_cols=117 Identities=20% Similarity=0.156 Sum_probs=80.2
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEe-ccc--------hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIV-RSI--------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~-~~~--------~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
..+++|+-+.++.+.. -|..+++|.= ++. .-.++...+|..++.++....+.. ..++++. .+..
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~---P~v~dvD--~~~~ 74 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPV---PIVYDVD--PDNG 74 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCC---CeEEEEc--CCCC
Confidence 3578999999998855 3444666642 211 112355678999999998876533 3333332 3456
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeec
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~ 230 (323)
.|+|||. |..|.+++... . ..++..+=.-+.-||..||+|+||.++||++...
T Consensus 75 ~I~me~I~G~~lkd~l~~~-----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~ 128 (204)
T COG3642 75 LIVMEYIEGELLKDALEEA-----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG 128 (204)
T ss_pred EEEEEEeCChhHHHHHHhc-----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC
Confidence 7999999 66777788654 1 3445555566678999999999999999998643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.3e-09 Score=93.91 Aligned_cols=120 Identities=20% Similarity=0.086 Sum_probs=84.9
Q ss_pred EEEEEECCCCcEEEEEEeccchh------------hHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc--CceEEEEEc
Q 020652 108 VVECFDNEKKELVAIKIVRSINK------------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNHICIVFE 173 (323)
Q Consensus 108 V~~~~~~~~~~~vAiK~~~~~~~------------~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~--~~~~~lv~e 173 (323)
|.++. ..|+.|.||....... ....+.+|...+.++...+|..+..+-+...-.. ...-+||||
T Consensus 38 vvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 44443 3456788886542221 1114778999999999888866655544321111 235789999
Q ss_pred cCCC--CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEee
Q 020652 174 KLGP--SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (323)
Q Consensus 174 ~~~~--~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~ 229 (323)
++++ +|.+++........+......++.+++..+.-||..||+|+|+++.|||++.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~ 173 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHL 173 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEec
Confidence 9944 7999986432234567778899999999999999999999999999999964
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=2.7e-10 Score=99.05 Aligned_cols=185 Identities=18% Similarity=0.266 Sum_probs=122.4
Q ss_pred EEEEEEECCCCcEEEEEEec----cchhhH-HHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc-----eEEEEEccC-
Q 020652 107 QVVECFDNEKKELVAIKIVR----SINKYR-EAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN-----HICIVFEKL- 175 (323)
Q Consensus 107 ~V~~~~~~~~~~~vAiK~~~----~~~~~~-~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~-----~~~lv~e~~- 175 (323)
.||++-++..|..|+--.+. ++.+.+ +....-...|-.+.|.|+ ++++.+|.+.. ...++.||+
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnl-----vkfH~yw~d~K~~e~~rviFiteyms 155 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNL-----VKFHKYWTDKKYEEKPRVIFITEYMS 155 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHH-----HHHHHhhcccccccccceEEEEeccc
Confidence 36777776666555422221 111111 122223445667778887 88888886643 578999999
Q ss_pred CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 176 GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 176 ~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~--iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
.|+|.++|++. ....+......+|+.||+.||.|||+.. |+|+++.-+-|++..+|-+|+.--....
T Consensus 156 sgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s--------- 226 (458)
T KOG1266|consen 156 SGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDS--------- 226 (458)
T ss_pred chhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccc---------
Confidence 99999999843 2346788889999999999999999985 9999999999999776655543110000
Q ss_pred ccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~ 316 (323)
....++.+ .........|-++|.|||.-.....+.++|||+||....||..+..
T Consensus 227 ----~h~s~~~~-------~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 227 ----THPSVNST-------REAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred ----cchhhhhh-------hHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 00000000 0011112245678999998776677889999999999999977653
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.2e-09 Score=90.47 Aligned_cols=112 Identities=28% Similarity=0.309 Sum_probs=69.7
Q ss_pred EEEEEEECCCCcEEEEEEeccc---------------------------hhhHHHHHHHHHHHHHHHhCCCCCcceEEEc
Q 020652 107 QVVECFDNEKKELVAIKIVRSI---------------------------NKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159 (323)
Q Consensus 107 ~V~~~~~~~~~~~vAiK~~~~~---------------------------~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~ 159 (323)
.||.|.. ..+..+|+|+.+.. ........+|.+.|.++...++..+ ..+
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP---~p~ 76 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVP---KPY 76 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS-----EE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCC---cEE
Confidence 3888875 46778999987421 0112456779999999987765333 333
Q ss_pred ceeccCceEEEEEccCC--CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHHCCceecCCCCCcEEEee
Q 020652 160 NWFDYRNHICIVFEKLG--PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF-MHELRLIHTDLKPENILLVS 229 (323)
Q Consensus 160 ~~~~~~~~~~lv~e~~~--~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~-lH~~~iiHrDlKp~NIli~~ 229 (323)
++. .-+|||||++ |.....+.... ++.+....++.+++..+.. +|..||+|+||.+.|||+..
T Consensus 77 ~~~----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~ 142 (188)
T PF01163_consen 77 DYN----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDD 142 (188)
T ss_dssp EEE----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEET
T ss_pred EEe----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeec
Confidence 322 2369999996 64333333321 2234566777888885555 57999999999999999964
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=3e-08 Score=82.76 Aligned_cols=129 Identities=13% Similarity=0.129 Sum_probs=94.3
Q ss_pred ecccCcEEEEEEEECCCCcEEEEEEec-cc------hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc--CceEEE
Q 020652 100 MGEGTFGQVVECFDNEKKELVAIKIVR-SI------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RNHICI 170 (323)
Q Consensus 100 lG~G~fg~V~~~~~~~~~~~vAiK~~~-~~------~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~--~~~~~l 170 (323)
-|+||.+-|+..... |+.+=+|.-. .. ...+..+.+|+..|..+...++..+.++ +.+.-.. .-..+|
T Consensus 26 ~~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L 102 (216)
T PRK09902 26 YRRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL 102 (216)
T ss_pred cCCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence 366888888876533 3346667543 10 2245788999999999999888655544 2222211 234689
Q ss_pred EEccCC--CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC
Q 020652 171 VFEKLG--PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (323)
Q Consensus 171 v~e~~~--~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~ 231 (323)
|+|-++ .+|.+++.+......+......++.+++..+.-||+.|+.|+|+-+.||+++..+
T Consensus 103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g 165 (216)
T PRK09902 103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEG 165 (216)
T ss_pred EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCC
Confidence 999885 6999998765434567777789999999999999999999999999999996443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.1e-08 Score=92.40 Aligned_cols=128 Identities=16% Similarity=0.218 Sum_probs=98.0
Q ss_pred CcEEEEEEEECCCCcEEEEEEeccchhh-HHHHHHHHHHHHHHHhCCCCCcceEEEcceecc----CceEEEEEccC--C
Q 020652 104 TFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----RNHICIVFEKL--G 176 (323)
Q Consensus 104 ~fg~V~~~~~~~~~~~vAiK~~~~~~~~-~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~----~~~~~lv~e~~--~ 176 (323)
--.+.|+|....+|..|++|.+...... ......-++.++++.|.|+ |.+.+.|.. +..+++|++|. .
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~Nv-----V~frevf~t~tF~D~SlvlvYDYyP~s 362 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNV-----VPFREVFLTYTFGDLSLVLVYDYYPSS 362 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCce-----eehhhhhhhhccCcceEEEEEecCCCC
Confidence 3456799999999999999998422111 1122335778999999998 888888763 45689999998 5
Q ss_pred CCHHHHHHhc-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceecc
Q 020652 177 PSLYDFLRKN-------------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (323)
Q Consensus 177 ~~L~~~l~~~-------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~ 236 (323)
++|.++.-.. .+...+|+.+|.++.|+..||.++|+.|+.-+-|.+.+||+..+.+++|+
T Consensus 363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS 435 (655)
T KOG3741|consen 363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRIS 435 (655)
T ss_pred chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEe
Confidence 6888875422 12357789999999999999999999999999999999999765544443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=7.5e-08 Score=81.38 Aligned_cols=98 Identities=30% Similarity=0.322 Sum_probs=75.8
Q ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEcceecc-CceEEEEEccC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Q 020652 132 REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHICIVFEKL-G-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208 (323)
Q Consensus 132 ~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~-~~~~~lv~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~ 208 (323)
...+.+|...+..+....|..+..+-+...-.. ....++|+|++ + .+|.+++.... ..+......++.+++..+.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHH
Confidence 346788999999999888866655544332111 13468999999 4 37999988644 2667778889999999999
Q ss_pred HHHHCCceecCCCCCcEEEeecC
Q 020652 209 FMHELRLIHTDLKPENILLVSAE 231 (323)
Q Consensus 209 ~lH~~~iiHrDlKp~NIli~~~~ 231 (323)
-||++||+|+|+++.|||+..++
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~ 155 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDD 155 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCC
Confidence 99999999999999999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.8e-08 Score=90.89 Aligned_cols=193 Identities=16% Similarity=0.200 Sum_probs=120.9
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCcceE----EEcceeccCceEEEE
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCV----QIRNWFDYRNHICIV 171 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~----~~~~~~~~~~~~~lv 171 (323)
.+.||+|+-+.+|-.-...+ .+.|++....-..+.- .+..|.... |+.+ ...++ .+++- ..+..+.+.
T Consensus 16 gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aq--k~a~la~~p~~p~~-~~rvaWPqa~L~G~-~~~~~iGfl 88 (637)
T COG4248 16 GRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQ--KVAELAATPDAPLL-NYRVAWPQATLHGG-RRGKVIGFL 88 (637)
T ss_pred CccccCCccceeeecchhhc---hhheeecCCCchHHHH--HHHHhccCCCCcch-hhhhcccHHHhhCC-CccceeEEe
Confidence 47899999999996532211 3457775432211111 111222211 1111 00011 11111 112237888
Q ss_pred EccC-CC-CHHHHHH----hcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 172 FEKL-GP-SLYDFLR----KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 172 ~e~~-~~-~L~~~l~----~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
|..+ |. .+.+++. ++....+.+..+.+.++.++.+..-||..|.+-+|+.++|+|+.+++.|.+.|-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsD------ 162 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSD------ 162 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccc------
Confidence 9988 43 4555443 2333457789999999999999999999999999999999999988877765521
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhc-----CCCCCcchhHHHHHHHHHHHhcC-CCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSV-SNCYL 319 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg-~~pf~ 319 (323)
...|++-|. .....+|.+.|.+||.-. +..-+...|.|.||+++|+|+.| +.||.
T Consensus 163 -------------sfqi~~ng~------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys 223 (637)
T COG4248 163 -------------SFQINANGT------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS 223 (637)
T ss_pred -------------ceeeccCCc------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence 012222111 111237889999999754 33456789999999999999876 99998
Q ss_pred CC
Q 020652 320 TP 321 (323)
Q Consensus 320 ~~ 321 (323)
|-
T Consensus 224 GI 225 (637)
T COG4248 224 GI 225 (637)
T ss_pred cc
Confidence 74
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.5e-08 Score=85.40 Aligned_cols=130 Identities=28% Similarity=0.302 Sum_probs=90.1
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc-----------------------hhhHHHHHHHHHHHHHHHhCCC
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----------------------NKYREAAMIEIDVLQRLARHDI 150 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-----------------------~~~~~~~~~Ei~~l~~l~~~~i 150 (323)
+.+..+||-|--+.||.|.+. .|..+|||.-+.. ...+..+.+|.++|.+|.....
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999875 6778999975310 0123556789999999875522
Q ss_pred CCcceEEEcceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEee
Q 020652 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (323)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~ 229 (323)
. +..-++ -+.-.+|||+. |..|...- +..+....++..|+.-+.-+-..||||+|+.+=||++++
T Consensus 172 ~---VP~P~~----~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 172 K---VPKPIA----WNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred C---CCCccc----cccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 1 122222 24567999999 65555432 234445556666666666666899999999999999988
Q ss_pred cCceeccCc
Q 020652 230 AEYVKVPDY 238 (323)
Q Consensus 230 ~~~~ki~d~ 238 (323)
+|.+.+.||
T Consensus 238 dg~~~vIDw 246 (304)
T COG0478 238 DGDIVVIDW 246 (304)
T ss_pred CCCEEEEeC
Confidence 776655555
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.68 E-value=5.7e-07 Score=75.50 Aligned_cols=131 Identities=18% Similarity=0.244 Sum_probs=85.1
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhH----------HHHHHHHHHHHHHHhCCCCCc---ce
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----------EAAMIEIDVLQRLARHDIGGT---RC 155 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~----------~~~~~Ei~~l~~l~~~~i~~~---~~ 155 (323)
.+.++|.+.+.+-......|.+- .-.++.+++|..+...... ....+++..+.++....+... .+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 45678999999988888878766 4456779999875322111 223445555666655443221 22
Q ss_pred EEEcceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC
Q 020652 156 VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (323)
Q Consensus 156 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~ 231 (323)
+...-.+......+++|||+ |..|.+... +++. +...+..++.-||+.|+.|+|..|.|+++..++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~ 172 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG 172 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc
Confidence 22222333345677999999 767766532 3332 445677788999999999999999999986443
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=3e-09 Score=100.17 Aligned_cols=187 Identities=16% Similarity=0.083 Sum_probs=135.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
..|...+-+++|+++++++.+...+...+ .+++... .....++++|.+++|||. .+..++-++.+.+.+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~----l~~rl~~eLLdK~n~P~~----~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT----LSRRLAIELLDKVNNPNP----VVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc----hhhHHHHHHHHHccCCCC----cccccccCCcccccchh
Confidence 34566678899999999999877776655 6766543 345568999999999982 26666667777889999
Q ss_pred EccC-CC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 172 FEKL-GP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 172 ~e~~-~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
|+++ ++ +....+.... ..+.+-+...+.+.-+++|+++|+.-=+||| ||+..+
T Consensus 313 ~~i~s~~rs~~~~~~~se-~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-------------------- 367 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSE-IALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-------------------- 367 (829)
T ss_pred hhhhcCCccccccCChhh-HhhhhhhhhhhhhhhcccccccccccccCcc----cccccc--------------------
Confidence 9999 44 2222111100 1233445566777788899999998778998 887532
Q ss_pred ccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
...++.||+........ .....+|+.++|||++....+....|.||+|+-..+|.-|.+|-.+
T Consensus 368 --------~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 368 --------EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred --------cccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 34577788877655544 4557899999999999999999999999999877788777776544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.6e-07 Score=87.73 Aligned_cols=144 Identities=18% Similarity=0.222 Sum_probs=90.7
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch-----------------------------------hhHH------HHH
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------------------------------KYRE------AAM 136 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-----------------------------------~~~~------~~~ 136 (323)
+.|+.++-|+||+|+.. +|+.||||+.+..- +..+ ++.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 67999999999999865 49999999975210 0011 223
Q ss_pred HHHHHHHHHHhCCCCCcceEEEcce-eccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 020652 137 IEIDVLQRLARHDIGGTRCVQIRNW-FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR 214 (323)
Q Consensus 137 ~Ei~~l~~l~~~~i~~~~~~~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ 214 (323)
+|...+.++++..-.... +.+-.. ++..+.-.|+|||+ |..+.+...-.. ..++.+.+.....++. +..+-..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~-v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPD-VYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCC-eEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 455566666542222222 333333 34456678999999 777777742221 2355433333222221 33444589
Q ss_pred ceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 215 LIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 215 iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+.|.|..|.||++..+|.+...|||+..+...
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999988888888887666544
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.1e-06 Score=74.68 Aligned_cols=120 Identities=20% Similarity=0.181 Sum_probs=80.9
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccchh-------------------------hHHHHHHHHHHHHHHHhCCCCC
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------------------------YREAAMIEIDVLQRLARHDIGG 152 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~-------------------------~~~~~~~Ei~~l~~l~~~~i~~ 152 (323)
..|.+|--+.||+|.. .++..+|+|+++.... ......+|...|+++....+..
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3677777788999974 6788999999863210 1123456888999988776533
Q ss_pred cceEEEcceeccCceEEEEEccCCCCH--HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEe
Q 020652 153 TRCVQIRNWFDYRNHICIVFEKLGPSL--YDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLV 228 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~lv~e~~~~~L--~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~ 228 (323)
+. -+.+ ....|||||+|... .-.|+. ..+..+.+..+..++++.+.-|-. .++||+||..=|||+.
T Consensus 133 P~---Pi~~----~~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~ 201 (268)
T COG1718 133 PE---PIAF----RNNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH 201 (268)
T ss_pred CC---ceee----cCCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence 22 2221 12469999995431 111111 123444678888899999888876 9999999999999986
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.56 E-value=2.4e-06 Score=73.05 Aligned_cols=82 Identities=21% Similarity=0.268 Sum_probs=57.1
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC-
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~- 175 (323)
++.|+.|..+.||++.... ..+++|+.... ........|..+++.+....+..+.++............+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 5789999999999997655 47899987654 4556778899999999887662233332111222334579999999
Q ss_pred CCCHHH
Q 020652 176 GPSLYD 181 (323)
Q Consensus 176 ~~~L~~ 181 (323)
|.++..
T Consensus 79 g~~~~~ 84 (239)
T PF01636_consen 79 GRPLDD 84 (239)
T ss_dssp SEEHHH
T ss_pred cccccc
Confidence 666666
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.56 E-value=3.4e-06 Score=70.42 Aligned_cols=123 Identities=16% Similarity=0.280 Sum_probs=92.6
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccch-----------------hhHHHHHHHHHHHHHHH-hCCCCCcceEEEc
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------------KYREAAMIEIDVLQRLA-RHDIGGTRCVQIR 159 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-----------------~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~ 159 (323)
..||+|+.-.||.- ..+...+||+..... ....+..+|+.....+. ..++...++.+++
T Consensus 7 ~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 57899999999853 344446889887544 22456778888888888 7777778889999
Q ss_pred ceeccCceEEEEEccC-C------CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeec
Q 020652 160 NWFDYRNHICIVFEKL-G------PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230 (323)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~------~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~ 230 (323)
++.+++.-..+|+|.. + .+|.+++.+.. +++ .+...+. .-.+||-+++|+.+|++|.||++...
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRR 154 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEec
Confidence 9999988889999975 2 38999996653 655 3333333 33468889999999999999999764
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.6e-06 Score=72.15 Aligned_cols=72 Identities=14% Similarity=0.149 Sum_probs=50.7
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccCCC
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP 177 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~ 177 (323)
..||+|..+.||+. . +..+++|+..... ......+|.++++.+....+.. ...+.+.+..+...+|||++.|
T Consensus 7 ~~i~~G~t~~~y~~---~-~~~~VlR~~~~~~-~~~~i~~E~~~l~~l~~~glpv---P~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH---K-TGKWMLKLYNPGF-DKETIKREFDASRKVFSLGIPT---PHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe---c-CCCEEEEeCCCCC-CHHHHHHHHHHHHHHHHcCCCC---CceEEEEecCCeeeeeeeecCC
Confidence 57899999999984 2 4457789876422 3345688999999998765533 3445555556667899999933
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.43 E-value=7.3e-06 Score=68.07 Aligned_cols=119 Identities=21% Similarity=0.276 Sum_probs=83.4
Q ss_pred CcEEEEeeecccCc-EEEEEEEECCCCcEEEEEEecc----c--------h----------hhHHHHHHHHHHHHHHHhC
Q 020652 92 PRYRILSKMGEGTF-GQVVECFDNEKKELVAIKIVRS----I--------N----------KYREAAMIEIDVLQRLARH 148 (323)
Q Consensus 92 ~~y~~~~~lG~G~f-g~V~~~~~~~~~~~vAiK~~~~----~--------~----------~~~~~~~~Ei~~l~~l~~~ 148 (323)
..++.++.||.|.- |.||+++. .|+.||+|++.. . . .....+..|.+...+|+..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 46899999999999 99999964 577999999421 0 0 1223567889988888877
Q ss_pred CCCCcceEEEcceeccC------------------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 020652 149 DIGGTRCVQIRNWFDYR------------------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210 (323)
Q Consensus 149 ~i~~~~~~~~~~~~~~~------------------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~l 210 (323)
+-.+...++.++|..-. ....||.||....- .+..+. +.+|.+-|..+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~~----~~~~~~dl~~~ 180 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIRD----IPQMLRDLKIL 180 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchhH----HHHHHHHHHHH
Confidence 65444457888876221 12357777662211 133333 45667777889
Q ss_pred HHCCceecCCCCCcEE
Q 020652 211 HELRLIHTDLKPENIL 226 (323)
Q Consensus 211 H~~~iiHrDlKp~NIl 226 (323)
|..||+-+|+|+.|..
T Consensus 181 ~k~gI~~~Dv~~~ny~ 196 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR 196 (207)
T ss_pred HHCCeeeccCcccccc
Confidence 9999999999999998
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=9e-08 Score=91.15 Aligned_cols=103 Identities=17% Similarity=0.325 Sum_probs=75.9
Q ss_pred HHHHHHHHHHH-CCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCcccccc
Q 020652 202 QLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS 280 (323)
Q Consensus 202 qi~~aL~~lH~-~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~g 280 (323)
+++.||.|+|. .++||++|.|++|.++..+.+|++.|+++-....... .....-|+++.... .-
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~--------~p~~~yd~~lp~~~-------~~ 171 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTE--------YPFSEYDPPLPLLL-------QP 171 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCc--------cccccCCCCCChhh-------cc
Confidence 34499999996 5899999999999999999999999987654433221 11233333333221 23
Q ss_pred CCccccchhhcCCCCCcchhHHHHHHHHHHHh-cCCCCCC
Q 020652 281 TRHYRAPEVILGLGWNYPCDLWSVGCILVELC-SVSNCYL 319 (323)
Q Consensus 281 t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~-tg~~pf~ 319 (323)
...|.|||.+.+...+.++|++||||++|-+. .|+.-+.
T Consensus 172 ~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~ 211 (700)
T KOG2137|consen 172 HLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIA 211 (700)
T ss_pred CcccccchhhccccccccccceeeeeEEEEEecCCcchhh
Confidence 55799999999988889999999999999888 5554443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=5.4e-06 Score=66.85 Aligned_cols=114 Identities=22% Similarity=0.215 Sum_probs=75.7
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEc
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 173 (323)
-++.+.|++|.+|.||++.+ .+..+|+|+-+ .+..+..+..|.++|..++-.++. .+++.+. ..++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr-~ds~r~~l~kEakiLeil~g~~~~----p~vy~yg----~~~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRR-RDSPRRNLEKEAKILEILAGEGVT----PEVYFYG----EDFIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeec--cCceEEEEEec-CCcchhhHHHHHHHHHHhhhcCCC----ceEEEec----hhhhhhh
Confidence 35678899999999999965 45679999754 455677889999999999876652 3333332 2345699
Q ss_pred cC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC-CC-cEEE
Q 020652 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLK-PE-NILL 227 (323)
Q Consensus 174 ~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlK-p~-NIli 227 (323)
|+ |.+|.++-... ....+ ..++.+---|-..||-|..|. |. ||++
T Consensus 93 ~i~G~~L~~~~~~~-----~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv 140 (201)
T COG2112 93 YIDGRPLGKLEIGG-----DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLV 140 (201)
T ss_pred hhcCcchhhhhhcc-----cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEe
Confidence 99 66887765421 22222 334444344556799999886 34 4444
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.16 E-value=2.1e-05 Score=68.10 Aligned_cols=75 Identities=15% Similarity=0.092 Sum_probs=49.8
Q ss_pred eecccCc-EEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC-C
Q 020652 99 KMGEGTF-GQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G 176 (323)
Q Consensus 99 ~lG~G~f-g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~-~ 176 (323)
.|-.|.+ +.||+.... +..+.+|+..... .....+|+++++.+... +. +.+++.+....+..++|||++ |
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~-~~---vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP--TYELEREAERLRWLAGK-LP---VPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc--ccchHHHHHHHHHHHhc-CC---CCeEEEEEecCCccEEEEEeeCC
Confidence 4455555 788998643 3568888875432 33567899999998754 32 345555555556678999999 6
Q ss_pred CCHHH
Q 020652 177 PSLYD 181 (323)
Q Consensus 177 ~~L~~ 181 (323)
.+|..
T Consensus 77 ~~l~~ 81 (244)
T cd05150 77 VPAAA 81 (244)
T ss_pred ccHhH
Confidence 55553
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.16 E-value=4.7e-05 Score=77.46 Aligned_cols=78 Identities=14% Similarity=0.091 Sum_probs=52.1
Q ss_pred EeeecccCcEEEEEEEECCCC--cEEEEEEeccch--hhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceeccC---ceE
Q 020652 97 LSKMGEGTFGQVVECFDNEKK--ELVAIKIVRSIN--KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYR---NHI 168 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~--~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~~---~~~ 168 (323)
+++|+.|.++.+|+......+ ..+++|+..... .....+.+|.++++.+. |.++..+ +++.++.+. +..
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP---~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVP---KVYCLCTDASVIGTA 119 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCC---cEEEEecCCCcCCCc
Confidence 578899999999998765432 357777754322 22346789999999997 5665433 444444332 457
Q ss_pred EEEEccCCC
Q 020652 169 CIVFEKLGP 177 (323)
Q Consensus 169 ~lv~e~~~~ 177 (323)
|+|||++.|
T Consensus 120 flVME~v~G 128 (822)
T PLN02876 120 FYIMEYLEG 128 (822)
T ss_pred eEEEEecCC
Confidence 899999933
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.2e-05 Score=74.65 Aligned_cols=144 Identities=16% Similarity=0.179 Sum_probs=84.5
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccc--------------------------------hhhHH------HHHHHH
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSI--------------------------------NKYRE------AAMIEI 139 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--------------------------------~~~~~------~~~~Ei 139 (323)
+.||.-+.|+|++|+.+. |+.||||+-+.. ++..+ ++.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999999765 999999986421 01111 123344
Q ss_pred HHHHHHH----hCCCC-CcceEEEcceeccCceEEEEEccC-CCCHH--HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 020652 140 DVLQRLA----RHDIG-GTRCVQIRNWFDYRNHICIVFEKL-GPSLY--DFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211 (323)
Q Consensus 140 ~~l~~l~----~~~i~-~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~--~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH 211 (323)
+...+.+ |-+.. ...+.+++ ++....-.|+|||+ |..+. +.|.+.+ ++...+...+.+.. ++-+-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~--~~qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAY--LEQIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHH--HHHHH
Confidence 4333332 22210 11123332 23345678999999 65443 4455543 66654444333322 23344
Q ss_pred HCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCccccc
Q 020652 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272 (323)
Q Consensus 212 ~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~ 272 (323)
..|++|+|-.|.||++..++ +....+.+-|||+.....
T Consensus 319 ~~GffHaDPHPGNilv~~~~-----------------------~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNP-----------------------EGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred hcCCccCCCCCCcEEEecCC-----------------------CCCccEEEEccccccccc
Confidence 67899999999999997532 234556777888765443
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.08 E-value=3.2e-05 Score=66.70 Aligned_cols=76 Identities=14% Similarity=0.073 Sum_probs=44.3
Q ss_pred eeecccCcE-EEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhC-CCCCcceEEEcceeccCceEEEEEccC
Q 020652 98 SKMGEGTFG-QVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEKL 175 (323)
Q Consensus 98 ~~lG~G~fg-~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~-~i~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (323)
+.|+.|+.. .||+.. ..+++|+... ........+|.+++..+... .+..+.++......+.....+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~-~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSA-AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCc-cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777766 488762 2367787554 33345788899999998753 333333222111111112458899998
Q ss_pred -CCCH
Q 020652 176 -GPSL 179 (323)
Q Consensus 176 -~~~L 179 (323)
|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 6444
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00022 Score=64.24 Aligned_cols=120 Identities=25% Similarity=0.301 Sum_probs=85.2
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccc---------------------------hhhHHHHHHHHHHHHHHHhCCC
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSI---------------------------NKYREAAMIEIDVLQRLARHDI 150 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---------------------------~~~~~~~~~Ei~~l~~l~~~~i 150 (323)
..|..|--+.||.|.. ..|..+|||+++.. ....-.+..|++.|++|+...|
T Consensus 150 GCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 150 GCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred cccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4577788888999974 56777999988521 0112345679999999998887
Q ss_pred CCcceEEEcceeccCceEEEEEccCCCCHHH--HHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCcEEE
Q 020652 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYD--FLRKNSYRSFPIDLVRELGRQLLESVAFM-HELRLIHTDLKPENILL 227 (323)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~--~l~~~~~~~l~~~~~~~i~~qi~~aL~~l-H~~~iiHrDlKp~NIli 227 (323)
..+--+-+. .-.|||+++|.+-+- .|+. ..++...+..+-.|++.-+.-| |.+++||.||.-=|+|+
T Consensus 229 P~PePIlLk-------~hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 229 PCPEPILLK-------NHVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY 298 (520)
T ss_pred CCCCceeee-------cceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE
Confidence 655443332 246999999653222 2322 2577778888888888877766 56899999999999997
Q ss_pred e
Q 020652 228 V 228 (323)
Q Consensus 228 ~ 228 (323)
-
T Consensus 299 h 299 (520)
T KOG2270|consen 299 H 299 (520)
T ss_pred E
Confidence 3
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00025 Score=61.01 Aligned_cols=75 Identities=15% Similarity=0.329 Sum_probs=47.8
Q ss_pred EeeecccCcEEEEEEEECC-CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC
Q 020652 97 LSKMGEGTFGQVVECFDNE-KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~-~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (323)
++.|..|-...+|++.... .++.|++|+............+|+.+++.+....+ . ++++..+.. .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl-~---P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGL-A---PKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCC-C---CeEEEEeCC----cEEEEee
Confidence 4678888888999986443 35678899765432222233579999999987665 2 333333321 3799998
Q ss_pred -CCCH
Q 020652 176 -GPSL 179 (323)
Q Consensus 176 -~~~L 179 (323)
|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 5443
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0014 Score=60.73 Aligned_cols=75 Identities=20% Similarity=0.210 Sum_probs=50.4
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccc--------hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--------~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.+.||.|.+..||++.+...++.++||.-... ....+....|.+.|+.+.... ...+++++.+. ....
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~--p~~VPkV~~~D--~~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYV--PDLVPKVYHYD--EELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhC--CCCCCeEEEEC--CCCC
Confidence 46899999999999998654457999974311 123456677888888876421 12335555543 3456
Q ss_pred EEEEccC
Q 020652 169 CIVFEKL 175 (323)
Q Consensus 169 ~lv~e~~ 175 (323)
++|||++
T Consensus 107 ~lVME~L 113 (401)
T PRK09550 107 VTVMEDL 113 (401)
T ss_pred EEEEecC
Confidence 8999998
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0014 Score=59.17 Aligned_cols=77 Identities=14% Similarity=0.098 Sum_probs=47.9
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcc---eeccCceEEEEEc
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN---WFDYRNHICIVFE 173 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~---~~~~~~~~~lv~e 173 (323)
.+.|+.|....+|+.... ++ .+++|++. ....+....|+.++..|....+..+.++.-.+ +....+..+++|+
T Consensus 27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~--~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFE--RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeC-CC-cEEEEEec--cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 456777888889988643 33 58889875 22234455678888888776654443332111 1123456789999
Q ss_pred cC-CC
Q 020652 174 KL-GP 177 (323)
Q Consensus 174 ~~-~~ 177 (323)
++ |.
T Consensus 103 ~l~G~ 107 (319)
T PRK05231 103 FLEGK 107 (319)
T ss_pred ecCCC
Confidence 98 54
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00063 Score=60.66 Aligned_cols=78 Identities=13% Similarity=0.107 Sum_probs=50.0
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcc---eeccCceEEEEEc
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN---WFDYRNHICIVFE 173 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~---~~~~~~~~~lv~e 173 (323)
++.|..|....+|+... .+..+++|+... ...+....|+.++..+.+..+..+.++...+ +....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK--VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC--CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 56788888889998854 334588898764 2345677799999999876653222222111 1123456789999
Q ss_pred cC-CCC
Q 020652 174 KL-GPS 178 (323)
Q Consensus 174 ~~-~~~ 178 (323)
++ |..
T Consensus 95 ~i~G~~ 100 (296)
T cd05153 95 FLAGEH 100 (296)
T ss_pred eCCCCC
Confidence 99 544
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0014 Score=58.96 Aligned_cols=78 Identities=13% Similarity=0.034 Sum_probs=47.8
Q ss_pred EEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcc---eeccCceEEEE
Q 020652 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN---WFDYRNHICIV 171 (323)
Q Consensus 95 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~---~~~~~~~~~lv 171 (323)
.-++.++.|....+|++.. .++ .+++|+..... ..+....|++++..|....+..+.++.-.+ +....+..+++
T Consensus 25 ~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred eeccccCCccccceEEEEe-CCC-cEEEEEecCCC-CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 3456778888888998863 334 47788765421 234456788888888766553333322111 11224567899
Q ss_pred EccC
Q 020652 172 FEKL 175 (323)
Q Consensus 172 ~e~~ 175 (323)
|+|+
T Consensus 102 ~e~i 105 (307)
T TIGR00938 102 VEFL 105 (307)
T ss_pred EEeC
Confidence 9998
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0008 Score=60.21 Aligned_cols=75 Identities=17% Similarity=0.198 Sum_probs=47.6
Q ss_pred EeeecccCcEEEEEEEECC------CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 97 LSKMGEGTFGQVVECFDNE------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~------~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
++.|..|-...+|++.... .++.+++|+............+|..+++.+....+ . .+++..+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~-~---P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNL-G---PKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCC-C---CceEEEeCC----Cc
Confidence 3566677777889886533 25789999876543333456779999999987664 2 333333332 25
Q ss_pred EEccC-CCCH
Q 020652 171 VFEKL-GPSL 179 (323)
Q Consensus 171 v~e~~-~~~L 179 (323)
|+||+ |..+
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 78887 5443
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00024 Score=63.01 Aligned_cols=131 Identities=20% Similarity=0.215 Sum_probs=91.0
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEecc----------ch-------------hhHHHHHHHHHHHHHHHhCCC
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----------IN-------------KYREAAMIEIDVLQRLARHDI 150 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~----------~~-------------~~~~~~~~Ei~~l~~l~~~~i 150 (323)
+.+.++||-|--+-||.+-+. .|+..++|+-+. .. -.+-.+.+|...|+.|..+..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 677899999999999999764 566788885321 00 012345679999999987654
Q ss_pred CCcceEEEcceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEee
Q 020652 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (323)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~ 229 (323)
.. ...++ .+.-|+|||++ |-.|.+.-+- . .+..+...++.-+.-|..+|+||+|..-=||++.+
T Consensus 173 pV---PkpiD----~~RH~Vvmelv~g~Pl~~v~~v-----~---d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 173 PV---PKPID----HNRHCVVMELVDGYPLRQVRHV-----E---DPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKD 237 (465)
T ss_pred CC---CCccc----ccceeeHHHhhcccceeeeeec-----C---ChHHHHHHHHHHHHHHHHcCceecccchheeEEec
Confidence 22 22222 24568999999 7677654321 1 12334445555566788899999999999999999
Q ss_pred cCceeccCccc
Q 020652 230 AEYVKVPDYKF 240 (323)
Q Consensus 230 ~~~~ki~d~~~ 240 (323)
++.++++||--
T Consensus 238 d~~i~vIDFPQ 248 (465)
T KOG2268|consen 238 DDKIVVIDFPQ 248 (465)
T ss_pred CCCEEEeechH
Confidence 99999999853
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.28 E-value=8.7e-05 Score=77.08 Aligned_cols=154 Identities=12% Similarity=0.013 Sum_probs=101.4
Q ss_pred HHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC-CCCHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHH
Q 020652 135 AMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYR--SFPIDLVRELGRQLLESVAFMH 211 (323)
Q Consensus 135 ~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~--~l~~~~~~~i~~qi~~aL~~lH 211 (323)
...|...++...|.++.+.. .++.. ......+..++++ +|.+++.+-+...+ .+....+.....+.+.+..-+|
T Consensus 1276 ll~e~de~~~~~h~~~~~~p-~rI~p--s~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDP-LRIPP--SESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred hhhhhhhhhhhhceeeeccc-ccCCC--CCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 33455555566777652111 11111 1233567899999 99999988754321 2333334444444477777777
Q ss_pred HC-----CceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCc---cccccCCc
Q 020652 212 EL-----RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRH 283 (323)
Q Consensus 212 ~~-----~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~ 283 (323)
+. -.+|+++|+-|.+|..+.. +|+.++|+.+...... ...++++.
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~---------------------------v~~gk~gLdKIknp~~sf~Gl~l~sp~ 1405 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYN---------------------------VKLGKGGLDKIKNPVLSFFGLELCSPI 1405 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCc---------------------------ccccccccccccCchHhhhhhhhCCHH
Confidence 54 2789999999999865544 4555666555322222 23478899
Q ss_pred cccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 284 YRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 284 y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
|+++++...-.++.++|+|+.|+.+|++.-|..+|
T Consensus 1406 ~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1406 YVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 99999988888998899999999999998887665
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0038 Score=54.44 Aligned_cols=71 Identities=13% Similarity=0.066 Sum_probs=43.6
Q ss_pred eecccCcEEEEEEEECCCCcEEEEEEeccchhhH-HHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC-C
Q 020652 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR-EAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G 176 (323)
Q Consensus 99 ~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~-~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~-~ 176 (323)
.+..|-.+.+|+.. .+++.+++|+........ -...+|..+++.+....+ .+.++ .... -++||||+ |
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~-~P~~i---~~~~----~~~v~e~i~G 72 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGL-APKPI---LVNE----HWLLVEWLEG 72 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCC-CCceE---EEeC----CEEEEEeccC
Confidence 34567778899885 446678888754322211 235679999999987655 23322 2221 26899998 5
Q ss_pred CCH
Q 020652 177 PSL 179 (323)
Q Consensus 177 ~~L 179 (323)
..+
T Consensus 73 ~~~ 75 (256)
T TIGR02721 73 EVI 75 (256)
T ss_pred ccc
Confidence 443
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0013 Score=54.64 Aligned_cols=98 Identities=21% Similarity=0.205 Sum_probs=71.5
Q ss_pred HHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccCC-CCHHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHH--
Q 020652 137 IEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLG-PSLYDFLRK-NSYRSFPIDLVRELGRQLLESVAFMHE-- 212 (323)
Q Consensus 137 ~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~-- 212 (323)
.|.-+++.+.+.. ++.++++.+.. +++.||.+ +++...... .....-++..+..++.+++..+++++.
T Consensus 8 ~E~lll~~l~~~~----~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 8 NEPLLLQLLQGSE----PFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred cHHHHHHHcCCCC----CCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 4777888887632 44888887743 56889984 444321000 011246899999999999999999987
Q ss_pred -CCceecCCCCCcEEEeecCceeccCccccc
Q 020652 213 -LRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 213 -~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
..+.-.|++++|+-+++++.+|+.|..-+.
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred CCcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 458889999999999999999998886433
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0064 Score=54.34 Aligned_cols=104 Identities=18% Similarity=0.158 Sum_probs=65.8
Q ss_pred EEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCC-CCCcceEEEcceec---cCceEEEE
Q 020652 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFD---YRNHICIV 171 (323)
Q Consensus 96 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~-i~~~~~~~~~~~~~---~~~~~~lv 171 (323)
-.+.||.|..+.||+.... ++ .+.+|+.+. ......+..|...|+.+.... + .+.++++.+. ..+..+||
T Consensus 18 ~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~-~~~~~~~~~Ea~~L~~L~~~~~v---pVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 18 RVECISEQPYAALWALYDS-QG-NPMPLMARS-FSTPGVAQQEAWKLSMLARSGTV---RMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred eeeecCCccceeEEEEEcC-CC-CEEEEEecc-cccchHHHHHHHHHHHHccCCCC---CcCcEEEEeccCCcCCCeEEE
Confidence 3578999999999998543 23 366787432 223457889999999997643 3 3344554443 34668999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~ 212 (323)
||++ |.++.+. .........+..+++.+|.-||+
T Consensus 92 mE~i~G~~~~~~-------~~~~~~~~~l~~~l~~~La~LH~ 126 (297)
T PRK10593 92 LERLRGVSVEAP-------ARTPERWEQLKDQIVEGLLAWHR 126 (297)
T ss_pred EeccCCEecCCC-------CCCHHHHHHHHHHHHHHHHHHhC
Confidence 9999 6555431 12223344455566666666765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0034 Score=64.12 Aligned_cols=157 Identities=22% Similarity=0.334 Sum_probs=99.4
Q ss_pred HHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 020652 134 AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212 (323)
Q Consensus 134 ~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~ 212 (323)
....|+..+.++.|.|++......+...+.. -...+..++| ..++.+.+...+ ..+..+++.+..+++.||.|+|+
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHH
Confidence 3455777888999999866655555544332 1223445678 778888887765 68889999999999999999999
Q ss_pred CCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEe--eCCCcccccCCccc--cccCCccccch
Q 020652 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI--DFGSTTFEHQDHSY--VVSTRHYRAPE 288 (323)
Q Consensus 213 ~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~--Dfg~a~~~~~~~~~--~~gt~~y~aPE 288 (323)
....| +.+...... ....+........ ||+........... ..-+..+.++|
T Consensus 305 ~~l~~-------v~L~~s~~~-----------------~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e 360 (1351)
T KOG1035|consen 305 LSLEH-------VVLSASSSK-----------------ESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADE 360 (1351)
T ss_pred hccce-------eEEeccccc-----------------ccccCccceeecchhhhcccccCCCcccchhhcCcccccccc
Confidence 84433 333221100 0001222233333 66666554433222 23455677888
Q ss_pred hhcCCCCCcc--hhHHHHHHHHHHHhcCCCC
Q 020652 289 VILGLGWNYP--CDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 289 ~~~~~~~~~~--~DiwSlG~il~el~tg~~p 317 (323)
......++.+ .|+|.+|..+..+..|..+
T Consensus 361 ~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i 391 (1351)
T KOG1035|consen 361 DLKENTAKKSRLTDLWCLGLLLLQLSQGEDI 391 (1351)
T ss_pred ccccccchhhhhhHHHHHHHHHhhhhhcCcc
Confidence 8777665544 7999999999998877543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.023 Score=51.83 Aligned_cols=82 Identities=21% Similarity=0.188 Sum_probs=49.4
Q ss_pred eecccCcEEEEEEEECCCCcEEEEEEec----c----chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 99 KMGEGTFGQVVECFDNEKKELVAIKIVR----S----INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 99 ~lG~G~fg~V~~~~~~~~~~~vAiK~~~----~----~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
.||.|....||++.+...++.|+||.-. . .....++...|...|+..... ....+.+++.+ +.....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~--~P~~vP~vy~~--D~e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEH--VPHLVPRIFHF--DTEMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhcc--CccccCeEEEE--cccccee
Confidence 5799999999999975444679999643 1 112234556788888665432 11233444432 2344568
Q ss_pred EEccC-C-CCHHHHHH
Q 020652 171 VFEKL-G-PSLYDFLR 184 (323)
Q Consensus 171 v~e~~-~-~~L~~~l~ 184 (323)
|||++ . ..|.+.+.
T Consensus 78 vMEdL~~~~ilR~~Li 93 (370)
T TIGR01767 78 VMEDLSHHKIARKGLI 93 (370)
T ss_pred hHhhCccchHHHHHHH
Confidence 99998 3 34545444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0082 Score=54.85 Aligned_cols=76 Identities=16% Similarity=0.065 Sum_probs=47.1
Q ss_pred EEeeecccCcEEEEEEEECC----CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 96 ILSKMGEGTFGQVVECFDNE----KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 96 ~~~~lG~G~fg~V~~~~~~~----~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
-++.|-.|-...+|++.... .++.|++|+........-....|..+++.+...++. .++++.+..+ .|
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~----P~~~~~~~~g----~v 111 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQG----PRLLGRFPNG----RV 111 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCC----CceEEEECCc----eE
Confidence 34566568888899986432 246788998754332222336799999999887763 3344444332 46
Q ss_pred EccC-CCCH
Q 020652 172 FEKL-GPSL 179 (323)
Q Consensus 172 ~e~~-~~~L 179 (323)
.+|+ +.+|
T Consensus 112 ~efi~g~~l 120 (344)
T PLN02236 112 EEFIHARTL 120 (344)
T ss_pred EEeeCCCCC
Confidence 7777 4443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.018 Score=52.33 Aligned_cols=74 Identities=11% Similarity=0.223 Sum_probs=44.8
Q ss_pred EeeecccCcEEEEEEEECCC---CcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEc
Q 020652 97 LSKMGEGTFGQVVECFDNEK---KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~---~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e 173 (323)
++.|..|-...+|++..... +..|++|+........-...+|..+++.+...++. .+++.++..+ +|.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~----P~~l~~~~~G----~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFG----AKLLGVFGNG----MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCC----CceeEEeCCc----Eeeh
Confidence 45555577778888864432 23788898754332222345699999999887764 3344444322 4777
Q ss_pred cC-CCC
Q 020652 174 KL-GPS 178 (323)
Q Consensus 174 ~~-~~~ 178 (323)
|+ +.+
T Consensus 91 fi~g~~ 96 (330)
T PLN02421 91 FINART 96 (330)
T ss_pred hhcCCC
Confidence 77 443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.018 Score=50.96 Aligned_cols=47 Identities=23% Similarity=0.093 Sum_probs=30.6
Q ss_pred eecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHh
Q 020652 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147 (323)
Q Consensus 99 ~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~ 147 (323)
..++|-...|+.+. ...|+.+++|+-+. ........+|.++|+.+..
T Consensus 18 ~~~~g~~~~v~~i~-~~~g~~~VlR~p~~-~~~~~~l~rE~~vL~~L~~ 64 (276)
T cd05152 18 LNESGLDFQVVFAK-DTDGVPWVLRIPRR-PDVSERAAAEKRVLALVRK 64 (276)
T ss_pred ecCCcceeEEEEEE-cCCCCeEEEEecCC-HHHHHHHHHHHHHHHHHHh
Confidence 34555555666653 23466788887643 3334567889999999975
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.04 Score=50.92 Aligned_cols=84 Identities=23% Similarity=0.216 Sum_probs=51.8
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEec----cc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVR----SI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~----~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
.+.||.|.-..||++.+...++.|+||.-. .. .-..++...|.++|+......- ..+.+++.+ +.....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P--~~VP~vy~~--D~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAP--GLVPKVYLF--DSVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCC--CcCCeEEEE--CcHHhh
Confidence 678999999999999874445678999642 11 2234566778888887654211 123444432 234456
Q ss_pred EEEccC-C-CCHHHHHH
Q 020652 170 IVFEKL-G-PSLYDFLR 184 (323)
Q Consensus 170 lv~e~~-~-~~L~~~l~ 184 (323)
+|||++ . ..|.+.|.
T Consensus 110 ~vMEdL~~~~ilR~~Li 126 (409)
T PRK12396 110 CVMEDLSDHTILRTALI 126 (409)
T ss_pred HHHHhCcccHHHHHHHH
Confidence 888888 3 23444443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.12 Score=46.84 Aligned_cols=70 Identities=16% Similarity=0.080 Sum_probs=42.8
Q ss_pred cEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcc--eeccCceEEEEEccC
Q 020652 105 FGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN--WFDYRNHICIVFEKL 175 (323)
Q Consensus 105 fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~--~~~~~~~~~lv~e~~ 175 (323)
-..||+... .++..+++|+.+...........|++.+..|....+.....+..-+ ....++..+.+++++
T Consensus 38 eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~ 109 (325)
T PRK11768 38 ENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRR 109 (325)
T ss_pred cceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeee
Confidence 346888864 3456689998764433456677899999888775543111122222 122345678889888
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.087 Score=47.16 Aligned_cols=66 Identities=11% Similarity=0.240 Sum_probs=39.2
Q ss_pred EEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcc---eeccCceEEEEEccC-CC
Q 020652 107 QVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN---WFDYRNHICIVFEKL-GP 177 (323)
Q Consensus 107 ~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~---~~~~~~~~~lv~e~~-~~ 177 (323)
.||++.. ..| .+++|++... .+....|+.++..|....+..+.++...+ +...++..+++++++ |.
T Consensus 11 ~v~~v~t-~~g-~~~LK~~~~~---~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~ 80 (313)
T TIGR02906 11 NVYKVET-DSG-NKCLKKINYP---PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGR 80 (313)
T ss_pred cEEEEEe-CCC-CeEEEEcCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCc
Confidence 3888763 233 5788987532 23456678888888776653333333211 112356789999998 53
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.03 Score=50.30 Aligned_cols=75 Identities=12% Similarity=0.036 Sum_probs=41.1
Q ss_pred EEeeecccCcEEEEEEEECCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc--eEEE
Q 020652 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN--HICI 170 (323)
Q Consensus 96 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~--~~~l 170 (323)
+++.+..|....+|...+. ++.+++. ... .........+|..+++.+..-.+ .+...+..+..+. ..|.
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~v---P~p~~~~~~~~~~~g~pf~ 102 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDV---PVPRAFGLCGEGYLGTPFY 102 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCC---CCcccccccccCCCCCceE
Confidence 4445544444445555433 6777777 331 12233445667888877765333 2234444444443 6799
Q ss_pred EEccCC
Q 020652 171 VFEKLG 176 (323)
Q Consensus 171 v~e~~~ 176 (323)
||+++.
T Consensus 103 v~~~ve 108 (321)
T COG3173 103 VMEWVE 108 (321)
T ss_pred EEEEec
Confidence 999983
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.094 Score=48.74 Aligned_cols=73 Identities=16% Similarity=0.150 Sum_probs=46.4
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEec-----cch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVR-----SIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~-----~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.+.||.|....||+..+. ++.++||.-. ... ...++...|...|+.+.... ...+.+++.+.+ +..
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~--p~~VPkVy~~de--d~~ 110 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLC--PDHVPEVYHFDR--TMA 110 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcC--CCCCCeEEEECC--CCC
Confidence 678999999999999863 4458899754 111 12344455677777665321 123456666555 345
Q ss_pred EEEEccC
Q 020652 169 CIVFEKL 175 (323)
Q Consensus 169 ~lv~e~~ 175 (323)
+++||++
T Consensus 111 vlvME~L 117 (418)
T PLN02756 111 LIGMRYL 117 (418)
T ss_pred EEEEeec
Confidence 7789999
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.027 Score=51.77 Aligned_cols=62 Identities=24% Similarity=0.349 Sum_probs=44.8
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HHCCceecCCCCCcEEEeecCc
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM-HELRLIHTDLKPENILLVSAEY 232 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~l-H~~~iiHrDlKp~NIli~~~~~ 232 (323)
..|+-+|. |.++..+++... .+++....++.-...||.-+ --.+++|.|+.|.||++.-...
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~t 383 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNKT 383 (565)
T ss_pred ceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecCC
Confidence 45566677 889999988654 56666666666666665544 3578999999999999965443
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.06 E-value=0.17 Score=46.91 Aligned_cols=76 Identities=20% Similarity=0.250 Sum_probs=44.5
Q ss_pred EEeeecccCcEEEEEEEECCCC-c-----EEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 96 ILSKMGEGTFGQVVECFDNEKK-E-----LVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 96 ~~~~lG~G~fg~V~~~~~~~~~-~-----~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
.++.|..|-...+|++...... . .|.+++........-.-.+|+.+++.+...+++ .++++.+.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glg----P~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFG----PKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCC----CeEEEecCC----E
Confidence 4456666888899998643321 1 244443322111112235689999999887763 455555543 5
Q ss_pred EEEccC-CCCH
Q 020652 170 IVFEKL-GPSL 179 (323)
Q Consensus 170 lv~e~~-~~~L 179 (323)
++.||+ |.+|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 888888 5443
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.025 Score=47.77 Aligned_cols=51 Identities=20% Similarity=0.146 Sum_probs=31.4
Q ss_pred CcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC
Q 020652 117 KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (323)
Q Consensus 117 ~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (323)
++.|++|+........-....|..+++.+...++. ..++..+..+ +|.+|+
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~----p~~~~~~~~g----~v~e~i 52 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLG----PKIIYFFENG----RVEEFI 52 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSS----S-EEEEETTE----EEEE--
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCC----CeEEEEcCCC----cEEEEe
Confidence 45688898876544455667799999999887663 3444444332 455776
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.021 Score=51.04 Aligned_cols=68 Identities=21% Similarity=0.347 Sum_probs=43.3
Q ss_pred HHHHHHHHHHHHHHHHHHHH----CCceecCCCCCcEEEeecCc---eeccCcccccccCCCCCccccCCCCCCceEeeC
Q 020652 193 IDLVRELGRQLLESVAFMHE----LRLIHTDLKPENILLVSAEY---VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265 (323)
Q Consensus 193 ~~~~~~i~~qi~~aL~~lH~----~~iiHrDlKp~NIli~~~~~---~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Df 265 (323)
.+-++.++.||+.-.-.+-+ .+.+|-||||+||||-.... +++.|-.+. .++.-..+|.||
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~v------------F~Epi~~~LnDF 345 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYV------------FNEPIKACLNDF 345 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEE------------eccchhhhhccc
Confidence 45677888888754323322 46899999999999966542 233332221 234456788999
Q ss_pred CCccccc
Q 020652 266 GSTTFEH 272 (323)
Q Consensus 266 g~a~~~~ 272 (323)
..++..+
T Consensus 346 DfSqv~~ 352 (444)
T PHA03111 346 DFSQVAN 352 (444)
T ss_pred CHHHHcc
Confidence 9876543
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.18 Score=44.76 Aligned_cols=75 Identities=16% Similarity=0.213 Sum_probs=48.8
Q ss_pred EEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEcc
Q 020652 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEK 174 (323)
Q Consensus 95 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~ 174 (323)
+-.+.++.|....+|+.. .+++.+.+|+-. ......+..|.+-|+.|...+- ..+.+.+.+....+.-+|+|||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~--~~~~~~f~~Ea~gL~~L~~~~~--~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNS--ESGRDMFEGEAEGLKALAEANP--IRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEE--GGGCCHHHHHHHHHHHHCHTTT--SBS--EEEEEE-SSCCEEEEE-
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecC--hhhHHHHHHHHHHHHHHHhcCC--CCCCeEEEEEeecCCceEEEEe
Confidence 345788999999999885 667778899765 3444568889999999954332 3456666666666667999999
Q ss_pred C
Q 020652 175 L 175 (323)
Q Consensus 175 ~ 175 (323)
+
T Consensus 94 l 94 (288)
T PF03881_consen 94 L 94 (288)
T ss_dssp -
T ss_pred e
Confidence 8
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.11 E-value=0.32 Score=44.11 Aligned_cols=78 Identities=19% Similarity=0.140 Sum_probs=48.6
Q ss_pred eecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcc-eEEEcce--eccCc--eEEEEEc
Q 020652 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR-CVQIRNW--FDYRN--HICIVFE 173 (323)
Q Consensus 99 ~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~-~~~~~~~--~~~~~--~~~lv~e 173 (323)
.|.+ .-..||+.... .|+ +++|+.... ....+...|+..+..+....+.... +..+-+- ..... +.+-+++
T Consensus 33 ~l~s-~eN~~f~~~~~-~g~-~iLki~~~~-~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~ 108 (331)
T COG2334 33 GLNS-EENSNFRVQTE-DGR-YILKIYRPG-WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE 108 (331)
T ss_pred cccc-ccCceEEEEec-CCC-eEEEEecCC-CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence 4444 44568888643 333 489998876 6667788899999999877663322 1222221 11133 7888999
Q ss_pred cC-CCCHH
Q 020652 174 KL-GPSLY 180 (323)
Q Consensus 174 ~~-~~~L~ 180 (323)
|+ |..+.
T Consensus 109 ~l~G~~~~ 116 (331)
T COG2334 109 YLPGRPLE 116 (331)
T ss_pred ecCCcCcC
Confidence 99 55554
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.16 Score=43.09 Aligned_cols=112 Identities=15% Similarity=0.169 Sum_probs=68.2
Q ss_pred cCcEEEEEEEECCCCcEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC-CCCH
Q 020652 103 GTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSL 179 (323)
Q Consensus 103 G~fg~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L 179 (323)
++.++.-.+.... |- ..+|++..... ...-+..+.++++++. .| +++..- ....+.++.|+| ....
T Consensus 73 ~gNsTl~~~kt~i-G~-L~lKKi~slp~~~~~~~y~nky~v~Armh--Gi-----lrL~ND--n~~~yGvIlE~Cy~~~i 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-GP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GI-----LRLKND--NNYKYGVILERCYKIKI 141 (308)
T ss_pred CCceEEEEecccc-ch-hhhhhccCCCcccchhhhhhhhhHHHHhh--he-----eEeecC--CCceeEEEEeeccCccc
Confidence 3444444443322 43 34555543322 2334566788888873 33 676642 445678999999 3211
Q ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--CCceecCCCCCcEEEeecCceeccCccc
Q 020652 180 YDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE--LRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 180 ~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
.. ..++.-=+.+|.-.|+ .+.+|+|-.|+|||-+..|.+|+.|-+-
T Consensus 142 -----------~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 -----------NF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred -----------ch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 11 1111112466778884 4799999999999999999999988653
|
The function of this family is unknown. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.72 E-value=0.34 Score=45.85 Aligned_cols=74 Identities=20% Similarity=0.157 Sum_probs=46.7
Q ss_pred EEeeecccCcEEEEEEEECC--------CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 96 ILSKMGEGTFGQVVECFDNE--------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 96 ~~~~lG~G~fg~V~~~~~~~--------~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
-++.|..|-.-.+|++.... .++.|.+|+.-......-....|..+++.+....+. .++++.+..
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~----P~l~~~f~g--- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIA----PQLLNTFSG--- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCC----CceEEEeCC---
Confidence 45677777777888886432 146788898754333222345689999999887774 344444432
Q ss_pred EEEEEccC-CC
Q 020652 168 ICIVFEKL-GP 177 (323)
Q Consensus 168 ~~lv~e~~-~~ 177 (323)
+.|.||+ |.
T Consensus 182 -g~I~efi~g~ 191 (442)
T PTZ00296 182 -GRIEEWLYGD 191 (442)
T ss_pred -CEEEEeeCCc
Confidence 3567777 44
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.42 E-value=0.75 Score=48.31 Aligned_cols=81 Identities=16% Similarity=0.128 Sum_probs=45.6
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhC--CCCCcceEEEcc-e----ec--cC-ce
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH--DIGGTRCVQIRN-W----FD--YR-NH 167 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~--~i~~~~~~~~~~-~----~~--~~-~~ 167 (323)
+.|+ |..-.+|+... .+++.+++|+.+.. ........|.++|..|... .+..+.++.-.+ - .. .+ .+
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~-~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPS-EPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCc-cchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4564 34567787753 45667999998753 2333455567777777643 443333333221 1 11 11 25
Q ss_pred EEEEEccC-CCCHHH
Q 020652 168 ICIVFEKL-GPSLYD 181 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~ 181 (323)
.+.+++|+ |..+.+
T Consensus 108 ~vrLl~~l~G~~l~~ 122 (1013)
T PRK06148 108 LLRLLSWLPGTPLAE 122 (1013)
T ss_pred EEEEEeccCCCcHHh
Confidence 67889999 655554
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.35 E-value=0.085 Score=47.50 Aligned_cols=68 Identities=21% Similarity=0.293 Sum_probs=40.9
Q ss_pred HHHHHHHHHHHHHHHHHHH----HCCceecCCCCCcEEEeecCce---eccCcccccccCCCCCccccCCCCCCceEeeC
Q 020652 193 IDLVRELGRQLLESVAFMH----ELRLIHTDLKPENILLVSAEYV---KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265 (323)
Q Consensus 193 ~~~~~~i~~qi~~aL~~lH----~~~iiHrDlKp~NIli~~~~~~---ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Df 265 (323)
.+-++.++.||+.-.--+- ..+.+|-||||+||||-+.... ++.+-.+. ..+.-..+|.||
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~v------------F~Epi~~~LnDF 341 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYV------------FKEPIRCCLNDF 341 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEE------------ecccceeeeccc
Confidence 4557778888764321121 2468999999999999655432 22222111 234445688999
Q ss_pred CCccccc
Q 020652 266 GSTTFEH 272 (323)
Q Consensus 266 g~a~~~~ 272 (323)
..++..+
T Consensus 342 DfSqv~~ 348 (434)
T PF05445_consen 342 DFSQVAN 348 (434)
T ss_pred CHHHhcc
Confidence 8876543
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.11 E-value=0.12 Score=48.98 Aligned_cols=49 Identities=18% Similarity=0.289 Sum_probs=36.3
Q ss_pred HHHHHHHHHHHHHhCCCCCcceEEEcceecc-CceEEEEEccCCCCHHHHHHhcC
Q 020652 134 AAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHICIVFEKLGPSLYDFLRKNS 187 (323)
Q Consensus 134 ~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~-~~~~~lv~e~~~~~L~~~l~~~~ 187 (323)
+..-..+.++.+.|.|. ..+.++-.. .....+|||+++.+|.+++....
T Consensus 28 ~ilgr~~~lktl~~~~l-----~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~ 77 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNL-----CQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN 77 (725)
T ss_pred HHhhhhHHHHhhcCccc-----eeeEeeecCccceEEEEehhhccchHHHHHhcc
Confidence 34556788899999887 555554433 24588999999999999987653
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 323 | ||||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 7e-64 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-61 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-61 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-61 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-58 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 6e-57 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-46 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-43 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-43 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-43 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-40 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-40 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-39 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 8e-33 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-32 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 6e-32 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-27 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-27 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-20 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-20 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-20 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-20 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-19 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-19 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-19 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-19 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-19 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-19 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-19 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-19 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-19 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-19 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-19 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-19 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-19 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-19 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-19 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-19 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-19 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-19 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-19 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-19 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-19 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-19 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-19 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-19 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-19 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-19 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-19 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-19 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-19 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-19 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-19 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-19 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-19 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-19 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-19 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-19 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-19 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-19 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-19 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-19 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-19 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-19 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-19 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-19 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-19 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-19 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-19 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-19 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-19 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-19 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-19 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-18 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-18 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-18 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-18 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-18 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-18 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-18 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-18 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-18 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-17 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-17 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-17 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-17 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-17 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-16 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-16 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-15 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-15 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-14 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-14 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-14 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-14 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-14 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-14 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-14 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-14 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-14 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 8e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-13 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-13 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-13 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-13 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-13 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-13 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-13 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-13 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-13 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-13 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-13 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 9e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-12 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-12 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-12 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 3e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 5e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 5e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 6e-12 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 7e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-12 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 8e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-11 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-11 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-11 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-11 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-11 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-11 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-11 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-11 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-11 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-11 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-11 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-11 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-11 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-11 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 8e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 8e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-11 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-11 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-11 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-10 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-10 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-10 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-09 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-09 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-09 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 8e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 8e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 8e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-09 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-09 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 9e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-08 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-08 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 3e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-08 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-08 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-07 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-07 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-07 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-07 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-07 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-07 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-07 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-07 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 8e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-07 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-07 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-07 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-07 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 9e-07 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-07 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-07 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-06 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-06 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 1e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-06 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 1e-06 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 2e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-06 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-06 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-06 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-06 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-06 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-06 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-06 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-06 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-06 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-06 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-06 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-06 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-06 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 5e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 6e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-06 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-06 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-06 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-06 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 7e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 8e-06 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 8e-06 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 8e-06 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 8e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-06 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 8e-06 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 8e-06 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 8e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-06 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 9e-06 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-06 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 9e-06 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 9e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-06 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-06 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-06 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 9e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-06 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-05 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-05 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-05 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-05 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-05 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-05 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-05 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-05 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-05 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-05 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 8e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 8e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 9e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-04 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-04 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-04 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-04 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-04 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-04 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-04 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-04 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-04 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-04 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-04 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-04 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-04 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 6e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 6e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-04 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 8e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-04 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-04 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 9e-04 |
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 408 bits (1051), Expect = e-143
Identities = 94/248 (37%), Positives = 149/248 (60%), Gaps = 2/248 (0%)
Query: 66 PRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV 125
+ ++ DD+ H+ + G L + ++ KMG+GTFG+V+ C + K+ A+K+V
Sbjct: 9 SGRENLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV 68
Query: 126 RSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
R+I KY +A IE D+L+++ DI V+ F Y +H+C++FE LGPSLY+ + +
Sbjct: 69 RNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITR 128
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
N+Y F I+ ++ ++L+++ ++ ++ L HTDLKPENILL + K
Sbjct: 129 NNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305
K ++ KS+ IKLIDFG TF+ H +++TR YRAPEVIL LGW+ D+WS G
Sbjct: 189 KKIQIYR--TKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFG 246
Query: 306 CILVELCS 313
C+L EL +
Sbjct: 247 CVLAELYT 254
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 384 bits (989), Expect = e-134
Identities = 110/240 (45%), Positives = 164/240 (68%), Gaps = 10/240 (4%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSINKYREA 134
DDK+GH V IG+ L RY I+ +GEGTFG+VVEC D+ + K VA+KI+R++ KYREA
Sbjct: 3 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREA 62
Query: 135 AMIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI 193
A +EI+VL+++ D CV + +WF++ H+CI FE LG + ++FL++N+++ +P+
Sbjct: 63 ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPL 122
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
VR + QL ++ F+HE +L HTDLKPENIL V++E+ + + S +
Sbjct: 123 PHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH--------KSCEEK 174
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
K+++I++ DFGS TF+H+ H+ +V+TRHYR PEVIL LGW PCD+WS+GCIL E
Sbjct: 175 SVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 383 bits (985), Expect = e-134
Identities = 109/236 (46%), Positives = 155/236 (65%), Gaps = 10/236 (4%)
Query: 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSINKYREAAMIE 138
H + G+ L+ RY I+ +GEG FG+VVEC D++ VA+KIV+++++Y EAA E
Sbjct: 2 MHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE 61
Query: 139 IDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVR 197
I VL+ L D T RCVQ+ WF++ HICIVFE LG S YDF+++N + F +D +R
Sbjct: 62 IQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIR 121
Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
++ Q+ +SV F+H +L HTDLKPENIL V ++Y + + K + +
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD--------ERTLIN 173
Query: 258 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
IK++DFGS T++ + HS +VSTRHYRAPEVIL LGW+ PCD+WS+GCIL+E
Sbjct: 174 PDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 335 bits (862), Expect = e-114
Identities = 90/239 (37%), Positives = 137/239 (57%), Gaps = 26/239 (10%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD G YV +++ RY +L +G+G+FGQVV+ +D++ + VA+K+VR+ ++ A
Sbjct: 81 DDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA 140
Query: 136 MIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
EI +L+ L + D T + + F +RNHIC+ FE L +LY+ ++KN ++ F +
Sbjct: 141 AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLP 200
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
LVR+ +L+ + +H+ R+IH DLKPENILL
Sbjct: 201 LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ------------------------- 235
Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
S IK+IDFGS+ +EHQ + +R YRAPEVILG + P D+WS+GCIL EL +
Sbjct: 236 QGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 325 bits (836), Expect = e-111
Identities = 90/241 (37%), Positives = 140/241 (58%), Gaps = 28/241 (11%)
Query: 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAA 135
DD + Y+ GE RY I S +G+G+FGQVV+ +D ++E VAIKI+++ + A
Sbjct: 38 DDDNYDYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA 97
Query: 136 MIEIDVLQRLARHDIGGT-RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
IE+ +L+ + +HD V ++ F +RNH+C+VFE L +LYD LR ++R ++
Sbjct: 98 QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLN 157
Query: 195 LVRELGRQLLESVAFMH--ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252
L R+ +Q+ ++ F+ EL +IH DLKPENILL +
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN----------------------- 194
Query: 253 NLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
PK SAIK++DFGS+ Q + +R YR+PEV+LG+ ++ D+WS+GCILVE+
Sbjct: 195 --PKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMH 252
Query: 313 S 313
+
Sbjct: 253 T 253
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 307 bits (788), Expect = e-103
Identities = 74/250 (29%), Positives = 122/250 (48%), Gaps = 33/250 (13%)
Query: 76 DDKDGHYVFAIGENLT-PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA 134
G++ GE RY ++ K+G G F V D VA+KIVR Y EA
Sbjct: 2 YRPGGYHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA 61
Query: 135 AMIEIDVLQRLARHD------IGGTRCVQIRNWFDYRN----HICIVFEKLGPSLYDFLR 184
A EI +LQR+ D +G +++ + F+++ H+ +VFE LG +L ++
Sbjct: 62 AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK 121
Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243
K +R P+ V+++ +QLL + +MH +IHTD+KPEN+L+ + +
Sbjct: 122 KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE--------- 172
Query: 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWS 303
IK+ D G+ + + ++ + TR YR+PEV+LG W D+WS
Sbjct: 173 ------------NLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWS 220
Query: 304 VGCILVELCS 313
C++ EL +
Sbjct: 221 TACLIFELIT 230
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 2e-86
Identities = 80/272 (29%), Positives = 137/272 (50%), Gaps = 30/272 (11%)
Query: 72 PWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY 131
K G+++ IG+ RY ++ K+G G F V +D + K+ VA+K+V+S Y
Sbjct: 17 DPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHY 76
Query: 132 REAAMIEIDVLQRLARHDI---GGTRCVQIRNWFDYR----NHICIVFEKLGPSLYDFLR 184
E A+ EI +L+ + D VQ+ + F HIC+VFE LG L ++
Sbjct: 77 TETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWII 136
Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTDLKPENILLVSAEY------VKVPD 237
K++Y+ P+ V+++ +Q+L+ + ++H + R+IHTD+KPENILL E + +
Sbjct: 137 KSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATE 196
Query: 238 YKFLSRSSKDGSYFKNLP----------------KSSAIKLIDFGSTTFEHQDHSYVVST 281
++ GS P + +K+ D G+ + H+ + + T
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT 256
Query: 282 RHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
R YR+ EV++G G+N P D+WS C+ EL +
Sbjct: 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELAT 288
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-41
Identities = 59/238 (24%), Positives = 103/238 (43%), Gaps = 53/238 (22%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
Y IL ++G G +V + NEKK++ AIK V + N+ ++ EI L +L +
Sbjct: 29 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQ- 85
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
+ +++ ++ +I +V E L +L+K +S + + +LE+V
Sbjct: 86 -HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHT 142
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 268
+H+ ++H+DLKP N L+V DG +KLIDFG +
Sbjct: 143 IHQHGIVHSDLKPANFLIV------------------DGM----------LKLIDFGIAN 174
Query: 269 TFEHQDHSYVVSTR----HYRAPEVILGLGW-----------NYPCDLWSVGCILVEL 311
+ S V ++ +Y PE I + + D+WS+GCIL +
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-40
Identities = 59/238 (24%), Positives = 103/238 (43%), Gaps = 53/238 (22%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
Y IL ++G G +V + NEKK++ AIK V + N+ ++ EI L +L +
Sbjct: 10 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQ- 66
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
+ +++ ++ +I +V E L +L+K +S + + +LE+V
Sbjct: 67 -HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHT 123
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 268
+H+ ++H+DLKP N L+V DG +KLIDFG +
Sbjct: 124 IHQHGIVHSDLKPANFLIV------------------DGM----------LKLIDFGIAN 155
Query: 269 TFEHQDHSYVVSTR----HYRAPEVILGLG-----------WNYPCDLWSVGCILVEL 311
+ S V ++ +Y PE I + + D+WS+GCIL +
Sbjct: 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 213
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-39
Identities = 59/238 (24%), Positives = 103/238 (43%), Gaps = 53/238 (22%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
Y IL ++G G +V + NEKK++ AIK V + N+ ++ EI L +L +
Sbjct: 57 IYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKL-QQ- 113
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
+ +++ ++ +I +V E L +L+K +S + + +LE+V
Sbjct: 114 -HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHT 170
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 268
+H+ ++H+DLKP N L+V DG +KLIDFG +
Sbjct: 171 IHQHGIVHSDLKPANFLIV------------------DGM----------LKLIDFGIAN 202
Query: 269 TFEHQDHSYVVSTR----HYRAPEVILGLGWN-----------YPCDLWSVGCILVEL 311
+ S V ++ +Y PE I + + D+WS+GCIL +
Sbjct: 203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 260
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-39
Identities = 52/225 (23%), Positives = 87/225 (38%), Gaps = 38/225 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
++ LS++G G++G+V + E L A+K S K R + E+ +++ +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
CV++ ++ + + E GPSL S P V R L ++A
Sbjct: 118 ----CCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAH 172
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 268
+H L+H D+KP NI L G KL DFG
Sbjct: 173 LHSQGLVHLDVKPANIFL-----------------GPRGR----------CKLGDFGLLV 205
Query: 269 TFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
Y APE++ G + D++S+G ++E+
Sbjct: 206 ELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVA 249
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 55/242 (22%), Positives = 99/242 (40%), Gaps = 44/242 (18%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
T Y + +G G++ C A+KI I+K + EI++L R +
Sbjct: 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKI---IDKSKRDPTEEIEILLRYGQ 74
Query: 148 HD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
H I + +++ +D ++ +V E + G L D + + + F + + +
Sbjct: 75 HPNI-----ITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITK 127
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+V ++H ++H DLKP NIL V +I++ DF
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDES-----------------------GNPESIRICDF 164
Query: 266 G-STTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL-VELCSVSNCYLTP 321
G + ++ T ++ APEV+ G++ CD+WS+G +L L TP
Sbjct: 165 GFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGY-----TP 219
Query: 322 FA 323
FA
Sbjct: 220 FA 221
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-37
Identities = 51/237 (21%), Positives = 82/237 (34%), Gaps = 46/237 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH---- 148
++ + +G G FGQV + + IK + E A E+ L +L H
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNNEKAEREVKALAKL-DHVNIV 67
Query: 149 --------DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
+ + I E +L ++ K L EL
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
Q+ + V ++H +LI+ DLKP NI L
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFL-----------------VDTKQ---------- 160
Query: 260 IKLIDFG-STTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSV 314
+K+ DFG T+ ++ + T Y +PE I + DL+++G IL EL V
Sbjct: 161 VKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV 217
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 56/231 (24%), Positives = 99/231 (42%), Gaps = 25/231 (10%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD---- 149
+ ++ +G+G FGQVV+ + AIK +R + + E+ +L L H
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVR 66
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQL 203
+ V+ ++ + I E +LYD + + + D L RQ+
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQI 125
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKL 262
LE+++++H +IH DLKP NI + + VK+ D F L+++ L +
Sbjct: 126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD--FGLAKNVHRSLDILKLDSQNLPGS 183
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELC 312
D ++ + T Y A EV+ G G N D++S+G I E+
Sbjct: 184 SDNLTS---------AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 42/235 (17%), Positives = 87/235 (37%), Gaps = 36/235 (15%)
Query: 93 RYRILSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
+ +GEG F QV E D + K+ +K+ + N + ++ L+
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL---RKNSYRSFPIDLVRELGRQ 202
+H ++ + ++N +V E +L + + + + P LV +
Sbjct: 126 QHMF-----MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+L + +H+ +IH D+KP+N +L + S+ + L
Sbjct: 181 MLYMIEQVHDCEIIHGDIKPDNFIL----------------GNGFLEQDDEDDLSAGLAL 224
Query: 263 IDFG-STTFEHQDHSYVVS----TRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
ID G S + + + T ++ E++ WNY D + V + +
Sbjct: 225 IDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML 279
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-37
Identities = 65/235 (27%), Positives = 109/235 (46%), Gaps = 38/235 (16%)
Query: 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAM 136
G RY I+ +G+G+FG+V++C D ++ A+K++ + NK +
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69
Query: 137 IEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDL 195
E+++L++L +I +++ + + IV E G L+D + K F
Sbjct: 70 REVELLKKLDHPNI-----MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHD 122
Query: 196 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255
+ +Q+ + +MH+ ++H DLKPENILL S E
Sbjct: 123 AARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE------------------------ 158
Query: 256 KSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
K IK+IDFG +T Q+ + T +Y APEV+ G ++ CD+WS G IL
Sbjct: 159 KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-37
Identities = 44/227 (19%), Positives = 82/227 (36%), Gaps = 20/227 (8%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
+ L K+G G FG V +C + AIK + + + + A+ E+ L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLES 206
V+ + + +H+ I E G SL D + +N F +++L Q+
Sbjct: 72 ----HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++H + L+H D+KP NI + + K+ D G
Sbjct: 128 LRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN--------KVMFKIGDLG 179
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELC 312
T + A EV+ D++++ +V
Sbjct: 180 HVTRISSPQV-EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAA 225
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-37
Identities = 67/231 (29%), Positives = 110/231 (47%), Gaps = 46/231 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
+Y + K+GEG++G V +C + + ++VAIK ++ A+ EI +L++L +H
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL-ESEDDPVIKKIALREIRMLKQL-KH 61
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ V + F + + +VFE ++ L + R P LV+ + Q L++V
Sbjct: 62 PNL-----VNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAV 115
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
F H+ IH D+KPENIL+ +K IKL DFG
Sbjct: 116 NFCHKHNCIHRDVKPENILI-----------------TKHSV----------IKLCDFGF 148
Query: 267 STTFEHQDHSY--VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCS 313
+ Y V+TR YR+PE+++G Y P D+W++GC+ EL S
Sbjct: 149 ARLLTGPSDYYDDEVATRWYRSPELLVG-DTQYGPPVDVWAIGCVFAELLS 198
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-37
Identities = 51/239 (21%), Positives = 97/239 (40%), Gaps = 40/239 (16%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
+ L +Y I +G G FG V C + K+ K V+ + EI +L R
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-R 59
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
H + + F+ + ++FE + G +++ + +++ + Q+ E+
Sbjct: 60 HR----NILHLHESFESMEELVMIFEFISGLDIFERINTSAF-ELNEREIVSYVHQVCEA 114
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ F+H + H D++PENI+ + +SS IK+I+FG
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQT-------------------------RRSSTIKIIEFG 149
Query: 267 STTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL-VELCSVSNCYLTPF 322
++ + + Y APEV + D+WS+G ++ V L ++ PF
Sbjct: 150 QARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN-----PF 203
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-36
Identities = 62/239 (25%), Positives = 112/239 (46%), Gaps = 39/239 (16%)
Query: 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI 137
G +V + RY+ +G+G+FG+V+ C D + A+K++ R + + + +
Sbjct: 14 GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73
Query: 138 --EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID 194
E+ +L++L +I +++ +F+ + + +V E G L+D + F
Sbjct: 74 LREVQLLKQLDHPNI-----MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEV 126
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
+ RQ+L + +MH+ +++H DLKPEN+LL S
Sbjct: 127 DAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS----------------------- 163
Query: 255 PKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
K + I++IDFG +T + T +Y APEV+ G ++ CD+WS G IL L
Sbjct: 164 -KDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYIL 220
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 46/231 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
+Y L +GEG++G V++C + + +VAIK + + AM EI +L++L RH
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL-ESDDDKMVKKIAMREIKLLKQL-RH 83
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ + V + + +VFE + ++ D L +V++ Q++ +
Sbjct: 84 ENL-----VNLLEVCKKKKRWYLVFEFVDHTILDDLELFP-NGLDYQVVQKYLFQIINGI 137
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
F H +IH D+KPENIL+ S+ G +KL DFG
Sbjct: 138 GFCHSHNIIHRDIKPENILV-----------------SQSGV----------VKLCDFGF 170
Query: 267 STTFEHQDHSY--VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCS 313
+ T Y V+TR YRAPE+++G Y D+W++GC++ E+
Sbjct: 171 ARTLAAPGEVYDDEVATRWYRAPELLVG-DVKYGKAVDVWAIGCLVTEMFM 220
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-36
Identities = 61/240 (25%), Positives = 108/240 (45%), Gaps = 38/240 (15%)
Query: 78 KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREA 134
G ++ + +L+ Y+ + K+G G +G+V+ C D AIKI+
Sbjct: 23 TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK 82
Query: 135 AMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPI 193
+ E+ VL+ L +I +++ ++F+ + + +V E G L+D + F
Sbjct: 83 LLEEVAVLKLLDHPNI-----MKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK--FNE 135
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
+ +Q+L V ++H+ ++H DLKPEN+LL S E
Sbjct: 136 VDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE---------------------- 173
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
K + IK++DFG + + T +Y APEV+ ++ CD+WS+G IL L
Sbjct: 174 --KDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFIL 230
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-36
Identities = 64/257 (24%), Positives = 102/257 (39%), Gaps = 44/257 (17%)
Query: 68 TGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS 127
PP +G N +RI K+G G F +V VA+K V+
Sbjct: 8 MQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI 67
Query: 128 IN----KYREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYD 181
+ K R + EID+L++L H + ++ F N + IV E L
Sbjct: 68 FDLMDAKARADCIKEIDLLKQL-NHPNV-----IKYYASFIEDNELNIVLELADAGDLSR 121
Query: 182 FLR--KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239
++ K R P V + QL ++ MH R++H D+KP N+ +
Sbjct: 122 MIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI------------ 169
Query: 240 FLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQDH--SYVVSTRHYRAPEVILGLGWN 296
+ G +KL D G F + +V T +Y +PE I G+N
Sbjct: 170 -----TATGV----------VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 214
Query: 297 YPCDLWSVGCILVELCS 313
+ D+WS+GC+L E+ +
Sbjct: 215 FKSDIWSLGCLLYEMAA 231
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-36
Identities = 57/244 (23%), Positives = 93/244 (38%), Gaps = 41/244 (16%)
Query: 87 GENLTPRYRILSK-MGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVL 142
EN Y + SK +G G F V +C + A K + R R + EI VL
Sbjct: 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVL 82
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR 201
+ R + + ++ + I ++ E G ++ + V L +
Sbjct: 83 ELAKSCP----RVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK 138
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
Q+LE V ++H+ ++H DLKP+NILL S IK
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIY------------------------PLGDIK 174
Query: 262 LIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL-VELCSVSNCY 318
++DFG + ++ T Y APE++ D+W++G I + L S
Sbjct: 175 IVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTS--- 231
Query: 319 LTPF 322
PF
Sbjct: 232 --PF 233
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-36
Identities = 56/239 (23%), Positives = 106/239 (44%), Gaps = 40/239 (16%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
N+ + + +G G F +V +L A+K ++ +R++++ EI VL+++
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+I V + + ++ H +V + + G L+D + + + + +Q+L
Sbjct: 65 HENI-----VTLEDIYESTTHYYLVMQLVSGGELFDRILERGV--YTEKDASLVIQQVLS 117
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+V ++HE ++H DLKPEN+L ++ E ++S I + DF
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPE------------------------ENSKIMITDF 153
Query: 266 G-STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL-VELCSVSNCYLTPF 322
G S ++ S T Y APEV+ ++ D WS+G I + LC PF
Sbjct: 154 GLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYP-----PF 207
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-36
Identities = 60/226 (26%), Positives = 102/226 (45%), Gaps = 39/226 (17%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRL 145
+ L+ + + S++G G V C ++ A+K + K + ++ EI VL RL
Sbjct: 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK---VLKKTVDKKIVRTEIGVLLRL 105
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+ +I ++++ F+ I +V E G L+D + + Y + + +Q+L
Sbjct: 106 SHPNI-----IKLKEIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAADAVKQIL 158
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
E+VA++HE ++H DLKPEN+L + + +K+ D
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPA------------------------PDAPLKIAD 194
Query: 265 FG-STTFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
FG S EHQ V T Y APE++ G + D+WSVG I
Sbjct: 195 FGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-36
Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 41/229 (17%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y L K+GEG+FG+ + E IK + K RE + E+ VL + +H
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHP 83
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I VQ R F+ + IV + G L+ + F D + + Q+ ++
Sbjct: 84 NI-----VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL 138
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
+H+ +++H D+K +NI L +KDG+ ++L DFG
Sbjct: 139 KHVHDRKILHRDIKSQNIFL-----------------TKDGT----------VQLGDFGI 171
Query: 267 STTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ + T +Y +PE+ +N D+W++GC+L ELC+
Sbjct: 172 ARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-35
Identities = 63/254 (24%), Positives = 95/254 (37%), Gaps = 49/254 (19%)
Query: 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-- 137
G + + K+G G FG V + IK INK R +
Sbjct: 10 GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKT---INKDRSQVPMEQ 66
Query: 138 ---EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL--RKNSYRSF 191
EI+VL+ L +I ++I F+ +++ IV E G L + + + ++
Sbjct: 67 IEAEIEVLKSLDHPNI-----IKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKAL 121
Query: 192 PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251
V EL +Q++ ++A+ H ++H DLKPENIL
Sbjct: 122 SEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS-------------------- 161
Query: 252 KNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL- 308
S IK+IDFG D T Y APEV + CD+WS G ++
Sbjct: 162 ----PHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMY 216
Query: 309 VELCSVSNCYLTPF 322
L PF
Sbjct: 217 FLLTGCL-----PF 225
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 53/235 (22%), Positives = 89/235 (37%), Gaps = 47/235 (20%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR---------EAAMIEI 139
Y + +G+G F V C + E + A+KI ++ + E E
Sbjct: 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKI---VDVAKFTSSPGLSTEDLKREA 77
Query: 140 DVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL--RKNSYRSFPIDLV 196
+ L I V++ + + +VFE + G L + R ++ + +
Sbjct: 78 SICHMLKHPHI-----VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
RQ+LE++ + H+ +IH D+KP +LL S E
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE------------------------N 168
Query: 257 SSAIKLIDFG-STTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
S+ +KL FG + V T H+ APEV+ + P D+W G IL
Sbjct: 169 SAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-35
Identities = 55/253 (21%), Positives = 101/253 (39%), Gaps = 44/253 (17%)
Query: 66 PRTGSPPW-RPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKI 124
P S + + ++ + Y + ++G+G F V C A KI
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61
Query: 125 VRSINK----YREAAMI--EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GP 177
IN R+ + E + ++L +I V++ + + +VF+ + G
Sbjct: 62 ---INTKKLSARDFQKLEREARICRKLQHPNI-----VRLHDSIQEESFHYLVFDLVTGG 113
Query: 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
L++ + + + +Q+LES+A+ H ++H +LKPEN+LL S
Sbjct: 114 ELFEDIVAREF--YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA------ 165
Query: 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGW 295
K +A+KL DFG + ++ T Y +PEV+ +
Sbjct: 166 ------------------KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY 207
Query: 296 NYPCDLWSVGCIL 308
+ P D+W+ G IL
Sbjct: 208 SKPVDIWACGVIL 220
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-35
Identities = 56/240 (23%), Positives = 99/240 (41%), Gaps = 41/240 (17%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLA 146
++ Y IL ++G G FG V C + + K + + EI ++ +L
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL- 105
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
H + + + + F+ + + ++ E L G L+D + Y V RQ E
Sbjct: 106 HHP----KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACE 160
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ MHE ++H D+KPENI+ + K+S++K+IDF
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCET-------------------------KKASSVKIIDF 195
Query: 266 GSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL-VELCSVSNCYLTPF 322
G T + D +T + APE++ + D+W++G + V L +S PF
Sbjct: 196 GLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS-----PF 250
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-35
Identities = 65/237 (27%), Positives = 109/237 (45%), Gaps = 38/237 (16%)
Query: 78 KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---RSINKYREA 134
G RY I+ +G+G+FG+V++C D ++ A+K++ + NK
Sbjct: 8 SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST 67
Query: 135 AMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPI 193
+ E+++L++L +I +++ + + IV E G L+D + K F
Sbjct: 68 ILREVELLKKLDHPNI-----MKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSE 120
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
+ +Q+ + +MH+ ++H DLKPENILL S E
Sbjct: 121 HDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE---------------------- 158
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
K IK+IDFG +T Q+ + T +Y APEV+ G ++ CD+WS G IL
Sbjct: 159 --KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVIL 212
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-35
Identities = 54/246 (21%), Positives = 98/246 (39%), Gaps = 46/246 (18%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEID 140
EN+ Y ++G G F V +C + A K ++ RE E+
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
+L+ + ++ + + ++ + + ++ E + G L+DFL + + E
Sbjct: 67 ILKEIQHPNV-----ITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEF 119
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
+Q+L V ++H L++ H DLKPENI+L+
Sbjct: 120 LKQILNGVYYLHSLQIAHFDLKPENIMLLDRN-----------------------VPKPR 156
Query: 260 IKLIDFG-STTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL-VELCSVSN 316
IK+IDFG + + + + T + APE++ D+WS+G I + L S
Sbjct: 157 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS- 215
Query: 317 CYLTPF 322
PF
Sbjct: 216 ----PF 217
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-35
Identities = 56/238 (23%), Positives = 105/238 (44%), Gaps = 49/238 (20%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--------------SINKYRE 133
+ Y + K+G G +G+V+ C + AIK+++ +I K+ E
Sbjct: 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91
Query: 134 AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFP 192
EI +L+ L +I +++ + F+ + + +V E G L++ + F
Sbjct: 92 EIYNEISLLKSLDHPNI-----IKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FD 144
Query: 193 IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252
+ +Q+L + ++H+ ++H D+KPENILL +
Sbjct: 145 ECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKN--------------------- 183
Query: 253 NLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
IK++DFG ++F +D+ + T +Y APEV+ +N CD+WS G I+
Sbjct: 184 ---SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIM 237
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-35
Identities = 57/245 (23%), Positives = 100/245 (40%), Gaps = 46/245 (18%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEIDV 141
+ Y + ++G G F V +C + A K ++ RE E+++
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELG 200
L+ + RH + + + F+ + + ++ E + G L+DFL + D +
Sbjct: 62 LREI-RHP----NIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQFL 114
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
+Q+L+ V ++H R+ H DLKPENI+L+ + I
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKN-----------------------VPNPRI 151
Query: 261 KLIDFG-STTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL-VELCSVSNC 317
KLIDFG + E + + T + APE++ D+WS+G I + L S
Sbjct: 152 KLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS-- 209
Query: 318 YLTPF 322
PF
Sbjct: 210 ---PF 211
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-35
Identities = 57/247 (23%), Positives = 101/247 (40%), Gaps = 48/247 (19%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEID 140
+ + Y I ++G G F V +C + A K ++ RE E+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFL-RKNSYRSFPIDLVRE 198
+L+++ H++ + + + ++ R + ++ E + G L+DFL +K S +
Sbjct: 68 ILRQVLHHNV-----ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATS 119
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
+Q+L+ V ++H ++ H DLKPENI+L+
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKN-----------------------IPIP 156
Query: 259 AIKLIDFG-STTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL-VELCSVS 315
IKLIDFG + E + T + APE++ D+WS+G I + L S
Sbjct: 157 HIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS 216
Query: 316 NCYLTPF 322
PF
Sbjct: 217 -----PF 218
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-34
Identities = 55/246 (22%), Positives = 98/246 (39%), Gaps = 46/246 (18%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-------SINKYREAAMIEID 140
+ + Y I ++G G F V +C + A K ++ RE E+
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
+L+++ +I + + + ++ R + ++ E + G L+DFL + +
Sbjct: 68 ILRQVLHPNI-----ITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSF 120
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
+Q+L+ V ++H ++ H DLKPENI+L+
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIMLLDKN-----------------------IPIPH 157
Query: 260 IKLIDFG-STTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL-VELCSVSN 316
IKLIDFG + E + T + APE++ D+WS+G I + L S
Sbjct: 158 IKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS- 216
Query: 317 CYLTPF 322
PF
Sbjct: 217 ----PF 218
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 52/229 (22%), Positives = 96/229 (41%), Gaps = 38/229 (16%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI-EIDVLQ 143
T Y++ ++G+G F V C + A I+ + ++ + E + +
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICR 65
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
L +I V++ + H ++F+ + G L++ + Y + +Q
Sbjct: 66 LLKHPNI-----VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHCIQQ 118
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+LE+V H++ ++H +LKPEN+LL S K +A+KL
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKL------------------------KGAAVKL 154
Query: 263 IDFG-STTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
DFG + E + ++ T Y +PEV+ + P DLW+ G IL
Sbjct: 155 ADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 66/238 (27%), Positives = 99/238 (41%), Gaps = 50/238 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA-------AMIEIDVLQRL 145
RY ++++G G +G V + D VA+K VR + + E+ +L+RL
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR-VPNGGGGGGGLPISTVREVALLRRL 68
Query: 146 --ARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
H + V + D + +VFE + L +L K P + +++L RQ
Sbjct: 69 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
L + F+H ++H DLKPENIL+ + G +KL
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILV-----------------TSGG----------TVKL 161
Query: 263 IDFG-------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
DFG VV T YRAPEV+L + P D+WSVGCI E+
Sbjct: 162 ADFGLARIYSYQMALTPV----VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-34
Identities = 69/269 (25%), Positives = 115/269 (42%), Gaps = 61/269 (22%)
Query: 66 PRTGSPPWRPDDKDGHYVFAI--------GENLTPRYRILSKMGEGTFGQVVECFDNEKK 117
P DKDG V + Y +G G+FG V + +
Sbjct: 20 PSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSG 79
Query: 118 ELVAIKIVRSINKY--REAAMIEIDVLQRLARHDIGGTRCVQIRNWF------DYRNHIC 169
ELVAIK V ++ RE + ++++L H V++R +F ++
Sbjct: 80 ELVAIKKVLQDKRFKNRE-----LQIMRKL-DHC----NIVRLRYFFYSSGEKKDEVYLN 129
Query: 170 IVFEKLGPSLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227
+V + + ++Y R + ++ P+ V+ QL S+A++H + H D+KP+N+LL
Sbjct: 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 189
Query: 228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-TFEHQDH--SYVVSTRHY 284
+ P ++ +KL DFGS + SY+ +R+Y
Sbjct: 190 -------------------------D-PDTAVLKLCDFGSAKQLVRGEPNVSYIC-SRYY 222
Query: 285 RAPEVILGLGWNY--PCDLWSVGCILVEL 311
RAPE+I G +Y D+WS GC+L EL
Sbjct: 223 RAPELIFGAT-DYTSSIDVWSAGCVLAEL 250
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 62/240 (25%), Positives = 98/240 (40%), Gaps = 41/240 (17%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLA 146
+++ Y I ++G G FG V + A K V + ++ +E EI + L
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL- 211
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
RH V + + F+ N + +++E + G L++ + D E RQ+ +
Sbjct: 212 RHP----TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCK 266
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ MHE +H DLKPENI+ + +S+ +KLIDF
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTT-------------------------KRSNELKLIDF 301
Query: 266 GSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL-VELCSVSNCYLTPF 322
G T S T + APEV G Y D+WSVG + + L +S PF
Sbjct: 302 GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS-----PF 356
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 52/228 (22%), Positives = 92/228 (40%), Gaps = 42/228 (18%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR----EAAMIEIDVLQ 143
++ Y + + +G G++G+V + A K I KY + EI++++
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKK---IPKYFVEDVDRFKQEIEIMK 61
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
L +I +++ F+ I +V E G L++ + F + +
Sbjct: 62 SLDHPNI-----IRLYETFEDNTDIYLVMELCTGGELFERVVHKRV--FRESDAARIMKD 114
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+L +VA+ H+L + H DLKPEN L ++ S +KL
Sbjct: 115 VLSAVAYCHKLNVAHRDLKPENFLFLTDS------------------------PDSPLKL 150
Query: 263 IDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
IDFG V T +Y +P+V+ G + CD WS G ++
Sbjct: 151 IDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMM 197
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 52/255 (20%), Positives = 86/255 (33%), Gaps = 63/255 (24%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY-REAAMIEIDVLQRLARHD-I 150
Y + K+GEG F V A+K + + RE A E D+ + H I
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNI 88
Query: 151 GGTRCVQIRNWF----DYRNHICIVFE--KLGPSLYDFL--RKNSYRSFPIDLVRELGRQ 202
+++ + ++ ++ K G +L++ + K+ D + L
Sbjct: 89 -----LRLVAYCLRERGAKHEAWLLLPFFKRG-TLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+ + +H H DLKP NILL +G L
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILL-----------------GDEGQP----------VL 175
Query: 263 IDFGSTTFEH------------QDHSYVVSTRHYRAPEVI---LGLGWNYPCDLWSVGCI 307
+D GS QD + T YRAPE+ + D+WS+GC+
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235
Query: 308 LVELCSVSNCYLTPF 322
L + P+
Sbjct: 236 LYAMM----FGEGPY 246
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-34
Identities = 64/230 (27%), Positives = 97/230 (42%), Gaps = 46/230 (20%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHD-IGGTRCVQI 158
GEG+F +C + + A+KI I+K EA EI L+ H I V++
Sbjct: 20 GEGSFSICRKCVHKKSNQAFAVKI---ISKRMEANTQKEITALKLCEGHPNI-----VKL 71
Query: 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIH 217
F + H +V E L G L++ R + F + R+L+ +V+ MH++ ++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFE--RIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVH 129
Query: 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQDHS 276
DLKPEN+L + IK+IDFG + +
Sbjct: 130 RDLKPENLLFTDEN------------------------DNLEIKIIDFGFARLKPPDNQP 165
Query: 277 Y--VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL-VELCSVSNCYLTPFA 323
T HY APE++ G++ CDLWS+G IL L PF
Sbjct: 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ-----VPFQ 210
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-34
Identities = 57/244 (23%), Positives = 103/244 (42%), Gaps = 47/244 (19%)
Query: 88 ENLTPRYRILSKM-GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA 146
+T Y++ ++ G G G+V+ECF + A+K+ + A E+D + +
Sbjct: 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL---LYD-SPKARQEVDHHWQAS 79
Query: 147 RHD-IGGTRCVQIRNWFD----YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELG 200
I V I + ++ + + I+ E + G L+ +++ ++F E+
Sbjct: 80 GGPHI-----VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 134
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
R + ++ F+H + H D+KPEN+L S E K + +
Sbjct: 135 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKE------------------------KDAVL 170
Query: 261 KLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL-VELCSVSNCY 318
KL DFG + T +Y APEV+ ++ CD+WS+G I+ + LC
Sbjct: 171 KLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF---- 226
Query: 319 LTPF 322
PF
Sbjct: 227 -PPF 229
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 6e-34
Identities = 50/242 (20%), Positives = 96/242 (39%), Gaps = 44/242 (18%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLA 146
++L +G G+ G VV + + VA+K + + + A++EI +L
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKR---MLIDFCDIALMEIKLLTESD 66
Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELG----- 200
H + ++ + I E +L D + + + L +E
Sbjct: 67 DHPNV-----IRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
RQ+ VA +H L++IH DLKP+NIL+ + SS+ + + ++ I
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVST--------------SSRFTADQQTGAENLRI 167
Query: 261 KLIDFG-STTFEHQDHSYVVSTRH------YRAPEVILGLGW-------NYPCDLWSVGC 306
+ DFG + S+ + + +RAPE++ D++S+GC
Sbjct: 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGC 227
Query: 307 IL 308
+
Sbjct: 228 VF 229
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 7e-34
Identities = 57/286 (19%), Positives = 102/286 (35%), Gaps = 84/286 (29%)
Query: 77 DKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR------SINK 130
++ ++ L +Y + +G+G++G V +N+ + + AIKI+ K
Sbjct: 11 RENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPK 70
Query: 131 YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYR 189
E E+ ++++L +I ++ ++ +IC+V E G L D L
Sbjct: 71 DVERIKTEVRLMKKLHHPNI-----ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 190 --------------------------------------SFPIDLVRELGRQLLESVAFMH 211
L+ + RQ+ ++ ++H
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-STTF 270
+ H D+KPEN L + KS IKL+DFG S F
Sbjct: 186 NQGICHRDIKPENFLFST-------------------------NKSFEIKLVDFGLSKEF 220
Query: 271 EHQDHSY------VVSTRHYRAPEVILGLGWNY--PCDLWSVGCIL 308
++ T ++ APEV+ +Y CD WS G +L
Sbjct: 221 YKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-33
Identities = 52/230 (22%), Positives = 94/230 (40%), Gaps = 43/230 (18%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR------EAAMIEIDV 141
+ Y + ++G+G F V C A KI IN + + E +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI---INTKKLSARDFQKLEREARI 58
Query: 142 LQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELG 200
++L +I V++ + + +VF+ + G L++ + + +
Sbjct: 59 CRKLQHPNI-----VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCI 111
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
+Q+LES+A+ H ++H +LKPEN+LL S K +A+
Sbjct: 112 QQILESIAYCHSNGIVHRNLKPENLLLASKA------------------------KGAAV 147
Query: 261 KLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
KL DFG + ++ T Y +PEV+ ++ P D+W+ G IL
Sbjct: 148 KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 4e-33
Identities = 66/266 (24%), Positives = 96/266 (36%), Gaps = 60/266 (22%)
Query: 83 VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDV 141
+GE R R+ + EG F V E D A+K + S + A + E+
Sbjct: 22 TVELGEL---RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCF 78
Query: 142 LQRLARHD----IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYR-SFPIDLV 196
+++L+ H + + ++ E L +FL+K R D V
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV 138
Query: 197 RELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
++ Q +V MH + +IH DLK EN+LL S G+
Sbjct: 139 LKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL-----------------SNQGTI---- 177
Query: 255 PKSSAIKLIDFGSTTFEHQDHSYVVS-----------TRH----YRAPEVI---LGLGWN 296
KL DFGS T Y S TR+ YR PE+I
Sbjct: 178 ------KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG 231
Query: 297 YPCDLWSVGCILVELCSVSNCYLTPF 322
D+W++GCIL LC PF
Sbjct: 232 EKQDIWALGCILYLLC----FRQHPF 253
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-33
Identities = 63/288 (21%), Positives = 114/288 (39%), Gaps = 53/288 (18%)
Query: 29 PPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGE 88
P P P P P P F ++G + D + V +
Sbjct: 11 PVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVT--SQ 68
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148
L G G G+V++ F+ +E A+K+++ K R E+++ R ++
Sbjct: 69 VL----------GLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQC 114
Query: 149 D-IGGTRCVQIRNWFD----YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
I V+I + ++ R + IV E L G L+ ++ ++F E+ +
Sbjct: 115 PHI-----VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 169
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+ E++ ++H + + H D+KPEN+L S ++ +KL
Sbjct: 170 IGEAIQYLHSINIAHRDVKPENLLYTSKR------------------------PNAILKL 205
Query: 263 IDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
DFG +S T +Y APEV+ ++ CD+WS+G I+
Sbjct: 206 TDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-33
Identities = 47/236 (19%), Positives = 82/236 (34%), Gaps = 46/236 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHD- 149
+ + +G+G V + +L AIK+ S + + M E +VL++L H
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKN 68
Query: 150 IGGTRCVQIRNWFDYRN--HICIVFEKL-GPSLYDFLRKN-SYRSFPIDLVRELGRQLLE 205
I V++ + H ++ E SLY L + + P + R ++
Sbjct: 69 I-----VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ + E ++H ++KP NI+ V E S KL DF
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGE-----------------------DGQSVYKLTDF 160
Query: 266 G-STTFEHQDHSY-VVSTRHYRAPEVILGLGWNYP--------CDLWSVGCILVEL 311
G + E + + T Y P++ DLWS+G
Sbjct: 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-33
Identities = 55/234 (23%), Positives = 91/234 (38%), Gaps = 29/234 (12%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD- 149
+ + +G G FG V E + AIK +R + RE M E+ L +L H
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPG 64
Query: 150 -------IGGTRCVQIRNWFDYRNHICIVFEKL--GPSLYDFLRKNSYRSFP-IDLVREL 199
+ + ++ I + L +L D++ + +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQ-LCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSS 258
Q+ E+V F+H L+H DLKP NI + VKV D F L + + +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD--FGLVTAMDQDEEEQTVLTPM 181
Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
+ H+ V T+ Y +PE I G +++ D++S+G IL EL
Sbjct: 182 P-----------AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 8e-33
Identities = 47/236 (19%), Positives = 82/236 (34%), Gaps = 46/236 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHD- 149
+ + +G+G V + +L AIK+ S + + M E +VL++L H
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKN 68
Query: 150 IGGTRCVQIRNWFDYRN--HICIVFEKL-GPSLYDFLRKN-SYRSFPIDLVRELGRQLLE 205
I V++ + H ++ E SLY L + + P + R ++
Sbjct: 69 I-----VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG 123
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ + E ++H ++KP NI+ V E S KL DF
Sbjct: 124 GMNHLRENGIVHRNIKPGNIMRVIGE-----------------------DGQSVYKLTDF 160
Query: 266 G-STTFEHQDHSY-VVSTRHYRAPEVILGLGWNYP--------CDLWSVGCILVEL 311
G + E + + T Y P++ DLWS+G
Sbjct: 161 GAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-32
Identities = 50/252 (19%), Positives = 88/252 (34%), Gaps = 43/252 (17%)
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN 129
SP DD D I + + +G G G +V VA+K + +
Sbjct: 4 SPSLEQDDGDEETSVVIVGKI--SFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRI--LP 58
Query: 130 KYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSY 188
+ A E+ +L+ H ++ ++ R I E +L +++ + +
Sbjct: 59 ECFSFADREVQLLRESDEHPNV-----IRYFCTEKDRQFQYIAIELCAATLQEYVEQKDF 113
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
++ L +Q +A +H L ++H DLKP NIL+
Sbjct: 114 AHLGLE-PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISM------------------- 153
Query: 249 SYFKNLPKSSAIKLIDFG-STTFEHQDHSY-----VVSTRHYRAPEVILGL---GWNYPC 299
N + DFG HS+ V T + APE++ Y
Sbjct: 154 ---PNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTV 210
Query: 300 DLWSVGCILVEL 311
D++S GC+ +
Sbjct: 211 DIFSAGCVFYYV 222
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 70/260 (26%), Positives = 108/260 (41%), Gaps = 43/260 (16%)
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSK--MGEGTFGQVVECFDNEKKELVAIKIVR- 126
P P D V A + Y + +G G FGQV +C + +A KI++
Sbjct: 65 DIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT 124
Query: 127 SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK 185
K +E EI V+ +L H +Q+ + F+ +N I +V E + G L+D +
Sbjct: 125 RGMKDKEEVKNEISVMNQL-DHA----NLIQLYDAFESKNDIVLVMEYVDGGELFDRIID 179
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
SY + +Q+ E + MH++ ++H DLKPENIL V+
Sbjct: 180 ESY-NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN---------------- 222
Query: 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWS 303
+ IK+IDFG T + APEV+ ++P D+WS
Sbjct: 223 ---------RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWS 273
Query: 304 VGCIL-VELCSVSNCYLTPF 322
VG I + L +S PF
Sbjct: 274 VGVIAYMLLSGLS-----PF 288
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-32
Identities = 68/236 (28%), Positives = 103/236 (43%), Gaps = 48/236 (20%)
Query: 93 RYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSINKYRE----AAMIEIDVLQRL-- 145
+Y ++++GEG +G+V + D VA+K VR + E + + E+ VL+ L
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLET 70
Query: 146 ARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
H + V + D + +VFE + L +L K P + ++++ QLL
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 130
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+ F+H R++H DLKP+NIL+ + G IKL D
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILV-----------------TSSG----------QIKLAD 163
Query: 265 FG-------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
FG VV T YRAPEV+L + P DLWSVGCI E+
Sbjct: 164 FGLARIYSFQMALTSV----VV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 214
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-32
Identities = 50/230 (21%), Positives = 102/230 (44%), Gaps = 41/230 (17%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH 148
Y+++ K+G G + +V E + E V +KI++ + K + EI +L+ L
Sbjct: 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLRGG 90
Query: 149 D--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
I V+ +VFE + + DF K Y++ +R ++L++
Sbjct: 91 PNIITLADIVKDPVSRTP----ALVFEHVNNT--DF--KQLYQTLTDYDIRFYMYEILKA 142
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ + H + ++H D+KP N+++ + ++LID+G
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMID--------------------------HEHRKLRLIDWG 176
Query: 267 STTFEHQDHSYV--VSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCS 313
F H Y V++R+++ PE+++ ++Y D+WS+GC+L +
Sbjct: 177 LAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 226
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 52/228 (22%), Positives = 83/228 (36%), Gaps = 46/228 (20%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
++G G+FG+V D + A+K VR + E+ L
Sbjct: 59 WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR----LEVFRVEELVACAGL-SSP--- 110
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
R V + + I E L G SL +++ P D Q LE + ++H
Sbjct: 111 -RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLH 167
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG----- 266
R++H D+K +N+LL S DGS L DFG
Sbjct: 168 TRRILHGDVKADNVLL-----------------SSDGS---------RAALCDFGHALCL 201
Query: 267 ---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
Y+ T + APEV++G + D+WS C+++ +
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHM 249
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-32
Identities = 65/231 (28%), Positives = 106/231 (45%), Gaps = 46/231 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+Y L K+GEGT+G V + + E E+VA+K VR ++ E +A+ EI +L+ L +H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKEL-KH 60
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V++ + + +VFE L + + ++V+ QLL+ +
Sbjct: 61 KNI-----VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGL 114
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
F H ++H DLKP+N+L+ +++G +KL +FG
Sbjct: 115 GFCHSRNVLHRDLKPQNLLI-----------------NRNGE----------LKLANFGL 147
Query: 267 STTFEHQDHSY--VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCS 313
+ F Y V T YR P+V+ G Y D+WS GCI EL +
Sbjct: 148 ARAFGIPVRCYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELAN 197
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-32
Identities = 61/231 (26%), Positives = 110/231 (47%), Gaps = 42/231 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
RYR ++K+GEGT+G+V + D E VAIK +R + E A+ E+ +L+ L +H
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-LEHEEEGVPGTAIREVSLLKEL-QH 92
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I +++++ + + + ++FE L ++ + + +++ QL+ V
Sbjct: 93 RNI-----IELKSVIHHNHRLHLIFEYAENDLKKYM--DKNPDVSMRVIKSFLYQLINGV 145
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
F H R +H DLKP+N+LL S +S+ +K+ DFG
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSV------------SDASETP----------VLKIGDFGL 183
Query: 267 --STTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCS 313
+ + ++ + T YR PE++LG +Y D+WS+ CI E+
Sbjct: 184 ARAFGIPIRQFTHEIITLWYRPPEILLG-SRHYSTSVDIWSIACIWAEMLM 233
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-32
Identities = 67/241 (27%), Positives = 110/241 (45%), Gaps = 54/241 (22%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEIDVLQR 144
GE Y +G G+FG V + E E VAIK V ++ RE + +++
Sbjct: 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE-----LQIMRI 88
Query: 145 LARHDIGGTRCVQIRNWF------DYRNHICIVFEKLGPSLYDFLR--KNSYRSFPIDLV 196
+ +H V ++ +F + +V E + ++Y R ++ P+ L+
Sbjct: 89 V-KHP----NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLI 143
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
+ QLL S+A++H + + H D+KP+N+LL + P
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLL-------------------------D-PP 177
Query: 257 SSAIKLIDFGS--TTFEHQDH-SYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVEL 311
S +KLIDFGS + + SY+ +R+YRAPE+I G NY D+WS GC++ EL
Sbjct: 178 SGVLKLIDFGSAKILIAGEPNVSYIC-SRYYRAPELIFG-ATNYTTNIDIWSTGCVMAEL 235
Query: 312 C 312
Sbjct: 236 M 236
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 9e-32
Identities = 52/227 (22%), Positives = 86/227 (37%), Gaps = 33/227 (14%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD- 149
+ + ++G G FG V+ + E VAIK R K RE +EI ++++L H
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPN 73
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRS-FPIDLVRELGRQLLES 206
+ + + E G L +L + +R L + +
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++HE R+IH DLKPENI+L + K+ID G
Sbjct: 134 LRYLHENRIIHRDLKPENIVLQPGP------------------------QRLIHKIIDLG 169
Query: 267 -STTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ + + + V T Y APE++ + D WS G + E
Sbjct: 170 YAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFEC 216
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 70/242 (28%), Positives = 110/242 (45%), Gaps = 50/242 (20%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMI-----E 138
+ L Y + +G G G+V F+ + + VAIKI+ +I REA E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 139 IDVLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLV 196
I++L++L H I ++I+N+FD ++ IV E + G L+D + N
Sbjct: 66 IEILKKL-NHPCI-----IKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKR--LKEATC 116
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
+ Q+L +V ++HE +IH DLKPEN+LL S E +
Sbjct: 117 KLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------------------------E 152
Query: 257 SSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGL---GWNYPCDLWSVGCIL-VE 310
IK+ DFG + + + T Y APEV++ + G+N D WS+G IL +
Sbjct: 153 DCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFIC 212
Query: 311 LC 312
L
Sbjct: 213 LS 214
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 71/263 (26%), Positives = 107/263 (40%), Gaps = 22/263 (8%)
Query: 66 PRTGSPPWRPDDKDGHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAI 122
+ G + + RY I +G G++G V E +D +K +VAI
Sbjct: 24 QQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAI 83
Query: 123 K-IVRSINKYREAAMI--EIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPS 178
K I+R + I EI +L RL HD + + I + + + +V E
Sbjct: 84 KKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIADSD 142
Query: 179 LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
R ++ L LL V ++H ++H DLKP N L+ VKV D
Sbjct: 143 FKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCD- 199
Query: 239 KF-LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHS-----YVVSTRHYRAPEVILG 292
F L+R+ + S + T ++ +VV TR YRAPE+IL
Sbjct: 200 -FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVV-TRWYRAPELILL 257
Query: 293 LGWNY--PCDLWSVGCILVELCS 313
NY D+WS+GCI EL +
Sbjct: 258 QE-NYTEAIDVWSIGCIFAELLN 279
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 117 bits (297), Expect = 2e-31
Identities = 66/232 (28%), Positives = 106/232 (45%), Gaps = 49/232 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+Y L K+GEGT+G V + +N E A+K +R + K E + EI +L+ L +H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIR-LEKEDEGIPSTTIREISILKEL-KH 59
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V++ + + + +VFE L L L + QLL +
Sbjct: 60 SNI-----VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGI 113
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
A+ H+ R++H DLKP+N+L+ +++G +K+ DFG
Sbjct: 114 AYCHDRRVLHRDLKPQNLLI-----------------NREG----------ELKIADFGL 146
Query: 267 STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCS 313
+ F Y +V T YRAP+V++G Y D+WSVGCI E+ +
Sbjct: 147 ARAFGIPVRKYTHEIV-TLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVN 196
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 65/318 (20%), Positives = 110/318 (34%), Gaps = 66/318 (20%)
Query: 10 PHKNMDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTG 69
+++ R++ R P + N P + F P
Sbjct: 25 EIRHLPNLNREQRRAFIRSLRDDPSQSANLLA--EAKKLNDAQPKGTENLYFQSMGPEDE 82
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV---- 125
P W + +Y +G G V C A+KI+
Sbjct: 83 LPDWAA-----------AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTA 131
Query: 126 -----RSINKYREAAMIEIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPS 178
+ + REA E +L+++A H I + + + ++ + + +VF+ +
Sbjct: 132 ERLSPEQLEEVREATRRETHILRQVAGHPHI-----ITLIDSYESSSFMFLVFDLMRKGE 186
Query: 179 LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
L+D+L + R + R LLE+V+F+H ++H DLKPENILL
Sbjct: 187 LFDYLTEKVA--LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD--------- 235
Query: 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGL--- 293
+ I+L DFG + + T Y APE++
Sbjct: 236 ------------------NMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDE 277
Query: 294 ---GWNYPCDLWSVGCIL 308
G+ DLW+ G IL
Sbjct: 278 THPGYGKEVDLWACGVIL 295
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-31
Identities = 54/239 (22%), Positives = 93/239 (38%), Gaps = 50/239 (20%)
Query: 89 NLTPRYRILSKM-GEGTFGQVVECFDNEKKELVAIKIV-RSINKYREAAMIEIDVLQRLA 146
Y++ + GEG +V C + + A+KI+ + R E+++L +
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68
Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
H + +++ +F+ + +VFEK+ G S+ + K R F + + +
Sbjct: 69 GHRNV-----LELIEFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVA 121
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
++ F+H + H DLKPENIL + S +K+ D
Sbjct: 122 SALDFLHNKGIAHRDLKPENILCEHPN------------------------QVSPVKICD 157
Query: 265 FG-STTFEHQDHSYVVSTR---------HYRAPEVILGLGW---NY--PCDLWSVGCIL 308
F + + +ST Y APEV+ Y CDLWS+G IL
Sbjct: 158 FDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-31
Identities = 60/235 (25%), Positives = 96/235 (40%), Gaps = 48/235 (20%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI-----EID 140
E L +Y++ +G G FG V VAIK V I+ + E E+
Sbjct: 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 98
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS--LYDFLRKNSYRSFPIDLVRE 198
+L+++ G +++ +WF+ + ++ E+ P L+DF+ + + +L R
Sbjct: 99 LLKKV-SSGFSG--VIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARS 153
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
Q+LE+V H ++H D+K ENIL+ D
Sbjct: 154 FFWQVLEAVRHCHNCGVLHRDIKDENILI---------DLNRGE---------------- 188
Query: 259 AIKLIDFGSTTFEHQDHSYVVS--TRHYRAPEVILGLGWNY---PCDLWSVGCIL 308
+KLIDFGS +D Y TR Y PE I Y +WS+G +L
Sbjct: 189 -LKLIDFGSGAL-LKDTVYTDFDGTRVYSPPEWIRYHR--YHGRSAAVWSLGILL 239
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 8e-31
Identities = 66/234 (28%), Positives = 109/234 (46%), Gaps = 49/234 (20%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA------AMIEIDVLQRLA 146
RY L +GEG F V + D ++VAIK ++ ++ A+ EI +LQ L
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL- 69
Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
H I + + + F ++++I +VF+ + L ++ NS ++ L+
Sbjct: 70 SHPNI-----IGLLDAFGHKSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQ 123
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ ++H+ ++H DLKP N+LL ++G +KL DF
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLL-----------------DENG----------VLKLADF 156
Query: 266 G-STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCS 313
G + +F + +Y VV TR YRAPE++ G Y D+W+VGCIL EL
Sbjct: 157 GLAKSFGSPNRAYTHQVV-TRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLL 208
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-31
Identities = 52/247 (21%), Positives = 94/247 (38%), Gaps = 54/247 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
Y +L +G G++G+ + +++ K + + ++ + E+++L+ L +H
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHP 65
Query: 150 -IGGTRCVQIRNWFDYR--NHICIVFEKL-GPSLYDFLR--KNSYRSFPIDLVRELGRQL 203
I V+ + R + IV E G L + + + V + QL
Sbjct: 66 NI-----VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 204 LESVAFMHELRL-----IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
++ H +H DLKP N+ L +
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFL-----------------DGKQN--------- 154
Query: 259 AIKLIDFG-STTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVS 315
+KL DFG + H V T +Y +PE + + +N D+WS+GC+L ELC
Sbjct: 155 -VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELC--- 210
Query: 316 NCYLTPF 322
+ PF
Sbjct: 211 -ALMPPF 216
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-31
Identities = 70/232 (30%), Positives = 110/232 (47%), Gaps = 49/232 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+Y+ L K+GEGT+G V + D+ + +VA+K +R ++ E A+ EI +L+ L H
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIR-LDAEDEGIPSTAIREISLLKEL-HH 78
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V + + + +VFE + L L +N ++ QLL V
Sbjct: 79 PNI-----VSLIDVIHSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGV 132
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
A H+ R++H DLKP+N+L+ + DG+ +KL DFG
Sbjct: 133 AHCHQHRILHRDLKPQNLLI-----------------NSDGA----------LKLADFGL 165
Query: 267 STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCS 313
+ F SY VV T YRAP+V++G Y D+WS+GCI E+ +
Sbjct: 166 ARAFGIPVRSYTHEVV-TLWYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMIT 215
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-30
Identities = 66/241 (27%), Positives = 106/241 (43%), Gaps = 48/241 (19%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV-------RSINKYREAAMI--E 138
+ L Y + +G G G+V F+ + + VAI+I+ S + A + E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 139 IDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVR 197
I++L++L H ++I+N+FD IV E + G L+D + N +
Sbjct: 191 IEILKKL-NHP----CIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKR--LKEATCK 242
Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
Q+L +V ++HE +IH DLKPEN+LL S E +
Sbjct: 243 LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------------------------ED 278
Query: 258 SAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGL---GWNYPCDLWSVGCIL-VEL 311
IK+ DFG + + + T Y APEV++ + G+N D WS+G IL + L
Sbjct: 279 CLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 338
Query: 312 C 312
Sbjct: 339 S 339
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-30
Identities = 64/262 (24%), Positives = 105/262 (40%), Gaps = 65/262 (24%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--RE------------ 133
E + +Y + +G G+FG V E FD E + A+K V +Y RE
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNI 62
Query: 134 ----------------AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGP 177
D + +++ + ++ ++ E +
Sbjct: 63 IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122
Query: 178 SLYDFLR--KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
+L+ L+ S RS P++L+ QL +V F+H L + H D+KP+N+L+
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV-------- 174
Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS--TTFEHQDH-SYVVSTRHYRAPEVILG 292
N K + +KL DFGS + +Y+ +R YRAPE++LG
Sbjct: 175 -----------------N-SKDNTLKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPELMLG 215
Query: 293 LGWNYPC--DLWSVGCILVELC 312
Y DLWS+GC+ EL
Sbjct: 216 -ATEYTPSIDLWSIGCVFGELI 236
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 58/241 (24%), Positives = 95/241 (39%), Gaps = 54/241 (22%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV----------RSINKYREAAMI 137
Y +G G V C + A+KI+ + + REA +
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 138 EIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDL 195
E+D+L++++ H I +Q+++ ++ +VF+ + L+D+L +
Sbjct: 73 EVDILRKVSGHPNI-----IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKE 125
Query: 196 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255
R++ R LLE + +H+L ++H DLKPENILL
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENILLDD-------------------------- 159
Query: 256 KSSAIKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGL------GWNYPCDLWSVGCI 307
IKL DFG + V T Y APE+I G+ D+WS G I
Sbjct: 160 -DMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
Query: 308 L 308
+
Sbjct: 219 M 219
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-30
Identities = 67/236 (28%), Positives = 116/236 (49%), Gaps = 52/236 (22%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
+++ L K+G GT+ V + + VA+K V+ ++ E A+ EI +++ L +H
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKEL-KH 62
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLR----KNSYRSFPIDLVRELGRQL 203
+ I V++ + N + +VFE + L ++ N+ R ++LV+ QL
Sbjct: 63 ENI-----VRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
L+ +AF HE +++H DLKP+N+L+ +K G +KL
Sbjct: 118 LQGLAFCHENKILHRDLKPQNLLI-----------------NKRGQ----------LKLG 150
Query: 264 DFG-STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCS 313
DFG + F +++ VV T YRAP+V++G Y D+WS GCIL E+ +
Sbjct: 151 DFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMG-SRTYSTSIDIWSCGCILAEMIT 204
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-30
Identities = 63/232 (27%), Positives = 103/232 (44%), Gaps = 49/232 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYRE----AAMIEIDVLQRLARH 148
Y L K+GEGT+ V + LVA+K +R ++ E A+ E+ +L+ L +H
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDL-KH 59
Query: 149 D-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V + + + +VFE L L +L + + V+ QLL +
Sbjct: 60 ANI-----VTLHDIIHTEKSLTLVFEYLDKDLKQYL-DDCGNIINMHNVKLFLFQLLRGL 113
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
A+ H +++H DLKP+N+L+ ++ G +KL DFG
Sbjct: 114 AYCHRQKVLHRDLKPQNLLI-----------------NERG----------ELKLADFGL 146
Query: 267 STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCS 313
+ +Y VV T YR P+++LG +Y D+W VGCI E+ +
Sbjct: 147 ARAKSIPTKTYDNEVV-TLWYRPPDILLG-STDYSTQIDMWGVGCIFYEMAT 196
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-30
Identities = 51/221 (23%), Positives = 94/221 (42%), Gaps = 41/221 (18%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIR 159
G+GT+G V D + +AIK + + Y + EI + + L +H VQ
Sbjct: 31 GKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHK----NIVQYL 85
Query: 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPID--LVRELGRQLLESVAFMHELRLI 216
F I I E++ G SL L ++ + + + +Q+LE + ++H+ +++
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALL-RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 217 HTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS---TTFEHQ 273
H D+K +N+L+ ++ G +K+ DFG+ +
Sbjct: 145 HRDIKGDNVLI----------------NTYSGV----------LKISDFGTSKRLAGINP 178
Query: 274 DHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELC 312
T Y APE+I G+ D+WS+GC ++E+
Sbjct: 179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMA 219
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-29
Identities = 57/253 (22%), Positives = 95/253 (37%), Gaps = 46/253 (18%)
Query: 70 SPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RS 127
PP P E YR+ +G+G FG V + VAIK++
Sbjct: 9 GPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNR 68
Query: 128 INKYREAAMI-----EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPS--LY 180
+ + + E+ +L ++ G +++ +WF+ + +V E+ P+ L+
Sbjct: 69 VLGWSPLSDSVTCPLEVALLWKV-GAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLF 127
Query: 181 DFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240
D++ + R Q++ ++ H ++H D+K ENIL+
Sbjct: 128 DYITEKGP--LGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILI------------- 172
Query: 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVS--TRHYRAPEVILGLGWNY- 297
+ G KLIDFGS D Y TR Y PE I Y
Sbjct: 173 ---DLRRGC----------AKLIDFGSGAL-LHDEPYTDFDGTRVYSPPEWISRHQ--YH 216
Query: 298 --PCDLWSVGCIL 308
P +WS+G +L
Sbjct: 217 ALPATVWSLGILL 229
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 63/247 (25%), Positives = 103/247 (41%), Gaps = 53/247 (21%)
Query: 83 VFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEID 140
R+++ G+GTFG V + VAIK V ++ RE ++I
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE---LQIM 70
Query: 141 VLQRLARHDIGGTRCVQIRNWF-----DYRNHIC--IVFEKLGPSLYDFLRKNSYR--SF 191
+ H VQ++++F R I +V E + +L+ R R +
Sbjct: 71 QDLAVLHHP----NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAP 126
Query: 192 PIDLVRELGRQLLESVAFMHE--LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
P L++ QL+ S+ +H + + H D+KP N+L+
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV---------------------- 164
Query: 250 YFKNLPKSSAIKLIDFGS--TTFEHQDH-SYVVSTRHYRAPEVILGLGWNYPC--DLWSV 304
N +KL DFGS + + +Y+ +R+YRAPE+I G +Y D+WSV
Sbjct: 165 ---N-EADGTLKLCDFGSAKKLSPSEPNVAYIC-SRYYRAPELIFGNQ-HYTTAVDIWSV 218
Query: 305 GCILVEL 311
GCI E+
Sbjct: 219 GCIFAEM 225
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-28
Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 44/228 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
RY +G+G F + E D + KE+ A KIV + K + + EI + + L H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AH 74
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+ V +F+ + + +V E SL + ++ ++ R RQ++
Sbjct: 75 QHV-----VGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLG 127
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
++H R+IH DLK N+ L ++D +K+ DFG
Sbjct: 128 CQYLHRNRVIHRDLKLGNLFL-----------------NEDLE----------VKIGDFG 160
Query: 267 -STTFEHQDHSYVVS--TRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+T E+ V T +Y APEV+ G ++ D+WS+GCI+ L
Sbjct: 161 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 208
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 29/251 (11%), Positives = 62/251 (24%), Gaps = 59/251 (23%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--------INKYREAAMIEIDVLQR 144
+ +++ + G V D E+ E A+K+ + + EA +L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 145 LARHDIGGTRCVQIRNWFDYRNH-----------------ICIVFEKLGPSLYDFLRKNS 187
R + + ++ ++ L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 188 YRS-----FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242
+ I + L QL+ A + L+H P+N+ +
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI--------------- 227
Query: 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCD 300
DG + L D + Y E + + +
Sbjct: 228 --MPDGR----------LMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALN 275
Query: 301 LWSVGCILVEL 311
W +G + +
Sbjct: 276 AWQLGLSIYRV 286
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 67/229 (29%), Positives = 102/229 (44%), Gaps = 12/229 (5%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMI--EIDVLQRL 145
++ Y I +G G++G V +D ++ VAIK + R + I EI +L RL
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL 82
Query: 146 ARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+ D I + I + + + IV E L + + + + ++ + LL
Sbjct: 83 -KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLT--EEHIKTILYNLL 139
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLI 263
F+HE +IH DLKP N LL VKV D F L+R+ + +
Sbjct: 140 LGENFIHESGIIHRDLKPANCLLNQDCSVKVCD--FGLARTINSEKDTNIVNDLEENEEP 197
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVEL 311
+ + Q S+VV TR YRAPE+IL + D+WS GCI EL
Sbjct: 198 GPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 69/292 (23%), Positives = 111/292 (38%), Gaps = 68/292 (23%)
Query: 29 PPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPWRPDDKDGHYVFAIGE 88
P P P K G+P A A P P D +
Sbjct: 2 PAPADPGK-------------AGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRR------- 41
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQR 144
RY +G+G F + E D + KE+ A KIV + K + + EI + +
Sbjct: 42 ----RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS 97
Query: 145 LARH-DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQ 202
L H + V +F+ + + +V E SL + ++ ++ R RQ
Sbjct: 98 L-AHQHV-----VGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQ 149
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
++ ++H R+IH DLK N+ L ++D +K+
Sbjct: 150 IVLGCQYLHRNRVIHRDLKLGNLFL-----------------NEDLE----------VKI 182
Query: 263 IDFG-STTFEHQDHSYVVS--TRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
DFG +T E+ V T +Y APEV+ G ++ D+WS+GCI+ L
Sbjct: 183 GDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTL 234
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-28
Identities = 64/239 (26%), Positives = 110/239 (46%), Gaps = 50/239 (20%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA----AMIEIDVLQRLARH 148
+Y L+K+G+GTFG+V + + + VA+K V + +E A+ EI +LQ L +H
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLL-KH 75
Query: 149 D-IGGTRCV---QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+ + + + + + I +VF+ L L N F + ++ + + LL
Sbjct: 76 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLL 134
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+ ++H +++H D+K N+L+ ++DG +KL D
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLI-----------------TRDGV----------LKLAD 167
Query: 265 FG-----STTFEHQDHSY---VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCS 313
FG S Q + Y VV T YR PE++LG +Y P DLW GCI+ E+ +
Sbjct: 168 FGLARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWT 224
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-28
Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 24/228 (10%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLA 146
N++ +++ S +GEG +G V E+VAIK + +K A EI +L+
Sbjct: 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF- 66
Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+H+ I +Q + F+ N + I+ E + L+ + D ++ Q L
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD---DHIQYFIYQTLR 123
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLID 264
+V +H +IH DLKP N+L+ S +KV D F L+R + + + P +++
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCD--FGLARIIDESAADNSEPTGQQSGMVE 181
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVEL 311
+V TR YRAPEV+L ++ D+WS GCIL EL
Sbjct: 182 ------------FVA-TRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-28
Identities = 53/250 (21%), Positives = 106/250 (42%), Gaps = 46/250 (18%)
Query: 74 RPDDKDGHYVFAIGENLTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--- 129
+ DD + A+G + R+ + ++G G+F V + D E VA ++
Sbjct: 7 QQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK 66
Query: 130 KYREAAMIEIDVLQRLARHDIGGTRCVQ-IRNWFDY---RNHICIVFEKL-GPSLYDFLR 184
R+ E ++L+ L +H V+ +W + I +V E + +L +L+
Sbjct: 67 SERQRFKEEAEMLKGL-QHP----NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK 121
Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMHE--LRLIHTDLKPENILLVSAEYVKVPDYKFLS 242
+ ++ I ++R RQ+L+ + F+H +IH DLK +NI +
Sbjct: 122 R--FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI--------------- 164
Query: 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDL 301
+ GS +K+ D G T + + V+ T + APE+ ++ D+
Sbjct: 165 -TGPTGS----------VKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDV 212
Query: 302 WSVGCILVEL 311
++ G ++E+
Sbjct: 213 YAFGMCMLEM 222
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-28
Identities = 50/228 (21%), Positives = 98/228 (42%), Gaps = 59/228 (25%)
Query: 88 ENLTPRYRILSKM-GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA 146
+ Y++ S++ G G G+V++ F+ +E A+K+++ K R E+++ R +
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRAS 68
Query: 147 RHD-IGGTRCVQIRNWFD----YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELG 200
+ I V+I + ++ R + IV E L G L+ ++ ++F E+
Sbjct: 69 QCPHI-----VRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123
Query: 201 RQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
+ + E++ ++H + + H D+KPEN+L S ++ +
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKR------------------------PNAIL 159
Query: 261 KLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
KL DFG A E G ++ CD+WS+G I+
Sbjct: 160 KLTDFG------------------FAKET-TGEKYDKSCDMWSLGVIM 188
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-28
Identities = 45/228 (19%), Positives = 97/228 (42%), Gaps = 43/228 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
+++ + +G+G+F V VAIK++ +++ K + E+ + +L +H
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KH 70
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
I +++ N+F+ N++ +V E + +L+ + F + R Q++
Sbjct: 71 PSI-----LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITG 124
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++H ++H DL N+LL +++ + IK+ DFG
Sbjct: 125 MLYLHSHGILHRDLTLSNLLL-----------------TRNMN----------IKIADFG 157
Query: 267 -STTFEHQDHSYVVS--TRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+T + + T +Y +PE+ D+WS+GC+ L
Sbjct: 158 LATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTL 205
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 62/234 (26%), Positives = 99/234 (42%), Gaps = 56/234 (23%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR--EAAMI----------EID 140
+Y +S +G G FG V D EK + V +K I K + E I EI
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKF---IKKEKVLEDCWIEDPKLGKVTLEIA 81
Query: 141 VLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEKLGPS--LYDFLRKNSYRSFPIDLVR 197
+L R+ H +I +++ + F+ + +V EK G L+ F+ ++ L
Sbjct: 82 ILSRV-EHANI-----IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLAS 133
Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
+ RQL+ +V ++ +IH D+K ENI++ F
Sbjct: 134 YIFRQLVSAVGYLRLKDIIHRDIKDENIVI---------AEDF----------------- 167
Query: 258 SAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCIL 308
IKLIDFGS + + T Y APEV++G + P ++WS+G L
Sbjct: 168 -TIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 69/231 (29%), Positives = 112/231 (48%), Gaps = 20/231 (8%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYREAAMI--EIDVLQRL 145
++ +Y ++ K+G+G +G V + D E+VA+K I + +A EI +L L
Sbjct: 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTEL 65
Query: 146 ARHD-IGGTRCVQIRNWF--DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
+ H+ I V + N D + +VF+ + L+ +R N + + Q
Sbjct: 66 SGHENI-----VNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEP---VHKQYVVYQ 117
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIK 261
L++ + ++H L+H D+KP NILL + +VKV D F LSRS + N S +
Sbjct: 118 LIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVAD--FGLSRSFVNIRRVTNNIPLSINE 175
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVEL 311
+ YV TR YRAPE++LG + D+WS+GCIL E+
Sbjct: 176 NTENFDDDQPILTD-YVA-TRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-26
Identities = 57/247 (23%), Positives = 94/247 (38%), Gaps = 60/247 (24%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVL 142
+L RY L +G G G V DN+ + VAIK + + R EI ++
Sbjct: 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-----EIKII 62
Query: 143 QRLARHD--IG--------GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFP 192
+RL HD + G++ N + IV E + L + L +
Sbjct: 63 RRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE-- 119
Query: 193 IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFK 252
+ R QLL + ++H ++H DLKP N+ + +
Sbjct: 120 -EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT----------------------- 155
Query: 253 NLPKSSAIKLIDFG--STTFEHQDHS-----YVVSTRHYRAPEVILGL-GWNYPCDLWSV 304
+ +K+ DFG H H +V T+ YR+P ++L + D+W+
Sbjct: 156 ---EDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAA 211
Query: 305 GCILVEL 311
GCI E+
Sbjct: 212 GCIFAEM 218
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-26
Identities = 51/227 (22%), Positives = 93/227 (40%), Gaps = 42/227 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
+ I +G+G FG V + + K ++A+K++ + K + E+++ L RH
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RH 68
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+I +++ +F + ++ E ++Y L+K F +L +
Sbjct: 69 PNI-----LRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANA 121
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+++ H R+IH D+KPEN+LL G +K+ DFG
Sbjct: 122 LSYCHSKRVIHRDIKPENLLL-----------------GSAGE----------LKIADFG 154
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
S + + T Y PE+I G + DLWS+G + E
Sbjct: 155 WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL 201
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 64/249 (25%), Positives = 105/249 (42%), Gaps = 44/249 (17%)
Query: 74 RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
+ + Y +G++ + RY+ L +G G G V +D VAIK + R
Sbjct: 41 KSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ 100
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
A A E+ +++ + H I + + + +V E + +L ++
Sbjct: 101 NQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM 159
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
+ + L Q+L + +H +IH DLKP NI++ S
Sbjct: 160 E----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---------------- 199
Query: 246 KDGSYFKNLPKSSAIKLIDFG-STTFEHQDHS--YVVSTRHYRAPEVILGLGWNYPCDLW 302
+K++DFG + T YVV TR+YRAPEVILG+G+ D+W
Sbjct: 200 -----------DCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIW 247
Query: 303 SVGCILVEL 311
SVGCI+ E+
Sbjct: 248 SVGCIMGEM 256
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 69/242 (28%), Positives = 101/242 (41%), Gaps = 43/242 (17%)
Query: 81 HYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--E 138
V ++ PRY LS +GEG +G V +DN K VAIK + E
Sbjct: 16 EMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE 75
Query: 139 IDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVR 197
I +L R RH+ I G + + + IV + + LY L+ D +
Sbjct: 76 IKILLRF-RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ---HLSNDHIC 131
Query: 198 ELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKS 257
Q+L + ++H ++H DLKP N+LL + +
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---------------------------T 164
Query: 258 SAIKLIDFG--STTFEHQDHS-----YVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILV 309
+K+ DFG DH+ YV TR YRAPE++L G+ D+WSVGCIL
Sbjct: 165 CDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIMLNSKGYTKSIDIWSVGCILA 223
Query: 310 EL 311
E+
Sbjct: 224 EM 225
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 67/249 (26%), Positives = 105/249 (42%), Gaps = 44/249 (17%)
Query: 74 RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
R + Y IG++ + RY+ L +G G G V +D + VAIK + R
Sbjct: 4 RSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ 63
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
A A E+ +++ + H IG + + + IV E + +L ++
Sbjct: 64 NQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM 122
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
+ L Q+L + +H +IH DLKP NI++ S
Sbjct: 123 ELDHER----MSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---------------- 162
Query: 246 KDGSYFKNLPKSSAIKLIDFG---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLW 302
+K++DFG + YVV TR+YRAPEVILG+G+ D+W
Sbjct: 163 -----------DCTLKILDFGLARTAGTSFMMTPYVV-TRYYRAPEVILGMGYKENVDIW 210
Query: 303 SVGCILVEL 311
SVGCI+ E+
Sbjct: 211 SVGCIMGEM 219
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-25
Identities = 65/248 (26%), Positives = 101/248 (40%), Gaps = 42/248 (16%)
Query: 74 RPDDKDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSIN 129
P + G Y + + + YR L +G G +G V D VAIK + R
Sbjct: 4 PPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ 63
Query: 130 KYREA--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK 185
A A E+ +L+ + RH+ IG D +V +G L ++
Sbjct: 64 SELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH 122
Query: 186 NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245
D ++ L Q+L+ + ++H +IH DLKP N+ +
Sbjct: 123 EKLGE---DRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE---------------- 163
Query: 246 KDGSYFKNLPKSSAIKLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWS 303
+K++DFG + + + YVV TR YRAPEVIL + D+WS
Sbjct: 164 -----------DCELKILDFGLARQADSEMTGYVV-TRWYRAPEVILNWMRYTQTVDIWS 211
Query: 304 VGCILVEL 311
VGCI+ E+
Sbjct: 212 VGCIMAEM 219
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 9e-25
Identities = 41/189 (21%), Positives = 76/189 (40%), Gaps = 21/189 (11%)
Query: 127 SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK 185
S +A ++I + + + V + ++ I + +L D++ +
Sbjct: 100 SSPSPMDAPSVKIRRMDPFSTKNT-----VGQLQPSSPKVYLYIQMQLCRKENLKDWMNR 154
Query: 186 NSYRSFP-IDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSR 243
+ + Q+ E+V F+H L+H DLKP NI + VKV D F L
Sbjct: 155 RCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD--FGLVT 212
Query: 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWS 303
+ + + + + H+ V T+ Y +PE I G +++ D++S
Sbjct: 213 AMDQDEEEQTVL-----------TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFS 261
Query: 304 VGCILVELC 312
+G IL EL
Sbjct: 262 LGLILFELL 270
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 102 bits (254), Expect = 9e-25
Identities = 30/261 (11%), Positives = 73/261 (27%), Gaps = 70/261 (26%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY---------REAAMIEIDVLQ 143
+ +G+ +E D E E + + + E + +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 144 RLARHDIGGTRCVQIRNWFDYRNH-----------------ICIVFEKLGPSLYDFL--- 183
+ + R + + ++ ++ +L F
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 184 --RKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241
++++S +L Q++ +A +H L+HT L+P +I+L
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL-------------- 239
Query: 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGW------ 295
+ G + L F + +R + PE+
Sbjct: 240 ---DQRGG----------VFLTGFEHLVRDGARVV-SSVSRGFEPPELEARRATISYHRD 285
Query: 296 -----NYPCDLWSVGCILVEL 311
+ D W++G ++ +
Sbjct: 286 RRTLMTFSFDAWALGLVIYWI 306
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 61/244 (25%), Positives = 98/244 (40%), Gaps = 43/244 (17%)
Query: 78 KDGHYVFAIGENL---TPRYRILSKMGEGTFGQVVECFDNEKKELVAIK-IVRSINKYRE 133
K G Y + + Y + +G G +G V D E VAIK + R
Sbjct: 7 KKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF 66
Query: 134 A--AMIEIDVLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYR 189
A A E+ +L+ + +H+ IG + +V + L +
Sbjct: 67 AKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--- 122
Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
F + ++ L Q+L+ + ++H ++H DLKP N+ +
Sbjct: 123 -FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE-------------------- 161
Query: 250 YFKNLPKSSAIKLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCI 307
+K++DFG + + + YVV TR YRAPEVIL N D+WSVGCI
Sbjct: 162 -------DCELKILDFGLARHADAEMTGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCI 213
Query: 308 LVEL 311
+ E+
Sbjct: 214 MAEM 217
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-24
Identities = 55/237 (23%), Positives = 95/237 (40%), Gaps = 46/237 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
+ I +G+G FG V + + K ++A+K++ + K + EI++ L RH
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RH 73
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+I +++ N+F R I ++ E LY L+K+ F +L ++
Sbjct: 74 PNI-----LRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADA 126
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ + HE ++IH D+KPEN+L+ +K+ DFG
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGE---------------------------LKIADFG 159
Query: 267 -STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
S + T Y PE+I G + DLW G + E + PF
Sbjct: 160 WSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFL----VGMPPF 212
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 67/236 (28%), Positives = 91/236 (38%), Gaps = 44/236 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIG 151
RY + +G G FG D KELVA+K + E EI R RH +I
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINH-RSLRHPNI- 78
Query: 152 GTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V+ + H+ I+ E G LY+ + F D R +QLL V++
Sbjct: 79 ----VRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYC 132
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H +++ H DLK EN LL DGS +K+ DFG +
Sbjct: 133 HSMQICHRDLKLENTLL-------------------DGSPAPR------LKICDFGYSKS 167
Query: 271 EHQDH--SYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCIL-VELCSVSNCYLTPF 322
V T Y APEV+L ++ D+WS G L V L PF
Sbjct: 168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV----GAY-PF 218
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-24
Identities = 52/254 (20%), Positives = 89/254 (35%), Gaps = 51/254 (20%)
Query: 78 KDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREA 134
K + + + Y + + G++G V D+E VAIK V +
Sbjct: 5 KGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEG-IPVAIKRVFNTVSDGRT 63
Query: 135 AMI------------EIDVLQRLARHD-IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYD 181
I EI +L H I G R + + + + +V E + L
Sbjct: 64 VNILSDSFLCKRVLREIRLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ 122
Query: 182 FLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241
+ ++ +L + +HE ++H DL P NILL
Sbjct: 123 VIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD------------ 169
Query: 242 SRSSKDGSYFKNLPKSSAIKLIDFG-STTFEHQDHS--YVVSTRHYRAPEVILGL-GWNY 297
++ I + DF + + YV R YRAPE+++ G+
Sbjct: 170 ---------------NNDITICDFNLAREDTADANKTHYVT-HRWYRAPELVMQFKGFTK 213
Query: 298 PCDLWSVGCILVEL 311
D+WS GC++ E+
Sbjct: 214 LVDMWSAGCVMAEM 227
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 5e-24
Identities = 32/265 (12%), Positives = 74/265 (27%), Gaps = 70/265 (26%)
Query: 90 LTPRYRILSK---MGEGTFGQVVECFDNEKKELVAIKIVRSINK---------YREAAMI 137
L R R L + +G+ +E D E E + + + E +
Sbjct: 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL 132
Query: 138 EIDVLQRLARHDIGGTRCVQIRNWFDYRNH-----------------ICIVFEKLGPSLY 180
+ + + R + + ++ ++ +L
Sbjct: 133 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 192
Query: 181 DFL-----RKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
F ++++S +L Q++ +A +H L+HT L+P +I+L
Sbjct: 193 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL-------- 244
Query: 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVIL 291
+ G + L F + + A ++
Sbjct: 245 ---------DQRGG----------VFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLP 285
Query: 292 GLG-----WNYPCDLWSVGCILVEL 311
+ D W++G + +
Sbjct: 286 FGQHHPTLMTFAFDTWTLGLAIYWI 310
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-24
Identities = 61/235 (25%), Positives = 100/235 (42%), Gaps = 49/235 (20%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEID 140
+ RY+ LS +G G +G V FD + VA+K + + YR E+
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-----ELR 80
Query: 141 VLQRLARHD--IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRE 198
+L+ + +H+ IG + N + +V +G L + ++ D V+
Sbjct: 81 LLKHM-KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD---DHVQF 136
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
L Q+L + ++H +IH DLKP N+ +
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNE---------------------------DC 169
Query: 259 AIKLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVEL 311
+K++DFG + + YV TR YRAPE++L +N D+WSVGCI+ EL
Sbjct: 170 ELKILDFGLARHTADEMTGYVA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 8e-24
Identities = 54/242 (22%), Positives = 96/242 (39%), Gaps = 52/242 (21%)
Query: 93 RYRILS-KMGEGTFGQV--VECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD 149
+ K+G GT+G V + D + + A+K + +A EI +L+ L +H
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLREL-KHP 78
Query: 150 -IGGTRCVQIRNWFDYRNHICI--VFE-------KLGPSLYDFLRKNSYRSFPIDLVREL 199
+ + ++ F + +F+ + P +V+ L
Sbjct: 79 NV-----ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
Q+L+ + ++H ++H DLKP NIL++ P+
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEG-----------------------PERGR 170
Query: 260 IKLIDFG-STTFEHQDHSY-----VVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVEL 311
+K+ D G + F VV T YRAPE++LG +Y D+W++GCI EL
Sbjct: 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAEL 229
Query: 312 CS 313
+
Sbjct: 230 LT 231
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 4e-23
Identities = 48/233 (20%), Positives = 100/233 (42%), Gaps = 44/233 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD--- 149
+ ++ +G GT+GQV + + +L AIK++ E EI++L++ + H
Sbjct: 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
G +N + + +V E S+ D ++ + + + + R++L
Sbjct: 85 TYYG---AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
++ +H+ ++IH D+K +N+LL +++ +KL+DFG
Sbjct: 142 LSHLHQHKVIHRDIKGQNVLL-----------------TENAE----------VKLVDFG 174
Query: 267 ---STTFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVEL 311
+ + T ++ APEVI +++ DLWS+G +E+
Sbjct: 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 8e-23
Identities = 52/232 (22%), Positives = 95/232 (40%), Gaps = 51/232 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQRLAR 147
+ ++ +GEG +G+V + +E VA+KI ++ R EI + + L
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI---VDMKRAVDCPENIKKEICINKML-N 63
Query: 148 H-DIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
H ++ V+ N + E G L+D + + P + QL+
Sbjct: 64 HENV-----VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 116
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
V ++H + + H D+KPEN+LL D N +K+ DF
Sbjct: 117 GVVYLHGIGITHRDIKPENLLL-------------------DER--DN------LKISDF 149
Query: 266 G-STTFEHQDHSYVVSTR----HYRAPEVILGLGWN-YPCDLWSVGCILVEL 311
G +T F + + +++ Y APE++ ++ P D+WS G +L +
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-22
Identities = 60/229 (26%), Positives = 101/229 (44%), Gaps = 44/229 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
Y I +GEG+FG+V + ++ VA+K + + + K + EI L +L RH
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL-KLLRH 68
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I +++ + I +V E G L+D++ + + D R +Q++ ++
Sbjct: 69 PHI-----IKLYDVITTPTDIVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICAI 121
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
+ H +++H DLKPEN+LL D N +K+ DFG
Sbjct: 122 EYCHRHKIVHRDLKPENLLL---------DDN------------LN------VKIADFGL 154
Query: 268 TTFEHQDHSYVVS--TRHYRAPEVILGLGWNYP-CDLWSVGCIL-VELC 312
+ + S + +Y APEVI G + P D+WS G +L V L
Sbjct: 155 SNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV 203
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-22
Identities = 48/229 (20%), Positives = 96/229 (41%), Gaps = 40/229 (17%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
+ K+GEG+ G V + VA+K++ + R + E+ +++
Sbjct: 41 GDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ 100
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
++ V++ + + ++ E L G +L D + + I V +L+
Sbjct: 101 HFNV-----VEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATV---CEAVLQ 152
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
++A++H +IH D+K ++ILL + DG +KL DF
Sbjct: 153 ALAYLHAQGVIHRDIKSDSILL-----------------TLDGR----------VKLSDF 185
Query: 266 G---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
G + + +V T ++ APEVI + D+WS+G +++E+
Sbjct: 186 GFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEM 234
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-22
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 40/229 (17%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLA 146
+ +Y K+G+G G V D + VAI+ + + ++ +I EI V++
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+I V + + + + +V E L G SL D + + I V R+ L+
Sbjct: 76 NPNI-----VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQ 127
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
++ F+H ++IH D+K +NILL DGS +KL DF
Sbjct: 128 ALEFLHSNQVIHRDIKSDNILL-----------------GMDGS----------VKLTDF 160
Query: 266 GST---TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
G T E S +V T ++ APEV+ + D+WS+G + +E+
Sbjct: 161 GFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEM 209
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-22
Identities = 52/232 (22%), Positives = 95/232 (40%), Gaps = 51/232 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQRLAR 147
+ ++ +GEG +G+V + +E VA+KI ++ R EI + + L
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI---VDMKRAVDCPENIKKEICINKML-N 63
Query: 148 H-DIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
H ++ V+ N + E G L+D + + P + QL+
Sbjct: 64 HENV-----VKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG--MPEPDAQRFFHQLMA 116
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
V ++H + + H D+KPEN+LL D N +K+ DF
Sbjct: 117 GVVYLHGIGITHRDIKPENLLL-------------------DER--DN------LKISDF 149
Query: 266 G-STTFEHQDHSYVVSTR----HYRAPEVILGLGWN-YPCDLWSVGCILVEL 311
G +T F + + +++ Y APE++ ++ P D+WS G +L +
Sbjct: 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 7e-22
Identities = 52/223 (23%), Positives = 89/223 (39%), Gaps = 39/223 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHDIG 151
+ +S++G G G V + ++A K++ K I E+ VL I
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI- 93
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
F I I E + G SL L+K P ++ ++ +++ + ++
Sbjct: 94 -VGFYGA---FYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYL 147
Query: 211 H-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-ST 268
+ +++H D+KP NIL+ + G IKL DFG S
Sbjct: 148 REKHKIMHRDVKPSNILV-----------------NSRGE----------IKLCDFGVSG 180
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
+ V TR Y +PE + G ++ D+WS+G LVE+
Sbjct: 181 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 9e-22
Identities = 56/225 (24%), Positives = 99/225 (44%), Gaps = 38/225 (16%)
Query: 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI 150
+ +L K+GEG++G V + E ++VAIK V + + + EI ++Q+ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHV 86
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
V+ + + IV E S+ D +R + ++ D + + + L+ + +
Sbjct: 87 -----VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEY 140
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST- 268
+H +R IH D+K NILL + +G KL DFG
Sbjct: 141 LHFMRKIHRDIKAGNILL-----------------NTEGH----------AKLADFGVAG 173
Query: 269 --TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T + V+ T + APEVI +G+N D+WS+G +E+
Sbjct: 174 QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEM 218
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 65/307 (21%), Positives = 108/307 (35%), Gaps = 66/307 (21%)
Query: 18 PRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPW-RPD 76
P P P +P K C + G S G P GSP P
Sbjct: 16 PDIDPLEALMTNPVVPESKRFCW-NCGRPVGRSDSETKGASE---GWCPYCGSPYSFLPQ 71
Query: 77 DKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSIN--KYRE 133
G+ + +Y + + G G + D N V +K + + +
Sbjct: 72 -------LNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQA 124
Query: 134 AAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC-----IVFEKL-GPSLYDFLRKNS 187
AM E L + I VQI N+ ++ + IV E + G SL
Sbjct: 125 MAMAERQFLAEVVHPSI-----VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--- 176
Query: 188 YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247
+ P+ ++L +++++H + L++ DLKPENI+L +++
Sbjct: 177 -QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML-----------------TEE 218
Query: 248 GSYFKNLPKSSAIKLIDFG---STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSV 304
+KLID G Y+ T ++APE++ G D+++V
Sbjct: 219 Q-----------LKLIDLGAVSRIN----SFGYLYGTPGFQAPEIVRT-GPTVATDIYTV 262
Query: 305 GCILVEL 311
G L L
Sbjct: 263 GRTLAAL 269
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-21
Identities = 40/137 (29%), Positives = 66/137 (48%), Gaps = 8/137 (5%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
P +R+ K+G G FG++ + E VAIK+ ++ +E ++L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-QLHLEYRFYKQL----GS 63
Query: 152 GTRCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
G Q+ +F + +V E LGPSL D L R+F + V + QL+ + ++
Sbjct: 64 GDGIPQVY-YFGPCGKYNAMVLELLGPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYV 121
Query: 211 HELRLIHTDLKPENILL 227
H LI+ D+KPEN L+
Sbjct: 122 HSKNLIYRDVKPENFLI 138
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 47/250 (18%), Positives = 90/250 (36%), Gaps = 67/250 (26%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+Y + ++G+G++G V ++ A+K+ ++K +
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKV---LSKKKLIRQAGFPRRPPPRGTRPAP 70
Query: 153 TRCVQIRNWFD--YR-------------------------NHICIVFEKL-GPSLYDFLR 184
C+Q R + Y+ +H+ +VFE + + +
Sbjct: 71 GGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT 130
Query: 185 KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244
D R + L++ + ++H ++IH D+KP N+L+
Sbjct: 131 LKP---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV----------------- 170
Query: 245 SKDGSYFKNLPKSSAIKLIDFG-STTFEHQDH--SYVVSTRHYRAPEVILGLGWNY---P 298
+DG IK+ DFG S F+ D S V T + APE + +
Sbjct: 171 GEDGH----------IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKA 220
Query: 299 CDLWSVGCIL 308
D+W++G L
Sbjct: 221 LDVWAMGVTL 230
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-21
Identities = 60/247 (24%), Positives = 98/247 (39%), Gaps = 53/247 (21%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYR------EAAMIEID 140
+ YR+L +G+G F +V VAIKI I+K + + E+
Sbjct: 10 EQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKI---IDKTQLNPTSLQKLFREVR 66
Query: 141 VLQRLARH-DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRE 198
+++ L H +I V++ + + ++ E G ++D+L + R
Sbjct: 67 IMKIL-NHPNI-----VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR--MKEKEARS 118
Query: 199 LGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSS 258
RQ++ +V + H+ R++H DLK EN+LL D +
Sbjct: 119 KFRQIVSAVQYCHQKRIVHRDLKAENLLL-----------------DADMN--------- 152
Query: 259 AIKLIDFG-STTFEHQDH-SYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSVS 315
IK+ DFG S F Y APE+ G ++ P D+WS+G IL L
Sbjct: 153 -IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLV--- 208
Query: 316 NCYLTPF 322
PF
Sbjct: 209 -SGSLPF 214
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-21
Identities = 43/137 (31%), Positives = 66/137 (48%), Gaps = 8/137 (5%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
RYR+ K+G G+FG + D E VAIK+ K+ + + E + + + G
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI-ESKIYKMMQ----G 63
Query: 152 GTRCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
G IR W ++ +V E LGPSL D L R F + V L Q++ + ++
Sbjct: 64 GVGIPTIR-WCGAEGDYNVMVMELLGPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYI 121
Query: 211 HELRLIHTDLKPENILL 227
H IH D+KP+N L+
Sbjct: 122 HSKNFIHRDVKPDNFLM 138
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-21
Identities = 44/238 (18%), Positives = 90/238 (37%), Gaps = 60/238 (25%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHD-I 150
+ ++G G +G V + +++A+K +R+ +E + ++D+ R
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPI--DLVRELGRQLLESVA 208
V + I E + SL F ++ + I D++ ++ +++++
Sbjct: 69 -----VTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALE 123
Query: 209 FMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
+H +L +IH D+KP N+L+ + G +K+ DFG
Sbjct: 124 HLHSKLSVIHRDVKPSNVLI-----------------NALGQ----------VKMCDFGI 156
Query: 267 ---------STTFEHQDHSYVVSTRHYRAPEVILG----LGWNYPCDLWSVGCILVEL 311
+ Y APE I G++ D+WS+G ++EL
Sbjct: 157 SGYLVDDVAKDID--------AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-21
Identities = 64/232 (27%), Positives = 93/232 (40%), Gaps = 49/232 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
Y + +G GTFG+V VA+KI+ + I I EI L +L RH
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNL-KLFRH 70
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
I +++ +V E + G L+D++ K+ R L +Q+L +
Sbjct: 71 PHI-----IKLYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSA 123
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
V + H ++H DLKPEN+LL D N K+ DFG
Sbjct: 124 VDYCHRHMVVHRDLKPENVLL---------DAH------------MN------AKIADFG 156
Query: 267 STTFEHQDHSYVVSTR----HYRAPEVILGLGWNYP-CDLWSVGCIL-VELC 312
+ + T +Y APEVI G + P D+WS G IL LC
Sbjct: 157 LSNMMSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC 206
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-21
Identities = 45/248 (18%), Positives = 89/248 (35%), Gaps = 63/248 (25%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI------------- 137
YRI+ + +G F +++ C + + A+K + K R+
Sbjct: 32 DYRIIRTLNQGKFNKIILC--EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 138 ---EIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY----- 188
E+ ++ + +++ C+ + + I++E + S+ F
Sbjct: 90 FKNELQIITDI-KNE----YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY 144
Query: 189 -RSFPIDLVRELGRQLLESVAFMHELRLI-HTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
PI +++ + + +L S +++H + I H D+KP NIL+ K
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM-----------------DK 187
Query: 247 DGSYFKNLPKSSAIKLIDFG-STTFEHQDHSYVVSTRHYRAPEVILGLGW--NYPCDLWS 303
+G +KL DFG S + T + PE D+WS
Sbjct: 188 NGR----------VKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWS 237
Query: 304 VGCILVEL 311
+G L +
Sbjct: 238 LGICLYVM 245
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-21
Identities = 58/225 (25%), Positives = 93/225 (41%), Gaps = 41/225 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDI 150
+ L K+G+G+FG+V + DN +++VAIKI+ E EI VL + +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
+ + + I+ E L G S D L I + R++L+ + +
Sbjct: 83 -----TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATIL---REILKGLDY 134
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--- 266
+H + IH D+K N+LL S+ G +KL DFG
Sbjct: 135 LHSEKKIHRDIKAANVLL-----------------SEHGE----------VKLADFGVAG 167
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311
T + V T + APEVI ++ D+WS+G +EL
Sbjct: 168 QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 212
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-20
Identities = 59/228 (25%), Positives = 92/228 (40%), Gaps = 51/228 (22%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-----I 150
+ +G G FG V C + + VAIK + S R+A ++E+ L R+ H
Sbjct: 12 VEEVVGRGAFGVV--CKAKWRAKDVAIKQIES-ESERKAFIVELRQLSRV-NHPNIVKLY 67
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK-NSYRSFPIDLVRELGRQLLESVA 208
G N +C+V E G SLY+ L + Q + VA
Sbjct: 68 GACL-----------NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 209 FMHELR---LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
++H ++ LIH DLKP N+LLV+ V +K+ DF
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTV--------------------------LKICDF 150
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
G+ + + + APEV G ++ CD++S G IL E+ +
Sbjct: 151 GTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT 198
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-20
Identities = 50/237 (21%), Positives = 88/237 (37%), Gaps = 60/237 (25%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD-I 150
L +MG GT GQV + + ++A+K +R + + ++++DV+ + I
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
VQ F + I E +G ++ P ++ ++ +++++ ++
Sbjct: 87 -----VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYL 140
Query: 211 H-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG--- 266
+ +IH D+KP NILL + G IKL DFG
Sbjct: 141 KEKHGVIHRDVKPSNILL-----------------DERGQ----------IKLCDFGISG 173
Query: 267 -------STTFEHQDHSYVVSTRHYRAPEVI-----LGLGWNYPCDLWSVGCILVEL 311
Y APE I ++ D+WS+G LVEL
Sbjct: 174 RLVDDKAKDRS--------AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 90.8 bits (225), Expect = 1e-20
Identities = 41/137 (29%), Positives = 68/137 (49%), Gaps = 8/137 (5%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
++R+ K+G G+FG++ + + E VAIK+ K+ + E + + L G
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY-ESKIYRILQ----G 61
Query: 152 GTRCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
GT +R WF ++ +V + LGPSL D L R + V L Q++ V F+
Sbjct: 62 GTGIPNVR-WFGVEGDYNVLVMDLLGPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 211 HELRLIHTDLKPENILL 227
H +H D+KP+N L+
Sbjct: 120 HSKSFLHRDIKPDNFLM 136
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-20
Identities = 53/229 (23%), Positives = 103/229 (44%), Gaps = 43/229 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHDIG 151
+ I+ ++G+G FG+V + + E L A K++ + ++ I EI++L I
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI- 78
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V++ + + + I+ E G ++ + + R ++ + RQ+LE++ F+
Sbjct: 79 ----VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFL 133
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST-- 268
H R+IH DLK N+L+ + +G I+L DFG +
Sbjct: 134 HSKRIIHRDLKAGNVLM-----------------TLEGD----------IRLADFGVSAK 166
Query: 269 -TFEHQDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVEL 311
Q + T ++ APEV++ ++Y D+WS+G L+E+
Sbjct: 167 NLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-20
Identities = 39/137 (28%), Positives = 63/137 (45%), Gaps = 8/137 (5%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
Y++ ++GEG+FG + E + + VAIK + + E + L G
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD-EYRTYKLL----AG 64
Query: 152 GTRCVQIRNWF-DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
T + +F H +V + LGPSL D L R F + V +Q+L V +
Sbjct: 65 CTGIPNVY-YFGQEGLHNVLVIDLLGPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 211 HELRLIHTDLKPENILL 227
HE L++ D+KP+N L+
Sbjct: 123 HEKSLVYRDIKPDNFLI 139
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-20
Identities = 58/238 (24%), Positives = 94/238 (39%), Gaps = 55/238 (23%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI----EIDVLQ 143
++ + L ++G G+FG V D E+VAIK + K E+ LQ
Sbjct: 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
+L + +Q R + + +V E S D L + + + +
Sbjct: 110 KLRHPNT-----IQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGA 163
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
L+ +A++H +IH D+K NILL S+ G +KL
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILL-----------------SEPGL----------VKLG 196
Query: 264 DFGS-------TTFEHQDHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVEL 311
DFGS +F V T ++ APEVIL + ++ D+WS+G +EL
Sbjct: 197 DFGSASIMAPANSF--------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-20
Identities = 39/192 (20%), Positives = 68/192 (35%), Gaps = 47/192 (24%)
Query: 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
++ + K+G G FG + F K E A +V+ + E+ QR+A+ D
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 152 GTRCVQIRN---------WF--------DYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
+ + YR +V E+LG L +N +F
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYR---FMVMERLGIDLQKISGQN--GTFKKS 151
Query: 195 LVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNL 254
V +LG ++L+ + ++HE +H D+K N+LL
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL-------------------------GY 186
Query: 255 PKSSAIKLIDFG 266
+ L D+G
Sbjct: 187 KNPDQVYLADYG 198
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-20
Identities = 33/197 (16%), Positives = 65/197 (32%), Gaps = 54/197 (27%)
Query: 92 PRYRILSKMGEGTFGQV--------VECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQ 143
++++ S G + + C +K+ ++K+ + E + Q
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRL----FNEQNFFQ 97
Query: 144 RLARHD-------IGGTRCVQIRN--WF-----DYRNHICIVFEKLGPSLYDFLRKNSYR 189
R A+ + T + I F YR +V LG SL L +
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYR---FLVLPSLGRSLQSALDVSPKH 154
Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
V ++ +LL+++ F+HE +H ++ ENI +
Sbjct: 155 VLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV---------------------- 192
Query: 250 YFKNLPKSSAIKLIDFG 266
+ S + L +G
Sbjct: 193 ---DPEDQSQVTLAGYG 206
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-20
Identities = 53/231 (22%), Positives = 91/231 (39%), Gaps = 45/231 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--EIDVLQRLARHD-I 150
+ L ++G G +G V + +++A+K +RS +E + ++DV+ R + I
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRK---NSYRSFPIDLVRELGRQLLESV 207
VQ I E + S F + P +++ ++ ++++
Sbjct: 84 -----VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 208 AFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ L++IH D+KP NILL + G+ IKL DFG
Sbjct: 139 NHLKENLKIIHRDIKPSNILL-----------------DRSGN----------IKLCDFG 171
Query: 267 -STTFEH-QDHSYVVSTRHYRAPEVI----LGLGWNYPCDLWSVGCILVEL 311
S + R Y APE I G++ D+WS+G L EL
Sbjct: 172 ISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-20
Identities = 47/226 (20%), Positives = 90/226 (39%), Gaps = 30/226 (13%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHD----- 149
+G+G FGQ ++ E E++ +K + ++ + + E+ V++ L H
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKF 72
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
IG + + + E + G +L ++ +P + + +A
Sbjct: 73 IGV--LYK-------DKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMA 122
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++H + +IH DL N L+ + V V D F L+R D +S
Sbjct: 123 YLHSMNIIHRDLNSHNCLVRENKNVVVAD--FGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
T VV ++ APE+I G ++ D++S G +L E+
Sbjct: 181 T---------VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIG 217
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 66/230 (28%), Positives = 94/230 (40%), Gaps = 45/230 (19%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMI--EIDVLQRLARH 148
Y + +G GTFG+V VA+KI+ + I I EI L +L RH
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL-KLFRH 75
Query: 149 -DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
I +++ + I +V E + G L+D++ KN R L +Q+L
Sbjct: 76 PHI-----IKLYQVISTPSDIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSG 128
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
V + H ++H DLKPEN+LL D N K+ DFG
Sbjct: 129 VDYCHRHMVVHRDLKPENVLL---------DAH------------MN------AKIADFG 161
Query: 267 STTFEHQDHSYVVS--TRHYRAPEVILGLGWNYP-CDLWSVGCIL-VELC 312
+ S + +Y APEVI G + P D+WS G IL LC
Sbjct: 162 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC 211
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-19
Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 38/227 (16%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIGGTRCV 156
GEG+F VV + AIKI+ I K + E DV+ RL H V
Sbjct: 39 GEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPF----FV 93
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
++ F + L ++RK SF R +++ ++ ++H +
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
IH DLKPENILL ++++ D+ S + + + +F
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR--------------ANSF----- 192
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
V T Y +PE++ DLW++GCI+ +L L PF
Sbjct: 193 ---VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV----AGLPPF 232
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 49/235 (20%), Positives = 97/235 (41%), Gaps = 56/235 (23%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAM---IEIDVLQRLAR 147
+Y + +GEG++G+V E D+E A+KI+ + + + EI +L+RL R
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-R 64
Query: 148 H-DIGGTRCVQIRN--WFDYRNHICIVFE--KLGPS-LYDFLRKNSYRSFPIDLVRELGR 201
H ++ +Q+ + + + + + +V E G + D + + + FP+
Sbjct: 65 HKNV-----IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE---KRFPVCQAHGYFC 116
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
QL++ + ++H ++H D+KP N+LL + G+ +K
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLL-----------------TTGGT----------LK 149
Query: 262 LIDFG-STTFEHQDHSYVVSTR----HYRAPEVILGLGWNY---PCDLWSVGCIL 308
+ G + T ++ PE+ GL + D+WS G L
Sbjct: 150 ISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLD-TFSGFKVDIWSAGVTL 203
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-19
Identities = 46/236 (19%), Positives = 77/236 (32%), Gaps = 53/236 (22%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI--------EIDVLQRLAR 147
++G+G FG V + + K +VAIK + + E MI E+ ++ L
Sbjct: 23 YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-N 81
Query: 148 HD-----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR 201
H G N +V E + LY L + + L
Sbjct: 82 HPNIVKLYGLMH-----------NPPRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLML 129
Query: 202 QLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
+ + +M ++H DL+ NI L S +
Sbjct: 130 DIALGIEYMQNQNPPIVHRDLRSPNIFLQS----------------------LDENAPVC 167
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY--PCDLWSVGCILVELCS 313
K+ DFG + S ++ + APE I +Y D +S IL + +
Sbjct: 168 AKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT 223
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 5e-19
Identities = 51/234 (21%), Positives = 85/234 (36%), Gaps = 49/234 (20%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMI-----EIDVLQRLARHD 149
+ +G G FG+V F + VA+K R + I E + L +H
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAML-KHP 66
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQL 203
G C++ ++C+V E G L L + P D++ Q+
Sbjct: 67 NIIALRGV--CLK-------EPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQI 114
Query: 204 LESVAFMHE---LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
+ ++H+ + +IH DLK NIL+ + +
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILI-------------------LQKVENGDLSNKIL 155
Query: 261 KLIDFGSTTFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
K+ DFG H+ + APEVI ++ D+WS G +L EL +
Sbjct: 156 KITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT 209
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 38/209 (18%), Positives = 71/209 (33%), Gaps = 58/209 (27%)
Query: 84 FAIGENLT----PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSINKYREA 134
FA+GE +T +++ +G+G FG + N +K+ S N
Sbjct: 23 FAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF- 81
Query: 135 AMIEIDVLQRLARHDIGGTRCVQIRN---------WF--------DYRNHICIVFEKLGP 177
E+ QR A+ + + YR ++ ++ G
Sbjct: 82 --TELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYR---FMIMDRFGS 136
Query: 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
L N+ + F V +L ++L+ + ++HE +H D+K N+LL
Sbjct: 137 DLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL---------- 185
Query: 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
N + L+D+G
Sbjct: 186 ---------------NYKNPDQVYLVDYG 199
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 53/242 (21%), Positives = 101/242 (41%), Gaps = 57/242 (23%)
Query: 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--------INKY-REAAM 136
IG+ + RY+I+ K+G G V D VAIK + + ++ RE
Sbjct: 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHN 64
Query: 137 IEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDL 195
+L+ +I V + + + + +V E + GP+L +++ + +D
Sbjct: 65 S-----SQLSHQNI-----VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDT 112
Query: 196 VRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255
Q+L+ + H++R++H D+KP+NIL+ + +
Sbjct: 113 AINFTNQILDGIKHAHDMRIVHRDIKPQNILI-----------------DSNKT------ 149
Query: 256 KSSAIKLIDFG------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309
+K+ DFG T+ +H V+ T Y +PE G + D++S+G +L
Sbjct: 150 ----LKIFDFGIAKALSETSLTQTNH--VLGTVQYFSPEQAKGEATDECTDIYSIGIVLY 203
Query: 310 EL 311
E+
Sbjct: 204 EM 205
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 55/265 (20%), Positives = 89/265 (33%), Gaps = 65/265 (24%)
Query: 63 GAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAI 122
G +PR + ++G F YR+ +G G G V E D ++ +VA+
Sbjct: 13 GLVPRGSHMDGTAESREG-TQFG-------PYRLRRLVGRGGMGDVYEAEDTVRERIVAL 64
Query: 123 KIVRS--------INKY-REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFE 173
K++ + REA RL + V I ++ + + +
Sbjct: 65 KLMSETLSSDPVFRTRMQREA-----RTAGRLQEPHV-----VPIHDFGEIDGQLYVDMR 114
Query: 174 KL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 232
+ G L LR+ + RQ+ ++ H H D+KPENIL+
Sbjct: 115 LINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV----- 167
Query: 233 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG------STTFEHQDHSYVVSTRHYRA 286
S D L+DFG V T +Y A
Sbjct: 168 ------------SADD----------FAYLVDFGIASATTDEKLTQ--LGNTVGTLYYMA 203
Query: 287 PEVILGLGWNYPCDLWSVGCILVEL 311
PE Y D++++ C+L E
Sbjct: 204 PERFSESHATYRADIYALTCVLYEC 228
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-17
Identities = 54/237 (22%), Positives = 95/237 (40%), Gaps = 50/237 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIV--RSINKYREAAMIEIDVLQRLARHDI 150
Y + +G G V + KKE VAIK + + + EI + + +I
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRE------LGRQL 203
V F ++ + +V + L G S+ D ++ + V + + R++
Sbjct: 76 -----VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREV 130
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
LE + ++H+ IH D+K NILL +DGS +++
Sbjct: 131 LEGLEYLHKNGQIHRDVKAGNILL-----------------GEDGS----------VQIA 163
Query: 264 DFG-----STTFEHQDHSY---VVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVEL 311
DFG +T + + V T + APEV+ G+++ D+WS G +EL
Sbjct: 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 220
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 80.0 bits (197), Expect = 5e-17
Identities = 42/236 (17%), Positives = 80/236 (33%), Gaps = 50/236 (21%)
Query: 94 YRILSKMGEG--TFGQVVECFDNEKKELVAIKIV---RSINKYREAAMIEIDVLQRLARH 148
Y +L+ +G+G V E V ++ + N+ E+ V +
Sbjct: 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+I V R F N + +V + S D + + + + + +L+++
Sbjct: 87 NI-----VPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++H + +H +K +IL+ S DG + L S
Sbjct: 142 DYIHHMGYVHRSVKASHILI-----------------SVDGK----------VYLSGLRS 174
Query: 268 ----------TTFEHQDHSYVVSTRHYRAPEVI--LGLGWNYPCDLWSVGCILVEL 311
H Y V + +PEV+ G++ D++SVG EL
Sbjct: 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 230
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 7e-17
Identities = 51/234 (21%), Positives = 93/234 (39%), Gaps = 42/234 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
YR+L G+G FG+V C ++ A K + K A+ E +L+++
Sbjct: 189 YRVL---GKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ V + ++ ++ +C+V + G L + FP ++ +
Sbjct: 246 V-----VSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+H R+++ DLKPENILL ++++ D L+ +G
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLG-LAVHVPEGQ----------------TIK 343
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
V T Y APEV+ + + D W++GC+L E+ +PF
Sbjct: 344 GR--------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMI----AGQSPF 385
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 54/233 (23%), Positives = 88/233 (37%), Gaps = 54/233 (23%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD--- 149
I K+G G+FG V + VA+KI+ + + + E+ +++RL RH
Sbjct: 41 IKEKIGAGSFGTVHRAEWHGSD--VAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIV 97
Query: 150 --IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYR-SFPIDLVRELGRQLLE 205
+G Q ++ IV E L SLY L K+ R + + +
Sbjct: 98 LFMGA--VTQ-------PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAK 148
Query: 206 SVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
+ ++H ++H +LK N+L+ VKV
Sbjct: 149 GMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV---------------------------C 181
Query: 264 DFGSTTFEHQDHSYVVS---TRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
DFG + + S T + APEV+ N D++S G IL EL +
Sbjct: 182 DFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 54/234 (23%), Positives = 97/234 (41%), Gaps = 43/234 (18%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ + +G G+FG+V+ E A+KI+ + K ++ + E +LQ +
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFP 101
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V++ F +++ +V E G ++ LR+ F R Q++ +
Sbjct: 102 F----LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFE 155
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++H L LI+ DLKPEN+L+ Y++V D+ F K + +
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF-------------------AKRVKGRTW 196
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
T T APE+IL G+N D W++G ++ E+ PF
Sbjct: 197 TL--------CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA----AGYPPF 238
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-16
Identities = 52/251 (20%), Positives = 90/251 (35%), Gaps = 69/251 (27%)
Query: 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--------INKY-REAAM 136
+L+ RY + +G G +V D VA+K++R+ ++ REA
Sbjct: 6 TPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREA-- 63
Query: 137 IEIDVLQRLAR---------HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKN 186
Q A +D G + IV E + G +L D +
Sbjct: 64 ------QNAAALNHPAIVAVYDTGEAETPAGPLPY-------IVMEYVDGVTLRDIVHTE 110
Query: 187 SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246
E+ +++ F H+ +IH D+KP NI++ S
Sbjct: 111 --GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI-----------------SA 151
Query: 247 DGSYFKNLPKSSAIKLIDFG------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300
A+K++DFG + + V+ T Y +PE G + D
Sbjct: 152 TN----------AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSD 201
Query: 301 LWSVGCILVEL 311
++S+GC+L E+
Sbjct: 202 VYSLGCVLYEV 212
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-16
Identities = 52/236 (22%), Positives = 97/236 (41%), Gaps = 44/236 (18%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIG 151
++ +G G FG+V +++ A+K++ + K ++A E D++ +
Sbjct: 73 VVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV- 131
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
VQ+ F ++ +V E + G L + + P R +++ ++ +
Sbjct: 132 ----VQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAI 184
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H + IH D+KP+N+LL + ++K+ D+ + +K+G T
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG---------------MVRCDTA 229
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYP----CDLWSVGCILVELCSVSNCYLTPF 322
V T Y +PEV+ G + CD WSVG L E+ TPF
Sbjct: 230 --------VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML----VGDTPF 273
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 55/237 (23%), Positives = 96/237 (40%), Gaps = 43/237 (18%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIG 151
IL +G G FG+V ++ A+KI+ + K E A E DVL I
Sbjct: 78 ILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI- 136
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
+ F N++ +V + G L L K R P ++ R +++ ++ +
Sbjct: 137 ----TTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIAIDSV 191
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H+L +H D+KP+NIL+ ++++ D+ + +DG S+
Sbjct: 192 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG---------------TVQSSVA 236
Query: 271 EHQDHSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCSVSNCYLTPF 322
V T Y +PE++ + + CD WS+G + E+ TPF
Sbjct: 237 --------VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEML----YGETPF 281
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 5e-16
Identities = 49/237 (20%), Positives = 90/237 (37%), Gaps = 46/237 (19%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SI--NKYREAAMIEIDVLQRLARHDI 150
+ +G G FG+V C + ++ A+K + I + A+ E +L +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL-----V 246
Query: 151 GGTRC---VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
C V + F + + + + + G L+ L ++ F +R +++
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILG 304
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ MH +++ DLKP NILL +V++ D A
Sbjct: 305 LEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL------------------ACDFSKKK 346
Query: 267 STTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
V T Y APEV+ G+ ++ D +S+GC+L +L +PF
Sbjct: 347 PHAS--------VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL----RGHSPF 391
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 5e-16
Identities = 50/238 (21%), Positives = 92/238 (38%), Gaps = 47/238 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
+R+L G G FG+V C +L A K + K + AM+E +L ++
Sbjct: 190 FRVL---GRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-----KLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
I V + F+ + +C+V + +Y+ N F Q++
Sbjct: 247 I-----VSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN--PGFQEPRAIFYTAQIV 299
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+ +H+ +I+ DLKPEN+LL V++ D + + + K
Sbjct: 300 SGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL----AVELKAGQTKTK-------- 347
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
+ T + APE++LG +++ D +++G L E+ PF
Sbjct: 348 ----GY--------AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMI----AARGPF 389
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-16
Identities = 51/233 (21%), Positives = 90/233 (38%), Gaps = 53/233 (22%)
Query: 95 RILSKMGEGTFGQVVE-CFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD- 149
+ ++G G+FG V + + + VA+K++ + +A E+ VL++ RH
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD----VAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVN 81
Query: 150 ----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+G + + IV + G SLY L + F + + ++ RQ
Sbjct: 82 ILLFMGYST----------APQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTA 130
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLI 263
+ ++H +IH DLK NI L VK+ D F L+
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGD--FGLAT-------------------- 168
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCS 313
S + + + APEVI N + D+++ G +L EL +
Sbjct: 169 -EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 7e-16
Identities = 57/239 (23%), Positives = 94/239 (39%), Gaps = 45/239 (18%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIG 151
IL +G G F +V + ++ A+KI+ + K E + E DVL R I
Sbjct: 65 ILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI- 123
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
Q+ F N++ +V E G L L K R P ++ R +++ ++ +
Sbjct: 124 ----TQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGER-IPAEMARFYLAEIVMAIDSV 178
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H L +H D+KP+NILL ++++ D+ + DG S
Sbjct: 179 HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG---------------TVRSLVA 223
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNY-------PCDLWSVGCILVELCSVSNCYLTPF 322
V T Y +PE++ +G CD W++G E+ TPF
Sbjct: 224 --------VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF----YGQTPF 270
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 48/240 (20%), Positives = 86/240 (35%), Gaps = 55/240 (22%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-----I 150
+L +G+G +G+V + + E VA+KI S ++ E+ L RH+ I
Sbjct: 12 LLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRETELYNTVML-RHENILGFI 68
Query: 151 GGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ + ++ ++G SLYD+L+ + + + +A
Sbjct: 69 ASDMTSR-----HSSTQLWLITHYHEMG-SLYDYLQLTT---LDTVSCLRIVLSIASGLA 119
Query: 209 FMHELRL--------IHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSA 259
+H H DLK +NIL+ + D L+ S +
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD--LGLAVM-----------HSQS 166
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP------CDLWSVGCILVELCS 313
+D G+ V T+ Y APEV+ D+W+ G +L E+
Sbjct: 167 TNQLDVGNNP--------RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR 218
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-14
Identities = 45/238 (18%), Positives = 88/238 (36%), Gaps = 56/238 (23%)
Query: 96 ILSKMGEGTFGQVVE-CFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD-- 149
I +G+G FGQV + E VAI+++ +A E+ ++ RH+
Sbjct: 37 IGELIGKGRFGQVYHGRWHGE----VAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENV 91
Query: 150 ---IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+G C+ H+ I+ G +LY +R ++ R++ +++++
Sbjct: 92 VLFMGA--CMS-------PPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVK 141
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLID 264
+ ++H ++H DLK +N+ V + D F L S +
Sbjct: 142 GMGYLHAKGILHKDLKSKNV-FYDNGKVVITD--FGLFSISGVLQAGRR----------- 187
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP---------CDLWSVGCILVELCS 313
+ APE+I L + D++++G I EL +
Sbjct: 188 -------EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 51/234 (21%), Positives = 90/234 (38%), Gaps = 39/234 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
+ L +G+G+FG+V+ EL A+KI++ + E M+E VL +
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
Q+ + F + + V E + G L +++ F ++ +
Sbjct: 403 F----LTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLF 456
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
F+ +I+ DLK +N++L S ++K+ D+ K+ I G T
Sbjct: 457 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM----CKEN--------------IWDGVT 498
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
T T Y APE+I + D W+ G +L E+ PF
Sbjct: 499 T------KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML----AGQAPF 542
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 4e-14
Identities = 53/241 (21%), Positives = 98/241 (40%), Gaps = 48/241 (19%)
Query: 92 PRYRI-----LSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVL 142
P+Y + L +G G+FG+V A+K+++ + + ++ E +L
Sbjct: 1 PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR 201
+ H +++ F I ++ + + G L+ LRK + FP + +
Sbjct: 61 SIV-THPF----IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAA 113
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
++ ++ ++H +I+ DLKPENILL ++K+ D+ F K
Sbjct: 114 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF-------------------AK 154
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321
+ + T T Y APEV+ +N D WS G ++ E+ TP
Sbjct: 155 YVPDVTYTL--------CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML----AGYTP 202
Query: 322 F 322
F
Sbjct: 203 F 203
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 55/239 (23%), Positives = 100/239 (41%), Gaps = 50/239 (20%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD- 149
IL +G+G+FG+V N+ K++ A+K + + E E+ ++Q L H
Sbjct: 18 EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPF 76
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ V + F + +V + LG L L++N F + V+ +L+ ++
Sbjct: 77 L-----VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALD 129
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG-S 267
++ R+IH D+KP+NILL D + G + + DF +
Sbjct: 130 YLQNQRIIHRDMKPDNILL---------D--------EHGH----------VHITDFNIA 162
Query: 268 TTFEHQDHSYVVS-TRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
+ ++ T+ Y APE+ G G+++ D WS+G EL P+
Sbjct: 163 AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL----RGRRPY 217
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-14
Identities = 31/234 (13%), Positives = 72/234 (30%), Gaps = 57/234 (24%)
Query: 96 ILSKMGEGTFGQVVE--CFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD- 149
L+K+ E G++ + N+ + +K+++ + + E L+ H
Sbjct: 14 FLTKLNENHSGELWKGRWQGND----IVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPN 68
Query: 150 ----IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+G C H ++ + SLY+ L + + + +
Sbjct: 69 VLPVLGA--CQS-----PPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121
Query: 205 ESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+AF+H L + L ++++ +D + ++
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMI-----------------DEDMT----------ARI 154
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP---CDLWSVGCILVELCS 313
+ + APE + + D+WS +L EL +
Sbjct: 155 SMADVKFSFQSPG--RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT 206
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 5e-14
Identities = 51/234 (21%), Positives = 103/234 (44%), Gaps = 39/234 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ +L +G G++ +V+ + + A+K+V+ +N + E V ++ + H
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V + + F + + V E + G L +++ R P + R ++ ++
Sbjct: 71 F----LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALN 124
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++HE +I+ DLK +N+LL S ++K+ DY K+G + G T
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM----CKEG--------------LRPGDT 166
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
T S T +Y APE++ G + + D W++G ++ E+ +PF
Sbjct: 167 T------STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM----AGRSPF 210
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 8e-14
Identities = 47/227 (20%), Positives = 89/227 (39%), Gaps = 43/227 (18%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
+ K+G G +G+V E + VA+K ++ E + E V++ + +H
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQL 281
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+G C + I+ E G +L D+LR+ + + ++ + Q+ ++
Sbjct: 282 LG--VCTR-------EPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAM 331
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFG 266
++ + IH +L N L+ VKV D F LSR +Y + IK
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVAD--FGLSRLMTGDTYTAHAGAKFPIKWT--- 386
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
APE + ++ D+W+ G +L E+ +
Sbjct: 387 -------------------APESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 8e-14
Identities = 50/234 (21%), Positives = 103/234 (44%), Gaps = 39/234 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ +L +G G++ +V+ + + A+++V+ +N + E V ++ + H
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V + + F + + V E + G L +++ R P + R ++ ++
Sbjct: 114 F----LVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALN 167
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++HE +I+ DLK +N+LL S ++K+ DY K+G + G T
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM----CKEG--------------LRPGDT 209
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
T S T +Y APE++ G + + D W++G ++ E+ +PF
Sbjct: 210 T------STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMM----AGRSPF 253
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 1e-13
Identities = 49/240 (20%), Positives = 84/240 (35%), Gaps = 55/240 (22%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-----I 150
+ +G+G FG+V + E VA+KI S + EI L RH+ I
Sbjct: 46 LQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFI 102
Query: 151 GGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ +V + + G SL+D+L + + ++ + +L +A
Sbjct: 103 AADNKDN-----GTWTQLWLVSDYHEHG-SLFDYLNRYT---VTVEGMIKLALSTASGLA 153
Query: 209 FMHELRL--------IHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSA 259
+H + H DLK +NIL+ + D L+ SA
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD--LGLAVR-----------HDSA 200
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP------CDLWSVGCILVELCS 313
ID V T+ Y APEV+ D++++G + E+
Sbjct: 201 TDTIDIAPNH--------RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 252
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 39/227 (17%)
Query: 101 GEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHDIGGTRCV 156
G+G+FG+V+ ++ A+K+++ +I K +E M E +VL + +H V
Sbjct: 47 GKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF----LV 102
Query: 157 QIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRL 215
+ F + + V + + G L+ L++ R F R ++ ++ ++H L +
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNI 160
Query: 216 IHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH 275
++ DLKPENILL S ++ + D+ K+ I+ STT
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGL----CKEN--------------IEHNSTT------ 196
Query: 276 SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
S T Y APEV+ ++ D W +G +L E+ L PF
Sbjct: 197 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML----YGLPPF 239
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-13
Identities = 49/234 (20%), Positives = 95/234 (40%), Gaps = 39/234 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ + +G+G+FG+V + + AIK ++ + + M+E VL H
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ F + ++ V E L G L ++ F + +++ +
Sbjct: 79 F----LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQ 132
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
F+H +++ DLK +NILL ++K+ D+ K+ + +
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGM----CKEN--------------MLGDAK 174
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
T +++ T Y APE++LG +N+ D WS G +L E+ +PF
Sbjct: 175 T-----NTF-CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEML----IGQSPF 218
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-13
Identities = 57/234 (24%), Positives = 99/234 (42%), Gaps = 49/234 (20%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
+ L ++G+G FG V C + E+VA+K ++ S ++ EI++L+ L +HD
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 71
Query: 150 IGGTRCVQIRN--WFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
V+ + + R ++ ++ E G SL D+L+K+ R I L+ + Q+ +
Sbjct: 72 ----NIVKYKGVCYSAGRRNLKLIMEYLPYG-SLRDYLQKHKERIDHIKLL-QYTSQICK 125
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ ++ R IH DL NIL+ + VK+ DF
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIG---------------------------DF 158
Query: 266 GSTTFEHQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVELCS 313
G T QD + APE + ++ D+WS G +L EL +
Sbjct: 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 59/235 (25%), Positives = 96/235 (40%), Gaps = 55/235 (23%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD 149
+ L ++G+G FG V C + E+VA+K ++ S ++ EI++L+ L +HD
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHD 102
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
G C R ++ ++ E G SL D+L+K+ R I L+ + Q
Sbjct: 103 NIVKYKG--VCYS-----AGRRNLKLIMEYLPYG-SLRDYLQKHKERIDHIKLL-QYTSQ 153
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+ + + ++ R IH DL NIL+ + VK+
Sbjct: 154 ICKGMEYLGTKRYIHRDLATRNILVENENRVKIG-------------------------- 187
Query: 263 IDFGSTTFEHQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVEL 311
DFG T QD Y APE + ++ D+WS G +L EL
Sbjct: 188 -DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 241
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 41/235 (17%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ L +G+GTFG+V+ + A+KI++ I E A + E VLQ +RH
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHP 208
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
++ F + +C V E G L+ L + R F D R G +++ ++
Sbjct: 209 F----LTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALD 262
Query: 209 FMHELR-LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++H + +++ DLK EN++L ++K+ D+ K+G I G+
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGL----CKEG--------------IKDGA 304
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
T T Y APEV+ + D W +G ++ E+ C PF
Sbjct: 305 TM------KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM----CGRLPF 349
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 68.0 bits (165), Expect = 5e-13
Identities = 55/259 (21%), Positives = 85/259 (32%), Gaps = 62/259 (23%)
Query: 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---------SINKYREAAMIEIDV 141
T + + K+GEG FG+V + VAIKI+ S K E + EI +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 142 LQRLARHDIG------------GTRCVQ-------IRNWFDYRN---------------- 166
+ L+ CVQ ++ W Y +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 167 -HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPEN 224
I + FE G L K S + + + QL S+A LR H DL N
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLS----SLATAKSILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 225 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHY 284
+LL K+ Y +SS S + +ID+ + E
Sbjct: 193 VLLKKTSLKKL-HYTLNGKSSTIPSC------GLQVSIIDYTLSRLERDGIVVFCDV--S 243
Query: 285 RAPEVILGLGWNYPCDLWS 303
++ G G +Y D++
Sbjct: 244 MDEDLFTGDG-DYQFDIYR 261
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 5e-13
Identities = 50/234 (21%), Positives = 88/234 (37%), Gaps = 39/234 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ L +G+G+FG+V+ EL A+KI++ + + + M+E VL +
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
Q+ + F + + V E + G L F ++ +
Sbjct: 82 F----LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
F+ +I+ DLK +N++L S ++K+ D+ K+ I G T
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM----CKEN--------------IWDGVT 177
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
T T Y APE+I + D W+ G +L E+ PF
Sbjct: 178 T------KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEML----AGQAPF 221
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 6e-13
Identities = 53/234 (22%), Positives = 97/234 (41%), Gaps = 39/234 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ + +G+G+FG+V+ E +L A+K+++ I + + M E +L H
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
Q+ F + + V E + G L R F R +++ ++
Sbjct: 85 F----LTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISALM 138
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
F+H+ +I+ DLK +N+LL + K+ D+ + K+G I G T
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHEGHCKLADF-GM---CKEG--------------ICNGVT 180
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
T + T Y APE++ + + D W++G +L E+ C PF
Sbjct: 181 T------ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEML----CGHAPF 224
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 6e-13
Identities = 41/169 (24%), Positives = 76/169 (44%), Gaps = 26/169 (15%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+ + +GEG FG+V C + E VA+K ++ S + EI++L+ L H
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YH 82
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+ G C + D N I ++ E G SL ++L KN + + +
Sbjct: 83 ENIVKYKG--ICTE-----DGGNGIKLIMEFLPSG-SLKEYLPKNKNKINLKQQL-KYAV 133
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGS 249
Q+ + + ++ + +H DL N+L+ S VK+ D F L+++ +
Sbjct: 134 QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGD--FGLTKAIETDK 180
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 8e-13
Identities = 57/237 (24%), Positives = 98/237 (41%), Gaps = 46/237 (19%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAA--MIEIDVLQRLARHD 149
+ L +G+GTFG+V+ + A+KI+R I E A + E VLQ
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN----- 61
Query: 150 IGGTRC---VQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
TR ++ F + +C V E G L+ L + R F + R G +++
Sbjct: 62 ---TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVS 116
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
++ ++H +++ D+K EN++L ++K+ D+ K+G I
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL----CKEG--------------ISD 158
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
G+T T Y APEV+ + D W +G ++ E+ C PF
Sbjct: 159 GATM------KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM----CGRLPF 205
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 46/241 (19%), Positives = 85/241 (35%), Gaps = 57/241 (23%)
Query: 96 ILSKMGEGTFGQVVEC-FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
++ ++G+G +G+V + EK VA+K+ + + EI + RH+
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGEK---VAVKVFFTTEEASWFRETEIYQTVLM-RHENILGF 96
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I ++ + ++ + + G SLYD+L+ + + +L + +
Sbjct: 97 IAA--DIKGTG---SWTQLYLITDYHENG-SLYDYLKSTT---LDAKSMLKLAYSSVSGL 147
Query: 208 AFMHELRL--------IHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSS 258
+H H DLK +NIL+ + D L+ S
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIAD--LGLAVK-----------FIS 194
Query: 259 AIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYP------CDLWSVGCILVELC 312
+D T V T+ Y PEV+ D++S G IL E+
Sbjct: 195 DTNEVDIPPNT--------RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
Query: 313 S 313
Sbjct: 247 R 247
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 55/232 (23%), Positives = 91/232 (39%), Gaps = 49/232 (21%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVRSINKYREAAMI-EIDVLQRLARHD 149
+ +S++G+G FG V C + LVA+K ++ ++ EI +L+ L D
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSD 84
Query: 150 IGGTRCVQIRN--WFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
V+ R + R + +V E G L DFL+++ R L+ Q+ +
Sbjct: 85 ----FIVKYRGVSYGPGRQSLRLVMEYLPSG-CLRDFLQRHRARLDASRLL-LYSSQICK 138
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ ++ R +H DL NIL+ S +VK+ DF
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIA---------------------------DF 171
Query: 266 GSTTFEHQDHSYVVSTRHYR------APEVILGLGWNYPCDLWSVGCILVEL 311
G D Y V + APE + ++ D+WS G +L EL
Sbjct: 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 46/159 (28%), Positives = 82/159 (51%), Gaps = 13/159 (8%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
++ K+G G FG+V N+ + VA+K ++ + EA + E +V++ L +HD +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTL-QHD----K 244
Query: 155 CVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
V++ + I I+ E G SL DFL+ + P+ + + Q+ E +AF+ +
Sbjct: 245 LVKLHAVV-TKEPIYIITEFMAKG-SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
IH DL+ NIL+ ++ K+ D F L+R +D Y
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIAD--FGLARVIEDNEY 339
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 41/225 (18%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
R+ K+G+G FG+V N VAIK ++ EA + E V+++L RH+ +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 240
Query: 155 CVQIRNWFDY----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
VQ+ Y I IV E + SL DFL+ + + + + ++ Q+ +A+
Sbjct: 241 LVQL-----YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+ + +H DL+ NIL+ KV D F L+R +D Y IK
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVAD--FGLARLIEDNEYTARQGAKFPIKWT----- 348
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
APE L + D+WS G +L EL +
Sbjct: 349 -----------------APEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 6e-12
Identities = 50/250 (20%), Positives = 90/250 (36%), Gaps = 66/250 (26%)
Query: 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD- 149
+ ++L G FG V + E VA+KI +K E+ L + +H+
Sbjct: 23 SMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHEN 79
Query: 150 ----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
IG + + + ++ + G SL DFL+ N + + + +
Sbjct: 80 ILQFIGA--EKRGTS---VDVDLWLITAFHEKG-SLSDFLKANV---VSWNELCHIAETM 130
Query: 204 LESVAFMHE----------LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
+A++HE + H D+K +N+LL + +
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL-----------------KNNLT---- 169
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVS-----TRHYRAPEVILG-LGWNYP----CDLWS 303
+ DFG S + TR Y APEV+ G + + D+++
Sbjct: 170 ------ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYA 223
Query: 304 VGCILVELCS 313
+G +L EL S
Sbjct: 224 MGLVLWELAS 233
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 6e-12
Identities = 60/225 (26%), Positives = 95/225 (42%), Gaps = 41/225 (18%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
R+ K+G+G FG+V N VAIK ++ EA + E V+++L RH+ +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKL-RHE----K 323
Query: 155 CVQIRNWFDY----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
VQ+ Y I IV E + SL DFL+ + + + + ++ Q+ +A+
Sbjct: 324 LVQL-----YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+ + +H DL+ NIL+ KV D F L+R +D Y IK
Sbjct: 379 VERMNYVHRDLRAANILVGENLVCKVAD--FGLARLIEDNEYTARQGAKFPIKWT----- 431
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
APE L + D+WS G +L EL +
Sbjct: 432 -----------------APEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 6e-12
Identities = 49/234 (20%), Positives = 97/234 (41%), Gaps = 46/234 (19%)
Query: 101 GEGTFGQVV---ECFDNEKKELVAIKIVR-----SINKYREAAMIEIDVLQRLARHD-IG 151
G G +G+V + ++ +L A+K+++ K E E VL+ + + +
Sbjct: 63 GTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL- 121
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V + F + ++ + + G L+ L + F V+ +++ ++ +
Sbjct: 122 ----VTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHL 175
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H+L +I+ D+K ENILL S +V + D+ SK+ + D
Sbjct: 176 HKLGIIYRDIKLENILLDSNGHVVLTDFGL----SKEF-------------VADETERA- 217
Query: 271 EHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSVSNCYLTPF 322
+ + T Y AP+++ G G + D WS+G ++ EL +PF
Sbjct: 218 ----YDF-CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL----TGASPF 262
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-12
Identities = 29/190 (15%), Positives = 54/190 (28%), Gaps = 30/190 (15%)
Query: 66 PRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIV 125
+ +PP G + RYR+L G Q + D VA+ V
Sbjct: 11 RESSAPPDDVQLVPGARI------ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFV 64
Query: 126 RSINK---------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175
RL+R I ++ + R +V E +
Sbjct: 65 DPQGVLPDDVLQETLSRT--------LRLSR--IDKPGVARVLDVVHTRAGGLVVAEWIR 114
Query: 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235
G SL + P+ +R + L + H + + P + + V +
Sbjct: 115 GGSLQEVADT---SPSPVGAIR-AMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVL 170
Query: 236 PDYKFLSRSS 245
+ ++
Sbjct: 171 AYPATMPDAN 180
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 8e-12
Identities = 49/243 (20%), Positives = 80/243 (32%), Gaps = 54/243 (22%)
Query: 96 ILSKMGEGTFGQVVEC-FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
+L +G G +G V + D VA+K+ N+ I + + HD
Sbjct: 17 LLELIGRGRYGAVYKGSLDERP---VAVKVFSFANRQNFINEKNIYRVPLM-EHDNIARF 72
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I G R D R +V E G SL +L ++ L + +
Sbjct: 73 IVG--D--ERVTADGRMEYLLVMEYYPNG-SLXKYLSLHT---SDWVSSCRLAHSVTRGL 124
Query: 208 AFMHE---------LRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKS 257
A++H + H DL N+L+ + + D F LS + +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD--FGLSMRLTGNRLVRPGEED 182
Query: 258 SAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-------GWNYPCDLWSVGCILVE 310
+A V T Y APEV+ G D++++G I E
Sbjct: 183 NA---------------AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227
Query: 311 LCS 313
+
Sbjct: 228 IFM 230
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 9e-12
Identities = 52/238 (21%), Positives = 101/238 (42%), Gaps = 46/238 (19%)
Query: 95 RILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRS---INKYREAA--MIEIDVLQRLA 146
+L +G+G +G+V + ++ A+K+++ + ++ A E ++L+
Sbjct: 20 ELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE-V 78
Query: 147 RHD-IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
+H I V + F + ++ E L G L+ L + F D ++
Sbjct: 79 KHPFI-----VDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEIS 131
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
++ +H+ +I+ DLKPENI+L +VK+ D+ K+ I
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL----CKES--------------IH 173
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTPF 322
G+ T H++ T Y APE+++ G N D WS+G ++ ++ PF
Sbjct: 174 DGTVT-----HTF-CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDML----TGAPPF 221
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 46/169 (27%), Positives = 80/169 (47%), Gaps = 28/169 (16%)
Query: 95 RILSKMGEGTFGQVVEC----FDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARH 148
+ + +GEG FG+V ++ E+VA+K +++ ++R EID+L+ L H
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YH 92
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+ G C + +V E LG SL D+L ++S L+ +
Sbjct: 93 EHIIKYKG--CCED-----AGAASLQLVMEYVPLG-SLRDYLPRHSIG--LAQLL-LFAQ 141
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGS 249
Q+ E +A++H IH DL N+LL + VK+ D F L+++ +G
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGD--FGLAKAVPEGH 188
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 38/166 (22%), Positives = 70/166 (42%), Gaps = 21/166 (12%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
+ K+G G +G+V E + VA+K ++ E + E V++ + +H
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQL 74
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+G C + I+ E G +L D+LR+ + + ++ + Q+ ++
Sbjct: 75 LG--VCTR-------EPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFK 252
++ + IH DL N L+ VKV D F LSR +Y
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHLVKVAD--FGLSRLMTGDTYTA 168
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 63.3 bits (155), Expect = 1e-11
Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 66/246 (26%)
Query: 96 ILSKMGEGTFGQVV---ECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHD 149
+L +G+G+FG+V + ++ ++L A+K+++ + R +E D+L H
Sbjct: 28 LLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE-VNHP 86
Query: 150 -IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
I V++ F + ++ + L G L+ L K F + V+ +L ++
Sbjct: 87 FI-----VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALAL 139
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
+H L +I+ DLKPENILL ++G IKL DFG
Sbjct: 140 DHLHSLGIIYRDLKPENILL-----------------DEEGH----------IKLTDFGL 172
Query: 267 ----------STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSN 316
+ +F T Y APEV+ G D WS G ++ E+
Sbjct: 173 SKESIDHEKKAYSF--------CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEML---- 220
Query: 317 CYLTPF 322
PF
Sbjct: 221 TGTLPF 226
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 47/198 (23%), Positives = 73/198 (36%), Gaps = 30/198 (15%)
Query: 63 GAIPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAI 122
++G R KD + E+L + ++G G FG+V LVA+
Sbjct: 91 PLTKKSGVVLHRAVPKDKWVLNH--EDLV----LGEQIGRGNFGEVFSGRLRADNTLVAV 144
Query: 123 KIVR--SINKYREAAMIEIDVLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE-- 173
K R + + E +L++ H IG C Q + I IV E
Sbjct: 145 KSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIG--VCTQ-------KQPIYIVMELV 194
Query: 174 KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233
+ G FLR R L+ ++ + ++ IH DL N L+ +
Sbjct: 195 QGG-DFLTFLRTEGARLRVKTLL-QMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVL 252
Query: 234 KVPDYKF-LSRSSKDGSY 250
K+ D F +SR DG Y
Sbjct: 253 KISD--FGMSREEADGVY 268
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 6e-11
Identities = 44/170 (25%), Positives = 73/170 (42%), Gaps = 26/170 (15%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
+ +GEG FG V + VAIK + + + RE + E +++ H
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP 76
Query: 150 IGGTRCVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
V++ N + I+ E LG L FL+ Y L+ QL
Sbjct: 77 ----HIVKL-----IGVITENPVWIIMELCTLG-ELRSFLQVRKYSLDLASLI-LYAYQL 125
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFK 252
++A++ R +H D+ N+L+ S + VK+ D F LSR +D +Y+K
Sbjct: 126 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGD--FGLSRYMEDSTYYK 173
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 8e-11
Identities = 44/170 (25%), Positives = 73/170 (42%), Gaps = 26/170 (15%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
+ +GEG FG+V E +K VA+K + +E M E +++ L H
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHP 73
Query: 150 IGGTRCVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
V++ I+ E G L +L +N + LV Q+
Sbjct: 74 ----HIVKL-----IGIIEEEPTWIIMELYPYG-ELGHYLERNKNSLKVLTLV-LYSLQI 122
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFK 252
+++A++ + +H D+ NIL+ S E VK+ D F LSR +D Y+K
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPECVKLGD--FGLSRYIEDEDYYK 170
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 9e-11
Identities = 54/232 (23%), Positives = 88/232 (37%), Gaps = 50/232 (21%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
+ +GEG FG V + VAIK + + + RE + E +++ H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHP 451
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
IG + N + I+ E LG L FL+ + L+ Q
Sbjct: 452 HIVKLIG--VITE--------NPVWIIMELCTLG-ELRSFLQVRKFSLDLASLI-LYAYQ 499
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSAIK 261
L ++A++ R +H D+ N+L+ S + VK+ D F LSR +D +Y+K IK
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD--FGLSRYMEDSTYYKASKGKLPIK 557
Query: 262 LIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ APE I + D+W G + E+
Sbjct: 558 WM----------------------APESINFRRFTSASDVWMFGVCMWEILM 587
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-10
Identities = 44/164 (26%), Positives = 72/164 (43%), Gaps = 23/164 (14%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
+ ++G G FG V + K + VAIK +R E + E +V+ +L H
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQL 68
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
G C++ + IC+V E + G L D+LR L+ + + E +
Sbjct: 69 YG--VCLE-------QAPICLVTEFMEHG-CLSDYLRTQRGLFAAETLL-GMCLDVCEGM 117
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
A++ E +IH DL N L+ + +KV D F ++R D Y
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSD--FGMTRFVLDDQY 159
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-10
Identities = 46/163 (28%), Positives = 84/163 (51%), Gaps = 21/163 (12%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154
+++ ++G G FG+V + N + VA+K ++ + +A + E +++++L +H R
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQL-QHQ----R 69
Query: 155 CVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V++ Y + I I+ E + G SL DFL+ S I+ + ++ Q+ E +A
Sbjct: 70 LVRL-----YAVVTQEPIYIITEYMENG-SLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
F+ E IH DL+ NIL+ K+ D F L+R +D Y
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIAD--FGLARLIEDNEY 164
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 35/170 (20%), Positives = 76/170 (44%), Gaps = 29/170 (17%)
Query: 95 RILSKMGEGTFGQVVECF---DNEKKEL-VAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+ + +G G FG V + + EK ++ VAIK +R + K + + E V+ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DN 76
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+G C+ + + ++ + G L D++R++ L+
Sbjct: 77 PHVCRLLG--ICLT--------STVQLITQLMPFG-CLLDYVREHKDNIGSQYLL-NWCV 124
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
Q+ + + ++ + RL+H DL N+L+ + ++VK+ D F L++
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITD--FGLAKLLGAEEK 172
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 3e-10
Identities = 42/166 (25%), Positives = 68/166 (40%), Gaps = 23/166 (13%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
+L ++G G FG V + + VA+K+++ + + E + +L H
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKF 68
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
G C + I IV E G L ++LR + P L+ E+ + E +
Sbjct: 69 YG--VCSK-------EYPIYIVTEYISNG-CLLNYLRSHGKGLEPSQLL-EMCYDVCEGM 117
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFK 252
AF+ + IH DL N L+ VKV D F ++R D Y
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSD--FGMTRYVLDDQYVS 161
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-10
Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 28/163 (17%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLAR 147
R+L K+G+G+FG V + K VA+K ++ S + + + E++ + L
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-D 79
Query: 148 HDIGGTRCVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
H +++ Y + +V E LG SL D LRK+ L
Sbjct: 80 HR----NLIRL-----YGVVLTPPMKMVTELAPLG-SLLDRLRKHQGHFLLGTLS-RYAV 128
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSR 243
Q+ E + ++ R IH DL N+LL + + VK+ D F L R
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD--FGLMR 169
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 5e-10
Identities = 39/156 (25%), Positives = 69/156 (44%), Gaps = 25/156 (16%)
Query: 99 KMGEGTFGQVVE-CFDNEKKEL-VAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTR 154
++G G FG V + + KK++ VAIK+++ + E M E ++ +L +
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNP----Y 71
Query: 155 CVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
V++ + +V E G L+ FL ++ EL Q+ +
Sbjct: 72 IVRL-----IGVCQAEALMLVMEMAGGG-PLHKFLVGKREEIPVSNVA-ELLHQVSMGMK 124
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSR 243
++ E +H DL N+LLV+ Y K+ D F LS+
Sbjct: 125 YLEEKNFVHRDLAARNVLLVNRHYAKISD--FGLSK 158
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 6e-10
Identities = 47/256 (18%), Positives = 81/256 (31%), Gaps = 30/256 (11%)
Query: 14 MDKRPRKRPRLTWDVPPPLPPPKVLPALYCVQEFGNGGMPNYACSSMFYGAIPRTGSPPW 73
M R V + P+ P L + Y + +
Sbjct: 7 MGHHHHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHI 66
Query: 74 RPDDKDGHYVFAIGENLTPRYR----ILSKMGEGTFGQVVECF---DNEKKELVAIKIVR 126
+ V A+ + +G G FG V ++ KK A+K +
Sbjct: 67 DLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN 126
Query: 127 SINKYREAA--MIEIDVLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGP 177
I E + + E +++ H +G +V K G
Sbjct: 127 RITDIGEVSQFLTEGIIMKDF-SHPNVLSLLG---IC-----LRSEGSPLVVLPYMKHG- 176
Query: 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237
L +F+R ++ DL+ G Q+ + + F+ + +H DL N +L VKV D
Sbjct: 177 DLRNFIRNETHNPTVKDLIG-FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVAD 235
Query: 238 YKF-LSRSSKDGSYFK 252
F L+R D +
Sbjct: 236 --FGLARDMYDKEFDS 249
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 8e-10
Identities = 42/164 (25%), Positives = 72/164 (43%), Gaps = 23/164 (14%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
L ++G G FG V + + VAIK+++ + + + E V+ L H+
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQL 84
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
G C + + I I+ E G L ++LR+ +R L+ E+ + + E++
Sbjct: 85 YG--VCTK-------QRPIFIITEYMANG-CLLNYLREMRHRFQTQQLL-EMCKDVCEAM 133
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
++ + +H DL N L+ VKV D F LSR D Y
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSD--FGLSRYVLDDEY 175
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 8e-10
Identities = 41/169 (24%), Positives = 73/169 (43%), Gaps = 23/169 (13%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
++L +G+G FG V+ K VA+K +++ + +A + E V+ +L RH
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHSNLVQL 251
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+G V+ + + IV E G SL D+LR D + + + E++
Sbjct: 252 LG--VIVE------EKGGLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 302
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLP 255
++ +H DL N+L+ KV D F L++ + LP
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSEDNVAKVSD--FGLTKEASSTQDTGKLP 349
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 40/169 (23%), Positives = 66/169 (39%), Gaps = 27/169 (15%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
I +G G G+V ++ VAIK ++ + R + E ++ + H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHP 110
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
G + IV E + G SL FLR + + + LV + R
Sbjct: 111 NIIRLEG--VVTR-------GRLAMIVTEYMENG-SLDTFLRTHDGQFTIMQLV-GMLRG 159
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
+ + ++ +L +H DL N+L+ S KV D F LSR +D
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSD--FGLSRVLEDDPD 206
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 55/241 (22%), Positives = 90/241 (37%), Gaps = 60/241 (24%)
Query: 95 RILSKMGEGTFGQVVE-------CFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLA 146
+G+GTF ++ + + + V +K++ + Y E+ ++ +L
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL- 69
Query: 147 RHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVREL 199
H G CV + +V E K G SL +L+KN + + E+
Sbjct: 70 SHKHLVLNYG--VCVC-------GDENILVQEFVKFG-SLDTYLKKNKNCINILWKL-EV 118
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
+QL ++ F+ E LIH ++ +NILL+ E K + F
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF------------------- 159
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYR------APEVIL-GLGWNYPCDLWSVGCILVELC 312
IKL D G + V+ + PE I N D WS G L E+C
Sbjct: 160 IKLSDPGIS-------ITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212
Query: 313 S 313
S
Sbjct: 213 S 213
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 40/178 (22%), Positives = 68/178 (38%), Gaps = 26/178 (14%)
Query: 95 RILSKMGEGTFGQVVECF---DNEKKELVAIKIVRSINKYREAA--MIEIDVLQRLARHD 149
+G G FG V ++ KK A+K + I E + + E +++ H
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHP 86
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
+G +V K G L +F+R ++ DL+ G Q
Sbjct: 87 NVLSLLG---IC-----LRSEGSPLVVLPYMKHG-DLRNFIRNETHNPTVKDLIG-FGLQ 136
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSA 259
+ + + ++ + +H DL N +L VKV D F L+R D Y+ K+ A
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVAD--FGLARDMYDKEYYSVHNKTGA 192
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 50/246 (20%), Positives = 86/246 (34%), Gaps = 32/246 (13%)
Query: 10 PHKNMDKRPRKRPRLTWDVPPPLPPPKVLPA-LYCVQEFGNGGMPNYACSSMFYGAIPRT 68
P + P L + Y + M
Sbjct: 259 ASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESP 318
Query: 69 GSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVE-CFDNEKKEL-VAIKIVR 126
S P DK +F +NL ++G G FG V + + KK++ VAIK+++
Sbjct: 319 FSDPEELKDKK---LFLKRDNLL---IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK 372
Query: 127 --SINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY----RNHICIVFE--KLGPS 178
+ E M E ++ +L + V++ + +V E G
Sbjct: 373 QGTEKADTEEMMREAQIMHQL-DNP----YIVRL-----IGVCQAEALMLVMEMAGGG-P 421
Query: 179 LYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238
L+ FL ++ EL Q+ + ++ E +H +L N+LLV+ Y K+ D
Sbjct: 422 LHKFLVGKREEIPVSNVA-ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISD- 479
Query: 239 KF-LSR 243
F LS+
Sbjct: 480 -FGLSK 484
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 41/190 (21%), Positives = 71/190 (37%), Gaps = 41/190 (21%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVL 142
PR + +G G FG+VVE + VA+K+++ + +EA M E+ ++
Sbjct: 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIM 103
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
L +H+ +G C + ++ E G L +FLR+ S
Sbjct: 104 SHLGQHENIVNLLGA--CTH-------GGPVLVITEYCCYG-DLLNFLRRKSRVLETDPA 153
Query: 196 VRELGRQLLES------------VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LS 242
+AF+ IH D+ N+LL + K+ D F L+
Sbjct: 154 FAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD--FGLA 211
Query: 243 RSSKDGSYFK 252
R + S +
Sbjct: 212 RDIMNDSNYI 221
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-09
Identities = 39/170 (22%), Positives = 71/170 (41%), Gaps = 29/170 (17%)
Query: 95 RILSKMGEGTFGQVVECF---DNEKKEL-VAIKIVR--SINKYREAAMIEIDVLQRLARH 148
R L +G G FG V + + E ++ V IK++ S + +A + + L H
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DH 74
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+G C + + +V + LG SL D +R++ P L+ G
Sbjct: 75 AHIVRLLG--LCPG--------SSLQLVTQYLPLG-SLLDHVRQHRGALGPQLLL-NWGV 122
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
Q+ + + ++ E ++H +L N+LL S V+V D F ++
Sbjct: 123 QIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVAD--FGVADLLPPDDK 170
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-09
Identities = 35/170 (20%), Positives = 76/170 (44%), Gaps = 29/170 (17%)
Query: 95 RILSKMGEGTFGQVVECF---DNEKKEL-VAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+ + +G G FG V + + EK ++ VAIK +R + K + + E V+ + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DN 76
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
+G C+ + + ++ + G L D++R++ L+
Sbjct: 77 PHVCRLLG--ICLT--------STVQLITQLMPFG-CLLDYVREHKDNIGSQYLL-NWCV 124
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
Q+ + + ++ + RL+H DL N+L+ + ++VK+ D F L++
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITD--FGLAKLLGAEEK 172
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 5e-09
Identities = 57/248 (22%), Positives = 96/248 (38%), Gaps = 70/248 (28%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVE-CFDNEKKEL-VAIKIVR---SINKYREAAMIEIDVL 142
+ LT + L G G FG V + + +K VA+KI++ + ++ + E +V+
Sbjct: 16 KLLTLEDKEL---GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 72
Query: 143 QRLARHDIGGTRCVQIRNWFDY----RNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLV 196
Q+L + V++ +V E +LG L +L++N R +
Sbjct: 73 QQL-DNP----YIVRM-----IGICEAESWMLVMEMAELG-PLNKYLQQN--RHVKDKNI 119
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
EL Q+ + ++ E +H DL N+LLV+ Y K+
Sbjct: 120 IELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS-------------------- 159
Query: 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYR------APEVILGLGWNY-----PCDLWSVG 305
DFG + D +Y + H + APE I NY D+WS G
Sbjct: 160 -------DFGLSKALRADENYYKAQTHGKWPVKWYAPECI-----NYYKFSSKSDVWSFG 207
Query: 306 CILVELCS 313
++ E S
Sbjct: 208 VLMWEAFS 215
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 6e-09
Identities = 40/169 (23%), Positives = 73/169 (43%), Gaps = 23/169 (13%)
Query: 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD----- 149
++L +G+G FG V+ K VA+K +++ + +A + E V+ +L RH
Sbjct: 24 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKN-DATAQAFLAEASVMTQL-RHSNLVQL 79
Query: 150 IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+G + + + + IV E G SL D+LR D + + + E++
Sbjct: 80 LG---VI-----VEEKGGLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLP 255
++ +H DL N+L+ KV D F L++ + LP
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSD--FGLTKEASSTQDTGKLP 177
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 27/169 (15%)
Query: 95 RILSKMGEGTFGQVVE---CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHD 149
I +G G FG+V ++K+ VAIK ++ K R + E ++ + H
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHP 106
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
G + + IV E + G SL FLRK+ + I LV + R
Sbjct: 107 NIIRLEG--VVTK-------SKPVMIVTEYMENG-SLDSFLRKHDAQFTVIQLV-GMLRG 155
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
+ + ++ ++ +H DL NIL+ S KV D F L R +D
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSD--FGLGRVLEDDPE 202
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 47/194 (24%), Positives = 71/194 (36%), Gaps = 45/194 (23%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVL 142
PR R+ +G G FG+VVE ++ VA+K+++ + REA M E+ VL
Sbjct: 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
L H +G C ++ E G L +FLR+
Sbjct: 81 SYLGNHMNIVNLLG--ACTI-------GGPTLVITEYCCYG-DLLNFLRRKRDSFICSKT 130
Query: 196 VRELGRQLLESV----------------AFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239
+ ++ AF+ IH DL NILL K+ D
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD-- 188
Query: 240 F-LSRSSKDGSYFK 252
F L+R K+ S +
Sbjct: 189 FGLARDIKNDSNYV 202
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 40/170 (23%), Positives = 67/170 (39%), Gaps = 28/170 (16%)
Query: 95 RILSKMGEGTFGQVVE----CFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARH 148
+G G FG+V + +K+ VAIK ++ K R + E ++ + H
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SH 105
Query: 149 D-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGR 201
G + + I+ E + G +L FLR+ + LV + R
Sbjct: 106 HNIIRLEG--VISK-------YKPMMIITEYMENG-ALDKFLREKDGEFSVLQLV-GMLR 154
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSY 250
+ + ++ + +H DL NIL+ S KV D F LSR +D
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSD--FGLSRVLEDDPE 202
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 5e-08
Identities = 45/182 (24%), Positives = 69/182 (37%), Gaps = 40/182 (21%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF--DNEKKELVAIKIVRSINKYREAA--MIEIDVLQRL 145
I +GEG FGQV++ + + AIK ++ + E++VL +L
Sbjct: 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 82
Query: 146 ARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRE 198
H +G C R ++ + E G +L DFLRK+
Sbjct: 83 GHHPNIINLLG--ACEH-------RGYLYLAIEYAPHG-NLLDFLRKSRVLETDPAFAIA 132
Query: 199 LG-------RQLLE---SVA----FMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSR 243
+QLL VA ++ + + IH DL NIL+ K+ D F LSR
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIAD--FGLSR 190
Query: 244 SS 245
Sbjct: 191 GQ 192
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 42/192 (21%), Positives = 68/192 (35%), Gaps = 42/192 (21%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
PR R+ +G G FGQV+E VA+K+++ + E M E+ +L
Sbjct: 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 84
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
+ H +G + ++ E K G +L +LR P +
Sbjct: 85 IHIGHHLNVVNLLG---AC-----TKPGGPLMVIVEFCKFG-NLSTYLRSKRNEFVPYKV 135
Query: 196 VRELGRQLLESV--------------AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF- 240
E + ++ F+ + IH DL NILL VK+ D F
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD--FG 193
Query: 241 LSRSSKDGSYFK 252
L+R +
Sbjct: 194 LARDIYKDPDYV 205
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 37/181 (20%), Positives = 65/181 (35%), Gaps = 27/181 (14%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF---DNEKKELVAIKIVR---SINKYREAAMIEIDVLQ 143
P + +G+G FG V E ++ VA+K+++ + E + E ++
Sbjct: 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMK 80
Query: 144 RLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL- 195
H +G ++ K G L+ FL + P +L
Sbjct: 81 EF-DHPHVAKLVG---VSLRSRAKGRLPIPMVILPFMKHG-DLHAFLLASRIGENPFNLP 135
Query: 196 VREL---GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYF 251
++ L + + ++ IH DL N +L V V D F LSR G Y+
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD--FGLSRKIYSGDYY 193
Query: 252 K 252
+
Sbjct: 194 R 194
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 2e-07
Identities = 37/185 (20%), Positives = 68/185 (36%), Gaps = 36/185 (19%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
R +I ++G+G+FG V E +E + VAIK V RE + E V+
Sbjct: 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 143 QRLARHDIGGTR----CVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLV 196
+ H + R Q ++ E G L +LR ++
Sbjct: 83 KEFNCHHV--VRLLGVVSQ-------GQPTLVIMELMTRG-DLKSYLRSLRPAMANNPVL 132
Query: 197 RELGRQLLESVA--------FMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKD 247
+ +A +++ + +H DL N ++ VK+ D F ++R +
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD--FGMTRDIYE 190
Query: 248 GSYFK 252
Y++
Sbjct: 191 TDYYR 195
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-07
Identities = 38/178 (21%), Positives = 65/178 (36%), Gaps = 26/178 (14%)
Query: 95 RILSKMGEGTFGQVVECF---DNEKKELVAIKIVRSINKYREAA--MIEIDVLQRLARHD 149
+G+G FG V + + AIK + I + ++ + E +++ L H
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHP 82
Query: 150 -----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
IG + ++ G L F+R DL+ G Q
Sbjct: 83 NVLALIG---IM-----LPPEGLPHVLLPYMCHG-DLLQFIRSPQRNPTVKDLI-SFGLQ 132
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYFKNLPKSSA 259
+ + ++ E + +H DL N +L + VKV D F L+R D Y+ A
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVAD--FGLARDILDREYYSVQQHRHA 188
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 5e-07
Identities = 37/181 (20%), Positives = 68/181 (37%), Gaps = 28/181 (15%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF---DNEKKELVAIKIVRSIN---KYREAAMIEIDVLQ 143
R + +GEG FG V+E ++ VA+K ++ N + E + E ++
Sbjct: 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMK 91
Query: 144 RLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL- 195
H +G V I ++ K G L+ +L + + P +
Sbjct: 92 DF-SHPNVIRLLG----VCIEMSSQGIPKPMVILPFMKYG-DLHTYLLYSRLETGPKHIP 145
Query: 196 VREL---GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-LSRSSKDGSYF 251
++ L + + ++ +H DL N +L V V D F LS+ G Y+
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVAD--FGLSKKIYSGDYY 203
Query: 252 K 252
+
Sbjct: 204 R 204
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 38/194 (19%), Positives = 75/194 (38%), Gaps = 45/194 (23%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-------FDNEKKELVAIKIVRSINKYREAA--MIEID 140
PR R+ +GEG FGQVV + VA+K+++S ++ + + E++
Sbjct: 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEME 126
Query: 141 VLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPI 193
+++ + +H +G C Q + ++ E G +L ++L+
Sbjct: 127 MMKMIGKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLQARRPPGLEY 176
Query: 194 DLVRELG-------RQLLESV-------AFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239
+ L+ ++ + IH DL N+L+ +K+ D
Sbjct: 177 SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD-- 234
Query: 240 F-LSRSSKDGSYFK 252
F L+R Y+K
Sbjct: 235 FGLARDIHHIDYYK 248
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 5e-07
Identities = 43/200 (21%), Positives = 74/200 (37%), Gaps = 52/200 (26%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSI--NKYREAAMIEIDVL 142
PR + +G G FG+V+ VA+K+++ + REA M E+ ++
Sbjct: 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 102
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
+L H+ +G C I ++FE G L ++LR + ++
Sbjct: 103 TQLGSHENIVNLLGA--CTL-------SGPIYLIFEYCCYG-DLLNYLRSKREKFSEDEI 152
Query: 196 VRELGRQLLESV---------------------AFMHELRLIHTDLKPENILLVSAEYV- 233
E ++L E F+ +H DL N+ LV+ V
Sbjct: 153 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV-LVTHGKVV 211
Query: 234 KVPDYKF-LSRSSKDGSYFK 252
K+ D F L+R S +
Sbjct: 212 KICD--FGLARDIMSDSNYV 229
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 1e-06
Identities = 42/190 (22%), Positives = 70/190 (36%), Gaps = 42/190 (22%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQ 143
R I ++GEG FG+V + K LVA+K ++ + R+ E ++L
Sbjct: 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLT 98
Query: 144 RLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLV 196
L +H G C + + +VFE + G L FLR + + +
Sbjct: 99 ML-QHQHIVRFFG--VCTE-------GRPLLMVFEYMRHG-DLNRFLRSHGPDAKLLAGG 147
Query: 197 RELGRQLLESVAFMH-------------ELRLIHTDLKPENILLVSAEYVKVPDYKF-LS 242
++ L + L +H DL N L+ VK+ D F +S
Sbjct: 148 EDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGD--FGMS 205
Query: 243 RSSKDGSYFK 252
R Y++
Sbjct: 206 RDIYSTDYYR 215
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 40/194 (20%), Positives = 81/194 (41%), Gaps = 45/194 (23%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-------FDNEKKELVAIKIVRSINKYREAA--MIEID 140
PR ++ +GEG FGQVV ++ VA+K+++ ++ + + E++
Sbjct: 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 138
Query: 141 VLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNS--YRSF 191
+++ + +H +G C Q + ++ E G +L ++LR +
Sbjct: 139 MMKMIGKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLRARRPPGMEY 188
Query: 192 PIDLVRELGRQLLES--------VA----FMHELRLIHTDLKPENILLVSAEYVKVPDYK 239
D+ R Q+ +A ++ + IH DL N+L+ +K+ D
Sbjct: 189 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD-- 246
Query: 240 F-LSRSSKDGSYFK 252
F L+R + Y+K
Sbjct: 247 FGLARDINNIDYYK 260
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 37/194 (19%), Positives = 76/194 (39%), Gaps = 45/194 (23%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-------FDNEKKELVAIKIVRSINKYREAA--MIEID 140
PR ++ +GEG FGQVV ++ VA+K+++ ++ + + E++
Sbjct: 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 92
Query: 141 VLQRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPI 193
+++ + +H +G C Q + ++ E G +L ++LR
Sbjct: 93 MMKMIGKHKNIINLLG--ACTQ-------DGPLYVIVEYASKG-NLREYLRARRPPGMEY 142
Query: 194 DLVRELG-------RQLLESV-------AFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239
+ L+ ++ + IH DL N+L+ +K+ D
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD-- 200
Query: 240 F-LSRSSKDGSYFK 252
F L+R + Y+K
Sbjct: 201 FGLARDINNIDYYK 214
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 6e-06
Identities = 38/192 (19%), Positives = 67/192 (34%), Gaps = 44/192 (22%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVL 142
+ + ++GE FG+V + E+ + VAIK ++ + RE E +
Sbjct: 7 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLR 66
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNS--YRSFPI 193
RL +H +G + + ++F G L++FL S
Sbjct: 67 ARL-QHPNVVCLLG--VVTK-------DQPLSMIFSYCSHG-DLHEFLVMRSPHSDVGST 115
Query: 194 DLVRELGRQLLESV------------AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF- 240
D R + L ++ ++H DL N+L+ VK+ D
Sbjct: 116 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISD--LG 173
Query: 241 LSRSSKDGSYFK 252
L R Y+K
Sbjct: 174 LFREVYAADYYK 185
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 6e-06
Identities = 42/191 (21%), Positives = 70/191 (36%), Gaps = 43/191 (22%)
Query: 92 PRYRI--LSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKYREAA-MIEIDVLQ 143
R I ++GEG FG+V + K LVA+K ++ E ++L
Sbjct: 13 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLT 72
Query: 144 RLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDLV 196
L +H+ G C + + +VFE K G L FLR + + +
Sbjct: 73 NL-QHEHIVKFYG--VCGD-------GDPLIMVFEYMKHG-DLNKFLRAHGPDAMILVDG 121
Query: 197 RELGR-------QLLESV-------AFMHELRLIHTDLKPENILLVSAEYVKVPDYKF-L 241
+ Q+L ++ +H DL N L+ + VK+ D F +
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGD--FGM 179
Query: 242 SRSSKDGSYFK 252
SR Y++
Sbjct: 180 SRDVYSTDYYR 190
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 47/227 (20%), Positives = 77/227 (33%), Gaps = 61/227 (26%)
Query: 66 PRTGSPPWRPDDKDGHYVFAIGENLTPRYRI--LSKMGEGTFGQVVEC-----FDNEKKE 118
P P + K + PR I + +GEG FG+V + E
Sbjct: 26 PMYQRMPLLLNPKLLSLEY-------PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFT 78
Query: 119 LVAIKIVRSI--NKYREAAMIEIDVLQRLARHD-----IGGTRCVQIRNWFDYRNHICIV 171
+VA+K+++ + E ++ + +G C +C++
Sbjct: 79 MVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLG--VCAV-------GKPMCLL 128
Query: 172 FE--KLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV---------------------- 207
FE G L +FLR S + +L + S
Sbjct: 129 FEYMAYG-DLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGM 187
Query: 208 AFMHELRLIHTDLKPENILLVSAEY-VKVPDYKF-LSRSSKDGSYFK 252
A++ E + +H DL N LV VK+ D F LSR+ Y+K
Sbjct: 188 AYLSERKFVHRDLATRNC-LVGENMVVKIAD--FGLSRNIYSADYYK 231
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 2e-05
Identities = 21/130 (16%), Positives = 45/130 (34%), Gaps = 9/130 (6%)
Query: 99 KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQI 158
++ F ++ E +++ ++ + K E L+R G Q
Sbjct: 83 RIETSEFDKMDEYLYGDER--FDMRRISPKEKVFIWTEKEFRNLERAKEA---GVSVPQP 137
Query: 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIH 217
+ Y ++ ++ L R V + ++E+V ++ E L+H
Sbjct: 138 ---YTYMKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVH 194
Query: 218 TDLKPENILL 227
DL NI+
Sbjct: 195 ADLSEYNIMY 204
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 6e-05
Identities = 42/200 (21%), Positives = 70/200 (35%), Gaps = 52/200 (26%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
PR + +GEG FG+VV+ VA+K+++ E + E +VL
Sbjct: 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVL 80
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSFPIDL 195
+++ H G C Q + ++ E K G SL FLR++
Sbjct: 81 KQV-NHPHVIKLYGA--CSQ-------DGPLLLIVEYAKYG-SLRGFLRESRKVGPGYLG 129
Query: 196 VRELGRQLLESV----------------------AFMHELRLIHTDLKPENILLVSAEYV 233
++ E++L+H DL NIL+ +
Sbjct: 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKM 189
Query: 234 KVPDYKF-LSRSSKDGSYFK 252
K+ D F LSR + +
Sbjct: 190 KISD--FGLSRDVYEEDSYV 207
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 9e-05
Identities = 41/187 (21%), Positives = 71/187 (37%), Gaps = 40/187 (21%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
PR I + +G G FG+V E ++ VA+K + + ++ ++E ++
Sbjct: 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII 87
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSF---- 191
+ H IG +Q I+ E G L FLR+ R
Sbjct: 88 SKF-NHQNIVRCIG--VSLQ-------SLPRFILMELMAGG-DLKSFLRETRPRPSQPSS 136
Query: 192 --PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY---VKVPDYKF-LSRSS 245
+DL+ + R + ++ E IH D+ N LL K+ D F ++R
Sbjct: 137 LAMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD--FGMARDI 193
Query: 246 KDGSYFK 252
SY++
Sbjct: 194 YRASYYR 200
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 40/187 (21%), Positives = 70/187 (37%), Gaps = 40/187 (21%)
Query: 92 PRYRI--LSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSINKYREAA--MIEIDVL 142
PR I + +G G FG+V E ++ VA+K + + ++ ++E ++
Sbjct: 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII 128
Query: 143 QRLARHD-----IGGTRCVQIRNWFDYRNHICIVFE--KLGPSLYDFLRKNSYRSF---- 191
+ H IG +Q I+ E G L FLR+ R
Sbjct: 129 SKF-NHQNIVRCIG--VSLQ-------SLPRFILLELMAGG-DLKSFLRETRPRPSQPSS 177
Query: 192 --PIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY---VKVPDYKF-LSRSS 245
+DL+ + R + ++ E IH D+ N LL K+ D F ++R
Sbjct: 178 LAMLDLLH-VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD--FGMARDI 234
Query: 246 KDGSYFK 252
Y++
Sbjct: 235 YRAGYYR 241
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 40.2 bits (93), Expect = 9e-04
Identities = 23/91 (25%), Positives = 36/91 (39%), Gaps = 24/91 (26%)
Query: 142 LQRLARHDIGGTRCVQIRNWFD-------YRNHICI---VFEKLGPSLYDFLRK---NSY 188
L++ RHD T + + Y+ +IC +E+L ++ DFL K N
Sbjct: 503 LEQKIRHD--STAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLI 560
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTD 219
S DL+R +A M E I +
Sbjct: 561 CSKYTDLLR---------IALMAEDEAIFEE 582
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 323 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.9 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.41 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.19 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.18 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.84 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.71 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.5 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.44 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.31 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.27 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.24 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.16 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.88 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.82 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.63 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.59 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.44 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.42 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.39 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.31 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.25 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.14 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.0 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.81 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.7 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.97 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.93 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.68 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 93.39 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-56 Score=402.68 Aligned_cols=198 Identities=27% Similarity=0.476 Sum_probs=170.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++|+++++||+|+||+||+|+++.+++.||||++... ....+.+.+|+.+|++++|+|| +++++++++.+.+
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----V~~~~~~~~~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI-----VQYRESFEENGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCC-----CcEEEEEEECCEE
Confidence 5899999999999999999999999999999998643 3456778899999999999999 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
||||||| ||+|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.++
T Consensus 99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g---------------- 162 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG---------------- 162 (350)
T ss_dssp EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC----------------
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC----------------
Confidence 9999999 89999999876656789999999999999999999999999999999999996555
Q ss_pred CCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
.+||+|||+|+..... ....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.
T Consensus 163 -----------~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 228 (350)
T 4b9d_A 163 -----------TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228 (350)
T ss_dssp -----------CEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -----------CEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 4566666666654332 23468999999999999999999999999999999999999999763
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-56 Score=396.58 Aligned_cols=196 Identities=26% Similarity=0.391 Sum_probs=173.1
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++++.||+|+||+||+|+++.+++.||||++.+. ....+.+.+|+++|++++|+|| ++++++|++.+.
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~~~~~~~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF-----VKLYFTFQDDEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEeCCE
Confidence 4699999999999999999999999999999999743 2345678899999999999998 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+||||||| ||+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~v------------- 171 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHI------------- 171 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCE-------------
T ss_pred EEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCE-------------
Confidence 99999999 899999998765 79999999999999999999999999999999999999766554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccC-----CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
||+|||+|+.... .....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.
T Consensus 172 --------------Kl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 172 --------------QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp --------------EECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --------------EEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 5555555544321 123468999999999999999999999999999999999999999763
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=396.52 Aligned_cols=195 Identities=25% Similarity=0.407 Sum_probs=172.1
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
...|+++++||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|+.++|+|| ++++++|.+.+.+|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnI-----V~l~~~~~~~~~~~ 147 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV-----VEMYNSYLVGDELW 147 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTB-----CCEEEEEEETTEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEECCEEE
Confidence 356999999999999999999999999999999996432 334567899999999999998 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
|||||| ||+|.+++.+. .+++..++.++.||+.||+|||++|||||||||+||||+.+|.
T Consensus 148 ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~---------------- 208 (346)
T 4fih_A 148 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR---------------- 208 (346)
T ss_dssp EEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC----------------
T ss_pred EEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC----------------
Confidence 999999 89999999864 5999999999999999999999999999999999999976554
Q ss_pred CccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+||+|||+|+.... .....+||+.|||||++.+..|+.++|||||||++|||++|++||.+
T Consensus 209 -----------vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 272 (346)
T 4fih_A 209 -----------VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 272 (346)
T ss_dssp -----------EEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -----------EEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 46666666654322 22346899999999999999999999999999999999999999976
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-55 Score=381.68 Aligned_cols=196 Identities=27% Similarity=0.476 Sum_probs=161.3
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||+||+|++..+++.||||++.+. ....+.+.+|+.+++.++|||| +++++++++.+.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~~~~~~~~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHI-----IKLYDVIKSKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTB-----CCEEEEEECSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCC-----CeEEEEEEECCE
Confidence 5799999999999999999999999999999998643 2335678899999999999998 999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
+|+|||||+|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 88 ~~ivmEy~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--------------- 150 (275)
T 3hyh_A 88 IIMVIEYAGNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--------------- 150 (275)
T ss_dssp EEEEEECCCEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC---------------
T ss_pred EEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC---------------
Confidence 99999999999999998765 7999999999999999999999999999999999999965554
Q ss_pred CCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+||+|||+|+..... ....+||+.|||||++.+..| +.++|||||||++|||+||+.||.+.
T Consensus 151 ------------vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 151 ------------VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp ------------EEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------EEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 566666666543322 234689999999999999876 58999999999999999999999763
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-55 Score=401.99 Aligned_cols=196 Identities=24% Similarity=0.401 Sum_probs=172.7
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
....|+++++||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|+.++|+|| ++++++|.+.+.+
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnI-----V~l~~~~~~~~~~ 223 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV-----VEMYNSYLVGDEL 223 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTB-----CCEEEEEEETTEE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCC-----CceEEEEEECCEE
Confidence 3467999999999999999999999999999999997432 344568899999999999998 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
||||||| ||+|.+++... .+++..++.++.||+.||+|||++|||||||||+||||+.+|.
T Consensus 224 ~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--------------- 285 (423)
T 4fie_A 224 WVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--------------- 285 (423)
T ss_dssp EEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC---------------
T ss_pred EEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC---------------
Confidence 9999999 89999999764 5999999999999999999999999999999999999976654
Q ss_pred CCccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+||+|||+|+.... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+
T Consensus 286 ------------vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 349 (423)
T 4fie_A 286 ------------VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 349 (423)
T ss_dssp ------------EEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ------------EEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 45566665554322 23446899999999999999999999999999999999999999976
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=387.21 Aligned_cols=193 Identities=26% Similarity=0.369 Sum_probs=168.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
+.|++.++||+|+||+||+|+++.+|+.||||+++.... ..+|+.+++.++|||| |++++++.+++.+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~----~~~E~~il~~l~HpnI-----V~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF----RVEELVACAGLSSPRI-----VPLYGAVREGPWVNIF 128 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC----CTHHHHTTTTCCCTTB-----CCEEEEEEETTEEEEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh----HHHHHHHHHhCCCCCC-----CcEEEEEEECCEEEEE
Confidence 469999999999999999999999999999999975332 2469999999999998 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||| ||+|.+++++.+ .+++..++.++.||+.||+|||++|||||||||+||||+.+|.
T Consensus 129 mEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~------------------ 188 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS------------------ 188 (336)
T ss_dssp ECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC------------------
T ss_pred EeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC------------------
Confidence 9999 899999998765 7999999999999999999999999999999999999976541
Q ss_pred cccCCCCCCceEeeCCCcccccCC--------ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQD--------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
.+||+|||+|+..... ...++||+.|||||++.+..|+.++|||||||+||||+||+.||.+.
T Consensus 189 --------~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 259 (336)
T 4g3f_A 189 --------RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQY 259 (336)
T ss_dssp --------CEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred --------EEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence 2456666655443211 12358999999999999999999999999999999999999999864
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=376.64 Aligned_cols=197 Identities=24% Similarity=0.418 Sum_probs=168.0
Q ss_pred eCCcE-EEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc-
Q 020652 90 LTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (323)
Q Consensus 90 ~~~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~- 164 (323)
..++| ++.++||+|+||+||+|.+..+++.||+|++... ....+.+.+|+.++++++|||| |+++++|+.
T Consensus 23 ~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----V~~~~~~~~~ 97 (290)
T 3fpq_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI-----VRFYDSWEST 97 (290)
T ss_dssp TTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEEEE
T ss_pred CCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEeec
Confidence 34566 7888999999999999999999999999998642 3445678899999999999999 889988764
Q ss_pred ---CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEeecCceeccCc
Q 020652 165 ---RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDY 238 (323)
Q Consensus 165 ---~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--iiHrDlKp~NIli~~~~~~ki~d~ 238 (323)
.+.+||||||| +|+|.+++.+.. .+++..++.++.||+.||+|||++| ||||||||+||||+.
T Consensus 98 ~~~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~--------- 166 (290)
T 3fpq_A 98 VKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--------- 166 (290)
T ss_dssp ETTEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESS---------
T ss_pred cCCCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEEC---------
Confidence 45689999999 899999998765 7999999999999999999999998 999999999999953
Q ss_pred ccccccCCCCCccccCCCCCCceEeeCCCcccccCC-ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
.++.+||+|||+|+..... ....+||+.|||||++.+ .|+.++|||||||+||||+||+.|
T Consensus 167 -----------------~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~P 228 (290)
T 3fpq_A 167 -----------------PTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP 228 (290)
T ss_dssp -----------------TTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred -----------------CCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCC
Confidence 2234566677766543322 334689999999999876 699999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 229 f~~ 231 (290)
T 3fpq_A 229 YSE 231 (290)
T ss_dssp TTT
T ss_pred CCC
Confidence 975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=384.89 Aligned_cols=196 Identities=27% Similarity=0.439 Sum_probs=164.1
Q ss_pred CcEEEEeeecccCcEEEEEEEEC---CCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 92 PRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
++|++++.||+|+||+||+|++. .+++.||||++++.. .....+.+|+++|++++|||| +++++++++.
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~~~~~~~ 98 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI-----VKLHYAFQTE 98 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTE-----ECEEEEEEET
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCC-----CeEEEEEEEC
Confidence 46999999999999999999874 468899999986432 233467789999999999988 9999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+.+||||||| ||+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 99 ~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~v----------- 165 (304)
T 3ubd_A 99 GKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHI----------- 165 (304)
T ss_dssp TEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCE-----------
T ss_pred CEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCE-----------
Confidence 9999999999 999999998865 79999999999999999999999999999999999999766655
Q ss_pred CCCCCccccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
||+|||+|+... ......+||+.|||||++.+..|+.++|||||||+||||+||+.||.+.
T Consensus 166 ----------------Kl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 166 ----------------KLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp ----------------EEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ----------------EecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 555555544321 1223468999999999999999999999999999999999999999863
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-52 Score=381.55 Aligned_cols=206 Identities=25% Similarity=0.459 Sum_probs=168.2
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec--
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD-- 163 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~-- 163 (323)
.+.++|++++.||+|+||+||+|+++.+|+.||||+++.. ....+.+.+|+.+|+.++|+|| +++++++.
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~l~~~~~~~ 125 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNI-----IAIKDILRPT 125 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEECCCS
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCc-----ceEeeeeecc
Confidence 3456899999999999999999999999999999999743 2344567899999999999999 77777654
Q ss_pred ----cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 164 ----YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 164 ----~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
+.+.+|||||||+|+|.+++.+.+ .+++..++.++.||+.||+|||++|||||||||+|||++.++.+|++|||
T Consensus 126 ~~~~~~~~~~ivmE~~~g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLMESDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp SCTTTCCCEEEEEECCSEEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred cccccCCEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecc
Confidence 446899999999889999998765 79999999999999999999999999999999999999776655555555
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
+++....... .........+||+.|||||++.+. .|+.++||||+||++|||++|++||
T Consensus 204 la~~~~~~~~--------------------~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF 263 (398)
T 4b99_A 204 MARGLCTSPA--------------------EHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF 263 (398)
T ss_dssp TCBCC---------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSS
T ss_pred eeeecccCcc--------------------ccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCC
Confidence 4332211000 001122346899999999999886 5699999999999999999999999
Q ss_pred CCC
Q 020652 319 LTP 321 (323)
Q Consensus 319 ~~~ 321 (323)
.+.
T Consensus 264 ~g~ 266 (398)
T 4b99_A 264 PGK 266 (398)
T ss_dssp CCS
T ss_pred CCC
Confidence 763
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=370.15 Aligned_cols=197 Identities=22% Similarity=0.343 Sum_probs=166.9
Q ss_pred CcEEEEeeecccCcEEEEEEEEC-----CCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
++|.+.++||+|+||+||+|++. .+++.||||+++.. ....+.+.+|+++|++++|+|| +++++++.++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnI-----V~l~g~~~~~ 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI-----VKFYGVCVEG 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECSS
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCC-----ccEEEEEeeC
Confidence 57999999999999999999875 35788999999743 3456778999999999999999 9999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcC-----------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCce
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNS-----------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~-----------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ 233 (323)
+.+||||||| +|+|.+++.+.. ...+++..+..++.||+.||+|||+++||||||||+|||++.++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 9999999999 999999997642 3469999999999999999999999999999999999999776655
Q ss_pred eccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHHHHHHHH
Q 020652 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308 (323)
Q Consensus 234 ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 308 (323)
||+|||+|+..... .....||+.|||||++.+..|+.++|||||||+|
T Consensus 168 ---------------------------Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl 220 (299)
T 4asz_A 168 ---------------------------KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVL 220 (299)
T ss_dssp ---------------------------EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ---------------------------EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHH
Confidence 55555555432221 1224689999999999999999999999999999
Q ss_pred HHHhc-CCCCCCC
Q 020652 309 VELCS-VSNCYLT 320 (323)
Q Consensus 309 ~el~t-g~~pf~~ 320 (323)
|||+| |+.||.+
T Consensus 221 ~Ellt~G~~Pf~~ 233 (299)
T 4asz_A 221 WEIFTYGKQPWYQ 233 (299)
T ss_dssp HHHHTTTCCTTTT
T ss_pred HHHHcCCCCCCCC
Confidence 99999 8999976
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=364.33 Aligned_cols=209 Identities=28% Similarity=0.367 Sum_probs=158.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc---
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN--- 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~--- 166 (323)
++|++++.||+|+||+||+|+++.+++.||||+++.. ....+.+.+|+.+|++++|||| ++++++|...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnI-----V~~~~~~~~~~~~~ 79 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI-----VRYFNAWLEKNTTE 79 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEEEC---
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEecCccc
Confidence 3599999999999999999999999999999998643 3445678899999999999999 88888875433
Q ss_pred ---------eEEEEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceec
Q 020652 167 ---------HICIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235 (323)
Q Consensus 167 ---------~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki 235 (323)
++|+||||| +++|.+++..... ...++..++.++.||+.||+|||++|||||||||+|||++.++.+||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEE
Confidence 479999999 9999999986542 23456778999999999999999999999999999999988887777
Q ss_pred cCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCC
Q 020652 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~ 315 (323)
+|||+++....+..... ... ...........+||+.|||||++.+..|+.++|||||||++|||++
T Consensus 160 ~DFGla~~~~~~~~~~~--------~~~----~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~-- 225 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQT--------VLT----PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-- 225 (299)
T ss_dssp CCCCCC--------------------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS--
T ss_pred ccCccceecCCCccccc--------ccc----ccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc--
Confidence 77776554332211000 000 0000111234589999999999999999999999999999999996
Q ss_pred CCCCC
Q 020652 316 NCYLT 320 (323)
Q Consensus 316 ~pf~~ 320 (323)
||.+
T Consensus 226 -Pf~~ 229 (299)
T 4g31_A 226 -PFST 229 (299)
T ss_dssp -CCSS
T ss_pred -CCCC
Confidence 6654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=367.11 Aligned_cols=202 Identities=22% Similarity=0.319 Sum_probs=165.2
Q ss_pred CcEEEEeeecccCcEEEEEEEEC-----CCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 92 PRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+|.+.++||+|+||+||+|+++ .+++.||||+++.. ....+.+.+|+++|++++|+|| |++++++.+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnI-----V~l~g~~~~~ 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI-----VRFFGVCTEG 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECSS
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEEC
Confidence 56899999999999999999865 36889999999753 3456789999999999999999 9999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNS-------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~-------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~ 231 (323)
+.+||||||| +|+|.+++.+.. ...+++..+..++.||+.||+|||+++||||||||+||||+.++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 9999999999 999999997643 13589999999999999999999999999999999999998776
Q ss_pred ceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHH
Q 020652 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311 (323)
Q Consensus 232 ~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 311 (323)
.+||+|||+++.....+. .......+||+.|||||++.+..|+.++|||||||+||||
T Consensus 196 ~~Ki~DFGla~~~~~~~~----------------------~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~El 253 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDY----------------------YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEI 253 (329)
T ss_dssp EEEECCCC--------------------------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cEEEcccccceeccCCCc----------------------ceecCcccccccccChhhhcCCCCCccccccchHHHHHHH
Confidence 665555554332111000 0011235799999999999999999999999999999999
Q ss_pred hc-CCCCCCC
Q 020652 312 CS-VSNCYLT 320 (323)
Q Consensus 312 ~t-g~~pf~~ 320 (323)
+| |+.||.+
T Consensus 254 lt~G~~Pf~~ 263 (329)
T 4aoj_A 254 FTYGKQPWYQ 263 (329)
T ss_dssp HTTSCCTTCS
T ss_pred HcCCCCCCCC
Confidence 99 8999975
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=364.38 Aligned_cols=198 Identities=25% Similarity=0.370 Sum_probs=160.0
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
.+++++.++||+|+||+||+|++.. .||||+++. .....+.+.+|+.++++++|+|| +++++++.. +.
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNI-----V~l~g~~~~-~~ 105 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNI-----LLFMGYMTK-DN 105 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECS-SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEC-Ce
Confidence 3578899999999999999997643 499999863 23455778999999999999999 888887764 56
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+||||||| +|+|.+++.... ..+++..+..++.||+.||+|||+++||||||||+|||++.++.+||+|||+++....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred EEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 89999999 999999997654 4699999999999999999999999999999999999998776665555554322111
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC---CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.. ........+||+.|||||++.+. .|+.++|||||||+||||+||+.||.+
T Consensus 185 ~~----------------------~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~ 239 (307)
T 3omv_A 185 WS----------------------GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH 239 (307)
T ss_dssp -------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC----------------------cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCC
Confidence 00 00112335899999999999753 589999999999999999999999975
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=363.77 Aligned_cols=198 Identities=23% Similarity=0.289 Sum_probs=166.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEEC-----CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
...+++.++||+|+||+||+|... .+++.||||+++.. ....+.+.+|+.++++++|+|| +++++++.
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNI-----V~l~g~~~ 99 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV-----VCLLGVVT 99 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTB-----CCEEEEEC
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCC-----CCcceEEE
Confidence 356899999999999999999863 46789999998643 3445789999999999999999 99999999
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEe
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~ 228 (323)
..+.++|||||| +|+|.++|.... ...+++..+..++.||+.||+|||+++||||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 999999999999 999999997532 13589999999999999999999999999999999999998
Q ss_pred ecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccC-----CccccccCCccccchhhcCCCCCcchhHHH
Q 020652 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWS 303 (323)
Q Consensus 229 ~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 303 (323)
.++.+|| +|||+++.... .....+||+.|||||++.+..|+.++||||
T Consensus 180 ~~~~~Ki---------------------------~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwS 232 (308)
T 4gt4_A 180 DKLNVKI---------------------------SDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWS 232 (308)
T ss_dssp GGGCEEE---------------------------CCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHH
T ss_pred CCCCEEE---------------------------CCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhh
Confidence 7665555 55555443211 122357999999999999999999999999
Q ss_pred HHHHHHHHhc-CCCCCCC
Q 020652 304 VGCILVELCS-VSNCYLT 320 (323)
Q Consensus 304 lG~il~el~t-g~~pf~~ 320 (323)
|||+||||+| |..||.+
T Consensus 233 fGvvl~El~t~g~~Pf~~ 250 (308)
T 4gt4_A 233 YGVVLWEVFSYGLQPYCG 250 (308)
T ss_dssp HHHHHHHHHTTTCCTTTT
T ss_pred HHHHHHHHHhCCCCCCCC
Confidence 9999999998 8999976
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=365.60 Aligned_cols=210 Identities=24% Similarity=0.394 Sum_probs=170.6
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEEC---CCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceecc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~ 164 (323)
.+.++|++.++||+|+||+||+|+++ .+++.||||++.... ....+.+|+++|+.+ .|+|| ++++++|.+
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nI-----v~l~~~~~~ 91 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNV-----MGVKYCFRK 91 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTB-----CCCSEEEEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCC-----ceEEEEEEE
Confidence 45678999999999999999999875 467899999886543 345678899999998 58888 899999999
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeec-CceeccCccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA-EYVKVPDYKFLS 242 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~-~~~ki~d~~~~~ 242 (323)
.+++|+||||| +++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999 899999984 49999999999999999999999999999999999999876 788899998876
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCccc---------------ccCCccccccCCccccchhhcCC-CCCcchhHHHHHH
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTF---------------EHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGC 306 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~---------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~ 306 (323)
...... ..+.+|+.+.. ........+||+.|||||++.+. .|+.++||||+||
T Consensus 167 ~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~ 235 (361)
T 4f9c_A 167 GTHDTK-----------IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGV 235 (361)
T ss_dssp ECTTCS-----------CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred ccCCcc-----------ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHH
Confidence 543322 12222221111 11122345899999999999876 5899999999999
Q ss_pred HHHHHhcCCCCCCC
Q 020652 307 ILVELCSVSNCYLT 320 (323)
Q Consensus 307 il~el~tg~~pf~~ 320 (323)
++|||+||+.||..
T Consensus 236 il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 236 IFLSLLSGRYPFYK 249 (361)
T ss_dssp HHHHHHHTCSSSSC
T ss_pred HHHHHHHCCCCCCC
Confidence 99999999999964
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=384.20 Aligned_cols=195 Identities=23% Similarity=0.345 Sum_probs=164.1
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHH---HHHHHhCCCCCcceEEEcceecc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDV---LQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~---l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. .......+|..+ ++.++|||| ++++++|++
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~I-----V~l~~~f~~ 263 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI-----VCMSYAFHT 263 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTB-----CCEEEEEEC
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCE-----eEEEEEEEE
Confidence 57999999999999999999999999999999997432 222334445444 444567777 999999999
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
.+.+||||||| ||+|.++|.+.+ .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~v---------- 331 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHV---------- 331 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCE----------
T ss_pred CCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCE----------
Confidence 99999999999 999999998875 79999999999999999999999999999999999999766655
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccC-CccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||+|..... .....+||+.|||||++.+ ..|+.++|||||||+||||++|.+||.+
T Consensus 332 -----------------KL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~ 393 (689)
T 3v5w_A 332 -----------------RISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 393 (689)
T ss_dssp -----------------EECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCG
T ss_pred -----------------EecccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 5555555544322 2344699999999999974 5899999999999999999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=359.87 Aligned_cols=204 Identities=24% Similarity=0.343 Sum_probs=167.8
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCC-----cEEEEEEeccc--hhhHHHHHHHHHHHHHHHh-CCCCCcceEEEcce
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKK-----ELVAIKIVRSI--NKYREAAMIEIDVLQRLAR-HDIGGTRCVQIRNW 161 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~-----~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~-~~i~~~~~~~~~~~ 161 (323)
-.++|++.++||+|+||+||+|.+..++ +.||||++... ....+.+.+|+.+|+++.| +|| |+++++
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnI-----V~l~g~ 136 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV-----VNLLGA 136 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcE-----EEEEEE
Confidence 3468999999999999999999976543 67999998743 3445678899999999987 577 999998
Q ss_pred ecc-CceEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 020652 162 FDY-RNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (323)
Q Consensus 162 ~~~-~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NI 225 (323)
+.. ++.++|||||| +|+|.++|++.. ...+++..+..++.||+.||+|||+++||||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 755 56799999999 999999997542 13589999999999999999999999999999999999
Q ss_pred EEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHH
Q 020652 226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305 (323)
Q Consensus 226 li~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 305 (323)
|++.++.+||+|||+++....+... ......+||+.|||||++.+..|+.++||||||
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~----------------------~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~G 274 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDY----------------------VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 274 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTS----------------------EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred eeCCCCCEEECcchhhhhcccCCCc----------------------eeeccccccccccCHHHHhcCCCCCcccEeehH
Confidence 9988777766666655433221110 011235789999999999999999999999999
Q ss_pred HHHHHHhc-CCCCCCC
Q 020652 306 CILVELCS-VSNCYLT 320 (323)
Q Consensus 306 ~il~el~t-g~~pf~~ 320 (323)
|+||||+| |+.||.+
T Consensus 275 v~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 275 VLLWEIFSLGASPYPG 290 (353)
T ss_dssp HHHHHHTTTSCCSSTT
T ss_pred HHHHHHHhCCCCCCCC
Confidence 99999998 9999976
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=381.09 Aligned_cols=202 Identities=28% Similarity=0.446 Sum_probs=178.3
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
.+.++|++++.||+|+||+||+|+++.+|+.||||++... ....+.+.+|+.+|+.++|+|| ++++++|.+.+.
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnI-----v~l~~~~~~~~~ 228 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL-----VNLHDAFEDDNE 228 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTB-----CCEEEEEECSSE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCC-----CeEEEEEEECCE
Confidence 3457899999999999999999999999999999998753 3445678899999999999998 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+||||||| ||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 229 ~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~---------------- 291 (573)
T 3uto_A 229 MVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK---------------- 291 (573)
T ss_dssp EEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS----------------
T ss_pred EEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC----------------
Confidence 99999999 899999997543 369999999999999999999999999999999999999642
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
..+.+||+|||+|+...... ...+||+.|||||++.+..|+.++|||||||++|||++|..||.+.
T Consensus 292 ---------~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~ 359 (573)
T 3uto_A 292 ---------RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 359 (573)
T ss_dssp ---------SCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ---------CCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 23467888888887654433 3468999999999999999999999999999999999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=354.37 Aligned_cols=192 Identities=22% Similarity=0.255 Sum_probs=154.4
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc----
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN---- 166 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~---- 166 (323)
..+|.+.++||+|+||+||+|++ +|+.||||++............|+..+.+++|+|| +++++++...+
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNI-----v~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI-----LGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTB-----CCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCC-----CcEEEEEEecCCCce
Confidence 35799999999999999999986 58899999997654444444556666778889988 88888876543
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCcEEEeecCceeccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL--------RLIHTDLKPENILLVSAEYVKVPD 237 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--------~iiHrDlKp~NIli~~~~~~ki~d 237 (323)
.+||||||| +|+|.++++.. .++++.+..++.|++.||+|||++ +||||||||+||||+.++.+
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~---- 147 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC---- 147 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE----
T ss_pred EEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE----
Confidence 689999999 89999999875 499999999999999999999987 99999999999999766655
Q ss_pred cccccccCCCCCccccCCCCCCceEeeCCCcccccCC-------ccccccCCccccchhhcCC------CCCcchhHHHH
Q 020652 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGL------GWNYPCDLWSV 304 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSl 304 (323)
||+|||+|+..... ....+||+.|||||++.+. .++.++|||||
T Consensus 148 -----------------------Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~ 204 (303)
T 3hmm_A 148 -----------------------CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAM 204 (303)
T ss_dssp -----------------------EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHH
T ss_pred -----------------------EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhH
Confidence 45555554432211 1235799999999999765 36789999999
Q ss_pred HHHHHHHhcCCCCCC
Q 020652 305 GCILVELCSVSNCYL 319 (323)
Q Consensus 305 G~il~el~tg~~pf~ 319 (323)
||+||||+||..||.
T Consensus 205 Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 205 GLVFWEIARRCSIGG 219 (303)
T ss_dssp HHHHHHHHHTBCBTT
T ss_pred HHHHHHHHHCCCCCC
Confidence 999999999988764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=337.81 Aligned_cols=241 Identities=40% Similarity=0.743 Sum_probs=197.9
Q ss_pred CCCCceeEecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceE
Q 020652 77 DKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCV 156 (323)
Q Consensus 77 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~ 156 (323)
+....+.+..+..+.++|+++++||+|+||+||+|++..+++.||||++.......+....|+.+++.+.+..+.|++++
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 33445667788899999999999999999999999999999999999998766667778889999999985555556669
Q ss_pred EEcceeccCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceecc
Q 020652 157 QIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (323)
Q Consensus 157 ~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~ 236 (323)
++++++...+..++||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.....+..
T Consensus 100 ~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 179 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSL 179 (360)
T ss_dssp CEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEE
T ss_pred cccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccc
Confidence 99999999999999999999999999998766679999999999999999999999999999999999999753211000
Q ss_pred CcccccccCCCCCc-cccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCC
Q 020652 237 DYKFLSRSSKDGSY-FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 237 d~~~~~~~~~~~~~-~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~ 315 (323)
.. ... ..++.. .........+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 180 -~~-~~~-~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 180 -IT-VRR-VTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp -EE-EEC-TTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred -cc-hhc-ccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 00 000 000000 00002356789999999987766666778999999999999999999999999999999999999
Q ss_pred CCCCC
Q 020652 316 NCYLT 320 (323)
Q Consensus 316 ~pf~~ 320 (323)
.||.+
T Consensus 257 ~pf~~ 261 (360)
T 3llt_A 257 LLFRT 261 (360)
T ss_dssp CSCCC
T ss_pred CCCCC
Confidence 99975
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=334.05 Aligned_cols=197 Identities=23% Similarity=0.377 Sum_probs=166.7
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccC
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~ 165 (323)
.++|++++.||+|+||+||+|++..+++.||||++++. ....+...+|..+++.+ +|+|| +++++++...
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~I-----v~l~~~~~~~ 96 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL-----TQLFCCFQTP 96 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTB-----CCEEEEEECS
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCce-----eeEEEEEEeC
Confidence 36799999999999999999999999999999998753 23345677899999988 58887 8999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+.+|+||||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 97 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~i----------- 163 (353)
T 3txo_A 97 DRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHC----------- 163 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCE-----------
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCE-----------
Confidence 9999999999 899999998765 69999999999999999999999999999999999999766655
Q ss_pred CCCCCccccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 164 ----------------kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 227 (353)
T 3txo_A 164 ----------------KLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227 (353)
T ss_dssp ----------------EECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ----------------EEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence 555555554321 1223458999999999999989999999999999999999999999763
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=327.02 Aligned_cols=195 Identities=26% Similarity=0.428 Sum_probs=172.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||+||+|++..+++.||+|++++.. ...+.+.+|+.+++.+.|+|| +++++++.+.+.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~I-----v~~~~~~~~~~~ 80 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI-----IRMWGTFQDAQQ 80 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTB-----CCEEEEEECSSE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCC-----ceEeEEEEeCCE
Confidence 57999999999999999999999999999999987432 234567789999999999988 899999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+||||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--------------- 143 (318)
T 1fot_A 81 IFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--------------- 143 (318)
T ss_dssp EEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS---------------
T ss_pred EEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC---------------
Confidence 99999999 889999998765 699999999999999999999999999999999999996555
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 144 ------------~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 205 (318)
T 1fot_A 144 ------------HIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205 (318)
T ss_dssp ------------CEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ------------CEEEeecCcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 45666666666555445556899999999999999999999999999999999999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=328.55 Aligned_cols=195 Identities=23% Similarity=0.406 Sum_probs=169.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++++.||+|+||+||+|++..+++.||||++++. ....+.+.+|+.+++.++|+|| +++++++...+.
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~l~~~~~~~~~ 79 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL-----TALKYAFQTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTB-----CCEEEEEECSSE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcC-----cceEEEEEeCCE
Confidence 5799999999999999999999999999999998743 2334567889999999999888 889999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+||||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 80 ~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~v------------- 144 (337)
T 1o6l_A 80 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHI------------- 144 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCE-------------
T ss_pred EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCE-------------
Confidence 99999999 889999998765 69999999999999999999999999999999999999766655
Q ss_pred CCCccccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 145 --------------kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 207 (337)
T 1o6l_A 145 --------------KITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp --------------EECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------------EEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC
Confidence 455555444311 122345899999999999999999999999999999999999999975
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=325.30 Aligned_cols=198 Identities=27% Similarity=0.412 Sum_probs=171.5
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
..++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.++|+|| +++++++...+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~l~~~~~~~~ 87 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI-----VKLFEVIETEK 87 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEECSS
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEECC
Confidence 346799999999999999999999999999999998643 2345667899999999999998 89999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.+|+||||+ +++|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~------------- 152 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN------------- 152 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC-------------
T ss_pred EEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC-------------
Confidence 999999999 899999998765 6999999999999999999999999999999999999966554
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccC--CccccccCCccccchhhcCCCCC-cchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|||++|+.||.+.
T Consensus 153 --------------~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 153 --------------IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp --------------EEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --------------EEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 56666666543322 22345899999999999988875 8999999999999999999999763
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=335.43 Aligned_cols=217 Identities=40% Similarity=0.743 Sum_probs=190.7
Q ss_pred CceeEecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCC-CCCcceEEE
Q 020652 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHD-IGGTRCVQI 158 (323)
Q Consensus 80 ~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~-i~~~~~~~~ 158 (323)
+.+....++.+..+|++++.||+|+||+||+|.+..+++.||||++.......+.+.+|+.+++.++|.+ ..+.+++.+
T Consensus 85 ~~~~~~~~~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~ 164 (429)
T 3kvw_A 85 GSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHM 164 (429)
T ss_dssp SCBCCCTTCEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCE
T ss_pred CCccccCCCcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEE
Confidence 3444556678889999999999999999999999999999999999877666778889999999998763 234566999
Q ss_pred cceeccCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCc
Q 020652 159 RNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (323)
Q Consensus 159 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~ 238 (323)
++++...+.+++||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 165 ~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~------ 238 (429)
T 3kvw_A 165 LENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR------ 238 (429)
T ss_dssp EEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTS------
T ss_pred EeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCC------
Confidence 99999999999999999889999999877667999999999999999999999999999999999999965432
Q ss_pred ccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
..+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 239 -------------------~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf 299 (429)
T 3kvw_A 239 -------------------SGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLL 299 (429)
T ss_dssp -------------------CCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred -------------------cceEEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCC
Confidence 2378888888877666666678999999999999999999999999999999999999999
Q ss_pred CCC
Q 020652 319 LTP 321 (323)
Q Consensus 319 ~~~ 321 (323)
.+.
T Consensus 300 ~~~ 302 (429)
T 3kvw_A 300 PGE 302 (429)
T ss_dssp CCS
T ss_pred CCC
Confidence 763
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=324.96 Aligned_cols=202 Identities=25% Similarity=0.433 Sum_probs=178.0
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++.......+.+.+|+.+++.++|+|| +++++++...+.+
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~~~~ 76 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI-----LHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTB-----CCEEEEEEETTEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCC-----CeEeEEEecCCEE
Confidence 45688999999999999999999999999999999998666666778899999999999998 8999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~----------------- 138 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR----------------- 138 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-----------------
T ss_pred EEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-----------------
Confidence 9999999 889999997643 369999999999999999999999999999999999999641
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
....+||+|||++....... ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 139 --------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 206 (321)
T 1tki_A 139 --------RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp --------SCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --------CCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence 13457888888876543332 3357999999999999988999999999999999999999999763
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=330.21 Aligned_cols=216 Identities=39% Similarity=0.721 Sum_probs=190.9
Q ss_pred ceeEecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCcceEEEc
Q 020652 81 HYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIR 159 (323)
Q Consensus 81 ~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~ 159 (323)
.+.+..++.+.++|++.+.||+|+||+||+|++..+++.||||+++......+.+..|+.+++.+. |+++.+.+++.+.
T Consensus 43 ~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 43 DYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred cEEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 456677889999999999999999999999999999999999999876666677888999999997 5566666779999
Q ss_pred ceeccCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCcEEEeecCceeccC
Q 020652 160 NWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH--ELRLIHTDLKPENILLVSAEYVKVPD 237 (323)
Q Consensus 160 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~iiHrDlKp~NIli~~~~~~ki~d 237 (323)
+++...+..|+||||++++|.+++.......+++..++.++.|++.||.||| +.||+||||||+|||++.+
T Consensus 123 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~------- 195 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP------- 195 (382)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESST-------
T ss_pred eeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecC-------
Confidence 9999999999999999889999999876567999999999999999999999 5799999999999999532
Q ss_pred cccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
....+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 196 ------------------~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p 257 (382)
T 2vx3_A 196 ------------------KRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPL 257 (382)
T ss_dssp ------------------TSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ------------------CCCcEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 34467888888887766666667899999999999999999999999999999999999999
Q ss_pred CCCC
Q 020652 318 YLTP 321 (323)
Q Consensus 318 f~~~ 321 (323)
|.+.
T Consensus 258 f~~~ 261 (382)
T 2vx3_A 258 FSGA 261 (382)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 9863
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=332.28 Aligned_cols=243 Identities=32% Similarity=0.570 Sum_probs=195.0
Q ss_pred CCCceeEecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCC---Ccc
Q 020652 78 KDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG---GTR 154 (323)
Q Consensus 78 ~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~---~~~ 154 (323)
..+.+.+.+++.+.++|++.++||+|+||+||+|++..+++.||||++.......+.+.+|+.+++.+.|.+.. +.+
T Consensus 23 ~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~ 102 (397)
T 1wak_A 23 KGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102 (397)
T ss_dssp C--CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGG
T ss_pred CCCceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcce
Confidence 34566778899999999999999999999999999999999999999987766778889999999999976533 345
Q ss_pred eEEEcceec----cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEee
Q 020652 155 CVQIRNWFD----YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVS 229 (323)
Q Consensus 155 ~~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~iiHrDlKp~NIli~~ 229 (323)
++++++++. ....+|+||||++++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++.
T Consensus 103 iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~ 182 (397)
T 1wak_A 103 VVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSV 182 (397)
T ss_dssp BCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECC
T ss_pred eeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEec
Confidence 688888876 56789999999988999988876556799999999999999999999998 9999999999999987
Q ss_pred cCceeccCcccccccCC------C-----------CC-----ccccCCCCCCceEeeCCCcccccCCccccccCCccccc
Q 020652 230 AEYVKVPDYKFLSRSSK------D-----------GS-----YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAP 287 (323)
Q Consensus 230 ~~~~ki~d~~~~~~~~~------~-----------~~-----~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aP 287 (323)
++.....+++....... . +. ..........+||+|||.+..........+||+.|+||
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aP 262 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSL 262 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCH
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCC
Confidence 65322111111000000 0 00 00000122478999999998776666667899999999
Q ss_pred hhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 288 EVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 288 E~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
|++.+..++.++|||||||++|||++|+.||.+
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 295 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEP 295 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCC
Confidence 999999999999999999999999999999975
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=320.67 Aligned_cols=203 Identities=25% Similarity=0.412 Sum_probs=172.5
Q ss_pred ecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc----chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcc
Q 020652 85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (323)
Q Consensus 85 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~ 160 (323)
.+++.+.++|++.+.||+|+||.||+|++..+++.||+|++.. .....+.+.+|+.+++.++|+|| +++++
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----v~~~~ 78 (294)
T 4eqm_A 4 MIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI-----VSMID 78 (294)
T ss_dssp CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTB-----CCEEE
T ss_pred chhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCC-----ceEEE
Confidence 3567888999999999999999999999999999999998853 23445678899999999999998 88999
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
++...+.+|+||||+ +++|.+++.... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+
T Consensus 79 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~------ 150 (294)
T 4eqm_A 79 VDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTL------ 150 (294)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCE------
T ss_pred eeeeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE------
Confidence 999999999999999 889999998765 69999999999999999999999999999999999999765544
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~ 315 (323)
||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 151 ---------------------kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~ 209 (294)
T 4eqm_A 151 ---------------------KIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209 (294)
T ss_dssp ---------------------EECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ---------------------EEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence 55555555433221 22357999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 020652 316 NCYLTP 321 (323)
Q Consensus 316 ~pf~~~ 321 (323)
.||.+.
T Consensus 210 ~pf~~~ 215 (294)
T 4eqm_A 210 PPFNGE 215 (294)
T ss_dssp CSSCSS
T ss_pred CCCCCC
Confidence 999763
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=332.43 Aligned_cols=195 Identities=21% Similarity=0.392 Sum_probs=168.4
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~ 166 (323)
++|++++.||+|+||+||+|++..+++.||+|++++.. ...+.+..|..++.++ +|+|| +++++++...+
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~I-----v~l~~~~~~~~ 126 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL-----VGLHSCFQTES 126 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTB-----CCEEEEEECSS
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCc-----CeeEEEEEECC
Confidence 57999999999999999999999999999999987532 2234577899999887 78888 89999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.+|+||||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~i------------ 192 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHI------------ 192 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCE------------
T ss_pred EEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCE------------
Confidence 999999999 899999998765 79999999999999999999999999999999999999766655
Q ss_pred CCCCccccCCCCCCceEeeCCCcccc---cCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||+++.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 193 ---------------kL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 193 ---------------KLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp ---------------EECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred ---------------EEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 55555555431 1223346899999999999999999999999999999999999999963
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=326.68 Aligned_cols=196 Identities=24% Similarity=0.380 Sum_probs=169.7
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccC
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~ 165 (323)
.++|++.+.||+|+||.||+|+++.+++.||||++++.. ...+....|..++..+ .|+|| +++++++...
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~i-----v~l~~~~~~~ 90 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL-----THMFCTFQTK 90 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTB-----CCEEEEEECS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCC-----CcEEEEEEeC
Confidence 367999999999999999999999999999999987532 3345677899999887 78888 8899999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+.+|+||||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~v----------- 157 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHI----------- 157 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCE-----------
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCE-----------
Confidence 9999999999 899999998764 69999999999999999999999999999999999999766655
Q ss_pred CCCCCccccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||+++... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 158 ----------------kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (345)
T 1xjd_A 158 ----------------KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220 (345)
T ss_dssp ----------------EECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ----------------EEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence 555555544321 122346899999999999999999999999999999999999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=330.20 Aligned_cols=203 Identities=27% Similarity=0.487 Sum_probs=176.8
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh-------hHHHHHHHHHHHHHHHhCCCCCcceEEEcc
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~ 160 (323)
..+.++|++.+.||+|+||+||+|.+..+++.||+|++..... ..+.+.+|+.+++.+.|+|| +++++
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~l~~ 82 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI-----ITLHD 82 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTB-----CCEEE
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCC-----CcEEE
Confidence 4566789999999999999999999999999999999874321 34678899999999999988 89999
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
++...+.+++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 83 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~------- 153 (361)
T 2yab_A 83 VYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI------- 153 (361)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTS-------
T ss_pred EEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCC-------
Confidence 999999999999999 899999997654 7999999999999999999999999999999999999965431
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
....+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 154 ----------------~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~P 217 (361)
T 2yab_A 154 ----------------PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217 (361)
T ss_dssp ----------------SSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred ----------------CccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 1225688888877654332 2345799999999999999999999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 218 f~~ 220 (361)
T 2yab_A 218 FLG 220 (361)
T ss_dssp SCC
T ss_pred CCC
Confidence 976
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=328.78 Aligned_cols=195 Identities=26% Similarity=0.434 Sum_probs=173.1
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++++.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.++|+|| +++++++...+.
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~ 115 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL-----VKLEFSFKDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSSE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEcCCE
Confidence 57999999999999999999999999999999986432 234667889999999999888 889999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+||||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g--------------- 178 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--------------- 178 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---------------
T ss_pred EEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC---------------
Confidence 99999999 899999998765 699999999999999999999999999999999999996555
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+||+|||++..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 179 ------------~~kL~DFg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 240 (350)
T 1rdq_E 179 ------------YIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp ------------CEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ------------CEEEcccccceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC
Confidence 45666666666555445556899999999999999999999999999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=328.90 Aligned_cols=206 Identities=25% Similarity=0.409 Sum_probs=177.6
Q ss_pred EecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcc
Q 020652 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (323)
Q Consensus 84 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~ 160 (323)
......+.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.++|+|| +++++
T Consensus 21 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~ 95 (362)
T 2bdw_A 21 MNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI-----VRLHD 95 (362)
T ss_dssp ---CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred ecCCCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEE
Confidence 334556678899999999999999999999999999999998643 2344678899999999999998 89999
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
++...+..|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~-------- 165 (362)
T 2bdw_A 96 SIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA-------- 165 (362)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS--------
T ss_pred EEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC--------
Confidence 999999999999999 889999997654 699999999999999999999999999999999999996542
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
....+||+|||++....... ...+||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 166 ----------------~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P 229 (362)
T 2bdw_A 166 ----------------KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229 (362)
T ss_dssp ----------------TTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ----------------CCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 23457888888876544322 235899999999999999999999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 230 f~~ 232 (362)
T 2bdw_A 230 FWD 232 (362)
T ss_dssp SCC
T ss_pred CCC
Confidence 975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=323.02 Aligned_cols=237 Identities=46% Similarity=0.898 Sum_probs=200.3
Q ss_pred CCCCCceeEecCceeCCcEEEEeeecccCcEEEEEEEECCCC-cEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCC-Cc
Q 020652 76 DDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKK-ELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG-GT 153 (323)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~-~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~-~~ 153 (323)
++..+.+....++.+.++|++.+.||+|+||+||+|.+..++ +.||+|+++......+.+.+|+.+++.+.|++.. +.
T Consensus 3 ~~~~~~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~ 82 (355)
T 2eu9_A 3 DDKEGHLVCRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKF 82 (355)
T ss_dssp BCTTSCBCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCS
T ss_pred cccCCCcccccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCce
Confidence 455677888899999999999999999999999999998777 7899999987667778888999999999987643 33
Q ss_pred ceEEEcceeccCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCce
Q 020652 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ 233 (323)
.++.+.+++...+..++||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+...+..
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~ 162 (355)
T 2eu9_A 83 LCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFE 162 (355)
T ss_dssp CBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEE
T ss_pred eEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccc
Confidence 46788888988999999999999899999887665679999999999999999999999999999999999999765544
Q ss_pred eccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc
Q 020652 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313 (323)
Q Consensus 234 ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t 313 (323)
.+.+..... ....+....+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 163 ~~~~~~~~~--------~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 163 TLYNEHKSC--------EEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp EEECCC-CC--------CEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccccc--------cccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence 332221100 001134567899999999877666667789999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 020652 314 VSNCYLT 320 (323)
Q Consensus 314 g~~pf~~ 320 (323)
|..||.+
T Consensus 235 g~~pf~~ 241 (355)
T 2eu9_A 235 GFTLFQT 241 (355)
T ss_dssp SSCSCCC
T ss_pred CCCCCCC
Confidence 9999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=320.89 Aligned_cols=231 Identities=47% Similarity=0.864 Sum_probs=194.1
Q ss_pred eeEecCceeCCcEEEEeeecccCcEEEEEEEE-CCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCC-CcceEEEc
Q 020652 82 YVFAIGENLTPRYRILSKMGEGTFGQVVECFD-NEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG-GTRCVQIR 159 (323)
Q Consensus 82 ~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~-~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~-~~~~~~~~ 159 (323)
..+..++.+.++|++.+.||+|+||.||+|.+ ..+++.||||+++......+.+.+|+.+++.++|++.. +.++++++
T Consensus 4 ~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 4 LICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp GTCSTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred eeeecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 44567788999999999999999999999998 56889999999987666778889999999999998643 34568999
Q ss_pred ceeccCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 160 NWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 160 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
+++...+.+++||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++..+.....+.+
T Consensus 84 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~ 163 (339)
T 1z57_A 84 EWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPK 163 (339)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred cccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCc
Confidence 99999999999999999999999988765679999999999999999999999999999999999999765433222211
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
.... ........+||+|||.+...........||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 164 ~~~~--------~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 164 IKRD--------ERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp --CE--------EEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccc--------cccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCC
Confidence 1000 00012456899999999877666666789999999999999999999999999999999999999997
Q ss_pred C
Q 020652 320 T 320 (323)
Q Consensus 320 ~ 320 (323)
+
T Consensus 236 ~ 236 (339)
T 1z57_A 236 T 236 (339)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=334.55 Aligned_cols=199 Identities=26% Similarity=0.460 Sum_probs=159.6
Q ss_pred eCCcEEEE-eeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceecc---
Q 020652 90 LTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY--- 164 (323)
Q Consensus 90 ~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~--- 164 (323)
+.++|.+. +.||+|+||+||+|.+..+++.||||++... ..+.+|+.++.++ +|+|| +++++++..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~----~~~~~E~~~~~~~~~hp~i-----v~l~~~~~~~~~ 129 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHI-----VRIVDVYENLYA 129 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTB-----CCEEEEEEEEET
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc----hhHHHHHHHHHHhcCCCCc-----ceEeEEEeeccc
Confidence 34567776 7899999999999999999999999998643 3456788887554 67887 777777654
Q ss_pred -CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
...+|+||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~----------- 198 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR----------- 198 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSS-----------
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCC-----------
Confidence 67899999999 88999999876555799999999999999999999999999999999999996521
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
..+.+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 199 -------------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 265 (400)
T 1nxk_A 199 -------------PNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_dssp -------------TTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred -------------CCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 2345677888877654322 2346899999999999999999999999999999999999999975
Q ss_pred C
Q 020652 321 P 321 (323)
Q Consensus 321 ~ 321 (323)
.
T Consensus 266 ~ 266 (400)
T 1nxk_A 266 N 266 (400)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=326.94 Aligned_cols=203 Identities=28% Similarity=0.411 Sum_probs=174.7
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch------hhHHHHHHHHHHHHHHHhCCCCCcceEEEccee
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~ 162 (323)
.+.++|++.+.||+|+||+||+|.+..+++.||||++.... ...+.+.+|+.+++.++|+|| +++++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~ 95 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI-----VELLETY 95 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCC-----CcEEEEE
Confidence 45578999999999999999999999999999999986422 135678899999999999998 8999999
Q ss_pred ccCceEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 163 DYRNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
...+.+|+||||| +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~-------- 167 (351)
T 3c0i_A 96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKE-------- 167 (351)
T ss_dssp EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSS--------
T ss_pred EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCC--------
Confidence 9999999999999 89999888643 223589999999999999999999999999999999999996543
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~ 316 (323)
....+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 168 ----------------~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 231 (351)
T 3c0i_A 168 ----------------NSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231 (351)
T ss_dssp ----------------TTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ----------------CCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCC
Confidence 2344788888877654332 223579999999999999999999999999999999999999
Q ss_pred CCCC
Q 020652 317 CYLT 320 (323)
Q Consensus 317 pf~~ 320 (323)
||.+
T Consensus 232 pf~~ 235 (351)
T 3c0i_A 232 PFYG 235 (351)
T ss_dssp SSCS
T ss_pred CCCC
Confidence 9975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=324.74 Aligned_cols=198 Identities=21% Similarity=0.397 Sum_probs=169.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~ 166 (323)
++|++++.||+|+||.||+|++..+++.||+|++.+. ....+.+.+|+.+++++ +|+|| +++++++...+
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~i-----v~l~~~~~~~~ 83 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFL-----VGLHSCFQTES 83 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTB-----CCEEEEEECSS
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCcc-----CeEEEEEEeCC
Confidence 5799999999999999999999999999999998743 23345677899999887 78888 89999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.+|+||||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999 899999998765 69999999999999999999999999999999999999877766555555543211
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
. ........+||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 162 ~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 162 R------------------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp C------------------------TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C------------------------CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 1 11122345899999999999999999999999999999999999999964
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=335.48 Aligned_cols=196 Identities=24% Similarity=0.428 Sum_probs=168.4
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
..++|++++.||+|+||+||+|++..+++.||+|++.+.. ...+.+.+|+.+++.++|+|| +++++++.+.
T Consensus 67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~I-----v~l~~~~~~~ 141 (410)
T 3v8s_A 67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-----VQLFYAFQDD 141 (410)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTB-----CCEEEEEECS
T ss_pred CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEEC
Confidence 3468999999999999999999999999999999986422 122347789999999999998 8999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
..+|+||||+ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~i----------- 207 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHL----------- 207 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCE-----------
T ss_pred CEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCE-----------
Confidence 9999999999 99999999764 59999999999999999999999999999999999999766554
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCC----CCcchhHHHHHHHHHHHhcCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLG----WNYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~el~tg~~ 316 (323)
||+|||++...... ....+||+.|+|||++.+.. ++.++|||||||++|||++|+.
T Consensus 208 ----------------kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~ 271 (410)
T 3v8s_A 208 ----------------KLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271 (410)
T ss_dssp ----------------EECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSC
T ss_pred ----------------EEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCC
Confidence 55555555433222 22458999999999998765 7899999999999999999999
Q ss_pred CCCC
Q 020652 317 CYLT 320 (323)
Q Consensus 317 pf~~ 320 (323)
||.+
T Consensus 272 Pf~~ 275 (410)
T 3v8s_A 272 PFYA 275 (410)
T ss_dssp TTCC
T ss_pred CCCC
Confidence 9975
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=335.33 Aligned_cols=198 Identities=26% Similarity=0.407 Sum_probs=168.5
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh----hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK----YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~----~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
..++|+++++||+|+||+||+|++..+++.||+|++.+... ..+.+.+|+.++..++|+|| +++++++...
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~I-----v~l~~~~~~~ 146 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWI-----TTLHYAFQDD 146 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTB-----CCEEEEEECS
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEeeC
Confidence 44689999999999999999999999999999999874321 22337789999999999988 8999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+.+|+||||+ +++|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~v----------- 214 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHI----------- 214 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCE-----------
T ss_pred CEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCE-----------
Confidence 9999999999 999999998743 369999999999999999999999999999999999999766655
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhc-----CCCCCcchhHHHHHHHHHHHhcCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg~ 315 (323)
||+|||++...... ....+||+.|+|||++. ...++.++|||||||++|||++|+
T Consensus 215 ----------------kL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~ 278 (437)
T 4aw2_A 215 ----------------RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278 (437)
T ss_dssp ----------------EECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSS
T ss_pred ----------------EEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCC
Confidence 55555555332211 12358999999999997 456899999999999999999999
Q ss_pred CCCCC
Q 020652 316 NCYLT 320 (323)
Q Consensus 316 ~pf~~ 320 (323)
.||.+
T Consensus 279 ~Pf~~ 283 (437)
T 4aw2_A 279 TPFYA 283 (437)
T ss_dssp CTTCC
T ss_pred CCCCC
Confidence 99976
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=335.04 Aligned_cols=202 Identities=25% Similarity=0.410 Sum_probs=175.2
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
..+.++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+.+|+.+++.++|+|| +++++++..
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~l~~~~~~ 81 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI-----VRLHDSISE 81 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTB-----CCEEEEEEC
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCC-----CeEEEEEEE
Confidence 455678999999999999999999999999999999986432 344668899999999999998 899999999
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
.+..|+||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+.
T Consensus 82 ~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~------------ 147 (444)
T 3soa_A 82 EGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKL------------ 147 (444)
T ss_dssp SSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSS------------
T ss_pred CCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccC------------
Confidence 99999999999 899999998765 699999999999999999999999999999999999996431
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCCc---cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
....+||+|||++....... ...+||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 148 ------------~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~ 215 (444)
T 3soa_A 148 ------------KGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215 (444)
T ss_dssp ------------TTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ------------CCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 33567888888876544322 235899999999999999999999999999999999999999965
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=326.59 Aligned_cols=197 Identities=23% Similarity=0.341 Sum_probs=168.4
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccC
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~ 165 (323)
.++|++++.||+|+||+||+|++..+++.||||++++.. ...+.+..|..++..+ .|++| +++++++...
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~i-----v~l~~~~~~~ 93 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL-----TQLHSCFQTM 93 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTB-----CCEEEEEECS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEE-----eeEEEEEEcC
Confidence 367999999999999999999999999999999987532 3345677888888876 56766 8899999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+.+|+||||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 94 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~v----------- 160 (353)
T 2i0e_A 94 DRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHI----------- 160 (353)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCE-----------
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcE-----------
Confidence 9999999999 899999998765 69999999999999999999999999999999999999766655
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccc---cCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
||+|||++... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 161 ----------------kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 161 ----------------KIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp ----------------EECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ----------------EEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 55555544431 11223468999999999999999999999999999999999999999763
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=318.84 Aligned_cols=196 Identities=28% Similarity=0.427 Sum_probs=170.6
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
..++|++.++||+|+||+||+|.+..+++.||||++.... ...+.+.+|+.+++.++|+|| +++++++...+.+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~~ 92 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI-----VNYLDSYLVGDEL 92 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCC-----CeEeEEEEECCEE
Confidence 4468999999999999999999999999999999986432 345668899999999999998 8999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||||+ +++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~-------------- 155 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSV-------------- 155 (297)
T ss_dssp EEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCE--------------
T ss_pred EEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCE--------------
Confidence 9999999 99999999875 49999999999999999999999999999999999999765544
Q ss_pred CCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 156 -------------kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 218 (297)
T 3fxz_A 156 -------------KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (297)
T ss_dssp -------------EECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -------------EEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 55555555432221 2335799999999999999999999999999999999999999975
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=316.95 Aligned_cols=203 Identities=33% Similarity=0.573 Sum_probs=166.3
Q ss_pred cCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch------hhHHHHHHHHHHHHHHH---hCCCCCcceE
Q 020652 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------KYREAAMIEIDVLQRLA---RHDIGGTRCV 156 (323)
Q Consensus 86 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~------~~~~~~~~Ei~~l~~l~---~~~i~~~~~~ 156 (323)
+++.+.++|++.++||+|+||+||+|++..+++.||||++.... .......+|+.+++.+. |+|| +
T Consensus 3 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni-----v 77 (308)
T 3g33_A 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV-----V 77 (308)
T ss_dssp -------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTB-----C
T ss_pred CCcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCe-----E
Confidence 45667789999999999999999999999999999999986322 12345677888888876 8888 8
Q ss_pred EEcceeccCc-----eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC
Q 020652 157 QIRNWFDYRN-----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (323)
Q Consensus 157 ~~~~~~~~~~-----~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~ 231 (323)
++++++.... .+++||||++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 78 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 78 RLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG 157 (308)
T ss_dssp CEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS
T ss_pred EeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC
Confidence 8888776543 68999999988999999987655699999999999999999999999999999999999997655
Q ss_pred ceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccC--CccccccCCccccchhhcCCCCCcchhHHHHHHHHH
Q 020652 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (323)
Q Consensus 232 ~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (323)
. +||+|||++..... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 158 ~---------------------------~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 210 (308)
T 3g33_A 158 T---------------------------VKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 210 (308)
T ss_dssp C---------------------------EEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHH
T ss_pred C---------------------------EEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHH
Confidence 4 46666666544322 223458999999999999999999999999999999
Q ss_pred HHhcCCCCCCC
Q 020652 310 ELCSVSNCYLT 320 (323)
Q Consensus 310 el~tg~~pf~~ 320 (323)
||++|+.||.+
T Consensus 211 ~l~~g~~pf~~ 221 (308)
T 3g33_A 211 EMFRRKPLFCG 221 (308)
T ss_dssp HTTTSSCSCCC
T ss_pred HHHhCCCCCCC
Confidence 99999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=337.00 Aligned_cols=225 Identities=28% Similarity=0.447 Sum_probs=162.1
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEccee---
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF--- 162 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~--- 162 (323)
.+.++|++++.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+|+.++|+|| +++++++
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l~~~~~~~ 124 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV-----VKVLDIVIPK 124 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEECCCS
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCC-----CceEEEEecC
Confidence 3457899999999999999999999999999999998642 2345678899999999999998 7888877
Q ss_pred --ccCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 163 --DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 163 --~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
+....+|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus 125 ~~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 125 DVEKFDELYVVLEIADSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp CTTTCCCEEEEECCCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred CcccCceEEEEEeccccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeeccccc
Confidence 3446799999999999999998754 799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCccccC---CCCCCceEeeCCCcccccCCccccccCCccccchhhc-CCCCCcchhHHHHHHHHHHHhc---
Q 020652 241 LSRSSKDGSYFKNL---PKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCS--- 313 (323)
Q Consensus 241 ~~~~~~~~~~~~~~---~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~el~t--- 313 (323)
+............. .......+.+|+............+||+.|+|||++. +..|+.++|||||||+||||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 87654432211111 1112234455554444444445568999999999874 5679999999999999999999
Q ss_pred --------CCCCCCC
Q 020652 314 --------VSNCYLT 320 (323)
Q Consensus 314 --------g~~pf~~ 320 (323)
|+++|.+
T Consensus 283 ~~~~~~~~~~p~f~g 297 (458)
T 3rp9_A 283 ENVAYHADRGPLFPG 297 (458)
T ss_dssp TTCSSGGGCCCSCC-
T ss_pred ccccccccccccCCC
Confidence 6777765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=321.79 Aligned_cols=203 Identities=25% Similarity=0.326 Sum_probs=172.2
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCce
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
.+.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+++.+ .|+|+ +++++++...+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i-----~~~~~~~~~~~~ 79 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGI-----PQVYYFGPCGKY 79 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTS-----CCEEEEEEETTE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCC-----CEEEEEEecCCc
Confidence 35578999999999999999999999999999999986432 234578899999999 88888 888899999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
.++||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 80 ~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~--------------- 143 (330)
T 2izr_A 80 NAMVLELLGPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGN--------------- 143 (330)
T ss_dssp EEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGG---------------
T ss_pred cEEEEEeCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCC---------------
Confidence 99999999999999998753 47999999999999999999999999999999999999987654
Q ss_pred CCccccCCCCCCceEeeCCCcccccCC----------ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
.....+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 144 -------~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~P 216 (330)
T 2izr_A 144 -------KTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216 (330)
T ss_dssp -------TCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred -------CCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCC
Confidence 11223566666666532221 1345899999999999999999999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 217 f~~ 219 (330)
T 2izr_A 217 WQG 219 (330)
T ss_dssp TTT
T ss_pred ccc
Confidence 976
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=332.08 Aligned_cols=199 Identities=26% Similarity=0.397 Sum_probs=169.0
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
..++|++++.||+|+||+||+|+++.+++.||||++++.. ...+.+.+|+.++..++|+|| +++++++.+.
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~I-----v~l~~~~~~~ 133 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI-----TQLHFAFQDE 133 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTB-----CCEEEEEECS
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEeeC
Confidence 3468999999999999999999999999999999987432 223447789999999999988 8999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+.+|+||||+ +++|.+++.+.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~v----------- 201 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHI----------- 201 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCE-----------
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCE-----------
Confidence 9999999999 999999998753 369999999999999999999999999999999999999766655
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhc-------CCCCCcchhHHHHHHHHHHHhc
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVIL-------GLGWNYPCDLWSVGCILVELCS 313 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~el~t 313 (323)
||+|||++...... ....+||+.|+|||++. +..++.++|||||||++|||++
T Consensus 202 ----------------kL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyellt 265 (412)
T 2vd5_A 202 ----------------RLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265 (412)
T ss_dssp ----------------EECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHH
T ss_pred ----------------EEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHh
Confidence 55555554432221 12358999999999997 3568999999999999999999
Q ss_pred CCCCCCCC
Q 020652 314 VSNCYLTP 321 (323)
Q Consensus 314 g~~pf~~~ 321 (323)
|+.||.+.
T Consensus 266 G~~Pf~~~ 273 (412)
T 2vd5_A 266 GQTPFYAD 273 (412)
T ss_dssp SSCTTCCS
T ss_pred CCCCCCCC
Confidence 99999763
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=320.36 Aligned_cols=203 Identities=27% Similarity=0.488 Sum_probs=176.0
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh-------hHHHHHHHHHHHHHHHhCCCCCcceEEEcc
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~ 160 (323)
+.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ..+.+.+|+.+++.++|+|| +++++
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~ 81 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV-----ITLHE 81 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCC-----CcEEE
Confidence 3456789999999999999999999999999999999864321 35678899999999999998 88999
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
++......++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~-------- 151 (326)
T 2y0a_A 82 VYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN-------- 151 (326)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSS--------
T ss_pred EEEeCCEEEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCC--------
Confidence 999999999999999 899999997654 799999999999999999999999999999999999997554
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccC--CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
.....+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 152 ---------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 216 (326)
T 2y0a_A 152 ---------------VPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216 (326)
T ss_dssp ---------------SSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred ---------------CCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCC
Confidence 1123567888887765432 22345799999999999999999999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 217 f~~ 219 (326)
T 2y0a_A 217 FLG 219 (326)
T ss_dssp SCC
T ss_pred CCC
Confidence 975
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-44 Score=322.42 Aligned_cols=199 Identities=26% Similarity=0.403 Sum_probs=171.7
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
...++|++.+.||+|+||+||+|.+..+++.||||++.... ...+.+.+|+.+++.++|+|| +++++++..
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~l~~~~~~ 80 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHI-----IKLYDVITT 80 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTB-----CCEEEEEEC
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEe
Confidence 34578999999999999999999999999999999986432 223568899999999999998 899999999
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 165 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
.+.+++||||++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~lv~E~~~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~------------ 146 (336)
T 3h4j_B 81 PTDIVMVIEYAGGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN------------ 146 (336)
T ss_dssp SSEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC------------
T ss_pred CCEEEEEEECCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC------------
Confidence 99999999999999999998765 6999999999999999999999999999999999999965554
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+||+|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.
T Consensus 147 ---------------~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 147 ---------------VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp ---------------EEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred ---------------EEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 566666665543222 234579999999999998876 78999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-44 Score=325.50 Aligned_cols=198 Identities=29% Similarity=0.423 Sum_probs=166.9
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
.++|++++.||+|+||+||+|++..+++.||||++.......+.+.+|+.+++.++|+|| +++++++...+.+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~~~l 93 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNI-----VRFKEVILTPTHLAI 93 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTB-----CCEEEEEECSSEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCC-----CcEEEEEeeCCEEEE
Confidence 367999999999999999999999999999999998766666778899999999999998 899999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 94 v~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~------------------ 153 (361)
T 3uc3_A 94 IMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSP------------------ 153 (361)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSS------------------
T ss_pred EEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC------------------
Confidence 99999 899999998765 699999999999999999999999999999999999996433
Q ss_pred ccccCCCCCCceEeeCCCccccc--CCccccccCCccccchhhcCCCCCcc-hhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEH--QDHSYVVSTRHYRAPEVILGLGWNYP-CDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~ 320 (323)
...+||+|||++.... ......+||+.|+|||++.+..++.+ +|||||||++|||++|+.||.+
T Consensus 154 -------~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (361)
T 3uc3_A 154 -------APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220 (361)
T ss_dssp -------SCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred -------CceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence 2346788888776322 22334579999999999998887755 8999999999999999999976
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=326.42 Aligned_cols=196 Identities=26% Similarity=0.454 Sum_probs=169.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
.++|++++.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.+++.++|+|| +++++++...+
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~I-----v~l~~~~~~~~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL-----VNLWYSFQDEE 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSS
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEeCC
Confidence 468999999999999999999999999999999986432 234567889999999999988 88999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~------------- 153 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH------------- 153 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC-------------
T ss_pred EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC-------------
Confidence 999999999 999999998754 6999999999999999999999999999999999999976554
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccC--CccccccCCccccchhhcC---CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 154 --------------vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 154 --------------VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp --------------EEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------------EEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence 45566665544322 2234689999999999974 4589999999999999999999999974
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=316.84 Aligned_cols=201 Identities=31% Similarity=0.493 Sum_probs=169.3
Q ss_pred cCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEccee
Q 020652 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 86 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~ 162 (323)
.++.+.++|+++++||+|+||+||+|++. +++.||+|++.... ...+.+.+|+.+++.++|+|| +++++++
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~ 88 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI-----VSLIDVI 88 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCE-----eeeeeEE
Confidence 34667889999999999999999999985 58899999987432 234667899999999999998 8999999
Q ss_pred ccCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 163 DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 163 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
...+.+++||||+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 89 ~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~---------- 157 (311)
T 3niz_A 89 HSERCLTLVFEFMEKDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA---------- 157 (311)
T ss_dssp CCSSCEEEEEECCSEEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC----------
T ss_pred ccCCEEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC----------
Confidence 9999999999999889999988654 46999999999999999999999999999999999999976554
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 158 -----------------~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf 220 (311)
T 3niz_A 158 -----------------LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF 220 (311)
T ss_dssp -----------------EEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred -----------------EEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCC
Confidence 466666665543221 223478999999999987 46899999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 221 ~~ 222 (311)
T 3niz_A 221 PG 222 (311)
T ss_dssp CC
T ss_pred CC
Confidence 76
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=333.04 Aligned_cols=206 Identities=29% Similarity=0.491 Sum_probs=168.2
Q ss_pred CceeEecCc---eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCc
Q 020652 80 GHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGT 153 (323)
Q Consensus 80 ~~~~~~~~~---~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~ 153 (323)
..+.+.+++ .+.++|+++++||+|+||+||+|++..+++.||||++... ....+.+.+|+.+++.++|+||
T Consensus 47 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI--- 123 (464)
T 3ttj_A 47 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI--- 123 (464)
T ss_dssp CEEEEEC--CEEEEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTB---
T ss_pred cceeeecCCcceeecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCC---
Confidence 445555555 5678999999999999999999999999999999998742 3445677899999999999998
Q ss_pred ceEEEcceeccC------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 020652 154 RCVQIRNWFDYR------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227 (323)
Q Consensus 154 ~~~~~~~~~~~~------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli 227 (323)
+++++++... ..+|+||||++++|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 124 --v~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll 197 (464)
T 3ttj_A 124 --ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 197 (464)
T ss_dssp --CCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred --CcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE
Confidence 7888877543 56899999998888888753 48999999999999999999999999999999999999
Q ss_pred eecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHH
Q 020652 228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305 (323)
Q Consensus 228 ~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 305 (323)
+.++. +||+|||+++..... ....+||+.|+|||++.+..|+.++||||||
T Consensus 198 ~~~~~---------------------------~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 250 (464)
T 3ttj_A 198 KSDCT---------------------------LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 250 (464)
T ss_dssp CTTSC---------------------------EEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHH
T ss_pred eCCCC---------------------------EEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHH
Confidence 76554 566666666543322 2345899999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCC
Q 020652 306 CILVELCSVSNCYLTP 321 (323)
Q Consensus 306 ~il~el~tg~~pf~~~ 321 (323)
|++|||++|+.||.+.
T Consensus 251 ~il~ell~g~~pF~g~ 266 (464)
T 3ttj_A 251 CIMGEMVRHKILFPGR 266 (464)
T ss_dssp HHHHHHHHSSCSSCCS
T ss_pred HHHHHHHhCCCCCCCC
Confidence 9999999999999863
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=327.42 Aligned_cols=195 Identities=25% Similarity=0.429 Sum_probs=159.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHH-HHHHHhCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDV-LQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~-l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
++|++++.||+|+||+||+|+++.+++.||||++.+.. .....+..|..+ ++.++|+|| +++++++...+
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~I-----v~l~~~~~~~~ 112 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL-----VGLHFSFQTAD 112 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTB-----CCEEEEEECSS
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCC-----CCEEEEEEeCC
Confidence 57999999999999999999999999999999987533 222344556555 455667776 89999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.+|+||||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~--------- 181 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLT--------- 181 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEEC---------
T ss_pred EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEe---------
Confidence 999999999 889999998765 69999999999999999999999999999999999999776655555
Q ss_pred CCCCccccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
|||+++... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 182 ------------------DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 241 (373)
T 2r5t_A 182 ------------------DFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241 (373)
T ss_dssp ------------------CCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ------------------eCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 555443211 122346899999999999999999999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=323.46 Aligned_cols=198 Identities=27% Similarity=0.510 Sum_probs=164.7
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+.++|++++.||+|+||.||+|.+..+++.||||++.. .....+.+.+|+.+++.++|+|| +++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~l~~~~~~~ 96 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV-----IGLLDVFTPD 96 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTB-----CCCSEEECSC
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCC-----CCceeeEecC
Confidence 345789999999999999999999999999999999853 23345677899999999999998 7788877654
Q ss_pred ------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 166 ------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 166 ------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
..+|+||||++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 97 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-------- 165 (367)
T 1cm8_A 97 ETLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-------- 165 (367)
T ss_dssp SSTTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC--------
T ss_pred CccccCceEEEEEecCCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC--------
Confidence 356999999999999999874 599999999999999999999999999999999999996554
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
.+||+|||+++.........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 166 -------------------~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 226 (367)
T 1cm8_A 166 -------------------ELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF 226 (367)
T ss_dssp -------------------CEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred -------------------CEEEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC
Confidence 4566777766655544555689999999999988 67999999999999999999999999
Q ss_pred CCC
Q 020652 319 LTP 321 (323)
Q Consensus 319 ~~~ 321 (323)
.+.
T Consensus 227 ~~~ 229 (367)
T 1cm8_A 227 KGS 229 (367)
T ss_dssp CCS
T ss_pred CCC
Confidence 863
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=326.61 Aligned_cols=223 Identities=26% Similarity=0.439 Sum_probs=166.3
Q ss_pred CceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHH-hCCCCCcceEEEccee
Q 020652 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWF 162 (323)
Q Consensus 87 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~ 162 (323)
+..+.++|++++.||+|+||.||+|.+..+++.||||++.. .....+...+|+.+++.+. |+|| +++++++
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~ni-----v~l~~~~ 78 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENI-----VNLLNVL 78 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTB-----CCEEEEE
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCC-----CeeeeEE
Confidence 44566899999999999999999999999999999998853 2344566778999999998 8888 8888887
Q ss_pred cc--CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 163 DY--RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 163 ~~--~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
.. ...+|+||||++++|.+++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 79 RADNDRDVYLVFDYMETDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp ECTTSSCEEEEEECCSEEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ecCCCCEEEEEecccCcCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 64 3479999999988999999874 599999999999999999999999999999999999999888888888887
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCc-ccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGST-TFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a-~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
+.............. ..+.+.... ..........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 156 a~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf 231 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIP----LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF 231 (388)
T ss_dssp CEESSSCCCCCCCGG----GCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccccccc----ccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC
Confidence 655432211000000 000000000 000111233589999999999987 57899999999999999999999999
Q ss_pred CCC
Q 020652 319 LTP 321 (323)
Q Consensus 319 ~~~ 321 (323)
.+.
T Consensus 232 ~~~ 234 (388)
T 3oz6_A 232 PGS 234 (388)
T ss_dssp CCS
T ss_pred CCC
Confidence 763
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-43 Score=322.78 Aligned_cols=206 Identities=19% Similarity=0.251 Sum_probs=175.4
Q ss_pred CcEEEEeeeccc--CcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEG--TFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G--~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
++|+++++||+| +||.||+|++..+++.||||++... ....+.+.+|+.+++.++|+|| +++++++...+
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~ 99 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNI-----VPYRATFIADN 99 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETT
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCC-----CcEeEEEEECC
Confidence 579999999999 9999999999999999999998743 3345667889999999999998 89999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||.+..
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~-- 177 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS-- 177 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE--
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee--
Confidence 999999999 89999999887555799999999999999999999999999999999999998888887777775432
Q ss_pred CCCCccccCCCCCCceEeeCCCcccc-cCCccccccCCccccchhhcC--CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFE-HQDHSYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+.+.|..... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+
T Consensus 178 ----------------~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 178 ----------------MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp ----------------CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ----------------eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 2222221111 111223478999999999988 5799999999999999999999999976
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=311.56 Aligned_cols=213 Identities=19% Similarity=0.323 Sum_probs=172.5
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc-chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS-INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~-~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
++|++.+.||+|+||+||+|.+..+++.||+|++.. .....+.+.+|+.+++.++|+|| +++++++...+..++
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~~~l 84 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV-----LKFIGVLYKDKRLNF 84 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCc-----ccEEEEEecCCeeEE
Confidence 579999999999999999999999999999998764 34556778899999999999988 899999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 85 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 85 ITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999 889999998754 4699999999999999999999999999999999999998877777766666543322211
Q ss_pred ccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
..... . .............+||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 164 ~~~~~--------~--~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~ 224 (310)
T 3s95_A 164 QPEGL--------R--SLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224 (310)
T ss_dssp --------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred ccccc--------c--cccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence 00000 0 0000001111245799999999999999999999999999999999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=320.90 Aligned_cols=201 Identities=27% Similarity=0.495 Sum_probs=162.0
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
+.+.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.++++++|+|| +++++++...+.
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~ 122 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNI-----IKLKEIFETPTE 122 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTB-----CCEEEEEECSSE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCC-----cceeeeEecCCe
Confidence 456788999999999999999999999999999999987543 34567789999999999998 899999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 123 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~---------------- 184 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATP---------------- 184 (349)
T ss_dssp EEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSS----------------
T ss_pred EEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecC----------------
Confidence 99999999 899999998654 69999999999999999999999999999999999999641
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+....+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 185 --------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 252 (349)
T 2w4o_A 185 --------APDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252 (349)
T ss_dssp --------STTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred --------CCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 12455778888877654332 2345799999999999999999999999999999999999999965
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=309.62 Aligned_cols=205 Identities=24% Similarity=0.325 Sum_probs=173.9
Q ss_pred CceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccC
Q 020652 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 87 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~ 165 (323)
++.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+++.+ .|+++ +.+++++...
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i-----~~~~~~~~~~ 78 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGI-----PNVYYFGQEG 78 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTC-----CCEEEEEEET
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCC-----CeEEeecCCC
Confidence 4567789999999999999999999999999999999886433 334577899999999 56777 7778888888
Q ss_pred ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 166 NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
...++||||++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 79 ~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~------------- 144 (298)
T 1csn_A 79 LHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNS------------- 144 (298)
T ss_dssp TEEEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSS-------------
T ss_pred ceeEEEEEecCCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCC-------------
Confidence 9999999999999999998754 46999999999999999999999999999999999999976552
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCC----------ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~ 315 (323)
.....+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 145 ---------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 215 (298)
T 1csn_A 145 ---------KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 215 (298)
T ss_dssp ---------TTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred ---------CCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCC
Confidence 12334677777766543321 23357999999999999999999999999999999999999
Q ss_pred CCCCC
Q 020652 316 NCYLT 320 (323)
Q Consensus 316 ~pf~~ 320 (323)
.||.+
T Consensus 216 ~pf~~ 220 (298)
T 1csn_A 216 LPWQG 220 (298)
T ss_dssp CTTSS
T ss_pred CCcch
Confidence 99976
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=323.20 Aligned_cols=201 Identities=25% Similarity=0.440 Sum_probs=174.8
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++|+|| +++++++.....+
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~~~ 123 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL-----INLHDAFEDKYEM 123 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTB-----CCEEEEEECSSEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCC-----CeEEEEEEeCCEE
Confidence 4468999999999999999999999999999999987542 344578899999999999988 8999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~----------------- 185 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK----------------- 185 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-----------------
T ss_pred EEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC-----------------
Confidence 9999999 899999987543 469999999999999999999999999999999999999532
Q ss_pred CCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
....+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 186 --------~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 253 (387)
T 1kob_A 186 --------KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253 (387)
T ss_dssp --------TCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred --------CCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence 2345788888887654432 23357999999999999999999999999999999999999999763
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=309.37 Aligned_cols=195 Identities=31% Similarity=0.521 Sum_probs=166.4
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++|+++++||+|+||+||+|++..+++.||||++... ....+.+.+|+.++++++|+|| +++++++...+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI-----VRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCE-----eeEEeEEEeCCEE
Confidence 5799999999999999999999999999999998643 2334677899999999999988 8999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
++||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 77 ~lv~e~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~--------------- 140 (292)
T 3o0g_A 77 TLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGEL--------------- 140 (292)
T ss_dssp EEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCE---------------
T ss_pred EEEEecCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCE---------------
Confidence 9999999888888877644 469999999999999999999999999999999999999765544
Q ss_pred CccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
||+|||.+..... ......||+.|+|||++.+.. ++.++|||||||++|||++|..||.
T Consensus 141 ------------kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 141 ------------KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp ------------EECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred ------------EEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc
Confidence 5555555543321 123347899999999998765 8999999999999999999888864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=321.63 Aligned_cols=208 Identities=21% Similarity=0.300 Sum_probs=166.1
Q ss_pred eCCcEEEEeeecccCcEEEEEE-----EECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH---hCCCCCcceEEEcce
Q 020652 90 LTPRYRILSKMGEGTFGQVVEC-----FDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA---RHDIGGTRCVQIRNW 161 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~-----~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~---~~~i~~~~~~~~~~~ 161 (323)
..++|++.+.||+|+||+||+| .+..+++.||||++.... ...+..|+.+++.+. |+|+ +.++++
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~e~~~~~~l~~~~~~~i-----v~~~~~ 135 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN--PWEFYIGTQLMERLKPSMQHMF-----MKFYSA 135 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC--HHHHHHHHHHHHHSCGGGGGGB-----CCEEEE
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC--hhHHHHHHHHHHHhhhhhhhhh-----hhhhee
Confidence 3468999999999999999999 467789999999987543 446778888888876 4555 899999
Q ss_pred eccCceEEEEEccC-CCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccC
Q 020652 162 FDYRNHICIVFEKL-GPSLYDFLRKN---SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (323)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d 237 (323)
+...+..|+||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||++.+..-
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~---- 211 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE---- 211 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC----
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC----
Confidence 99999999999999 89999999742 23469999999999999999999999999999999999999752100
Q ss_pred cccccccCCCCCccccCCCCCCceEeeCCCccccc-----CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHh
Q 020652 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH-----QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 312 (323)
.. ...+....+||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 212 --------~~----~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 279 (365)
T 3e7e_A 212 --------QD----DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML 279 (365)
T ss_dssp --------C----------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHH
T ss_pred --------cc----ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHH
Confidence 00 001124567888888885432 1123357999999999999999999999999999999999
Q ss_pred cCCCCCCC
Q 020652 313 SVSNCYLT 320 (323)
Q Consensus 313 tg~~pf~~ 320 (323)
||+.||..
T Consensus 280 tg~~pf~~ 287 (365)
T 3e7e_A 280 FGTYMKVK 287 (365)
T ss_dssp HSSCCCEE
T ss_pred hCCCcccc
Confidence 99999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=333.51 Aligned_cols=199 Identities=23% Similarity=0.380 Sum_probs=171.3
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
.++|++.+.||+|+||+||+|++..+++.||||++.+.. ...+.+.+|+.+++.++|+|| +++++++....
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-----v~l~~~~~~~~ 258 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFI-----VSLAYAFETKT 258 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTB-----CCEEEEEECSS
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCE-----eeEEEEEeeCC
Confidence 368999999999999999999999999999999986432 234567889999999999988 88999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 167 HICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
.+|+||||+ |++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~v---------- 328 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNV---------- 328 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCE----------
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCE----------
Confidence 999999999 899999998643 3469999999999999999999999999999999999999766655
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 329 -----------------kL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~ 391 (543)
T 3c4z_A 329 -----------------RISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391 (543)
T ss_dssp -----------------EECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -----------------EEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCC
Confidence 55555555433221 1234899999999999999999999999999999999999999976
Q ss_pred C
Q 020652 321 P 321 (323)
Q Consensus 321 ~ 321 (323)
.
T Consensus 392 ~ 392 (543)
T 3c4z_A 392 R 392 (543)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=321.32 Aligned_cols=199 Identities=24% Similarity=0.458 Sum_probs=170.6
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCce
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
.+.++|++.+.||+|+||+||+|.+..+++.||||++..... ...+|++++.++ .|+|| +++++++.+.+.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~i-----v~~~~~~~~~~~ 90 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNI-----ITLKDVYDDGKY 90 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTB-----CCEEEEEECSSE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCc-----CeEEEEEEcCCE
Confidence 456789999999999999999999999999999999875432 235688888888 68888 899999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+||||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||+....
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~--------------- 153 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDES--------------- 153 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS---------------
T ss_pred EEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCC---------------
Confidence 99999999 899999998764 699999999999999999999999999999999999984321
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.....+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 154 --------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 154 --------GNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp --------CSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred --------CCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 11234788888887654332 2345799999999999988899999999999999999999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=332.45 Aligned_cols=210 Identities=28% Similarity=0.495 Sum_probs=178.0
Q ss_pred CceeEecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--------------hhHHHHHHHHHHHHHH
Q 020652 80 GHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--------------KYREAAMIEIDVLQRL 145 (323)
Q Consensus 80 ~~~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--------------~~~~~~~~Ei~~l~~l 145 (323)
+.+.......+.++|+++++||+|+||+||+|.+..+++.||||++.... ...+.+.+|+.+++.+
T Consensus 24 ~~~~~~~~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 103 (504)
T 3q5i_A 24 GMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103 (504)
T ss_dssp GGGCCEECSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC
T ss_pred hheeeccCCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC
Confidence 34444555677889999999999999999999999999999999987432 2346788999999999
Q ss_pred HhCCCCCcceEEEcceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 020652 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN 224 (323)
Q Consensus 146 ~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~N 224 (323)
+|+|| +++++++.....+|+||||| +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|
T Consensus 104 ~hpni-----v~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~N 176 (504)
T 3q5i_A 104 DHPNI-----IKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHNIVHRDIKPEN 176 (504)
T ss_dssp CCTTB-----CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCCCC-----CeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHH
Confidence 99998 99999999999999999999 889999998765 69999999999999999999999999999999999
Q ss_pred EEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHH
Q 020652 225 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLW 302 (323)
Q Consensus 225 Ili~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Diw 302 (323)
||++.++ ....+||+|||++...... ....+||+.|+|||++.+ .++.++|||
T Consensus 177 il~~~~~------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Diw 231 (504)
T 3q5i_A 177 ILLENKN------------------------SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVW 231 (504)
T ss_dssp EEESSTT------------------------CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHH
T ss_pred EEEecCC------------------------CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHH
Confidence 9996543 2235788888888654432 234579999999999875 689999999
Q ss_pred HHHHHHHHHhcCCCCCCCC
Q 020652 303 SVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 303 SlG~il~el~tg~~pf~~~ 321 (323)
||||++|+|++|..||.+.
T Consensus 232 slG~il~~ll~g~~pf~~~ 250 (504)
T 3q5i_A 232 SCGVIMYILLCGYPPFGGQ 250 (504)
T ss_dssp HHHHHHHHHHHSSCSSCCS
T ss_pred HHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999763
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=313.97 Aligned_cols=204 Identities=24% Similarity=0.357 Sum_probs=170.7
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
.+.++|++.+.||+|+||+||+|.+..+++.||||++.... ...+.+.+|+.++++++|+|| +++++++....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~ 80 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI-----VKLFAIEEETT 80 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEECTT
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCc-----ceEEEEeecCC
Confidence 44578999999999999999999999999999999987433 334667899999999999998 88888776544
Q ss_pred --eEEEEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 167 --HICIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 167 --~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+....
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~----------- 149 (319)
T 4euu_A 81 TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE----------- 149 (319)
T ss_dssp TCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECT-----------
T ss_pred CceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccC-----------
Confidence 889999999 8999999986432 2399999999999999999999999999999999999983221
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhc--------CCCCCcchhHHHHHHHHHHHh
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVIL--------GLGWNYPCDLWSVGCILVELC 312 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~el~ 312 (323)
+....+||+|||++....... ....||+.|+|||++. +..++.++|||||||++|||+
T Consensus 150 ------------~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~ 217 (319)
T 4euu_A 150 ------------DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217 (319)
T ss_dssp ------------TSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHH
T ss_pred ------------CCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHH
Confidence 233456788888776543332 3357999999999986 567899999999999999999
Q ss_pred cCCCCCCC
Q 020652 313 SVSNCYLT 320 (323)
Q Consensus 313 tg~~pf~~ 320 (323)
+|+.||..
T Consensus 218 ~g~~pf~~ 225 (319)
T 4euu_A 218 TGSLPFRP 225 (319)
T ss_dssp HSSCSEEC
T ss_pred hCCCCCCC
Confidence 99999964
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=335.03 Aligned_cols=200 Identities=23% Similarity=0.396 Sum_probs=173.0
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
..++|++.+.||+|+||.||+|++..+++.||||++.+.. .....+.+|+.+|+.++|+|| +++++++...
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~I-----v~l~~~~~~~ 256 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFV-----VSLAYAYETK 256 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTB-----CCEEEEEECS
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCE-----eeEEEEEeeC
Confidence 3467999999999999999999999999999999986432 234567889999999999988 8899999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+.+|+||||+ |++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~v----------- 325 (576)
T 2acx_A 257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHI----------- 325 (576)
T ss_dssp SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCE-----------
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCe-----------
Confidence 9999999999 9999999987665569999999999999999999999999999999999999766554
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 326 ----------------KL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 326 ----------------RISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp ----------------EECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred ----------------EEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 55555555443222 23358999999999999999999999999999999999999999863
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=314.74 Aligned_cols=197 Identities=24% Similarity=0.389 Sum_probs=162.3
Q ss_pred CCcEEEEeeecccCcEEEEEEEEC---CCCcEEEEEEeccch-----hhHHHHHHHHHHHHHHHhCCCCCcceEEEccee
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~ 162 (323)
.++|++.+.||+|+||.||+|++. .+++.||+|+++... .....+.+|+.+++.++|+|| +++++++
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~ 90 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI-----VDLIYAF 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTB-----CCEEEEE
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCc-----cceeEEE
Confidence 367999999999999999999985 689999999987532 233456789999999999988 8899999
Q ss_pred ccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
...+.+|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~-------- 160 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHV-------- 160 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCE--------
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcE--------
Confidence 9999999999999 899999998765 68999999999999999999999999999999999999766555
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 161 -------------------kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf 221 (327)
T 3a62_A 161 -------------------KLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221 (327)
T ss_dssp -------------------EECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred -------------------EEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCC
Confidence 5555555443211 123357999999999999999999999999999999999999999
Q ss_pred CCC
Q 020652 319 LTP 321 (323)
Q Consensus 319 ~~~ 321 (323)
.+.
T Consensus 222 ~~~ 224 (327)
T 3a62_A 222 TGE 224 (327)
T ss_dssp CCS
T ss_pred CCC
Confidence 763
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=318.34 Aligned_cols=198 Identities=26% Similarity=0.415 Sum_probs=167.6
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
+.++|++.+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.++|+|| +++++++...+.
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~~~ 79 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV-----VKFYGHRREGNI 79 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTB-----CCEEEEEECSSE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCC-----CeEEEEEecCCe
Confidence 3468999999999999999999999999999999986432 234567889999999999998 899999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~-------------- 143 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN-------------- 143 (323)
T ss_dssp EEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--------------
T ss_pred EEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--------------
Confidence 99999999 889999987654 6999999999999999999999999999999999999966554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccC-----CccccccCCccccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+||+|||++..... .....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 144 -------------~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 210 (323)
T 3tki_A 144 -------------LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210 (323)
T ss_dssp -------------EEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred -------------EEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 56666666543221 1223579999999999988775 7889999999999999999999975
Q ss_pred C
Q 020652 321 P 321 (323)
Q Consensus 321 ~ 321 (323)
.
T Consensus 211 ~ 211 (323)
T 3tki_A 211 P 211 (323)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=324.71 Aligned_cols=215 Identities=27% Similarity=0.411 Sum_probs=167.0
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+.++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.+|+.++|+|| +++++++...
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nI-----v~l~~~~~~~ 97 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYI-----IRLYDLIIPD 97 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEECCCS
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCc-----ceEEEEEecC
Confidence 4567899999999999999999999999999999998742 2345678899999999999998 7888877655
Q ss_pred -----ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 166 -----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 166 -----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
..+|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~~~~~lv~e~~~~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 98 DLLKFDELYIVLEIADSDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CTTTCCCEEEEEECCSEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCCcCCeEEEEEecCCcCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 5799999999889999998754 699999999999999999999999999999999999998888887777777
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCC-------cccccCCccccccCCccccchhh-cCCCCCcchhHHHHHHHHHHHh
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGS-------TTFEHQDHSYVVSTRHYRAPEVI-LGLGWNYPCDLWSVGCILVELC 312 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~-------a~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~el~ 312 (323)
+.......... ...++.. ...........+||+.|+|||++ .+..++.++|||||||++|||+
T Consensus 176 a~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell 246 (432)
T 3n9x_A 176 ARTINSEKDTN---------IVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246 (432)
T ss_dssp CEEC----------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred ccccccccccc---------ccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHH
Confidence 65443321100 0000000 00001122446899999999987 4557999999999999999999
Q ss_pred cCCCCCC
Q 020652 313 SVSNCYL 319 (323)
Q Consensus 313 tg~~pf~ 319 (323)
+|..||.
T Consensus 247 ~g~~p~~ 253 (432)
T 3n9x_A 247 NMLQSHI 253 (432)
T ss_dssp TTCTTTC
T ss_pred hcccccc
Confidence 8655553
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=310.78 Aligned_cols=202 Identities=24% Similarity=0.323 Sum_probs=165.4
Q ss_pred EecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEc
Q 020652 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIR 159 (323)
Q Consensus 84 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~ 159 (323)
...++.+.++|++.++||+|+||+||+|++..+++.||||++... .........|+..+..+ .|+|+ ++++
T Consensus 49 ~~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~i-----v~l~ 123 (311)
T 3p1a_A 49 SRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC-----VRLE 123 (311)
T ss_dssp TSSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTB-----CCEE
T ss_pred CCccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcE-----EEEE
Confidence 344566678999999999999999999999999999999988642 23334455666666666 78887 8999
Q ss_pred ceeccCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 160 NWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 160 ~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
+++..++.+++||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 124 ~~~~~~~~~~lv~e~~~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~------ 196 (311)
T 3p1a_A 124 QAWEEGGILYLQTELCGPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRC------ 196 (311)
T ss_dssp EEEEETTEEEEEEECCCCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCE------
T ss_pred EEEEeCCEEEEEEeccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCE------
Confidence 9999999999999999999999988764 469999999999999999999999999999999999999776655
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|||++|..|
T Consensus 197 ---------------------kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~ 254 (311)
T 3p1a_A 197 ---------------------KLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMEL 254 (311)
T ss_dssp ---------------------EECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCC
T ss_pred ---------------------EEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence 55555554432221 123468999999999887 789999999999999999999766
Q ss_pred CC
Q 020652 318 YL 319 (323)
Q Consensus 318 f~ 319 (323)
|.
T Consensus 255 ~~ 256 (311)
T 3p1a_A 255 PH 256 (311)
T ss_dssp CS
T ss_pred CC
Confidence 54
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=317.39 Aligned_cols=214 Identities=34% Similarity=0.597 Sum_probs=178.6
Q ss_pred cCcee-CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCC------CCcceEEE
Q 020652 86 IGENL-TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDI------GGTRCVQI 158 (323)
Q Consensus 86 ~~~~~-~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i------~~~~~~~~ 158 (323)
.++.+ .++|++.+.||+|+||+||+|++..+++.||||++.......+.+.+|+.+++++.|.+. .+++++++
T Consensus 12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 12 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred cCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 34433 468999999999999999999999999999999998766667788899999999984321 01233888
Q ss_pred cceeccCc----eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEeecCce
Q 020652 159 RNWFDYRN----HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYV 233 (323)
Q Consensus 159 ~~~~~~~~----~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~iiHrDlKp~NIli~~~~~~ 233 (323)
++++...+ .+++|||+++++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~- 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS- 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET-
T ss_pred HHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC-
Confidence 88876543 79999999999999999886656799999999999999999999998 9999999999999965431
Q ss_pred eccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc
Q 020652 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313 (323)
Q Consensus 234 ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t 313 (323)
.+....+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++
T Consensus 171 --------------------~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 230 (373)
T 1q8y_A 171 --------------------PENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230 (373)
T ss_dssp --------------------TTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH
T ss_pred --------------------CcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHh
Confidence 012335788899988776665566689999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 020652 314 VSNCYLT 320 (323)
Q Consensus 314 g~~pf~~ 320 (323)
|+.||.+
T Consensus 231 g~~pf~~ 237 (373)
T 1q8y_A 231 GDFLFEP 237 (373)
T ss_dssp SSCCC--
T ss_pred CCCCCCC
Confidence 9999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=315.81 Aligned_cols=201 Identities=24% Similarity=0.336 Sum_probs=165.1
Q ss_pred CceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEccee
Q 020652 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 87 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~ 162 (323)
...+.++|++.+.||+|+||.||+|++..+++.||||++... ......+.+|+.++++++|+|| +++++++
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~ 81 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI-----VAVYDTG 81 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTB-----CCEEEEE
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCc-----ceEEEee
Confidence 356778999999999999999999999999999999998743 2334567889999999999988 7788776
Q ss_pred ccCc----eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccC
Q 020652 163 DYRN----HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (323)
Q Consensus 163 ~~~~----~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d 237 (323)
.... ..|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 82 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~k--- 156 (311)
T 3ork_A 82 EAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK--- 156 (311)
T ss_dssp EEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEE---
T ss_pred eccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEE---
Confidence 6543 459999999 889999998765 699999999999999999999999999999999999998766554
Q ss_pred cccccccCCCCCccccCCCCCCceEeeCCCcccccC------CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHH
Q 020652 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVEL 311 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 311 (323)
|+|||++..... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 157 ------------------------l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 212 (311)
T 3ork_A 157 ------------------------VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 212 (311)
T ss_dssp ------------------------ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred ------------------------EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHH
Confidence 555554433211 11234789999999999999999999999999999999
Q ss_pred hcCCCCCCCC
Q 020652 312 CSVSNCYLTP 321 (323)
Q Consensus 312 ~tg~~pf~~~ 321 (323)
++|+.||.+.
T Consensus 213 l~g~~pf~~~ 222 (311)
T 3ork_A 213 LTGEPPFTGD 222 (311)
T ss_dssp HHSSCSCCCS
T ss_pred HhCCCCCCCC
Confidence 9999999763
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=313.57 Aligned_cols=197 Identities=30% Similarity=0.527 Sum_probs=154.5
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
++|+++++||+|+||+||+|.+..+++.||+|+++... ...+.+.+|+.+++.++|+|| +++++++...+.++
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~~~~ 79 (317)
T 2pmi_A 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI-----VRLYDVIHTENKLT 79 (317)
T ss_dssp --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTB-----CCEEEEECCTTEEE
T ss_pred cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCc-----ceEEEEEEECCeEE
Confidence 57999999999999999999999999999999986432 234678899999999999998 89999999999999
Q ss_pred EEEccCCCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 170 IVFEKLGPSLYDFLRKNS----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 170 lv~e~~~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
+||||+.++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~------------ 147 (317)
T 2pmi_A 80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQL------------ 147 (317)
T ss_dssp EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE------------
T ss_pred EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCE------------
Confidence 999999889999987542 1358999999999999999999999999999999999999766554
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 148 ---------------kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 211 (317)
T 2pmi_A 148 ---------------KLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG 211 (317)
T ss_dssp ---------------EECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ---------------EECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 55555555433211 2234789999999999874 689999999999999999999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=303.36 Aligned_cols=201 Identities=25% Similarity=0.418 Sum_probs=175.3
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.++++++|+|+ +++++++...
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~ 77 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI-----VRLHDSIQEE 77 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEECS
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCc-----CeEEEEEEcC
Confidence 4568899999999999999999999999999999998643 2344667889999999999988 8899999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+..++||||+ +++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++
T Consensus 78 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~------------- 142 (284)
T 3kk8_A 78 SFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA------------- 142 (284)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSS-------------
T ss_pred CEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCC-------------
Confidence 9999999999 889999988765 699999999999999999999999999999999999996543
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
....+||+|||.+....... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+
T Consensus 143 -----------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 209 (284)
T 3kk8_A 143 -----------KGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209 (284)
T ss_dssp -----------TTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -----------CCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC
Confidence 23447888888876544332 235799999999999999999999999999999999999999965
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=312.90 Aligned_cols=196 Identities=30% Similarity=0.539 Sum_probs=153.5
Q ss_pred CcEEEE---eeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceeccCce
Q 020652 92 PRYRIL---SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~---~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++. +.||+|+||+||+|.+..+++.||||++... ......+|+.+++.+. |+|| +++++++.....
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~ni-----v~~~~~~~~~~~ 80 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNI-----VKLHEVFHDQLH 80 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTB-----CCEEEEEECSSE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCe-----eEEEEEEEcCCE
Confidence 467776 7899999999999999999999999998643 3456778999999997 8888 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.|+||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~--------------- 143 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDEN--------------- 143 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-----------------
T ss_pred EEEEEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCC---------------
Confidence 99999999 889999998764 799999999999999999999999999999999999997543
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
....+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 144 ---------~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 211 (325)
T 3kn6_A 144 ---------DNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS 211 (325)
T ss_dssp -----------CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred ---------CcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 2234677778777643322 2345789999999999999999999999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=317.37 Aligned_cols=203 Identities=29% Similarity=0.529 Sum_probs=166.2
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
..++|+++++||+|+||+||+|++..+++.||||++.... ...+.+.+|+.+++.++|+|| +++++++...+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~ 106 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNI-----IELKSVIHHNH 106 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTB-----CCEEEEEEETT
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCc-----ceEEEEEecCC
Confidence 3468999999999999999999999999999999987432 223456789999999999988 89999999999
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.+++||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 107 ~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~-------------- 170 (329)
T 3gbz_A 107 RLHLIFEYAENDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDA-------------- 170 (329)
T ss_dssp EEEEEEECCSEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----------------
T ss_pred EEEEEEecCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCC--------------
Confidence 999999999889999998765 6999999999999999999999999999999999999965431
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+....+||+|||++...... ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.
T Consensus 171 --------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 241 (329)
T 3gbz_A 171 --------SETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGD 241 (329)
T ss_dssp ----------CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --------CccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 23345788888877653322 2335789999999999875 4899999999999999999999999753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=310.62 Aligned_cols=203 Identities=27% Similarity=0.495 Sum_probs=175.2
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh-------hHHHHHHHHHHHHHHHhCCCCCcceEEEcc
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~ 160 (323)
+.+.++|++.+.||+|+||.||+|++..+++.||+|++..... ..+.+.+|+.+++.+.|+|+ +++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~ 82 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV-----ITLHD 82 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCc-----ceEEE
Confidence 3456789999999999999999999999999999999864321 35678899999999999998 88999
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
++...+..++||||+ +++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~------- 153 (321)
T 2a2a_A 83 VYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNI------- 153 (321)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTS-------
T ss_pred EEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCC-------
Confidence 999999999999999 899999998754 6999999999999999999999999999999999999975541
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
....+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 154 ----------------~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 217 (321)
T 2a2a_A 154 ----------------PIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217 (321)
T ss_dssp ----------------SSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred ----------------CcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCC
Confidence 1124677777777654332 2335799999999999999999999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 218 f~~ 220 (321)
T 2a2a_A 218 FLG 220 (321)
T ss_dssp SCC
T ss_pred CCC
Confidence 975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=307.79 Aligned_cols=195 Identities=29% Similarity=0.508 Sum_probs=163.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++|++++.||+|+||+||+|++ .+++.||+|++.... ...+.+.+|+.+++.++|+|| +++++++...+..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI-----VKLYDVIHTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTB-----CCEEEEEECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCE-----eeeeeEEccCCeE
Confidence 5799999999999999999998 678999999986432 233677899999999999988 8999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
++||||+.++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 76 ~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~--------------- 139 (288)
T 1ob3_A 76 VLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGEL--------------- 139 (288)
T ss_dssp EEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE---------------
T ss_pred EEEEEecCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCE---------------
Confidence 9999999779999998654 469999999999999999999999999999999999999766655
Q ss_pred CccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 140 ------------kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (288)
T 1ob3_A 140 ------------KIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (288)
T ss_dssp ------------EECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ------------EEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 5555554433221 11234789999999999764 589999999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=328.66 Aligned_cols=201 Identities=33% Similarity=0.569 Sum_probs=174.1
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+.++|++.++||+|+||+||+|.+..+++.||||++... ....+.+.+|+.++++++|+|| +++++++...
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~ 93 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI-----MKLFEILEDS 93 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEECS
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCc-----CeEEEEEEcC
Confidence 3457899999999999999999999999999999998632 2345678899999999999998 8999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
..+|+||||| +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 94 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~------------- 158 (486)
T 3mwu_A 94 SSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE------------- 158 (486)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSS-------------
T ss_pred CEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC-------------
Confidence 9999999999 899999988765 699999999999999999999999999999999999995432
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
....+||+|||++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.
T Consensus 159 -----------~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~ 225 (486)
T 3mwu_A 159 -----------KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK 225 (486)
T ss_dssp -----------TTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -----------CCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 3456788888887654332 234579999999999987 5999999999999999999999999763
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=328.11 Aligned_cols=198 Identities=23% Similarity=0.401 Sum_probs=162.2
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
..++|++++.||+|+||.||+|++..+++.||||++... ......+.+|+.+++.++|+|| +.+++++...
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~l~~~~~~~ 220 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFL-----TALKYSFQTH 220 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTS-----CCEEEEEEET
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeE-----eeEEEEEeeC
Confidence 346899999999999999999999999999999998743 2233456789999999999988 8899999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
+.+|+||||+ +++|.+++.... .+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+
T Consensus 221 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~---------- 288 (446)
T 4ejn_A 221 DRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI---------- 288 (446)
T ss_dssp TEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCE----------
T ss_pred CEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCE----------
Confidence 9999999999 889999998765 79999999999999999999998 999999999999999766555
Q ss_pred cCCCCCccccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 289 -----------------kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 351 (446)
T 4ejn_A 289 -----------------KITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351 (446)
T ss_dssp -----------------EECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -----------------EEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 555555554321 112345899999999999999999999999999999999999999975
Q ss_pred C
Q 020652 321 P 321 (323)
Q Consensus 321 ~ 321 (323)
.
T Consensus 352 ~ 352 (446)
T 4ejn_A 352 Q 352 (446)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=315.69 Aligned_cols=198 Identities=20% Similarity=0.325 Sum_probs=166.2
Q ss_pred CCcEEEEeeecccCcEEEEEEEEC-------CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDN-------EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN 160 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~ 160 (323)
.++|++.+.||+|+||.||+|++. .++..||||+++.. ....+.+.+|+.+++.+ +|+|| +++++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI-----v~~~~ 154 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI-----INLLG 154 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTB-----CCEEE
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCE-----eeEEE
Confidence 468999999999999999999875 34567999998743 33456788999999999 79988 89999
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NI 225 (323)
++...+.+|+||||+ +++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 999999999999999 8899999987531 3588999999999999999999999999999999999
Q ss_pred EEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchh
Q 020652 226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCD 300 (323)
Q Consensus 226 li~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D 300 (323)
|++.++.+ ||+|||++...... .....||+.|+|||++.+..++.++|
T Consensus 235 ll~~~~~~---------------------------kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 287 (370)
T 2psq_A 235 LVTENNVM---------------------------KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 287 (370)
T ss_dssp EECTTCCE---------------------------EECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHH
T ss_pred EECCCCCE---------------------------EEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHH
Confidence 99766655 55555544432211 12235788999999999999999999
Q ss_pred HHHHHHHHHHHhc-CCCCCCC
Q 020652 301 LWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 301 iwSlG~il~el~t-g~~pf~~ 320 (323)
||||||++|||++ |..||.+
T Consensus 288 vwslG~il~ellt~g~~p~~~ 308 (370)
T 2psq_A 288 VWSFGVLMWEIFTLGGSPYPG 308 (370)
T ss_dssp HHHHHHHHHHHHTTSCCSSTT
T ss_pred HHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999 9999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=339.45 Aligned_cols=197 Identities=23% Similarity=0.350 Sum_probs=168.5
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceeccC
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~~ 165 (323)
.++|++++.||+|+||+||+|++..+++.||||++++. ....+....|..++..+. |++| +.+++++...
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i-----~~l~~~~~~~ 414 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFL-----TQLHSCFQTM 414 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTB-----CCEEEECBCS
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeE-----EEEEEEEEeC
Confidence 46799999999999999999999999999999998743 233456778888888774 5555 8899999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+.+||||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~i----------- 481 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHI----------- 481 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCE-----------
T ss_pred CEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcE-----------
Confidence 9999999999 899999998765 69999999999999999999999999999999999999766655
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccc---cCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFE---HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
||+|||+++.. .......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.
T Consensus 482 ----------------kL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 482 ----------------KIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp ----------------EECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ----------------EEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 55555555431 11223468999999999999999999999999999999999999999863
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=315.29 Aligned_cols=205 Identities=30% Similarity=0.497 Sum_probs=165.4
Q ss_pred CceeEecCc---eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCc
Q 020652 80 GHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGT 153 (323)
Q Consensus 80 ~~~~~~~~~---~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~ 153 (323)
..+.+.+++ .+.++|++++.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++|+||
T Consensus 10 ~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni--- 86 (371)
T 2xrw_A 10 NFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI--- 86 (371)
T ss_dssp GEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTB---
T ss_pred cceEeecCCcccchhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCc---
Confidence 345555555 4568999999999999999999999999999999998642 3345667899999999999998
Q ss_pred ceEEEcceeccCc------eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 020652 154 RCVQIRNWFDYRN------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227 (323)
Q Consensus 154 ~~~~~~~~~~~~~------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli 227 (323)
+++++++.... .+|+||||++++|.+++.. .+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 87 --v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~ 160 (371)
T 2xrw_A 87 --IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 160 (371)
T ss_dssp --CCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred --cceEEeeccccccccccceEEEEEcCCCCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE
Confidence 77887776543 7899999998899998863 58999999999999999999999999999999999999
Q ss_pred eecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHH
Q 020652 228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305 (323)
Q Consensus 228 ~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 305 (323)
+.++. +||+|||++...... ....+||+.|+|||++.+..++.++||||||
T Consensus 161 ~~~~~---------------------------~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 213 (371)
T 2xrw_A 161 KSDCT---------------------------LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 213 (371)
T ss_dssp CTTSC---------------------------EEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHH
T ss_pred cCCCC---------------------------EEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHH
Confidence 76554 455666655443222 2235789999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCC
Q 020652 306 CILVELCSVSNCYLT 320 (323)
Q Consensus 306 ~il~el~tg~~pf~~ 320 (323)
|++|||++|+.||.+
T Consensus 214 ~il~el~~g~~pf~~ 228 (371)
T 2xrw_A 214 CIMGEMIKGGVLFPG 228 (371)
T ss_dssp HHHHHHHHSSCSSCC
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999976
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=330.22 Aligned_cols=205 Identities=30% Similarity=0.515 Sum_probs=177.3
Q ss_pred ecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcc
Q 020652 85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (323)
Q Consensus 85 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~ 160 (323)
.....+.++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.++++++|+|| +++++
T Consensus 19 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~ 93 (484)
T 3nyv_A 19 HSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI-----MKLYE 93 (484)
T ss_dssp CCCCCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTB-----CCEEE
T ss_pred cCCCcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCC-----CcEEE
Confidence 34456678999999999999999999999999999999998642 3345778899999999999998 89999
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
++...+.+++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~--------- 162 (484)
T 3nyv_A 94 FFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK--------- 162 (484)
T ss_dssp EEECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS---------
T ss_pred EEEeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecC---------
Confidence 999999999999999 899999998765 69999999999999999999999999999999999999532
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
+....+||+|||++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..|
T Consensus 163 ---------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p 226 (484)
T 3nyv_A 163 ---------------SKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP 226 (484)
T ss_dssp ---------------STTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ---------------CCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCC
Confidence 23456788888877654332 234579999999999987 689999999999999999999999
Q ss_pred CCCC
Q 020652 318 YLTP 321 (323)
Q Consensus 318 f~~~ 321 (323)
|.+.
T Consensus 227 f~~~ 230 (484)
T 3nyv_A 227 FNGA 230 (484)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 9763
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=309.30 Aligned_cols=199 Identities=29% Similarity=0.437 Sum_probs=171.9
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
....++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.++|+|| +++++++.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~ 111 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV-----VGFHGFFE 111 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEE
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEe
Confidence 34457899999999999999999999999999999998643 2455678899999999999988 88999999
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
..+..++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~--------- 180 (335)
T 2owb_A 112 DNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEV--------- 180 (335)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCE---------
T ss_pred cCCeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCE---------
Confidence 999999999999 789999988764 69999999999999999999999999999999999999765544
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 181 ------------------kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 242 (335)
T 2owb_A 181 ------------------KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 242 (335)
T ss_dssp ------------------EECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ------------------EEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCC
Confidence 5555555543221 1223578999999999999999999999999999999999999997
Q ss_pred C
Q 020652 320 T 320 (323)
Q Consensus 320 ~ 320 (323)
+
T Consensus 243 ~ 243 (335)
T 2owb_A 243 T 243 (335)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=307.59 Aligned_cols=198 Identities=24% Similarity=0.326 Sum_probs=161.6
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
...++|++.+.||+|+||+||+|++ +++.||||++... ....+.+.+|+.++++++|+|| +++++++...
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~ 106 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI-----VLFMGAVTQP 106 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEECST
T ss_pred CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEEC
Confidence 3446899999999999999999976 5788999998643 2344578899999999999998 8999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEeecCceeccCcccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~--iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
+.+++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--------- 177 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--------- 177 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC---------
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc---------
Confidence 9999999999 8899999986431 13899999999999999999999999 999999999999976554
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 178 ------------------~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf 239 (309)
T 3p86_A 178 ------------------VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239 (309)
T ss_dssp ------------------EEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTT
T ss_pred ------------------EEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 455666655432222 22357999999999999999999999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 240 ~~ 241 (309)
T 3p86_A 240 GN 241 (309)
T ss_dssp TT
T ss_pred CC
Confidence 75
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=311.00 Aligned_cols=196 Identities=30% Similarity=0.425 Sum_probs=162.4
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHh--CCCCCcceEEEcceecc
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLAR--HDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~--~~i~~~~~~~~~~~~~~ 164 (323)
..++|++.+.||+|+||.||+|.+ .+++.||||++... ....+.+.+|+.+++.+.| +|| +++++++..
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i-----v~~~~~~~~ 80 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI-----IRLYDYEIT 80 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTB-----CCEEEEEEC
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCce-----EEEeeeEee
Confidence 356799999999999999999987 46889999998643 3344678899999999987 566 899999999
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 165 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
.+.+++|||+.+++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++ ++.
T Consensus 81 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~------------ 145 (343)
T 3dbq_A 81 DQYIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGM------------ 145 (343)
T ss_dssp SSEEEEEECCCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTE------------
T ss_pred CCEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCc------------
Confidence 99999999977999999998865 799999999999999999999999999999999999995 343
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcC-----------CCCCcchhHHHHHHHH
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILG-----------LGWNYPCDLWSVGCIL 308 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il 308 (323)
+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++
T Consensus 146 ---------------~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il 210 (343)
T 3dbq_A 146 ---------------LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210 (343)
T ss_dssp ---------------EEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHH
T ss_pred ---------------EEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHH
Confidence 466666666543222 123579999999999965 5789999999999999
Q ss_pred HHHhcCCCCCCCC
Q 020652 309 VELCSVSNCYLTP 321 (323)
Q Consensus 309 ~el~tg~~pf~~~ 321 (323)
|||++|+.||...
T Consensus 211 ~ell~g~~pf~~~ 223 (343)
T 3dbq_A 211 YYMTYGKTPFQQI 223 (343)
T ss_dssp HHHHHSSCTTTTC
T ss_pred HHHHhCCCcchhh
Confidence 9999999999763
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=311.25 Aligned_cols=199 Identities=23% Similarity=0.316 Sum_probs=166.2
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCc---EEEEEEecc--chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAiK~~~~--~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
...++|++.+.||+|+||+||+|.+..+++ .||||+++. .....+.+.+|+.+++.++|+|| +++++++.
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~ 120 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI-----IRLEGVVT 120 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEE
Confidence 345789999999999999999999986655 599999874 34455678899999999999988 88999999
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
..+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~--------- 190 (325)
T 3kul_A 121 RGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVC--------- 190 (325)
T ss_dssp GGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE---------
T ss_pred eCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCE---------
Confidence 999999999999 889999997653 469999999999999999999999999999999999999766555
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCCc------cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VS 315 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~ 315 (323)
||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 191 ------------------kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~ 252 (325)
T 3kul_A 191 ------------------KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE 252 (325)
T ss_dssp ------------------EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred ------------------EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCC
Confidence 555555544322211 11246778999999998899999999999999999999 99
Q ss_pred CCCCC
Q 020652 316 NCYLT 320 (323)
Q Consensus 316 ~pf~~ 320 (323)
.||.+
T Consensus 253 ~p~~~ 257 (325)
T 3kul_A 253 RPYWN 257 (325)
T ss_dssp CTTTT
T ss_pred CCccc
Confidence 99965
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=317.82 Aligned_cols=198 Identities=28% Similarity=0.517 Sum_probs=152.8
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc-
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY- 164 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~- 164 (323)
.+.++|++++.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++|+|| +++++++..
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~ 100 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV-----IGLLDVFTPA 100 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCCSEEECSC
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEecC
Confidence 4568999999999999999999999999999999998642 2345677899999999999998 777777654
Q ss_pred -----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 165 -----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 165 -----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
...+|+|||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 101 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-------- 169 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-------- 169 (367)
T ss_dssp SSGGGCCCCEEEEECCCEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC--------
T ss_pred CccccCCeEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC--------
Confidence 3568999999999999998763 599999999999999999999999999999999999996554
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
.+||+|||+++.........+||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 170 -------------------~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 230 (367)
T 2fst_X 170 -------------------ELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 230 (367)
T ss_dssp -------------------CEEECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred -------------------CEEEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 4566666666554444445689999999999987 67899999999999999999999999
Q ss_pred CCC
Q 020652 319 LTP 321 (323)
Q Consensus 319 ~~~ 321 (323)
.+.
T Consensus 231 ~~~ 233 (367)
T 2fst_X 231 PGT 233 (367)
T ss_dssp CCS
T ss_pred CCC
Confidence 763
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=328.56 Aligned_cols=201 Identities=30% Similarity=0.515 Sum_probs=171.3
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
..+.++|+++++||+|+||+||+|++..+++.||+|++... ......+.+|+.+++.++|+|| +++++++..
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~ 107 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI-----MKLYDFFED 107 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTB-----CCEEEEEEC
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCC-----CeEEEEEEe
Confidence 34567899999999999999999999999999999998743 2334678899999999999998 899999999
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
...+|+||||| +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++..+
T Consensus 108 ~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~------------ 173 (494)
T 3lij_A 108 KRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKE------------ 173 (494)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS------------
T ss_pred CCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCC------------
Confidence 99999999999 889999988765 699999999999999999999999999999999999996532
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
....+||+|||++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+
T Consensus 174 ------------~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (494)
T 3lij_A 174 ------------KDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGG 239 (494)
T ss_dssp ------------TTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ------------CCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 3345788888888654432 234579999999999864 689999999999999999999999976
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=315.44 Aligned_cols=200 Identities=31% Similarity=0.466 Sum_probs=165.4
Q ss_pred CCcEEE--EeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 91 TPRYRI--LSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 91 ~~~y~~--~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
.+.|.+ .+.||+|+||.||+|.+..+++.||+|+++... ...+.+.+|+.++++++|+|| +++++++...+.
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~~~ 160 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL-----IQLYDAFESKND 160 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSSE
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCC-----CeEEEEEEECCE
Confidence 344655 678999999999999999999999999987543 455678899999999999988 899999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+..+
T Consensus 161 ~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~---------------- 223 (373)
T 2x4f_A 161 IVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNR---------------- 223 (373)
T ss_dssp EEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEET----------------
T ss_pred EEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecC----------------
Confidence 99999999 889999887643 369999999999999999999999999999999999998532
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
....+||+|||++...... ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 224 ---------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 291 (373)
T 2x4f_A 224 ---------DAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291 (373)
T ss_dssp ---------TTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred ---------CCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 2234677777777654322 22347999999999999989999999999999999999999999763
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=317.23 Aligned_cols=204 Identities=21% Similarity=0.289 Sum_probs=170.1
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEE-----ECCCCcEEEEEEecc--chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcc
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECF-----DNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~-----~~~~~~~vAiK~~~~--~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~ 160 (323)
+...++|++.+.||+|+||+||+|. +..+++.||||+++. .......+.+|+.++++++|+|| +++++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~ 141 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI-----VRCIG 141 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCC-----CeEEE
Confidence 3445789999999999999999999 455788999999864 23445568889999999999998 88999
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCcee
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSY-----RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~k 234 (323)
++......++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 142 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~--- 218 (367)
T 3l9p_A 142 VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG--- 218 (367)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS---
T ss_pred EEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCC---
Confidence 999888999999999 8899999986432 3589999999999999999999999999999999999997543
Q ss_pred ccCcccccccCCCCCccccCCCCCCceEeeCCCccccc-----CCccccccCCccccchhhcCCCCCcchhHHHHHHHHH
Q 020652 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH-----QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (323)
Q Consensus 235 i~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (323)
....+||+|||+++... .......||+.|+|||++.+..++.++|||||||++|
T Consensus 219 ---------------------~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ 277 (367)
T 3l9p_A 219 ---------------------PGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 277 (367)
T ss_dssp ---------------------TTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred ---------------------CCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHH
Confidence 22346777777765321 1223357899999999999999999999999999999
Q ss_pred HHhc-CCCCCCC
Q 020652 310 ELCS-VSNCYLT 320 (323)
Q Consensus 310 el~t-g~~pf~~ 320 (323)
||++ |..||.+
T Consensus 278 ellt~g~~pf~~ 289 (367)
T 3l9p_A 278 EIFSLGYMPYPS 289 (367)
T ss_dssp HHHTTSCCSSTT
T ss_pred HHHhCCCCCCCC
Confidence 9998 9999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=325.39 Aligned_cols=200 Identities=28% Similarity=0.394 Sum_probs=171.5
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
....++|++.+.||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.++|+|| +++++++.
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnI-----v~l~~~~~ 86 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHI-----IKLYQVIS 86 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTB-----CCEEEEEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEE
Confidence 334578999999999999999999999999999999987432 234578899999999999988 89999999
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
..+.+|+||||+ +++|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~---------- 154 (476)
T 2y94_A 87 TPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN---------- 154 (476)
T ss_dssp CSSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC----------
T ss_pred ECCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC----------
Confidence 999999999999 899999997654 6999999999999999999999999999999999999976554
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
+||+|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.
T Consensus 155 -----------------vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 217 (476)
T 2y94_A 155 -----------------AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217 (476)
T ss_dssp -----------------EEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred -----------------eEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCC
Confidence 455566655443222 234579999999999998775 689999999999999999999997
Q ss_pred CC
Q 020652 320 TP 321 (323)
Q Consensus 320 ~~ 321 (323)
+.
T Consensus 218 ~~ 219 (476)
T 2y94_A 218 DD 219 (476)
T ss_dssp CS
T ss_pred CC
Confidence 63
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=311.63 Aligned_cols=198 Identities=28% Similarity=0.396 Sum_probs=168.8
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
....+|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.++++++|+|| +++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~ 125 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT-----IQYRGCYLR 125 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEE
T ss_pred chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEE
Confidence 3446799999999999999999999999999999998642 2334568899999999999998 889999999
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 165 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
.+..++||||+.++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 126 ~~~~~lv~e~~~g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~----------- 193 (348)
T 1u5q_A 126 EHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLV----------- 193 (348)
T ss_dssp TTEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEE-----------
T ss_pred CCeEEEEEecCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCE-----------
Confidence 99999999999889999887543 469999999999999999999999999999999999999876655
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++..... ....+||+.|+|||++. +..++.++|||||||++|||++|+.||.+
T Consensus 194 ----------------kL~DfG~a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 255 (348)
T 1u5q_A 194 ----------------KLGDFGSASIMAP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255 (348)
T ss_dssp ----------------EECCCTTCBSSSS-BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ----------------EEeeccCceecCC-CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 5555555543322 22357999999999985 45789999999999999999999999965
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=307.21 Aligned_cols=195 Identities=23% Similarity=0.406 Sum_probs=159.8
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh---------------------------hHHHHHHHHHHHH
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---------------------------YREAAMIEIDVLQ 143 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~---------------------------~~~~~~~Ei~~l~ 143 (323)
.++|++.+.||+|+||.||+|++..+++.||||++..... ..+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 3689999999999999999999999999999999864321 1245788999999
Q ss_pred HHHhCCCCCcceEEEcceecc--CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 020652 144 RLARHDIGGTRCVQIRNWFDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 220 (323)
Q Consensus 144 ~l~~~~i~~~~~~~~~~~~~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDl 220 (323)
.++|+|| +++++++.. ...+++||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||
T Consensus 92 ~l~h~~i-----v~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNV-----VKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDI 163 (298)
T ss_dssp TCCCTTB-----CCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred hCCCCCC-----CeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 9999988 888888876 56899999999 7888776543 36999999999999999999999999999999
Q ss_pred CCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCC---
Q 020652 221 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG--- 294 (323)
Q Consensus 221 Kp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~--- 294 (323)
||+|||++.++. +||+|||++...... .....||+.|+|||++.+..
T Consensus 164 kp~Nil~~~~~~---------------------------~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 216 (298)
T 2zv2_A 164 KPSNLLVGEDGH---------------------------IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIF 216 (298)
T ss_dssp CGGGEEECTTSC---------------------------EEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCE
T ss_pred CHHHEEECCCCC---------------------------EEEecCCCccccccccccccCCcCCccccChhhhccCCCCC
Confidence 999999976554 455555555443222 12347999999999998765
Q ss_pred CCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 295 WNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 295 ~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++.++|||||||++|||++|+.||.+
T Consensus 217 ~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 217 SGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp ESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 37889999999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=300.14 Aligned_cols=199 Identities=28% Similarity=0.352 Sum_probs=166.0
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... .+.+.+|+.+++.+.|+++. ..+..++......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~e~~~l~~l~~~~~i----~~~~~~~~~~~~~ 80 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVGI----PTIRWCGAEGDYN 80 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-CCHHHHHHHHHHHHTTSTTC----CCEEEEEEETTEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-hhHHHHHHHHHHHhhcCCCC----CccccccCCCCce
Confidence 466889999999999999999999999999999998865332 34578899999999998762 2233444567789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEe---ecCceeccCcccccccC
Q 020652 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV---SAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~---~~~~~ki~d~~~~~~~~ 245 (323)
++||||++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++ .++.
T Consensus 81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~------------- 146 (296)
T 3uzp_A 81 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL------------- 146 (296)
T ss_dssp EEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTC-------------
T ss_pred EEEEEecCCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCe-------------
Confidence 9999999999999998544 4699999999999999999999999999999999999994 4444
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCC----------ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~ 315 (323)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 147 --------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 212 (296)
T 3uzp_A 147 --------------VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212 (296)
T ss_dssp --------------EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred --------------EEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCC
Confidence 455555555432221 23357999999999999999999999999999999999999
Q ss_pred CCCCC
Q 020652 316 NCYLT 320 (323)
Q Consensus 316 ~pf~~ 320 (323)
.||.+
T Consensus 213 ~pf~~ 217 (296)
T 3uzp_A 213 LPWQG 217 (296)
T ss_dssp CTTSS
T ss_pred CCCCC
Confidence 99975
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=312.87 Aligned_cols=201 Identities=17% Similarity=0.240 Sum_probs=157.1
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCC-----CcEEEEEEeccchhhHHHHHHHHHHHHHHHh----------CCCCCc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEK-----KELVAIKIVRSINKYREAAMIEIDVLQRLAR----------HDIGGT 153 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~-----~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~----------~~i~~~ 153 (323)
...++|++.+.||+|+||+||+|.+..+ ++.||||++..... .+.+|+.+++.+.+ ..+.|+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ 108 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG---PLFTELKFYQRAAKPEQIQKWIRTRKLKYL 108 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH---HHHHHHHHHHHHCCHHHHHHHHHHTTCSCC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch---hHHHHHHHHHhhhhhHHHHHHHHHhhccCC
Confidence 3446899999999999999999998765 57899999865332 23344444444322 223334
Q ss_pred ceEEEcceeccC----ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEe-
Q 020652 154 RCVQIRNWFDYR----NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV- 228 (323)
Q Consensus 154 ~~~~~~~~~~~~----~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~- 228 (323)
+++++++++... .+.|+||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 109 ~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 109 GVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp CSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES
T ss_pred CCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec
Confidence 448888887653 5689999999999999998753 4699999999999999999999999999999999999997
Q ss_pred -ecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccC----------CccccccCCccccchhhcCCCCCc
Q 020652 229 -SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ----------DHSYVVSTRHYRAPEVILGLGWNY 297 (323)
Q Consensus 229 -~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~ 297 (323)
.++. +||+|||+++.... ......||+.|+|||++.+..++.
T Consensus 188 ~~~~~---------------------------~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 240 (364)
T 3op5_A 188 KNPDQ---------------------------VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSR 240 (364)
T ss_dssp SCTTC---------------------------EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCH
T ss_pred CCCCe---------------------------EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCc
Confidence 4444 45555555533211 112346999999999999999999
Q ss_pred chhHHHHHHHHHHHhcCCCCCCC
Q 020652 298 PCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 298 ~~DiwSlG~il~el~tg~~pf~~ 320 (323)
++|||||||++|||+||+.||.+
T Consensus 241 ~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 241 RGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp HHHHHHHHHHHHHHHHSCCTTGG
T ss_pred hhhHHHHHHHHHHHHhCCCCccc
Confidence 99999999999999999999985
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=300.18 Aligned_cols=201 Identities=26% Similarity=0.451 Sum_probs=172.7
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.++|+|| +++++++...+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~ 80 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNI-----IRLYETFEDNTD 80 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSSE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCE-----eeEEEEEecCCe
Confidence 3557899999999999999999999999999999998643 3345678899999999999988 889999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.++||||+ +++|.+++.... .+++..++.++.|++.||+|||++||+||||||+||++..+
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~---------------- 142 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD---------------- 142 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS----------------
T ss_pred EEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecC----------------
Confidence 99999999 889999998765 69999999999999999999999999999999999998321
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+....+||+|||.+...... .....||+.|+|||++.+. ++.++|||||||++|||++|+.||.+.
T Consensus 143 --------~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (277)
T 3f3z_A 143 --------SPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP 210 (277)
T ss_dssp --------STTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --------CCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCC
Confidence 13445677888877543322 2345799999999998764 899999999999999999999999763
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=302.30 Aligned_cols=199 Identities=27% Similarity=0.346 Sum_probs=161.0
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.+.++|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|+.+++.+.|+++. ..+..++...+..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i----~~~~~~~~~~~~~ 80 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGI----PTIRWCGAEGDYN 80 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTC----CCEEEEEEETTEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCC----CeeeeecCCCCce
Confidence 45578999999999999999999999999999999876432 224577899999999998762 2334445667889
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE---eecCceeccCcccccccC
Q 020652 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL---VSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli---~~~~~~ki~d~~~~~~~~ 245 (323)
++||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 81 ~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~------------- 146 (296)
T 4hgt_A 81 VMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNL------------- 146 (296)
T ss_dssp EEEEECCCCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTC-------------
T ss_pred EEEEEccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCe-------------
Confidence 9999999999999998544 369999999999999999999999999999999999999 44444
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCC----------ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~ 315 (323)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 147 --------------~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 212 (296)
T 4hgt_A 147 --------------VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212 (296)
T ss_dssp --------------EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred --------------EEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCC
Confidence 455555555432221 12357999999999999999999999999999999999999
Q ss_pred CCCCC
Q 020652 316 NCYLT 320 (323)
Q Consensus 316 ~pf~~ 320 (323)
.||.+
T Consensus 213 ~pf~~ 217 (296)
T 4hgt_A 213 LPWQG 217 (296)
T ss_dssp CTTSS
T ss_pred CCCcc
Confidence 99976
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=303.45 Aligned_cols=205 Identities=25% Similarity=0.306 Sum_probs=175.4
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCC-------cEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKK-------ELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~-------~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~ 160 (323)
...++|++.+.||+|+||+||+|.+..++ ..||+|++... ....+.+.+|+.+++.++|+|| +++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~ 79 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL-----VLNYG 79 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTB-----CCEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCE-----eEEEE
Confidence 34578999999999999999999998877 46999998643 3455778899999999999998 89999
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
++...+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++..++.|++
T Consensus 80 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 158 (289)
T 4fvq_A 80 VCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPP 158 (289)
T ss_dssp EECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred EEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccc
Confidence 999989999999999 799999998754 349999999999999999999999999999999999999988876655543
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
.+||+|||.+...... ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+
T Consensus 159 -------------------~~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~ 218 (289)
T 4fvq_A 159 -------------------FIKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218 (289)
T ss_dssp -------------------EEEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred -------------------eeeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence 3799999988654332 33568999999999988 67999999999999999999965444
Q ss_pred C
Q 020652 319 L 319 (323)
Q Consensus 319 ~ 319 (323)
.
T Consensus 219 ~ 219 (289)
T 4fvq_A 219 L 219 (289)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=311.94 Aligned_cols=196 Identities=29% Similarity=0.490 Sum_probs=161.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhh--HHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY--REAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~--~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
++|+++++||+|+||+||+|++..+++.||+|++...... ...+.+|+.+++.++|+|| +++++++...+..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-----VTLHDIIHTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTB-----CCEEEEEECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCC-----CeeeeEEeeCCEEE
Confidence 5799999999999999999999999999999998743321 1234579999999999988 88999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 77 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~---------------- 139 (324)
T 3mtl_A 77 LVFEYLDKDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGEL---------------- 139 (324)
T ss_dssp EEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCE----------------
T ss_pred EEecccccCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCE----------------
Confidence 999999889999998764 469999999999999999999999999999999999999766655
Q ss_pred ccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+
T Consensus 140 -----------kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (324)
T 3mtl_A 140 -----------KLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203 (324)
T ss_dssp -----------EECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred -----------EEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 45555544332211 123478999999999987 5689999999999999999999999976
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=313.88 Aligned_cols=193 Identities=28% Similarity=0.430 Sum_probs=162.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHh--CCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLAR--HDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~--~~i~~~~~~~~~~~~~~~~ 166 (323)
.+|++.+.||+|+||+||+|.+.. ++.||||++... ....+.+.+|+.+++.+.| +|| +++++++...+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~i-----v~~~~~~~~~~ 129 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI-----IRLYDYEITDQ 129 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTB-----CCEEEEEECSS
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeE-----EEEEEEEecCC
Confidence 469999999999999999999865 889999998643 3445678899999999985 666 89999999999
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 167 HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.+|+|||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++ ++
T Consensus 130 ~~~lv~E~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~--------------- 191 (390)
T 2zmd_A 130 YIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG--------------- 191 (390)
T ss_dssp EEEEEEECCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SS---------------
T ss_pred EEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CC---------------
Confidence 999999966899999998765 789999999999999999999999999999999999984 33
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcC-----------CCCCcchhHHHHHHHHHH
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILG-----------LGWNYPCDLWSVGCILVE 310 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~e 310 (323)
.+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++||
T Consensus 192 ------------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~e 259 (390)
T 2zmd_A 192 ------------MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259 (390)
T ss_dssp ------------CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHH
T ss_pred ------------eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHH
Confidence 3566666666543222 123579999999999976 368899999999999999
Q ss_pred HhcCCCCCCC
Q 020652 311 LCSVSNCYLT 320 (323)
Q Consensus 311 l~tg~~pf~~ 320 (323)
|++|+.||..
T Consensus 260 ll~G~~Pf~~ 269 (390)
T 2zmd_A 260 MTYGKTPFQQ 269 (390)
T ss_dssp HHHSSCTTTT
T ss_pred HHHCCCcchh
Confidence 9999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=311.52 Aligned_cols=193 Identities=25% Similarity=0.298 Sum_probs=161.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC----ce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR----NH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~----~~ 167 (323)
++|++.++||+|+||+||+|++. ++.||||++...........+|+.++++++|+|| +++++++... ..
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI-----LQFIGAEKRGTSVDVD 96 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTB-----CCEEEEEEEECSSSEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCc-----hhhcceeccCCCCCce
Confidence 57999999999999999999875 7899999998666666667779999999999988 8888887763 35
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC----------CceecCCCCCcEEEeecCceecc
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL----------RLIHTDLKPENILLVSAEYVKVP 236 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~----------~iiHrDlKp~NIli~~~~~~ki~ 236 (323)
+++||||+ +++|.+++... .+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~--- 170 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA--- 170 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCE---
T ss_pred EEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeE---
Confidence 79999999 88999999875 499999999999999999999999 99999999999999765544
Q ss_pred CcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCC-----CCCcchhHHHHHH
Q 020652 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGL-----GWNYPCDLWSVGC 306 (323)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~ 306 (323)
||+|||++...... .....||+.|+|||++.+. .++.++|||||||
T Consensus 171 ------------------------kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~ 226 (322)
T 3soc_A 171 ------------------------CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGL 226 (322)
T ss_dssp ------------------------EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHH
T ss_pred ------------------------EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHH
Confidence 55555555432211 2225799999999999873 4567899999999
Q ss_pred HHHHHhcCCCCCCCC
Q 020652 307 ILVELCSVSNCYLTP 321 (323)
Q Consensus 307 il~el~tg~~pf~~~ 321 (323)
++|||+||+.||.++
T Consensus 227 il~el~tg~~pf~~~ 241 (322)
T 3soc_A 227 VLWELASRCTAADGP 241 (322)
T ss_dssp HHHHHHTTBTTSSSC
T ss_pred HHHHHHhCCCCCCCC
Confidence 999999999999764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=312.32 Aligned_cols=215 Identities=24% Similarity=0.391 Sum_probs=177.4
Q ss_pred CCCceeEecCceeCCcEEEE-eeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHh-CCCCC
Q 020652 78 KDGHYVFAIGENLTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLAR-HDIGG 152 (323)
Q Consensus 78 ~~~~~~~~~~~~~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~-~~i~~ 152 (323)
..+...+..++.+.++|.+. +.||+|+||+||+|.+..+++.||+|++.... .....+.+|+.+++.+.+ +|+
T Consensus 14 ~~~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i-- 91 (327)
T 3lm5_A 14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV-- 91 (327)
T ss_dssp --CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTB--
T ss_pred cchhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCE--
Confidence 34455667778889999998 89999999999999999999999999987432 335678899999999865 777
Q ss_pred cceEEEcceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC
Q 020652 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (323)
Q Consensus 153 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~ 231 (323)
+++++++...+.+++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++...
T Consensus 92 ---v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~ 168 (327)
T 3lm5_A 92 ---INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIY 168 (327)
T ss_dssp ---CCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBT
T ss_pred ---EEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCC
Confidence 89999999999999999999 88999998765446799999999999999999999999999999999999996511
Q ss_pred ceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHH
Q 020652 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (323)
Q Consensus 232 ~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (323)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 169 ------------------------~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 224 (327)
T 3lm5_A 169 ------------------------PLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAY 224 (327)
T ss_dssp ------------------------TBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred ------------------------CCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHH
Confidence 1334677777766544322 23357999999999999999999999999999999
Q ss_pred HHhcCCCCCCCC
Q 020652 310 ELCSVSNCYLTP 321 (323)
Q Consensus 310 el~tg~~pf~~~ 321 (323)
||++|+.||.+.
T Consensus 225 ~ll~g~~pf~~~ 236 (327)
T 3lm5_A 225 MLLTHTSPFVGE 236 (327)
T ss_dssp HHHHSSCSSCCS
T ss_pred HHHhCCCCCCCC
Confidence 999999999753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=301.52 Aligned_cols=202 Identities=20% Similarity=0.243 Sum_probs=171.5
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh--------hHHHHHHHHHHHHHHHhCCCCCcceEEEcc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~--------~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~ 160 (323)
...++|++.+.||+|+||+||+|++..+++.||+|++..... ..+.+.+|+.+++.++|+|| +++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~ 90 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI-----VKLYG 90 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTB-----CCEEE
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCc-----hhhhe
Confidence 345789999999999999999999999999999999864221 11568899999999999988 88888
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEeecCceeccC
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPD 237 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--iiHrDlKp~NIli~~~~~~ki~d 237 (323)
++.... ++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++| |+||||||+|||++.++.
T Consensus 91 ~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~----- 162 (287)
T 4f0f_A 91 LMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE----- 162 (287)
T ss_dssp EETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCT-----
T ss_pred eecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCC-----
Confidence 887665 6999999 899999987654 46999999999999999999999999 999999999999965431
Q ss_pred cccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhc--CCCCCcchhHHHHHHHHHHHhcCC
Q 020652 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL--GLGWNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~el~tg~ 315 (323)
+....+||+|||++...........||+.|+|||++. ...++.++|||||||++|||++|+
T Consensus 163 -----------------~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 225 (287)
T 4f0f_A 163 -----------------NAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225 (287)
T ss_dssp -----------------TCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSS
T ss_pred -----------------CCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCC
Confidence 2233478899998876666556678999999999984 445789999999999999999999
Q ss_pred CCCCC
Q 020652 316 NCYLT 320 (323)
Q Consensus 316 ~pf~~ 320 (323)
.||..
T Consensus 226 ~pf~~ 230 (287)
T 4f0f_A 226 GPFDE 230 (287)
T ss_dssp CTTTT
T ss_pred CCCcc
Confidence 99975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=306.18 Aligned_cols=193 Identities=25% Similarity=0.412 Sum_probs=166.9
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
.|...++||+|+||.||+|++..+++.||||++.... ...+.+.+|+.+++.++|+|+ +++++++...+..++|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~lv 120 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV-----VEMYKSYLVGEELWVL 120 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCc-----ceEEEEEEECCEEEEE
Confidence 4888899999999999999999999999999987433 345668899999999999988 8889999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||+ +++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+
T Consensus 121 ~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~----------------- 180 (321)
T 2c30_A 121 MEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRV----------------- 180 (321)
T ss_dssp ECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCE-----------------
T ss_pred EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcE-----------------
Confidence 9999 89999998753 59999999999999999999999999999999999999765544
Q ss_pred cccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 181 ----------kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 181 ----------KLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp ----------EECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ----------EEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 55555555433221 2335799999999999999999999999999999999999999975
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=307.98 Aligned_cols=202 Identities=25% Similarity=0.437 Sum_probs=167.0
Q ss_pred eeCCcEEEE-eeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccC
Q 020652 89 NLTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 89 ~~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+.++|++. +.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.++.++ .|+|| +++++++...
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i-----~~~~~~~~~~ 83 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNV-----LELIEFFEEE 83 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTB-----CCEEEEEEET
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCe-----eeEEEEEeeC
Confidence 456789996 78999999999999999999999999986433 3456788999999885 68888 8999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+.+++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~------------ 149 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQ------------ 149 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSS------------
T ss_pred CEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCC------------
Confidence 9999999999 899999998764 6999999999999999999999999999999999999976543
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccC----------CccccccCCccccchhhcC-----CCCCcchhHHHHHHHHH
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQ----------DHSYVVSTRHYRAPEVILG-----LGWNYPCDLWSVGCILV 309 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~ 309 (323)
...+||+|||++..... .....+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 150 ------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~ 217 (316)
T 2ac3_A 150 ------------VSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217 (316)
T ss_dssp ------------SCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHH
T ss_pred ------------cCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHH
Confidence 12356666665543211 1123469999999999975 45789999999999999
Q ss_pred HHhcCCCCCCCC
Q 020652 310 ELCSVSNCYLTP 321 (323)
Q Consensus 310 el~tg~~pf~~~ 321 (323)
||++|+.||.+.
T Consensus 218 ~l~~g~~pf~~~ 229 (316)
T 2ac3_A 218 ILLSGYPPFVGR 229 (316)
T ss_dssp HHHHSSCSCCCC
T ss_pred HHHHCCCCCccc
Confidence 999999999763
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=299.66 Aligned_cols=202 Identities=27% Similarity=0.500 Sum_probs=172.6
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-------hhHHHHHHHHHHHHHHHhCCCCCcceEEEccee
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~ 162 (323)
+.++|++.+.||+|+||.||+|++..+++.||+|++.... ...+.+.+|+.++++++|+|+ +++++++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~ 77 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI-----ITLHDIF 77 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCe-----eehhhee
Confidence 3467999999999999999999999999999999986432 135678899999999999988 8899999
Q ss_pred ccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
...+..++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 78 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~---------- 145 (283)
T 3bhy_A 78 ENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKN---------- 145 (283)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS----------
T ss_pred cCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCC----------
Confidence 9999999999999 899999998754 699999999999999999999999999999999999997544
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
.....+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 146 -------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 212 (283)
T 3bhy_A 146 -------------VPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 212 (283)
T ss_dssp -------------SSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred -------------CCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCC
Confidence 12235788888877654322 233578999999999999999999999999999999999999997
Q ss_pred CC
Q 020652 320 TP 321 (323)
Q Consensus 320 ~~ 321 (323)
+.
T Consensus 213 ~~ 214 (283)
T 3bhy_A 213 GE 214 (283)
T ss_dssp CS
T ss_pred Cc
Confidence 63
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=310.20 Aligned_cols=196 Identities=34% Similarity=0.595 Sum_probs=165.3
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC---
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR--- 165 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~--- 165 (323)
.++|++++.||+|+||.||+|++..+++.||||++... ....+.+.+|+.++++++|+|| +++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~ 100 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI-----IGINDIIRAPTIE 100 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTB-----CCCCEEECCSSTT
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCC-----ccceeEEecCCcc
Confidence 47899999999999999999999999999999998742 3344678899999999999998 7777776543
Q ss_pred --ceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 166 --NHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 166 --~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
...|+|||+++++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 101 ~~~~~~iv~e~~~~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~----------- 166 (364)
T 3qyz_A 101 QMKDVYIVQDLMETDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD----------- 166 (364)
T ss_dssp TCCCEEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC-----------
T ss_pred ccceEEEEEcccCcCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC-----------
Confidence 478999999988999999874 5999999999999999999999999999999999999976554
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCC------ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~ 316 (323)
+||+|||.+...... ....+||+.|+|||++.+. .++.++|||||||++|||++|+.
T Consensus 167 ----------------~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 230 (364)
T 3qyz_A 167 ----------------LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230 (364)
T ss_dssp ----------------EEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSC
T ss_pred ----------------EEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCC
Confidence 455555555433211 1234799999999987654 58999999999999999999999
Q ss_pred CCCCC
Q 020652 317 CYLTP 321 (323)
Q Consensus 317 pf~~~ 321 (323)
||.+.
T Consensus 231 pf~~~ 235 (364)
T 3qyz_A 231 IFPGK 235 (364)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 99763
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=303.37 Aligned_cols=197 Identities=32% Similarity=0.568 Sum_probs=163.0
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
.++|+++++||+|+||+||+|.+..+++.||||++.... ...+.+.+|+.++++++|+|+ +++++++...+.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~ 76 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL-----VNLLEVFRRKRR 76 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCc-----cchhheeecCCe
Confidence 468999999999999999999999999999999886432 335667889999999999998 899999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.++||||+ +++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~-------------- 140 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV-------------- 140 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--------------
T ss_pred EEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--------------
Confidence 99999999 677877776554 6999999999999999999999999999999999999965554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+||+|||.+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 141 -------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 141 -------------IKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp -------------EEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -------------EEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 566666666543221 123478999999999987 56899999999999999999999999763
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=308.04 Aligned_cols=213 Identities=27% Similarity=0.343 Sum_probs=163.1
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC--
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-- 165 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~-- 165 (323)
+.++|++.+.||+|+||+||+|++..+++.||||++... ....+.+.+|+.++++++|+|| +++++++...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~ 78 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI-----VRYFNAWLETPP 78 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTB-----CCEEEEEEECCS
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEEecc
Confidence 346799999999999999999999999999999998732 3355778899999999999998 7777665332
Q ss_pred -------------------------------------------------------ceEEEEEccC-CCCHHHHHHhcCC-
Q 020652 166 -------------------------------------------------------NHICIVFEKL-GPSLYDFLRKNSY- 188 (323)
Q Consensus 166 -------------------------------------------------------~~~~lv~e~~-~~~L~~~l~~~~~- 188 (323)
...++||||| +++|.+++.....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 2489999999 8899999986542
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCc
Q 020652 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268 (323)
Q Consensus 189 ~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a 268 (323)
...++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++............ ...
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~--------~~~---- 226 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV--------LTP---- 226 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC---------------------
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc--------ccc----
Confidence 23566678999999999999999999999999999999987776666666655443322110000 000
Q ss_pred ccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 269 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
...........||+.|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 227 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp -----CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred ccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 000011223479999999999999999999999999999999999987763
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=314.54 Aligned_cols=198 Identities=32% Similarity=0.556 Sum_probs=161.4
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec------
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD------ 163 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~------ 163 (323)
..++|++.+.||+|+||+||+|++..+++.||||++...... ..+|+.+++.++|+|| +++++++.
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~---~~~E~~il~~l~hpnI-----v~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY---KNRELDIMKVLDHVNI-----IKLVDYFYTTGDEE 76 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS---CCHHHHHHTTCCCTTB-----CCEEEEEEEC----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch---HHHHHHHHHHcCCCCc-----cchhheeeecCccc
Confidence 457899999999999999999999999999999988654322 3469999999999998 77777763
Q ss_pred --------------------------------cCceEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHH
Q 020652 164 --------------------------------YRNHICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAF 209 (323)
Q Consensus 164 --------------------------------~~~~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~ 209 (323)
...++++||||++++|.+.+.. .....+++..++.++.||+.||.|
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3445899999998898888763 223479999999999999999999
Q ss_pred HHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccC--CccccccCCccccc
Q 020652 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAP 287 (323)
Q Consensus 210 lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aP 287 (323)
||++||+||||||+|||++. ..+.+||+|||++..... ......||+.|+||
T Consensus 157 LH~~gi~H~Dikp~Nil~~~--------------------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aP 210 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNS--------------------------KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAP 210 (383)
T ss_dssp HHTTTEECSCCCGGGEEEET--------------------------TTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCH
T ss_pred HHHCcCccCccCHHHEEEcC--------------------------CCCcEEEEECCCCcccCCCCCCcCcccCCCccCH
Confidence 99999999999999999963 123456677776654322 22335789999999
Q ss_pred hhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 288 EVILGL-GWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 288 E~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
|++.+. .++.++|||||||++|||++|+.||.+.
T Consensus 211 E~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 245 (383)
T 3eb0_A 211 ELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGE 245 (383)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCC
Confidence 999875 4899999999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=303.11 Aligned_cols=200 Identities=22% Similarity=0.312 Sum_probs=174.4
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
...++|++.+.||+|+||.||+|.+..+++.||+|++.......+.+.+|+.+++.++|+|+ +++++++...+..
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~ 84 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTREPPF 84 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEccCCCE
Confidence 44578999999999999999999999999999999998766677888999999999999998 8899999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||||+ +++|.+++.......+++..++.++.|++.||.|||++||+||||||+||+++.++.++++
T Consensus 85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~----------- 153 (288)
T 3kfa_A 85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA----------- 153 (288)
T ss_dssp EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEEC-----------
T ss_pred EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEc-----------
Confidence 9999999 7899999988665679999999999999999999999999999999999999776655555
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCc----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
|||.+....... ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 154 ----------------Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 154 ----------------DFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp ----------------CCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ----------------cCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 555443322211 12357889999999999899999999999999999999 9999975
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=314.73 Aligned_cols=201 Identities=13% Similarity=0.107 Sum_probs=152.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHH--hCCCCCcceEEEc---cee
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLA--RHDIGGTRCVQIR---NWF 162 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~--~~~i~~~~~~~~~---~~~ 162 (323)
..|++.+.||+|+||+||+|.+..+++.||||++... ....+.+.+|+.+++.+. |+|+.... +.++ +.+
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~-~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR-RRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhc-eeEEeeehhe
Confidence 3599999999999999999999999999999999863 344566778877777775 88862111 1221 222
Q ss_pred ccC-----------------ceEEEEEccCCCCHHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHHHCCceecC
Q 020652 163 DYR-----------------NHICIVFEKLGPSLYDFLRKNSYRSFPIDLV------RELGRQLLESVAFMHELRLIHTD 219 (323)
Q Consensus 163 ~~~-----------------~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~------~~i~~qi~~aL~~lH~~~iiHrD 219 (323)
... ..+|+||||++++|.+++.... ..+++... ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 211 4589999999999999998643 23455555 67779999999999999999999
Q ss_pred CCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC--CCCCc
Q 020652 220 LKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG--LGWNY 297 (323)
Q Consensus 220 lKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ 297 (323)
|||+|||++.++. +||+|||++...........||+.|+|||++.+ ..++.
T Consensus 220 ikp~NIll~~~~~---------------------------~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 272 (371)
T 3q60_A 220 FTPDNLFIMPDGR---------------------------LMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTH 272 (371)
T ss_dssp CSGGGEEECTTSC---------------------------EEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCH
T ss_pred CCHHHEEECCCCC---------------------------EEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCc
Confidence 9999999976554 566666666554443334567899999999987 67999
Q ss_pred chhHHHHHHHHHHHhcCCCCCCCC
Q 020652 298 PCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 298 ~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
++|||||||++|||++|+.||.+.
T Consensus 273 ~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 273 ALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp HHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred cccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999865
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=301.27 Aligned_cols=202 Identities=28% Similarity=0.447 Sum_probs=169.8
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
.+.++|++.++||+|+||.||+|.+..+++.+|+|++.... ...+.+.+|+.+++.++|+|| +++++++...+
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~~~ 93 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNI-----IKIFEVFEDYH 93 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSS
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchH-----HhHHHheecCC
Confidence 34578999999999999999999999999999999987533 335678899999999999998 88999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 167 HICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
..++||||+ +++|.+++... ....+++..++.++.||+.||+|||++||+||||||+||+++..
T Consensus 94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~------------- 160 (285)
T 3is5_A 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDT------------- 160 (285)
T ss_dssp EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSS-------------
T ss_pred eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecC-------------
Confidence 999999999 88999988643 12469999999999999999999999999999999999999532
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+....+||+|||++...... .....||+.|+|||++. ..++.++|||||||++|||++|+.||.+
T Consensus 161 -----------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~ 227 (285)
T 3is5_A 161 -----------SPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG 227 (285)
T ss_dssp -----------STTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred -----------CCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence 13456788888888654332 23457999999999986 4689999999999999999999999975
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=310.51 Aligned_cols=209 Identities=27% Similarity=0.503 Sum_probs=171.8
Q ss_pred CCCCceeEecCc---eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCC
Q 020652 77 DKDGHYVFAIGE---NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDI 150 (323)
Q Consensus 77 ~~~~~~~~~~~~---~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i 150 (323)
...+.+...+.. .+.++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++|+||
T Consensus 24 ~~~g~~~~~~~~~~~~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 103 (371)
T 4exu_A 24 RKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV 103 (371)
T ss_dssp SCTTEEEEEETTEEEEEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred ccccceeeeeccceecccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCc
Confidence 344555555443 4778999999999999999999999999999999998742 3345678899999999999998
Q ss_pred CCcceEEEcceeccCceE------EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 020652 151 GGTRCVQIRNWFDYRNHI------CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN 224 (323)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~------~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~N 224 (323)
+++++++...+.. ++||||++++|.+++.. .+++..++.++.||+.||+|||++||+||||||+|
T Consensus 104 -----v~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 174 (371)
T 4exu_A 104 -----IGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGN 174 (371)
T ss_dssp -----CCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred -----hhhhhheeccCCcccceeEEEEEccccccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHH
Confidence 8888888766544 99999998899888742 59999999999999999999999999999999999
Q ss_pred EEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHH
Q 020652 225 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWS 303 (323)
Q Consensus 225 Ili~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS 303 (323)
||++.++ .+||+|||.+...........||+.|+|||++.+ ..++.++||||
T Consensus 175 Ill~~~~---------------------------~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 227 (371)
T 4exu_A 175 LAVNEDC---------------------------ELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWS 227 (371)
T ss_dssp EEECTTC---------------------------CEEECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHH
T ss_pred eEECCCC---------------------------CEEEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHH
Confidence 9986544 4567777776655555555689999999999987 67899999999
Q ss_pred HHHHHHHHhcCCCCCCCC
Q 020652 304 VGCILVELCSVSNCYLTP 321 (323)
Q Consensus 304 lG~il~el~tg~~pf~~~ 321 (323)
|||++|||++|+.||.+.
T Consensus 228 lG~il~el~~g~~pf~~~ 245 (371)
T 4exu_A 228 VGCIMAEMLTGKTLFKGK 245 (371)
T ss_dssp HHHHHHHHHHSSCSCCCS
T ss_pred HHHHHHHHHhCCCCCCCC
Confidence 999999999999999763
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=299.03 Aligned_cols=195 Identities=27% Similarity=0.400 Sum_probs=167.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+.+|+.++++++|+|| +++++++...+..++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKL-----VQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTB-----CCEEEEECSSSSEEEE
T ss_pred hhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCE-----eeEEEEEecCCceEEE
Confidence 57999999999999999999986 46779999998766566788999999999999988 8999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~----------------- 145 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVI----------------- 145 (269)
T ss_dssp EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCE-----------------
T ss_pred EEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCE-----------------
Confidence 9999 889999997654 469999999999999999999999999999999999999766554
Q ss_pred cccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+
T Consensus 146 ----------kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~ 210 (269)
T 4hcu_A 146 ----------KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 210 (269)
T ss_dssp ----------EECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ----------EeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC
Confidence 55555555432221 122356788999999998999999999999999999999 9999975
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=321.29 Aligned_cols=200 Identities=32% Similarity=0.501 Sum_probs=163.2
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---------hhHHHHHHHHHHHHHHHhCCCCCcceEEEc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQIR 159 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~ 159 (323)
.+.++|++.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+|++++|+|| ++++
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~l~ 206 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI-----IKIK 206 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTB-----CCCC
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCE-----eeEE
Confidence 45678999999999999999999999999999999986432 112246789999999999998 7888
Q ss_pred ceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCc
Q 020652 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (323)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~ 238 (323)
+++.. +..++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++..+
T Consensus 207 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~------- 276 (419)
T 3i6u_A 207 NFFDA-EDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------- 276 (419)
T ss_dssp EEEES-SEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS-------
T ss_pred EEEec-CceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCC-------
Confidence 88754 4579999999 889999887654 799999999999999999999999999999999999996432
Q ss_pred ccccccCCCCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcC---CCCCcchhHHHHHHHHHHHhc
Q 020652 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCS 313 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~t 313 (323)
....+||+|||++....... ...+||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 277 -----------------~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~llt 339 (419)
T 3i6u_A 277 -----------------EDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 339 (419)
T ss_dssp -----------------SSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHH
T ss_pred -----------------CcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHH
Confidence 23457888888887654332 34689999999999864 568899999999999999999
Q ss_pred CCCCCCC
Q 020652 314 VSNCYLT 320 (323)
Q Consensus 314 g~~pf~~ 320 (323)
|..||.+
T Consensus 340 g~~pf~~ 346 (419)
T 3i6u_A 340 GYPPFSE 346 (419)
T ss_dssp SSCSSCC
T ss_pred CCCCCCC
Confidence 9999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=302.92 Aligned_cols=201 Identities=25% Similarity=0.441 Sum_probs=171.6
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh-hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~-~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
.+.++|++.+.||+|+||.||+|++..+++.||+|++..... ..+.+.+|+.+++.++|+|| +++++++...+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 80 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI-----VTLEDIYESTTH 80 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTB-----CCEEEEEECSSE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCe-----eehhhhcccCCE
Confidence 455789999999999999999999999999999999875432 34567899999999999998 888999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.++||||+ +++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~---------------- 142 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTP---------------- 142 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSS----------------
T ss_pred EEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecC----------------
Confidence 99999999 889999998765 69999999999999999999999999999999999998321
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC-ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+....+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 143 --------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 209 (304)
T 2jam_A 143 --------EENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209 (304)
T ss_dssp --------STTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred --------CCCCCEEEccCCcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 13445677777777654332 2335799999999999999999999999999999999999999965
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=312.21 Aligned_cols=198 Identities=28% Similarity=0.503 Sum_probs=169.6
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh---------hHHHHHHHHHHHHHHHhCCCCCcceEEEc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---------YREAAMIEIDVLQRLARHDIGGTRCVQIR 159 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~---------~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~ 159 (323)
.+.++|++.+.||+|+||.||+|++..+++.||||++..... ..+.+.+|+.+++.++|+|| ++++
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~I-----v~~~ 95 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI-----IKVL 95 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTB-----CCEE
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCE-----eeEE
Confidence 455789999999999999999999999999999999875321 22346679999999999988 8999
Q ss_pred ceeccCceEEEEEccC-CC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccC
Q 020652 160 NWFDYRNHICIVFEKL-GP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (323)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d 237 (323)
+++...+.+++||||+ ++ +|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.
T Consensus 96 ~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~----- 168 (335)
T 3dls_A 96 DIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT----- 168 (335)
T ss_dssp EEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC-----
T ss_pred EEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc-----
Confidence 9999999999999998 55 9999998765 6999999999999999999999999999999999999965544
Q ss_pred cccccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCC-CcchhHHHHHHHHHHHhcC
Q 020652 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSV 314 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg 314 (323)
+||+|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|||++|
T Consensus 169 ----------------------~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 226 (335)
T 3dls_A 169 ----------------------IKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFE 226 (335)
T ss_dssp ----------------------EEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHS
T ss_pred ----------------------EEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhC
Confidence 566666666543322 233579999999999998876 8899999999999999999
Q ss_pred CCCCCC
Q 020652 315 SNCYLT 320 (323)
Q Consensus 315 ~~pf~~ 320 (323)
..||..
T Consensus 227 ~~pf~~ 232 (335)
T 3dls_A 227 ENPFCE 232 (335)
T ss_dssp SCSCSS
T ss_pred CCchhh
Confidence 999964
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=317.40 Aligned_cols=196 Identities=30% Similarity=0.511 Sum_probs=160.5
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc------C
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY------R 165 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~------~ 165 (323)
.+|++.+.||+|+||+||+|++..+++.||||++..... ...+|+++++.++|+|| +++++++.. .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~E~~il~~l~hpni-----v~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR---FKNRELQIMRKLDHCNI-----VRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT---SCCHHHHHHHTCCCTTB-----CCEEEEEEEEETTTTE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHcCCCCc-----cceeeEEeccCCCCcc
Confidence 469999999999999999999999999999999865432 23469999999999998 777666532 2
Q ss_pred ceEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 166 NHICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
.++++||||+.++|.+++.. .....+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 126 ~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~------------ 193 (420)
T 1j1b_A 126 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT------------ 193 (420)
T ss_dssp EEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTT------------
T ss_pred eeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCC------------
Confidence 35789999998788877653 2234799999999999999999999999999999999999997432
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccC--CccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
..+||+|||+++.... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 194 --------------~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~ 259 (420)
T 1j1b_A 194 --------------AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 259 (420)
T ss_dssp --------------TEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------------CeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 2356777776654322 22335789999999999775 799999999999999999999999976
Q ss_pred C
Q 020652 321 P 321 (323)
Q Consensus 321 ~ 321 (323)
.
T Consensus 260 ~ 260 (420)
T 1j1b_A 260 D 260 (420)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=308.53 Aligned_cols=204 Identities=27% Similarity=0.468 Sum_probs=164.4
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc----
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY---- 164 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~---- 164 (323)
++|+++++||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.++|+|+ +++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~ 91 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV-----VNLIEICRTKASP 91 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTB-----CCEEEEEEEC---
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCc-----ccHhheeeccccc
Confidence 68999999999999999999999999999999886432 234567889999999999998 777777655
Q ss_pred ----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 165 ----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 165 ----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
.+.+++||||++++|.+.+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 92 ~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -----CEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccCCceEEEEEeccCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 45789999999889999887654 4699999999999999999999999999999999999997766555555554
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
+........ ..........||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 171 a~~~~~~~~--------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 230 (351)
T 3mi9_A 171 ARAFSLAKN--------------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 230 (351)
T ss_dssp CEECCCCSS--------------------SSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccc--------------------ccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCC
Confidence 322211100 001112234789999999999874 58999999999999999999999997
Q ss_pred CC
Q 020652 320 TP 321 (323)
Q Consensus 320 ~~ 321 (323)
+.
T Consensus 231 ~~ 232 (351)
T 3mi9_A 231 GN 232 (351)
T ss_dssp CS
T ss_pred CC
Confidence 63
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=311.41 Aligned_cols=202 Identities=27% Similarity=0.436 Sum_probs=167.5
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc------hhhHHHHHHHHHHHHHHHhCCCCCcceEEEccee
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~------~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~ 162 (323)
.+.++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+.+|+.+++.++|+|| +++++++
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~ 97 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI-----ARLYEVY 97 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCc-----ceeehhh
Confidence 4567899999999999999999999999999999998643 2345678899999999999988 8999999
Q ss_pred ccCceEEEEEccC-CCCHHHHHHhcC--------------------------------------CCCCCHHHHHHHHHHH
Q 020652 163 DYRNHICIVFEKL-GPSLYDFLRKNS--------------------------------------YRSFPIDLVRELGRQL 203 (323)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~~qi 203 (323)
...+..++||||+ +++|.+++.... ...+++..++.++.||
T Consensus 98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 177 (345)
T 3hko_A 98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177 (345)
T ss_dssp ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence 9999999999999 999999985210 1124677889999999
Q ss_pred HHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccC-------Ccc
Q 020652 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-------DHS 276 (323)
Q Consensus 204 ~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~ 276 (323)
+.||+|||++||+||||||+|||++.++ ...+||+|||++..... ...
T Consensus 178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 232 (345)
T 3hko_A 178 FSALHYLHNQGICHRDIKPENFLFSTNK-------------------------SFEIKLVDFGLSKEFYKLNNGEYYGMT 232 (345)
T ss_dssp HHHHHHHHHTTEECCCCCGGGEEESCSS-------------------------SCCEEECCCTTCEEGGGTTCC------
T ss_pred HHHHHHHHHCCccccCCChhhEEEecCC-------------------------CceEEEeeccccccccccCcccccccc
Confidence 9999999999999999999999996543 22467777777754322 123
Q ss_pred ccccCCccccchhhcC--CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 277 YVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 277 ~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+
T Consensus 233 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 278 (345)
T 3hko_A 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG 278 (345)
T ss_dssp --CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 3579999999999976 5789999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=319.20 Aligned_cols=205 Identities=23% Similarity=0.355 Sum_probs=169.2
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
..+.++|++.+.||+|+||+||+|++..+++.||||++.... ...+.+.+|++++++++|+|| +++++++...
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-----v~~~~~~~~~ 79 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI-----VKLFAIEEET 79 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEECT
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCC-----CeEEEeeccC
Confidence 345678999999999999999999999999999999987433 334667899999999999998 8888887664
Q ss_pred c--eEEEEEccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 166 N--HICIVFEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 166 ~--~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
+ ..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+....
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~---------- 149 (396)
T 4eut_A 80 TTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGE---------- 149 (396)
T ss_dssp TTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECT----------
T ss_pred CCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecC----------
Confidence 4 789999999 8899999975432 2399999999999999999999999999999999999983221
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcC--------CCCCcchhHHHHHHHHHHH
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILG--------LGWNYPCDLWSVGCILVEL 311 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el 311 (323)
+....+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 150 -------------~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el 216 (396)
T 4eut_A 150 -------------DGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (396)
T ss_dssp -------------TSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHH
T ss_pred -------------CCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHH
Confidence 223346777777775543322 23579999999999875 4677899999999999999
Q ss_pred hcCCCCCCC
Q 020652 312 CSVSNCYLT 320 (323)
Q Consensus 312 ~tg~~pf~~ 320 (323)
++|+.||.+
T Consensus 217 ~tg~~Pf~~ 225 (396)
T 4eut_A 217 ATGSLPFRP 225 (396)
T ss_dssp HHSSCSEEC
T ss_pred HHCCCCCCC
Confidence 999999964
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=309.25 Aligned_cols=205 Identities=23% Similarity=0.328 Sum_probs=166.8
Q ss_pred eCCcEEEEeeecccCcEEEEEEE-----ECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcce
Q 020652 90 LTPRYRILSKMGEGTFGQVVECF-----DNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW 161 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~-----~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~ 161 (323)
..++|++.+.||+|+||.||+|+ +..+++.||||+++.. ....+.+.+|+.+++++ .|+|| ++++++
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni-----v~~~~~ 94 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV-----VNLLGA 94 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce-----eeeeee
Confidence 35789999999999999999998 5567789999999753 23446788999999999 67888 888888
Q ss_pred eccC-ceEEEEEccC-CCCHHHHHHhcCC---------------------------------------------------
Q 020652 162 FDYR-NHICIVFEKL-GPSLYDFLRKNSY--------------------------------------------------- 188 (323)
Q Consensus 162 ~~~~-~~~~lv~e~~-~~~L~~~l~~~~~--------------------------------------------------- 188 (323)
+... ..+++||||+ +++|.+++.....
T Consensus 95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 7764 4589999999 8899999986542
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCC
Q 020652 189 -------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLP 255 (323)
Q Consensus 189 -------------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~ 255 (323)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~------ 248 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD------ 248 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT------
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc------
Confidence 1289999999999999999999999999999999999998777666666665433221110
Q ss_pred CCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCC
Q 020652 256 KSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLTP 321 (323)
Q Consensus 256 ~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~ 321 (323)
........||+.|+|||++.+..++.++|||||||++|||+| |..||.+.
T Consensus 249 ----------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 299 (359)
T 3vhe_A 249 ----------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299 (359)
T ss_dssp ----------------CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ----------------chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCcc
Confidence 001123468999999999999999999999999999999998 99999763
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=311.05 Aligned_cols=202 Identities=27% Similarity=0.427 Sum_probs=173.9
Q ss_pred cCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 86 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
+++...++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.++|+|| +++++++.
T Consensus 27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~ 101 (360)
T 3eqc_A 27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI-----VGFYGAFY 101 (360)
T ss_dssp CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTB-----CCEEEEEE
T ss_pred ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCE-----EEEeEEEE
Confidence 3455668899999999999999999999999999999998743 3445678899999999999988 89999999
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEeecCceeccCcccc
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
..+..++||||+ +++|.+++.... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++
T Consensus 102 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~---------- 169 (360)
T 3eqc_A 102 SDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG---------- 169 (360)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC----------
T ss_pred ECCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC----------
Confidence 999999999999 889999998765 699999999999999999999996 999999999999986544
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCccccc-CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH-QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 170 -----------------~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 170 -----------------EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp -----------------CEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred -----------------CEEEEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 45777777664322 222345799999999999999999999999999999999999999976
Q ss_pred C
Q 020652 321 P 321 (323)
Q Consensus 321 ~ 321 (323)
.
T Consensus 233 ~ 233 (360)
T 3eqc_A 233 P 233 (360)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=302.62 Aligned_cols=206 Identities=24% Similarity=0.366 Sum_probs=165.9
Q ss_pred eeCCcEEEEeeecccCcEEEEEEE----ECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~----~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
...++|+++++||+|+||+||+|+ +..+++.||||++... ....+.+.+|+.++++++|+|| +++++++.
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~ 81 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI-----VKYKGVCY 81 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEC
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEe
Confidence 345789999999999999999998 5678999999998753 3445678899999999999998 88888764
Q ss_pred c--CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 164 Y--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 164 ~--~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
. ...+++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGL 160 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence 4 45689999999 889999998754 3599999999999999999999999999999999999998877666655554
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+........ .........||..|+|||++.+..++.++|||||||++|||+||..||..
T Consensus 161 ~~~~~~~~~---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 219 (295)
T 3ugc_A 161 TKVLPQDKE---------------------FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 219 (295)
T ss_dssp CC----------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred cccccCCcc---------------------eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCC
Confidence 432211100 00011123467789999999999999999999999999999999999875
Q ss_pred C
Q 020652 321 P 321 (323)
Q Consensus 321 ~ 321 (323)
+
T Consensus 220 ~ 220 (295)
T 3ugc_A 220 P 220 (295)
T ss_dssp H
T ss_pred C
Confidence 3
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=296.53 Aligned_cols=197 Identities=23% Similarity=0.333 Sum_probs=167.8
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
..++|++.+.||+|+||.||+|.+. ++..||+|++.......+.+.+|+.++++++|+|| +++++++...+..+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKL-----VKFYGVCSKEYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCE-----eeEEEEEccCCceE
Confidence 3468999999999999999999876 56779999998766566778999999999999988 88999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 80 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~--------------- 143 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCV--------------- 143 (268)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCE---------------
T ss_pred EEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCE---------------
Confidence 999999 889999998754 359999999999999999999999999999999999999765554
Q ss_pred CccccCCCCCCceEeeCCCcccccCCc----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
||+|||.+....... ....+|+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 144 ------------~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (268)
T 3sxs_A 144 ------------KVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208 (268)
T ss_dssp ------------EECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ------------EEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc
Confidence 555555554332221 11345778999999999889999999999999999999 9999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=297.56 Aligned_cols=199 Identities=29% Similarity=0.444 Sum_probs=171.2
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
...++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.+.|+|| +++++++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~ 86 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHV-----VGFHGFFED 86 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEEC
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCE-----eeeeeeecc
Confidence 4456899999999999999999999999999999998643 2345678889999999999988 889999999
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
.+..++||||+ +++|.+++.... .+++..++.++.|++.||+|||++||+||||||+||+++.++.+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~---------- 154 (294)
T 2rku_A 87 NDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEV---------- 154 (294)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE----------
T ss_pred CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCE----------
Confidence 99999999999 789999988764 69999999999999999999999999999999999999765554
Q ss_pred cCCCCCccccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 155 -----------------kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 217 (294)
T 2rku_A 155 -----------------KIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217 (294)
T ss_dssp -----------------EECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred -----------------EEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 555555554322 112234789999999999998999999999999999999999999976
Q ss_pred C
Q 020652 321 P 321 (323)
Q Consensus 321 ~ 321 (323)
.
T Consensus 218 ~ 218 (294)
T 2rku_A 218 S 218 (294)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=299.43 Aligned_cols=196 Identities=22% Similarity=0.357 Sum_probs=165.0
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
.++|++.+.||+|+||+||+|.+. ++..||+|++.......+.+.+|+.+++.++|+|| +++++++...+..++
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~l 96 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL-----VQLYGVCTKQRPIFI 96 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTB-----CCEEEEECSSSSEEE
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCE-----eeEEEEEecCCCeEE
Confidence 357999999999999999999876 67789999998665566778999999999999988 899999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.
T Consensus 97 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~----------------- 158 (283)
T 3gen_A 97 ITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV----------------- 158 (283)
T ss_dssp EECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC-----------------
T ss_pred EEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC-----------------
Confidence 99999 899999998643 36999999999999999999999999999999999999976554
Q ss_pred ccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
+||+|||.+...... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus 159 ----------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~ 224 (283)
T 3gen_A 159 ----------VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224 (283)
T ss_dssp ----------EEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ----------EEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 455566655433221 112356788999999998899999999999999999998 9999975
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=320.13 Aligned_cols=203 Identities=25% Similarity=0.353 Sum_probs=166.3
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
..+.++|++.++||+|+||.||+|++..+++.||||++..... .+.+.+|+.+++.+.|++.. ..+..++.....
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~il~~L~~~~~i----~~i~~~~~~~~~ 77 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLLYESKIYRILQGGTGI----PNVRWFGVEGDY 77 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-SCCHHHHHHHHHHTTTSTTC----CCEEEEEEETTE
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-cHHHHHHHHHHHHhcCCCCC----CeEEEEEeeCCE
Confidence 3567899999999999999999999999999999998764332 23577899999999986541 334445566788
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
.+|||||++++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+..
T Consensus 78 ~~lvme~~g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~----------------- 139 (483)
T 3sv0_A 78 NVLVMDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG----------------- 139 (483)
T ss_dssp EEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG-----------------
T ss_pred EEEEEECCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecC-----------------
Confidence 99999999999999998644 469999999999999999999999999999999999999411
Q ss_pred CCccccCCCCCCceEeeCCCcccccCC----------ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
+....+||+|||++...... .....||+.|+|||++.+..++.++|||||||+||||++|+.|
T Consensus 140 -------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~P 212 (483)
T 3sv0_A 140 -------RRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212 (483)
T ss_dssp -------GGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred -------CCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence 12234555555555433221 1245799999999999999999999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 213 f~~ 215 (483)
T 3sv0_A 213 WQG 215 (483)
T ss_dssp TSS
T ss_pred Ccc
Confidence 986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=321.44 Aligned_cols=195 Identities=16% Similarity=0.171 Sum_probs=155.7
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc----chhhHHHHHHHHHH---HHHHHhCCCCCcceEEEc----
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDV---LQRLARHDIGGTRCVQIR---- 159 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~Ei~~---l~~l~~~~i~~~~~~~~~---- 159 (323)
.++|++.+.||+|+||+||+|++..+++.||||++.. .....+.+.+|+.+ ++.++|+|| ++++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpni-----v~~~~~~~ 146 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ-----AKVHLRFI 146 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHH-----HHHHHCBC
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHH-----HHHHhhhh
Confidence 4689999999999999999999999999999999863 23345678899954 444467766 6665
Q ss_pred ---ceeccCc-----------------eEEEEEccCCCCHHHHHHhcCCCCCCH-------HHHHHHHHHHHHHHHHHHH
Q 020652 160 ---NWFDYRN-----------------HICIVFEKLGPSLYDFLRKNSYRSFPI-------DLVRELGRQLLESVAFMHE 212 (323)
Q Consensus 160 ---~~~~~~~-----------------~~~lv~e~~~~~L~~~l~~~~~~~l~~-------~~~~~i~~qi~~aL~~lH~ 212 (323)
++++..+ ..|+||||++|+|.+++.... .+++ ..+..++.||+.||+|||+
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~--~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 224 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL--SHSSTHKSLVHHARLQLTLQVIRLLASLHH 224 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH--HTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc--ccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 4444332 388999999889999998643 3444 7888899999999999999
Q ss_pred CCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC
Q 020652 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG 292 (323)
Q Consensus 213 ~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~ 292 (323)
+||+||||||+|||++.++. +||+|||++..........+| +.|+|||++.+
T Consensus 225 ~~ivHrDikp~NIll~~~~~---------------------------~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~ 276 (377)
T 3byv_A 225 YGLVHTYLRPVDIVLDQRGG---------------------------VFLTGFEHLVRDGARVVSSVS-RGFEPPELEAR 276 (377)
T ss_dssp TTEECSCCCGGGEEECTTCC---------------------------EEECCGGGCEETTCEEECCCC-TTCCCHHHHHH
T ss_pred CCeecCCCCHHHEEEcCCCC---------------------------EEEEechhheecCCcccCCCC-cCccChhhhcc
Confidence 99999999999999976554 466666666544444444578 99999999988
Q ss_pred C-----------CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 293 L-----------GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 293 ~-----------~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
. .++.++|||||||++|||++|+.||.+
T Consensus 277 ~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~ 315 (377)
T 3byv_A 277 RATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315 (377)
T ss_dssp HTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred cccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcc
Confidence 7 899999999999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=297.22 Aligned_cols=196 Identities=25% Similarity=0.408 Sum_probs=166.8
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.++|+|| +++++++...+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 82 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI-----LRLYGYFHDAT 82 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSS
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCC-----cchhheEecCC
Confidence 367999999999999999999999999999999986432 234567889999999999988 89999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
..++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~----------- 149 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELK----------- 149 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEE-----------
T ss_pred EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEE-----------
Confidence 999999999 789999998765 699999999999999999999999999999999999997666554
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCC-ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
|+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 150 ----------------l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 209 (279)
T 3fdn_A 150 ----------------IADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209 (279)
T ss_dssp ----------------ECSCCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ----------------EEeccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC
Confidence 4555544322211 2234789999999999999999999999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=302.30 Aligned_cols=201 Identities=23% Similarity=0.426 Sum_probs=165.4
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceecc--
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY-- 164 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~-- 164 (323)
....++|++.+.||+|+||.||+|++..+++.||||++.......+.+.+|+.+++++ .|+|| +++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~~~~~~~~~~ 94 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNI-----ATYYGAFIKKN 94 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTB-----CCEEEEEEECC
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCe-----eeeeeEEeecc
Confidence 4456889999999999999999999999999999999976655667888999999999 68888 778887765
Q ss_pred ----CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 165 ----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 165 ----~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
.+.+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~------- 167 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE------- 167 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC-------
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC-------
Confidence 46899999999 779999998764457999999999999999999999999999999999999976554
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhc-----CCCCCcchhHHHHHHHHHHH
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVEL 311 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el 311 (323)
+||+|||++...... .....||+.|+|||++. +..++.++|||||||++|+|
T Consensus 168 --------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l 227 (326)
T 2x7f_A 168 --------------------VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227 (326)
T ss_dssp --------------------EEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHH
T ss_pred --------------------EEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHH
Confidence 455555555433221 22347899999999997 45688999999999999999
Q ss_pred hcCCCCCCC
Q 020652 312 CSVSNCYLT 320 (323)
Q Consensus 312 ~tg~~pf~~ 320 (323)
++|..||.+
T Consensus 228 ~~g~~p~~~ 236 (326)
T 2x7f_A 228 AEGAPPLCD 236 (326)
T ss_dssp HHSSCTTTT
T ss_pred HhCCCCCCC
Confidence 999999965
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=307.40 Aligned_cols=199 Identities=21% Similarity=0.313 Sum_probs=167.1
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCC-------CcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEc
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEK-------KELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIR 159 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~-------~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~ 159 (323)
..++|++.++||+|+||+||+|++..+ +..||||+++.. ....+.+.+|+++++.+ +|+|| ++++
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI-----v~~~ 141 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI-----INLL 141 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEE
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchh-----hhhe
Confidence 346899999999999999999997543 357999998743 33446788999999999 89988 8999
Q ss_pred ceeccCceEEEEEccC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCc
Q 020652 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPEN 224 (323)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~N 224 (323)
+++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 221 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcce
Confidence 9999999999999999 8899999987541 359999999999999999999999999999999999
Q ss_pred EEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcch
Q 020652 225 ILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPC 299 (323)
Q Consensus 225 Ili~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~ 299 (323)
||++.++.+ ||+|||++...... .....||+.|+|||++.+..++.++
T Consensus 222 Ill~~~~~~---------------------------kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 274 (382)
T 3tt0_A 222 VLVTEDNVM---------------------------KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 274 (382)
T ss_dssp EEECTTCCE---------------------------EECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHH
T ss_pred EEEcCCCcE---------------------------EEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchh
Confidence 999766555 55555554432211 1223578899999999999999999
Q ss_pred hHHHHHHHHHHHhc-CCCCCCC
Q 020652 300 DLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 300 DiwSlG~il~el~t-g~~pf~~ 320 (323)
|||||||++|||++ |..||.+
T Consensus 275 DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 275 DVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTT
T ss_pred HHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999 9999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=323.40 Aligned_cols=199 Identities=21% Similarity=0.314 Sum_probs=172.6
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
...+|++.++||+|+||.||+|.+..+++.||||+++......+.+.+|+.++++++|+|| +++++++.....++
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~l~~~~~~~~~~~ 292 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTREPPFY 292 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSCE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCE-----eeEEEEEecCCcEE
Confidence 3467999999999999999999999999999999998666667789999999999999998 89999999889999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~-------- 364 (495)
T 1opk_A 293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL-------- 364 (495)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTC--------
T ss_pred EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeeccc--------
Confidence 999999 89999999876656799999999999999999999999999999999999998776665555554
Q ss_pred CccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
++..... .....+|..|+|||++.+..++.++|||||||+||||+| |..||.+
T Consensus 365 -------------------a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~ 422 (495)
T 1opk_A 365 -------------------SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422 (495)
T ss_dssp -------------------EECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred -------------------ceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC
Confidence 4332211 112345778999999998899999999999999999999 9999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=296.35 Aligned_cols=218 Identities=20% Similarity=0.246 Sum_probs=172.3
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceec
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~ 163 (323)
..+.++|++.+.||+|+||+||+|.+..+++.||||++... ......+.+|+..+..+ .|+|| +++++++.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~i-----v~~~~~~~ 81 (289)
T 1x8b_A 7 SRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV-----VRYFSAWA 81 (289)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTB-----CCEEEEEE
T ss_pred ccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCe-----eeeeeeee
Confidence 34557899999999999999999999999999999998742 33456678899999998 88888 88999999
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
..+..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.....+...
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 82 EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp ETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------
T ss_pred cCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccc
Confidence 999999999999 889999998642 13689999999999999999999999999999999999998776544433221
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
... ...+....+||+|||.+....... ...||+.|+|||++.+. .++.++|||||||++|||++|..++.
T Consensus 162 ~~~--------~~~~~~~~~kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 162 DED--------DWASNKVMFKIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp ----------------CCCEEECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred ccc--------cccCCceEEEEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 100 001245578999999987655433 34699999999999876 56689999999999999999998764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=295.91 Aligned_cols=196 Identities=23% Similarity=0.408 Sum_probs=149.3
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++.++|+|+ +++++++...+.
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 85 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSI-----LELYNYFEDSNY 85 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTB-----CCEEEEEECSSE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCe-----EeEEEEEccCCe
Confidence 46999999999999999999999999999999986432 223668889999999999988 889999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~-------------- 150 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN-------------- 150 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--------------
T ss_pred EEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--------------
Confidence 99999999 889999998653 46999999999999999999999999999999999999976554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 151 -------------~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 214 (278)
T 3cok_A 151 -------------IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214 (278)
T ss_dssp -------------EEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred -------------EEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 45566665543321 12234789999999999998899999999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=308.23 Aligned_cols=195 Identities=25% Similarity=0.409 Sum_probs=162.8
Q ss_pred CcEEEEeeecccCcEEEEEEEEC---CCCcEEEEEEeccch-----hhHHHHHHHHHHHHHHH-hCCCCCcceEEEccee
Q 020652 92 PRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWF 162 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAiK~~~~~~-----~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~ 162 (323)
++|++.+.||+|+||+||+|++. .+++.||||+++... ...+.+.+|+.+++.+. |+|| +.+++++
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~~ 128 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL-----VTLHYAF 128 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTB-----CCEEEEE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCce-----eEEEEEE
Confidence 68999999999999999999984 589999999986422 23455677999999995 7877 8888999
Q ss_pred ccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
...+.+++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~-------- 198 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHV-------- 198 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCE--------
T ss_pred eeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcE--------
Confidence 9899999999999 889999998765 69999999999999999999999999999999999999766555
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccC----CccccccCCccccchhhcCC--CCCcchhHHHHHHHHHHHhcCC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ----DHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~ 315 (323)
||+|||++..... .....+||+.|+|||++.+. .++.++|||||||++|||++|+
T Consensus 199 -------------------kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~ 259 (355)
T 1vzo_A 199 -------------------VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259 (355)
T ss_dssp -------------------EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred -------------------EEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCC
Confidence 5555555433211 12235799999999999863 4789999999999999999999
Q ss_pred CCCCC
Q 020652 316 NCYLT 320 (323)
Q Consensus 316 ~pf~~ 320 (323)
.||..
T Consensus 260 ~pf~~ 264 (355)
T 1vzo_A 260 SPFTV 264 (355)
T ss_dssp CTTSC
T ss_pred CCCcc
Confidence 99964
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-41 Score=315.22 Aligned_cols=195 Identities=24% Similarity=0.346 Sum_probs=164.4
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC-ceEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-NHIC 169 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~-~~~~ 169 (323)
.++|++.+.||+|+||.||+|.+. ++.||||+++... ..+.+.+|+.++++++|+|| +++++++... +.++
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNL-----VQLLGVIVEEKGGLY 263 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTB-----CCEEEEEECTTSCEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCE-----EEEEEEEEcCCCceE
Confidence 468999999999999999999875 6789999997644 45678999999999999998 8888876554 4799
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~---------------- 327 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV---------------- 327 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC----------------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC----------------
Confidence 999999 889999999876455899999999999999999999999999999999999976554
Q ss_pred CccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
+||+|||+++..........+|..|+|||++.+..++.++|||||||++|||+| |+.||.+
T Consensus 328 -----------~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 389 (450)
T 1k9a_A 328 -----------AKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 389 (450)
T ss_dssp -----------EEECCCTTCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred -----------EEEeeCCCcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 456666665543333333467889999999999999999999999999999998 9999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=295.58 Aligned_cols=196 Identities=26% Similarity=0.432 Sum_probs=169.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++|+|+ +++++++...+.
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 88 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNI-----LRMYNYFHDRKR 88 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSSE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCE-----eeEEEEEEcCCE
Confidence 67999999999999999999999999999999986432 234568889999999999988 889999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.++||||+ +++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-------------- 152 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE-------------- 152 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--------------
T ss_pred EEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--------------
Confidence 99999999 789999998765 6999999999999999999999999999999999999976554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccC-CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 153 -------------~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 153 -------------LKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp -------------EEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred -------------EEEecccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 45556665543322 123357899999999999999999999999999999999999999753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=317.37 Aligned_cols=204 Identities=25% Similarity=0.500 Sum_probs=157.1
Q ss_pred ceeCCcEEE-EeeecccCcEEEEEEEEC--CCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEccee--
Q 020652 88 ENLTPRYRI-LSKMGEGTFGQVVECFDN--EKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF-- 162 (323)
Q Consensus 88 ~~~~~~y~~-~~~lG~G~fg~V~~~~~~--~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~-- 162 (323)
+.+.+.|++ .++||+|+||+||+|++. .+++.||||++.... ....+.+|+.+|+.++|+|| +++++++
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~ 89 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG-ISMSACREIALLRELKHPNV-----ISLQKVFLS 89 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS-CCHHHHHHHHHHHHCCCTTB-----CCCCEEEEE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC-CCHHHHHHHHHHHhcCCCCe-----eeEeeEEec
Confidence 345567887 458999999999999965 578899999987533 23467889999999999998 8888888
Q ss_pred ccCceEEEEEccCCCCHHHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceec
Q 020652 163 DYRNHICIVFEKLGPSLYDFLRKNS-------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235 (323)
Q Consensus 163 ~~~~~~~lv~e~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki 235 (323)
.....+|+||||++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+...+
T Consensus 90 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~---- 165 (405)
T 3rgf_A 90 HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEG---- 165 (405)
T ss_dssp TTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSS----
T ss_pred CCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCC----
Confidence 4577899999999889999886321 12499999999999999999999999999999999999994321
Q ss_pred cCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC------ccccccCCccccchhhcCC-CCCcchhHHHHHHHH
Q 020652 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCIL 308 (323)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il 308 (323)
+..+.+||+|||++...... ....+||+.|+|||++.+. .++.++|||||||++
T Consensus 166 -------------------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il 226 (405)
T 3rgf_A 166 -------------------PERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 226 (405)
T ss_dssp -------------------TTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHH
T ss_pred -------------------CCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHH
Confidence 23456788888877654321 2335899999999999885 589999999999999
Q ss_pred HHHhcCCCCCCC
Q 020652 309 VELCSVSNCYLT 320 (323)
Q Consensus 309 ~el~tg~~pf~~ 320 (323)
|||++|+.||.+
T Consensus 227 ~ell~g~~pf~~ 238 (405)
T 3rgf_A 227 AELLTSEPIFHC 238 (405)
T ss_dssp HHHHHSSCTTCC
T ss_pred HHHHhCCCCCCC
Confidence 999999999965
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=304.79 Aligned_cols=201 Identities=32% Similarity=0.501 Sum_probs=168.1
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---------hhHHHHHHHHHHHHHHHhCCCCCcceEEE
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQI 158 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~ 158 (323)
..+.++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++|+|| +++
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~ 80 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI-----IKI 80 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTB-----CCE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCC-----ceE
Confidence 345578999999999999999999999999999999986432 122346789999999999998 788
Q ss_pred cceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccC
Q 020652 159 RNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (323)
Q Consensus 159 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d 237 (323)
++++.... .++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~------ 151 (322)
T 2ycf_A 81 KNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQE------ 151 (322)
T ss_dssp EEEEESSS-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS------
T ss_pred eeEEcCCc-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCC------
Confidence 88877655 89999999 889999987654 799999999999999999999999999999999999996543
Q ss_pred cccccccCCCCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhc---CCCCCcchhHHHHHHHHHHHh
Q 020652 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELC 312 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~ 312 (323)
....+||+|||++....... ....||+.|+|||++. +..++.++|||||||++|||+
T Consensus 152 ------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~ 213 (322)
T 2ycf_A 152 ------------------EDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL 213 (322)
T ss_dssp ------------------SSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHH
T ss_pred ------------------CCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHH
Confidence 23357888888887654332 2357999999999974 457899999999999999999
Q ss_pred cCCCCCCC
Q 020652 313 SVSNCYLT 320 (323)
Q Consensus 313 tg~~pf~~ 320 (323)
+|..||..
T Consensus 214 ~g~~pf~~ 221 (322)
T 2ycf_A 214 SGYPPFSE 221 (322)
T ss_dssp HSSCSSCS
T ss_pred hCCCCCcc
Confidence 99999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=303.09 Aligned_cols=212 Identities=28% Similarity=0.410 Sum_probs=167.1
Q ss_pred CceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 87 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
...+.++|++.+.||+|+||.||+|.+..+++.||||++... ......+.+|+.+++.++|+|| +++++++..
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~ 80 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI-----ITIFNIQRP 80 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTB-----CCEEEECCC
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCc-----CCeeeeecc
Confidence 345678999999999999999999999999999999998643 3345567899999999999998 666665443
Q ss_pred -----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 165 -----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 165 -----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
....++||||++++|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 81 DSFENFNEVYIIQELMQTDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp SCSTTCCCEEEEECCCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred cccCccceEEEEEeccCccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecc
Confidence 4789999999988999999874 59999999999999999999999999999999999999877766666666
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
++........... ............+||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 158 ~a~~~~~~~~~~~--------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 223 (353)
T 2b9h_A 158 LARIIDESAADNS--------------EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223 (353)
T ss_dssp TCEECC------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred ccccccccccccc--------------CccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCC
Confidence 5443221110000 00000001123478999999998865 67899999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 224 ~~ 225 (353)
T 2b9h_A 224 PG 225 (353)
T ss_dssp CC
T ss_pred CC
Confidence 76
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=299.62 Aligned_cols=200 Identities=28% Similarity=0.455 Sum_probs=161.5
Q ss_pred CceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEccee---
Q 020652 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF--- 162 (323)
Q Consensus 87 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~--- 162 (323)
+..+.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.++|+|+ +++++++
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~ 80 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNI-----VKVFEILGPS 80 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEECTT
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCe-----eEEEEecccc
Confidence 456788999999999999999999999999999999988643 3445678899999999999998 6666655
Q ss_pred -----------ccCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEee-c
Q 020652 163 -----------DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-A 230 (323)
Q Consensus 163 -----------~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~-~ 230 (323)
...+..++||||++++|.+++... .+++..++.++.|++.||+|||++||+||||||+||+++. +
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 81 GSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED 157 (320)
T ss_dssp SCBCCC----CCSCSEEEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT
T ss_pred ccccccccccccccCceeEEeeccCCCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC
Confidence 345789999999988999999753 5999999999999999999999999999999999999963 3
Q ss_pred CceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccC------CccccccCCccccchhhcC-CCCCcchhHHH
Q 020652 231 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILG-LGWNYPCDLWS 303 (323)
Q Consensus 231 ~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwS 303 (323)
+. +||+|||.+..... ......||..|+|||++.+ ..++.++||||
T Consensus 158 ~~---------------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 210 (320)
T 2i6l_A 158 LV---------------------------LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWA 210 (320)
T ss_dssp TE---------------------------EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHH
T ss_pred Ce---------------------------EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHh
Confidence 34 45555555543221 1223467999999999876 67899999999
Q ss_pred HHHHHHHHhcCCCCCCCC
Q 020652 304 VGCILVELCSVSNCYLTP 321 (323)
Q Consensus 304 lG~il~el~tg~~pf~~~ 321 (323)
|||++|||++|+.||.+.
T Consensus 211 lG~il~el~~g~~pf~~~ 228 (320)
T 2i6l_A 211 AGCIFAEMLTGKTLFAGA 228 (320)
T ss_dssp HHHHHHHHHHSSCSSCCS
T ss_pred HHHHHHHHHhCCCCCCCC
Confidence 999999999999999763
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=300.72 Aligned_cols=195 Identities=22% Similarity=0.313 Sum_probs=156.1
Q ss_pred CceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHH--HHhCCCCCcceEEEcceec-
Q 020652 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR--LARHDIGGTRCVQIRNWFD- 163 (323)
Q Consensus 87 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~--l~~~~i~~~~~~~~~~~~~- 163 (323)
.+.+.++|++.+.||+|+||+||+|.+ +++.||||++.... ...+..|.+++.. ++|+|| +++++++.
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~ni-----v~~~~~~~~ 73 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENI-----LGFIASDMT 73 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTB-----CCEEEEEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCe-----eeEEEeecc
Confidence 345678999999999999999999987 68899999987543 3445667777766 678888 66666533
Q ss_pred ---cCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCcEEEeecC
Q 020652 164 ---YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH--------ELRLIHTDLKPENILLVSAE 231 (323)
Q Consensus 164 ---~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH--------~~~iiHrDlKp~NIli~~~~ 231 (323)
....+++||||+ +++|.++++.. .+++..+..++.|++.||+||| ++||+||||||+|||++.++
T Consensus 74 ~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 74 SRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EETTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred ccCCCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC
Confidence 346789999999 88999999653 5999999999999999999999 99999999999999997665
Q ss_pred ceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-------ccccccCCccccchhhcCC------CCCcc
Q 020652 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGL------GWNYP 298 (323)
Q Consensus 232 ~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~------~~~~~ 298 (323)
.+ ||+|||++...... .....||+.|+|||++.+. .++.+
T Consensus 151 ~~---------------------------kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 203 (301)
T 3q4u_A 151 QC---------------------------CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR 203 (301)
T ss_dssp CE---------------------------EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHH
T ss_pred CE---------------------------EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCch
Confidence 55 55555555332211 1224799999999999886 44579
Q ss_pred hhHHHHHHHHHHHhcC----------CCCCCC
Q 020652 299 CDLWSVGCILVELCSV----------SNCYLT 320 (323)
Q Consensus 299 ~DiwSlG~il~el~tg----------~~pf~~ 320 (323)
+|||||||++|||+|| ..||..
T Consensus 204 ~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 204 VDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp HHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred hhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 9999999999999999 778754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=305.52 Aligned_cols=201 Identities=23% Similarity=0.351 Sum_probs=168.2
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEEC-----CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcc
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~ 160 (323)
+...++|++.+.||+|+||.||+|++. .+++.||||+++.. ....+.+.+|+.+++.++|+|| +++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~ 117 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI-----VKLLG 117 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCE-----EEEEE
Confidence 344578999999999999999999987 45589999998743 3345678899999999999988 89999
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSY----------------------RSFPIDLVRELGRQLLESVAFMHELRLIH 217 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~aL~~lH~~~iiH 217 (323)
++...+..++||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+|
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH 197 (343)
T 1luf_A 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 197 (343)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 999999999999999 8899999987421 46899999999999999999999999999
Q ss_pred cCCCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccC-----CccccccCCccccchhhcC
Q 020652 218 TDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILG 292 (323)
Q Consensus 218 rDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~ 292 (323)
|||||+|||++.++.+ ||+|||++..... ......||+.|+|||++.+
T Consensus 198 ~Dlkp~NIl~~~~~~~---------------------------kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 250 (343)
T 1luf_A 198 RDLATRNCLVGENMVV---------------------------KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 250 (343)
T ss_dssp SCCSGGGEEECGGGCE---------------------------EECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred CCCCcceEEECCCCeE---------------------------EEeecCCCcccccCccccccCCCcccceecChhhhcc
Confidence 9999999999776655 5555555433211 1123467899999999999
Q ss_pred CCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 293 LGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 293 ~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
..++.++|||||||++|||++ |..||.+
T Consensus 251 ~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 251 NRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 899999999999999999999 9999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=302.41 Aligned_cols=198 Identities=28% Similarity=0.494 Sum_probs=164.1
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
..++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.++|+|| +++++++...+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~ 97 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENL-----VNLLEVCKKKK 97 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETT
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCE-----eeEEEEeecCC
Confidence 346899999999999999999999999999999988532 2344567789999999999998 89999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
..++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 98 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~------------- 162 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV------------- 162 (331)
T ss_dssp EEEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC-------------
T ss_pred EEEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc-------------
Confidence 999999999 666666655443 6999999999999999999999999999999999999976554
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+||+|||.+...... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.
T Consensus 163 --------------~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 163 --------------VKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp --------------EEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred --------------EEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 456666655432221 2234789999999999876 6899999999999999999999999763
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=309.09 Aligned_cols=200 Identities=19% Similarity=0.228 Sum_probs=159.0
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECC---CCcEEEEEEeccchh------------hHHHHHHHHHHHHHHHhCCCCCc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSINK------------YREAAMIEIDVLQRLARHDIGGT 153 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vAiK~~~~~~~------------~~~~~~~Ei~~l~~l~~~~i~~~ 153 (323)
...++|++.+.||+|+||.||+|.+.. +++.+|||++..... ....+.+|+.+++.+.|+||
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni--- 110 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI--- 110 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC---
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCc---
Confidence 345789999999999999999999987 788999999864321 11235567777888888888
Q ss_pred ceEEEcceecc----CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEee
Q 020652 154 RCVQIRNWFDY----RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (323)
Q Consensus 154 ~~~~~~~~~~~----~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~ 229 (323)
+++++++.. ....|+||||++++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 111 --~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 111 --PLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY 186 (345)
T ss_dssp --CCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEES
T ss_pred --ceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEcc
Confidence 888887766 77899999999889999998765 7999999999999999999999999999999999999976
Q ss_pred cCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccC----------CccccccCCccccchhhcCCCCCcch
Q 020652 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ----------DHSYVVSTRHYRAPEVILGLGWNYPC 299 (323)
Q Consensus 230 ~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~ 299 (323)
++ ...+||+|||++..... ......||+.|+|||++.+..++.++
T Consensus 187 ~~-------------------------~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 241 (345)
T 2v62_A 187 KN-------------------------PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRS 241 (345)
T ss_dssp SS-------------------------TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHH
T ss_pred CC-------------------------CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchh
Confidence 54 12445556665543211 11335799999999999999999999
Q ss_pred hHHHHHHHHHHHhcCCCCCCC
Q 020652 300 DLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 300 DiwSlG~il~el~tg~~pf~~ 320 (323)
|||||||++|||++|+.||.+
T Consensus 242 Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 242 DVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp HHHHHHHHHHHHHHSSCTTGG
T ss_pred hHHHHHHHHHHHHhCCCCccc
Confidence 999999999999999999964
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=303.00 Aligned_cols=199 Identities=28% Similarity=0.482 Sum_probs=168.4
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---------hhHHHHHHHHHHHHHH-HhCCCCCcceEE
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRL-ARHDIGGTRCVQ 157 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~ 157 (323)
..+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ...+.+.+|+.+++++ .|+|| +.
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~ 164 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHI-----IT 164 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTB-----CC
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE-----eE
Confidence 345578999999999999999999999999999999986432 2245678899999999 79988 88
Q ss_pred EcceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceecc
Q 020652 158 IRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (323)
Q Consensus 158 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~ 236 (323)
+++++......++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~i--- 239 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQI--- 239 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE---
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCE---
Confidence 889999999999999999 889999998764 69999999999999999999999999999999999999765544
Q ss_pred CcccccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcC------CCCCcchhHHHHHHHH
Q 020652 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG------LGWNYPCDLWSVGCIL 308 (323)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il 308 (323)
||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++
T Consensus 240 ------------------------kl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il 295 (365)
T 2y7j_A 240 ------------------------RLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295 (365)
T ss_dssp ------------------------EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHH
T ss_pred ------------------------EEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHH
Confidence 55555555433221 233579999999999863 3588999999999999
Q ss_pred HHHhcCCCCCCC
Q 020652 309 VELCSVSNCYLT 320 (323)
Q Consensus 309 ~el~tg~~pf~~ 320 (323)
|||++|..||.+
T Consensus 296 ~ell~g~~pf~~ 307 (365)
T 2y7j_A 296 FTLLAGSPPFWH 307 (365)
T ss_dssp HHHHHSSCSSCC
T ss_pred HHHHHCCCCCCC
Confidence 999999999965
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=306.53 Aligned_cols=201 Identities=28% Similarity=0.494 Sum_probs=162.1
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh------hHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ..+.+.+|+.+++.++|+|| +++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~ 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI-----IGLLDAFGH 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTB-----CCEEEEECC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCC-----CeEEEEEee
Confidence 4679999999999999999999999999999999864221 12457789999999999988 899999999
Q ss_pred CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 165 RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 165 ~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
.+..++||||+.++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 84 ~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 84 KSNISLVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp TTCCEEEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred CCceEEEEEcCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 99999999999779999987654 46899999999999999999999999999999999999977666555555543322
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
... .......+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.
T Consensus 163 ~~~------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 163 GSP------------------------NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp TSC------------------------CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCC------------------------cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 110 0111234789999999999765 5899999999999999999999999763
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=313.65 Aligned_cols=202 Identities=20% Similarity=0.321 Sum_probs=167.1
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.++|++.+.||+|+||.||+|.+..+++.||||+++.. ....+.+.+|+.+++.++|+|| +++++++...+.+
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~~~~~ 187 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNI-----VRLIGVCTQKQPI 187 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTB-----CCEEEEECSSSSC
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEecCCCc
Confidence 36799999999999999999999999999999998743 2334567889999999999988 8999999988899
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 188 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999 899999998654 35899999999999999999999999999999999999987766666655553321100
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
. .........++..|+|||++.+..++.++|||||||++|||+| |..||.+
T Consensus 267 ~----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~ 318 (377)
T 3cbl_A 267 V----------------------YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN 318 (377)
T ss_dssp E----------------------EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred c----------------------eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 0 0000011235678999999998889999999999999999998 9999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=299.03 Aligned_cols=213 Identities=26% Similarity=0.332 Sum_probs=152.7
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHH-hCCCCCcceEEEccee------
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWF------ 162 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~------ 162 (323)
..+|++.++||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++++. |+|| +++++++
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----v~~~~~~~~~~~~ 101 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI-----VQFCSAASIGKEE 101 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTB-----CCEEEEEEECTTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCCh-----hhccccccccccc
Confidence 35799999999999999999999999999999987543 344567889999999996 9998 6676666
Q ss_pred --ccCceEEEEEccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEeecCceeccC
Q 020652 163 --DYRNHICIVFEKLGPSLYDFLRKN-SYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPD 237 (323)
Q Consensus 163 --~~~~~~~lv~e~~~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~--iiHrDlKp~NIli~~~~~~ki~d 237 (323)
.....++++|||++++|.+++... ....+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|
T Consensus 102 ~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp STTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred cccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEec
Confidence 445678999999988999998752 2246999999999999999999999999 99999999999998877777777
Q ss_pred cccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhh---cCCCCCcchhHHHHHHHHHHHhcC
Q 020652 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI---LGLGWNYPCDLWSVGCILVELCSV 314 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~el~tg 314 (323)
||++............ ..............||+.|+|||++ .+..++.++|||||||++|||++|
T Consensus 182 fg~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g 249 (337)
T 3ll6_A 182 FGSATTISHYPDYSWS------------AQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249 (337)
T ss_dssp CTTCBCCSSCC-------------------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHS
T ss_pred CccceeccccCccccc------------ccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhC
Confidence 7665443322110000 0000000111234689999999998 566789999999999999999999
Q ss_pred CCCCCC
Q 020652 315 SNCYLT 320 (323)
Q Consensus 315 ~~pf~~ 320 (323)
+.||..
T Consensus 250 ~~p~~~ 255 (337)
T 3ll6_A 250 QHPFED 255 (337)
T ss_dssp SCCC--
T ss_pred CCCCcc
Confidence 999965
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=296.35 Aligned_cols=198 Identities=28% Similarity=0.397 Sum_probs=166.0
Q ss_pred CceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc--
Q 020652 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-- 164 (323)
Q Consensus 87 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~-- 164 (323)
+..+..+|++.+.||+|+||.||+|.+..+++.||+|++.... +.+.+|+.+++.++|+|+ +++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~ 77 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN---EKAEREVKALAKLDHVNI-----VHYNGCWDGFD 77 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS---GGGHHHHHHHHHCCCTTB-----CCEEEEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc---HHHHHHHHHHHhCCCCCE-----EEEeeeEeccc
Confidence 4556678999999999999999999999999999999987543 346689999999999998 666665543
Q ss_pred --------------CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEee
Q 020652 165 --------------RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (323)
Q Consensus 165 --------------~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~ 229 (323)
...+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 157 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVD 157 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEE
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcC
Confidence 45689999999 789999998664457999999999999999999999999999999999999987
Q ss_pred cCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHH
Q 020652 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 307 (323)
Q Consensus 230 ~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 307 (323)
++.+|++||| .+...... .....||+.|+|||++.+..++.++|||||||+
T Consensus 158 ~~~~kl~Dfg---------------------------~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 210 (284)
T 2a19_B 158 TKQVKIGDFG---------------------------LVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLI 210 (284)
T ss_dssp TTEEEECCCT---------------------------TCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHH
T ss_pred CCCEEECcch---------------------------hheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHH
Confidence 7766555555 44332211 223468999999999999999999999999999
Q ss_pred HHHHhcCCCCCC
Q 020652 308 LVELCSVSNCYL 319 (323)
Q Consensus 308 l~el~tg~~pf~ 319 (323)
+|||++|..||.
T Consensus 211 l~~l~~~~~~~~ 222 (284)
T 2a19_B 211 LAELLHVCDTAF 222 (284)
T ss_dssp HHHHHSCCSSHH
T ss_pred HHHHHhcCCcch
Confidence 999999998874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=298.98 Aligned_cols=195 Identities=25% Similarity=0.400 Sum_probs=161.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++.++|+|| +++++++...+.
T Consensus 34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----v~~~~~~~~~~~ 108 (309)
T 2h34_A 34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV-----VPIHDFGEIDGQ 108 (309)
T ss_dssp CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTE
T ss_pred ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCe-----eEEEEEEeeCCe
Confidence 67999999999999999999999999999999987432 234678889999999999988 889999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.++||||+ +++|.+++.... .+++..++.++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~------------- 173 (309)
T 2h34_A 109 LYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFA------------- 173 (309)
T ss_dssp EEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE-------------
T ss_pred EEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCE-------------
Confidence 99999999 789999998764 69999999999999999999999999999999999999766555
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 174 --------------kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (309)
T 2h34_A 174 --------------YLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237 (309)
T ss_dssp --------------EECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS
T ss_pred --------------EEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC
Confidence 55555544332221 1234689999999999998999999999999999999999999975
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=301.96 Aligned_cols=201 Identities=20% Similarity=0.288 Sum_probs=159.1
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEE----EEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELV----AIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~v----AiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
.++|++.+.||+|+||+||+|++..+++.+ |+|.+... ....+.+.+|+.++++++|+|| +++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~ 88 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV-----CRLLGICLT 88 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTB-----CCEEEEEES
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCE-----eEEEEEEec
Confidence 367999999999999999999998887654 77766532 2345678899999999999998 888888876
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
.. .++|||++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred CC-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 55 77888988 999999998754 4699999999999999999999999999999999999998877766666665433
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
...... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.+
T Consensus 167 ~~~~~~----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 222 (327)
T 3poz_A 167 LGAEEK----------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp HTTTCC-----------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccCCcc----------------------cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC
Confidence 221110 000112356889999999999999999999999999999999 9999976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=306.49 Aligned_cols=209 Identities=18% Similarity=0.184 Sum_probs=166.1
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCC--------CcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCC----------
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEK--------KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG---------- 152 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~--------~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~---------- 152 (323)
.++|++.+.||+|+||.||+|++..+ ++.||||++... +.+.+|+.++++++|+|+..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 46899999999999999999999874 889999998753 35778999999999988732
Q ss_pred cceEEEcceecc-CceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC
Q 020652 153 TRCVQIRNWFDY-RNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (323)
Q Consensus 153 ~~~~~~~~~~~~-~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~ 231 (323)
.+++.+++++.. ....++||||++++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~ 196 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPED 196 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTE
T ss_pred cCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCC
Confidence 223445666655 6789999999999999999976334799999999999999999999999999999999999998776
Q ss_pred --ceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHH
Q 020652 232 --YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (323)
Q Consensus 232 --~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (323)
.+||+|||++.......... ...........||+.|+|||++.+..++.++|||||||++|
T Consensus 197 ~~~~kl~Dfg~a~~~~~~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 259 (352)
T 2jii_A 197 QSQVTLAGYGFAFRYCPSGKHV-----------------AYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCML 259 (352)
T ss_dssp EEEEEECCGGGCBCSSGGGCCC-----------------CCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred CceEEEecCcceeeccCCCccc-----------------cccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHH
Confidence 66666666554332211100 00001112347999999999999999999999999999999
Q ss_pred HHhcCCCCCCC
Q 020652 310 ELCSVSNCYLT 320 (323)
Q Consensus 310 el~tg~~pf~~ 320 (323)
||++|+.||.+
T Consensus 260 el~~g~~pf~~ 270 (352)
T 2jii_A 260 KWLYGFLPWTN 270 (352)
T ss_dssp HHHHSCCTTGG
T ss_pred HHHhCCCCccc
Confidence 99999999975
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=302.15 Aligned_cols=204 Identities=22% Similarity=0.332 Sum_probs=166.4
Q ss_pred eCCcEEEEeeecccCcEEEEEEEE-----CCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcce
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW 161 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~ 161 (323)
..++|++.+.||+|+||.||+|.+ ..+++.||||++... ....+.+.+|+.+++++ .|+|| ++++++
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~~ 117 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI-----VNLLGA 117 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCe-----eeEEEE
Confidence 346899999999999999999997 345678999998743 23456788999999999 89998 899999
Q ss_pred eccCceEEEEEccC-CCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 020652 162 FDYRNHICIVFEKL-GPSLYDFLRKNSY---------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTD 219 (323)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrD 219 (323)
+...+..++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++||+|||
T Consensus 118 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 99999999999999 8899999986542 2378999999999999999999999999999
Q ss_pred CCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcch
Q 020652 220 LKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPC 299 (323)
Q Consensus 220 lKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 299 (323)
|||+|||++.++.+||+|||++........ ........||+.|+|||++.+..++.++
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 255 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSN----------------------YVVRGNARLPVKWMAPESLFEGIYTIKS 255 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTT----------------------SEEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCcc----------------------ceeccCccCccCccCHHHhccCCCChhH
Confidence 999999998777666666665433221110 0001224578899999999998999999
Q ss_pred hHHHHHHHHHHHhc-CCCCCCC
Q 020652 300 DLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 300 DiwSlG~il~el~t-g~~pf~~ 320 (323)
|||||||++|||+| |..||.+
T Consensus 256 Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 256 DVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp HHHHHHHHHHHHTTTSCCSSTT
T ss_pred hHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999998 9999976
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=291.66 Aligned_cols=198 Identities=29% Similarity=0.515 Sum_probs=167.9
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----------hhHHHHHHHHHHHHHHH-hCCCCCcceEE
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----------KYREAAMIEIDVLQRLA-RHDIGGTRCVQ 157 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----------~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~ 157 (323)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++++. |+|+ ++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i-----~~ 88 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI-----IQ 88 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB-----CC
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE-----ee
Confidence 45578999999999999999999999999999999986431 23456788999999996 8888 88
Q ss_pred EcceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceecc
Q 020652 158 IRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVP 236 (323)
Q Consensus 158 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~ 236 (323)
+++++...+..++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~--- 163 (298)
T 1phk_A 89 LKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNI--- 163 (298)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE---
T ss_pred eeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcE---
Confidence 999999999999999999 789999998764 69999999999999999999999999999999999999765544
Q ss_pred CcccccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhc------CCCCCcchhHHHHHHHH
Q 020652 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVIL------GLGWNYPCDLWSVGCIL 308 (323)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il 308 (323)
||+|||.+...... .....||+.|+|||++. ...++.++|||||||++
T Consensus 164 ------------------------kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l 219 (298)
T 1phk_A 164 ------------------------KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219 (298)
T ss_dssp ------------------------EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHH
T ss_pred ------------------------EEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHH
Confidence 55555555432221 22347899999999985 45688999999999999
Q ss_pred HHHhcCCCCCCC
Q 020652 309 VELCSVSNCYLT 320 (323)
Q Consensus 309 ~el~tg~~pf~~ 320 (323)
|||++|..||.+
T Consensus 220 ~~l~~g~~p~~~ 231 (298)
T 1phk_A 220 YTLLAGSPPFWH 231 (298)
T ss_dssp HHHHHSSCSSCC
T ss_pred HHHHHCCCCCcC
Confidence 999999999965
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=305.92 Aligned_cols=201 Identities=22% Similarity=0.284 Sum_probs=168.7
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
+...++|++.+.||+|+||.||+|.+ .+++.||||++... ....+.+.+|+.+++.++|+|| +++++++...+
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~ 108 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHL-----VSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTB-----CCEEEECCCTT
T ss_pred HHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEcCCC
Confidence 44667899999999999999999996 46889999988643 3345678899999999999988 89999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSY--RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
..++||||+ +++|.+++..... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~---------- 178 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVP---------- 178 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCE----------
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCE----------
Confidence 999999999 8899999875432 358999999999999999999999999999999999999765555
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccC-----CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 179 -----------------kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~ 241 (321)
T 2qkw_B 179 -----------------KITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241 (321)
T ss_dssp -----------------EECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTC
T ss_pred -----------------EEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcc
Confidence 5555555443211 112346899999999999889999999999999999999999999
Q ss_pred CCC
Q 020652 319 LTP 321 (323)
Q Consensus 319 ~~~ 321 (323)
.+.
T Consensus 242 ~~~ 244 (321)
T 2qkw_B 242 VQS 244 (321)
T ss_dssp SCS
T ss_pred ccc
Confidence 764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=297.94 Aligned_cols=204 Identities=24% Similarity=0.369 Sum_probs=165.3
Q ss_pred CCcEEEEeeecccCcEEEEEEE----ECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 91 TPRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~----~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
..+|++.+.||+|+||.||+|+ +..+++.||+|++.... ...+.+.+|+.+++.++|+|+ +++++++..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~ 94 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI-----VKYKGICTE 94 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTB-----CCEEEEEEC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCe-----eeeeeEEec
Confidence 4679999999999999999998 57789999999987432 334678899999999999988 888888776
Q ss_pred C--ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 165 R--NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 165 ~--~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
. +.+++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.++++|||++
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 173 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccc
Confidence 5 6789999999 889999996654 36999999999999999999999999999999999999988776655555543
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
........ .........||..|+|||++.+..++.++|||||||++|||++|..||..+
T Consensus 174 ~~~~~~~~---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 232 (302)
T 4e5w_A 174 KAIETDKE---------------------YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232 (302)
T ss_dssp EECCTTCC---------------------EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred ccccCCCc---------------------ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcch
Confidence 32211110 000112246788899999999989999999999999999999999987653
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=297.48 Aligned_cols=192 Identities=22% Similarity=0.528 Sum_probs=164.3
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceecc--Cce
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDY--RNH 167 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~--~~~ 167 (323)
.++|++.+.||+|+||+||+|++..+++.||||++... ..+.+.+|+.+++.+. |+|+ +++++++.. ...
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~E~~~l~~l~~~~~i-----~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNI-----ITLADIVKDPVSRT 107 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--CHHHHHHHHHHHHHHTTSTTB-----CCEEEEEECTTTCC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc--chHHHHHHHHHHHHcCCCCCE-----EEeeeeeccCCCCc
Confidence 46899999999999999999999999999999998743 3466889999999998 8888 888888876 678
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.++||||+ +++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 108 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~--------------- 167 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH--------------- 167 (330)
T ss_dssp EEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT---------------
T ss_pred eEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCC---------------
Confidence 99999999 889998875 388999999999999999999999999999999999997544
Q ss_pred CCCccccCCCCCCceEeeCCCcccccC--CccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
..+||+|||++..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 168 -----------~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 168 -----------RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp -----------TEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred -----------CEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 2356666766654322 2233578999999999987 5789999999999999999999999954
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=299.71 Aligned_cols=203 Identities=21% Similarity=0.340 Sum_probs=166.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEEC-----CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
.++|++.+.||+|+||.||+|.+. .+++.||||++... ....+.+.+|+.+++.++|+|| +++++++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~ 96 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV-----IKLYGACS 96 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCce-----eeEEEEEe
Confidence 468999999999999999999883 45588999998743 3345678899999999999988 88999999
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNSY----------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDL 220 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~----------------------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDl 220 (323)
..+..++||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+||||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 999999999999 8999999987542 23889999999999999999999999999999
Q ss_pred CCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchh
Q 020652 221 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCD 300 (323)
Q Consensus 221 Kp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 300 (323)
||+||+++.++.+|++|||++........ ........+|+.|+|||++.+..++.++|
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 234 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDS----------------------YVKRSQGRIPVKWMAIESLFDHIYTTQSD 234 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSC----------------------EECSSCCCSCGGGCCHHHHHHCEECHHHH
T ss_pred chheEEEcCCCCEEEcccccccccccccc----------------------ceeccCCCCcccccChhhhcCCCcCchhh
Confidence 99999998766655555554322211100 00112235688999999999988999999
Q ss_pred HHHHHHHHHHHhc-CCCCCCC
Q 020652 301 LWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 301 iwSlG~il~el~t-g~~pf~~ 320 (323)
||||||++|||++ |..||.+
T Consensus 235 i~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 235 VWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp HHHHHHHHHHHHTTSCCSSTT
T ss_pred HHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999 9999976
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-41 Score=294.75 Aligned_cols=202 Identities=22% Similarity=0.276 Sum_probs=159.4
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCC---CcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
...++|++.+.||+|+||.||+|.+..+ +..||+|++... ....+.+.+|+.+++.++|+|+ +++++++.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~ 86 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI-----VKLIGVIT 86 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCcc-----ceEEEEEc
Confidence 4457899999999999999999998654 457999988642 3445678899999999999988 78888774
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
.+..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+|++|||++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred -cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence 45689999999 789999998654 469999999999999999999999999999999999999887766665555433
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 165 ~~~~~~-----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~ 220 (281)
T 1mp8_A 165 YMEDST-----------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220 (281)
T ss_dssp -------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccCccc-----------------------ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCc
Confidence 221100 000112356789999999998899999999999999999996 9999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=302.85 Aligned_cols=200 Identities=28% Similarity=0.450 Sum_probs=147.6
Q ss_pred eeCCcEEEEe-eecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc---
Q 020652 89 NLTPRYRILS-KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--- 164 (323)
Q Consensus 89 ~~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~--- 164 (323)
.+.++|++.+ .||+|+||+||+|.+..+++.||||++.......++ ....++.+.|+|+ +++++++..
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e---~~~~~~~~~h~~i-----~~~~~~~~~~~~ 96 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQE---VDHHWQASGGPHI-----VCILDVYENMHH 96 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHH---HHHHHHHTTSTTB-----CCEEEEEEEEET
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHH---HHHHHHhcCCCCh-----HHHHHHHhhccC
Confidence 4567899965 599999999999999999999999998754433222 2233556678887 777777665
Q ss_pred -CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
...+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~----------- 165 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE----------- 165 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSS-----------
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecC-----------
Confidence 55689999999 88999999977656799999999999999999999999999999999999996532
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCC-ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
....+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+
T Consensus 166 -------------~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (336)
T 3fhr_A 166 -------------KDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS 231 (336)
T ss_dssp -------------TTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred -------------CCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 2445788888888654332 2345789999999999888899999999999999999999999965
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=296.20 Aligned_cols=203 Identities=27% Similarity=0.392 Sum_probs=169.7
Q ss_pred CCcEEEEeeecccCcEEEEEEEE-----CCCCcEEEEEEeccch--hhHHHHHHHHHHHHHH-HhCCCCCcceEEEccee
Q 020652 91 TPRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~ 162 (323)
.++|++.+.||+|+||.||+|.+ ..+++.||||++.... ...+.+.+|+.+++++ +|+|| +++++++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----~~~~~~~ 96 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI-----VNLLGAC 96 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCe-----eeEEEEE
Confidence 46899999999999999999985 4577899999987432 3456788999999999 89988 8899999
Q ss_pred ccCceEEEEEccC-CCCHHHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 020652 163 DYRNHICIVFEKL-GPSLYDFLRKNSY----------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (323)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~----------------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NI 225 (323)
...+..++||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 9999999999999 8899999987542 1489999999999999999999999999999999999
Q ss_pred EEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHH
Q 020652 226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305 (323)
Q Consensus 226 li~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 305 (323)
+++.++.+|++|||++......... .......||+.|+|||++.+..++.++||||||
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 234 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNY----------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 234 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTS----------------------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred EEcCCCCEEEccccccccccccccc----------------------eeccCCCCcceeeChHHhcCCCCChHHHHHHHH
Confidence 9988777766666655433221100 001123578899999999999999999999999
Q ss_pred HHHHHHhc-CCCCCCC
Q 020652 306 CILVELCS-VSNCYLT 320 (323)
Q Consensus 306 ~il~el~t-g~~pf~~ 320 (323)
|++|||+| |..||.+
T Consensus 235 ~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 235 IFLWELFSLGSSPYPG 250 (313)
T ss_dssp HHHHHHHTTTCCSSTT
T ss_pred HHHHHHHhCCCCCCCc
Confidence 99999999 9999976
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=291.12 Aligned_cols=199 Identities=27% Similarity=0.383 Sum_probs=162.5
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
....++|++.+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++.++|+|+ +++++++.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~ 81 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHI-----IKLYQVIS 81 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTB-----CCEEEEEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCE-----eEEEEEEe
Confidence 445578999999999999999999999999999999986432 234577889999999999988 88899999
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
..+..++||||+ +++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~--------- 150 (276)
T 2h6d_A 82 TPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNA--------- 150 (276)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCE---------
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCE---------
Confidence 999999999999 889999998765 69999999999999999999999999999999999999766555
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
||+|||.+...... .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.
T Consensus 151 ------------------~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 212 (276)
T 2h6d_A 151 ------------------KIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212 (276)
T ss_dssp ------------------EECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ------------------EEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 55555544432221 123468999999999988765 689999999999999999999997
Q ss_pred C
Q 020652 320 T 320 (323)
Q Consensus 320 ~ 320 (323)
.
T Consensus 213 ~ 213 (276)
T 2h6d_A 213 D 213 (276)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=296.94 Aligned_cols=200 Identities=33% Similarity=0.561 Sum_probs=165.9
Q ss_pred eCCcEEEEeeecccCcEEEEEEEEC-CCCcEEEEEEeccch---hhHHHHHHHHHHHHHH---HhCCCCCcceEEEccee
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDN-EKKELVAIKIVRSIN---KYREAAMIEIDVLQRL---ARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~-~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l---~~~~i~~~~~~~~~~~~ 162 (323)
..++|++.+.||+|+||.||+|++. .+++.||+|++.... .....+.+|+.+++.+ .|+|| +++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i-----~~~~~~~ 83 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV-----VRLFDVC 83 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTB-----CCEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCe-----Eeeeeee
Confidence 3468999999999999999999995 678999999886422 1223566788888887 68887 7777776
Q ss_pred c-----cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccC
Q 020652 163 D-----YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPD 237 (323)
Q Consensus 163 ~-----~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d 237 (323)
. .....++||||++++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~----- 158 (326)
T 1blx_A 84 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ----- 158 (326)
T ss_dssp EEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC-----
T ss_pred eecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC-----
Confidence 5 567899999999889999998876556999999999999999999999999999999999999976554
Q ss_pred cccccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCC
Q 020652 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~ 315 (323)
+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 159 ----------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 216 (326)
T 1blx_A 159 ----------------------IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216 (326)
T ss_dssp ----------------------EEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ----------------------EEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCC
Confidence 456666655443221 22357899999999999999999999999999999999999
Q ss_pred CCCCCC
Q 020652 316 NCYLTP 321 (323)
Q Consensus 316 ~pf~~~ 321 (323)
.||.+.
T Consensus 217 ~pf~~~ 222 (326)
T 1blx_A 217 PLFRGS 222 (326)
T ss_dssp CSCCCS
T ss_pred CCCCCC
Confidence 999763
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=308.60 Aligned_cols=199 Identities=30% Similarity=0.527 Sum_probs=159.4
Q ss_pred CceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc--
Q 020652 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-- 164 (323)
Q Consensus 87 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~-- 164 (323)
++....+|++.+.||+|+||+||+|++..+++ +|+|++...... ..+|+.+++.++|+|| +++++++..
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~---~~~E~~il~~l~h~ni-----v~l~~~~~~~~ 105 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF---KNRELQIMRIVKHPNV-----VDLKAFFYSNG 105 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS---CCHHHHHHHTCCCTTB-----CCEEEEEEEES
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch---HHHHHHHHHhCCCCCc-----ceEEEEEEecC
Confidence 45566789999999999999999999987777 788876543322 2369999999999998 777777743
Q ss_pred ----CceEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEe-ecCceeccC
Q 020652 165 ----RNHICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SAEYVKVPD 237 (323)
Q Consensus 165 ----~~~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~-~~~~~ki~d 237 (323)
...+++||||+.+++.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++ .++.
T Consensus 106 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~----- 180 (394)
T 4e7w_A 106 DKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGV----- 180 (394)
T ss_dssp SSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTE-----
T ss_pred CCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCc-----
Confidence 334889999997777665542 1224799999999999999999999999999999999999997 4444
Q ss_pred cccccccCCCCCccccCCCCCCceEeeCCCcccccC--CccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcC
Q 020652 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSV 314 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg 314 (323)
+||+|||+++.... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 181 ----------------------~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 238 (394)
T 4e7w_A 181 ----------------------LKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238 (394)
T ss_dssp ----------------------EEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred ----------------------EEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 56666666654322 22345789999999999775 589999999999999999999
Q ss_pred CCCCCCC
Q 020652 315 SNCYLTP 321 (323)
Q Consensus 315 ~~pf~~~ 321 (323)
+.||.+.
T Consensus 239 ~~pf~~~ 245 (394)
T 4e7w_A 239 QPLFPGE 245 (394)
T ss_dssp SCSSCCS
T ss_pred CCCCCCC
Confidence 9999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=291.08 Aligned_cols=195 Identities=24% Similarity=0.406 Sum_probs=164.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc----
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY---- 164 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~---- 164 (323)
..|++.+.||+|+||.||+|.+..++..||+|++... ....+.+.+|+.+++.++|+|| +++++++..
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~ 100 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI-----VRFYDSWESTVKG 100 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEEESSS
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCe-----eeeeeeeccccCC
Confidence 4589999999999999999999999999999998642 3445678899999999999998 777776654
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEeecCceeccCcccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
...+++||||+ +++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 101 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~------------ 166 (290)
T 1t4h_A 101 KKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG------------ 166 (290)
T ss_dssp CEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS------------
T ss_pred CceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEEC------------
Confidence 46799999999 889999998764 6999999999999999999999999 999999999999951
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccCC-ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
..+.+||+|||++...... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+
T Consensus 167 --------------~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 167 --------------PTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp --------------TTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred --------------CCCCEEEeeCCCcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 2234567777766543332 233579999999998875 589999999999999999999999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=303.84 Aligned_cols=196 Identities=27% Similarity=0.503 Sum_probs=162.9
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+.++|.+.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++|+|| +++++++...
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 95 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENV-----IGLLDVFTPA 95 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCCSEEECSC
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCc-----ccHhheEecc
Confidence 4567899999999999999999999999999999998642 2345677899999999999998 7888877665
Q ss_pred c------eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 166 N------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 166 ~------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
. .+|+||||++++|.+++.. .+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 96 ~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~-------- 163 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQTDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-------- 163 (353)
T ss_dssp SSGGGCCCCEEEEECCSEEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC--------
T ss_pred cccccceeEEEEeccccCCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC--------
Confidence 4 3599999998888877642 599999999999999999999999999999999999996554
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
.+||+|||.+...........||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 164 -------------------~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf 224 (353)
T 3coi_A 164 -------------------ELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF 224 (353)
T ss_dssp -------------------CEEECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred -------------------cEEEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 4566666666554444445678999999999987 67899999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 225 ~~ 226 (353)
T 3coi_A 225 KG 226 (353)
T ss_dssp BS
T ss_pred CC
Confidence 76
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=294.32 Aligned_cols=200 Identities=22% Similarity=0.363 Sum_probs=154.0
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh---hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
...++|++.+.||+|+||+||+|++..+++.||+|++..... ..+.+..+...++.+.|+|+ +++++++...
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i-----v~~~~~~~~~ 78 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT-----VTFYGALFRE 78 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEECS
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeE-----EEEeeeeecc
Confidence 345789999999999999999999999999999999874322 22223334444666677777 8999999999
Q ss_pred ceEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEeecCceeccCccccc
Q 020652 166 NHICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 166 ~~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
+..++||||++++|.+++.. .....+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+
T Consensus 79 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~--------- 149 (290)
T 3fme_A 79 GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQV--------- 149 (290)
T ss_dssp SSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCE---------
T ss_pred CCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCE---------
Confidence 99999999998899888764 1234799999999999999999999998 99999999999999765544
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhh----cCCCCCcchhHHHHHHHHHHHhcCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVI----LGLGWNYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~el~tg~~ 316 (323)
||+|||.+...... .....||+.|+|||++ .+..++.++|||||||++|||++|+.
T Consensus 150 ------------------kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 211 (290)
T 3fme_A 150 ------------------KMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRF 211 (290)
T ss_dssp ------------------EBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSC
T ss_pred ------------------EEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCC
Confidence 55555555433222 1224689999999997 45578999999999999999999999
Q ss_pred CCCC
Q 020652 317 CYLT 320 (323)
Q Consensus 317 pf~~ 320 (323)
||..
T Consensus 212 p~~~ 215 (290)
T 3fme_A 212 PYDS 215 (290)
T ss_dssp SSCC
T ss_pred Cccc
Confidence 9974
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=316.24 Aligned_cols=198 Identities=26% Similarity=0.394 Sum_probs=166.4
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
...++|++.+.||+|+||+||+|.+. ++..||||+++......+.+.+|+.+++.++|+|| +++++++. .+.+
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~l~~~~~-~~~~ 257 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKL-----VKLHAVVT-KEPI 257 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTB-----CCEEEEEC-SSSC
T ss_pred echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCE-----eeEEEEEe-CCcc
Confidence 34568999999999999999999885 46779999998766667889999999999999998 77888776 5678
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||||+ +++|.+++.......+++..+..++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~-------------- 323 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVC-------------- 323 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCE--------------
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcE--------------
Confidence 9999999 8999999985433468999999999999999999999999999999999999765544
Q ss_pred CCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
||+|||+++..... .....+|..|+|||++.+..++.++|||||||++|||+| |+.||.+
T Consensus 324 -------------kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 324 -------------KIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp -------------EECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred -------------EEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 55555555443221 112346788999999998899999999999999999999 9999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=293.91 Aligned_cols=196 Identities=28% Similarity=0.418 Sum_probs=169.1
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
...+|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.+.|+|+ +++++++.....
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 94 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV-----TKYYGSYLKDTK 94 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCE-----eEEEEEEecCCe
Confidence 345799999999999999999999999999999998643 3345778899999999999988 888999988899
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.++||||+ +++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.
T Consensus 95 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-------------- 157 (303)
T 3a7i_A 95 LWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE-------------- 157 (303)
T ss_dssp EEEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--------------
T ss_pred EEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--------------
Confidence 99999999 78999998753 5999999999999999999999999999999999999976554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 158 -------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 158 -------------VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp -------------EEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -------------EEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence 455555555433221 2335789999999999999999999999999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=295.11 Aligned_cols=200 Identities=30% Similarity=0.453 Sum_probs=161.4
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc----chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS----INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~----~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
...++|++.+.||+|+||.||+|.+..+++.||||++.. .....+.+.+|+.+++.++|+|+ +++++++..
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~ 103 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV-----IKYYASFIE 103 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEc
Confidence 344679999999999999999999999999999999874 23455678899999999999988 888999988
Q ss_pred CceEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
.+..++||||+ +++|.+++... ....+++..++.++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~-------- 175 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVV-------- 175 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCE--------
T ss_pred CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCE--------
Confidence 99999999999 78999998742 23468999999999999999999999999999999999999766555
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 176 -------------------kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 236 (310)
T 2wqm_A 176 -------------------KLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF 236 (310)
T ss_dssp -------------------EECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred -------------------EEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 55555554432221 12346899999999999999999999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 237 ~~ 238 (310)
T 2wqm_A 237 YG 238 (310)
T ss_dssp C-
T ss_pred cc
Confidence 65
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=290.49 Aligned_cols=195 Identities=27% Similarity=0.384 Sum_probs=167.5
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+.+|+.+++.++|+|+ +++++++...+..++|
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKL-----VQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTB-----CCEEEEECSSSSCEEE
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCE-----eeEEEEEccCCCeEEE
Confidence 57999999999999999999986 66789999998766566788999999999999988 8899999888999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~----------------- 143 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVI----------------- 143 (267)
T ss_dssp ECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCE-----------------
T ss_pred EeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCE-----------------
Confidence 9999 889999998754 468999999999999999999999999999999999999766655
Q ss_pred cccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++ |+.||.+
T Consensus 144 ----------kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (267)
T 3t9t_A 144 ----------KVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208 (267)
T ss_dssp ----------EECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ----------EEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC
Confidence 55555554432211 122356788999999998899999999999999999999 8999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=302.75 Aligned_cols=200 Identities=24% Similarity=0.428 Sum_probs=160.7
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch------------hhHHHHHHHHHHHHHHHhCCCCCcce
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN------------KYREAAMIEIDVLQRLARHDIGGTRC 155 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~------------~~~~~~~~Ei~~l~~l~~~~i~~~~~ 155 (323)
..+.++|++.+.||+|+||.||+|.+.. ++.||||++.... ...+.+.+|+.+++.++|+||
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i----- 91 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI----- 91 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB-----
T ss_pred HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc-----
Confidence 4567899999999999999999999865 8999999885321 123678899999999999998
Q ss_pred EEEccee-----ccCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeec
Q 020652 156 VQIRNWF-----DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSA 230 (323)
Q Consensus 156 ~~~~~~~-----~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~ 230 (323)
+++++++ .....+|+||||++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 170 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN 170 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred cceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCC
Confidence 7777776 3445799999999889999988653 469999999999999999999999999999999999999655
Q ss_pred CceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccC--CccccccCCccccchhhcC-CCCCcchhHHHHHHH
Q 020652 231 EYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCI 307 (323)
Q Consensus 231 ~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~i 307 (323)
+. +||+|||.+..... ......||+.|+|||++.+ ..++.++|||||||+
T Consensus 171 ~~---------------------------~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 223 (362)
T 3pg1_A 171 ND---------------------------ITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCV 223 (362)
T ss_dssp CC---------------------------EEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHH
T ss_pred CC---------------------------EEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHH
Confidence 54 56666666543222 1233578999999999987 678999999999999
Q ss_pred HHHHhcCCCCCCCC
Q 020652 308 LVELCSVSNCYLTP 321 (323)
Q Consensus 308 l~el~tg~~pf~~~ 321 (323)
+|+|++|+.||.+.
T Consensus 224 l~~l~~g~~pf~~~ 237 (362)
T 3pg1_A 224 MAEMFNRKALFRGS 237 (362)
T ss_dssp HHHHHHSSCSCCCS
T ss_pred HHHHHhCCCCCCCC
Confidence 99999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=293.68 Aligned_cols=196 Identities=26% Similarity=0.414 Sum_probs=167.3
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++|+|+ +++++++...+..+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV-----VKFYGHRREGNIQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTB-----CCEEEEEEETTEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCc-----eeeeeEEEcCCEEE
Confidence 57999999999999999999999999999999986432 345678899999999999988 88999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~--------------- 144 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNL--------------- 144 (276)
T ss_dssp EEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCE---------------
T ss_pred EEEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCE---------------
Confidence 999999 789999887543 69999999999999999999999999999999999999765544
Q ss_pred CccccCCCCCCceEeeCCCcccccC-----CccccccCCccccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
||+|||.+..... ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.
T Consensus 145 ------------kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 211 (276)
T 2yex_A 145 ------------KISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (276)
T ss_dssp ------------EECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred ------------EEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence 5555555543211 1223578999999999988765 78999999999999999999999764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=295.78 Aligned_cols=199 Identities=28% Similarity=0.454 Sum_probs=163.9
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
+...++|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.+++.+.|+|+ +++++++...+.
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~ 98 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHV-----VKYYGSYFKNTD 98 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTB-----CCEEEEEEETTE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCC-----ccEEEEEEeCCE
Confidence 345578999999999999999999999999999999987533 34568889999999999988 888999988899
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~-------------- 163 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH-------------- 163 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--------------
T ss_pred EEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--------------
Confidence 99999999 779999997433 46999999999999999999999999999999999999976554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 164 -------------~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 164 -------------AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp -------------EEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -------------EEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 455555555433221 2234789999999999999999999999999999999999999975
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.02 Aligned_cols=200 Identities=16% Similarity=0.223 Sum_probs=152.7
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCc---EEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEccee
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~ 162 (323)
...++|++.+.||+|+||+||+|++..+++ .||||+++.. ....+.+.+|+.+++.++|+|| +++++++
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~ 94 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV-----AKLVGVS 94 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTB-----CCCCEEE
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCce-----ehhhcee
Confidence 345689999999999999999999887775 8999998742 3445678899999999999988 8888887
Q ss_pred ccCceE------EEEEccC-CCCHHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC
Q 020652 163 DYRNHI------CIVFEKL-GPSLYDFLRKNS----YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (323)
Q Consensus 163 ~~~~~~------~lv~e~~-~~~L~~~l~~~~----~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~ 231 (323)
...... ++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence 765544 9999999 889999997432 12589999999999999999999999999999999999997665
Q ss_pred ceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHHHHHH
Q 020652 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 306 (323)
Q Consensus 232 ~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 306 (323)
.+ ||+|||++...... .....+|+.|+|||++.+..++.++|||||||
T Consensus 175 ~~---------------------------kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 227 (323)
T 3qup_A 175 TV---------------------------CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGV 227 (323)
T ss_dssp CE---------------------------EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred CE---------------------------EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHH
Confidence 55 55555555432211 11235678899999999999999999999999
Q ss_pred HHHHHhc-CCCCCCC
Q 020652 307 ILVELCS-VSNCYLT 320 (323)
Q Consensus 307 il~el~t-g~~pf~~ 320 (323)
++|||++ |..||.+
T Consensus 228 il~ell~~g~~p~~~ 242 (323)
T 3qup_A 228 TMWEIMTRGQTPYAG 242 (323)
T ss_dssp HHHHHHTTSCCTTTT
T ss_pred HHHHHHhCCCCCccc
Confidence 9999999 9999975
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=297.96 Aligned_cols=204 Identities=24% Similarity=0.346 Sum_probs=170.0
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCc-----EEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcce
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKE-----LVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW 161 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~ 161 (323)
..++|++.+.||+|+||.||+|.+..+++ .||+|++... ....+.+.+|+.+++.+ .|+|| ++++++
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i-----v~~~~~ 118 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI-----VNLLGA 118 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCe-----eeEEEE
Confidence 34689999999999999999999877664 7999998743 23456788999999999 89988 899999
Q ss_pred eccCceEEEEEccC-CCCHHHHHHhcC------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEe
Q 020652 162 FDYRNHICIVFEKL-GPSLYDFLRKNS------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV 228 (323)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~ 228 (323)
+...+.+++||||+ +++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC
Confidence 99999999999999 889999997532 23589999999999999999999999999999999999999
Q ss_pred ecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHH
Q 020652 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308 (323)
Q Consensus 229 ~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 308 (323)
.++.+||+|||++........ ........||+.|+|||++.+..++.++|||||||++
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 256 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSN----------------------YIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTT----------------------SEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCCeEEECccccccccccccc----------------------eeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHH
Confidence 888777777776543221110 0001123578899999999998999999999999999
Q ss_pred HHHhc-CCCCCCC
Q 020652 309 VELCS-VSNCYLT 320 (323)
Q Consensus 309 ~el~t-g~~pf~~ 320 (323)
|||+| |..||.+
T Consensus 257 ~el~t~g~~p~~~ 269 (333)
T 2i1m_A 257 WEIFSLGLNPYPG 269 (333)
T ss_dssp HHHTTTSCCSSTT
T ss_pred HHHHcCCCCCCcc
Confidence 99998 9999976
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=302.33 Aligned_cols=201 Identities=23% Similarity=0.289 Sum_probs=159.8
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcE----EEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKEL----VAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~----vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
.++|++.+.||+|+||+||+|.+..+++. ||+|++.... ...+.+.+|+.+++.++|+|| +++++++.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~- 85 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI-----VRLLGLCP- 85 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTB-----CCEEEEEC-
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCc-----CeEEEEEc-
Confidence 36899999999999999999999888876 6777664322 223456779999999999998 88888876
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
....++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 45689999999 899999998653 3689999999999999999999999999999999999997766555555554433
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
...... ........||..|+|||++.+..++.++|||||||++|||+| |..||.+
T Consensus 165 ~~~~~~----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 220 (325)
T 3kex_A 165 LPPDDK----------------------QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG 220 (325)
T ss_dssp SCCCTT----------------------CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCcccc----------------------cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccc
Confidence 211110 001123467889999999999899999999999999999999 9999976
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=298.41 Aligned_cols=201 Identities=20% Similarity=0.287 Sum_probs=160.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEE----EEEEecc--chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELV----AIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~v----AiK~~~~--~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
.++|++.+.||+|+||.||+|.+..+++.+ |+|.+.. .....+.+.+|+.+++.++|+|| +++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~ 88 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV-----CRLLGICLT 88 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTB-----CCCCEEEES
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCe-----eEEEEEEec
Confidence 468999999999999999999998888765 6665542 23355778899999999999998 888888876
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
.. .+++||++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred CC-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 55 78889998 999999998754 4699999999999999999999999999999999999998877665555554332
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
...... ........||+.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 167 ~~~~~~----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 222 (327)
T 3lzb_A 167 LGAEEK----------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp -----------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccCccc----------------------cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 211100 001112356889999999999999999999999999999999 9999976
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=290.25 Aligned_cols=201 Identities=25% Similarity=0.354 Sum_probs=160.5
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.++|++.+.||+|+||.||+|.+. ++.||||++.... ...+.+.+|+.+++.++|+|| +++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~ 78 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNI-----IALRGVCLKE 78 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTB-----CCEEEEECCC
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCE-----eeEEEEEecC
Confidence 468999999999999999999874 7889999986432 234678889999999999998 8899999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCCCcEEEeecCceeccCcccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR---LIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
+..++||||+ +++|.+++... .+++..++.++.|++.||.|||++| |+||||||+||+++.....
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~-------- 147 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVEN-------- 147 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSS--------
T ss_pred CceEEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccccc--------
Confidence 9999999999 89999998643 6999999999999999999999999 9999999999999653210
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccCC-ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.......+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 148 -----------~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (271)
T 3dtc_A 148 -----------GDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216 (271)
T ss_dssp -----------SCCSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred -----------ccccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 0012456889999988654332 2335799999999999999999999999999999999999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=301.54 Aligned_cols=199 Identities=29% Similarity=0.441 Sum_probs=153.7
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC-----
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR----- 165 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~----- 165 (323)
.++|++.+.||+|+||+||+|++..+++.||||++............|+..+..++|+|| +++++++...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~ni-----v~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNI-----VQLQSYFYTLGERDR 96 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTB-----CCEEEEEEEECSSCT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCc-----ccHHHhhhccccccc
Confidence 367999999999999999999999999999999987655555567778888999999998 7777776442
Q ss_pred --ceEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHH--HCCceecCCCCCcEEEee-cCceeccCc
Q 020652 166 --NHICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMH--ELRLIHTDLKPENILLVS-AEYVKVPDY 238 (323)
Q Consensus 166 --~~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~iiHrDlKp~NIli~~-~~~~ki~d~ 238 (323)
..+++||||+.++|.+.+.. .....+++..++.++.|++.||.||| ++||+||||||+|||++. ++.
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~------ 170 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT------ 170 (360)
T ss_dssp TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE------
T ss_pred cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc------
Confidence 23899999997787776653 23347899999999999999999999 999999999999999975 444
Q ss_pred ccccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCC-CCcchhHHHHHHHHHHHhcCC
Q 020652 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~ 315 (323)
+||+|||++...... .....||+.|+|||++.+.. ++.++|||||||++|||++|+
T Consensus 171 ---------------------~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~ 229 (360)
T 3e3p_A 171 ---------------------LKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229 (360)
T ss_dssp ---------------------EEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSS
T ss_pred ---------------------EEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 566666666543322 22357899999999997654 899999999999999999999
Q ss_pred CCCCCC
Q 020652 316 NCYLTP 321 (323)
Q Consensus 316 ~pf~~~ 321 (323)
.||.+.
T Consensus 230 ~pf~~~ 235 (360)
T 3e3p_A 230 PIFRGD 235 (360)
T ss_dssp CSSCCS
T ss_pred CCcCCC
Confidence 999763
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=294.66 Aligned_cols=204 Identities=24% Similarity=0.351 Sum_probs=157.0
Q ss_pred ecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcce
Q 020652 85 AIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (323)
Q Consensus 85 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~ 161 (323)
..++...++|++.++||+|+||+||+|.+.. .||+|+++.. ....+.+.+|+.+++.++|+|+ +.++++
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~ 88 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI-----LLFMGY 88 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEE
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcE-----EEEEee
Confidence 3456777899999999999999999997643 4999998642 3445678899999999999998 777775
Q ss_pred eccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 162 FDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 162 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
. .....++||||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+
T Consensus 89 ~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (289)
T 3og7_A 89 S-TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGL 166 (289)
T ss_dssp E-CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred c-cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEcccee
Confidence 4 455689999999 899999997554 4699999999999999999999999999999999999998776665555554
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhc---CCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVIL---GLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
+....... .........||+.|+|||++. +..++.++|||||||++|||++|+.|
T Consensus 167 ~~~~~~~~----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 224 (289)
T 3og7_A 167 ATEKSRWS----------------------GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224 (289)
T ss_dssp ---------------------------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCT
T ss_pred cccccccc----------------------ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCC
Confidence 32211100 001112346899999999997 56788999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 225 ~~~ 227 (289)
T 3og7_A 225 YSN 227 (289)
T ss_dssp TSS
T ss_pred ccc
Confidence 976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=307.97 Aligned_cols=197 Identities=25% Similarity=0.355 Sum_probs=158.8
Q ss_pred CCcEEEEeeecccCcEEEEEEEEC---CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDN---EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~---~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.++|++.+.||+|+||.||+|++. .++..||||+++.. ....+.+.+|+.++++++|+|| +++++++...
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~~~~~~~~~ 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI-----IRLEGVVTKS 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECSS
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEeeC
Confidence 357999999999999999999876 46778999998743 3455678899999999999988 8999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~D------- 190 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSD------- 190 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECc-------
Confidence 9999999999 899999998654 4699999999999999999999999999999999999997666555555
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCc------cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH------SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNC 317 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~p 317 (323)
||++....... ....+|..|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus 191 --------------------fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P 250 (373)
T 2qol_A 191 --------------------FGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250 (373)
T ss_dssp --------------------C----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CT
T ss_pred --------------------CccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCC
Confidence 44443322111 11235778999999999999999999999999999998 9999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 251 ~~~ 253 (373)
T 2qol_A 251 YWE 253 (373)
T ss_dssp TTT
T ss_pred CCC
Confidence 964
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=299.50 Aligned_cols=203 Identities=26% Similarity=0.429 Sum_probs=167.7
Q ss_pred EecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh-------hHHHHHHHHHHHHHHHh--CCCCCcc
Q 020652 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRLAR--HDIGGTR 154 (323)
Q Consensus 84 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~Ei~~l~~l~~--~~i~~~~ 154 (323)
...++.+.++|++.+.||+|+||.||+|.+..+++.||||++..... ..+.+.+|+.+++++.| +|+
T Consensus 35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i---- 110 (320)
T 3a99_A 35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV---- 110 (320)
T ss_dssp -----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB----
T ss_pred ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc----
Confidence 44566788999999999999999999999999999999999864321 22446679999999975 666
Q ss_pred eEEEcceeccCceEEEEEccC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEe-ecC
Q 020652 155 CVQIRNWFDYRNHICIVFEKL-G-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SAE 231 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~lv~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~-~~~ 231 (323)
+++++++...+..++|||++ + ++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus 111 -~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 111 -IRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG 187 (320)
T ss_dssp -CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT
T ss_pred -eEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC
Confidence 89999999999999999999 4 89999998764 699999999999999999999999999999999999997 444
Q ss_pred ceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-ccccccCCccccchhhcCCCC-CcchhHHHHHHHHH
Q 020652 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILV 309 (323)
Q Consensus 232 ~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ 309 (323)
. +||+|||++...... .....||+.|+|||++.+..+ +.++|||||||++|
T Consensus 188 ~---------------------------~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ 240 (320)
T 3a99_A 188 E---------------------------LKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLY 240 (320)
T ss_dssp E---------------------------EEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHH
T ss_pred C---------------------------EEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHH
Confidence 4 466666665543322 223578999999999987765 68899999999999
Q ss_pred HHhcCCCCCCC
Q 020652 310 ELCSVSNCYLT 320 (323)
Q Consensus 310 el~tg~~pf~~ 320 (323)
||++|+.||..
T Consensus 241 el~~g~~pf~~ 251 (320)
T 3a99_A 241 DMVCGDIPFEH 251 (320)
T ss_dssp HHHHSSCSCCS
T ss_pred HHHHCCCCCCC
Confidence 99999999964
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=299.87 Aligned_cols=204 Identities=21% Similarity=0.289 Sum_probs=166.4
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEE-----ECCCCcEEEEEEecc--chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcc
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECF-----DNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~-----~~~~~~~vAiK~~~~--~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~ 160 (323)
+...++|++.+.||+|+||.||+|+ +..+++.||||++.. .......+.+|+.++++++|+|| +++++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~ 100 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI-----VRCIG 100 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCC-----CeEEE
Confidence 3445789999999999999999998 556788999999863 23445678899999999999998 88999
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCcee
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSY-----RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~k 234 (323)
++......|+||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 101 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~--- 177 (327)
T 2yfx_A 101 VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPG--- 177 (327)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS---
T ss_pred EEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCC---
Confidence 999888999999999 8999999987532 3489999999999999999999999999999999999997433
Q ss_pred ccCcccccccCCCCCccccCCCCCCceEeeCCCcccccC-----CccccccCCccccchhhcCCCCCcchhHHHHHHHHH
Q 020652 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (323)
Q Consensus 235 i~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (323)
....+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 178 ---------------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 236 (327)
T 2yfx_A 178 ---------------------PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 236 (327)
T ss_dssp ---------------------TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred ---------------------CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHH
Confidence 223467777776643221 122346899999999999889999999999999999
Q ss_pred HHhc-CCCCCCC
Q 020652 310 ELCS-VSNCYLT 320 (323)
Q Consensus 310 el~t-g~~pf~~ 320 (323)
||+| |..||.+
T Consensus 237 ellt~g~~p~~~ 248 (327)
T 2yfx_A 237 EIFSLGYMPYPS 248 (327)
T ss_dssp HHHTTSCCSSTT
T ss_pred HHHcCCCCCCCC
Confidence 9998 9999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=292.69 Aligned_cols=201 Identities=33% Similarity=0.570 Sum_probs=172.4
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.++++++|+|| +++++++..
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~ 92 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI-----MKLFEILED 92 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTB-----CCEEEEEEC
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCc-----cEEEEEEeC
Confidence 34567899999999999999999999999999999998643 2345678899999999999988 888999999
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
.+..++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++..+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~------------ 158 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKE------------ 158 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSS------------
T ss_pred CCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCC------------
Confidence 99999999999 899999987664 699999999999999999999999999999999999996532
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
....+||+|||.+....... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+
T Consensus 159 ------------~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (287)
T 2wei_A 159 ------------KDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG 224 (287)
T ss_dssp ------------TTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ------------CcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence 23457888888776543322 23468999999999876 489999999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=295.57 Aligned_cols=199 Identities=23% Similarity=0.426 Sum_probs=163.4
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-----hhHHHHHHHHHHHHHHHhCCCCCcceEEEccee--
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF-- 162 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~-- 162 (323)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++|+|| +++++++
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~ 77 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV-----IQLVDVLYN 77 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEC
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCe-----eEEEEEEEc
Confidence 4578999999999999999999999999999999987432 345678899999999999988 8888877
Q ss_pred ccCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 163 DYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 163 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
...+..++||||+.++|.+++.......+++..+..++.||+.||.|||++||+||||||+||+++.++.+++
T Consensus 78 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl------- 150 (305)
T 2wtk_C 78 EEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKI------- 150 (305)
T ss_dssp C---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE-------
T ss_pred CCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEe-------
Confidence 4556899999999666989888766568999999999999999999999999999999999999976665554
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccC-----CccccccCCccccchhhcCCC--CCcchhHHHHHHHHHHHhcCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~tg~ 315 (323)
+|||.+..... ......||+.|+|||++.+.. ++.++|||||||++|||++|+
T Consensus 151 --------------------~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~ 210 (305)
T 2wtk_C 151 --------------------SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210 (305)
T ss_dssp --------------------CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSS
T ss_pred --------------------eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCC
Confidence 45554433211 112346899999999998754 378999999999999999999
Q ss_pred CCCCC
Q 020652 316 NCYLT 320 (323)
Q Consensus 316 ~pf~~ 320 (323)
.||.+
T Consensus 211 ~p~~~ 215 (305)
T 2wtk_C 211 YPFEG 215 (305)
T ss_dssp CSCCC
T ss_pred CCCCC
Confidence 99975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=296.72 Aligned_cols=198 Identities=20% Similarity=0.327 Sum_probs=164.3
Q ss_pred CCcEEEEeeecccCcEEEEEEEEC-------CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDN-------EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN 160 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~-------~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~ 160 (323)
.++|++.+.||+|+||.||+|++. .+++.||||++... ....+.+.+|+.+++.+ +|+|| +++++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~ 108 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI-----INLLG 108 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCE-----eeEEE
Confidence 468999999999999999999976 45678999998743 33456788999999999 89988 88999
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NI 225 (323)
++...+.+++||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 188 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188 (334)
T ss_dssp EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence 999999999999999 8899999986531 2489999999999999999999999999999999999
Q ss_pred EEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchh
Q 020652 226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCD 300 (323)
Q Consensus 226 li~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D 300 (323)
+++.++.+ ||+|||++...... .....+|+.|+|||++.+..++.++|
T Consensus 189 ll~~~~~~---------------------------kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 241 (334)
T 2pvf_A 189 LVTENNVM---------------------------KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241 (334)
T ss_dssp EECTTCCE---------------------------EECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHH
T ss_pred EEcCCCCE---------------------------EEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHH
Confidence 99766555 55555554432221 12235688999999999888999999
Q ss_pred HHHHHHHHHHHhc-CCCCCCC
Q 020652 301 LWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 301 iwSlG~il~el~t-g~~pf~~ 320 (323)
||||||++|||++ |..||.+
T Consensus 242 i~slG~il~ellt~g~~p~~~ 262 (334)
T 2pvf_A 242 VWSFGVLMWEIFTLGGSPYPG 262 (334)
T ss_dssp HHHHHHHHHHHHTTSCCSSTT
T ss_pred HHHHHHHHHHHHhCCCCCcCc
Confidence 9999999999999 9999975
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=294.53 Aligned_cols=193 Identities=29% Similarity=0.417 Sum_probs=157.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
++|++.+.||+|+||+||+|.+. ++.||||++... ...+.+.+|+.++++++|+|| +++++++.. ..++|
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~--~~~lv 77 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNI-----VKLYGACLN--PVCLV 77 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTB-----CCEEEBCTT--TTEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCc-----CeEEEEEcC--CcEEE
Confidence 57999999999999999999874 678999998753 345678899999999999998 888887763 47899
Q ss_pred EccC-CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 172 FEKL-GPSLYDFLRKNSY-RSFPIDLVRELGRQLLESVAFMHE---LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~lH~---~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
|||+ +++|.+++..... ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-------------- 143 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-------------- 143 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT--------------
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC--------------
Confidence 9999 8899999986542 247899999999999999999999 89999999999999975543
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+||+|||.+...........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 144 ------------~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 205 (307)
T 2eva_A 144 ------------VLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205 (307)
T ss_dssp ------------EEEECCCCC------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred ------------EEEEcccccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence 24677777665544444445799999999999999999999999999999999999999974
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=292.30 Aligned_cols=198 Identities=25% Similarity=0.390 Sum_probs=165.0
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
...++|++.+.||+|+||.||+|.+. +++.||+|++.......+.+.+|+.+++.++|+|+ +++++++.. +..
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~-~~~ 82 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRL-----VRLYAVVTQ-EPI 82 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCc-----ceEEEEEcC-CCc
Confidence 34468999999999999999999975 56789999998665566788999999999999998 777777764 568
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||||+ +++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~-------------- 148 (279)
T 1qpc_A 83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSC-------------- 148 (279)
T ss_dssp EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCE--------------
T ss_pred EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCE--------------
Confidence 9999999 8999999975432369999999999999999999999999999999999999765544
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCc----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
||+|||.+....... ....+|..|+|||++.+..++.++|||||||++|||++ |+.||.+
T Consensus 149 -------------kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 213 (279)
T 1qpc_A 149 -------------KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (279)
T ss_dssp -------------EECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred -------------EECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence 555555554332221 12356789999999998889999999999999999999 9999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=313.13 Aligned_cols=197 Identities=27% Similarity=0.375 Sum_probs=162.8
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
..++|++.++||+|+||.||+|.+.. +..||||+++......+.+.+|+.++++++|+|| +++++++.. +.++
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-----VQLYAVVSE-EPIY 254 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSCE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCE-----eeEEEEEcC-CceE
Confidence 34689999999999999999999875 4569999998655556788999999999999998 788887765 6789
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~D----------- 323 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVAD----------- 323 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC-----------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECC-----------
Confidence 999999 88999999754334699999999999999999999999999999999999997766555555
Q ss_pred CccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
||++...... .....+|..|+|||++.+..++.++|||||||++|||++ |+.||.+
T Consensus 324 ----------------fG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 384 (452)
T 1fmk_A 324 ----------------FGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384 (452)
T ss_dssp ----------------CCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ----------------CccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence 5544432211 112346788999999998899999999999999999999 9999975
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=291.19 Aligned_cols=194 Identities=13% Similarity=0.176 Sum_probs=162.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC--
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR-- 165 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~-- 165 (323)
.++|++.+.||+|+||.||+|.+. ++.||+|++... ....+.+.+|+.++++++|+|| +++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~ 81 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV-----LPVLGACQSPPA 81 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTE-----ECEEEEECTTTS
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCch-----hheEEEEccCCC
Confidence 357999999999999999999874 788999998743 3445678899999999999888 9999998876
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEeecCceeccCccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
+..++||||+ +++|.+++.......+++..++.++.|++.||.|||++| |+||||||+||+++.++.+++.||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~---- 157 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMA---- 157 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGG----
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEec----
Confidence 7899999999 889999998766556999999999999999999999999 999999999999976665544444
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCc---chhHHHHHHHHHHHhcCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNY---PCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwSlG~il~el~tg~~pf~ 319 (323)
|.+... ......||+.|+|||++.+..++. ++|||||||++|||++|+.||.
T Consensus 158 -----------------------~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 212 (271)
T 3kmu_A 158 -----------------------DVKFSF--QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA 212 (271)
T ss_dssp -----------------------GSCCTT--SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT
T ss_pred -----------------------cceeee--cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 333221 112246899999999998865544 8999999999999999999997
Q ss_pred C
Q 020652 320 T 320 (323)
Q Consensus 320 ~ 320 (323)
+
T Consensus 213 ~ 213 (271)
T 3kmu_A 213 D 213 (271)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=297.03 Aligned_cols=202 Identities=25% Similarity=0.361 Sum_probs=167.5
Q ss_pred CcEEEEeeecccCcEEEEEEE----ECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec--c
Q 020652 92 PRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD--Y 164 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~----~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~--~ 164 (323)
++|++.+.||+|+||.||+|+ +..+++.||||++... ....+.+.+|+.++++++|+|| +++++++. .
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~ 97 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI-----VKYRGVSYGPG 97 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSS
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCce-----eEEEEEEecCC
Confidence 689999999999999999998 5678999999998754 3445668899999999999988 77777664 4
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
...+++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 56799999999 999999998643 2599999999999999999999999999999999999999888777777765443
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
....... ........||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 177 ~~~~~~~---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~ 232 (327)
T 3lxl_A 177 LPLDKDY---------------------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCS 232 (327)
T ss_dssp CCTTCSE---------------------EECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred cccCCcc---------------------ceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 2211100 0011123578899999999998899999999999999999999999865
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=291.04 Aligned_cols=197 Identities=25% Similarity=0.443 Sum_probs=164.5
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEccee--ccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF--DYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~--~~~~ 166 (323)
++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.++++++|+|| +++++++ ....
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI-----VRYYDRIIDRTNT 80 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEEEGGGT
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCC-----CeEEEEEecCCCc
Confidence 5799999999999999999999999999999998642 3445678899999999999988 7888866 4467
Q ss_pred eEEEEEccC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCcEEEeecCceeccCc
Q 020652 167 HICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLESVAFMHELR-----LIHTDLKPENILLVSAEYVKVPDY 238 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~lH~~~-----iiHrDlKp~NIli~~~~~~ki~d~ 238 (323)
.+++||||+ +++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~------ 154 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN------ 154 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC------
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC------
Confidence 899999999 789999997532 235999999999999999999999999 999999999999976554
Q ss_pred ccccccCCCCCccccCCCCCCceEeeCCCcccccCCc---cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCC
Q 020652 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~ 315 (323)
+||+|||.+....... ....||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 155 ---------------------~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 213 (279)
T 2w5a_A 155 ---------------------VKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM 213 (279)
T ss_dssp ---------------------EEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSS
T ss_pred ---------------------EEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCC
Confidence 4566666554433221 2347899999999999999999999999999999999999
Q ss_pred CCCCC
Q 020652 316 NCYLT 320 (323)
Q Consensus 316 ~pf~~ 320 (323)
.||..
T Consensus 214 ~p~~~ 218 (279)
T 2w5a_A 214 PPFTA 218 (279)
T ss_dssp CSSCC
T ss_pred CCCcc
Confidence 99975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=294.33 Aligned_cols=201 Identities=25% Similarity=0.464 Sum_probs=165.7
Q ss_pred CceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 87 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.....++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.++|+|+ +++++++...
T Consensus 14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~ 88 (302)
T 2j7t_A 14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI-----VKLLGAYYHD 88 (302)
T ss_dssp SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTB-----CCEEEEEECC
T ss_pred ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCE-----eeeeeeeeeC
Confidence 445668899999999999999999999999999999998643 2345678899999999999988 8889999888
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~----------- 156 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDI----------- 156 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCE-----------
T ss_pred CeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCE-----------
Confidence 9999999999 889999987643 469999999999999999999999999999999999999766555
Q ss_pred CCCCCccccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhc-----CCCCCcchhHHHHHHHHHHHhcCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg~~ 316 (323)
||+|||.+.... .......||+.|+|||++. +..++.++|||||||++|||++|..
T Consensus 157 ----------------kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 220 (302)
T 2j7t_A 157 ----------------RLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220 (302)
T ss_dssp ----------------EECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSC
T ss_pred ----------------EEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCC
Confidence 555555442211 1122347899999999984 5678999999999999999999999
Q ss_pred CCCC
Q 020652 317 CYLT 320 (323)
Q Consensus 317 pf~~ 320 (323)
||..
T Consensus 221 p~~~ 224 (302)
T 2j7t_A 221 PHHE 224 (302)
T ss_dssp TTTT
T ss_pred CCcc
Confidence 9975
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=298.18 Aligned_cols=193 Identities=21% Similarity=0.306 Sum_probs=153.3
Q ss_pred EecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHH--HHhCCCCCcceEEEcce
Q 020652 84 FAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR--LARHDIGGTRCVQIRNW 161 (323)
Q Consensus 84 ~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~--l~~~~i~~~~~~~~~~~ 161 (323)
...+..+.++|++.+.||+|+||.||+|++. ++.||||++..... ....+|.+++.. ++|+|| ++++++
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~--~~~~~e~~~~~~~~~~h~~i-----~~~~~~ 99 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE--ASWFRETEIYQTVLMRHENI-----LGFIAA 99 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH--HHHHHHHHHHTSTTCCCTTB-----CCEEEE
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc--chhhhHHHHHHHHhhcCCCe-----eeEEEE
Confidence 3345566789999999999999999999875 88999999865433 334445555444 377777 778887
Q ss_pred eccC----ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC--------CceecCCCCCcEEEe
Q 020652 162 FDYR----NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL--------RLIHTDLKPENILLV 228 (323)
Q Consensus 162 ~~~~----~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~--------~iiHrDlKp~NIli~ 228 (323)
+... ..+++||||+ +++|.+++... .+++..++.++.|++.||.|||++ ||+||||||+|||++
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp EEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred EccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 7665 7899999999 88999999775 599999999999999999999998 999999999999997
Q ss_pred ecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-------ccccccCCccccchhhcCCCCCcc---
Q 020652 229 SAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLGWNYP--- 298 (323)
Q Consensus 229 ~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~--- 298 (323)
.++.+ ||+|||++...... .....||+.|+|||++.+..++..
T Consensus 177 ~~~~~---------------------------kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 229 (337)
T 3mdy_A 177 KNGTC---------------------------CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQS 229 (337)
T ss_dssp TTSCE---------------------------EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHH
T ss_pred CCCCE---------------------------EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccC
Confidence 66655 55555554332111 123479999999999988766654
Q ss_pred ---hhHHHHHHHHHHHhcCC
Q 020652 299 ---CDLWSVGCILVELCSVS 315 (323)
Q Consensus 299 ---~DiwSlG~il~el~tg~ 315 (323)
+|||||||++|||+||.
T Consensus 230 ~~~~DiwslG~il~el~tg~ 249 (337)
T 3mdy_A 230 YIMADMYSFGLILWEVARRC 249 (337)
T ss_dssp HHHHHHHHHHHHHHHHHTTB
T ss_pred ccccchHHHHHHHHHHHhcc
Confidence 99999999999999993
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=297.37 Aligned_cols=201 Identities=20% Similarity=0.331 Sum_probs=167.9
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEEC-----CCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcc
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~ 160 (323)
+...++|++.+.||+|+||.||+|.+. .+++.||||++.... .....+.+|+.+++.++|+|| +++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~ 95 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV-----VRLLG 95 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTB-----CCEEE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCE-----eeeEE
Confidence 345578999999999999999999876 467889999987432 344568899999999999988 88999
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNS--------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~ 231 (323)
++...+..++||||+ +++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 999889999999999 889999997532 13578999999999999999999999999999999999996555
Q ss_pred ceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHHHHHH
Q 020652 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGC 306 (323)
Q Consensus 232 ~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 306 (323)
. +||+|||++...... .....||+.|+|||++.+..++.++|||||||
T Consensus 176 ~---------------------------~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 228 (322)
T 1p4o_A 176 T---------------------------VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 228 (322)
T ss_dssp C---------------------------EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred e---------------------------EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHH
Confidence 4 566666665433221 12236788999999999989999999999999
Q ss_pred HHHHHhc-CCCCCCC
Q 020652 307 ILVELCS-VSNCYLT 320 (323)
Q Consensus 307 il~el~t-g~~pf~~ 320 (323)
++|||++ |..||.+
T Consensus 229 il~el~~~g~~p~~~ 243 (322)
T 1p4o_A 229 VLWEIATLAEQPYQG 243 (322)
T ss_dssp HHHHHHHTSCCTTTT
T ss_pred HHHHHHhcCCCcccc
Confidence 9999999 8999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=291.64 Aligned_cols=200 Identities=29% Similarity=0.400 Sum_probs=163.1
Q ss_pred cCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHh--CCCCCcceEEEcc
Q 020652 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLAR--HDIGGTRCVQIRN 160 (323)
Q Consensus 86 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~--~~i~~~~~~~~~~ 160 (323)
......++|++.+.||+|+||.||+|.+. +++.||||++... ....+.+.+|+.+++++.| +|+ +++++
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i-----v~~~~ 95 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI-----IRLYD 95 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTB-----CCEEE
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCce-----EEEEE
Confidence 33445567999999999999999999985 5888999998632 3445678899999999986 566 88999
Q ss_pred eeccCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 161 WFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
++...+..++|||+.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||+++ +.+
T Consensus 96 ~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~------- 165 (313)
T 3cek_A 96 YEITDQYIYMVMECGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GML------- 165 (313)
T ss_dssp EEECSSEEEEEECCCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEE-------
T ss_pred EeecCCEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeE-------
Confidence 999999999999977999999998765 7899999999999999999999999999999999999953 444
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcC-----------CCCCcchhHHHH
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILG-----------LGWNYPCDLWSV 304 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSl 304 (323)
||+|||++...... .....||+.|+|||++.+ ..++.++|||||
T Consensus 166 --------------------kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~sl 225 (313)
T 3cek_A 166 --------------------KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225 (313)
T ss_dssp --------------------EECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHH
T ss_pred --------------------EEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHH
Confidence 55555555433221 123478999999999976 468899999999
Q ss_pred HHHHHHHhcCCCCCCCC
Q 020652 305 GCILVELCSVSNCYLTP 321 (323)
Q Consensus 305 G~il~el~tg~~pf~~~ 321 (323)
||++|||++|+.||...
T Consensus 226 G~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 226 GCILYYMTYGKTPFQQI 242 (313)
T ss_dssp HHHHHHHHHSSCTTTTC
T ss_pred HHHHHHHHhCCCchhhH
Confidence 99999999999999753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=292.56 Aligned_cols=198 Identities=23% Similarity=0.293 Sum_probs=162.2
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc-chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec----cC
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS-INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD----YR 165 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~-~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~----~~ 165 (323)
.++|++.+.||+|+||.||+|.+..+++.||||++.. .....+.+.+|+.+++.++|+|| +++++++. ..
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~ 102 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI-----LRLVAYCLRERGAK 102 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEEEEEETTE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCe-----eeEEEEEEeccCCC
Confidence 4689999999999999999999999999999998864 33456678899999999999998 77887775 34
Q ss_pred ceEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
...++||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~--------- 173 (317)
T 2buj_A 103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQP--------- 173 (317)
T ss_dssp EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCE---------
T ss_pred ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCE---------
Confidence 5789999999 88999999752 23469999999999999999999999999999999999999765544
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCC------------ccccccCCccccchhhcCCC---CCcchhHHHHHHH
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------------HSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCI 307 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~i 307 (323)
||+|||.+...... .....||+.|+|||++.+.. ++.++|||||||+
T Consensus 174 ------------------kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~i 235 (317)
T 2buj_A 174 ------------------VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235 (317)
T ss_dssp ------------------EECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHH
T ss_pred ------------------EEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHH
Confidence 55555554332110 11246799999999997654 6899999999999
Q ss_pred HHHHhcCCCCCCC
Q 020652 308 LVELCSVSNCYLT 320 (323)
Q Consensus 308 l~el~tg~~pf~~ 320 (323)
+|||++|+.||..
T Consensus 236 l~el~~g~~p~~~ 248 (317)
T 2buj_A 236 LYAMMFGEGPYDM 248 (317)
T ss_dssp HHHHHHSSCTTHH
T ss_pred HHHHHhCCCChhh
Confidence 9999999999853
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=295.00 Aligned_cols=199 Identities=23% Similarity=0.337 Sum_probs=162.3
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCC----cEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEccee
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~----~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~ 162 (323)
....+|++.+.||+|+||+||+|.+..++ ..||||++... ......+.+|+.+++.++|+|| +++++++
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~ 115 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI-----IRLEGVI 115 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEE
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEE
Confidence 34568999999999999999999887653 45999998743 3445678899999999999988 8899999
Q ss_pred ccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
...+..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+
T Consensus 116 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~-------- 186 (333)
T 1mqb_A 116 SKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVC-------- 186 (333)
T ss_dssp CSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE--------
T ss_pred ecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcE--------
Confidence 9999999999999 789999998653 469999999999999999999999999999999999999766555
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccCC------ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-C
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-V 314 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g 314 (323)
||+|||.+...... .....+|+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 187 -------------------kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 247 (333)
T 1mqb_A 187 -------------------KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 247 (333)
T ss_dssp -------------------EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -------------------EECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCC
Confidence 45555544432211 111246788999999999999999999999999999999 9
Q ss_pred CCCCCC
Q 020652 315 SNCYLT 320 (323)
Q Consensus 315 ~~pf~~ 320 (323)
+.||.+
T Consensus 248 ~~pf~~ 253 (333)
T 1mqb_A 248 ERPYWE 253 (333)
T ss_dssp CCTTTT
T ss_pred CCCccc
Confidence 999964
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=293.56 Aligned_cols=204 Identities=23% Similarity=0.331 Sum_probs=165.4
Q ss_pred eCCcEEEEeeecccCcEEEEEEEE-----CCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcce
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNW 161 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~-----~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~ 161 (323)
..++|++.+.||+|+||+||+|.+ ..+++.||||++... ....+.+.+|+.+++++ .|+|| ++++++
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~~ 99 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV-----VNLLGA 99 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCe-----eeEEEE
Confidence 346899999999999999999985 456789999998753 23445788999999999 57887 888888
Q ss_pred eccC-ceEEEEEccC-CCCHHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 020652 162 FDYR-NHICIVFEKL-GPSLYDFLRKNSY--------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (323)
Q Consensus 162 ~~~~-~~~~lv~e~~-~~~L~~~l~~~~~--------------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NI 225 (323)
+... ..+++||||+ +++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 7664 4589999999 7899999987542 1288999999999999999999999999999999999
Q ss_pred EEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHH
Q 020652 226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305 (323)
Q Consensus 226 li~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 305 (323)
+++.++.+|++|||++........ ........||+.|+|||++.+..++.++||||||
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG 237 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPD----------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTT----------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred EECCCCCEEECCCccccccccCcc----------------------ceeccCCCcceeecCchhhccccccchhHHHHHH
Confidence 998777666666665433221110 0001224678999999999999999999999999
Q ss_pred HHHHHHhc-CCCCCCC
Q 020652 306 CILVELCS-VSNCYLT 320 (323)
Q Consensus 306 ~il~el~t-g~~pf~~ 320 (323)
|++|||+| |..||.+
T Consensus 238 ~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 238 VLLWEIFSLGASPYPG 253 (316)
T ss_dssp HHHHHHHTTSCCSSTT
T ss_pred HHHHHHHhCCCCCCcc
Confidence 99999998 9999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=296.38 Aligned_cols=200 Identities=25% Similarity=0.463 Sum_probs=157.7
Q ss_pred CceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh-------hHHHHHHHHHHHHHH----HhCCCCCcce
Q 020652 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK-------YREAAMIEIDVLQRL----ARHDIGGTRC 155 (323)
Q Consensus 87 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~-------~~~~~~~Ei~~l~~l----~~~~i~~~~~ 155 (323)
++.+.++|++.+.||+|+||.||+|++..+++.||||++..... ....+.+|+.+++++ .|+||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i----- 100 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV----- 100 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSB-----
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCe-----
Confidence 35567889999999999999999999999999999999864321 223345799999999 68887
Q ss_pred EEEcceeccCceEEEEEcc-C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEe-ecCc
Q 020652 156 VQIRNWFDYRNHICIVFEK-L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLV-SAEY 232 (323)
Q Consensus 156 ~~~~~~~~~~~~~~lv~e~-~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~-~~~~ 232 (323)
+++++++...+..++|||+ + +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++ .++.
T Consensus 101 ~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp CCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTE
T ss_pred eeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCe
Confidence 8999999888899999999 5 789999998765 699999999999999999999999999999999999997 4444
Q ss_pred eeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-ccccccCCccccchhhcCCCCC-cchhHHHHHHHHHH
Q 020652 233 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVE 310 (323)
Q Consensus 233 ~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~e 310 (323)
+||+|||.+...... .....||+.|+|||++.+..+. .++|||||||++||
T Consensus 179 ---------------------------~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 231 (312)
T 2iwi_A 179 ---------------------------AKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYD 231 (312)
T ss_dssp ---------------------------EEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHH
T ss_pred ---------------------------EEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHH
Confidence 455666655443222 2334689999999999877664 58999999999999
Q ss_pred HhcCCCCCCC
Q 020652 311 LCSVSNCYLT 320 (323)
Q Consensus 311 l~tg~~pf~~ 320 (323)
|++|+.||..
T Consensus 232 l~~g~~pf~~ 241 (312)
T 2iwi_A 232 MVCGDIPFER 241 (312)
T ss_dssp HHHSSCSCCS
T ss_pred HHHCCCCCCC
Confidence 9999999964
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=287.71 Aligned_cols=202 Identities=27% Similarity=0.371 Sum_probs=163.7
Q ss_pred CCcEEEEe-eecccCcEEEEEEEEC--CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 91 TPRYRILS-KMGEGTFGQVVECFDN--EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 91 ~~~y~~~~-~lG~G~fg~V~~~~~~--~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.++|.+.+ .||+|+||.||+|.+. .+++.||||+++.. ....+.+.+|+.+++.++|+|| +++++++. .
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~-~ 81 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI-----VRLIGVCQ-A 81 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEE-S
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCE-----eEEEEEec-C
Confidence 35688877 9999999999999864 46788999999753 3456678899999999999988 88888884 4
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.++++|||++...
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 5689999999 789999997543 46999999999999999999999999999999999999988776666666554332
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+
T Consensus 161 ~~~~~~---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 216 (287)
T 1u59_A 161 GADDSY---------------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216 (287)
T ss_dssp TTCSCE---------------------ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccCcce---------------------eeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 211100 001112356889999999998889999999999999999998 9999975
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=301.00 Aligned_cols=200 Identities=19% Similarity=0.247 Sum_probs=166.6
Q ss_pred CceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh--hHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 87 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~--~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
.+...++|++.+.||+|+||.||+|++ .+++.||||++..... ....+.+|+.+++.++|+|| +++++++..
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~ 98 (326)
T 3uim_A 25 LQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-----LRLRGFCMT 98 (326)
T ss_dssp HHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTB-----CCCCEEECC
T ss_pred HHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCc-----cceEEEEec
Confidence 345567899999999999999999975 4688999999874322 22357889999999999988 899999999
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCCCcEEEeecCceeccCc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSY--RSFPIDLVRELGRQLLESVAFMHEL---RLIHTDLKPENILLVSAEYVKVPDY 238 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~lH~~---~iiHrDlKp~NIli~~~~~~ki~d~ 238 (323)
.+..++||||+ +++|.+++..... ..+++..+..++.|++.||.|||++ ||+||||||+|||++.++.
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~------ 172 (326)
T 3uim_A 99 PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE------ 172 (326)
T ss_dssp SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC------
T ss_pred CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC------
Confidence 99999999999 8899999986532 3489999999999999999999999 9999999999999976554
Q ss_pred ccccccCCCCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcC
Q 020652 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSV 314 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg 314 (323)
+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 173 ---------------------~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 231 (326)
T 3uim_A 173 ---------------------AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITG 231 (326)
T ss_dssp ---------------------EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHC
T ss_pred ---------------------EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhC
Confidence 456666655433221 1224689999999999988899999999999999999999
Q ss_pred CCCCC
Q 020652 315 SNCYL 319 (323)
Q Consensus 315 ~~pf~ 319 (323)
+.||.
T Consensus 232 ~~pf~ 236 (326)
T 3uim_A 232 QRAFD 236 (326)
T ss_dssp CCSBC
T ss_pred CCccc
Confidence 99995
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=296.55 Aligned_cols=203 Identities=20% Similarity=0.234 Sum_probs=150.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcc-----eeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN-----WFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~-----~~~~~~ 166 (323)
++|++.+.||+|+||.||+|++ +++.||||++............|+..+..+.|+|| +++++ .+....
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i-----~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNI-----ARFIVGDERVTADGRM 85 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTB-----CCEEEEEEEECTTSCE
T ss_pred HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcch-----hhheecccccccCCCc
Confidence 6799999999999999999975 68899999987544333333344444555788887 55554 233345
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---------CceecCCCCCcEEEeecCceecc
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL---------RLIHTDLKPENILLVSAEYVKVP 236 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---------~iiHrDlKp~NIli~~~~~~ki~ 236 (323)
.+++||||+ +++|.+++.... .++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred eEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 789999999 889999998764 68999999999999999999999 99999999999999776665555
Q ss_pred CcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-------CCCCcchhHHHHHHHHH
Q 020652 237 DYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-------LGWNYPCDLWSVGCILV 309 (323)
Q Consensus 237 d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ 309 (323)
|||++.......... . ..........+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 163 DFG~a~~~~~~~~~~----------~------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ 226 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVR----------P------GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226 (336)
T ss_dssp CCTTCEECSSSSCC-------------------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHH
T ss_pred eccceeecccccccC----------c------cccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHH
Confidence 555443222111000 0 000011123479999999999987 35667899999999999
Q ss_pred HHhcCCCCCCC
Q 020652 310 ELCSVSNCYLT 320 (323)
Q Consensus 310 el~tg~~pf~~ 320 (323)
||++|..||..
T Consensus 227 ell~g~~p~~~ 237 (336)
T 3g2f_A 227 EIFMRCTDLFP 237 (336)
T ss_dssp HHHTTBGGGST
T ss_pred HHHhcCCcCCC
Confidence 99999777643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=296.80 Aligned_cols=204 Identities=26% Similarity=0.415 Sum_probs=163.3
Q ss_pred eeCCcE-EEEeeecccCcEEEEEEEE----CCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcce
Q 020652 89 NLTPRY-RILSKMGEGTFGQVVECFD----NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (323)
Q Consensus 89 ~~~~~y-~~~~~lG~G~fg~V~~~~~----~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~ 161 (323)
.+.++| +++++||+|+||+||++.. ..+++.||||++... ....+.+.+|+.+++.++|+|| ++++++
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~ 101 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI-----IKYKGC 101 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcch-----hhEEEE
Confidence 345566 9999999999999987753 457899999998753 2445678899999999999988 888888
Q ss_pred ecc--CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCc
Q 020652 162 FDY--RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (323)
Q Consensus 162 ~~~--~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~ 238 (323)
+.. ...+++||||+ +++|.+++... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+||
T Consensus 102 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Df 178 (318)
T 3lxp_A 102 CEDAGAASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDF 178 (318)
T ss_dssp EEETTTTEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred EecCCCceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCc
Confidence 876 46899999999 88999999875 4999999999999999999999999999999999999977666555555
Q ss_pred ccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
|++........ .........||..|+|||++.+..++.++|||||||++|||++|..||
T Consensus 179 g~a~~~~~~~~---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~ 237 (318)
T 3lxp_A 179 GLAKAVPEGHE---------------------YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS 237 (318)
T ss_dssp GGCEECCTTCS---------------------EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred ccccccccccc---------------------ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcc
Confidence 54332211100 000112235788999999999988999999999999999999999999
Q ss_pred CCC
Q 020652 319 LTP 321 (323)
Q Consensus 319 ~~~ 321 (323)
..+
T Consensus 238 ~~~ 240 (318)
T 3lxp_A 238 QSP 240 (318)
T ss_dssp GSH
T ss_pred ccc
Confidence 753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=286.51 Aligned_cols=200 Identities=22% Similarity=0.285 Sum_probs=162.5
Q ss_pred CCcEEEEeeecccCcEEEEEEEECC---CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.++|++.+.||+|+||+||+|.+.. ++..||+|++... ....+.+.+|+.+++.++|+|+ +++++++..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~ 85 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI-----VKLIGIIEEE 85 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTB-----CCEEEEECSS
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCc-----ceEEEEEcCC
Confidence 3679999999999999999998654 3456999998753 3445678899999999999998 7888887654
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+|++|||++...
T Consensus 86 -~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 86 -PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp -SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred -CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 568999999 899999998754 46999999999999999999999999999999999999988777666666654322
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 164 ~~~~~-----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~ 217 (281)
T 3cc6_A 164 EDEDY-----------------------YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217 (281)
T ss_dssp --------------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ccccc-----------------------cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence 11100 00112356889999999998899999999999999999998 9999964
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=317.57 Aligned_cols=196 Identities=27% Similarity=0.376 Sum_probs=165.0
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
.++|++.++||+|+||.||+|.+.. +..||||+++......+.+.+|+.+|++++|+|| +++++++.. +.+|+
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpni-----v~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-----VQLYAVVSE-EPIYI 338 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSCEE
T ss_pred hhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCE-----eeEEEEEee-ccceE
Confidence 3579999999999999999999875 4569999998655556789999999999999998 788887765 67899
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
||||+ +++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~---------------- 402 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC---------------- 402 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE----------------
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcE----------------
Confidence 99999 8899999975433469999999999999999999999999999999999999766554
Q ss_pred ccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
||+|||++...... .....+|..|+|||++.+..++.++|||||||+||||++ |+.||.+
T Consensus 403 -----------kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~ 467 (535)
T 2h8h_A 403 -----------KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467 (535)
T ss_dssp -----------EECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred -----------EEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 55555555443221 112346788999999998899999999999999999999 9999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=291.50 Aligned_cols=195 Identities=24% Similarity=0.354 Sum_probs=156.7
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec-cCceEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD-YRNHIC 169 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~ 169 (323)
.++|++.+.||+|+||.||+|.+ +++.||+|+++... ..+.+.+|+.+++.++|+|+ +++++++. ..+..+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~~~~ 91 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNL-----VQLLGVIVEEKGGLY 91 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC---HHHHHTHHHHTTCCCTTB-----CCEEEEECCC--CCE
T ss_pred hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCE-----eeEEEEEEcCCCceE
Confidence 36799999999999999999976 47889999987543 45678899999999999988 88888754 445789
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||+ +++|.+++.......+++..+..++.|++.||.|||++||+||||||+||+++.++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~---------------- 155 (278)
T 1byg_A 92 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV---------------- 155 (278)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC----------------
T ss_pred EEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc----------------
Confidence 999999 779999998654334899999999999999999999999999999999999965554
Q ss_pred CccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
+||+|||.+...........+|+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 156 -----------~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 217 (278)
T 1byg_A 156 -----------AKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217 (278)
T ss_dssp -----------EEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred -----------EEEeeccccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 566666666544433344467889999999999899999999999999999998 9999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=316.31 Aligned_cols=202 Identities=26% Similarity=0.364 Sum_probs=161.3
Q ss_pred CCcEEEEe-eecccCcEEEEEEEEC--CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 91 TPRYRILS-KMGEGTFGQVVECFDN--EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 91 ~~~y~~~~-~lG~G~fg~V~~~~~~--~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+++.+.+ +||+|+||.||+|.+. .++..||||+++.. ....+.+.+|+.++++++|+|| +++++++..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpni-----v~l~~~~~~- 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI-----VRLIGVCQA- 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTB-----CCEEEEEES-
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCE-----eeEEEEecc-
Confidence 34566666 8999999999999875 35667999998753 2356788999999999999998 888888876
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+.+++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred CCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 5699999999 899999997653 46999999999999999999999999999999999999988777766666654332
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
..+... ........+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+
T Consensus 487 ~~~~~~---------------------~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~ 542 (613)
T 2ozo_A 487 GADDSY---------------------YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542 (613)
T ss_dssp C-----------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCCCce---------------------eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 111100 000111245789999999998999999999999999999998 9999976
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=289.79 Aligned_cols=208 Identities=25% Similarity=0.393 Sum_probs=158.8
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec------
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD------ 163 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~------ 163 (323)
+.++|++.+.||+|+||.||+|++..+++.||||++.......+.+.+|+.+++.++|+|+ +++++++.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV-----VRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEECCCCC
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHH-----HHHHHHHHhhcchh
Confidence 3467999999999999999999999999999999998766667788899999999999998 66666543
Q ss_pred -------cCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceec
Q 020652 164 -------YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235 (323)
Q Consensus 164 -------~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki 235 (323)
..+..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+||+++.++.+|+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEE
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEE
Confidence 356789999999 889999998654 46888999999999999999999999999999999999988777777
Q ss_pred cCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhc
Q 020652 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCS 313 (323)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~t 313 (323)
+|||++.......... .+ +...............||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 158 ~dfg~~~~~~~~~~~~---------~~-~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDIL---------KL-DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCCCSCTTC-----------------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred eeCcchhhcccccchh---------cc-ccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 7776554332111000 00 000000001112235789999999999875 68999999999999999998
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-40 Score=296.17 Aligned_cols=197 Identities=22% Similarity=0.320 Sum_probs=162.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEE--EEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELV--AIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~v--AiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~ 166 (323)
++|++.+.||+|+||.||+|++..++..+ |+|.+... ....+.+.+|+.+++++ .|+|| +++++++...+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~i-----v~~~~~~~~~~ 99 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI-----INLLGACEHRG 99 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTB-----CCEEEEEEETT
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCch-----hhhceeeeeCC
Confidence 57999999999999999999999888865 99988642 23445678899999999 78888 89999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~ 231 (323)
..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 999999999 889999997643 23689999999999999999999999999999999999997766
Q ss_pred ceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccC--CccccccCCccccchhhcCCCCCcchhHHHHHHHHH
Q 020652 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (323)
Q Consensus 232 ~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (323)
.+| |+|||++..... ......+|+.|+|||++.+..++.++|||||||++|
T Consensus 180 ~~k---------------------------L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 232 (327)
T 1fvr_A 180 VAK---------------------------IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 232 (327)
T ss_dssp CEE---------------------------ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred eEE---------------------------EcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHH
Confidence 554 455554432211 112235688999999999888999999999999999
Q ss_pred HHhc-CCCCCCC
Q 020652 310 ELCS-VSNCYLT 320 (323)
Q Consensus 310 el~t-g~~pf~~ 320 (323)
||++ |..||.+
T Consensus 233 ellt~g~~pf~~ 244 (327)
T 1fvr_A 233 EIVSLGGTPYCG 244 (327)
T ss_dssp HHHTTSCCTTTT
T ss_pred HHHcCCCCCCCC
Confidence 9998 9999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.86 Aligned_cols=200 Identities=24% Similarity=0.362 Sum_probs=161.9
Q ss_pred CcEEEEe-eecccCcEEEEEEE--ECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 92 PRYRILS-KMGEGTFGQVVECF--DNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 92 ~~y~~~~-~lG~G~fg~V~~~~--~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
++|++.+ .||+|+||.||+|. +..+++.||||++.... ...+.+.+|+.+++.++|+|+ +++++++ ..
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~-~~ 89 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI-----VRMIGIC-EA 89 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTB-----CCEEEEE-ES
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEE-CC
Confidence 5799998 99999999999995 45678899999987432 335678899999999999988 8888887 45
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+..++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+|++|||++...
T Consensus 90 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 90 ESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 6789999999 889999998764 6999999999999999999999999999999999999988776666666554322
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
...... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+
T Consensus 168 ~~~~~~---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 223 (291)
T 1xbb_A 168 RADENY---------------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223 (291)
T ss_dssp CTTCSE---------------------EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccCCCc---------------------ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 211100 000111246788999999998889999999999999999999 9999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=324.16 Aligned_cols=198 Identities=25% Similarity=0.358 Sum_probs=166.2
Q ss_pred ecCceeCCcEEEEeeecccCcEEEEEEEECC-CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcce
Q 020652 85 AIGENLTPRYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW 161 (323)
Q Consensus 85 ~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~ 161 (323)
..++.+.++|++.+.||+|+||+||+|.+.. +++.||||++... ....+.+.+|+.++++++|+|| ++++++
T Consensus 73 ~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~i-----v~~~~~ 147 (681)
T 2pzi_A 73 NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI-----VQIFNF 147 (681)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTB-----CCEEEE
T ss_pred CCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCc-----CeEeee
Confidence 4567888999999999999999999999976 7899999988632 3445677899999999999998 888888
Q ss_pred eccCce-----EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceec
Q 020652 162 FDYRNH-----ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKV 235 (323)
Q Consensus 162 ~~~~~~-----~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki 235 (323)
+...+. .||||||+ +++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 148 ~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~----- 218 (681)
T 2pzi_A 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE----- 218 (681)
T ss_dssp EEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-----
T ss_pred EeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-----
Confidence 876554 79999999 8899887754 59999999999999999999999999999999999998532
Q ss_pred cCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCC
Q 020652 236 PDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 236 ~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~ 315 (323)
.+||+|||++...... ....||+.|+|||++.+. ++.++|||||||++|||++|.
T Consensus 219 -----------------------~~kl~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~ 273 (681)
T 2pzi_A 219 -----------------------QLKLIDLGAVSRINSF-GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDL 273 (681)
T ss_dssp -----------------------CEEECCCTTCEETTCC-SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCC
T ss_pred -----------------------cEEEEecccchhcccC-CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCC
Confidence 4677888877655433 445799999999999775 489999999999999999999
Q ss_pred CCCCCC
Q 020652 316 NCYLTP 321 (323)
Q Consensus 316 ~pf~~~ 321 (323)
.||.+.
T Consensus 274 ~~~~~~ 279 (681)
T 2pzi_A 274 PTRNGR 279 (681)
T ss_dssp CEETTE
T ss_pred CCCccc
Confidence 998753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=287.83 Aligned_cols=203 Identities=17% Similarity=0.246 Sum_probs=159.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCC---CcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcce-eccC
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNW-FDYR 165 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~-~~~~ 165 (323)
.+|++.+.||+|+||+||+|.+..+ ...+|+|.+... ....+.+.+|+.++++++|+|+ ++++++ +...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~ 99 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV-----LSLLGICLRSE 99 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEECCSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCE-----eeeeeEEEcCC
Confidence 4699999999999999999987544 346899988742 3345678899999999999988 888887 4556
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+|++|||++...
T Consensus 100 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 100 GSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp SCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred CceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence 7889999999 889999997644 46899999999999999999999999999999999999987766666666654322
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
..... ..........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+
T Consensus 179 ~~~~~--------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 235 (298)
T 3f66_A 179 YDKEY--------------------YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 235 (298)
T ss_dssp SCGGG--------------------CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cccch--------------------hccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 11100 00011122467889999999999999999999999999999999 6666654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=303.08 Aligned_cols=213 Identities=22% Similarity=0.278 Sum_probs=162.9
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCc
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~ 166 (323)
+.+.+.|.+.+.||+|+||+||.+ ...+++.||||++... ..+.+.+|+.+++++ +|+|| +++++++...+
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~--~~~~~~~E~~~l~~l~~HpnI-----v~~~~~~~~~~ 82 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNV-----IRYYCSETTDR 82 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG--GHHHHHHHHHHHHHHTTSTTB-----CCEEEEEECSS
T ss_pred hhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH--HHHHHHHHHHHHHhccCCCCc-----CeEEEEEecCC
Confidence 445677888999999999999875 4567999999988643 335678899999987 79988 88889999999
Q ss_pred eEEEEEccCCCCHHHHHHhcCCCC-----CCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 167 HICIVFEKLGPSLYDFLRKNSYRS-----FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~~~~~~-----l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
.+|+|||||+++|.+++....... .++..+..++.||+.||+|||++||+||||||+|||++.++.......
T Consensus 83 ~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~--- 159 (434)
T 2rio_A 83 FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQ--- 159 (434)
T ss_dssp EEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCT---
T ss_pred eEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccc---
Confidence 999999999889999998654211 123345779999999999999999999999999999986542211100
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccCCc-------cccccCCccccchhhcC-------CCCCcchhHHHHHHH
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH-------SYVVSTRHYRAPEVILG-------LGWNYPCDLWSVGCI 307 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~-------~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~i 307 (323)
..+....+||+|||++....... ....||+.|+|||++.+ ..++.++|||||||+
T Consensus 160 -----------~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~i 228 (434)
T 2rio_A 160 -----------TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCV 228 (434)
T ss_dssp -----------TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHH
T ss_pred -----------cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHH
Confidence 01234567888888887644322 23479999999999976 568999999999999
Q ss_pred HHHHhc-CCCCCCCCC
Q 020652 308 LVELCS-VSNCYLTPF 322 (323)
Q Consensus 308 l~el~t-g~~pf~~~~ 322 (323)
+|||+| |..||...+
T Consensus 229 l~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 229 FYYILSKGKHPFGDKY 244 (434)
T ss_dssp HHHHHTTSCCTTCSTT
T ss_pred HHHHHhCCCCCCCCch
Confidence 999999 999997643
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=285.81 Aligned_cols=194 Identities=21% Similarity=0.274 Sum_probs=159.0
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCc---EEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
.|++.++||+|+||+||+|.+..+++ .||+|++.... ...+.+.+|+.+++.++|+|| +++++++...+.
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~~~ 96 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV-----LALIGIMLPPEG 96 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEECCSSS
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEecCCC
Confidence 47888999999999999999765554 79999987432 345678899999999999998 888888876554
Q ss_pred E-EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 168 I-CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 168 ~-~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
. ++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+
T Consensus 97 ~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~------------ 163 (298)
T 3pls_A 97 LPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTV------------ 163 (298)
T ss_dssp CCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCE------------
T ss_pred CcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE------------
Confidence 4 9999999 999999998643 468999999999999999999999999999999999999766555
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccC-------CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQ-------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
||+|||++..... ......+|+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 164 ---------------kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 164 ---------------KVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp ---------------EECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred ---------------EeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 5555554432211 122346788999999999999999999999999999999965554
Q ss_pred C
Q 020652 319 L 319 (323)
Q Consensus 319 ~ 319 (323)
.
T Consensus 229 ~ 229 (298)
T 3pls_A 229 Y 229 (298)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=292.63 Aligned_cols=204 Identities=25% Similarity=0.386 Sum_probs=165.0
Q ss_pred CCcEEEEeeecccCcEEEEEEE----ECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 91 TPRYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~----~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.++|++++.||+|+||.||+|+ +..+++.||||++... ....+.+.+|+.+++.++|+|| +++++++...
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----v~~~~~~~~~ 114 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI-----VKYKGVCYSA 114 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTB-----CCEEEEECC-
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEEec
Confidence 4679999999999999999998 4678999999998753 3445678899999999999988 7787776553
Q ss_pred --ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 166 --NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 166 --~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
..+++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+|++|||++.
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 3789999999 889999998764 369999999999999999999999999999999999999887766665555443
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
........ ........+|..|+|||++.+..++.++|||||||++|||+||..||..+
T Consensus 194 ~~~~~~~~---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 251 (326)
T 2w1i_A 194 VLPQDKEY---------------------YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251 (326)
T ss_dssp ECCSSCSE---------------------EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred hccccccc---------------------cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 22211100 00011235678899999999888999999999999999999999998653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=286.99 Aligned_cols=177 Identities=16% Similarity=0.075 Sum_probs=151.5
Q ss_pred ecCc-eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEc
Q 020652 85 AIGE-NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIR 159 (323)
Q Consensus 85 ~~~~-~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~ 159 (323)
..|+ .+.++|++.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.++|+|| ++++
T Consensus 23 ~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i-----v~~~ 97 (286)
T 3uqc_A 23 VPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGV-----ARVL 97 (286)
T ss_dssp CTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTB-----CCEE
T ss_pred CCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCc-----ceee
Confidence 4455 6678999999999999999999999999999999998743 2334678899999999999988 8999
Q ss_pred ceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCc
Q 020652 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (323)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~ 238 (323)
+++...+..|+||||+ +++|.+++... .....+..++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 98 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~----- 168 (286)
T 3uqc_A 98 DVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDV----- 168 (286)
T ss_dssp EEEEETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCE-----
T ss_pred EEEEECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCE-----
Confidence 9999999999999999 88999998542 4566788999999999999999999999999999999876654
Q ss_pred ccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
||+++ .|++ .++.++|||||||++|||+||+.||
T Consensus 169 ----------------------kl~~~-----------------~~~~-------~~~~~~Di~slG~il~elltg~~Pf 202 (286)
T 3uqc_A 169 ----------------------VLAYP-----------------ATMP-------DANPQDDIRGIGASLYALLVNRWPL 202 (286)
T ss_dssp ----------------------EECSC-----------------CCCT-------TCCHHHHHHHHHHHHHHHHHSEECS
T ss_pred ----------------------EEEec-----------------cccC-------CCCchhHHHHHHHHHHHHHHCCCCC
Confidence 44322 3444 3789999999999999999999999
Q ss_pred CCC
Q 020652 319 LTP 321 (323)
Q Consensus 319 ~~~ 321 (323)
.+.
T Consensus 203 ~~~ 205 (286)
T 3uqc_A 203 PEA 205 (286)
T ss_dssp CCC
T ss_pred CcC
Confidence 863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=297.29 Aligned_cols=202 Identities=21% Similarity=0.375 Sum_probs=169.9
Q ss_pred cCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhh------------------HHHHHHHHHHHHHHHh
Q 020652 86 IGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKY------------------REAAMIEIDVLQRLAR 147 (323)
Q Consensus 86 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~------------------~~~~~~Ei~~l~~l~~ 147 (323)
.++...++|++.+.||+|+||.||+|.+ +++.||||++...... .+.+.+|+.+++.++|
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 102 (348)
T 2pml_X 25 EKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN 102 (348)
T ss_dssp SSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC
T ss_pred hcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC
Confidence 3455668999999999999999999998 8999999998743221 1778899999999999
Q ss_pred CCCCCcceEEEcceeccCceEEEEEccC-CCCHHHH------HHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecC
Q 020652 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDF------LRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTD 219 (323)
Q Consensus 148 ~~i~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~------l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrD 219 (323)
+|+ +++++++...+..++||||+ +++|.++ +.......+++..++.++.||+.||.|||+ +||+|||
T Consensus 103 ~~i-----~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~d 177 (348)
T 2pml_X 103 EYC-----LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRD 177 (348)
T ss_dssp TTB-----CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCC
T ss_pred CCc-----ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecC
Confidence 988 89999999999999999999 7799998 665434579999999999999999999999 9999999
Q ss_pred CCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-ccccccCCccccchhhcCC-CCCc
Q 020652 220 LKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGL-GWNY 297 (323)
Q Consensus 220 lKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~ 297 (323)
|||+||+++.++. +||+|||.+...... .....||+.|+|||++.+. .++.
T Consensus 178 l~p~Nil~~~~~~---------------------------~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 230 (348)
T 2pml_X 178 VKPSNILMDKNGR---------------------------VKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNG 230 (348)
T ss_dssp CCGGGEEECTTSC---------------------------EEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEH
T ss_pred CChHhEEEcCCCc---------------------------EEEeccccccccccccccCCCCCcCccCchhhcCCCCCCc
Confidence 9999999966554 566666665543222 2335789999999999887 6666
Q ss_pred -chhHHHHHHHHHHHhcCCCCCCCC
Q 020652 298 -PCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 298 -~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
++|||||||++|||++|+.||.+.
T Consensus 231 ~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 231 AKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999763
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=294.84 Aligned_cols=206 Identities=24% Similarity=0.388 Sum_probs=150.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.++|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++|+|| +++++++...+..
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~~~~~~ 88 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI-----VSYYTSFVVKDEL 88 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTB-----CCEEEEEESSSCE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCE-----eeEEEEEeecCCc
Confidence 46799999999999999999999999999999988643 2334567789999999988888 8899999988999
Q ss_pred EEEEccC-CCCHHHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 169 CIVFEKL-GPSLYDFLRKN------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~------~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
++||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||+++.++.++++|||++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999 89999998741 2246899999999999999999999999999999999999987777766666654
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
......+.. ..........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+
T Consensus 169 ~~~~~~~~~-------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 229 (303)
T 2vwi_A 169 AFLATGGDI-------------------TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229 (303)
T ss_dssp HHCC----------------------------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred heeccCCCc-------------------cchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 332211100 00011123478999999999976 4689999999999999999999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=298.89 Aligned_cols=202 Identities=18% Similarity=0.232 Sum_probs=155.6
Q ss_pred cEEEEeeecccCcEEEEEEEECCC---CcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEccee-ccCc
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF-DYRN 166 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~-~~~~ 166 (323)
.|++.+.||+|+||+||+|.+..+ +..||+|.++.. ....+.+.+|+.++++++|+|| +++++++ ...+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~~ 164 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV-----LSLLGICLRSEG 164 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTB-----CCCCEEECCCSS
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCc-----ceEEEEEEcCCC
Confidence 589999999999999999987543 346899988642 3445678899999999999998 8888874 4456
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 165 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 165 SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp CCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccc
Confidence 889999999 889999997654 468999999999999999999999999999999999999766655555555432211
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
.... ..........+|+.|+|||++.+..++.++|||||||++|||+| |.+||.+
T Consensus 244 ~~~~--------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~ 299 (373)
T 3c1x_A 244 DKEF--------------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299 (373)
T ss_dssp ----------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred cccc--------------------ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCC
Confidence 1000 00001122357889999999999999999999999999999999 7788865
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=313.37 Aligned_cols=199 Identities=24% Similarity=0.370 Sum_probs=159.7
Q ss_pred EEEE-eeecccCcEEEEEEEE--CCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 94 YRIL-SKMGEGTFGQVVECFD--NEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 94 y~~~-~~lG~G~fg~V~~~~~--~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
+.+. ++||+|+||+||+|.+ ..+++.||||+++... ...+.+.+|+.++++++|+|| +++++++.. +.
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~l~~~~~~-~~ 443 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI-----VRMIGICEA-ES 443 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTB-----CCEEEEEES-SS
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEec-CC
Confidence 4443 4899999999999954 4567899999987432 335778999999999999998 888888865 45
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
.++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred EEEEEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 88999999 899999998764 699999999999999999999999999999999999999887776666665543322
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~ 321 (323)
+... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.
T Consensus 522 ~~~~---------------------~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~ 576 (635)
T 4fl3_A 522 DENY---------------------YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 576 (635)
T ss_dssp ----------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred Cccc---------------------cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1100 000112346788999999999999999999999999999998 99999763
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=288.13 Aligned_cols=198 Identities=16% Similarity=0.221 Sum_probs=156.0
Q ss_pred CCcEEEEeeecccCcEEEEEEEECC---CCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNE---KKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
.++|++.+.||+|+||.||+|.+.. +++.||+|++... ....+.+.+|+.++++++|+|| +++++++..
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~ 107 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV-----IRLLGVCIE 107 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEEEC
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCe-----eeeeEEEee
Confidence 4689999999999999999998765 5568999998743 3344668899999999999998 788887765
Q ss_pred Cc-----eEEEEEccC-CCCHHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCcee
Q 020652 165 RN-----HICIVFEKL-GPSLYDFLRKN----SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (323)
Q Consensus 165 ~~-----~~~lv~e~~-~~~L~~~l~~~----~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~k 234 (323)
.. ..++||||+ +++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+|
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEE
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEE
Confidence 43 469999999 88999998532 234699999999999999999999999999999999999997666555
Q ss_pred ccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHHHHHHHHH
Q 020652 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (323)
Q Consensus 235 i~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (323)
+ +|||++...... .....+++.|+|||++.+..++.++|||||||++|
T Consensus 188 l---------------------------~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 240 (313)
T 3brb_A 188 V---------------------------ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW 240 (313)
T ss_dssp E---------------------------CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHH
T ss_pred E---------------------------eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHH
Confidence 4 555544332211 12235788999999999999999999999999999
Q ss_pred HHhc-CCCCCCC
Q 020652 310 ELCS-VSNCYLT 320 (323)
Q Consensus 310 el~t-g~~pf~~ 320 (323)
||++ |..||.+
T Consensus 241 el~~~g~~p~~~ 252 (313)
T 3brb_A 241 EIATRGMTPYPG 252 (313)
T ss_dssp HHHTTSCCSSTT
T ss_pred HHHhcCCCCCcc
Confidence 9999 9999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=303.43 Aligned_cols=198 Identities=22% Similarity=0.235 Sum_probs=158.6
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCceEEEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
+|++.+.||+|+||+||. ....+++.||||++..... ..+.+|+.+|+.+ +|+|| +++++++......|+|
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~--~~~~~E~~~l~~l~~HpnI-----v~l~~~~~~~~~~~lv 96 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF--SFADREVQLLRESDEHPNV-----IRYFCTEKDRQFQYIA 96 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE--EECHHHHHHHHHSCCCTTB-----CCEEEEEEETTEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH--HHHHHHHHHHHhccCCCCc-----CeEEEEEecCCEEEEE
Confidence 699999999999999763 3456889999999864322 2356799999998 68888 8888999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 172 FEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 172 ~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||||+++|.+++.... ..+.+..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 97 ~E~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~-------------------- 155 (432)
T 3p23_A 97 IELCAATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPN-------------------- 155 (432)
T ss_dssp EECCSEEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCB--------------------
T ss_pred EECCCCCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCC--------------------
Confidence 9999889999998765 3455556788999999999999999999999999999996432
Q ss_pred ccCCCCCCceEeeCCCcccccCC------ccccccCCccccchhhcC---CCCCcchhHHHHHHHHHHHhc-CCCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCS-VSNCYLTP 321 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~t-g~~pf~~~ 321 (323)
.+....+||+|||++...... ....+||+.|+|||++.+ ..++.++|||||||++|||++ |..||...
T Consensus 156 --~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 156 --AHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp --TTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred --CCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 122345678888877654322 233579999999999984 567889999999999999999 99999754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=293.13 Aligned_cols=200 Identities=22% Similarity=0.298 Sum_probs=163.0
Q ss_pred eeEecCceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHH--HHhCCCCCcceEEEc
Q 020652 82 YVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR--LARHDIGGTRCVQIR 159 (323)
Q Consensus 82 ~~~~~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~--l~~~~i~~~~~~~~~ 159 (323)
..+..++.+.++|++.+.||+|+||.||+|.+ +++.||||++... ....+.+|++++.. ++|+|| ++++
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni-----~~~~ 102 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENI-----LGFI 102 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTB-----CCEE
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcE-----EEEE
Confidence 34455667778999999999999999999987 5889999998643 34567788888887 678887 8888
Q ss_pred ceeccCc----eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------HCCceecCCCCCcEE
Q 020652 160 NWFDYRN----HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH--------ELRLIHTDLKPENIL 226 (323)
Q Consensus 160 ~~~~~~~----~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH--------~~~iiHrDlKp~NIl 226 (323)
+++.... .+++||||+ +++|.+++.+. .+++..++.++.|++.||.||| ++||+||||||+|||
T Consensus 103 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIl 179 (342)
T 1b6c_B 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 179 (342)
T ss_dssp EEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEE
T ss_pred eeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEE
Confidence 8877665 899999999 78999999875 5999999999999999999999 899999999999999
Q ss_pred EeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-------ccccccCCccccchhhcCCC-----
Q 020652 227 LVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-------HSYVVSTRHYRAPEVILGLG----- 294 (323)
Q Consensus 227 i~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~----- 294 (323)
++.++.+ ||+|||++...... .....||+.|+|||++.+..
T Consensus 180 l~~~~~~---------------------------kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 232 (342)
T 1b6c_B 180 VKKNGTC---------------------------CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 232 (342)
T ss_dssp ECTTSCE---------------------------EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCH
T ss_pred ECCCCCE---------------------------EEEECCCceeccccccccccccccCCcCcccCCHhhhccccccccc
Confidence 9766554 55555555432221 12347999999999998763
Q ss_pred -CCcchhHHHHHHHHHHHhcC----------CCCCCC
Q 020652 295 -WNYPCDLWSVGCILVELCSV----------SNCYLT 320 (323)
Q Consensus 295 -~~~~~DiwSlG~il~el~tg----------~~pf~~ 320 (323)
++.++|||||||++|||+|| ..||..
T Consensus 233 ~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 233 ESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 33789999999999999999 778764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=289.08 Aligned_cols=198 Identities=25% Similarity=0.396 Sum_probs=145.1
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHH-HHHHHHhCCCCCcceEEEcceeccCce
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEID-VLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~-~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
.++|++.+.||+|+||.||+|.+..+++.||||++... ......+..|+. +++.+.|+|| +++++++...+.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~ni-----v~~~~~~~~~~~ 95 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI-----VQFYGALFREGD 95 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTB-----CCEEEEEECSSE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcE-----eeeeeEEEeCCc
Confidence 46899999999999999999999999999999998743 233344555555 5666677777 999999999999
Q ss_pred EEEEEccCCCCHHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEeecCceeccCcccccc
Q 020652 168 ICIVFEKLGPSLYDFLRK---NSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~---~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
.++||||+.++|.+++.. .....+++..+..++.|++.||.|||++ ||+||||||+||+++.++.+||+|
T Consensus 96 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~D------ 169 (327)
T 3aln_A 96 CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCD------ 169 (327)
T ss_dssp EEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECC------
T ss_pred eEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEcc------
Confidence 999999997798888763 2234799999999999999999999999 999999999999998766555555
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhh----cCCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVI----LGLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
||++...... .....||+.|+|||++ .+..++.++|||||||++|||++|+.|
T Consensus 170 ---------------------fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (327)
T 3aln_A 170 ---------------------FGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228 (327)
T ss_dssp ---------------------CSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCC
T ss_pred ---------------------CCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 4444332211 1223689999999998 456789999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 229 f~~ 231 (327)
T 3aln_A 229 YPK 231 (327)
T ss_dssp SSC
T ss_pred CCC
Confidence 975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=285.59 Aligned_cols=192 Identities=26% Similarity=0.419 Sum_probs=160.2
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (323)
...||+|+||.||+|.+..+++.||||++... ....+.+.+|+.+++.++|+|| +++++++...+..++||||+
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNI-----VQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTB-----CCEEEEEEETTEEEEEEECC
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCE-----eeEeeEEEeCCcEEEEEEeC
Confidence 34899999999999999999999999998743 3345678899999999999988 88999999999999999999
Q ss_pred -CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEee-cCceeccCcccccccCCCCCccc
Q 020652 176 -GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS-AEYVKVPDYKFLSRSSKDGSYFK 252 (323)
Q Consensus 176 -~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~-~~~~ki~d~~~~~~~~~~~~~~~ 252 (323)
+++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+||+++. ++
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--------------------- 160 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG--------------------- 160 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC---------------------
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC---------------------
Confidence 899999998653 235678999999999999999999999999999999999975 44
Q ss_pred cCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCCC--CCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 253 NLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGLG--WNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 253 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+||+|||.+...... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 161 ------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 161 ------VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp ------CEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred ------CEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 4566666665443221 22347899999999997653 88999999999999999999999964
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=299.05 Aligned_cols=214 Identities=22% Similarity=0.273 Sum_probs=165.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---------hhHHHHHHHHHHHHHHH---------hCCCC--
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLA---------RHDIG-- 151 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~Ei~~l~~l~---------~~~i~-- 151 (323)
++|++.++||+|+||+||+|++ +++.||||++.... ...+.+.+|+.+++.++ |+|+.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 5799999999999999999987 68999999987432 22367889999999997 77764
Q ss_pred ----------CcceEEEcceecc-------------CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Q 020652 152 ----------GTRCVQIRNWFDY-------------RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207 (323)
Q Consensus 152 ----------~~~~~~~~~~~~~-------------~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL 207 (323)
|++++++++++.. .+.+|+||||+ +|++.+.+.+ ..+++..++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 4555666777665 78899999999 7766666544 3589999999999999999
Q ss_pred HHHH-HCCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCcccc
Q 020652 208 AFMH-ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRA 286 (323)
Q Consensus 208 ~~lH-~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~a 286 (323)
+||| ++||+||||||+|||++.++.-. .++++.... ...-.....+||+|||+++..... ..+||+.|+|
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~-~~~~~~~~~------~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKK-LHYTLNGKS------STIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSE-EEEEETTEE------EEEECTTEEEEECCCTTCBEEETT--EEECCCCTTC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcc-eeeeccCcc------ccccCCCceEEEeeccccEecCCC--cEEEeecccC
Confidence 9999 99999999999999998765211 111110000 000012236799999998765533 4589999999
Q ss_pred chhhcCCCCCcchhHHHHHHH-HHHHhcCCCCCCC
Q 020652 287 PEVILGLGWNYPCDLWSVGCI-LVELCSVSNCYLT 320 (323)
Q Consensus 287 PE~~~~~~~~~~~DiwSlG~i-l~el~tg~~pf~~ 320 (323)
||++.+.. +.++||||||++ .+++++|..||.+
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 99999876 899999998777 7888999999853
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=284.00 Aligned_cols=192 Identities=26% Similarity=0.381 Sum_probs=159.4
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc-----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
|...++||+|+||.||+|.+ +++.||+|++... ....+.+.+|+.+++.++|+|+ +++++++...+..
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i-----~~~~~~~~~~~~~ 105 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENL-----VELLGFSSDGDDL 105 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSC
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCe-----EEEEEEEecCCce
Confidence 33458999999999999975 6788999998642 2345678899999999999988 8899999988999
Q ss_pred EEEEccC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
++||||+ +++|.+++.... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~------------- 172 (307)
T 2nru_A 106 CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTA------------- 172 (307)
T ss_dssp EEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCE-------------
T ss_pred EEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcE-------------
Confidence 9999999 899999997432 2469999999999999999999999999999999999999765555
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||.+...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 173 --------------kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~ 236 (307)
T 2nru_A 173 --------------KISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE 236 (307)
T ss_dssp --------------EECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred --------------EEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCccc
Confidence 55555554432211 122478999999999876 578999999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=283.08 Aligned_cols=196 Identities=27% Similarity=0.348 Sum_probs=146.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchh---hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK---YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~---~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++|++.+.||+|+||.||+|.+..+++.||||++..... ..+.+..+..+++.+.|+|| +++++++...+..
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i-----~~~~~~~~~~~~~ 99 (318)
T 2dyl_A 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI-----VQCFGTFITNTDV 99 (318)
T ss_dssp GGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTB-----CCEEEEEECSSEE
T ss_pred ccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCce-----eeEEEEEecCCcE
Confidence 679999999999999999999999999999999874322 22233344456777788887 8999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL-RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||||+++.+..+..... ..+++..++.++.|++.||.|||++ ||+||||||+||+++.++.+
T Consensus 100 ~lv~e~~~~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~-------------- 164 (318)
T 2dyl_A 100 FIAMELMGTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQI-------------- 164 (318)
T ss_dssp EEEECCCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCE--------------
T ss_pred EEEEeccCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCE--------------
Confidence 9999999777776665433 4699999999999999999999995 99999999999999765544
Q ss_pred CCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhc-----CCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||++...... .....||+.|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 165 -------------kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 165 -------------KLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp -------------EECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -------------EEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 55555555432221 22346899999999995 45688999999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=283.34 Aligned_cols=202 Identities=21% Similarity=0.328 Sum_probs=155.0
Q ss_pred CCcEEEEeeecccCcEEEEEEEECC-CCc--EEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNE-KKE--LVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~-~~~--~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
.++|++.+.||+|+||+||+|.+.. +++ .||+|+++.. ....+.+.+|+.+++.++|+|+ +++++++.
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----~~~~~~~~ 91 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL-----IRLYGVVL 91 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEC
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCc-----ccEEEEEc
Confidence 3579999999999999999998643 333 6899988642 2345678899999999999988 88888887
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
... .++||||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+|++|||++.
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred cCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccc
Confidence 655 88999999 899999998653 359999999999999999999999999999999999999887766665555433
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
........ ........+|..|+|||++.+..++.++|||||||++|||++ |+.||.+
T Consensus 170 ~~~~~~~~---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 227 (291)
T 1u46_A 170 ALPQNDDH---------------------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227 (291)
T ss_dssp ECCC-CCE---------------------EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccccccc---------------------hhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 22111100 001112357888999999998889999999999999999999 9999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=313.41 Aligned_cols=201 Identities=28% Similarity=0.420 Sum_probs=168.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc--chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc----
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY---- 164 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~--~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~---- 164 (323)
.++|++.++||+|+||.||+|.+..+++.||||++.. .....+.+.+|+.++++++|+|| +++++++..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnI-----V~l~~v~~~~~~~ 87 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV-----VSAREVPDGLQKL 87 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTB-----CCEEECCTTTCCC
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCC-----Cceeeeecccccc
Confidence 3689999999999999999999999999999998864 23445678899999999999998 777776554
Q ss_pred --CceEEEEEccC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 165 --RNHICIVFEKL-GPSLYDFLRKNS-YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 165 --~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
.+..++||||+ +++|.+++.... ...+++..++.++.|++.||.|||++||+||||||+||+++.++
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g--------- 158 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP--------- 158 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCS---------
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCC---------
Confidence 67789999999 999999998643 23589999999999999999999999999999999999997654
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
....+||+|||.+...... .....||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 159 ---------------~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf 223 (676)
T 3qa8_A 159 ---------------QRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223 (676)
T ss_dssp ---------------SSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSC
T ss_pred ---------------CceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 2234678888877654332 23357999999999999999999999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 224 ~~ 225 (676)
T 3qa8_A 224 LP 225 (676)
T ss_dssp CS
T ss_pred Cc
Confidence 65
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=307.08 Aligned_cols=198 Identities=22% Similarity=0.305 Sum_probs=163.0
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCC---CcEEEEEEecc--chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEK---KELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~---~~~vAiK~~~~--~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
...++|++.+.||+|+||.||+|.+..+ +..||||++.. .....+.+.+|+.+++.++|+|| +++++++.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~~~~~ 461 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI-----VKLIGVIT 461 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEe
Confidence 3457899999999999999999998654 46799998864 23445678899999999999998 88888875
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
.+..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~-- 537 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL-- 537 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCC--
T ss_pred -cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCC--
Confidence 45689999999 899999998654 4689999999999999999999999999999999999998877665555554
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNC 317 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~p 317 (323)
+...... .....+|+.|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 538 -------------------------a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~P 592 (656)
T 2j0j_A 538 -------------------------SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 592 (656)
T ss_dssp -------------------------CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred -------------------------CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCC
Confidence 4322111 112356789999999998899999999999999999997 9999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 593 f~~ 595 (656)
T 2j0j_A 593 FQG 595 (656)
T ss_dssp TTT
T ss_pred CCC
Confidence 975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=296.89 Aligned_cols=202 Identities=16% Similarity=0.121 Sum_probs=153.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCC-----------CCCcceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHD-----------IGGTRCV 156 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~-----------i~~~~~~ 156 (323)
..|.+.+.||+|+||+||+|.+..+++.||||++... ....+.+.+|+.+++.+.|.. +....++
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3588999999999999999999999999999998732 223466888999888887621 1111112
Q ss_pred EEc------ceecc-----CceEEEEEccCCCCHHHHHH-----hcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Q 020652 157 QIR------NWFDY-----RNHICIVFEKLGPSLYDFLR-----KNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDL 220 (323)
Q Consensus 157 ~~~------~~~~~-----~~~~~lv~e~~~~~L~~~l~-----~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDl 220 (323)
.+. .++.. ...++++|++++++|.+++. ......+++..+..++.||+.||+|||++||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 211 11111 23478899999999999985 222235778889999999999999999999999999
Q ss_pred CCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhh----------
Q 020652 221 KPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVI---------- 290 (323)
Q Consensus 221 Kp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~---------- 290 (323)
||+|||++.++. +||+|||++..........+| +.|+|||++
T Consensus 238 Kp~NILl~~~~~---------------------------~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~ 289 (413)
T 3dzo_A 238 RPVDIVLDQRGG---------------------------VFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQH 289 (413)
T ss_dssp CGGGEEECTTCC---------------------------EEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGG
T ss_pred ccceEEEecCCe---------------------------EEEEeccceeecCCccccCCC-CceeCchhhhccccccccc
Confidence 999999976554 566666665544444445578 999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 291 LGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 291 ~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
.+..++.++|||||||++|||++|+.||.+.
T Consensus 290 ~~~~~~~~~DvwSlGvil~elltg~~Pf~~~ 320 (413)
T 3dzo_A 290 HPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320 (413)
T ss_dssp CCEEECHHHHHHHHHHHHHHHHHSSCCCCTT
T ss_pred cCcCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 5556889999999999999999999999763
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=286.83 Aligned_cols=195 Identities=21% Similarity=0.297 Sum_probs=158.8
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
...++|++.+.||+|+||.||+|.+.. .+|+|++.... ...+.+.+|+.+++.++|+|+ +++++++...
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-----v~~~~~~~~~ 101 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENV-----VLFMGACMSP 101 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTB-----CCCCEEEECS
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCE-----eEEEEEEecC
Confidence 334689999999999999999998754 39999886432 223456779999999999988 8899999988
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+.+++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+++ ++.+
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~----------- 168 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKV----------- 168 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CC-----------
T ss_pred CceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCE-----------
Confidence 9999999999 889999997653 4689999999999999999999999999999999999996 3444
Q ss_pred CCCCCccccCCCCCCceEeeCCCccccc--------CCccccccCCccccchhhcC---------CCCCcchhHHHHHHH
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEH--------QDHSYVVSTRHYRAPEVILG---------LGWNYPCDLWSVGCI 307 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~--------~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwSlG~i 307 (323)
||+|||++.... .......||+.|+|||++.+ ..++.++|||||||+
T Consensus 169 ----------------~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~i 232 (319)
T 2y4i_B 169 ----------------VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232 (319)
T ss_dssp ----------------EECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHH
T ss_pred ----------------EEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHH
Confidence 555555543221 11223468999999999975 357899999999999
Q ss_pred HHHHhcCCCCCCC
Q 020652 308 LVELCSVSNCYLT 320 (323)
Q Consensus 308 l~el~tg~~pf~~ 320 (323)
+|||++|+.||.+
T Consensus 233 l~el~~g~~p~~~ 245 (319)
T 2y4i_B 233 WYELHAREWPFKT 245 (319)
T ss_dssp HHHHHHSSCSSSS
T ss_pred HHHHHhCCCCCCC
Confidence 9999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=271.75 Aligned_cols=179 Identities=26% Similarity=0.496 Sum_probs=150.7
Q ss_pred eCCcEEEE-eeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHH-HHHHhCCCCCcceEEEcceecc---
Q 020652 90 LTPRYRIL-SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVL-QRLARHDIGGTRCVQIRNWFDY--- 164 (323)
Q Consensus 90 ~~~~y~~~-~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l-~~l~~~~i~~~~~~~~~~~~~~--- 164 (323)
+.++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+|+.++ +.+.|+|| +++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~e~~~~~~~~~h~~i-----~~~~~~~~~~~~ 85 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHI-----VRIVDVYENLYA 85 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTB-----CCEEEEEEEEET
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc----HHHHHHHHHHHHhccCCCc-----hhHHhhhhhhcC
Confidence 34568877 7899999999999999999999999998643 3456788887 55578887 777777765
Q ss_pred -CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
...+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+||+++..+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~----------- 154 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR----------- 154 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS-----------
T ss_pred CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCC-----------
Confidence 67899999999 88999999987656799999999999999999999999999999999999996521
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
....+||+|||++.... +..++.++|||||||++|||++|+.||.+
T Consensus 155 -------------~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~ 200 (299)
T 3m2w_A 155 -------------PNAILKLTDFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYS 200 (299)
T ss_dssp -------------TTCCEEECCCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred -------------CCCcEEEeccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 24567888998775432 34578899999999999999999999965
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=284.52 Aligned_cols=183 Identities=19% Similarity=0.101 Sum_probs=126.0
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccc-----------hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceecc
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-----------NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-----------~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~ 164 (323)
...++.|++|.+..++....|+.||+|++.+. ....+++.+|+++|+++ .|+|| +++++++++
T Consensus 239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i-----~~~~~~~ed 313 (569)
T 4azs_A 239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDA-----PAVLAHGEN 313 (569)
T ss_dssp ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCC-----CCEEEEEEC
T ss_pred hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCe-----eEEEEEEEE
Confidence 45678889998888888889999999998642 23346788999999999 57777 999999999
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
++.+||||||+ |++|.++|.+.+ .+++. .|+.||+.||+|||++|||||||||+|||++.+|.+
T Consensus 314 ~~~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~v---------- 378 (569)
T 4azs_A 314 AQSGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHA---------- 378 (569)
T ss_dssp SSEEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCE----------
T ss_pred CCEEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCE----------
Confidence 99999999999 999999998765 57654 478999999999999999999999999999766655
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
||+|||+|+.... .....+||+.|||||++.+. +..++|+||+|+++++|.++..+
T Consensus 379 -----------------KL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 379 -----------------RLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -----------------EECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred -----------------EEeecccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 5555555543322 22346899999999999874 56789999999998887665433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-30 Score=247.22 Aligned_cols=179 Identities=19% Similarity=0.183 Sum_probs=136.5
Q ss_pred EEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---------hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---------KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 95 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---------~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
...+.||+|+||+||+| ...++.+|+|+..... ...+.+.+|++++++++|+|| +.+..++...
T Consensus 339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nI-----v~~~~~~~~~ 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGI-----PAPYIFDVDL 411 (540)
T ss_dssp ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTC-----CCCCEEEEET
T ss_pred CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCc-----CceEEEEEeC
Confidence 44679999999999999 4557788999764211 123457899999999999999 4223333345
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+..|+||||+ +++|.+++.. +..++.|++.||+|||++||+||||||+|||++.
T Consensus 412 ~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--------------- 466 (540)
T 3en9_A 412 DNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--------------- 466 (540)
T ss_dssp TTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---------------
T ss_pred CccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---------------
Confidence 5679999999 8999999865 5689999999999999999999999999999842
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCc----------cccccCCccccchhhcC--CCCCcchhHHHHHHHHHHHh
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDH----------SYVVSTRHYRAPEVILG--LGWNYPCDLWSVGCILVELC 312 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~----------~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~ 312 (323)
.+||+|||+++...... ...+||+.|||||++.+ ..|+..+|+||..+-..+.+
T Consensus 467 --------------~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v 532 (540)
T 3en9_A 467 --------------DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDV 532 (540)
T ss_dssp --------------SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHH
T ss_pred --------------eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHH
Confidence 56888888887654421 24689999999999987 57888899999999999988
Q ss_pred cCCCCCC
Q 020652 313 SVSNCYL 319 (323)
Q Consensus 313 tg~~pf~ 319 (323)
.++.+|.
T Consensus 533 ~~r~rY~ 539 (540)
T 3en9_A 533 ERRARYV 539 (540)
T ss_dssp HTCSCCC
T ss_pred HhccccC
Confidence 8877774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.7e-26 Score=203.75 Aligned_cols=155 Identities=24% Similarity=0.293 Sum_probs=117.9
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-------------------hhHHHHHHHHHHHHHHHhCCCCCc
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------------------KYREAAMIEIDVLQRLARHDIGGT 153 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-------------------~~~~~~~~Ei~~l~~l~~~~i~~~ 153 (323)
.|++.+.||+|+||.||+|.+ .+++.||||+++... .....+.+|+.+++++.| +
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~--~--- 164 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG--L--- 164 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT--S---
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC--C---
Confidence 466779999999999999999 889999999986322 134568899999999983 2
Q ss_pred ceEEEcceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCc
Q 020652 154 RCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEY 232 (323)
Q Consensus 154 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~ 232 (323)
.+.+++.. +..|+||||+ |++|.+ +. . .....++.|++.||.|||++||+||||||+|||++ ++.
T Consensus 165 ---~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~ 230 (282)
T 1zar_A 165 ---AVPKVYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEG 230 (282)
T ss_dssp ---SSCCEEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTE
T ss_pred ---CcCeEEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCc
Confidence 22222332 4569999999 789987 32 1 23457999999999999999999999999999997 554
Q ss_pred eeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC----------CCCCcchhHH
Q 020652 233 VKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG----------LGWNYPCDLW 302 (323)
Q Consensus 233 ~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Diw 302 (323)
+||+|||++. .+..++|||.+.. ..|+..+|+|
T Consensus 231 ---------------------------vkl~DFG~a~----------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~ 273 (282)
T 1zar_A 231 ---------------------------IWIIDFPQSV----------EVGEEGWREILERDVRNIITYFSRTYRTEKDIN 273 (282)
T ss_dssp ---------------------------EEECCCTTCE----------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHH
T ss_pred ---------------------------EEEEECCCCe----------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChH
Confidence 4677777664 3556899998864 3456677887
Q ss_pred HH
Q 020652 303 SV 304 (323)
Q Consensus 303 Sl 304 (323)
.+
T Consensus 274 ~~ 275 (282)
T 1zar_A 274 SA 275 (282)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=182.00 Aligned_cols=123 Identities=19% Similarity=0.154 Sum_probs=97.9
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcE--EEEEEeccchh-------------------------hHHHHHHHHHHHHHHH
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKEL--VAIKIVRSINK-------------------------YREAAMIEIDVLQRLA 146 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~--vAiK~~~~~~~-------------------------~~~~~~~Ei~~l~~l~ 146 (323)
|++.+.||+|+||.||+|.+..+|+. ||||+++.... ....+.+|+.+|+.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999998778988 99998753211 1235788999999999
Q ss_pred hCCCCCcceEEEcceeccCceEEEEEccCC--C----CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-HCCceecC
Q 020652 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLG--P----SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH-ELRLIHTD 219 (323)
Q Consensus 147 ~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~--~----~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH-~~~iiHrD 219 (323)
|+++..+.++.. +..+|||||++ | +|.++... .++..+..++.|++.||.||| ++||+|||
T Consensus 129 ~~~i~~p~~~~~-------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY-------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE-------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSS
T ss_pred hCCCCCCeEEEc-------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCC
Confidence 998755444432 24689999994 3 77776532 234567889999999999999 99999999
Q ss_pred CCCCcEEEe
Q 020652 220 LKPENILLV 228 (323)
Q Consensus 220 lKp~NIli~ 228 (323)
|||+|||++
T Consensus 197 lkp~NILl~ 205 (258)
T 1zth_A 197 LSEYNIMYI 205 (258)
T ss_dssp CSTTSEEES
T ss_pred CCHHHEEEc
Confidence 999999984
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=2.1e-19 Score=163.31 Aligned_cols=123 Identities=20% Similarity=0.207 Sum_probs=91.7
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-----------------------hhHHHHHHHHHHHHHHHhCCC
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-----------------------KYREAAMIEIDVLQRLARHDI 150 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-----------------------~~~~~~~~Ei~~l~~l~~~~i 150 (323)
|++..+||+|+||.||+|.+. +|+.||||+++... ..+-.+.+|...|.++.+..+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 999999999999999999874 68999999875210 011223568888999977765
Q ss_pred CCcceEEEcceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEee
Q 020652 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVS 229 (323)
Q Consensus 151 ~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~ 229 (323)
..+..+. .. ..+|||||+ |.+|.++. ..+.+..++.||+.+|.+||++|||||||||.|||+..
T Consensus 176 ~vp~p~~------~~-~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 176 PVPEPIA------QS-RHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIRE 240 (397)
T ss_dssp SCCCEEE------EE-TTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEE
T ss_pred CCCeeee------cc-CceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeC
Confidence 3332221 11 237999999 66765432 12235678899999999999999999999999999988
Q ss_pred cCc
Q 020652 230 AEY 232 (323)
Q Consensus 230 ~~~ 232 (323)
++.
T Consensus 241 dgd 243 (397)
T 4gyi_A 241 EKD 243 (397)
T ss_dssp EEC
T ss_pred CCC
Confidence 763
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=8e-13 Score=114.53 Aligned_cols=108 Identities=11% Similarity=0.094 Sum_probs=80.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
+.|++...++.|+.+.||++... ++.+++|+..... .....+.+|+.+++.+.. .+ .+.+++++....+..|+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~-~~---~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEG-KL---PVPKVLHFERHDGWSNL 87 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT-TS---CCCCEEEEEEETTEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhc-CC---CCCeEEEEEecCCceEE
Confidence 45899999999999999999643 6789999886421 223457889999999965 22 23566666777788999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~ 212 (323)
|||++ |.+|.+.+. +......++.++..+|..||+
T Consensus 88 v~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~ 123 (263)
T 3tm0_A 88 LMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHS 123 (263)
T ss_dssp EEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHH
T ss_pred EEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhC
Confidence 99999 778876531 112234678899999999998
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.29 E-value=7.7e-12 Score=107.78 Aligned_cols=105 Identities=13% Similarity=0.102 Sum_probs=69.8
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
.|.+....+.|..+.||++.. .+|+.+++|+.... ....+..|+.+++.+.+.++ .+.+++.+...++..++||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~---~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGV---PCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTC---CBCCEEEEEECSSCEEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCC---CCCeEEEeccCCCCCEEEE
Confidence 466555445666799999964 45677999987643 22456789999999987644 2344555666667789999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~ 213 (323)
|++ |.+|. .. .... ..++.+++..|..||+.
T Consensus 95 e~i~G~~l~--~~-----~~~~---~~~~~~l~~~l~~lh~~ 126 (264)
T 1nd4_A 95 GEVPGQDLL--SS-----HLAP---AEKVSIMADAMRRLHTL 126 (264)
T ss_dssp ECCSSEETT--TS-----CCCH---HHHHHHHHHHHHHHTTS
T ss_pred EecCCcccC--cC-----cCCH---hHHHHHHHHHHHHHhCC
Confidence 999 66663 11 1221 24566677777777764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.19 E-value=5e-11 Score=105.61 Aligned_cols=105 Identities=16% Similarity=0.146 Sum_probs=69.3
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHh-CCCCCcceEEEcceeccCceEEEEEccC-
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR-HDIGGTRCVQIRNWFDYRNHICIVFEKL- 175 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~-~~i~~~~~~~~~~~~~~~~~~~lv~e~~- 175 (323)
+.++.|.+..||++. ..+++|+... ......+.+|..+++.+.. ..+..+.++............|+||+++
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~-~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKH-SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESS-HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCC-cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 468999999999863 3488998653 2345678899999999854 3443333332211111112358899999
Q ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 020652 176 GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212 (323)
Q Consensus 176 ~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~ 212 (323)
|.+|.+.... .++.++...++.|++..|..||+
T Consensus 100 G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~ 132 (304)
T 3sg8_A 100 GVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHS 132 (304)
T ss_dssp CEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CeECCccccc----cCCHHHHHHHHHHHHHHHHHHHc
Confidence 6666653332 46777788888888888888885
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.18 E-value=9e-11 Score=106.37 Aligned_cols=108 Identities=14% Similarity=0.151 Sum_probs=74.1
Q ss_pred EEeeecccCcEEEEEEEECCCCcEEEEEEec--cch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC---ceE
Q 020652 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR---NHI 168 (323)
Q Consensus 96 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~--~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~---~~~ 168 (323)
.++.|+.|.++.||++... +..+++|+.. ... .....+.+|+.+++.+...++. +.+++.++... +..
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vp---vP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVP---VAKMYALCEDESVIGRA 116 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSC---CCCEEEEECCTTTTSSC
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCC---CCcEEEECCCCCccCCe
Confidence 4678999999999998753 4568888765 322 2234677899999999875543 34445555444 457
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~ 212 (323)
|+|||++ |..+.+. ....++......++.+++..|..||+
T Consensus 117 ~~vme~v~G~~l~~~----~~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQ----SLPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp EEEEECCCCBCCCCT----TCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEecCCeecCCC----ccccCCHHHHHHHHHHHHHHHHHHhC
Confidence 8999999 6555331 11247788888999999999999997
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=2.4e-07 Score=81.91 Aligned_cols=102 Identities=17% Similarity=0.105 Sum_probs=62.8
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhC-CCCCcceEEEccee-ccCceEEEEEcc
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWF-DYRNHICIVFEK 174 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~-~i~~~~~~~~~~~~-~~~~~~~lv~e~ 174 (323)
++.++.|....||+. +..+++|+.. .......+.+|..+|+.+.+. .+. +...+.+. ...+..++|||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~-~~~~~~~~~~E~~~L~~L~~~~~v~---VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK-SQQGADELNKEIQLLPLLVGCVKVN---IPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES-SHHHHHHHHHHHHHHHHHTTTCSSB---CCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC-CchHHHHHHHHHHHHHHHHhcCCCC---CCCeEeecccCCCceEEEEec
Confidence 356788999999988 4558889753 233456788999999999864 222 22333333 234567899999
Q ss_pred C-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 020652 175 L-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211 (323)
Q Consensus 175 ~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH 211 (323)
+ |.+|.+.... .++......++.++...|..||
T Consensus 95 i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH 128 (306)
T 3tdw_A 95 VQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELS 128 (306)
T ss_dssp CCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHH
T ss_pred cCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHh
Confidence 9 6666653211 2344444445555555555444
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=1.9e-06 Score=74.42 Aligned_cols=101 Identities=12% Similarity=0.155 Sum_probs=65.5
Q ss_pred eecccCcE-EEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC-C
Q 020652 99 KMGEGTFG-QVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G 176 (323)
Q Consensus 99 ~lG~G~fg-~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~-~ 176 (323)
.+..|..| .||+......+..+++|+-... ....+.+|..+|+.+.. .+ .+.+++.+....+..++|||++ |
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~-~v---PVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTA-FM---PLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTT-TS---CCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhcc-CC---CcCeEEEEEEECCeEEEEEEeeCC
Confidence 33445444 6999887777778999986532 34567789999998864 34 3455666667778899999999 6
Q ss_pred CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q 020652 177 PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211 (323)
Q Consensus 177 ~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH 211 (323)
.++.+...... .....+..++...|.-||
T Consensus 105 ~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh 133 (272)
T 4gkh_A 105 KTAFQVLEEYP------DSGENIVDALAVFLRRLH 133 (272)
T ss_dssp EEHHHHHHHCG------GGHHHHHHHHHHHHHHHH
T ss_pred ccccccccCCH------HHHHHHHHHHHHHHHHhc
Confidence 67776544311 112334455555555555
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=3.7e-06 Score=76.90 Aligned_cols=76 Identities=22% Similarity=0.253 Sum_probs=47.1
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccchh--------hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK--------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~--------~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.+.||.|.++.||++....+++.+++|....... ..+....|.++++.+.... ...+..++.+ +....
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~--~~~vP~~~~~--d~~~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV--PHLVPRVFYS--DTEMA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTC--GGGSCCEEEE--ETTTT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhC--CCCcCeEEEE--cCCcc
Confidence 5689999999999997666678899997642211 2234677999999886531 0112333332 23345
Q ss_pred EEEEccCC
Q 020652 169 CIVFEKLG 176 (323)
Q Consensus 169 ~lv~e~~~ 176 (323)
++|||++.
T Consensus 111 ~lvmE~l~ 118 (397)
T 2olc_A 111 VTVMEDLS 118 (397)
T ss_dssp EEEECCCT
T ss_pred EEEEEeCC
Confidence 79999993
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.27 E-value=1.6e-05 Score=70.82 Aligned_cols=76 Identities=12% Similarity=0.215 Sum_probs=43.7
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEc-c--eeccCceEEEEEc
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR-N--WFDYRNHICIVFE 173 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~-~--~~~~~~~~~lv~e 173 (323)
++.|+.|..+.||++... + ..+++|+.... ......|..+++.+....+..+.++... + +....+..+++|+
T Consensus 37 ~~~l~gG~~n~~~~v~~~-~-~~~vlk~~~~~---~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD-S-GAVCLKRIHRP---EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EEECC----CEEEEEEET-T-EEEEEEEECSC---HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeeccccccCcEEEEEeC-C-CCEEEEecCCC---HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 456777778899998653 3 34889988752 2344567788888876554222222211 1 1123567899999
Q ss_pred cC-CC
Q 020652 174 KL-GP 177 (323)
Q Consensus 174 ~~-~~ 177 (323)
++ |.
T Consensus 112 ~i~G~ 116 (346)
T 2q83_A 112 WIEGR 116 (346)
T ss_dssp CCCCB
T ss_pred eecCc
Confidence 99 54
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=2.8e-06 Score=76.47 Aligned_cols=81 Identities=7% Similarity=0.050 Sum_probs=52.2
Q ss_pred EEEeee-cccCcEEEEEEEECC------CCcEEEEEEeccch---h-hHHHHHHHHHHHHHHHhC-CCCCcceEEEccee
Q 020652 95 RILSKM-GEGTFGQVVECFDNE------KKELVAIKIVRSIN---K-YREAAMIEIDVLQRLARH-DIGGTRCVQIRNWF 162 (323)
Q Consensus 95 ~~~~~l-G~G~fg~V~~~~~~~------~~~~vAiK~~~~~~---~-~~~~~~~Ei~~l~~l~~~-~i~~~~~~~~~~~~ 162 (323)
...+.| +.|....+|+..... +++.+++|+..... . ....+.+|+.+++.+... .+..+ +++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP---~v~~~~ 99 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVP---RVRWIE 99 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCC---CEEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCC---cEEEEc
Confidence 345778 889999999886430 25678899765432 0 124567899999999865 44333 334333
Q ss_pred ccC---ceEEEEEccC-CCC
Q 020652 163 DYR---NHICIVFEKL-GPS 178 (323)
Q Consensus 163 ~~~---~~~~lv~e~~-~~~ 178 (323)
... +..++|||++ |.+
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~ 119 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVV 119 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBC
T ss_pred cCCCccCCceEEEEecCCCC
Confidence 333 3568999999 544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.88 E-value=7e-05 Score=65.67 Aligned_cols=69 Identities=10% Similarity=-0.018 Sum_probs=44.8
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC-
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~- 175 (323)
++.|+.|....+|++ +.+++|+............+|..+++.+....+. +.++ .... ..-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~-P~~~---~~~~--~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVS-PEVL---HVDP--ATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSS-CCEE---EECT--TTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCC-CceE---EEEC--CCCEEEEeecC
Confidence 578889999999998 4488898764322112235699999999887764 4433 2222 2346889998
Q ss_pred CC
Q 020652 176 GP 177 (323)
Q Consensus 176 ~~ 177 (323)
+|
T Consensus 91 ~g 92 (301)
T 3dxq_A 91 GA 92 (301)
T ss_dssp TC
T ss_pred CC
Confidence 65
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00019 Score=63.41 Aligned_cols=76 Identities=21% Similarity=0.231 Sum_probs=55.2
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC-
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~- 175 (323)
.+.|+.|.+..+|+... ++..+++|+.... ....+..|...|+.+.... ...+.+.+.+....+..++|||++
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~--~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS--YRSMFRAEADQLALLAKTN--SINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTT--SSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhC--CCCcceEEEEeecCCceEEEEEecc
Confidence 57899999999999864 4667889986532 3566788999999997642 123345555555567899999999
Q ss_pred CCC
Q 020652 176 GPS 178 (323)
Q Consensus 176 ~~~ 178 (323)
+..
T Consensus 115 G~~ 117 (312)
T 3jr1_A 115 KSK 117 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00019 Score=66.03 Aligned_cols=75 Identities=17% Similarity=0.226 Sum_probs=41.5
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEecc-----chh---hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRS-----INK---YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~-----~~~---~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++.||.|..+.||++.. +++.++||.... ... .......|.+++..+.... ...+.+++.+. ....
T Consensus 39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~--~~~vP~v~~~~--~~~~ 112 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLS--PDHVPEVYHFD--RTMA 112 (420)
T ss_dssp EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHS--GGGSCCEEEEE--TTTT
T ss_pred EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhC--CCCCCeEEEEC--CCcc
Confidence 57889999999999953 466799994321 111 0022233444444333211 01223444333 3556
Q ss_pred EEEEccC-CC
Q 020652 169 CIVFEKL-GP 177 (323)
Q Consensus 169 ~lv~e~~-~~ 177 (323)
++|||++ ++
T Consensus 113 ~lv~e~l~~g 122 (420)
T 2pyw_A 113 LIGMRYLEPP 122 (420)
T ss_dssp EEEECCCCTT
T ss_pred EEEEeecCCc
Confidence 8999999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00075 Score=59.43 Aligned_cols=80 Identities=10% Similarity=0.071 Sum_probs=47.3
Q ss_pred EEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEc-c--eeccCceEEEE
Q 020652 95 RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR-N--WFDYRNHICIV 171 (323)
Q Consensus 95 ~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~-~--~~~~~~~~~lv 171 (323)
.-++.|+.|....+|++... ++ .+++|+.... ...+.+..|+.+++.+....+..+.++... + +....+..+++
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 34577888988999998653 33 5889987652 123456679999999987665333322211 1 11223567899
Q ss_pred EccC-CC
Q 020652 172 FEKL-GP 177 (323)
Q Consensus 172 ~e~~-~~ 177 (323)
|+++ |.
T Consensus 102 ~~~l~G~ 108 (322)
T 2ppq_A 102 ISFLEGM 108 (322)
T ss_dssp EECCCCB
T ss_pred EEeCCCc
Confidence 9999 53
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0014 Score=56.89 Aligned_cols=75 Identities=11% Similarity=0.014 Sum_probs=51.4
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhC-CCCCcceEEEcceeccCceEEE
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARH-DIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~-~i~~~~~~~~~~~~~~~~~~~l 170 (323)
...-++.+|.|..+.||+... .+|+.|++|+..... .....+..|...|+.|... .+..+.+ +.+. .-++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v---~~~~----~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQV---AGWD----DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCE---EEEE----TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceE---Eecc----CceE
Confidence 456678999999999999974 567889999865322 2234577899999999654 3333333 3221 2368
Q ss_pred EEccC
Q 020652 171 VFEKL 175 (323)
Q Consensus 171 v~e~~ 175 (323)
|||++
T Consensus 88 v~e~l 92 (288)
T 3f7w_A 88 AMEWV 92 (288)
T ss_dssp EEECC
T ss_pred EEEee
Confidence 99998
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00055 Score=60.71 Aligned_cols=78 Identities=10% Similarity=0.036 Sum_probs=39.5
Q ss_pred eeecccCcEE-EEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC-
Q 020652 98 SKMGEGTFGQ-VVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL- 175 (323)
Q Consensus 98 ~~lG~G~fg~-V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~- 175 (323)
+.|+.|+... +|+... .+++.+++|...... .+....|+.+++.+....+..+.++ .+....+ +++||++
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~---~~d~~~g--~ll~e~l~ 95 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIY---AEEHARG--LLLIEDLG 95 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEE---EEETTTT--EEEECCCC
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCcee---eecCCCC--EEEEeeCC
Confidence 4565555444 566642 225567777654321 1334568888888887655333333 3222233 6899999
Q ss_pred CCCHHHHH
Q 020652 176 GPSLYDFL 183 (323)
Q Consensus 176 ~~~L~~~l 183 (323)
+.++.+++
T Consensus 96 ~~~l~~~l 103 (333)
T 3csv_A 96 DALFTEVI 103 (333)
T ss_dssp SCBHHHHH
T ss_pred CcchHHHh
Confidence 55665544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0014 Score=57.92 Aligned_cols=78 Identities=14% Similarity=0.181 Sum_probs=48.2
Q ss_pred eeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcc--eeccCceEEEEEccC
Q 020652 98 SKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRN--WFDYRNHICIVFEKL 175 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~--~~~~~~~~~lv~e~~ 175 (323)
..|+ |....||++.. .+|+.+++|+........+.+..|..+++.+....+..+.++...+ +....+..+++|+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3556 77788998753 3455689998864323345677799999999876542222221111 112245678899999
Q ss_pred CC
Q 020652 176 GP 177 (323)
Q Consensus 176 ~~ 177 (323)
+|
T Consensus 110 ~G 111 (328)
T 1zyl_A 110 GG 111 (328)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00074 Score=61.21 Aligned_cols=71 Identities=14% Similarity=0.190 Sum_probs=43.3
Q ss_pred EeeecccCcEEEEEEEECC-------CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 97 LSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~-------~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
++.|..|-...+|++.... .++.+++|+.-..........+|..+++.+...++. + +++..+.. .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~-P---~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLG-P---QLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSS-C---CEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCC-C---eEEEEcCC----c
Confidence 3567778888899987642 346789998643222345566899999999887763 3 33444443 2
Q ss_pred EEEccC
Q 020652 170 IVFEKL 175 (323)
Q Consensus 170 lv~e~~ 175 (323)
+||||+
T Consensus 127 ~v~e~i 132 (379)
T 3feg_A 127 RLEQYI 132 (379)
T ss_dssp EEEECC
T ss_pred cEEEEe
Confidence 899998
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0047 Score=56.93 Aligned_cols=71 Identities=14% Similarity=0.193 Sum_probs=48.3
Q ss_pred EEeeecccCcEEEEEEEECC-------CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 96 ILSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 96 ~~~~lG~G~fg~V~~~~~~~-------~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
-++.|+.|....||++.... .++.+++|+.... ...+.+..|..+++.+...++. +. +++.+..
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~-P~---l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLG-PK---LYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSS-SC---EEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCC-Cc---EEEEeCC----
Confidence 35678889999999997643 2577999987431 1114556799999999887763 33 3333332
Q ss_pred EEEEccC
Q 020652 169 CIVFEKL 175 (323)
Q Consensus 169 ~lv~e~~ 175 (323)
.+||||+
T Consensus 148 g~v~e~l 154 (429)
T 1nw1_A 148 GRLEEYI 154 (429)
T ss_dssp EEEECCC
T ss_pred CEEEEEe
Confidence 2889998
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0018 Score=58.26 Aligned_cols=71 Identities=18% Similarity=0.150 Sum_probs=42.5
Q ss_pred EeeecccCcEEEEEEEECC--------CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 97 LSKMGEGTFGQVVECFDNE--------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~--------~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++.|+.|....+|++.... .++.+++|+.............|..+++.+...++ .+.++ ..+. -
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~-~P~~~---~~~~----~ 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKI-APQLL---NTFN----G 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTS-SCCEE---EEET----T
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCC-CCceE---EecC----C
Confidence 4678888888999987543 13678899875432221224578999999987765 33332 2221 2
Q ss_pred EEEEccC
Q 020652 169 CIVFEKL 175 (323)
Q Consensus 169 ~lv~e~~ 175 (323)
++||||+
T Consensus 110 ~~v~e~i 116 (369)
T 3c5i_A 110 GRIEEWL 116 (369)
T ss_dssp EEEEECC
T ss_pred cEEEEEe
Confidence 6899998
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.00 E-value=0.005 Score=57.20 Aligned_cols=72 Identities=14% Similarity=0.075 Sum_probs=45.4
Q ss_pred EEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC
Q 020652 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL 175 (323)
Q Consensus 96 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 175 (323)
-++.|+.|-...+|++.....+..+++|+........-...+|..+++.+...++. .+++..+.. .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~----P~ll~~~~~----G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIA----KKIYVFFTN----GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSB----CCEEEEETT----EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCC----CCEEEEeCC----eEEEEee
Confidence 35678889999999998654457788998743211111125799999999877652 334444432 2599998
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.014 Score=51.93 Aligned_cols=72 Identities=15% Similarity=0.150 Sum_probs=43.7
Q ss_pred cccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCC-CcceEEEc-c--eeccCceEEEEEccC-
Q 020652 101 GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG-GTRCVQIR-N--WFDYRNHICIVFEKL- 175 (323)
Q Consensus 101 G~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~-~~~~~~~~-~--~~~~~~~~~lv~e~~- 175 (323)
|.|....||++.. .++ .+++|+..... ...|+.+++.|....+. .+..+... + +....+..+++|+|+
T Consensus 32 G~g~~N~vy~v~~-~~g-~~vLK~~~~~~-----~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~ 104 (339)
T 3i1a_A 32 GADTNAFAYQADS-ESK-SYFIKLKYGYH-----DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH 104 (339)
T ss_dssp TSCSSCEEEEEEC-SSC-EEEEEEEECSS-----CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred cCccccceEEEEe-CCC-CEEEEEecCcc-----chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence 4444688999864 344 78999876433 14578888888776553 22222211 1 123356789999999
Q ss_pred CCCH
Q 020652 176 GPSL 179 (323)
Q Consensus 176 ~~~L 179 (323)
|..+
T Consensus 105 G~~~ 108 (339)
T 3i1a_A 105 APNG 108 (339)
T ss_dssp CCBT
T ss_pred CCcC
Confidence 5443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.97 E-value=0.036 Score=45.76 Aligned_cols=97 Identities=13% Similarity=0.003 Sum_probs=60.9
Q ss_pred CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCceeccCcccccccCCCCCccccCCC
Q 020652 178 SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256 (323)
Q Consensus 178 ~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~ 256 (323)
+|.++|+..+ .+++++++|.++.|.+.+|.-+-. +.-..+=+-|..|++..+|.|...+
T Consensus 34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~------------------- 93 (229)
T 2yle_A 34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP------------------- 93 (229)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-------------------
T ss_pred cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-------------------
Confidence 8999998765 589999999999999999877622 1111222346888887777553321
Q ss_pred CCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc
Q 020652 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313 (323)
Q Consensus 257 ~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t 313 (323)
+.+. .....+.+||... ...+.+.=|||||+++|.-+-
T Consensus 94 ---------~~s~---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 94 ---------AADD---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ---------C---------------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---------cccc---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 0000 1122466888763 345678889999999998774
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.93 E-value=0.035 Score=50.94 Aligned_cols=74 Identities=15% Similarity=0.094 Sum_probs=47.2
Q ss_pred EeeecccCcEEEEEEEECCC-------CcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 97 LSKMGEGTFGQVVECFDNEK-------KELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~-------~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
++.|..|-...+|++..... ++.+++|+........-...+|..+++.+...++. +.+ ++.+. -+
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~-P~l---~~~~~----~~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIA-PNI---IADFP----EG 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSS-CCE---EEEET----TE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCC-CCE---EEEcC----CC
Confidence 46777788889999876521 57789998653222222235799999999877762 333 23222 26
Q ss_pred EEEccC-CCC
Q 020652 170 IVFEKL-GPS 178 (323)
Q Consensus 170 lv~e~~-~~~ 178 (323)
+||||+ |.+
T Consensus 147 ~I~efI~G~~ 156 (424)
T 3mes_A 147 RIEEFIDGEP 156 (424)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEeCCcc
Confidence 889999 533
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.68 E-value=0.18 Score=45.69 Aligned_cols=30 Identities=13% Similarity=0.248 Sum_probs=20.6
Q ss_pred EeeecccCcEEEEEEEECCC-------CcEEEEEEec
Q 020652 97 LSKMGEGTFGQVVECFDNEK-------KELVAIKIVR 126 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~-------~~~vAiK~~~ 126 (323)
++.|+-|-.-.+|++..... .+.|++++.-
T Consensus 57 v~~lsGG~SN~~y~v~~~~~~~~~~~~~~~~llRi~g 93 (401)
T 3g15_A 57 ISVIRGGLSNMLFQCSLPDTTATLGDEPRKVLLRLYG 93 (401)
T ss_dssp EEEEECSSEEEEEEEECCTTCCCSSSCCSEEEEEEEE
T ss_pred EEEeCCccccceEEEEECCCCcccccCCCeEEEEeCC
Confidence 46777788888999975432 3568888753
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=93.39 E-value=0.037 Score=52.80 Aligned_cols=26 Identities=12% Similarity=-0.139 Sum_probs=15.8
Q ss_pred CCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 295 WNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 295 ~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
....+++||.|++..|+++|+.++..
T Consensus 394 ~~~~t~vGTp~YmAPE~l~g~~~~~~ 419 (569)
T 4azs_A 394 SWPTNLVQSFFVFVNELFAENKSWNG 419 (569)
T ss_dssp CCSHHHHHHHHHHHHHHC--------
T ss_pred ccccCceechhhccHHHhCCCCCCcc
Confidence 34678999999999999999877654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 323 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-39 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-39 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-38 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-38 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-36 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-35 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-35 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-35 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-35 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-35 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-34 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-33 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-33 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-33 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-33 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-32 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-30 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-30 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-29 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-29 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-29 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-28 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-28 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-27 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-27 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-26 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-26 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-26 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 7e-26 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-25 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-25 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-25 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-24 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-24 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-24 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-24 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-24 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-23 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-23 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-22 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-22 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-21 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-20 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-14 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-39
Identities = 51/226 (22%), Positives = 89/226 (39%), Gaps = 39/226 (17%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDI 150
+ +S++G G G V + ++A K++ R + E+ VL
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSP- 64
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
V F I I E + G SL L+K P ++ ++ +++ + +
Sbjct: 65 ---YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTY 119
Query: 210 MHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+ E +++H D+KP NIL+ + G IKL DFG +
Sbjct: 120 LREKHKIMHRDVKPSNILV-----------------NSRGE----------IKLCDFGVS 152
Query: 269 TFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ V TR Y +PE + G ++ D+WS+G LVE+
Sbjct: 153 GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 198
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 139 bits (352), Expect = 2e-39
Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 35/225 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIG 151
Y IL ++G G FG V C + + K + + + EI ++ +L H
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHP-- 86
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
+ + + + F+ + + ++ E L G L+D + Y+ V RQ E + M
Sbjct: 87 --KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHM 143
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
HE ++H D+KPENI+ K+S++K+IDFG T
Sbjct: 144 HEHSIVHLDIKPENIMC-------------------------ETKKASSVKIIDFGLATK 178
Query: 271 EHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ D +T + APE++ + D+W++G + L S
Sbjct: 179 LNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 223
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 3e-39
Identities = 54/228 (23%), Positives = 103/228 (45%), Gaps = 40/228 (17%)
Query: 93 RYRILSKM-GEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG 151
Y++ S++ G G G+V++ F+ +E A+K+++ K R E+++ R ++
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQCP-- 65
Query: 152 GTRCVQIRNWFDY----RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
V+I + ++ R + IV E L G L+ ++ ++F E+ + + E+
Sbjct: 66 --HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++H + + H D+KPEN+L S + +KL DFG
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAI------------------------LKLTDFG 159
Query: 267 STTF--EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
H + T +Y APEV+ ++ CD+WS+G I+ L
Sbjct: 160 FAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 207
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 139 bits (351), Expect = 4e-39
Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 35/225 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIG 151
Y I ++G G FG V + A K V + + +E EI + L RH
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHP-- 83
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V + + F+ N + +++E + G L++ + + D E RQ+ + + M
Sbjct: 84 --TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHM 140
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
HE +H DLKPENI+ + +S+ +KLIDFG T
Sbjct: 141 HENNYVHLDLKPENIMFTT-------------------------KRSNELKLIDFGLTAH 175
Query: 271 --EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
Q T + APEV G Y D+WSVG + L S
Sbjct: 176 LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 220
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 6e-39
Identities = 58/243 (23%), Positives = 107/243 (44%), Gaps = 45/243 (18%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLAR 147
N + I+ ++G+G FG+V + + E L A K++ + + + E M+EID+L
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+I V++ + F Y N++ I+ E D + R ++ + +Q L+++
Sbjct: 69 PNI-----VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDAL 123
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++H+ ++IH DLK NIL + DG IKL DFG
Sbjct: 124 NYLHDNKIIHRDLKAGNILF-----------------TLDGD----------IKLADFGV 156
Query: 268 TTFEHQDHSY---VVSTRHYRAPEVILGL-----GWNYPCDLWSVGCILVELCSVSNCYL 319
+ + + T ++ APEV++ ++Y D+WS+G L+E+
Sbjct: 157 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA----EIE 212
Query: 320 TPF 322
P
Sbjct: 213 PPH 215
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 6e-39
Identities = 49/227 (21%), Positives = 89/227 (39%), Gaps = 40/227 (17%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARH 148
+ I +G+G FG V + + K ++A+K++ E+++ L
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+I +++ +F + ++ E ++Y L+K F +L ++
Sbjct: 67 NI-----LRLYGYFHDATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANAL 119
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
++ H R+IH D+KPEN+LL SA + K+ DFG
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGEL---------------------------KIADFGW 152
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
S + + T Y PE+I G + DLWS+G + E
Sbjct: 153 SVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 199
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 135 bits (341), Expect = 2e-38
Identities = 59/240 (24%), Positives = 99/240 (41%), Gaps = 52/240 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----------SINKYREAAMIEIDVL 142
Y +G G V C + A+KI+ + + REA + E+D+L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGR 201
++++ H +Q+++ ++ +VF+ + L+D+L + + R++ R
Sbjct: 64 RKVSGHP----NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMR 117
Query: 202 QLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIK 261
LLE + +H+L ++H DLKPENILL D + IK
Sbjct: 118 ALLEVICALHKLNIVHRDLKPENILL-----------------DDDMN----------IK 150
Query: 262 LIDFGSTTFEHQDHSY--VVSTRHYRAPEVILG------LGWNYPCDLWSVGCILVELCS 313
L DFG + V T Y APE+I G+ D+WS G I+ L +
Sbjct: 151 LTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA 210
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 7e-38
Identities = 45/229 (19%), Positives = 90/229 (39%), Gaps = 34/229 (14%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR 147
+ L +Y I +G G FG V C + K+ K V+ + EI +L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+I + + F+ + ++FE + G +++ + +++ + Q+ E+
Sbjct: 61 RNI-----LHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEA 114
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ F+H + H D++PENI+ + + K+I+FG
Sbjct: 115 LQFLHSHNIGHFDIRPENIIYQTRRSSTI-------------------------KIIEFG 149
Query: 267 STTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
++ + + Y APEV + D+WS+G ++ L S
Sbjct: 150 QARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (329), Expect = 2e-36
Identities = 60/233 (25%), Positives = 100/233 (42%), Gaps = 41/233 (17%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQ 143
++ + L ++G G+FG V D E+VAIK + N+ + + E+ LQ
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
+L RH +Q R + + +V E S D L + + + +
Sbjct: 71 KL-RHP----NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGA 124
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
L+ +A++H +IH D+K NILL S+ G +KL
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILL-----------------SEPGL----------VKLG 157
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGLG---WNYPCDLWSVGCILVELCS 313
DFGS + +S+ V T ++ APEVIL + ++ D+WS+G +EL
Sbjct: 158 DFGSASIMAPANSF-VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 130 bits (328), Expect = 3e-36
Identities = 56/232 (24%), Positives = 100/232 (43%), Gaps = 36/232 (15%)
Query: 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQR 144
E++ Y +G G F +V+ D ++LVAIK + ++ + EI VL +
Sbjct: 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHK 63
Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQL 203
+ +H V + + ++ H+ ++ + + G L+D + + + + L Q+
Sbjct: 64 I-KHP----NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF--YTERDASRLIFQV 116
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
L++V ++H+L ++H DLKPEN+L S L + S I +
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYS------------------------LDEDSKIMIS 152
Query: 264 DFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
DFG + E T Y APEV+ ++ D WS+G I L
Sbjct: 153 DFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 204
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-36
Identities = 51/223 (22%), Positives = 97/223 (43%), Gaps = 34/223 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIG 151
+Y K+G+G G V D + VAI+ + +E + EI V++ ++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNP-- 77
Query: 152 GTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
V + + + + +V E L G SL D + + + + R+ L+++ F+
Sbjct: 78 --NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFL 132
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
H ++IH D+K +NILL VK+ D+ F ++ + + S
Sbjct: 133 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-------------------- 172
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
S +V T ++ APEV+ + D+WS+G + +E+
Sbjct: 173 ----RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 1e-35
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 27/228 (11%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLA 146
++ PRY LS +GEG +G V +DN K VAIK + Y + + EI +L R
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+I G + + + +V +G LY L+ + D + Q+L
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRG 121
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++H ++H DLKP N+LL + +K+ D+ + D +
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH---------------- 165
Query: 267 STTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCS 313
+ V+TR YRAPE++L G+ D+WSVGCIL E+ S
Sbjct: 166 -----TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS 208
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 2e-35
Identities = 48/225 (21%), Positives = 90/225 (40%), Gaps = 33/225 (14%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLARHDI 150
+ ++ +GEG +G+V + +E VA+KIV E EI + + L H+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE- 63
Query: 151 GGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
V+ N + E G L+D + + P + QL+ V +
Sbjct: 64 ---NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVY 118
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
+H + + H D+KPEN+LL + +K+ D+ + +
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN--------------------- 157
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWN-YPCDLWSVGCILVELCS 313
+ + + T Y APE++ ++ P D+WS G +L + +
Sbjct: 158 -RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 201
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 127 bits (320), Expect = 3e-35
Identities = 49/236 (20%), Positives = 86/236 (36%), Gaps = 38/236 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
Y++ ++GEG+FG + E + + VAIK E + LA
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTG-- 62
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
+ + H +V + LGPSL D L R F + V +Q+L V +HE
Sbjct: 63 --IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE 119
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG------ 266
L++ D+KP+N L+ ++ I ++DFG
Sbjct: 120 KSLVYRDIKPDNFLIGRPNS----------------------KNANMIYVVDFGMVKFYR 157
Query: 267 ----STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318
+++ + T Y + LG + DL ++G + + S +
Sbjct: 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 213
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 127 bits (320), Expect = 3e-35
Identities = 52/226 (23%), Positives = 88/226 (38%), Gaps = 20/226 (8%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
RYR+ K+G G+FG + D E VAIK+ + IE + + +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVG-- 64
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
IR ++ +V E LGPSL D S R F + V L Q++ + ++H
Sbjct: 65 --IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS 121
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
IH D+KP+N L+ + + D K + +
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYI-------IDFGLAKKYRDAR-------THQHIPY 167
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318
+++ + T Y + LG+ + DL S+G +L+ S +
Sbjct: 168 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 213
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 6e-35
Identities = 62/228 (27%), Positives = 101/228 (44%), Gaps = 32/228 (14%)
Query: 93 RYRILSKMGEGTFGQVVECFDNE-KKELVAIKIVRSIN---KYREAAMIEIDVLQRLARH 148
+Y ++++GEG +G+V + D + VA+K VR + + E+ VL+ L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 149 D---IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+ + V + D + +VFE + L +L K P + ++++ QLL
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ F+H R++H DLKP+NIL+ S+ +K+ D
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD-------------------------FGL 162
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ VV T YRAPEV+L + P DLWSVGCI E+
Sbjct: 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 210
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-34
Identities = 50/241 (20%), Positives = 102/241 (42%), Gaps = 46/241 (19%)
Query: 85 AIGENLTPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEID 140
A+G + R+ + ++G G+F V + D E VA ++ R+ E +
Sbjct: 1 AVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAE 60
Query: 141 VLQRLARHDIGGTRCVQIRNWF----DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDL 195
+L+ L +H V+ + + + I +V E + +L +L++ + I +
Sbjct: 61 MLKGL-QHP----NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKV 113
Query: 196 VRELGRQLLESVAFMHEL--RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
+R RQ+L+ + F+H +IH DLK +NI + + GS
Sbjct: 114 LRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI----------------TGPTGS---- 153
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSY-VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELC 312
+K+ D G T + + V+ T + APE+ ++ D+++ G ++E+
Sbjct: 154 ------VKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMA 206
Query: 313 S 313
+
Sbjct: 207 T 207
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-33
Identities = 51/236 (21%), Positives = 95/236 (40%), Gaps = 48/236 (20%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHDI 150
Y +L +G G++G+ + +++ K + ++ + E+++L+ L +I
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65
Query: 151 GGTRCVQIRNWFDYR--NHICIVFEKL-GPSLYDFLRKNS--YRSFPIDLVRELGRQLLE 205
V+ + R + IV E G L + K + + + V + QL
Sbjct: 66 -----VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 206 SVAFMHEL-----RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAI 260
++ H ++H DLKP N+ L + +
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFL-----------------DGKQN----------V 153
Query: 261 KLIDFGSTTFEHQDHSY---VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
KL DFG + D S+ V T +Y +PE + + +N D+WS+GC+L ELC+
Sbjct: 154 KLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 209
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 6e-33
Identities = 60/225 (26%), Positives = 107/225 (47%), Gaps = 33/225 (14%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
++ + K+GEGT+G V + + E+VA+K +R A+ EI +L+ L +
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V++ + N + +VFE L L F+ ++ P+ L++ QLL+ +AF
Sbjct: 63 I-----VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
H R++H DLKP+N+L+ + +K+ D+
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT------------------- 158
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCS 313
+++ V T YRAPE++LG ++ D+WS+GCI E+ +
Sbjct: 159 -----YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 198
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 7e-33
Identities = 47/223 (21%), Positives = 89/223 (39%), Gaps = 37/223 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
++L +G+G FG V+ + VA+K +++ + +A + E V+ +L ++
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNL-- 62
Query: 153 TRCVQIRNWF-DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFM 210
VQ+ + + + IV E + SL D+LR D + + + E++ ++
Sbjct: 63 ---VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 211 HELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTF 270
+H DL N+L+ S+D K+ DFG T
Sbjct: 120 EGNNFVHRDLAARNVLV-----------------SEDNV----------AKVSDFGLTKE 152
Query: 271 EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ APE + ++ D+WS G +L E+ S
Sbjct: 153 ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 195
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 9e-33
Identities = 49/230 (21%), Positives = 86/230 (37%), Gaps = 38/230 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRL 145
+Y++ +G G FG V VAIK V +E+ +L+++
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
+ G +++ +WF+ + ++ E+ P F + +L R Q+LE
Sbjct: 65 SSGFSG---VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+V H ++H D+K ENIL+ +KLIDF
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDL--------------------------NRGELKLIDF 155
Query: 266 G-STTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCS 313
G + ++ TR Y PE I +WS+G +L ++
Sbjct: 156 GSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-32
Identities = 54/236 (22%), Positives = 95/236 (40%), Gaps = 40/236 (16%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEID 140
EN+ Y ++G G F V +C + A K ++ RE E+
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 141 VLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
+L+ + +H + + ++ + + ++ E + G L+DFL + S + E
Sbjct: 66 ILKEI-QHP----NVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 118
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
+Q+L V ++H L++ H DLKPENI+L+
Sbjct: 119 LKQILNGVYYLHSLQIAHFDLKPENIMLLD-----------------------RNVPKPR 155
Query: 260 IKLIDFGSTTFEHQDHSY--VVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
IK+IDFG + + + T + APE++ D+WS+G I L S
Sbjct: 156 IKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 2e-32
Identities = 50/226 (22%), Positives = 86/226 (38%), Gaps = 34/226 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
++ +GEG+F VV + AIKI+ E DV+ RL H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DH 67
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
V++ F + L ++RK SF R +++ ++
Sbjct: 68 P----FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSAL 121
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++H +IH DLKPENILL ++++ D+ S +
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES------------------- 162
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ + V T Y +PE++ DLW++GCI+ +L +
Sbjct: 163 ---KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 205
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-32
Identities = 50/229 (21%), Positives = 87/229 (37%), Gaps = 41/229 (17%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
+ + +G+G+FG+V + + AIK ++ ++ E M+E VL H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ F + ++ V E L G L ++ F + +++ +
Sbjct: 63 PF----LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGL 116
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
F+H +++ DLK +NIL KDG K+ DFG
Sbjct: 117 QFLHSKGIVYRDLKLDNIL-----------------LDKDGHI----------KIADFGM 149
Query: 268 TTF---EHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ T Y APE++LG +N+ D WS G +L E+
Sbjct: 150 CKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 198
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 5e-32
Identities = 54/228 (23%), Positives = 101/228 (44%), Gaps = 28/228 (12%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y L+K+G+GTFG+V + + + VA+K V N + A+ EI +LQ L +
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 150 IG---GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
+ + + + I +VF+ L L N F + ++ + + LL
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-LLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++H +++H D+K N+L+ +K+ D+ +
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGL-------------------ARAFSLA 170
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCS 313
+ ++ + VV T YR PE++LG + P DLW GCI+ E+ +
Sbjct: 171 KNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (292), Expect = 1e-30
Identities = 71/240 (29%), Positives = 110/240 (45%), Gaps = 33/240 (13%)
Query: 86 IGENLTP-RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQR 144
GE RY ++ K+G G F V D VA+KIVR Y EAA EI +LQR
Sbjct: 6 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQR 65
Query: 145 LARHDIGGTRCVQIRN----------WFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPID 194
+ D + + H+ +VFE LG +L ++K +R P+
Sbjct: 66 VNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLI 125
Query: 195 LVRELGRQLLESVAFMHELR-LIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
V+++ +QLL + +MH +IHTD+KPEN+L+ +
Sbjct: 126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP-------------------- 165
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
IK+ D G+ + + ++ + TR YR+PEV+LG W D+WS C++ EL +
Sbjct: 166 -ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 5e-30
Identities = 53/222 (23%), Positives = 98/222 (44%), Gaps = 31/222 (13%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+++ ++G G FG+V + N + VA+K ++ + +A + E +++++L +H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQL-QHQ--- 68
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
R V++ + I I+ E + SL DFL+ S I+ + ++ Q+ E +AF+
Sbjct: 69 -RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
E IH DL+ NIL+ K+ D+ L+R +D Y
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFG-LARLIEDNEYTA------------------- 166
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ APE I + D+WS G +L E+ +
Sbjct: 167 ---REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 113 bits (284), Expect = 2e-29
Identities = 47/228 (20%), Positives = 92/228 (40%), Gaps = 38/228 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
+ + +G G FG+V C + ++ A+K + + + A+ E +L ++
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
D V + F + + + + + G L+ L ++ F +R +++ +
Sbjct: 65 DC--PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGL 120
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG- 266
MH +++ DLKP NILL +V ++ D G
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHV---------------------------RISDLGL 153
Query: 267 STTFEHQDHSYVVSTRHYRAPEVIL-GLGWNYPCDLWSVGCILVELCS 313
+ F + V T Y APEV+ G+ ++ D +S+GC+L +L
Sbjct: 154 ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 201
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (281), Expect = 2e-29
Identities = 51/224 (22%), Positives = 90/224 (40%), Gaps = 37/224 (16%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
++IL +G G+FG+V A+K+++ K E E +L +
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I +++ F I ++ + + L + S R FP + + ++ ++ +
Sbjct: 66 I-----IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEY 119
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
+H +I+ DLKPENILL K+G IK+ DFG
Sbjct: 120 LHSKDIIYRDLKPENILL-----------------DKNGH----------IKITDFGFAK 152
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ + T Y APEV+ +N D WS G ++ E+ +
Sbjct: 153 YVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 196
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 110 bits (276), Expect = 4e-29
Identities = 48/234 (20%), Positives = 86/234 (36%), Gaps = 37/234 (15%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQR 144
+L+ RY + +G G +V D VA+K++R + E
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 145 LARHDIGGTRCVQIRNWFDYRNH----ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVREL 199
L I V + + + IV E + G +L D + E+
Sbjct: 64 LNHPAI-----VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEV 116
Query: 200 GRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSA 259
+++ F H+ +IH D+KP NI++ + VKV D+ + G+
Sbjct: 117 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS--------- 167
Query: 260 IKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ V+ T Y +PE G + D++S+GC+L E+ +
Sbjct: 168 ------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 209
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 5e-29
Identities = 61/255 (23%), Positives = 107/255 (41%), Gaps = 49/255 (19%)
Query: 65 IPRTGSPPWRPDDKDGHYVFAIGENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKI 124
+ G P RP + Y +G G+FG V + + ELVAIK
Sbjct: 7 VATPGQGPDRPQEVS--------------YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK 52
Query: 125 VRSINKYREAAMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFL 183
V +++ E+ ++++L +I R ++ +V + + ++Y
Sbjct: 53 VLQDKRFKNR---ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVA 109
Query: 184 RK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241
R + ++ P+ V+ QL S+A++H + H D+KP+N+LL
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD------------- 156
Query: 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTF--EHQDHSYVVSTRHYRAPEVILG-LGWNYP 298
P ++ +KL DFGS + + + +R+YRAPE+I G +
Sbjct: 157 -------------PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSS 203
Query: 299 CDLWSVGCILVELCS 313
D+WS GC+L EL
Sbjct: 204 IDVWSAGCVLAELLL 218
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 6e-29
Identities = 60/228 (26%), Positives = 107/228 (46%), Gaps = 43/228 (18%)
Query: 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHD 149
L +GEG F V + D ++VAIK ++ ++ A+ EI +LQ L+ +
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I + + + F ++++I +VF+ + L ++ NS P ++ L+ + +
Sbjct: 62 I-----IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTP-SHIKAYMLMTLQGLEY 115
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
+H+ ++H DLKP N+LL ++G +KL DFG
Sbjct: 116 LHQHWILHRDLKPNNLLL-----------------DENGV----------LKLADFGLAK 148
Query: 270 F---EHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCS 313
++ +++ V TR YRAPE++ G + D+W+VGCIL EL
Sbjct: 149 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL 196
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-28
Identities = 50/221 (22%), Positives = 86/221 (38%), Gaps = 29/221 (13%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
R+ K+G+G FG+V N VAIK ++ EA + E V+++L +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-- 74
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
VQ+ + SL DFL+ + + + + ++ Q+ +A++
Sbjct: 75 ---VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
+ +H DL+ NIL+ KV D+ L+R +D Y
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFG-LARLIEDNEYTA-------------------- 170
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ APE L + D+WS G +L EL +
Sbjct: 171 --RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 209
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-28
Identities = 57/244 (23%), Positives = 98/244 (40%), Gaps = 38/244 (15%)
Query: 78 KDGHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KY 131
+ G Y + + + YR L +G G +G V D VAIK + +
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 132 REAAMIEIDVLQRLARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRS 190
+ A E+ +L+ + ++ G D +V +G L ++
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH---EK 117
Query: 191 FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250
D ++ L Q+L+ + ++H +IH DLKP N+
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLA------------------------ 153
Query: 251 FKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILV 309
+ + +K++DFG + + V TR YRAPEVIL + + D+WSVGCI+
Sbjct: 154 ---VNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 210
Query: 310 ELCS 313
E+ +
Sbjct: 211 EMIT 214
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 3e-28
Identities = 51/228 (22%), Positives = 89/228 (39%), Gaps = 42/228 (18%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARHD 149
+ L +G+GTFG+V+ + A+KI+R + E VLQ
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEK-LGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ ++ F + +C V E G L+ L + R F + R G +++ ++
Sbjct: 67 L-----TALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALE 119
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++H +++ D+K EN++L KDG IK+ DFG
Sbjct: 120 YLHSRDVVYRDIKLENLML-----------------DKDGH----------IKITDFGLC 152
Query: 269 TFEHQDHS---YVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
D + T Y APEV+ + D W +G ++ E+
Sbjct: 153 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 110 bits (275), Expect = 3e-28
Identities = 50/225 (22%), Positives = 90/225 (40%), Gaps = 37/225 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR----SINKYREAAMIEIDVLQRLARH 148
++ + +G G+FG+V+ E A+KI+ K E + E +LQ +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
+ ++ D N ++ G ++ LR+ F R Q++ +
Sbjct: 102 FL----VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFE 155
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++H L LI+ DLKPEN+L+ + G I++ DFG
Sbjct: 156 YLHSLDLIYRDLKPENLLI-----------------DQQGY----------IQVTDFGFA 188
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ T APE+IL G+N D W++G ++ E+ +
Sbjct: 189 KRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 109 bits (272), Expect = 4e-28
Identities = 44/227 (19%), Positives = 99/227 (43%), Gaps = 43/227 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
Y+++ K+G G + +V E + E V +KI++ + K + EI +L+ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK--IKREIKILENLRGGP--- 90
Query: 153 TRCVQIRNWF--DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
+ + + +VFE + + +R ++L+++ +
Sbjct: 91 -NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDY 144
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
H + ++H D+KP N+++ + ++LID+G
Sbjct: 145 CHSMGIMHRDVKPHNVMIDH--------------------------EHRKLRLIDWGLAE 178
Query: 270 FEH--QDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCS 313
F H Q+++ V++R+++ PE+++ ++Y D+WS+GC+L +
Sbjct: 179 FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 6e-28
Identities = 49/233 (21%), Positives = 94/233 (40%), Gaps = 49/233 (21%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVR---SINKYREAAMIEIDVLQRLARHD 149
+ + ++G G+FG V + + VA+K++ + +A E+ VL++ +
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I + + + IV + G SLY L + F + + ++ RQ + +
Sbjct: 66 I-----LLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMD 118
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
++H +IH DLK NI L +D + +K+ DFG
Sbjct: 119 YLHAKSIIHRDLKSNNIFL-----------------HEDLT----------VKIGDFGLA 151
Query: 269 TFEHQDHSY-----VVSTRHYRAPEVILGLGWN---YPCDLWSVGCILVELCS 313
T + + + + + APEVI N + D+++ G +L EL +
Sbjct: 152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT 204
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 4e-27
Identities = 44/250 (17%), Positives = 84/250 (33%), Gaps = 55/250 (22%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKEL-----VAIKIVR--SINKYREAAMIEIDVLQRL 145
+G G FG+V+ + VA+K+++ + + REA M E+ ++ +L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYR--------------- 189
H+ V + I ++FE L ++LR +
Sbjct: 98 GSHE----NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 190 ------SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243
+ + Q+ + + F+ +H DL N+L+ + VK+ D+
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWS 303
D +Y + APE + + D+WS
Sbjct: 214 IMSDSNYVV----------------------RGNARLPVKWMAPESLFEGIYTIKSDVWS 251
Query: 304 VGCILVELCS 313
G +L E+ S
Sbjct: 252 YGILLWEIFS 261
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 6e-27
Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 34/225 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y L K+GEGT+G V + + E E+VA+K VR + +A+ EI +L+ L +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V++ + + +VFE + ++V+ QLL+ + F
Sbjct: 63 I-----VRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
H ++H DLKP+N+L+ +K+ ++
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--------------------- 155
Query: 270 FEHQDHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCS 313
+ +S V T YR P+V+ G + D+WS GCI EL +
Sbjct: 156 ---RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 7e-27
Identities = 53/245 (21%), Positives = 84/245 (34%), Gaps = 50/245 (20%)
Query: 93 RYRILSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
R +G G FG+VVE ++ VA+K+++ + REA M E+ VL L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRK----------------NSY 188
H V + ++ E L +FLR+ +
Sbjct: 84 GNHM----NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
+ ++ + Q+ + +AF+ IH DL NILL K+ D+ D
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
+Y + APE I + + D+WS G L
Sbjct: 200 NYVV----------------------KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237
Query: 309 VELCS 313
EL S
Sbjct: 238 WELFS 242
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 104 bits (261), Expect = 9e-27
Identities = 45/231 (19%), Positives = 88/231 (38%), Gaps = 29/231 (12%)
Query: 88 ENLTPRYRILSKMGEGTFGQVVECFD---NEKKELVAIKIVRS--INKYREAAMIEIDVL 142
E +I +G G FG+V +++ VAIK ++S K R + E ++
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81
Query: 143 QRLARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQ 202
+ ++ + + + I+ E + D + + F + + + R
Sbjct: 82 GQFDHPNV-----IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRG 136
Query: 203 LLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKL 262
+ + ++ ++ +H DL NIL+ S KV D+ LSR +D + + K+
Sbjct: 137 IAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFG-LSRFLEDDTSDPTYTSALGGKI 195
Query: 263 IDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ APE I + D+WS G ++ E+ S
Sbjct: 196 ------------------PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 228
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 104 bits (260), Expect = 1e-26
Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 41/228 (17%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
+Y L K+GEGT+G V + +N + A+K +R + EI +L+ L +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 150 IGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAF 209
I V++ + + + +VFE L L L + QLL +A+
Sbjct: 62 I-----VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAY 115
Query: 210 MHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTT 269
H+ R++H DLKP+N+L+ +++G +K+ DFG
Sbjct: 116 CHDRRVLHRDLKPQNLLI-----------------NREGE----------LKIADFGLAR 148
Query: 270 FEHQD---HSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCS 313
+++ + T YRAP+V++G ++ D+WSVGCI E+ +
Sbjct: 149 AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 1e-26
Identities = 55/225 (24%), Positives = 92/225 (40%), Gaps = 33/225 (14%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHD 149
RY+ L +G G G V +D VAIK + + + A E+ +++ + +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 150 IGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVA 208
I + + + +V E + +L ++ + + L Q+L +
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME----LDHERMSYLLYQMLCGIK 133
Query: 209 FMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGST 268
+H +IH DLKP NI++ S +K+ D T
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILD-------------------------FGLART 168
Query: 269 TFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ V TR+YRAPEVILG+G+ D+WSVGCI+ E+
Sbjct: 169 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVR 213
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 104 bits (259), Expect = 2e-26
Identities = 42/226 (18%), Positives = 88/226 (38%), Gaps = 37/226 (16%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+ K+G G +G+V E + VA+K ++ E + E V++ + +H
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP--- 73
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
VQ+ I+ E + +L D+LR+ + + ++ + Q+ ++ ++
Sbjct: 74 -NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
+ IH DL N L+ ++ +K+ DFG +
Sbjct: 133 KKNFIHRDLAARNCLV-----------------GENHL----------VKVADFGLSRLM 165
Query: 272 HQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
D H+ + APE + ++ D+W+ G +L E+ +
Sbjct: 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-26
Identities = 46/221 (20%), Positives = 85/221 (38%), Gaps = 29/221 (13%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+ ++G G FG V + K+ VAIK +R E + E +V+ +L H
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHP--- 60
Query: 153 TRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE 212
+ VQ+ + IC+VFE + + F + + + + E +A++ E
Sbjct: 61 -KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 213 LRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEH 272
+IH DL N L+ + +KV D+ D ++
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD-----------------------QY 156
Query: 273 QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ + +PEV ++ D+WS G ++ E+ S
Sbjct: 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 197
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 7e-26
Identities = 56/230 (24%), Positives = 100/230 (43%), Gaps = 35/230 (15%)
Query: 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRL 145
+ RY+ LS +G G +G V FD + VA+K + + + E+ +L+ +
Sbjct: 15 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 146 ARHDIGGTR-CVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLL 204
++ G + N + +V +G L + ++ + D V+ L Q+L
Sbjct: 75 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQIL 131
Query: 205 ESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLID 264
+ ++H +IH DLKP N+ + + +K++D
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLA---------------------------VNEDCELKILD 164
Query: 265 FGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCS 313
FG + + V+TR YRAPE++L +N D+WSVGCI+ EL +
Sbjct: 165 FGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.8 bits (248), Expect = 5e-25
Identities = 47/226 (20%), Positives = 83/226 (36%), Gaps = 34/226 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFD---NEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLAR 147
R + +GEG FG V + VAIK ++ + RE + E +++
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-D 66
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
H V++ N + I+ E + S + + QL ++
Sbjct: 67 HP----HIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 121
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
A++ R +H D+ N+L+ S + VK+ D+ LSR +D +Y+K
Sbjct: 122 AYLESKRFVHRDIAARNVLVSSNDCVKLGDF-GLSRYMEDSTYYK--------------- 165
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
S + APE I + D+W G + E+
Sbjct: 166 -------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 204
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.4 bits (247), Expect = 5e-25
Identities = 43/220 (19%), Positives = 84/220 (38%), Gaps = 29/220 (13%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGT 153
L ++G G FG V + + VAIK+++ + + + E V+ L+ +
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL--- 61
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
VQ+ + I I+ E + + F + E+ + + E++ ++
Sbjct: 62 --VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+ +H DL N L+ VKV D+ LSR D Y +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFG-LSRYVLDDEYTSS-------------------- 158
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ PEV++ ++ D+W+ G ++ E+ S
Sbjct: 159 --VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 6e-25
Identities = 44/240 (18%), Positives = 84/240 (35%), Gaps = 48/240 (20%)
Query: 93 RYRILSKMGEGTFGQVVECFDNE--KKELVAIKIVRSIN--KYREAAMIEIDVLQRLARH 148
+ +GEG FGQV++ + + AIK ++ E++VL +L H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 149 DIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY--------------RSFPI 193
+ + ++R ++ + E +L DFLRK+ +
Sbjct: 71 P----NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 126
Query: 194 DLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKN 253
+ + + ++ + + IH DL NIL+ K+ D+ LSR +
Sbjct: 127 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF-GLSRGQEV------ 179
Query: 254 LPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ + + A E + + D+WS G +L E+ S
Sbjct: 180 ------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 99.2 bits (246), Expect = 1e-24
Identities = 48/261 (18%), Positives = 88/261 (33%), Gaps = 60/261 (22%)
Query: 93 RYRILSKMGEGTFGQVVEC-----FDNEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
+ +GEG FG+V + E +VA+K+++ + + E ++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRS-------------- 190
V++ +C++FE + L +FLR S +
Sbjct: 74 DNP-----NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 191 --------FPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242
+ RQ+ +A++ E + +H DL N L+ VK+ D+ LS
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF-GLS 187
Query: 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLW 302
R+ Y+K + PE I + D+W
Sbjct: 188 RNIYSADYYKA---------------------DGNDAIPIRWMPPESIFYNRYTTESDVW 226
Query: 303 SVGCILVELCSVSNCYLTPFA 323
+ G +L E+ S L P+
Sbjct: 227 AYGVVLWEIFS---YGLQPYY 244
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 2e-24
Identities = 46/221 (20%), Positives = 94/221 (42%), Gaps = 33/221 (14%)
Query: 99 KMGEGTFGQVVECFDNEKK--ELVAIKIVR---SINKYREAAMIEIDVLQRLARHDIGGT 153
++G G FG V + + KK + VA+KI++ + ++ + E +V+Q+L +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNP---- 68
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
V++ + + + ++ L +L++N R + EL Q+ + ++ E
Sbjct: 69 YIVRMIGICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES 126
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+H DL N+LLV+ Y K+ D+ LS+ + ++
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDF-GLSK--------------------ALRADENYYK 165
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSV 314
++ + APE I ++ D+WS G ++ E S
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 206
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 3e-24
Identities = 41/227 (18%), Positives = 79/227 (34%), Gaps = 32/227 (14%)
Query: 93 RYRILSKMGEGTFGQVVECF----DNEKKELVAIKIVR--SINKYREAAMIEIDVLQRLA 146
+G G FG+V + +K+ VAIK ++ K R + E ++ + +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 147 RHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLES 206
H+I +++ + I+ E + D + F + + + R +
Sbjct: 68 HHNI-----IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 122
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
+ ++ + +H DL NIL+ S KV D+ D
Sbjct: 123 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT------------ 170
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
S + APE I + D+WS G ++ E+ +
Sbjct: 171 ---------SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 208
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 3e-24
Identities = 52/220 (23%), Positives = 85/220 (38%), Gaps = 33/220 (15%)
Query: 99 KMGEGTFGQVVECFDNEKKE--LVAIKIVR--SINKYREAAMIEIDVLQRLARHDIGGTR 154
++G G FG V + +K+ VAIK+++ + E M E ++ +L I
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI---- 71
Query: 155 CVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
V++ + +V E G L+ FL P+ V EL Q+ + ++ E
Sbjct: 72 -VRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK 128
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+H DL N+LLV+ Y K+ D+ D SY +
Sbjct: 129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY---------------------YT 167
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
S + APE I ++ D+WS G + E S
Sbjct: 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 207
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 3e-24
Identities = 39/228 (17%), Positives = 85/228 (37%), Gaps = 34/228 (14%)
Query: 93 RYRILSKMGEGTFGQVVECF---DNEKKELVAIKIVR----SINKYREAAMIEIDVLQRL 145
R+L K+G+G+FG V + K VA+K ++ S + + + E++ + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLE 205
++ +++ + +V E + F + + Q+ E
Sbjct: 69 DHRNL-----IRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 206 SVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDF 265
+ ++ R IH DL N+LL + + VK+ D+ + ++ +
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH--------------- 167
Query: 266 GSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ + + APE + +++ D W G L E+ +
Sbjct: 168 ------YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.1 bits (238), Expect = 2e-23
Identities = 44/233 (18%), Positives = 77/233 (33%), Gaps = 35/233 (15%)
Query: 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGG 152
+ +G+G FG+V + E VA+KI S + EI L +I G
Sbjct: 4 TIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 153 TRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKNSY-----RSFPIDLVRELGRQLLES 206
++ + + +V + SL+D+L + + + L +E
Sbjct: 62 FIAADNKDNGTW-TQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 207 VAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFG 266
V + + H DLK +NIL+ + D R P
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH--------- 171
Query: 267 STTFEHQDHSYVVSTRHYRAPEVILGLGWNYP------CDLWSVGCILVELCS 313
V T+ Y APEV+ D++++G + E+
Sbjct: 172 -----------RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 213
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 5e-23
Identities = 39/245 (15%), Positives = 84/245 (34%), Gaps = 50/245 (20%)
Query: 93 RYRILSKMGEGTFGQVVECFD-------NEKKELVAIKIVR--SINKYREAAMIEIDVLQ 143
R + +GEG FGQVV + VA+K+++ + K + E+++++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 144 RLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLR--------------KNSY 188
+ +H + + + ++ E +L ++L+ N
Sbjct: 74 MIGKHKN----IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129
Query: 189 RSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248
+ Q+ + ++ + IH DL N+L+ +K+ D+
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 249 SYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCIL 308
Y K + + APE + + + D+WS G +L
Sbjct: 190 YYKK----------------------TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 227
Query: 309 VELCS 313
E+ +
Sbjct: 228 WEIFT 232
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 1e-22
Identities = 38/220 (17%), Positives = 73/220 (33%), Gaps = 29/220 (13%)
Query: 99 KMGEGTFGQVVECFD---NEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGT 153
+G G FG V + KK A+K + I + E +++ + ++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV--- 90
Query: 154 RCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHEL 213
+ +V + +N + + + G Q+ + + F+
Sbjct: 91 -LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149
Query: 214 RLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ 273
+ +H DL N +L VKV D+ L+R D + K+
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADF-GLARDMYDKEFDSVHNKTG--------------- 193
Query: 274 DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ A E + + D+WS G +L EL +
Sbjct: 194 ----AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 5e-22
Identities = 39/237 (16%), Positives = 86/237 (36%), Gaps = 43/237 (18%)
Query: 93 RYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
+ + ++G+G+FG V E +E + VAIK V + + R + E V++
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 146 ARHDIGGTRCVQIRNWFDYRNHICIVFEKL-GPSLYDFLRKN--------SYRSFPIDLV 196
H + V++ ++ E + L +LR + +
Sbjct: 81 NCHHV-----VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 197 RELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPK 256
++ ++ + +A+++ + +H DL N ++ VK+ D+ + Y K
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK---- 191
Query: 257 SSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ + +PE + + D+WS G +L E+ +
Sbjct: 192 ------------------GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 230
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 9e-22
Identities = 40/226 (17%), Positives = 82/226 (36%), Gaps = 34/226 (15%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKEL----VAIKIVRSIN--KYREAAMIEIDVLQRLAR 147
++ + +G G FG V + + E VAIK +R K + + E V+ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 148 HDIGGTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESV 207
+ ++ I L D++R++ + + Q+ + +
Sbjct: 71 PHV-----CRLLGICLTSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGM 124
Query: 208 AFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGS 267
++ + RL+H DL N+L+ + ++VK+ D+ L++
Sbjct: 125 NYLEDRRLVHRDLAARNVLVKTPQHVKITDFG-LAKLLGAEEK----------------- 166
Query: 268 TTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS 313
+ A E IL + + D+WS G + EL +
Sbjct: 167 ----EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 1e-21
Identities = 44/232 (18%), Positives = 94/232 (40%), Gaps = 40/232 (17%)
Query: 93 RYRILSKMGEGTFGQV---VECFDNEKKELVAIKIVRSIN-----KYREAAMIEIDVLQR 144
+ +L +G G +G+V + ++ +L A+K+++ K E E VL+
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 145 LARHDIGGTRCVQIRNWFDYRNHICIVFE-KLGPSLYDFLRKNSYRSFPIDLVRELGRQL 203
+ + V + F + ++ + G L+ L + F V+ ++
Sbjct: 85 IRQSPF----LVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEI 138
Query: 204 LESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLI 263
+ ++ +H+L +I+ D+K ENILL S +V + D+ + + +
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL------------------SKEFV 180
Query: 264 DFGSTTFEHQDHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCS 313
+ + Y AP+++ G G + D WS+G ++ EL +
Sbjct: 181 ADETERAYDFCGTI-----EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 227
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.5 bits (213), Expect = 5e-20
Identities = 48/244 (19%), Positives = 83/244 (34%), Gaps = 49/244 (20%)
Query: 93 RYRILSKMGEGTFGQVVECFD-----NEKKELVAIKIVR--SINKYREAAMIEIDVLQRL 145
R ++ +G G FGQV+E VA+K+++ + + A M E+ +L +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 146 ARHDIGGTRCVQIRN-WFDYRNHICIVFEKL-GPSLYDFLRKN--------------SYR 189
H V + + ++ E +L +LR
Sbjct: 74 GHHLN----VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 190 SFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249
++ + Q+ + + F+ + IH DL NILL VK+ D+ KD
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309
Y + + APE I + D+WS G +L
Sbjct: 190 YVR----------------------KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 227
Query: 310 ELCS 313
E+ S
Sbjct: 228 EIFS 231
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.5 bits (164), Expect = 5e-14
Identities = 28/219 (12%), Positives = 60/219 (27%), Gaps = 31/219 (14%)
Query: 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVR-SINKYREAAMIEIDVLQRLARHD-IG 151
I MGEG V C+ + E +K + +++ +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 152 GTRCVQIRNWFDYRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMH 211
+ + + L + + ++ E+ +LE VA +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 212 ELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFE 271
++H DL N+L+ I +IDF +
Sbjct: 121 HRGIVHGDLSQYNVLVSEEG----------------------------IWIIDFPQSVEV 152
Query: 272 HQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVE 310
++ + R R + D+ S +++
Sbjct: 153 GEEGWREILERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 323 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.37 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.0 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.79 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.56 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.24 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.94 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-53 Score=367.68 Aligned_cols=196 Identities=25% Similarity=0.410 Sum_probs=172.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++.+.||+|+||+||+|+++.+++.||+|++.+. ....+.+.+|+.+++.++|+|| +++++++.+.+.
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI-----LRLYGYFHDATR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTB-----CCEEEEEECSSE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCC-----CeEEEEEEECCE
Confidence 5799999999999999999999999999999998642 2345678899999999999998 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+||||| +|+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~-------------- 144 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE-------------- 144 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--------------
T ss_pred EEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--------------
Confidence 99999999 899999998765 6999999999999999999999999999999999999976554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCC-ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+||+|||++...... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.
T Consensus 145 -------------~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 145 -------------LKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp -------------EEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred -------------EeecccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 466666666543322 23458999999999999999999999999999999999999999763
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=373.01 Aligned_cols=197 Identities=26% Similarity=0.415 Sum_probs=168.9
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.++|+++++||+|+||+||+|+++.+++.||||++.... ...+.+.+|+.++++++|+|| +++++++.+.+.+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnI-----v~~~~~~~~~~~~ 78 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV-----VKFYGHRREGNIQ 78 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTB-----CCEEEEEEETTEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCE-----eeEeeeeccCcee
Confidence 357999999999999999999999999999999986432 334568899999999999998 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
|+||||| +|+|.+++.+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 79 ~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~---------------- 140 (271)
T d1nvra_ 79 YLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD---------------- 140 (271)
T ss_dssp EEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC----------------
T ss_pred EEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC----------------
Confidence 9999999 889999997654 799999999999999999999999999999999999996554
Q ss_pred CCccccCCCCCCceEeeCCCcccccC-----CccccccCCccccchhhcCCCC-CcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
.+||+|||+|+.... .....+||+.|||||++.+..+ +.++|||||||++|||+||+.||.+.
T Consensus 141 -----------~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~ 209 (271)
T d1nvra_ 141 -----------NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 209 (271)
T ss_dssp -----------CEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred -----------CEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCC
Confidence 456666666654321 1234689999999999998876 57899999999999999999999764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-53 Score=371.85 Aligned_cols=196 Identities=28% Similarity=0.425 Sum_probs=172.1
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
.++|+++++||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+++.++|+|| +++++++...+.+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~~ 93 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI-----VNYLDSYLVGDELW 93 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTB-----CCEEEEEEETTEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCE-----eeEeEEEEECCEEE
Confidence 457999999999999999999999999999999987433 345678899999999999998 99999999999999
Q ss_pred EEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 170 IVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 170 lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+||||| +++|.+++.+. .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~---------------- 154 (293)
T d1yhwa1 94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS---------------- 154 (293)
T ss_dssp EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC----------------
T ss_pred EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc----------------
Confidence 999999 89999988764 5999999999999999999999999999999999999976554
Q ss_pred CccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+||+|||+++.... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.
T Consensus 155 -----------vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 219 (293)
T d1yhwa1 155 -----------VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (293)
T ss_dssp -----------EEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred -----------EeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC
Confidence 46666666554322 223457999999999999999999999999999999999999999763
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-53 Score=374.48 Aligned_cols=204 Identities=27% Similarity=0.455 Sum_probs=165.9
Q ss_pred CceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch--hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 87 GENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN--KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 87 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~--~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
.+++.++|++.+.||+|+||+||+|+++.+++.||||++.... ...+.+.+|+.+|+.++|+|| +++++++.+
T Consensus 4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~l~~~~~~ 78 (307)
T d1a06a_ 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI-----VALDDIYES 78 (307)
T ss_dssp CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTB-----CCEEEEEEC
T ss_pred CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEE
Confidence 4567788999999999999999999999999999999987432 334567789999999999998 999999999
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
++.+|+||||| |++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||+...
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~------------- 143 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL------------- 143 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS-------------
T ss_pred CCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeeccc-------------
Confidence 99999999999 899999998764 79999999999999999999999999999999999998532
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+.++.+||+|||+++..... ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.
T Consensus 144 -----------~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 212 (307)
T d1a06a_ 144 -----------DEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE 212 (307)
T ss_dssp -----------STTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred -----------CCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence 24456788888888765433 23468999999999999999999999999999999999999999763
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-53 Score=379.20 Aligned_cols=199 Identities=27% Similarity=0.413 Sum_probs=174.3
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
...++|+++++||+|+||+||+|++..+|+.||+|+++.. ....+.+.+|+.+|+.++|+|| ++++++|.+.+
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~l~~~~~~~~ 77 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI-----VGFYGAFYSDG 77 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTB-----CCEEEEEECSS
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEECC
Confidence 3457899999999999999999999999999999998743 3445678899999999999998 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
++|+||||| +++|.+++.+.. .+++..++.++.||+.||+|||+ +||+||||||+|||++.++
T Consensus 78 ~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~------------- 142 (322)
T d1s9ja_ 78 EISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG------------- 142 (322)
T ss_dssp EEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-------------
T ss_pred EEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-------------
Confidence 999999999 889999998765 69999999999999999999997 5999999999999986544
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccC-CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
.+||+|||+|..... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.
T Consensus 143 --------------~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 143 --------------EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp --------------CEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred --------------CEEEeeCCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 467777777765332 234568999999999999999999999999999999999999999764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=367.55 Aligned_cols=196 Identities=26% Similarity=0.392 Sum_probs=170.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++++.||+|+||+||+|+++.+++.||||++.+. ....+.+.+|++++++++|+|| +++++++.+.+.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~~~~~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF-----VKLYFTFQDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTB-----CCEEEEEECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCe-----eEEEEEEEECCE
Confidence 4699999999999999999999999999999998743 2334678899999999999998 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+||||| +|+|.+++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~-------------- 146 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH-------------- 146 (288)
T ss_dssp EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--------------
T ss_pred EEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--------------
Confidence 99999999 889999998765 7999999999999999999999999999999999999976554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccC-----CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+||+|||+|+.... .....+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.
T Consensus 147 -------------vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 147 -------------IQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp -------------EEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -------------EEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 45666666554321 122357999999999999999999999999999999999999999763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.9e-52 Score=369.03 Aligned_cols=195 Identities=26% Similarity=0.428 Sum_probs=176.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++++.||+|+||+||+|+++.+|+.||||++++. ....+.+.+|+.+++.++|||| +++++++.+.+.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI-----IRMWGTFQDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTB-----CCEEEEEECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcCh-----hheeeeEeeCCe
Confidence 4699999999999999999999999999999998742 2335678899999999999998 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+||||| |++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g--------------- 141 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG--------------- 141 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS---------------
T ss_pred eeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC---------------
Confidence 99999999 899999998765 789999999999999999999999999999999999986544
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+||+|||+|+.........+||+.|||||++.+..|+.++|||||||++|||+||+.||.+
T Consensus 142 ------------~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 203 (316)
T d1fota_ 142 ------------HIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 203 (316)
T ss_dssp ------------CEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ------------CEEEecCccceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC
Confidence 56777777777766666677999999999999999999999999999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-51 Score=371.98 Aligned_cols=201 Identities=28% Similarity=0.447 Sum_probs=177.2
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
+.++|++++.||+|+||+||+|+++.+|+.||||++.... ...+.+.+|+.+|++++|+|| +++++++.+.+.+
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~ 98 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL-----VNLHDAFEDDNEM 98 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTB-----CCEEEEEEETTEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCC-----CcEEEEEEECCEE
Confidence 3468999999999999999999999999999999987543 445678899999999999998 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
|+||||| +|+|.+++.+.. ..+++..++.++.||+.||+|||++|||||||||+|||+..+
T Consensus 99 ~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~----------------- 160 (350)
T d1koaa2 99 VMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK----------------- 160 (350)
T ss_dssp EEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-----------------
T ss_pred EEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC-----------------
Confidence 9999999 899999996543 369999999999999999999999999999999999998532
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
..+.+||+|||++....... ....||+.|||||++.+..|+.++|||||||++|||++|+.||.+.
T Consensus 161 --------~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 228 (350)
T d1koaa2 161 --------RSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 228 (350)
T ss_dssp --------TSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred --------CCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence 23567888888887654333 3468999999999999999999999999999999999999999763
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=363.11 Aligned_cols=203 Identities=27% Similarity=0.482 Sum_probs=179.8
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-------hhHHHHHHHHHHHHHHHhCCCCCcceEEEcc
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLARHDIGGTRCVQIRN 160 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~ 160 (323)
+.+.++|++.+.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+|++++|+|| +++++
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~ 80 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV-----ITLHE 80 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCC-----CcEEE
Confidence 456678999999999999999999999999999999986321 235778999999999999998 99999
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcc
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
++.+.+.+|+||||| +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 81 ~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~------- 151 (293)
T d1jksa_ 81 VYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNV------- 151 (293)
T ss_dssp EEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSS-------
T ss_pred EEEECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCC-------
Confidence 999999999999999 899999998765 7999999999999999999999999999999999999976542
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
....+|++|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 152 ----------------~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P 215 (293)
T d1jksa_ 152 ----------------PKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215 (293)
T ss_dssp ----------------SSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ----------------cccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCC
Confidence 2345789999988765433 3346899999999999999999999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 216 f~~ 218 (293)
T d1jksa_ 216 FLG 218 (293)
T ss_dssp SCC
T ss_pred CCC
Confidence 976
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=369.68 Aligned_cols=196 Identities=23% Similarity=0.406 Sum_probs=173.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++++.||+|+||+||+|+++.+++.||||++++. ....+.+.+|+.+|++++|+|| +++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~I-----v~l~~~~~~~~~ 79 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL-----TALKYAFQTHDR 79 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTB-----CCEEEEEECSSE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCE-----EEEEeeeccccc
Confidence 5799999999999999999999999999999999743 2344668899999999999998 999999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+|+||||| +|+|.+++.+.. .++++.++.++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 80 ~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~-------------- 143 (337)
T d1o6la_ 80 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-------------- 143 (337)
T ss_dssp EEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--------------
T ss_pred cccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--------------
Confidence 99999999 999999998875 7999999999999999999999999999999999999976554
Q ss_pred CCCccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
+||+|||+|+.... .....+||+.|||||++.+..|+.++|||||||++|||++|++||.+.
T Consensus 144 -------------vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~ 208 (337)
T d1o6la_ 144 -------------IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp -------------EEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -------------EEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc
Confidence 45566666554322 223468999999999999999999999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=358.72 Aligned_cols=196 Identities=24% Similarity=0.425 Sum_probs=167.5
Q ss_pred CCcE-EEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc--
Q 020652 91 TPRY-RILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-- 164 (323)
Q Consensus 91 ~~~y-~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~-- 164 (323)
+++| ++.++||+|+||+||+|++..+++.||+|++... ....+.+.+|+++|++++|+|| +++++++..
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~ 81 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI-----VRFYDSWESTV 81 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEEES
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCe-----eeEEEEEeecc
Confidence 4456 7788999999999999999999999999998643 3345678899999999999998 888888754
Q ss_pred --CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCCCcEEEeecCceeccCcc
Q 020652 165 --RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELR--LIHTDLKPENILLVSAEYVKVPDYK 239 (323)
Q Consensus 165 --~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--iiHrDlKp~NIli~~~~~~ki~d~~ 239 (323)
...+|+||||| +++|.+++.+.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~---------- 149 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG---------- 149 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESS----------
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeC----------
Confidence 45789999999 899999998765 7999999999999999999999998 999999999999953
Q ss_pred cccccCCCCCccccCCCCCCceEeeCCCcccccCC-ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 240 FLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
.++.+||+|||+++..... ....+||+.|||||++.+ .++.++|||||||++|||++|+.||
T Consensus 150 ----------------~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf 212 (270)
T d1t4ha_ 150 ----------------PTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY 212 (270)
T ss_dssp ----------------TTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ----------------CCCCEEEeecCcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCC
Confidence 2335677777777654333 344689999999999876 5999999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 213 ~~ 214 (270)
T d1t4ha_ 213 SE 214 (270)
T ss_dssp TT
T ss_pred CC
Confidence 75
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-52 Score=365.13 Aligned_cols=196 Identities=28% Similarity=0.512 Sum_probs=170.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc-hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI-NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~-~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
+.|+++++||+|+||+||+|+++.+++.||||++... ....+.+.+|+++|++++|+|| +++++++.+.+.+|+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~~~~~~~~~~~l 86 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI-----VKLLDAFYYENNLWI 86 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTB-----CCEEEEEEETTEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCC-----CeEEEEEeeCCeEEE
Confidence 4699999999999999999999999999999998643 3445678899999999999998 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
||||| +|+|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 87 vmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~------------------ 147 (288)
T d2jfla1 87 LIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG------------------ 147 (288)
T ss_dssp EEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS------------------
T ss_pred EEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC------------------
Confidence 99999 899999987643 3699999999999999999999999999999999999986544
Q ss_pred ccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhc-----CCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVIL-----GLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
.+||+|||+|...... ....+||+.|||||++. +..|+.++|||||||++|||+||+.||.+
T Consensus 148 ---------~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~ 217 (288)
T d2jfla1 148 ---------DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 217 (288)
T ss_dssp ---------CEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ---------CEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC
Confidence 4577777777543322 23468999999999984 45689999999999999999999999976
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-51 Score=371.21 Aligned_cols=196 Identities=26% Similarity=0.431 Sum_probs=176.4
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ...+.+.+|+.+|+.++|+|| +++++++.....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL-----VKLEFSFKDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcE-----eecccccccccc
Confidence 57999999999999999999999999999999986422 334678899999999999998 899999999999
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+++||||+ +++|.+++.+.. .+++..++.++.||+.||.|||++|||||||||+|||++.++
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g--------------- 178 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG--------------- 178 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS---------------
T ss_pred cccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC---------------
Confidence 99999999 999999998765 699999999999999999999999999999999999986544
Q ss_pred CCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
.+||+|||+++..........||+.|||||++.+..|+.++|||||||++|||+||+.||.+.
T Consensus 179 ------------~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 179 ------------YIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp ------------CEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ------------CEEeeeceeeeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence 567777777776666666678999999999999999999999999999999999999999763
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.3e-51 Score=369.51 Aligned_cols=199 Identities=26% Similarity=0.449 Sum_probs=175.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
++|++++.||+|+||+||+|++..+|+.||||++.... ...+.+.+|+.+|++++|+|| ++++++|.+++.+|+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~~~~~~~~~~~~~i 103 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL-----INLHDAFEDKYEMVL 103 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTB-----CCEEEEEECSSEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCC-----CcEEEEEEECCEEEE
Confidence 57999999999999999999999999999999987543 345667889999999999998 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
||||| +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++..
T Consensus 104 vmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~------------------- 163 (352)
T d1koba_ 104 ILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK------------------- 163 (352)
T ss_dssp EEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST-------------------
T ss_pred EEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc-------------------
Confidence 99999 899999876544 469999999999999999999999999999999999998531
Q ss_pred ccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
..+.+||+|||+|....... ....||+.|||||++.+..|+.++|||||||++|||+||+.||.+.
T Consensus 164 ------~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 231 (352)
T d1koba_ 164 ------KASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 231 (352)
T ss_dssp ------TCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ------CCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 34567888888887654433 3468999999999999999999999999999999999999999763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=359.61 Aligned_cols=200 Identities=24% Similarity=0.402 Sum_probs=158.3
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc--Cc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY--RN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~--~~ 166 (323)
++|++++.||+|+||+||+|+++.+|+.||||++... ....+.+.+|++++++++|+|| +++++++.+ .+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~ 78 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI-----VRYYDRIIDRTNT 78 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTB-----CCEEEEEEC----
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCE-----eeEEEEEEeCCCC
Confidence 4699999999999999999999999999999998643 3345678899999999999998 889988754 56
Q ss_pred eEEEEEccC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceecCCCCCcEEEeecCceeccCc
Q 020652 167 HICIVFEKL-GPSLYDFLRKN--SYRSFPIDLVRELGRQLLESVAFMHELR-----LIHTDLKPENILLVSAEYVKVPDY 238 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~~~-----iiHrDlKp~NIli~~~~~~ki~d~ 238 (323)
.+|+||||| +|+|.+++.+. ....+++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+||
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DF 158 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCH
T ss_pred EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeec
Confidence 789999999 89999998642 2247999999999999999999999976 999999999999977666655555
Q ss_pred ccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
|++.....+ .......+||+.|||||++.+..|+.++|||||||++|||+||+.||
T Consensus 159 G~a~~~~~~------------------------~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf 214 (269)
T d2java1 159 GLARILNHD------------------------TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 214 (269)
T ss_dssp HHHHHC-----------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred cceeecccC------------------------CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCC
Confidence 544322111 01122358999999999999999999999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 215 ~~ 216 (269)
T d2java1 215 TA 216 (269)
T ss_dssp CC
T ss_pred CC
Confidence 76
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-51 Score=364.54 Aligned_cols=197 Identities=27% Similarity=0.378 Sum_probs=168.2
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
...+|+++++||+|+||+||+|++..+++.||||++... ....+.+.+|+.+|++++|+|| +++++++.+.
T Consensus 13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-----v~~~~~~~~~ 87 (309)
T d1u5ra_ 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT-----IQYRGCYLRE 87 (309)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEEEET
T ss_pred cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCE-----eeEEEEEEEC
Confidence 345699999999999999999999999999999998643 2334568899999999999998 9999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+.+|+||||| +++|..++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 88 ~~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~----------- 154 (309)
T d1u5ra_ 88 HTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLV----------- 154 (309)
T ss_dssp TEEEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEE-----------
T ss_pred CEEEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCE-----------
Confidence 9999999999 777776666544 79999999999999999999999999999999999999766654
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcC---CCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILG---LGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
||+|||++..... ....+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.
T Consensus 155 ----------------Kl~DFG~a~~~~~-~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~ 217 (309)
T d1u5ra_ 155 ----------------KLGDFGSASIMAP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (309)
T ss_dssp ----------------EECCCTTCBSSSS-BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred ----------------EEeecccccccCC-CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC
Confidence 5566665554332 233579999999999975 35899999999999999999999999763
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=362.77 Aligned_cols=202 Identities=25% Similarity=0.433 Sum_probs=180.1
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.+-++|++.+.||+|+||+||+|.++.+++.||||+++........+.+|+++|+.++|+|| ++++++|++.+.+
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnI-----v~~~~~~~~~~~~ 76 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNI-----LHLHESFESMEEL 76 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTB-----CCEEEEEEETTEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCC-----CeEEEEEEECCEE
Confidence 35578999999999999999999999999999999998766666778899999999999998 9999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
|+||||| |++|.+++...+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~----------------- 138 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR----------------- 138 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-----------------
T ss_pred EEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC-----------------
Confidence 9999999 889999997654 369999999999999999999999999999999999999643
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCc--cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH--SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
....+||+|||++....... ....||+.|+|||.+.+..|+.++|||||||++|||++|+.||.+.
T Consensus 139 --------~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~ 206 (321)
T d1tkia_ 139 --------RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp --------SCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred --------CceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC
Confidence 23467888888887654332 3458999999999999999999999999999999999999999764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-50 Score=356.90 Aligned_cols=198 Identities=21% Similarity=0.313 Sum_probs=173.3
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
.++|++.++||+|+||+||+|++..+++.||||+++......+.+.+|+.+|++++|+|| +++++++..++.+++
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~~~~~~i 90 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNL-----VQLLGVCTREPPFYI 90 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSCEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCE-----ecCCccEeeCCeeEE
Confidence 357999999999999999999999999999999998766667789999999999999998 999999999999999
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
||||| +|+|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 91 v~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~---------------- 154 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV---------------- 154 (287)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE----------------
T ss_pred EeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcE----------------
Confidence 99999 8999999987766789999999999999999999999999999999999999776655
Q ss_pred ccccCCCCCCceEeeCCCcccccCCc----cccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQDH----SYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||+++...... ....||+.|||||++.+..|+.++|||||||++|||++|..||..
T Consensus 155 -----------Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~ 218 (287)
T d1opja_ 155 -----------KVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218 (287)
T ss_dssp -----------EECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred -----------EEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 555555555432221 123589999999999999999999999999999999997766643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.7e-50 Score=352.63 Aligned_cols=205 Identities=23% Similarity=0.318 Sum_probs=165.2
Q ss_pred ceeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 88 ENLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 88 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
..+.++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+.+|+++++.++|+|| +++++++.
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpni-----v~~~~~~~ 77 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI-----VAVYDTGE 77 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEE
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCC-----Ccccceee
Confidence 35678999999999999999999999999999999998642 2345578899999999999998 88888776
Q ss_pred cC----ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCc
Q 020652 164 YR----NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (323)
Q Consensus 164 ~~----~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~ 238 (323)
.. ..+|+||||| |++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++..+++||
T Consensus 78 ~~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~ 155 (277)
T d1o6ya_ 78 AETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF 155 (277)
T ss_dssp EECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCC
T ss_pred eccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehh
Confidence 53 3589999999 899999998765 7999999999999999999999999999999999999987776666666
Q ss_pred ccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
|+........ .........+||+.|||||++.+..++.++|||||||++|||+||++||
T Consensus 156 ~~~~~~~~~~---------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf 214 (277)
T d1o6ya_ 156 GIARAIADSG---------------------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 214 (277)
T ss_dssp TTCEECC-------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred hhhhhhcccc---------------------ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCC
Confidence 5432211100 0011223358999999999999999999999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 215 ~~ 216 (277)
T d1o6ya_ 215 TG 216 (277)
T ss_dssp CC
T ss_pred CC
Confidence 76
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=362.08 Aligned_cols=198 Identities=27% Similarity=0.467 Sum_probs=170.2
Q ss_pred eCCcEEEEe-eecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceecc---
Q 020652 90 LTPRYRILS-KMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDY--- 164 (323)
Q Consensus 90 ~~~~y~~~~-~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~--- 164 (323)
+.++|+++. .||+|+||+||+|++..+++.||||+++.. ....+|+.++.++ +|+|| ++++++|++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~----~~~~~E~~~~~~~~~hpnI-----v~l~~~~~~~~~ 79 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC----PKARREVELHWRASQCPHI-----VRIVDVYENLYA 79 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS----HHHHHHHHHHHHHTTSTTB-----CCEEEEEEEEET
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc----HHHHHHHHHHHHhcCCCCC-----CeEEEEEeeccc
Confidence 446799886 599999999999999999999999998643 3466799987665 68888 888888764
Q ss_pred -CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 165 -RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 165 -~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
...+|+||||| ||+|.+++.+.+...+++..++.++.||+.||+|||++||+||||||+|||++..+
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~----------- 148 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR----------- 148 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSS-----------
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccc-----------
Confidence 56799999999 88999999876656799999999999999999999999999999999999996532
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
....+||+|||+++..... ....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+
T Consensus 149 -------------~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~ 215 (335)
T d2ozaa1 149 -------------PNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215 (335)
T ss_dssp -------------TTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred -------------ccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence 3456788888888754332 3446899999999999999999999999999999999999999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=353.95 Aligned_cols=196 Identities=24% Similarity=0.392 Sum_probs=168.3
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc----hhhHHHHHHHHHHHH-HHHhCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI----NKYREAAMIEIDVLQ-RLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~----~~~~~~~~~Ei~~l~-~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
++|++++.||+|+||+||+|+++.+++.||||++++. ....+.+..|+.++. .++|+|| +++++++.+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~I-----v~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL-----THMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTB-----CCEEEEEECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcE-----EEEEEEEccCC
Confidence 4699999999999999999999999999999999743 233455667777765 5789988 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.+|+||||| +|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++..+.+
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~------------ 142 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHI------------ 142 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCE------------
T ss_pred ceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCce------------
Confidence 999999999 899999998765 79999999999999999999999999999999999999766655
Q ss_pred CCCCccccCCCCCCceEeeCCCccccc---CCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEH---QDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLTP 321 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 321 (323)
||+|||+++... ......+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.
T Consensus 143 ---------------kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~ 206 (320)
T d1xjda_ 143 ---------------KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 206 (320)
T ss_dssp ---------------EECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ---------------eccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC
Confidence 555555554322 1223357999999999999999999999999999999999999999863
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6e-49 Score=357.09 Aligned_cols=195 Identities=22% Similarity=0.344 Sum_probs=163.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----hhHHHHHHHHHH---HHHHHhCCCCCcceEEEcceecc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----KYREAAMIEIDV---LQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----~~~~~~~~Ei~~---l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
++|++++.||+|+||+||+|++..+|+.||||++.+.. .....+.+|..+ ++.++|+|| +++++++..
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnI-----v~l~~~~~~ 78 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI-----VCMSYAFHT 78 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTB-----CCEEEEEEC
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcE-----EEEEEEEEE
Confidence 57999999999999999999999999999999986422 222334455444 444457776 999999999
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
.+.+|+||||| +++|.+++.+.. .+++..++.++.||+.||+|||++|||||||||+|||++.++.
T Consensus 79 ~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~----------- 145 (364)
T d1omwa3 79 PDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH----------- 145 (364)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC-----------
T ss_pred CCEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc-----------
Confidence 99999999999 899999998765 7899999999999999999999999999999999999976554
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCC-ccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
+||+|||+|+..... ....+||+.|||||++.+ ..|+.++|||||||+||||+||+.||.+
T Consensus 146 ----------------iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 146 ----------------VRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp ----------------EEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred ----------------EEEeeeceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCC
Confidence 466666666543322 334589999999999975 5689999999999999999999999976
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-48 Score=342.06 Aligned_cols=197 Identities=30% Similarity=0.512 Sum_probs=169.8
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch----------hhHHHHHHHHHHHHHHH-hCCCCCcceEEEc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN----------KYREAAMIEIDVLQRLA-RHDIGGTRCVQIR 159 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~----------~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~ 159 (323)
.++|++.+.||+|+||+||+|++..+++.||||++.+.. ...+.+.+|+.+++++. |+|| ++++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnI-----v~~~ 76 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI-----IQLK 76 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB-----CCEE
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCe-----EEEE
Confidence 468999999999999999999999999999999986421 23456788999999997 8998 9999
Q ss_pred ceeccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCc
Q 020652 160 NWFDYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (323)
Q Consensus 160 ~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~ 238 (323)
+++.+++.+||||||| +++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 77 ~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~------ 148 (277)
T d1phka_ 77 DTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN------ 148 (277)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC------
T ss_pred eecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC------
Confidence 9999999999999999 899999998765 7999999999999999999999999999999999999976554
Q ss_pred ccccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcC------CCCCcchhHHHHHHHHHH
Q 020652 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILG------LGWNYPCDLWSVGCILVE 310 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~e 310 (323)
+||+|||++...... ....+||+.|+|||++.+ ..++.++||||+||++||
T Consensus 149 ---------------------~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilye 207 (277)
T d1phka_ 149 ---------------------IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYT 207 (277)
T ss_dssp ---------------------EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHH
T ss_pred ---------------------eEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhh
Confidence 456666666543322 233579999999999963 347889999999999999
Q ss_pred HhcCCCCCCCC
Q 020652 311 LCSVSNCYLTP 321 (323)
Q Consensus 311 l~tg~~pf~~~ 321 (323)
|++|+.||.+.
T Consensus 208 ml~g~~Pf~~~ 218 (277)
T d1phka_ 208 LLAGSPPFWHR 218 (277)
T ss_dssp HHHSSCSSCCS
T ss_pred hccCCCCCCCC
Confidence 99999999864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-49 Score=343.05 Aligned_cols=195 Identities=27% Similarity=0.393 Sum_probs=162.1
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
++|++.++||+|+||+||+|++. +++.||||+++......+++.+|++++++++|+|| +++++++...+.+++|
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnI-----v~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKL-----VQLYGVCLEQAPICLV 78 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECSSSSCEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCc-----ccccceeccCCceEEE
Confidence 46999999999999999999976 56789999998766667889999999999999999 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||+ +|+|.+++.... ..++++.+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||
T Consensus 79 ~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFG----------- 146 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG----------- 146 (263)
T ss_dssp EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccc-----------
Confidence 9999 999999987654 468999999999999999999999999999999999999877665555555
Q ss_pred cccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcC-CCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSV-SNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg-~~pf~~ 320 (323)
+++..... .....||+.|+|||++.+..|+.++|||||||++|||+|+ .+||..
T Consensus 147 ----------------la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~ 205 (263)
T d1sm2a_ 147 ----------------MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205 (263)
T ss_dssp ----------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred ----------------hheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC
Confidence 44332211 1224689999999999999999999999999999999995 555543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=345.45 Aligned_cols=198 Identities=26% Similarity=0.450 Sum_probs=167.4
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-------hhHHHHHHHHHHHHHHH--hCCCCCcceEEEcc
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------KYREAAMIEIDVLQRLA--RHDIGGTRCVQIRN 160 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-------~~~~~~~~Ei~~l~~l~--~~~i~~~~~~~~~~ 160 (323)
+.++|++.+.||+|+||+||+|++..+++.||||++.... .....+.+|+.++++++ |+|| +++++
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nI-----v~~~~ 76 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV-----IRLLD 76 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB-----CCEEE
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCc-----cEEEE
Confidence 4578999999999999999999999999999999986422 11233567999999997 6777 99999
Q ss_pred eeccCceEEEEEccC-C-CCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCc
Q 020652 161 WFDYRNHICIVFEKL-G-PSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~-~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~ 238 (323)
++...+..++||||+ + +++.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 77 ~~~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~-------- 146 (273)
T d1xwsa_ 77 WFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLN-------- 146 (273)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETT--------
T ss_pred EEeeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecC--------
Confidence 999999999999999 4 58888887765 79999999999999999999999999999999999999643
Q ss_pred ccccccCCCCCccccCCCCCCceEeeCCCcccccCC-ccccccCCccccchhhcCCCC-CcchhHHHHHHHHHHHhcCCC
Q 020652 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-HSYVVSTRHYRAPEVILGLGW-NYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~ 316 (323)
...+||+|||++...... ....+||+.|+|||++.+..+ +.++|||||||++|||+||+.
T Consensus 147 ------------------~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~ 208 (273)
T d1xwsa_ 147 ------------------RGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208 (273)
T ss_dssp ------------------TTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred ------------------CCeEEECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCC
Confidence 234577777777654333 244689999999999987765 577999999999999999999
Q ss_pred CCCC
Q 020652 317 CYLT 320 (323)
Q Consensus 317 pf~~ 320 (323)
||.+
T Consensus 209 Pf~~ 212 (273)
T d1xwsa_ 209 PFEH 212 (273)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 9975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=346.02 Aligned_cols=193 Identities=25% Similarity=0.374 Sum_probs=158.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEecc---chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCce
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRS---INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~---~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~ 167 (323)
.++|++.++||+|+||+||+|+.. ..||||+++. .....+.+.+|+.++++++|+|| +++++++.. +.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~~~~~~~~-~~ 77 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI-----LLFMGYSTA-PQ 77 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTB-----CCEEEEECS-SS
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCE-----eeeeEEEec-cE
Confidence 467999999999999999999754 3599999863 23455778899999999999998 788887654 56
Q ss_pred EEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCC
Q 020652 168 ICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSK 246 (323)
Q Consensus 168 ~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~ 246 (323)
+++||||| +|+|.+++.... ..+++..+..++.||+.||+|||+++||||||||+|||++.++.+
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~------------- 143 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTV------------- 143 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSE-------------
T ss_pred EEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCE-------------
Confidence 89999999 899999997654 369999999999999999999999999999999999999776655
Q ss_pred CCCccccCCCCCCceEeeCCCcccccC-----CccccccCCccccchhhcCC---CCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 247 DGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGL---GWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 247 ~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
||+|||+|+.... ......||+.|||||++.+. .|+.++|||||||+||||+||+.||
T Consensus 144 --------------Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf 209 (276)
T d1uwha_ 144 --------------KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209 (276)
T ss_dssp --------------EECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred --------------EEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCC
Confidence 5555555443221 12235799999999999753 5899999999999999999999999
Q ss_pred CC
Q 020652 319 LT 320 (323)
Q Consensus 319 ~~ 320 (323)
.+
T Consensus 210 ~~ 211 (276)
T d1uwha_ 210 SN 211 (276)
T ss_dssp TT
T ss_pred CC
Confidence 75
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=346.99 Aligned_cols=197 Identities=32% Similarity=0.552 Sum_probs=168.1
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch---hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN---KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~---~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++|+++++||+|+||+||+|++..+++.||||+++... ...+.+.+|++++++++|+|| +++++++.+++.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~I-----v~~~~~~~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI-----VKLLDVIHTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTB-----CCEEEEEEETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcE-----EEeccccccccce
Confidence 47999999999999999999999999999999986432 235678899999999999998 9999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
|+||||+++++.+++.......+++..++.++.||+.||+|||++|||||||||+|||++.++.+
T Consensus 77 ~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~--------------- 141 (298)
T d1gz8a_ 77 YLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAI--------------- 141 (298)
T ss_dssp EEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE---------------
T ss_pred eEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcc---------------
Confidence 99999998888888776655689999999999999999999999999999999999998765544
Q ss_pred CccccCCCCCCceEeeCCCcccccC---CccccccCCccccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQ---DHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||.++.... ......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+
T Consensus 142 ------------kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~ 205 (298)
T d1gz8a_ 142 ------------KLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205 (298)
T ss_dssp ------------EECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ------------eeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence 5555555543322 223347999999999988766 57899999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.7e-49 Score=347.54 Aligned_cols=204 Identities=23% Similarity=0.328 Sum_probs=159.9
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCc---EEEEEEecc--chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKE---LVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~---~vAiK~~~~--~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
++|++.+.||+|+||+||+|+++.+++ .||||.+.. .....+.+.+|+.+|++++|+|| +++++++...+
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~g~~~~~~ 100 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNV-----IHLEGVVTKST 100 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTB-----CCEEEEECSSS
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCC-----ccEEEEEeeCC
Confidence 579999999999999999999987664 588998763 34455678999999999999998 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.+++||||| +|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++...
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999 899999888654 469999999999999999999999999999999999999766655555555433221
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
..... ..........||+.|||||++.+..++.++|||||||++|||+| |+.||.+
T Consensus 180 ~~~~~-------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 180 DDTSD-------------------PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp -----------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCCCc-------------------ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence 11000 00000111357999999999999999999999999999999998 8999975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-49 Score=343.15 Aligned_cols=195 Identities=25% Similarity=0.404 Sum_probs=164.0
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
.++|++.++||+|+||+||+|+++ +++.||||+++......+.+.+|+.++++++|+|| +++++++.. +.+++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRL-----VRLYAVVTQ-EPIYI 84 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSCEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCE-----eEEEeeecc-CCeEE
Confidence 367999999999999999999975 67789999998766667789999999999999998 888887754 55789
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
||||| +|+|.+++.......+++..+..++.||+.||.|||+++|+||||||+||||+.++.+
T Consensus 85 v~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~---------------- 148 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSC---------------- 148 (272)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCE----------------
T ss_pred EEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccce----------------
Confidence 99999 9999998765443469999999999999999999999999999999999999766554
Q ss_pred ccccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
||+|||+|+..... .....||+.|||||++.+..++.++|||||||++|||+||..||.
T Consensus 149 -----------Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 149 -----------KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp -----------EECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred -----------eeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 55555555443222 123478999999999998899999999999999999999655443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.1e-48 Score=341.04 Aligned_cols=203 Identities=25% Similarity=0.337 Sum_probs=171.9
Q ss_pred eeCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHh-CCCCCcceEEEcceeccCce
Q 020652 89 NLTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLAR-HDIGGTRCVQIRNWFDYRNH 167 (323)
Q Consensus 89 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~-~~i~~~~~~~~~~~~~~~~~ 167 (323)
.+.++|++.++||+|+||+||+|++..+++.||||++.... ..+.+.+|+++++.+.| +|+ +.+++++..+..
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i-----~~~~~~~~~~~~ 75 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGI-----PNVYYFGQEGLH 75 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTC-----CCEEEEEEETTE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCC-----CEEEEEeecCCc
Confidence 45689999999999999999999999999999999886433 23446789999999987 454 677888888999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 168 ICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 168 ~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
.++||||++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++...
T Consensus 76 ~~~vme~~~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~---------------- 138 (293)
T d1csna_ 76 NVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPN---------------- 138 (293)
T ss_dssp EEEEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSS----------------
T ss_pred cEEEEEecCCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcc----------------
Confidence 99999999999999987654 4699999999999999999999999999999999999996532
Q ss_pred CCccccCCCCCCceEeeCCCcccccC----------CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQ----------DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNC 317 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~p 317 (323)
......+||+|||+|+.... .....+||+.|||||++.+..++.++|||||||++|||+||+.|
T Consensus 139 ------~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~P 212 (293)
T d1csna_ 139 ------SKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 212 (293)
T ss_dssp ------STTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ------cccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCc
Confidence 11234577778887765322 12335799999999999999999999999999999999999999
Q ss_pred CCC
Q 020652 318 YLT 320 (323)
Q Consensus 318 f~~ 320 (323)
|.+
T Consensus 213 f~~ 215 (293)
T d1csna_ 213 WQG 215 (293)
T ss_dssp TSS
T ss_pred CCC
Confidence 975
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=348.16 Aligned_cols=202 Identities=22% Similarity=0.342 Sum_probs=165.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCc-----EEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceec
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKE-----LVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~-----~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~ 163 (323)
++|++.++||+|+||+||+|++..+++ .||+|++... ......+.+|+.++.++ +|+|| +++++++.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnI-----v~l~~~~~ 111 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI-----VNLLGACT 111 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTB-----CCEEEEEC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcE-----eEEEEEEe
Confidence 579999999999999999999876554 6999988642 33456788999999999 78998 99999999
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNSY---------------------RSFPIDLVRELGRQLLESVAFMHELRLIHTDLK 221 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~~---------------------~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlK 221 (323)
..+.+|+||||| +|+|.+++..... ..+++..++.++.||+.||+|||+++|||||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK 191 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 191 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 999999999999 9999999976431 248899999999999999999999999999999
Q ss_pred CCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhH
Q 020652 222 PENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDL 301 (323)
Q Consensus 222 p~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 301 (323)
|+|||++.++.+||+|||+++....... ........||+.|||||++.+..|+.++||
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~----------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~Di 249 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSN----------------------YVVRGNARLPVKWMAPESLFEGIYTIKSDV 249 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTT----------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred hhccccccCCeEEEeeccccccccCCCc----------------------eeeeccccCCCccCChHHHcCCCCCcceec
Confidence 9999998777666655555433221110 000123468999999999999999999999
Q ss_pred HHHHHHHHHHhc-CCCCCCC
Q 020652 302 WSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 302 wSlG~il~el~t-g~~pf~~ 320 (323)
|||||++|||+| |+.||.+
T Consensus 250 wS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 250 WSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp HHHHHHHHHHTTTSCCSSTT
T ss_pred cchhHHHHHHHhCCCCCCCC
Confidence 999999999998 8999976
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-48 Score=349.27 Aligned_cols=207 Identities=27% Similarity=0.501 Sum_probs=171.7
Q ss_pred CceeEecCce---eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCc
Q 020652 80 GHYVFAIGEN---LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGT 153 (323)
Q Consensus 80 ~~~~~~~~~~---~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~ 153 (323)
|.+...+++. +.++|+++++||+|+||+||+|.++.+|+.||||+++.. ....+.+.+|+++|+.++|+|+
T Consensus 3 ~~~~~~~~~~~~~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpni--- 79 (346)
T d1cm8a_ 3 GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV--- 79 (346)
T ss_dssp SBCCEECSSSEECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTB---
T ss_pred CcEEEeccCceeecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCe---
Confidence 4455555554 789999999999999999999999999999999998742 3445678899999999999998
Q ss_pred ceEEEcceeccCc------eEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 020652 154 RCVQIRNWFDYRN------HICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227 (323)
Q Consensus 154 ~~~~~~~~~~~~~------~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli 227 (323)
++++++|...+ ++|+|||||+.+|.++++.. .+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 80 --v~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~ 154 (346)
T d1cm8a_ 80 --IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV 154 (346)
T ss_dssp --CCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred --eEEEEEeccCccccccceEEEEEecccccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc
Confidence 88888876543 67999999988998888764 59999999999999999999999999999999999998
Q ss_pred eecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-CCCcchhHHHHHH
Q 020652 228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGC 306 (323)
Q Consensus 228 ~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~ 306 (323)
+.++ .+|++|||.+..........+||+.|+|||++.+. .++.++|||||||
T Consensus 155 ~~~~---------------------------~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGv 207 (346)
T d1cm8a_ 155 NEDC---------------------------ELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGC 207 (346)
T ss_dssp CTTC---------------------------CEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHH
T ss_pred cccc---------------------------ccccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchH
Confidence 6544 55777777777766666677899999999999875 5789999999999
Q ss_pred HHHHHhcCCCCCCCC
Q 020652 307 ILVELCSVSNCYLTP 321 (323)
Q Consensus 307 il~el~tg~~pf~~~ 321 (323)
++|||++|++||.+.
T Consensus 208 il~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 208 IMAEMITGKTLFKGS 222 (346)
T ss_dssp HHHHHHHSSCSSCCS
T ss_pred HHHHHHHCcCCCCCC
Confidence 999999999999763
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=339.39 Aligned_cols=201 Identities=26% Similarity=0.348 Sum_probs=164.3
Q ss_pred CcEEEEe-eecccCcEEEEEEEECC--CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILS-KMGEGTFGQVVECFDNE--KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~-~lG~G~fg~V~~~~~~~--~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 166 (323)
++|.+.+ +||+|+||+||+|.++. ++..||||+++.. ....+.+.+|+++|++++|+|| +++++++.. +
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~l~g~~~~-~ 81 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI-----VRLIGVCQA-E 81 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEES-S
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCE-----eeEeeeecc-C
Confidence 4688888 49999999999998764 4557999998643 3445778999999999999998 888898865 4
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSS 245 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~ 245 (323)
.+|+||||| +|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred eEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 589999999 889999986543 469999999999999999999999999999999999999888777666666544322
Q ss_pred CCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 246 KDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 246 ~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
.... .........||+.|||||++.+..++.++|||||||++|||+| |+.||.+
T Consensus 161 ~~~~---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~ 215 (285)
T d1u59a_ 161 ADDS---------------------YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 215 (285)
T ss_dssp TCSC---------------------EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccc---------------------ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCC
Confidence 2111 0011123468999999999999999999999999999999998 9999975
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=343.64 Aligned_cols=192 Identities=30% Similarity=0.495 Sum_probs=156.9
Q ss_pred EEeeecccCcEEEEEEEECCCCcEEEEEEeccchh------hHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 96 ILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINK------YREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 96 ~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~------~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
.+++||+|+||+||+|+++.+|+.||||+++.... ..+.+.+|+.++++++|+|| +++++++..++++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnI-----v~~~~~~~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI-----IGLLDAFGHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTB-----CCEEEEECCTTCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCE-----eEEEeeeccCCcee
Confidence 46899999999999999999999999999864322 13457899999999999998 99999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+||||+.+++...+.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+
T Consensus 77 ivmE~~~~~~~~~~~~~~-~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~------------- 142 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLA------------- 142 (299)
T ss_dssp EEEECCSEEHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC-------------
T ss_pred ehhhhhcchHHhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccc-------------
Confidence 999999554444444332 479999999999999999999999999999999999999766655555
Q ss_pred ccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
|||.+...... ....+||+.|+|||++.+. .|+.++|||||||++|||+||..||.+
T Consensus 143 --------------DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 203 (299)
T d1ua2a_ 143 --------------DFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203 (299)
T ss_dssp --------------CCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred --------------cCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence 55544332221 2234799999999998754 689999999999999999999999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-47 Score=339.52 Aligned_cols=201 Identities=28% Similarity=0.356 Sum_probs=168.9
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
+.++|++.++||+|+||+||+|++..+++.||||++..... .+.+..|+++++.+.|+++ ++.+..++...+..+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~~~~E~~i~~~l~~~~~----i~~~~~~~~~~~~~~ 79 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-HPQLHIESKIYKMMQGGVG----IPTIRWCGAEGDYNV 79 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-SCCHHHHHHHHHHSTTSTT----CCCEEEEEEETTEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-CHHHHHHHHHHHHccCCCc----ccEEEEEEecCCEEE
Confidence 45789999999999999999999999999999998875332 3457889999999998875 245556667788999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 170 IVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 170 lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
+||||++++|.+.+.... ..+++..+..++.|++.||+|||++||+||||||+|||++..+
T Consensus 80 ivme~~~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~------------------ 140 (299)
T d1ckia_ 80 MVMELLGPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGK------------------ 140 (299)
T ss_dssp EEEECCCCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGG------------------
T ss_pred EEEEEcCCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccC------------------
Confidence 999999989888876554 4799999999999999999999999999999999999986432
Q ss_pred ccccCCCCCCceEeeCCCcccccCC----------ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQD----------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~----------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
....+||+|||+|+..... .....||+.|||||++.+..++.++|||||||++|||+||+.||.
T Consensus 141 ------~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~ 214 (299)
T d1ckia_ 141 ------KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQ 214 (299)
T ss_dssp ------GTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ------CCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCccc
Confidence 2345677777777543221 234589999999999999999999999999999999999999997
Q ss_pred C
Q 020652 320 T 320 (323)
Q Consensus 320 ~ 320 (323)
+
T Consensus 215 ~ 215 (299)
T d1ckia_ 215 G 215 (299)
T ss_dssp C
T ss_pred c
Confidence 6
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=335.67 Aligned_cols=195 Identities=23% Similarity=0.359 Sum_probs=168.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
++|++.++||+|+||+||+|+++ +++.||||+++......+++.+|+.++++++|+|| +++++++...+.+++|
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnI-----v~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKL-----VQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTB-----CCEEEEECCSSSEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCce-----eeEEEEEeeCCceEEE
Confidence 46889999999999999999984 77889999998776677889999999999999998 9999999999999999
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||+ +|+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+
T Consensus 78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~----------------- 139 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVV----------------- 139 (258)
T ss_dssp EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCE-----------------
T ss_pred EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcE-----------------
Confidence 9999 899999977554 368999999999999999999999999999999999999766555
Q ss_pred cccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+
T Consensus 140 ----------kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~ 204 (258)
T d1k2pa_ 140 ----------KVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 204 (258)
T ss_dssp ----------EECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ----------EECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC
Confidence 55555555432221 112468999999999999999999999999999999998 8999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=339.65 Aligned_cols=198 Identities=32% Similarity=0.569 Sum_probs=161.1
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCC-CcEEEEEEeccc---hhhHHHHHHHHHHHHHH---HhCCCCCcceEEEcceec
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEK-KELVAIKIVRSI---NKYREAAMIEIDVLQRL---ARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~-~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l---~~~~i~~~~~~~~~~~~~ 163 (323)
.++|+++++||+|+||+||+|++..+ ++.||||+++.. ......+.+|+.+++.+ +|+|| +++++++.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnI-----v~~~~~~~ 80 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV-----VRLFDVCT 80 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTB-----CCEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCc-----ceeeeeec
Confidence 46899999999999999999999765 678999998642 22233566788888877 58887 77777763
Q ss_pred -----cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCc
Q 020652 164 -----YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDY 238 (323)
Q Consensus 164 -----~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~ 238 (323)
....++++||++.+.+..+........+++..++.++.|++.||+|||++||+||||||+|||++..+.+
T Consensus 81 ~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~----- 155 (305)
T d1blxa_ 81 VSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI----- 155 (305)
T ss_dssp EEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE-----
T ss_pred ccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCe-----
Confidence 3467999999996665555555555679999999999999999999999999999999999999765544
Q ss_pred ccccccCCCCCccccCCCCCCceEeeCCCcccccC--CccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCC
Q 020652 239 KFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSN 316 (323)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~ 316 (323)
||+|||.+..... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.
T Consensus 156 ----------------------kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~ 213 (305)
T d1blxa_ 156 ----------------------KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213 (305)
T ss_dssp ----------------------EECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ----------------------eecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCC
Confidence 5555555543322 2234689999999999999999999999999999999999999
Q ss_pred CCCC
Q 020652 317 CYLT 320 (323)
Q Consensus 317 pf~~ 320 (323)
||.+
T Consensus 214 pf~~ 217 (305)
T d1blxa_ 214 LFRG 217 (305)
T ss_dssp SCCC
T ss_pred CCCC
Confidence 9975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-48 Score=337.62 Aligned_cols=194 Identities=24% Similarity=0.364 Sum_probs=158.2
Q ss_pred eeecccCcEEEEEEEEC--CCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEE
Q 020652 98 SKMGEGTFGQVVECFDN--EKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVF 172 (323)
Q Consensus 98 ~~lG~G~fg~V~~~~~~--~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~ 172 (323)
++||+|+||+||+|.++ .+++.||||+++.. ....+.+.+|+.+|++++|+|| ++++++++.+ ..+|||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~~g~~~~~-~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI-----VRMIGICEAE-SWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEESS-SEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCC-----ceEEEEeccC-CEEEEE
Confidence 47999999999999764 45678999998642 2345678999999999999999 8888888654 578999
Q ss_pred ccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCcc
Q 020652 173 EKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSYF 251 (323)
Q Consensus 173 e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~ 251 (323)
||| +|+|.+++.+.. .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+|++|||+++.......
T Consensus 87 E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~-- 162 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-- 162 (277)
T ss_dssp ECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS--
T ss_pred EcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccc--
Confidence 999 899999998765 799999999999999999999999999999999999998887776666665433221110
Q ss_pred ccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 252 KNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 252 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
.........||+.|||||++.+..++.++|||||||++|||+| |+.||.+
T Consensus 163 -------------------~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~ 213 (277)
T d1xbba_ 163 -------------------YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 213 (277)
T ss_dssp -------------------EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred -------------------ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC
Confidence 0001122468999999999999999999999999999999998 8999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-47 Score=332.06 Aligned_cols=195 Identities=23% Similarity=0.348 Sum_probs=159.3
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCC----cEEEEEEecc--chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKK----ELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~----~~vAiK~~~~--~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
+.|++.+.||+|+||+||+|.++.++ ..||||++.. .......+.+|+.++++++|+|| +++++++...
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nI-----v~~~g~~~~~ 81 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI-----IRLEGVISKY 81 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEECSS
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCE-----eeeeEEEecC
Confidence 56999999999999999999987654 4799999864 33445678899999999999998 9999999999
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+..++||||| ++++.+++.... ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~----------- 149 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVC----------- 149 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE-----------
T ss_pred CceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeE-----------
Confidence 9999999999 888988887654 469999999999999999999999999999999999999766655
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCC------ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQD------HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCY 318 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf 318 (323)
||+|||+++..... .....||+.|||||++.+..++.++|||||||++|||++|..||
T Consensus 150 ----------------Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 150 ----------------KVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp ----------------EECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ----------------EEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence 55555555432211 11236899999999999999999999999999999999966555
Q ss_pred C
Q 020652 319 L 319 (323)
Q Consensus 319 ~ 319 (323)
.
T Consensus 214 ~ 214 (283)
T d1mqba_ 214 Y 214 (283)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=339.38 Aligned_cols=197 Identities=33% Similarity=0.586 Sum_probs=159.7
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec----
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD---- 163 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~---- 163 (323)
+.++|+++++||+|+||+||+|.+..+++.||||++... ....+.+.+|+.+|+.++|+|+ +++++++.
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~i-----v~~~~~~~~~~~ 80 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENI-----IGINDIIRAPTI 80 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTB-----CCCCEEECCSST
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCC-----CcEEEEEeeccc
Confidence 457899999999999999999999999999999998743 3445678899999999999999 55555543
Q ss_pred -cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccc
Q 020652 164 -YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLS 242 (323)
Q Consensus 164 -~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~ 242 (323)
....+|++|++++++|.+++... .+++..++.++.||+.||+|||++|||||||||+|||++.++.+
T Consensus 81 ~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~--------- 148 (345)
T d1pmea_ 81 EQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDL--------- 148 (345)
T ss_dssp TTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCE---------
T ss_pred cccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCE---------
Confidence 33457777776799999999865 59999999999999999999999999999999999999766554
Q ss_pred ccCCCCCccccCCCCCCceEeeCCCcccccC------CccccccCCccccchhhcC-CCCCcchhHHHHHHHHHHHhcCC
Q 020652 243 RSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ------DHSYVVSTRHYRAPEVILG-LGWNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~ 315 (323)
||+|||++..... .....+||+.|+|||++.. ..++.++||||+||++|||++|+
T Consensus 149 ------------------kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~ 210 (345)
T d1pmea_ 149 ------------------KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210 (345)
T ss_dssp ------------------EECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred ------------------EEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCC
Confidence 5555555543221 1233579999999999855 46789999999999999999999
Q ss_pred CCCCCC
Q 020652 316 NCYLTP 321 (323)
Q Consensus 316 ~pf~~~ 321 (323)
.||.+.
T Consensus 211 ~pf~~~ 216 (345)
T d1pmea_ 211 PIFPGK 216 (345)
T ss_dssp CSCCCS
T ss_pred CCCCCC
Confidence 999763
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=335.07 Aligned_cols=195 Identities=26% Similarity=0.379 Sum_probs=161.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIV 171 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 171 (323)
++|++.+.||+|+||+||+|+++.+ +.||||+++......+.+.+|+.++++++|+|| +++++++.. +.+++|
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nI-----v~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKL-----VQLYAVVSE-EPIYIV 89 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTB-----CCEEEEECS-SSCEEE
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCE-----eEEEEEEec-CCeEEE
Confidence 5799999999999999999998765 569999998766667789999999999999998 889998855 557899
Q ss_pred EccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCCc
Q 020652 172 FEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGSY 250 (323)
Q Consensus 172 ~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~~ 250 (323)
|||| +|+|..++.......+++..++.++.||+.||+|||++||+||||||+||||+.++.+
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~----------------- 152 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVC----------------- 152 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE-----------------
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcE-----------------
Confidence 9999 8999999876544579999999999999999999999999999999999999876655
Q ss_pred cccCCCCCCceEeeCCCcccccCC----ccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 251 FKNLPKSSAIKLIDFGSTTFEHQD----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 251 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||..||..
T Consensus 153 ----------kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 153 ----------KVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp ----------EECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ----------EEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 45555554432211 1224689999999999999999999999999999999997666543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=333.78 Aligned_cols=200 Identities=20% Similarity=0.290 Sum_probs=160.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCc----EEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKE----LVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.+|+++++||+|+||+||+|.+..+++ .||+|.++.. ....+.+.+|+.++++++|+|| +++++++..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~g~~~~~ 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV-----CRLLGICLTS 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTB-----CCEEEEEESS
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEecC
Confidence 359999999999999999999988876 5788877532 3446778999999999999998 8999988765
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+ .+++||++ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 84 ~-~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 84 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp S-EEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred C-eeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 4 56677777 999999888754 57999999999999999999999999999999999999998877766666665433
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
..... ........||+.|||||++.+..|+.++|||||||++|||+| |..||.+
T Consensus 162 ~~~~~----------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~ 216 (317)
T d1xkka_ 162 GAEEK----------------------EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216 (317)
T ss_dssp TTTCC------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccc----------------------cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC
Confidence 22111 001112368999999999999999999999999999999998 8999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=329.79 Aligned_cols=201 Identities=22% Similarity=0.283 Sum_probs=159.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCC---cEEEEEEecc--chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR 165 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~---~~vAiK~~~~--~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 165 (323)
.++|++.+.||+|+||+||+|.+..++ ..||||.++. .....+.+.+|+.++++++|||| +++++++. .
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~l~~~~~-~ 79 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI-----VKLIGVIT-E 79 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEEC-S
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCE-----eeEEEEEe-c
Confidence 368999999999999999999987553 4688998863 33445678899999999999998 88999886 4
Q ss_pred ceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 166 NHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 166 ~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+||+++.++.+|++|||++...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred CeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 6789999999 899999887654 46999999999999999999999999999999999999988776655555543221
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLTP 321 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~~ 321 (323)
.... ........||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.
T Consensus 159 ~~~~-----------------------~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~ 213 (273)
T d1mp8a_ 159 EDST-----------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213 (273)
T ss_dssp -----------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cCCc-----------------------ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC
Confidence 1100 001123468999999999999999999999999999999998 89999763
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-46 Score=329.82 Aligned_cols=195 Identities=30% Similarity=0.511 Sum_probs=161.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++|+++++||+|+||+||+|+++ +++.||||+++.. ....+.+.+|+.+|++++|+|| +++++++...+..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnI-----v~~~~~~~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI-----VKLYDVIHTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTB-----CCEEEEEECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcE-----EeeeeecccCCce
Confidence 58999999999999999999985 7899999998643 2235678899999999999998 8999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCC
Q 020652 169 CIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDG 248 (323)
Q Consensus 169 ~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~ 248 (323)
+++||++++++...+.... ..+++..++.++.||+.||+|||++|||||||||+|||++.++.+
T Consensus 76 ~i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~--------------- 139 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGEL--------------- 139 (286)
T ss_dssp EEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCE---------------
T ss_pred eEEEEeehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCE---------------
Confidence 9999999666555555433 479999999999999999999999999999999999999766554
Q ss_pred CccccCCCCCCceEeeCCCcccccCC---ccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 249 SYFKNLPKSSAIKLIDFGSTTFEHQD---HSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 249 ~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
|++|||.+...... .....||+.|+|||.+.+. .++.++|||||||++|||++|+.||.+
T Consensus 140 ------------kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 140 ------------KIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp ------------EECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ------------EecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 55555555432221 2234789999999999865 568999999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=335.32 Aligned_cols=206 Identities=29% Similarity=0.477 Sum_probs=165.1
Q ss_pred CceeEecCc-e--eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCc
Q 020652 80 GHYVFAIGE-N--LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGT 153 (323)
Q Consensus 80 ~~~~~~~~~-~--~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~ 153 (323)
..+++.+|+ . +.++|+++++||+|+||+||+|++..+|+.||||++... ....+.+.+|+.++++++|+||
T Consensus 2 ~~~~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnI--- 78 (355)
T d2b1pa1 2 QFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI--- 78 (355)
T ss_dssp CEEEEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTB---
T ss_pred CCEEEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCe---
Confidence 456788888 3 448999999999999999999999999999999999743 3444568899999999999998
Q ss_pred ceEEEcceec------cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 020652 154 RCVQIRNWFD------YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227 (323)
Q Consensus 154 ~~~~~~~~~~------~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli 227 (323)
++++++|. ..+++|+|||||.+++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 79 --v~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~ 152 (355)
T d2b1pa1 79 --ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV 152 (355)
T ss_dssp --CCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred --eEEEEEEecccccccCceeEEEEeccchHHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc
Confidence 77777774 457899999999777777664 268999999999999999999999999999999999999
Q ss_pred eecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccC--CccccccCCccccchhhcCCCCCcchhHHHHH
Q 020652 228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305 (323)
Q Consensus 228 ~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 305 (323)
+.++.++ ++|||.++.... .....+||+.|+|||++.+..++.++||||+|
T Consensus 153 ~~~~~~k---------------------------l~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG 205 (355)
T d2b1pa1 153 KSDCTLK---------------------------ILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 205 (355)
T ss_dssp CTTCCEE---------------------------ECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHH
T ss_pred cccccee---------------------------eechhhhhccccccccccccccccccChhhhcCCCCCCCccccccc
Confidence 7666554 455554433222 22335789999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCC
Q 020652 306 CILVELCSVSNCYLTP 321 (323)
Q Consensus 306 ~il~el~tg~~pf~~~ 321 (323)
|++|||++|+.||.+.
T Consensus 206 ~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 206 CIMGEMVRHKILFPGR 221 (355)
T ss_dssp HHHHHHHHSSCSSCCS
T ss_pred chHHHHhhCCCCCCCC
Confidence 9999999999999753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-46 Score=331.74 Aligned_cols=203 Identities=27% Similarity=0.471 Sum_probs=159.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec-----
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD----- 163 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~----- 163 (323)
++|+++++||+|+||+||+|++..+|+.||||++... ....+.+.+|+.+|++++|+|+ +++++.+.
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~ni-----i~~~~~~~~~~~~ 84 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV-----VNLIEICRTKASP 84 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTB-----CCEEEEEEC----
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCc-----cceEeeeeccccc
Confidence 6899999999999999999999999999999998633 2344678899999999999998 55555442
Q ss_pred ---cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 164 ---YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 164 ---~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
..+.+|+||||+++.+........ ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~~~~-~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHTCTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ccccCceEEEEEeccCCCccchhhhcc-cccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecce
Confidence 245789999999666666554433 5799999999999999999999999999999999999998777666666665
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
+......... ........+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.
T Consensus 164 ~~~~~~~~~~--------------------~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 164 ARAFSLAKNS--------------------QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp CEECCC-------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eeeccccccc--------------------ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCC
Confidence 4332211100 00112234799999999999876 68999999999999999999999997
Q ss_pred C
Q 020652 320 T 320 (323)
Q Consensus 320 ~ 320 (323)
+
T Consensus 224 ~ 224 (318)
T d3blha1 224 G 224 (318)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-46 Score=335.92 Aligned_cols=194 Identities=30% Similarity=0.531 Sum_probs=160.4
Q ss_pred cEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec------cCc
Q 020652 93 RYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD------YRN 166 (323)
Q Consensus 93 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~------~~~ 166 (323)
+|+.+++||+|+||+||+|++..+++.||||++...... ..+|+.+|++++|+|| ++++++|. ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~---~~~Ei~il~~l~h~ni-----v~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF---KNRELQIMRKLDHCNI-----VRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS---CCHHHHHHHHCCCTTB-----CCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH---HHHHHHHHHhcCCCCC-----CcEEEEEEecCccCCce
Confidence 599999999999999999999999999999998754332 3469999999999998 77777663 344
Q ss_pred eEEEEEccCCCCHHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccccccc
Q 020652 167 HICIVFEKLGPSLYDFLRK--NSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRS 244 (323)
Q Consensus 167 ~~~lv~e~~~~~L~~~l~~--~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~ 244 (323)
++|||||||++++.+.+.. .....+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~------------- 159 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT------------- 159 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTT-------------
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCC-------------
Confidence 6899999997766655542 2334799999999999999999999999999999999999996432
Q ss_pred CCCCCccccCCCCCCceEeeCCCcccccC--CccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 245 SKDGSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 245 ~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
..+||+|||++..... .....+||+.|+|||.+.+. .|+.++|||||||++|||++|+.||.+
T Consensus 160 -------------~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 160 -------------AVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp -------------CCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred -------------CceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence 2467777777765432 23345899999999998764 689999999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-46 Score=327.45 Aligned_cols=194 Identities=24% Similarity=0.355 Sum_probs=158.0
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec-cCceEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD-YRNHICI 170 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~-~~~~~~l 170 (323)
++|++.++||+|+||.||+|+++ |+.||||+++.. ...+.+.+|++++++++|+|| +++++++. ..+.+++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnI-----v~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNL-----VQLLGVIVEEKGGLYI 78 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTB-----CCEEEEECCC--CCEE
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCE-----eeEEEEEEecCCcEEE
Confidence 46999999999999999999874 678999999753 345678999999999999998 99999774 4567899
Q ss_pred EEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCCCC
Q 020652 171 VFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKDGS 249 (323)
Q Consensus 171 v~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~~~ 249 (323)
||||+ +|+|.+++.+.....+++..++.++.||+.||.|||+++|+||||||+|||++.++
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~------------------ 140 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN------------------ 140 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS------------------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC------------------
Confidence 99999 99999999765434689999999999999999999999999999999999986554
Q ss_pred ccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 250 YFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 250 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
.+|++|||+++..........+|..|+|||++.+..++.++|||||||++|||+| |++||..
T Consensus 141 ---------~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~ 203 (262)
T d1byga_ 141 ---------VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203 (262)
T ss_dssp ---------CEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred ---------CEeecccccceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC
Confidence 4566777777665555555678999999999999999999999999999999998 7888865
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=327.09 Aligned_cols=202 Identities=23% Similarity=0.339 Sum_probs=154.8
Q ss_pred CcEEEEeeecccCcEEEEEEEECC-----CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHh-CCCCCcceEEEcceec
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLAR-HDIGGTRCVQIRNWFD 163 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~-~~i~~~~~~~~~~~~~ 163 (323)
++|++.++||+|+||+||+|++.. +++.||||+++.. ....+.+.+|..++.++.| +|+ +.+++++.
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~i-----v~~~~~~~ 87 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV-----VNLLGACT 87 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEEC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeE-----EEeeeeec
Confidence 579999999999999999999754 3468999998642 3345667788888888865 455 66666654
Q ss_pred -cCceEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEE
Q 020652 164 -YRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILL 227 (323)
Q Consensus 164 -~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli 227 (323)
.+..+++||||| +|+|.+++.... ...+++..+..++.||+.||+|||+++||||||||+||||
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 456789999999 999999997542 1358899999999999999999999999999999999999
Q ss_pred eecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHH
Q 020652 228 VSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCI 307 (323)
Q Consensus 228 ~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 307 (323)
+.++.+||+|||+++....... ........||+.|||||++.+..++.++|||||||+
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~----------------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvi 225 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPD----------------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 225 (299)
T ss_dssp CGGGCEEECC------CCSCTT----------------------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred CCCCcEEEccCcchhhcccccc----------------------ccccCceeeCccccchhHhhcCCCCcccceeehHHH
Confidence 8777666655555432221110 001223579999999999999999999999999999
Q ss_pred HHHHhcC-CCCCCC
Q 020652 308 LVELCSV-SNCYLT 320 (323)
Q Consensus 308 l~el~tg-~~pf~~ 320 (323)
+|||+|| ..||.+
T Consensus 226 l~ellt~~~~p~~~ 239 (299)
T d1ywna1 226 LWEIFSLGASPYPG 239 (299)
T ss_dssp HHHHHTTSCCSSTT
T ss_pred HHHHHhCCCCCCCC
Confidence 9999986 567765
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-45 Score=327.63 Aligned_cols=199 Identities=23% Similarity=0.359 Sum_probs=165.0
Q ss_pred eCCcEEEEeeecccCcEEEEEEEEC-----CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEccee
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~ 162 (323)
..++|++.++||+|+||+||+|+++ .+++.||||+++.. ....+.+.+|+.++++++|+|+ +++++++
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~ni-----v~~~~~~ 85 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI-----VKLLGVC 85 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTB-----CCEEEEE
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCc-----ccceeee
Confidence 3467999999999999999999875 35678999998743 3445678999999999999998 8999999
Q ss_pred ccCceEEEEEccC-CCCHHHHHHhcC----------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Q 020652 163 DYRNHICIVFEKL-GPSLYDFLRKNS----------------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTD 219 (323)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrD 219 (323)
...+..+++|||+ +++|.+++.... ...+++..+..++.|++.||+|||+++|||||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 9999999999999 899999997532 12488999999999999999999999999999
Q ss_pred CCCCcEEEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccC-----CccccccCCccccchhhcCCC
Q 020652 220 LKPENILLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ-----DHSYVVSTRHYRAPEVILGLG 294 (323)
Q Consensus 220 lKp~NIli~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~ 294 (323)
|||+|||++.++.+ ||+|||+++.... ......||+.|+|||.+.+..
T Consensus 166 lKp~NILld~~~~~---------------------------Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 218 (301)
T d1lufa_ 166 LATRNCLVGENMVV---------------------------KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 218 (301)
T ss_dssp CSGGGEEECGGGCE---------------------------EECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC
T ss_pred EcccceEECCCCcE---------------------------EEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC
Confidence 99999999776655 5555555432211 122357899999999999999
Q ss_pred CCcchhHHHHHHHHHHHhcCC-CCCCC
Q 020652 295 WNYPCDLWSVGCILVELCSVS-NCYLT 320 (323)
Q Consensus 295 ~~~~~DiwSlG~il~el~tg~-~pf~~ 320 (323)
|+.++|||||||++|||++|. +||.+
T Consensus 219 ~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 219 YTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CChhhhhccchhhHHHHHccCCCCCCC
Confidence 999999999999999999986 56764
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.7e-45 Score=329.12 Aligned_cols=191 Identities=23% Similarity=0.538 Sum_probs=161.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHH-hCCCCCcceEEEcceecc--CceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLA-RHDIGGTRCVQIRNWFDY--RNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~-~~~i~~~~~~~~~~~~~~--~~~~ 168 (323)
++|+++++||+|+||+||+|++..+++.||||+++... .+.+.+|+.+|+.+. |+|| ++++++|.. ...+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~Ei~il~~l~~hpnI-----v~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNI-----ITLADIVKDPVSRTP 107 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC--HHHHHHHHHHHHHHTTSTTB-----CCEEEEEECTTTCSE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH--HHHHHHHHHHHHhccCCCCC-----cEEEEEEEecCCCce
Confidence 57999999999999999999999999999999987533 456889999999996 8888 888888764 4579
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||||| +++|.++. ..+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~---------------- 166 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEH---------------- 166 (328)
T ss_dssp EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT----------------
T ss_pred eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCC----------------
Confidence 9999999 77876553 3699999999999999999999999999999999999997543
Q ss_pred CCccccCCCCCCceEeeCCCcccccC--CccccccCCccccchhhcCC-CCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQ--DHSYVVSTRHYRAPEVILGL-GWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
..+||+|||+|..... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 167 ----------~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~ 232 (328)
T d3bqca1 167 ----------RKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232 (328)
T ss_dssp ----------TEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ----------CeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCC
Confidence 2346666666654332 23345789999999998876 479999999999999999999999965
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=333.56 Aligned_cols=196 Identities=29% Similarity=0.514 Sum_probs=162.2
Q ss_pred eCCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec---
Q 020652 90 LTPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD--- 163 (323)
Q Consensus 90 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~--- 163 (323)
+.++|+++++||+|+||+||+|++..+|+.||||++... ....+.+.+|+.+|+.++|+|+ +++++++.
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~i-----v~~~~~~~~~~ 90 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV-----IGLLDVFTPAR 90 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTB-----CCCSEEECSCS
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCe-----eeEEEEEeecc
Confidence 457899999999999999999999999999999998743 2344567899999999999998 66666654
Q ss_pred ---cCceEEEEEccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCccc
Q 020652 164 ---YRNHICIVFEKLGPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKF 240 (323)
Q Consensus 164 ---~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~ 240 (323)
..+..+++|++++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~--------- 158 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC--------- 158 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC---------
T ss_pred ccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc---------
Confidence 33445555555599999998653 599999999999999999999999999999999999986554
Q ss_pred ccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 241 LSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
.+|++|||.+...........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.
T Consensus 159 ------------------~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~ 220 (348)
T d2gfsa1 159 ------------------ELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220 (348)
T ss_dssp ------------------CEEECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ------------------cccccccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence 457777777766655556678999999999987764 6899999999999999999999997
Q ss_pred C
Q 020652 320 T 320 (323)
Q Consensus 320 ~ 320 (323)
+
T Consensus 221 ~ 221 (348)
T d2gfsa1 221 G 221 (348)
T ss_dssp C
T ss_pred C
Confidence 6
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=327.70 Aligned_cols=196 Identities=24% Similarity=0.414 Sum_probs=164.7
Q ss_pred CcEEEEeeecccCcEEEEEEEE---CCCCcEEEEEEeccc-----hhhHHHHHHHHHHHHHHHh-CCCCCcceEEEccee
Q 020652 92 PRYRILSKMGEGTFGQVVECFD---NEKKELVAIKIVRSI-----NKYREAAMIEIDVLQRLAR-HDIGGTRCVQIRNWF 162 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~---~~~~~~vAiK~~~~~-----~~~~~~~~~Ei~~l~~l~~-~~i~~~~~~~~~~~~ 162 (323)
++|+++++||+|+||+||+|++ ..+|+.||||+++.. ....+.+.+|+.++++++| +|| +++++++
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnI-----v~~~~~~ 98 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL-----VTLHYAF 98 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTB-----CCEEEEE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeE-----EEeeeee
Confidence 5799999999999999999987 447899999998632 2334567789999999998 467 8999999
Q ss_pred ccCceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccc
Q 020652 163 DYRNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFL 241 (323)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~ 241 (323)
++...++++|||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~v-------- 168 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHV-------- 168 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCE--------
T ss_pred ccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCE--------
Confidence 9999999999999 999999998776 68899999999999999999999999999999999999766554
Q ss_pred cccCCCCCccccCCCCCCceEeeCCCcccccC----CccccccCCccccchhhcCC--CCCcchhHHHHHHHHHHHhcCC
Q 020652 242 SRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQ----DHSYVVSTRHYRAPEVILGL--GWNYPCDLWSVGCILVELCSVS 315 (323)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~ 315 (323)
||+|||+++.... ......||+.|+|||.+.+. .++.++|||||||+||||++|+
T Consensus 169 -------------------kL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~ 229 (322)
T d1vzoa_ 169 -------------------VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229 (322)
T ss_dssp -------------------EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred -------------------EEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCC
Confidence 5555555543221 12335799999999999765 4678999999999999999999
Q ss_pred CCCCCC
Q 020652 316 NCYLTP 321 (323)
Q Consensus 316 ~pf~~~ 321 (323)
.||.+.
T Consensus 230 ~PF~~~ 235 (322)
T d1vzoa_ 230 SPFTVD 235 (322)
T ss_dssp CTTSCT
T ss_pred CCCCCC
Confidence 999764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-45 Score=320.86 Aligned_cols=194 Identities=31% Similarity=0.505 Sum_probs=165.4
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccc---hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSI---NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~---~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
++|+++++||+|+||+||+|++..+++.||||+++.. ....+.+.+|+.+|+.++|+|+ +++++++......
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~ni-----v~~~~~~~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI-----VRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTB-----CCEEEEEECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCE-----Eeeccccccccce
Confidence 5899999999999999999999999999999998643 2345778899999999999988 8999999999999
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
+++|+++ +++|..++...+ .+++..++.++.|++.||+|||++||+||||||+|||++.++.
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--------------- 139 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--------------- 139 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC---------------
T ss_pred eEEeeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc---------------
Confidence 9999999 677777766544 7899999999999999999999999999999999999965544
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCc---cccccCCccccchhhcCCC-CCcchhHHHHHHHHHHHhcCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDH---SYVVSTRHYRAPEVILGLG-WNYPCDLWSVGCILVELCSVSNCYL 319 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~ 319 (323)
+||+|||.+....... ....+++.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 140 ------------~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 140 ------------LKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp ------------EEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred ------------eeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 4666666665433222 2246788999999998765 6899999999999999999999974
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=322.35 Aligned_cols=201 Identities=21% Similarity=0.328 Sum_probs=154.7
Q ss_pred CcEEEEeeecccCcEEEEEEEECCC-C--cEEEEEEeccc----hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEK-K--ELVAIKIVRSI----NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY 164 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~-~--~~vAiK~~~~~----~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~ 164 (323)
++|++.+.||+|+||+||+|++..+ + ..||||+++.. ....+.+.+|+.+|++++|+|| +++++++.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nI-----v~~~g~~~~ 82 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL-----IRLYGVVLT 82 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTB-----CCEEEEECS
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCE-----EEEEEEEee
Confidence 4699999999999999999986533 3 46899988642 3345678999999999999999 899999876
Q ss_pred CceEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccc
Q 020652 165 RNHICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSR 243 (323)
Q Consensus 165 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~ 243 (323)
. .+++||||| +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++..
T Consensus 83 ~-~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 83 P-PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred c-chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhh
Confidence 4 678999999 899999887654 3599999999999999999999999999999999999998877665555554332
Q ss_pred cCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhc-CCCCCCC
Q 020652 244 SSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 244 ~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~t-g~~pf~~ 320 (323)
...... .........||..|+|||++.+..++.++|||||||++|||+| |+.||.+
T Consensus 161 ~~~~~~---------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~ 217 (273)
T d1u46a_ 161 LPQNDD---------------------HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 217 (273)
T ss_dssp CCC-CC---------------------EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccCCC---------------------cceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC
Confidence 211110 0001122367889999999999999999999999999999998 8999975
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-45 Score=321.91 Aligned_cols=198 Identities=21% Similarity=0.323 Sum_probs=160.4
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCC-------cEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcc
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKK-------ELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRN 160 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~-------~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~ 160 (323)
.++|++.+.||+|+||.||+|++..++ ..||||+++.. ......+.+|...+.++ +|+|| +++++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnI-----v~~~~ 86 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI-----INLLG 86 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEE
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeE-----Eeccc
Confidence 368999999999999999999986654 47999998643 34456788899999998 68888 99999
Q ss_pred eeccCceEEEEEccC-CCCHHHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 020652 161 WFDYRNHICIVFEKL-GPSLYDFLRKNS--------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (323)
Q Consensus 161 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~--------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NI 225 (323)
++..++.+++||||| +|+|.+++.... ...+++..++.++.||+.||+|||+++||||||||+||
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence 999999999999999 999999997543 23589999999999999999999999999999999999
Q ss_pred EEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchh
Q 020652 226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCD 300 (323)
Q Consensus 226 li~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~D 300 (323)
|++.++.+ ||+|||.+...... .....||+.|+|||.+.+..|+.++|
T Consensus 167 Ll~~~~~~---------------------------kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~D 219 (299)
T d1fgka_ 167 LVTEDNVM---------------------------KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 219 (299)
T ss_dssp EECTTCCE---------------------------EECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHH
T ss_pred eecCCCCe---------------------------EeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhh
Confidence 99766655 45555554432221 12347899999999999999999999
Q ss_pred HHHHHHHHHHHhc-CCCCCCC
Q 020652 301 LWSVGCILVELCS-VSNCYLT 320 (323)
Q Consensus 301 iwSlG~il~el~t-g~~pf~~ 320 (323)
||||||++|||++ |.+||.+
T Consensus 220 iwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 220 VWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp HHHHHHHHHHHHTTSCCSSTT
T ss_pred hHHhHHHHHHhccCCCCCCCC
Confidence 9999999999998 7888865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-44 Score=318.75 Aligned_cols=203 Identities=27% Similarity=0.384 Sum_probs=167.6
Q ss_pred CCcEEEEeeecccCcEEEEEEEEC-----CCCcEEEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEccee
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDN-----EKKELVAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWF 162 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~ 162 (323)
.++|++.++||+|+||.||+|++. .+++.||||+++.. ......+.+|+.+++++ +|+|| +++++++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnI-----v~~~g~~ 96 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI-----VNLLGAC 96 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB-----CCEEEEE
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCE-----EEEEEEE
Confidence 368999999999999999999863 46678999998743 34456788999999999 58888 9999999
Q ss_pred ccCceEEEEEccC-CCCHHHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcE
Q 020652 163 DYRNHICIVFEKL-GPSLYDFLRKNS----------------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENI 225 (323)
Q Consensus 163 ~~~~~~~lv~e~~-~~~L~~~l~~~~----------------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NI 225 (323)
.....+++||||| +++|.+++.... ...+++..+..++.||+.||+|||+++|+||||||+||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NI 176 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccc
Confidence 9999999999999 899999997643 12588999999999999999999999999999999999
Q ss_pred EEeecCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHH
Q 020652 226 LLVSAEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVG 305 (323)
Q Consensus 226 li~~~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 305 (323)
+++.++.+|++|||+++........ .......||+.|+|||++.+..++.++||||||
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G 234 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNY----------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 234 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTS----------------------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred cccccCcccccccchheeccCCCcc----------------------eEeeecccChHHcCHHHhcCCCCCCcccccchH
Confidence 9988877777777665433221110 001224789999999999999999999999999
Q ss_pred HHHHHHhc-CCCCCCC
Q 020652 306 CILVELCS-VSNCYLT 320 (323)
Q Consensus 306 ~il~el~t-g~~pf~~ 320 (323)
|++|||+| |.+||.+
T Consensus 235 ~~l~ellt~g~p~~~~ 250 (311)
T d1t46a_ 235 IFLWELFSLGSSPYPG 250 (311)
T ss_dssp HHHHHHHTTTCCSSTT
T ss_pred HHHHHHHhCCCCCCCC
Confidence 99999998 5666654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-45 Score=321.67 Aligned_cols=200 Identities=21% Similarity=0.222 Sum_probs=153.1
Q ss_pred CCcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccC----c
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYR----N 166 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~----~ 166 (323)
+.+|.+.++||+|+||.||+|++ +|+.||||+++...........|+..+..++|+|| +++++++... .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnI-----v~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENI-----LGFIAADNKDNGTWT 74 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTB-----CCEEEEEEEECSSSE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcC-----cceEEEEEeCCCcce
Confidence 45799999999999999999975 68899999987554433334445555667788888 8888877653 3
Q ss_pred eEEEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCceecCCCCCcEEEeecCceeccC
Q 020652 167 HICIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE--------LRLIHTDLKPENILLVSAEYVKVPD 237 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~--------~~iiHrDlKp~NIli~~~~~~ki~d 237 (323)
.+|+||||| +|+|.+++++. .+++..+..++.|++.||.|||+ +||+||||||+||||+.++.+||+|
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 689999999 99999999875 49999999999999999999996 5999999999999997666555544
Q ss_pred cccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCC------CCcchhHHHHHHHHHHH
Q 020652 238 YKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLG------WNYPCDLWSVGCILVEL 311 (323)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~el 311 (323)
||++......... ........+||+.|||||++.+.. ++.++|||||||+||||
T Consensus 152 FGl~~~~~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el 211 (303)
T d1vjya_ 152 LGLAVRHDSATDT--------------------IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211 (303)
T ss_dssp CTTCEEEETTTTE--------------------ECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred cCccccccCCCcc--------------------eeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHH
Confidence 4443222111100 000112357999999999987653 56789999999999999
Q ss_pred hcCCCCCCC
Q 020652 312 CSVSNCYLT 320 (323)
Q Consensus 312 ~tg~~pf~~ 320 (323)
+||..||..
T Consensus 212 ~tg~~~~~~ 220 (303)
T d1vjya_ 212 ARRCSIGGI 220 (303)
T ss_dssp HHTBCBTTB
T ss_pred hhCCCCCCc
Confidence 999888743
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-45 Score=322.77 Aligned_cols=197 Identities=22% Similarity=0.323 Sum_probs=161.2
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcE--EEEEEeccc--hhhHHHHHHHHHHHHHH-HhCCCCCcceEEEcceeccCc
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKEL--VAIKIVRSI--NKYREAAMIEIDVLQRL-ARHDIGGTRCVQIRNWFDYRN 166 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~--vAiK~~~~~--~~~~~~~~~Ei~~l~~l-~~~~i~~~~~~~~~~~~~~~~ 166 (323)
++|++.++||+|+||+||+|+++.++.. ||||.++.. ....+.+.+|+.+|+++ +|+|| +++++++...+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnI-----v~~~~~~~~~~ 84 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI-----INLLGACEHRG 84 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTB-----CCEEEEEEETT
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCE-----eeEEEEEecCC
Confidence 4799999999999999999999888874 677776532 33456789999999998 68988 99999999999
Q ss_pred eEEEEEccC-CCCHHHHHHhc--------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecC
Q 020652 167 HICIVFEKL-GPSLYDFLRKN--------------SYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAE 231 (323)
Q Consensus 167 ~~~lv~e~~-~~~L~~~l~~~--------------~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~ 231 (323)
.+++||||+ +|+|.+++... ....+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999 99999999754 235799999999999999999999999999999999999997666
Q ss_pred ceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC--ccccccCCccccchhhcCCCCCcchhHHHHHHHHH
Q 020652 232 YVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD--HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (323)
Q Consensus 232 ~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (323)
.+ ||+|||+++..... .....||..|+|||.+.+..++.++|||||||++|
T Consensus 165 ~~---------------------------kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ 217 (309)
T d1fvra_ 165 VA---------------------------KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217 (309)
T ss_dssp CE---------------------------EECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred ce---------------------------EEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHH
Confidence 55 55555555432221 12346899999999999999999999999999999
Q ss_pred HHhcCC-CCCCC
Q 020652 310 ELCSVS-NCYLT 320 (323)
Q Consensus 310 el~tg~-~pf~~ 320 (323)
||++|. +||.+
T Consensus 218 ell~~~~~p~~~ 229 (309)
T d1fvra_ 218 EIVSLGGTPYCG 229 (309)
T ss_dssp HHHTTSCCTTTT
T ss_pred HHHhcCCCCCCC
Confidence 999975 56654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-43 Score=318.95 Aligned_cols=218 Identities=32% Similarity=0.526 Sum_probs=181.2
Q ss_pred eeEecCceeC-CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCC------Ccc
Q 020652 82 YVFAIGENLT-PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIG------GTR 154 (323)
Q Consensus 82 ~~~~~~~~~~-~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~------~~~ 154 (323)
++..+|+.+. +||+++++||+|+||+||+|++..+|+.||||++++.....+...+|+.+++.+.|+++. +.+
T Consensus 2 ~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~ 81 (362)
T d1q8ya_ 2 HPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANH 81 (362)
T ss_dssp CCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTT
T ss_pred CCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCc
Confidence 3456788886 579999999999999999999999999999999987766677888999999999988753 356
Q ss_pred eEEEcceeccC--ceEEEEEccC--CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCCCcEEEee
Q 020652 155 CVQIRNWFDYR--NHICIVFEKL--GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHE-LRLIHTDLKPENILLVS 229 (323)
Q Consensus 155 ~~~~~~~~~~~--~~~~lv~e~~--~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~iiHrDlKp~NIli~~ 229 (323)
++++++++... ...+++|+++ +++............+++..++.++.||+.||+|||+ +||+||||||+||||+.
T Consensus 82 iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~ 161 (362)
T d1q8ya_ 82 ILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 161 (362)
T ss_dssp BCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEE
T ss_pred eEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeec
Confidence 78888877543 4556666655 5556666665555689999999999999999999998 89999999999999976
Q ss_pred cCceeccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHH
Q 020652 230 AEYVKVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (323)
Q Consensus 230 ~~~~ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (323)
++.. .....++++|||.+..........+||+.|+|||++.+..++.++||||+||+++
T Consensus 162 ~~~~---------------------~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 220 (362)
T d1q8ya_ 162 VDSP---------------------ENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIF 220 (362)
T ss_dssp EETT---------------------TTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHH
T ss_pred cCcc---------------------cccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHH
Confidence 5421 1123468999999887776667789999999999999999999999999999999
Q ss_pred HHhcCCCCCCC
Q 020652 310 ELCSVSNCYLT 320 (323)
Q Consensus 310 el~tg~~pf~~ 320 (323)
||++|+.||..
T Consensus 221 el~~g~~pF~~ 231 (362)
T d1q8ya_ 221 ELITGDFLFEP 231 (362)
T ss_dssp HHHHSSCCC--
T ss_pred HHHHCCCCCCC
Confidence 99999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-43 Score=312.36 Aligned_cols=200 Identities=17% Similarity=0.207 Sum_probs=161.2
Q ss_pred EEEeeecccCcEEEEEEEECCCC---cEEEEEEecc--chhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceecc-CceE
Q 020652 95 RILSKMGEGTFGQVVECFDNEKK---ELVAIKIVRS--INKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDY-RNHI 168 (323)
Q Consensus 95 ~~~~~lG~G~fg~V~~~~~~~~~---~~vAiK~~~~--~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~-~~~~ 168 (323)
.+.++||+|+||+||+|++..++ ..||||+++. .....+.+.+|+++|++++|+|| +++++++.. ++..
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnI-----v~~~g~~~~~~~~~ 104 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV-----LSLLGICLRSEGSP 104 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTB-----CCCCEEEEETTTEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCE-----eEEeEEEEecCCce
Confidence 34688999999999999986653 3689999863 34455779999999999999998 888888654 5689
Q ss_pred EEEEccC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCceeccCcccccccCCC
Q 020652 169 CIVFEKL-GPSLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVKVPDYKFLSRSSKD 247 (323)
Q Consensus 169 ~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ki~d~~~~~~~~~~ 247 (323)
++||||| +++|.+++.... ..+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||++......
T Consensus 105 ~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 105 LVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 9999999 899999987654 46788899999999999999999999999999999999987777766666665433221
Q ss_pred CCccccCCCCCCceEeeCCCcccccCCccccccCCccccchhhcCCCCCcchhHHHHHHHHHHHhcCCCCCCC
Q 020652 248 GSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILVELCSVSNCYLT 320 (323)
Q Consensus 248 ~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 320 (323)
... .........||+.|+|||.+.+..++.++|||||||++|||+||..||..
T Consensus 184 ~~~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~ 236 (311)
T d1r0pa_ 184 EFD--------------------SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236 (311)
T ss_dssp TCC--------------------CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred ccc--------------------cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence 110 00011224689999999999999999999999999999999998888765
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=315.89 Aligned_cols=198 Identities=20% Similarity=0.334 Sum_probs=165.5
Q ss_pred CCcEEEEeeecccCcEEEEEEEECC-----CCcEEEEEEeccc--hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceec
Q 020652 91 TPRYRILSKMGEGTFGQVVECFDNE-----KKELVAIKIVRSI--NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFD 163 (323)
Q Consensus 91 ~~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~vAiK~~~~~--~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~ 163 (323)
.++|++.++||+|+||+||+|.+.. +++.||||+++.. ......+.+|+.++++++|+|| +++++++.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nI-----v~~~~~~~ 93 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV-----VRLLGVVS 93 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTB-----CCEEEEEC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCE-----eeeeeEEe
Confidence 3689999999999999999998753 3578999998743 3344568899999999999998 99999999
Q ss_pred cCceEEEEEccC-CCCHHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCcee
Q 020652 164 YRNHICIVFEKL-GPSLYDFLRKNS--------YRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYVK 234 (323)
Q Consensus 164 ~~~~~~lv~e~~-~~~L~~~l~~~~--------~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~k 234 (323)
..+..++||||+ +|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~--- 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF--- 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC---
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc---
Confidence 899999999999 999999986421 13478899999999999999999999999999999999986554
Q ss_pred ccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCC-----ccccccCCccccchhhcCCCCCcchhHHHHHHHHH
Q 020652 235 VPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQD-----HSYVVSTRHYRAPEVILGLGWNYPCDLWSVGCILV 309 (323)
Q Consensus 235 i~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 309 (323)
.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|
T Consensus 171 ------------------------~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~ 226 (308)
T d1p4oa_ 171 ------------------------TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 226 (308)
T ss_dssp ------------------------CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred ------------------------eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHH
Confidence 4566666666543222 12246899999999999999999999999999999
Q ss_pred HHhcCC-CCCCC
Q 020652 310 ELCSVS-NCYLT 320 (323)
Q Consensus 310 el~tg~-~pf~~ 320 (323)
||+||. .||.+
T Consensus 227 El~t~~~~p~~~ 238 (308)
T d1p4oa_ 227 EIATLAEQPYQG 238 (308)
T ss_dssp HHHHTSCCTTTT
T ss_pred HHHhCCCCCCCC
Confidence 999984 77764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=2.7e-27 Score=195.01 Aligned_cols=163 Identities=21% Similarity=0.235 Sum_probs=112.3
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-------------------hhHHHHHHHHHHHHHHHhCCCCCcc
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-------------------KYREAAMIEIDVLQRLARHDIGGTR 154 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-------------------~~~~~~~~Ei~~l~~l~~~~i~~~~ 154 (323)
+.+.++||+|+||+||+|.+. +|+.||||+++... .......+|...+.++.+.++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v---- 76 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAV---- 76 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSS----
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCc----
Confidence 457899999999999999874 68899999875210 112334568888888888776
Q ss_pred eEEEcceeccCceEEEEEccCCC-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCCCcEEEeecCce
Q 020652 155 CVQIRNWFDYRNHICIVFEKLGP-SLYDFLRKNSYRSFPIDLVRELGRQLLESVAFMHELRLIHTDLKPENILLVSAEYV 233 (323)
Q Consensus 155 ~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iiHrDlKp~NIli~~~~~~ 233 (323)
+..+++. ..+++|||+++ .+. .++...+..++.|++.+|.|||++||+||||||+|||++++
T Consensus 77 -~~~~~~~----~~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--- 139 (191)
T d1zara2 77 -PKVYAWE----GNAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--- 139 (191)
T ss_dssp -CCEEEEE----TTEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT---
T ss_pred -ceEEEec----CCEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC---
Confidence 4333322 12799999944 321 25556678899999999999999999999999999999643
Q ss_pred eccCcccccccCCCCCccccCCCCCCceEeeCCCcccccCCccccccCCccccc--hh---hcCCCCCcchhHHHHHHHH
Q 020652 234 KVPDYKFLSRSSKDGSYFKNLPKSSAIKLIDFGSTTFEHQDHSYVVSTRHYRAP--EV---ILGLGWNYPCDLWSVGCIL 308 (323)
Q Consensus 234 ki~d~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~gt~~y~aP--E~---~~~~~~~~~~DiwSlG~il 308 (323)
.++|+|||.|......... .|... +. +....|+.++|+||+.--+
T Consensus 140 -------------------------~~~liDFG~a~~~~~~~~~-----~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 140 -------------------------GIWIIDFPQSVEVGEEGWR-----EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp -------------------------EEEECCCTTCEETTSTTHH-----HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred -------------------------CEEEEECCCcccCCCCCcH-----HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 2577888877654322211 11111 00 1134678899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.37 E-value=8.1e-07 Score=74.23 Aligned_cols=85 Identities=12% Similarity=0.087 Sum_probs=56.6
Q ss_pred CcEEEEeeecccCcEEEEEEEECCCCcEEEEEEeccch-hhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEE
Q 020652 92 PRYRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSIN-KYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICI 170 (323)
Q Consensus 92 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~-~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 170 (323)
..|++.+..+.++.+.||+.. ..++.+++|+..... .....+.+|...+..+.. .+ .+.+++.+...++..++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~-~v---pvP~vl~~~~~~~~~~l 87 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEG-KL---PVPKVLHFERHDGWSNL 87 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTT-TS---CCCCEEEEEEETTEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhc-cC---CCCcEEEEEecCCceEE
Confidence 457777776656667899884 455667888775332 223346778888888853 22 23455566667788999
Q ss_pred EEccC-CCCHHHH
Q 020652 171 VFEKL-GPSLYDF 182 (323)
Q Consensus 171 v~e~~-~~~L~~~ 182 (323)
||+++ |.++.+.
T Consensus 88 v~~~l~G~~~~~~ 100 (263)
T d1j7la_ 88 LMSEADGVLCSEE 100 (263)
T ss_dssp EEECCSSEEHHHH
T ss_pred EEEeccccccccc
Confidence 99999 6666543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.00 E-value=1.4e-05 Score=70.83 Aligned_cols=76 Identities=21% Similarity=0.220 Sum_probs=46.2
Q ss_pred EeeecccCcEEEEEEEECCCCcEEEEEEeccc--------hhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceE
Q 020652 97 LSKMGEGTFGQVVECFDNEKKELVAIKIVRSI--------NKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHI 168 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~--------~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 168 (323)
.+.||.|....||++.+..+++.+++|.-... ....++...|...|+.+.... ...+.+++.+. ....
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~--p~~vP~v~~~d--~~~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHV--PHLVPRVFYSD--TEMA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTC--GGGSCCEEEEE--TTTT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhC--CCCcceEEEEc--CCCC
Confidence 46789999999999998888888999965321 112234567888888775421 12234444332 3345
Q ss_pred EEEEccCC
Q 020652 169 CIVFEKLG 176 (323)
Q Consensus 169 ~lv~e~~~ 176 (323)
++|||+++
T Consensus 107 ~lvmE~L~ 114 (392)
T d2pula1 107 VTVMEDLS 114 (392)
T ss_dssp EEEECCCT
T ss_pred EEEEeccC
Confidence 78999993
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.79 E-value=3.3e-05 Score=63.72 Aligned_cols=75 Identities=15% Similarity=0.126 Sum_probs=50.6
Q ss_pred eecccC-cEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEEEEEccC-C
Q 020652 99 KMGEGT-FGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHICIVFEKL-G 176 (323)
Q Consensus 99 ~lG~G~-fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~-~ 176 (323)
.+..|. .+.||+... .++..+++|...... ...+..|...++.+....+. +.+++.+....+..++||+++ |
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvp---vP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVP---CAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCC---BCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCC---CCceeeecccccceEEEEEeeec
Confidence 444454 467898874 456668889765432 23467799999999876653 344555566677889999999 5
Q ss_pred CCH
Q 020652 177 PSL 179 (323)
Q Consensus 177 ~~L 179 (323)
.++
T Consensus 91 ~~~ 93 (255)
T d1nd4a_ 91 QDL 93 (255)
T ss_dssp EET
T ss_pred ccc
Confidence 443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.56 E-value=0.00014 Score=62.48 Aligned_cols=70 Identities=16% Similarity=0.216 Sum_probs=48.7
Q ss_pred EEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEc--ceeccCceEEEEEccCC
Q 020652 106 GQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIR--NWFDYRNHICIVFEKLG 176 (323)
Q Consensus 106 g~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~--~~~~~~~~~~lv~e~~~ 176 (323)
-.||++.. .+|+.|++|+.+......+++..|+..+..|....+.....+... ..+......+.++++++
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 57999974 567789999987655556778889999999998766433222221 12344567888999884
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.24 E-value=0.00083 Score=59.04 Aligned_cols=70 Identities=14% Similarity=0.192 Sum_probs=48.2
Q ss_pred EeeecccCcEEEEEEEECC-------CCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcceEEEcceeccCceEE
Q 020652 97 LSKMGEGTFGQVVECFDNE-------KKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTRCVQIRNWFDYRNHIC 169 (323)
Q Consensus 97 ~~~lG~G~fg~V~~~~~~~-------~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 169 (323)
++.|+.|-.-.+|++.... ..+.|.+++.-.. .......+|..+++.+...++. .+++.++.. +
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~~idr~~E~~i~~~ls~~gl~----Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLG----PKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSS----SCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-chhhHHHHHHHHHHHHHhCCCC----CeEEEEcCC----c
Confidence 4688889999999998643 2456778876532 2233456799999999887762 344555543 5
Q ss_pred EEEccC
Q 020652 170 IVFEKL 175 (323)
Q Consensus 170 lv~e~~ 175 (323)
+||||+
T Consensus 118 ~I~efi 123 (395)
T d1nw1a_ 118 RLEEYI 123 (395)
T ss_dssp EEECCC
T ss_pred eEEEEe
Confidence 789988
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.94 E-value=0.002 Score=54.47 Aligned_cols=58 Identities=10% Similarity=0.098 Sum_probs=36.8
Q ss_pred EEEEeeecccCcEEEEEEEECCCCcEEEEEEeccchhhHHHHHHHHHHHHHHHhCCCCCcc
Q 020652 94 YRILSKMGEGTFGQVVECFDNEKKELVAIKIVRSINKYREAAMIEIDVLQRLARHDIGGTR 154 (323)
Q Consensus 94 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~~~~~~~~~~~~~~Ei~~l~~l~~~~i~~~~ 154 (323)
..-.+.|..|---+.|+.... .|+ +++|+.... ...+.+..|+.++..+...++..+.
T Consensus 20 ~~~~~~i~~G~~N~ny~v~t~-~g~-yVLri~~~~-~~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 20 LTSYKGIAEGVENSNFLLHTT-KDP-LILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp EEEEEEECC---EEEEEEEES-SCC-EEEEEECC----CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred ceEeecCCCCcccCeEEEEEC-CCc-EEEEEcCCC-CCHHHHHHHHHHHHhhhhccccccc
Confidence 444567778888889998654 344 889988643 2334566788899999888764433
|